Citrus Sinensis ID: 002146
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 960 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | yes | no | 0.946 | 0.974 | 0.584 | 0.0 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.281 | 0.328 | 0.644 | 1e-100 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.286 | 0.213 | 0.429 | 8e-65 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.262 | 0.392 | 0.466 | 5e-63 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.271 | 0.378 | 0.439 | 5e-61 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.263 | 0.337 | 0.449 | 4e-60 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.281 | 0.294 | 0.430 | 2e-59 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.270 | 0.156 | 0.359 | 2e-56 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.314 | 0.185 | 0.353 | 3e-55 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.272 | 0.158 | 0.436 | 3e-53 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1024 bits (2648), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 563/963 (58%), Positives = 693/963 (71%), Gaps = 54/963 (5%)
Query: 1 MRNIFKKLHIGSNHES-NRTNETLASTTSCATDHNRTSSSSS--NAAPPS-----PSASA 52
M++IFKKLH G N E NRTN+ + +D NR S++ A P S P A A
Sbjct: 1 MKHIFKKLHRGGNQEQQNRTNDA-----APPSDQNRIHVSANPPQATPSSVTETLPVAGA 55
Query: 53 ATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL-N 111
++ +SPAP +S +R DYM+SEEE+QVQLA+AISAS+S + EK QIRAATLLSL +
Sbjct: 56 TSSMASPAPTAAS-NRADYMSSEEEYQVQLALAISASNSQSSEDPEKHQIRAATLLSLGS 114
Query: 112 NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHL 171
++R D RD ++V A+ LSRQYWEY VLDYEE+VVD FYD+Y LSTD + QG++PSL L
Sbjct: 115 HQRMDSRRDSSEVVAQRLSRQYWEYGVLDYEEKVVDSFYDVYSLSTDSAKQGEMPSLEDL 174
Query: 172 ESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPV 231
ESN G GFE V+VNR ID +L EL+++A+CIAL T V +LVQ+LA+LV HMGG
Sbjct: 175 ESNHGTPGFEAVVVNRPIDSSLHELLEIAECIALGCSTTSVSVLVQRLAELVTEHMGGSA 234
Query: 232 KDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGS 291
+D++I+LARW E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGS
Sbjct: 235 EDSSIVLARWTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGS 294
Query: 292 HYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRT 351
HYTG EDDAVN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P +
Sbjct: 295 HYTGNEDDAVNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQF 354
Query: 352 SNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGI 411
SND PK EGSS +S + S L+ + +E+ +S S+P S
Sbjct: 355 SNDV------PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSP 406
Query: 412 SSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLN 471
SS + Q + SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLN
Sbjct: 407 SSVTSSTQLENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLN 460
Query: 472 PFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYM 531
PFQ KGA K + + V++F + NP+ GR P PMM KN + NE P++KE SY+
Sbjct: 461 PFQNKGADKLYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYI 519
Query: 532 EGILPKINREPN-NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
E +LPK++R+P N +S +TSS++ + +N+ +D+ + + S
Sbjct: 520 ENLLPKLHRDPRYGNTQSSYATSSSNGAIS---------SNVHGRDNVTFVSPVAVPSSF 570
Query: 591 ASSTSQLNGPPLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRF-MGTN 640
S+ +Q P +VED++ N+ +E P ++ E HD RK T D G +
Sbjct: 571 TSTENQFR-PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCD 629
Query: 641 LKLRDLESPSSSVDSSTSKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSSYGEVYHADW 698
+L+D ES SSS+DS++ + D Q+ DD DV ECEIPW DLV+ ERIGLGS YGEVYHADW
Sbjct: 630 PRLKDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGS-YGEVYHADW 688
Query: 699 NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758
+GTEVAVKKFLDQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPR
Sbjct: 689 HGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPR 748
Query: 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 818
GSL+RILHRP +DE+RRIKMALDVA GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV
Sbjct: 749 GSLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKV 808
Query: 819 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 878
DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW
Sbjct: 809 GDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWR 868
Query: 879 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938
GMNPMQVVGAVGFQNRRLEIPKELDP+V RII ECWQTDP+LRPSFAQLT LKPL RLV
Sbjct: 869 GMNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLV 928
Query: 939 IPS 941
+P+
Sbjct: 929 LPT 931
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 366 bits (939), Expect = e-100, Method: Compositional matrix adjust.
Identities = 176/273 (64%), Positives = 215/273 (78%), Gaps = 3/273 (1%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
+ +IPW DL + E+IG GS +G V+ A+W+G++VAVK ++QDF + EF REV IM+
Sbjct: 543 DMDIPWCDLNIKEKIGAGS-FGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 601
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARG 787
RLRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA DVA+G
Sbjct: 602 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
MN LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPE
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 721
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
VLR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 722 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 781
Query: 908 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940
II CW +P RPSFA + L+PL + +P
Sbjct: 782 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 814
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (636), Expect = 8e-65, Method: Compositional matrix adjust.
Identities = 122/284 (42%), Positives = 181/284 (63%), Gaps = 9/284 (3%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEV 703
+D + P ++ + +V++ F E E+P ++ +G RIG G YG+V+ W GTEV
Sbjct: 822 KDHQFPVPTIPAKIIEVEKPF-----EWEVPLSEIAIGARIGRGG-YGQVFRGSWRGTEV 875
Query: 704 AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFR 763
AVK + + + + + ++EV ++ +LRHPN+VLFMGA T P + I+TE+L RGSL
Sbjct: 876 AVKMLFNDNVNLKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLAN 935
Query: 764 ILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823
IL ++D R+++ D ARGM LH+ P I+HRDLK+ NLLVD +W VKV+DFGL
Sbjct: 936 ILLDESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGL 995
Query: 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 883
+ +K +TF +K+ GT W+APEVL E EK DVYS+ ++LWEL T +P+ G N M
Sbjct: 996 ATVKSHTF--AKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTM 1053
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
QVV ++ + RL +P P A ++ CW+TDP+ RPSF ++
Sbjct: 1054 QVVRSID-RGERLPMPAWCPPKYAALMNRCWETDPTHRPSFPEI 1096
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (620), Expect = 5e-63, Method: Compositional matrix adjust.
Identities = 119/255 (46%), Positives = 167/255 (65%), Gaps = 3/255 (1%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
+I + +G RIG G+ YGEVY W G++VAVKK + + L EF RE+ +M+ L
Sbjct: 368 DIDIHQIKIGVRIGKGN-YGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNL 426
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
RHPNV+ F+G+ PP++ I TE++PRGSL+ ILH Q+ IKM +D A+G+ L
Sbjct: 427 RHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYL 486
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
H STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR+
Sbjct: 487 HNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRS 544
Query: 852 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
+ EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R +P+ P +++
Sbjct: 545 QRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLI 604
Query: 912 ECWQTDPSLRPSFAQ 926
+C +PS RP+ Q
Sbjct: 605 DCLNENPSHRPTMEQ 619
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (603), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 116/264 (43%), Positives = 169/264 (64%), Gaps = 3/264 (1%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
+I + + +G RIG G+ +GEVY W G++VAVKK + + L EF RE+ +M+ L
Sbjct: 385 DIDTQQIKIGVRIGKGN-FGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNL 443
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
RHPNV+ F+G+ P++ I TE++PRGSL+ ILH ++ +M +D A+G+ L
Sbjct: 444 RHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYL 503
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
H STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR+
Sbjct: 504 HGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRS 561
Query: 852 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
+ EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R PK P +++
Sbjct: 562 QRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLK 621
Query: 912 ECWQTDPSLRPSFAQLTVALKPLQ 935
+C +PS RP+ Q L+ ++
Sbjct: 622 DCLNENPSQRPTMEQCLEILESIE 645
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 4e-60, Method: Compositional matrix adjust.
Identities = 119/265 (44%), Positives = 163/265 (61%), Gaps = 12/265 (4%)
Query: 677 DLVLGERIGLGSSYGEVYHADWNGTEVAVKKFL-----DQDFSGAALLEFKREVKIMRRL 731
++V+ RIG GS EV+ W G VA+KK D+DF L E +E IM +L
Sbjct: 490 EIVVQNRIGRGSC-AEVFTGTWRGIIVAIKKAKLLNEDDEDF----LNELAQEATIMSQL 544
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
RHPN+ F+G PP + I+ E++P GSL+RILH P +D R MALD+A+GMN L
Sbjct: 545 RHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGMNYL 604
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVL 849
H P ++HRDLKS NLLVD+++ VK+SDFGLS KH ++ + GTP W APEVL
Sbjct: 605 HCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTAPEVL 664
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909
RN+P EK DV+SF ++LWE+ T + P+ GM Q+V +VG R +P ++ R+
Sbjct: 665 RNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPFTRL 724
Query: 910 IWECWQTDPSLRPSFAQLTVALKPL 934
I ECW DP RPSF ++ L+ +
Sbjct: 725 ITECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (590), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 120/279 (43%), Positives = 178/279 (63%), Gaps = 9/279 (3%)
Query: 650 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKF- 708
S SV S+ Q F D EI + +L + ++G G+ +G VY W G+ VA+K+
Sbjct: 638 SGSVVEPPSQQQQYFSD----IEISFSELKISSKLGEGT-FGVVYKGLWRGSSVAIKQIK 692
Query: 709 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 768
+++D + L EF++E+ I+ RLRHPN+VL M A T PPNL ITE+LP GSL+ LH
Sbjct: 693 INEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSK 752
Query: 769 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828
+++ + K+A+ +A+GMN LH S ++HRD+KS NLL+D++ NVK+ DFGLS+LK
Sbjct: 753 KIKMNMQLYKKLAIQIAQGMNYLHLS--GVIHRDIKSLNLLLDEHMNVKICDFGLSKLKS 810
Query: 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 888
+ +KS G+P WM+PE+L E EK DVY+FG+ILWEL T +LP+ G++ +Q+ A
Sbjct: 811 KSTEMTKSI-GSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALA 869
Query: 889 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
V ++ R IP ++ +I CW DP RPSF ++
Sbjct: 870 VTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEI 908
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 221 bits (564), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 95/264 (35%), Positives = 172/264 (65%), Gaps = 4/264 (1%)
Query: 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI 727
+C I ++++ +GE+IGLGS YG VY W +VA+KKF+ Q LL + E+
Sbjct: 1389 LCSWVINYDEIKMGEQIGLGS-YGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAF 1447
Query: 728 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 787
+++L HPN++ +GA + PN+ I+TE++ +G+L + +++ ++IK+ +++A+G
Sbjct: 1448 LKKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKG 1507
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
++ LH+ P I+HRD+K N+L+D+NWNVK++DFG +R+K + ++ GTP W APE
Sbjct: 1508 ISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR--CGTPCWTAPE 1565
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
++RN+ +EK DV+SFG+++WE+ T K P+IG N M++ + ++ R +IP++ A
Sbjct: 1566 IIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFA 1624
Query: 908 RIIWECWQTDPSLRPSFAQLTVAL 931
+++ +CW + RP+ + + L
Sbjct: 1625 KLMRKCWHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 115/325 (35%), Positives = 185/325 (56%), Gaps = 23/325 (7%)
Query: 625 YHDRRKCTHDRFMG--TNLKLRDLESPSSSVDSSTSKVDQIFDDD--------------- 667
Y + + +RF G T + D ++ S + D S +I D D
Sbjct: 1294 YEIKFEILKNRFFGGITYVNYND-DTDSGTADDSNYDSGKIIDIDYMADIDKEDSFLTSA 1352
Query: 668 -VCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 726
+C I ++++ +G++IGLGS YG V++ W G +VAVKKF+ Q S LLEF+ E+
Sbjct: 1353 NMCRWIINYDEISIGKQIGLGS-YGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMA 1411
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
+ L+H N+V F+GA + PN+ I+TE++ G+L +L P ++ ++K+ A
Sbjct: 1412 FLSELKHSNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAM 1471
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846
G++ LH+S P IVHRD+K N+LVD+++NVK++DFG +R+K + ++ + GTP W AP
Sbjct: 1472 GIDYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAP 1529
Query: 847 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906
EV+R E EK DV+SFGV++WE+ T K P+ N M+V + + R IP +
Sbjct: 1530 EVIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDI-LEGGRPIIPSDCPHEF 1588
Query: 907 ARIIWECWQTDPSLRPSFAQLTVAL 931
A++I +CW RP+ ++ L
Sbjct: 1589 AKLIKKCWHAKAHKRPTMTEVVQQL 1613
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 120/275 (43%), Positives = 168/275 (61%), Gaps = 13/275 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
E E+ + +L E +G G S GEV+ A W GTEVAVKK ++ + + A FK+E+ M
Sbjct: 785 EWEVDFHELDFMESLGSGGS-GEVFKAMWKGTEVAVKKLVNSNITKDAERNFKQEIHRMT 843
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGM 788
LRHPNVVLFM A TRPPN+ I+ EF+ GSL+ +L + ++ RI++A A+GM
Sbjct: 844 SLRHPNVVLFMAASTRPPNMCIVMEFMSLGSLYDLLGNELVTEIPPVLRIRIAYQAAKGM 903
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS---TAGTPEWMA 845
+ LH+S IVHRDLKS NLL+D WNVKVSDFGL+++K N S + + + +W A
Sbjct: 904 HFLHSS--DIVHRDLKSLNLLLDSKWNVKVSDFGLTKIKDNNKGKSSTKEDSVCSIQWTA 961
Query: 846 PEVL--RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
PEVL + + DVYSFG+I+WEL T P+IG++P + AV N R EI +E
Sbjct: 962 PEVLSEKQDIDYILADVYSFGIIMWELMTRLRPYIGLSPAAIAVAVIRDNLRPEIQEEDI 1021
Query: 904 PLVA----RIIWECWQTDPSLRPSFAQLTVALKPL 934
L++ ++ CW D +RPSF ++ L L
Sbjct: 1022 NLMSSDYVELVNICWHKDTMIRPSFLEIMTKLSTL 1056
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 960 | ||||||
| 224125544 | 967 | predicted protein [Populus trichocarpa] | 0.982 | 0.975 | 0.682 | 0.0 | |
| 224130772 | 955 | predicted protein [Populus trichocarpa] | 0.963 | 0.968 | 0.684 | 0.0 | |
| 359487849 | 955 | PREDICTED: serine/threonine-protein kina | 0.969 | 0.974 | 0.679 | 0.0 | |
| 255542402 | 958 | map3k delta-1 protein kinase, putative [ | 0.965 | 0.967 | 0.676 | 0.0 | |
| 356535135 | 930 | PREDICTED: serine/threonine-protein kina | 0.937 | 0.967 | 0.654 | 0.0 | |
| 229335619 | 913 | EDR1 [Glycine max] | 0.937 | 0.985 | 0.655 | 0.0 | |
| 356576743 | 932 | PREDICTED: serine/threonine-protein kina | 0.937 | 0.965 | 0.651 | 0.0 | |
| 262213688 | 871 | EDR1 [Glycine max] | 0.884 | 0.974 | 0.650 | 0.0 | |
| 449435758 | 935 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.951 | 0.976 | 0.634 | 0.0 | |
| 298204924 | 876 | unnamed protein product [Vitis vinifera] | 0.892 | 0.978 | 0.641 | 0.0 |
| >gi|224125544|ref|XP_002319612.1| predicted protein [Populus trichocarpa] gi|222857988|gb|EEE95535.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1311 bits (3394), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 672/984 (68%), Positives = 781/984 (79%), Gaps = 41/984 (4%)
Query: 1 MRNIFKKLHIGSNHES--NRTNETLASTTSCAT-----DHNRTSSSSSNAAPPSPSASAA 53
M++IFKKLHIGSNHES NRT+ A++ S D +++ +S A+PP S S A
Sbjct: 1 MKHIFKKLHIGSNHESSPNRTSNETATSASSPPPSGSSDQRASATINSPASPPLTSPSPA 60
Query: 54 TAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLN-- 111
T A + TDY TSEEEFQVQLA+AISAS+S D +EKDQIRAATLLSL
Sbjct: 61 TTVQPSA----ISNLTDYFTSEEEFQVQLALAISASNSEFRDDTEKDQIRAATLLSLGGG 116
Query: 112 NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHL 171
N R D+ R+K + E +SR YWEYNVLDY E+V+DGFYD+ L T + QGK+PSL L
Sbjct: 117 NNRVDVDREKGEEKVEDMSRYYWEYNVLDYGEKVMDGFYDV--LCTSSAVQGKMPSLTDL 174
Query: 172 ESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPV 231
E+N +SGFE VIVNR ID LEEL+Q+AQCIALD PAT+V +LVQQLA+LV GHMGGPV
Sbjct: 175 ETNASSSGFEAVIVNRKIDPTLEELMQIAQCIALDCPATNVAVLVQQLAELVTGHMGGPV 234
Query: 232 KDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGS 291
KDAN++LA+W+ERS+ELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLVKGS
Sbjct: 235 KDANLILAKWIERSSELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLVKGS 294
Query: 292 HYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRT 351
HYTG+EDDAVNIIKL++EREFLVDLMAAPGTLIPAD+ SAKD+ FK IP LR+
Sbjct: 295 HYTGIEDDAVNIIKLKDEREFLVDLMAAPGTLIPADVPSAKDSTFK--------IPSLRS 346
Query: 352 SNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGI 411
+ND+G V+++P PL EG+SQ+S+VDG P N SE AESLP F S + G SSG+
Sbjct: 347 TNDTGVVFTRPNPLPGEGTSQSSSVDGISPFNSRLNSENAESLPFFSGSSSDAGVGSSGV 406
Query: 412 SSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
+++ P NQ +SS+ IGTS+YKG RG +AVGDG RMNVNVVPYG EDSK+LF+DL
Sbjct: 407 ANKAAPTNQFGNISSTAIGTSVYKGSRGGHAVGDGVRMNVNVVPYGPNSPEDSKNLFSDL 466
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK+ +H P E+K+ EF + NPV G PP P++ KN++ YNEVPR+KE
Sbjct: 467 NPFQIKGTGKSFMHHKPVENKINEFPGRKNNPVPG-PPAPLVWKNRYAYNEVPRRKENEL 525
Query: 531 MEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
+EG+ P+INREPNN + ASTSS SE P FK S++ N S+K+S++R+ S +L
Sbjct: 526 VEGLYPRINREPNNYNQSLASTSS-SEKVYPQGFKSSSNFNPSNKESDTRNYASSVSSAL 584
Query: 591 ASSTSQLNGPPLVEDLSSNSKDE---NPKNV-----------EDHEIGYHDRRKCTHDRF 636
+S SQ P VE+ +SN K+ + KN+ ED+EI +HDRRKCT+DRF
Sbjct: 585 SSDPSQCYSFPSVEEANSNFKENKLWDAKNLQNDSEAMAKEHEDNEIDFHDRRKCTYDRF 644
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHA 696
MGTNLKL+D ESPS+SVD + +VDQI DD EI WEDL++GERIGLGS YGEVYHA
Sbjct: 645 MGTNLKLKDPESPSASVDPISHRVDQIMDDVDVGDEICWEDLIIGERIGLGS-YGEVYHA 703
Query: 697 DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 756
DWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFL
Sbjct: 704 DWNGTEVAVKKFLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 763
Query: 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 816
PRGSL+RILHRP CQ+DEKRRI+MALDVARGMNCLH S PTIVHRDLKSPNLLVDKNW V
Sbjct: 764 PRGSLYRILHRPQCQIDEKRRIRMALDVARGMNCLHASIPTIVHRDLKSPNLLVDKNWTV 823
Query: 817 KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 876
KV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELAT++LP
Sbjct: 824 KVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATIRLP 883
Query: 877 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
W GMNPMQVVGAVGFQNRRLEIPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQR
Sbjct: 884 WSGMNPMQVVGAVGFQNRRLEIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQR 943
Query: 937 LVIPSHPDQPSSALPQEISVNSTP 960
LVIPSH DQPS L QEI+VNSTP
Sbjct: 944 LVIPSHLDQPSPPLQQEIAVNSTP 967
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130772|ref|XP_002328373.1| predicted protein [Populus trichocarpa] gi|222838088|gb|EEE76453.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1288 bits (3332), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 663/968 (68%), Positives = 768/968 (79%), Gaps = 43/968 (4%)
Query: 1 MRNIFKKLHIGSNHES--NRTNE--------TLASTTSCATDHNRTSSSSSNAAPPSPSA 50
M++IFKKLHIGSN+ES NRT+ SC++DH + +S A PPS S
Sbjct: 1 MKHIFKKLHIGSNNESSPNRTSNDTATSASTPPPPPPSCSSDHRAAGTGNSPANPPSTSP 60
Query: 51 SAATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL 110
S AT A ++ G+RTDY SEE+FQVQLA+AISAS+S D +EKDQIRAATLLSL
Sbjct: 61 SPATTAQP----LAFGNRTDYFASEEDFQVQLALAISASNSEFRDDTEKDQIRAATLLSL 116
Query: 111 N--NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSL 168
N R D+GR+K + E LSR YWEYNVLDY ERV+DGFYD++ T + QGK+PSL
Sbjct: 117 GGGNNRIDVGREKGEGKVEDLSRYYWEYNVLDYGERVMDGFYDVF--CTSSAVQGKMPSL 174
Query: 169 AHLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMG 228
LE+N G SGFE VIVNR +D ALEEL+Q+AQCIALD ATDV ILVQQLA+LV GHMG
Sbjct: 175 MDLETNAGGSGFEAVIVNRKVDPALEELMQIAQCIALDWLATDVTILVQQLAELVTGHMG 234
Query: 229 GPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLV 288
GPVKDAN++LA+WM+RSTELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLV
Sbjct: 235 GPVKDANLILAKWMDRSTELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLV 294
Query: 289 KGSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPI 348
KGSHYTG+EDDAVNIIKLE+EREFLVDLMAAPGTLIPAD+ SAKDT FK IP
Sbjct: 295 KGSHYTGIEDDAVNIIKLEDEREFLVDLMAAPGTLIPADVPSAKDTTFK--------IPA 346
Query: 349 LRTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAAS 408
R SN++G V+++ KPL EG+SQNS+VDG PL+ SE AESLPSF S G S
Sbjct: 347 PR-SNETGVVFARSKPLTGEGTSQNSSVDGISPLDRILCSENAESLPSFSGSSNNAGVGS 405
Query: 409 SGISSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLF 467
SG+S++ P NQ ++S+ GTS+YKG RG +A+GDG RMNVNVVPY EDSK+LF
Sbjct: 406 SGVSNKTAPTNQLGNIASTAFGTSVYKGSRGVHAIGDGLRMNVNVVPYVPNTSEDSKNLF 465
Query: 468 ADLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKE 527
ADLNPFQIKG GK+ +H P E+K+ EFQ + NPV PP P+M KN+ YNEVPR+K+
Sbjct: 466 ADLNPFQIKGTGKSFMHNKPAENKINEFQGRKNNPVPS-PPAPLMWKNRFAYNEVPRRKD 524
Query: 528 YSYMEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSG 587
+EG+ P+INREPNN +S +++S SE P FK S++ N S+++S++R++ S +
Sbjct: 525 NDNVEGLYPRINREPNNYNHSSLASTSLSEKVYPQGFKSSSNLNTSNRESDTRNSASSAS 584
Query: 588 PSLASSTSQLNGPPLVEDLSSNSKDE--NPKNV-----------EDHEIGYHDRRKCTHD 634
L+S T+Q P VE+++SN +++ + KN+ ED+EIG+HDRRKC HD
Sbjct: 585 SELSSYTNQGYSLPSVEEVNSNFEEKLWDAKNLQNDMEASVKESEDNEIGFHDRRKCIHD 644
Query: 635 RFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVY 694
RFMGTNLKL+ ESPS+SVDSST +VD+I DD EI WEDLV GERIGLGS YGEVY
Sbjct: 645 RFMGTNLKLKGPESPSTSVDSSTHRVDRILDDVDVGDEICWEDLVFGERIGLGS-YGEVY 703
Query: 695 HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754
HADWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITE
Sbjct: 704 HADWNGTEVAVKKFLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITE 763
Query: 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814
FLPRGSL+RILHRP CQ+DEKRRIKMALDVARGMNCLH STPTIVHRDLKSPNLLVD+NW
Sbjct: 764 FLPRGSLYRILHRPQCQIDEKRRIKMALDVARGMNCLHASTPTIVHRDLKSPNLLVDENW 823
Query: 815 NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 874
VKV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK
Sbjct: 824 TVKVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 883
Query: 875 LPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
PW GMNPMQVVGAVGFQNRRLEIPKE+DPLVARIIWECWQTDP+LRPSFA+L VAL PL
Sbjct: 884 SPWSGMNPMQVVGAVGFQNRRLEIPKEVDPLVARIIWECWQTDPNLRPSFAELAVALMPL 943
Query: 935 QRLVIPSH 942
QRLV+PSH
Sbjct: 944 QRLVVPSH 951
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487849|ref|XP_002271755.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1285 bits (3325), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/984 (67%), Positives = 776/984 (78%), Gaps = 53/984 (5%)
Query: 1 MRNIFKKLHIGSN-HESNRTNETLASTTS----CATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKKLHIGS+ H+ NR+NETL+S T+ CA+DH RTSS+ S+ +PPS S T
Sbjct: 1 MKHIFKKLHIGSSSHDPNRSNETLSSATTSSPACASDH-RTSSAQSSVSPPSSYPSPTT- 58
Query: 56 ASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRS 115
FQVQLA+AISAS+S+ D SEKDQIRAATLLSL R+
Sbjct: 59 ----------------------FQVQLALAISASNSDFRDDSEKDQIRAATLLSLGRHRT 96
Query: 116 DLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESNL 175
D RDK D +AE +SR+YW+YNVLDYEE+VVDGFYD+YGLSTDP QGK+PSL LE+NL
Sbjct: 97 DSVRDK-DESAESMSRRYWDYNVLDYEEKVVDGFYDVYGLSTDPVIQGKMPSLTDLETNL 155
Query: 176 GNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDAN 235
GNSGFEV++VNR ID ALEELVQVA CIALD PA +VG+LVQ+LA++V HMGGPV+DAN
Sbjct: 156 GNSGFEVIVVNRRIDPALEELVQVAHCIALDCPAAEVGVLVQRLAEIVTDHMGGPVRDAN 215
Query: 236 IMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTG 295
IML +WME +LR SL TS+LP+GS++IGLSRHRALLFK+LAD++ +PCRLVKGSHYTG
Sbjct: 216 IMLVKWMESRKDLRTSLHTSILPVGSLSIGLSRHRALLFKILADNVGVPCRLVKGSHYTG 275
Query: 296 VEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDS 355
VEDDAVNIIKL+ EREFLVDLM APGTLIPADILSAKD++ K YNP +SKIP L+ S D
Sbjct: 276 VEDDAVNIIKLDNEREFLVDLMGAPGTLIPADILSAKDSSLKSYNPKLSKIPTLQASKDP 335
Query: 356 GAVYSKPKPLHA--EGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISS 413
G VYS+PKPL EGSSQ ST++ SLP + ++SEK ESL SF S S + G +S IS
Sbjct: 336 GGVYSRPKPLLGDYEGSSQTSTIENSLPQDRKASSEKIESLDSFSSSSGDTGVGTSRISK 395
Query: 414 RVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNP 472
RVTP NQSD S IG S+YKG RG NAVGDG+RMNVN+VPY Q ED K+LFADLNP
Sbjct: 396 RVTPVNQSDLRPSLAIGASVYKGSRGANAVGDGSRMNVNIVPYNQNSTEDPKNLFADLNP 455
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
FQ+ G+ K S P E+KV+EFQ + + GRPP+P+M KN++ NEVPRKKE ++E
Sbjct: 456 FQMIGSSKASAQSKPMENKVDEFQREKNSAAPGRPPLPLMWKNRYANNEVPRKKENDFVE 515
Query: 533 GILPKINREPNN-NL-STSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
G+ PKINRE N+ NL S +++ ++TSE FK S +A +++K ++ +++ + L
Sbjct: 516 GLFPKINRETNDYNLPSLTSNNATTSEKVYSGVFKLSGNAYMNNKVNDDQNSSCNTTSML 575
Query: 591 ASSTSQLNGPPLVEDLSSNSKDENPKN-----------VEDH---EIGYHDRRKCTHDRF 636
A STSQ N L ED+++N ++ K+ ++H E G HD RK HD F
Sbjct: 576 APSTSQFNRLSLDEDVNANYNEKYHKDGKVFQSDMVDAAKEHDKNETGLHDHRKFRHDSF 635
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHA 696
M NL R+ ESP SSVDS KVDQ+F+D V ECEIPWEDLVLGERIGLGS YGEVYH
Sbjct: 636 MENNL--REAESPCSSVDSDAGKVDQMFED-VGECEIPWEDLVLGERIGLGS-YGEVYHG 691
Query: 697 DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 756
DWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFL
Sbjct: 692 DWNGTEVAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 751
Query: 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 816
PRGSL+RILHRP CQ+DEKRRIKMALDVA+GMNCLHTS PTIVHRDLKSPNLLVDKNWNV
Sbjct: 752 PRGSLYRILHRPSCQIDEKRRIKMALDVAKGMNCLHTSLPTIVHRDLKSPNLLVDKNWNV 811
Query: 817 KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 876
KV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE SNEKCDVYSFG+ILWELATL+LP
Sbjct: 812 KVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNENSNEKCDVYSFGIILWELATLRLP 871
Query: 877 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
W GMNPMQVVGAVGFQNRRL+IPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQR
Sbjct: 872 WSGMNPMQVVGAVGFQNRRLDIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQR 931
Query: 937 LVIPSHPDQPSSALPQEISVNSTP 960
LVIP H DQ S L QEISVNSTP
Sbjct: 932 LVIPQHLDQQSLTLQQEISVNSTP 955
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542402|ref|XP_002512264.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223548225|gb|EEF49716.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1271 bits (3289), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 670/991 (67%), Positives = 780/991 (78%), Gaps = 64/991 (6%)
Query: 1 MRNIFKKLHIGSNHESN-RTNETLASTTSCATDHNRTSSSSSNAAPPSPSASAATAASSP 59
M++IFKKLHIGS HE N R NET + + SC++DH RTSS
Sbjct: 1 MKHIFKKLHIGSGHEPNHRPNETPSPSQSCSSDH-RTSS--------------------- 38
Query: 60 APVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPE--DFSEKDQIRAATLLSL----NNR 113
V + S +S E++Q+QLA+A+SAS+SN E + E DQIRAATLLSL NN
Sbjct: 39 --VNAPASPPSTSSSPEDYQIQLALALSASASNSEFREDHENDQIRAATLLSLGGNHNNH 96
Query: 114 ------RSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPS 167
R D+ R+K ++AAE LSRQYWEYNVLDYEE+V+DGFYD++ S P Q K+PS
Sbjct: 97 THNPTHRIDMPRNKGELAAEALSRQYWEYNVLDYEEKVMDGFYDVF--SRSPVVQAKMPS 154
Query: 168 LAHLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHM 227
L LE+N G+S FE V++NR +DHALEELVQVAQCIALD PATDVGILVQ+LA++V GHM
Sbjct: 155 LTELETNPGSSSFEAVVINRAMDHALEELVQVAQCIALDCPATDVGILVQRLAEVVTGHM 214
Query: 228 GGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRL 287
GGPVKDANIMLARWMERST+LR+SL TS LPIGSI+IGLSRHRALLFKVLAD+IR PCRL
Sbjct: 215 GGPVKDANIMLARWMERSTDLRKSLHTSALPIGSIDIGLSRHRALLFKVLADNIRFPCRL 274
Query: 288 VKGSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIP 347
VKGSHYTG+EDDA+NIIKLE+EREFLVDLMA PGTLIPAD+LSAKDT FK YNP I+ I
Sbjct: 275 VKGSHYTGIEDDAINIIKLEDEREFLVDLMADPGTLIPADVLSAKDTTFKSYNPNINIIA 334
Query: 348 ILRTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAA 407
L++ N+S +Y++ P EGSSQNS++DGSLPL+ S++E AESL SF S G
Sbjct: 335 GLQSPNESEIIYTRSSPSFGEGSSQNSSMDGSLPLDRRSSNETAESLASFSGASSNVGVG 394
Query: 408 SSGISSRV-TPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSL 466
SSG S+V + NQ +SS IG YKGGRG +AV D RMNVNV+PYGQ EDS++L
Sbjct: 395 SSGGPSKVASSNQHGNISSLAIG---YKGGRGTHAVADAVRMNVNVIPYGQNSLEDSRNL 451
Query: 467 FADLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKK 526
F+DLNPFQIKG GK+ +H P E+KVE+F + N + GRPP P+ KN++ YNEVPRKK
Sbjct: 452 FSDLNPFQIKGTGKSFMHNKPAENKVEDFHGQKDNLLPGRPPAPLKWKNRYAYNEVPRKK 511
Query: 527 EYSYMEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALS 584
EY Y+EG+ P I+REPN N S ++S+S+ SE P S+ +N SS+D ++ ++ S
Sbjct: 512 EYDYIEGLFPGISREPNGYNQSSLASSSSTMSEKVYPQGLNSSSSSNTSSRDGDAWNSSS 571
Query: 585 GSGPSLASSTSQLNGPPLVEDLSSNSKDENPKNV--------------EDHEIGYHDRRK 630
G+ +LAS +Q LVE+ +S+ K E+P++ E++EIG+ DRRK
Sbjct: 572 GTNSALASGMNQCYKSSLVEEANSDFK-ESPRDAKNFQNDAEVTIRDDENNEIGFQDRRK 630
Query: 631 CTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSS 689
CTHDRFMG NLKL+ ES SSS+DS +KVDQIFDD DV ECEIPWEDL LGERIGLGS
Sbjct: 631 CTHDRFMGINLKLK--ESSSSSIDSGKNKVDQIFDDVDVGECEIPWEDLDLGERIGLGS- 687
Query: 690 YGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749
YGEVYHADWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNL
Sbjct: 688 YGEVYHADWNGTEVAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNL 747
Query: 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 809
SII+EFLPRGSL+RILHRPHCQ+DEKRRIKMALDVARGMNCLH+S PTIVHRDLKSPNLL
Sbjct: 748 SIISEFLPRGSLYRILHRPHCQIDEKRRIKMALDVARGMNCLHSSIPTIVHRDLKSPNLL 807
Query: 810 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 869
VDKNWNVKV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE
Sbjct: 808 VDKNWNVKVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 867
Query: 870 LATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 929
LATL+LPW GMNPMQVVGAVGFQNRRLEIPK++DP VA IIW+CWQ+DP+ RPSFA+LT
Sbjct: 868 LATLRLPWSGMNPMQVVGAVGFQNRRLEIPKDIDPKVAMIIWQCWQSDPNARPSFAELTT 927
Query: 930 ALKPLQRLVIPSHPDQPSSALPQEISVNSTP 960
ALKPLQRLVIPSH DQPSS L QEISVNSTP
Sbjct: 928 ALKPLQRLVIPSHLDQPSSPLQQEISVNSTP 958
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535135|ref|XP_003536104.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1198 bits (3099), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 637/973 (65%), Positives = 739/973 (75%), Gaps = 73/973 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLAS--TTSCATDHNRTSSSSSNAAPPSPSASAATAAS- 57
M+NIFKKLHIGS+H+ +R+NE S + SC D +++S+++ + + ++++ +
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEASPSVPSPSCVADQSQSSAATPASPSSASASASTVVVTP 77
Query: 58 -----SPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNN 112
+PV++ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 78 GGGGGGASPVMN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGG 134
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE
Sbjct: 135 HRIDSARNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLE 193
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
+N G G E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVK
Sbjct: 194 ANPG--GSELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVK 248
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
DA+IMLARW E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSH
Sbjct: 249 DASIMLARWTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSH 308
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTGVEDDAVNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++
Sbjct: 309 YTGVEDDAVNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPST 366
Query: 353 NDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSG 410
D+ YS+P +P H EGSSQNS V D SLP NG EK+E PS S + G S
Sbjct: 367 KDNEFSYSRPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSK 424
Query: 411 ISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
I ++ TPNQ + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADL
Sbjct: 425 IPNKGTPNQLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADL 483
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK
Sbjct: 484 NPFQIKGMGKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRK----- 538
Query: 531 MEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
N PN N ++ SS SE + S KP ++NI++ +
Sbjct: 539 -------TNHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQ 582
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
+LA T ++ P HD+R CT+DRFMG+NLKL+D ES
Sbjct: 583 TLAQVTGSVSPP------------------------NHDQRNCTYDRFMGSNLKLKDPES 618
Query: 649 PSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKK 707
PSSS+DS T++VDQI DD DV ECEIPWEDLVLGERIG+GS YGEVYHADWNGTEVAVKK
Sbjct: 619 PSSSIDSITNRVDQILDDVDVGECEIPWEDLVLGERIGIGS-YGEVYHADWNGTEVAVKK 677
Query: 708 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 767
FLDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHR
Sbjct: 678 FLDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHR 737
Query: 768 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827
P+CQ+DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLK
Sbjct: 738 PNCQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLK 797
Query: 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 887
HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVG
Sbjct: 798 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVG 857
Query: 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPS 947
AVGFQNRRL+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPS+ DQ +
Sbjct: 858 AVGFQNRRLDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSYQDQLA 917
Query: 948 SALPQEISVNSTP 960
+PQEISVNSTP
Sbjct: 918 PPMPQEISVNSTP 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|229335619|gb|ACQ57002.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1197 bits (3096), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 638/973 (65%), Positives = 740/973 (76%), Gaps = 73/973 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLAS--TTSCATDHNRTSSSSSNAAPPSPSASAATAAS- 57
M+NIFKKLHIGS+H+ +R+NE S + SC D +++S+++ + + ++++ +
Sbjct: 1 MKNIFKKLHIGSSHDPHRSNEASPSVPSPSCVADQSQSSAATPASPSSASASASTVVVTP 60
Query: 58 -----SPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNN 112
+PV++ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 61 GGGGGGASPVMN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGG 117
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE
Sbjct: 118 HRIDSARNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLE 176
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
+N G G E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVK
Sbjct: 177 ANPG--GSELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVK 231
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
DA+IMLARW E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSH
Sbjct: 232 DASIMLARWTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSH 291
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTGVEDDAVNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++
Sbjct: 292 YTGVEDDAVNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPST 349
Query: 353 NDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSG 410
D+ YS+P +P H EGSSQNS V D SLP NG EK+E PS S + G S
Sbjct: 350 KDNEFSYSRPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSK 407
Query: 411 ISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
I ++ TPNQ + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADL
Sbjct: 408 IPNKGTPNQLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADL 466
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK +H P E+K E +S + VSGRPP+P+M KN+H YNE PRK
Sbjct: 467 NPFQIKGMGKAPVHNKPVENKPPELKSTKNYAVSGRPPVPLMWKNRHAYNEDPRK----- 521
Query: 531 MEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
N PN N ++ SS SE + S KP ++NI++ +
Sbjct: 522 -------TNHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINNDVN----------- 563
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
A + +Q+ G +P N HD+R CT+DRFMG+NLKL+D ES
Sbjct: 564 --AQTLAQVTG------------SVSPPN--------HDQRNCTYDRFMGSNLKLKDPES 601
Query: 649 PSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKK 707
PSSS+DS T++VDQI DD DV ECEIPWEDLVLGERIG+GS YGEVYHADWNGTEVAVKK
Sbjct: 602 PSSSIDSITNRVDQILDDVDVGECEIPWEDLVLGERIGIGS-YGEVYHADWNGTEVAVKK 660
Query: 708 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 767
FLDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHR
Sbjct: 661 FLDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHR 720
Query: 768 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827
P+CQ+DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLK
Sbjct: 721 PNCQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLK 780
Query: 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 887
HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVG
Sbjct: 781 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVG 840
Query: 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPS 947
AVGFQNRRL+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPSH DQ +
Sbjct: 841 AVGFQNRRLDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSHHDQVA 900
Query: 948 SALPQEISVNSTP 960
+PQEISVNSTP
Sbjct: 901 PPMPQEISVNSTP 913
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576743|ref|XP_003556489.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1187 bits (3071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 635/975 (65%), Positives = 730/975 (74%), Gaps = 75/975 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLASTTS--CATDHNRTSSSSSNAAPPSPS--------A 50
M+NIFKKLHIGS+H+ +R+NE S CATD +++S+++ + +
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEPSPPVPSPSCATDQSQSSAATPPSPSSASPSPSPSTLVV 77
Query: 51 SAATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL 110
+ + +PVV+ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 78 TPSCGGGGASPVVN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSL 134
Query: 111 NNRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAH 170
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS
Sbjct: 135 GGHRIDSTRNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTD 193
Query: 171 LESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGP 230
LE+N G G E+VIVN+TID ALEEL+Q+AQCIALD P V LVQ+LA+LV HMGGP
Sbjct: 194 LEANPG--GSELVIVNQTIDPALEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGP 248
Query: 231 VKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKG 290
VKDA IMLARW E ELR SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRL+KG
Sbjct: 249 VKDAGIMLARWTETRAELRTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLLKG 308
Query: 291 SHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILR 350
SHYTGVEDDAVNIIKLE EREFLVDLMAAPGTLIPADILS KD+AFK YNP I +P L
Sbjct: 309 SHYTGVEDDAVNIIKLEGEREFLVDLMAAPGTLIPADILSTKDSAFKSYNPKI--LPSLP 366
Query: 351 TSNDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAAS 408
++ D+ YS+P +P H EGSSQNS + D SLP NG EK+E PS S E G
Sbjct: 367 STKDNEFSYSRPIQPFHGEGSSQNSVIKDYSLPWNGKPYFEKSE--PSNLGLSRESGTGP 424
Query: 409 SGISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFA 468
S I ++ TPNQ D L + + G SLYKG G N VGDG R+NVNVVPY DS++LFA
Sbjct: 425 SKIPNKGTPNQLDNLPALS-GASLYKGTLGMNTVGDGTRLNVNVVPYTNISPNDSRNLFA 483
Query: 469 DLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEY 528
DLNPFQIKG GK +H P E+K E +S + N VSGRPP+P+M KN+ YNE PRK
Sbjct: 484 DLNPFQIKGMGKAPVHNKPVENKPPELKSTKNNTVSGRPPVPLMWKNRPAYNEDPRK--- 540
Query: 529 SYMEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGS 586
N PN N ++ SSTSEN + S KP ++NI++ +
Sbjct: 541 ---------TNHNPNDYNPPLFVSNGSSTSENIDLSSSKPLYNSNINN---------DVN 582
Query: 587 GPSLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDL 646
+LA T ++ P HD+RKCT+DRFMG+NLKL+D
Sbjct: 583 AQTLAQVTGSVSPP------------------------NHDQRKCTYDRFMGSNLKLKDP 618
Query: 647 ESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAV 705
ESPSSS+DS T+++D I DD DV ECEIPWEDLVLGERIG+GS YGEVYHADWNGTEVAV
Sbjct: 619 ESPSSSIDSITNRIDPILDDVDVGECEIPWEDLVLGERIGIGS-YGEVYHADWNGTEVAV 677
Query: 706 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL 765
KKFLDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RIL
Sbjct: 678 KKFLDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRIL 737
Query: 766 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825
HR + Q+DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSR
Sbjct: 738 HRSNYQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSR 797
Query: 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 885
LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW MN MQV
Sbjct: 798 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSEMNTMQV 857
Query: 886 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 945
VGAVGFQNRRL+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPSH DQ
Sbjct: 858 VGAVGFQNRRLDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSHHDQ 917
Query: 946 PSSALPQEISVNSTP 960
+ +PQEISVNSTP
Sbjct: 918 VAPPMPQEISVNSTP 932
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|262213688|gb|ACY36006.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1180 bits (3052), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/965 (65%), Positives = 712/965 (73%), Gaps = 116/965 (12%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLASTTSCATDHNRTSSSSSNAAPPSPSASAATAASSPA 60
M+NIFKKLHIGS+H+ +R+NE SPS
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEA------------------------SPS----------- 42
Query: 61 PVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRSDLGRD 120
D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL R D R+
Sbjct: 43 ---------DFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGGHRIDSARN 93
Query: 121 KADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESNLGNSGF 180
K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE+N G G
Sbjct: 94 KDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLEANPG--GS 150
Query: 181 EVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLAR 240
E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVKDA+IMLAR
Sbjct: 151 ELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVKDASIMLAR 207
Query: 241 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 300
W E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSHYTGVEDDA
Sbjct: 208 WTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSHYTGVEDDA 267
Query: 301 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 360
VNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++ D+ YS
Sbjct: 268 VNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPSTKDNEFSYS 325
Query: 361 KP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPN 418
+P +P H EGSSQNS V D SLP NG EK + G S I ++ TPN
Sbjct: 326 RPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEK------------DSGVGPSKIPNKGTPN 373
Query: 419 QSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGA 478
Q + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADLNPFQIKG
Sbjct: 374 QLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADLNPFQIKGM 432
Query: 479 GKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKI 538
GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK
Sbjct: 433 GKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRK------------T 480
Query: 539 NREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ 596
N PN N ++ SS SE + S KP ++NI++ + +LA T
Sbjct: 481 NHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQTLAQVTGS 531
Query: 597 LNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSS 656
++ P HD+R CT+DRFMG+NLKL+D ESPSSS+DS
Sbjct: 532 VSPP------------------------NHDQRNCTYDRFMGSNLKLKDPESPSSSIDSI 567
Query: 657 TSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSG 715
T++VDQI DD DV ECEIPWEDLVLGERIG+GS YGEVYHADWNGTEVAVKKFLDQDFSG
Sbjct: 568 TNRVDQILDDVDVGECEIPWEDLVLGERIGIGS-YGEVYHADWNGTEVAVKKFLDQDFSG 626
Query: 716 AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK 775
AAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP+CQ+DEK
Sbjct: 627 AALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRPNCQIDEK 686
Query: 776 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835
RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHNTFLSSK
Sbjct: 687 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHNTFLSSK 746
Query: 836 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 895
STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGAVGFQNRR
Sbjct: 747 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGAVGFQNRR 806
Query: 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEIS 955
L+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPS+ DQ + +PQEIS
Sbjct: 807 LDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSYQDQLAPPMPQEIS 866
Query: 956 VNSTP 960
VNSTP
Sbjct: 867 VNSTP 871
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435758|ref|XP_004135661.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1178 bits (3047), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 623/982 (63%), Positives = 741/982 (75%), Gaps = 69/982 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNE-----TLASTTSCATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKK HIGSNHE NR+NE AS++ C +D NR + + + PP+
Sbjct: 1 MKHIFKKFHIGSNHEPNRSNENPSPVAAASSSPCVSD-NRGGNVTQVSVPPN-------- 51
Query: 56 ASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRS 115
R+DY +SEEEFQVQLA+AISAS+S+ D EKDQIRAATLLSL N R
Sbjct: 52 ------------RSDYFSSEEEFQVQLALAISASNSDFRDDPEKDQIRAATLLSLGNHRI 99
Query: 116 D-LGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESN 174
D RD+ D AAEVLSRQYWEYNVLDYEE+VV+GFYD+ LSTD + QGK+PSL+ +E++
Sbjct: 100 DSTARDQGD-AAEVLSRQYWEYNVLDYEEKVVNGFYDV--LSTDSAVQGKIPSLSDIEAS 156
Query: 175 LGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDA 234
G+SGFEVV+VN TID ALEELVQ+AQCIA D P T+V +LVQ+LA+LV GHMGGPVKDA
Sbjct: 157 FGSSGFEVVMVNMTIDPALEELVQIAQCIA-DCPGTEVRVLVQRLAELVMGHMGGPVKDA 215
Query: 235 NIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYT 294
+ MLARWMERSTELR SL TSVLPIGSINIGLSRHRALLFKVLADSI++PCRLVKGSHYT
Sbjct: 216 HFMLARWMERSTELRTSLHTSVLPIGSINIGLSRHRALLFKVLADSIKMPCRLVKGSHYT 275
Query: 295 GVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTA-FKPYNPLISKIPILRTSN 353
GVE+DAVNIIKLE+EREFLVDLMAAPGTL+PADI +AKDT FKPYNP +S+IP L SN
Sbjct: 276 GVEEDAVNIIKLEDEREFLVDLMAAPGTLLPADIFNAKDTTNFKPYNPKVSRIPSLHHSN 335
Query: 354 DSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISS 413
D G +KP EGSSQN + ++G + ES+PS SSG++
Sbjct: 336 DVGISSAKPTSGLEEGSSQNFGAEAISLMDGKLGYGRTESVPS-----------SSGVTC 384
Query: 414 RVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDG-ARMNVNVVPYGQTGQEDSKSLFADLNP 472
+ + LS GTS YKG GDG R+NVNVVP+GQ+ EDSK+LFADLNP
Sbjct: 385 XINSRLMENLSLLGTGTSRYKGAH----FGDGNVRLNVNVVPFGQS-SEDSKNLFADLNP 439
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
F I+G GK+ + +++K EE Q P G PP+P+ KN+ +N VP K EY YME
Sbjct: 440 FLIRGTGKSFIPNKFSDNKSEELQK----PTIGHPPVPLW-KNRFAFNAVPNKNEYDYME 494
Query: 533 GILPKINREPNN-NLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLA 591
G P+I+R PN+ N++ S+S S+ SE+ P SND + S + +E S+ S A
Sbjct: 495 GRFPRISRGPNDQNMALSSSNSTGSESVKPGGSGTSNDLSASVRSAEVGSSSSNMYAQPA 554
Query: 592 SSTSQLNGPPLVEDLSSNSKDENPKNVE------------DHEIGYHDRRKCTHDRFMGT 639
+ N P +++ + S E+ N + D+ I + +RRK T++R +GT
Sbjct: 555 FGMMEPNILPFIDEQNRKSNGEHSGNTDMEDEKVDAVDGRDNLIRFDNRRKFTYERSVGT 614
Query: 640 NLKLRDLESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSSYGEVYHADW 698
NL L+D +P V+ S+++ +Q++DD DV +CEI WEDLV+GERIGLGS YGEVYHADW
Sbjct: 615 NLILKDSGNPGLLVNPSSNRFEQVYDDVDVGQCEIQWEDLVIGERIGLGS-YGEVYHADW 673
Query: 699 NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758
N TEVAVKKFLDQDFSGAAL EFKREV IMR+LRHPN+VLFMGAVTRPPNLSI+TEFLPR
Sbjct: 674 NDTEVAVKKFLDQDFSGAALAEFKREVLIMRQLRHPNIVLFMGAVTRPPNLSIVTEFLPR 733
Query: 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 818
GSL+RI+HRP+CQ+DEKRRIKMALDVARGMNCLHTS PTIVHRDLKSPNLLVDKNWNVKV
Sbjct: 734 GSLYRIIHRPNCQIDEKRRIKMALDVARGMNCLHTSNPTIVHRDLKSPNLLVDKNWNVKV 793
Query: 819 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 878
SDFGLSRLKHNTFLSSKST GTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELATL+LPW
Sbjct: 794 SDFGLSRLKHNTFLSSKSTGGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATLRLPWS 853
Query: 879 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938
GMNPMQVVGAVGF+N+RLEIPKE+DP VARIIWECWQTDP+LRPSF+QL LKPLQRLV
Sbjct: 854 GMNPMQVVGAVGFRNQRLEIPKEVDPTVARIIWECWQTDPNLRPSFSQLANILKPLQRLV 913
Query: 939 IPSHPDQPSSALPQEISVNSTP 960
+P H DQPSS++ QEISVNSTP
Sbjct: 914 LPPHSDQPSSSVLQEISVNSTP 935
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204924|emb|CBI34231.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1163 bits (3008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 620/967 (64%), Positives = 714/967 (73%), Gaps = 110/967 (11%)
Query: 1 MRNIFKKLHIGSN-HESNRTNETLASTTS----CATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKKLHIGS+ H+ NR+NETL+S T+ CA+DH RTSS+ S+ +PPS S T
Sbjct: 1 MKHIFKKLHIGSSSHDPNRSNETLSSATTSSPACASDH-RTSSAQSSVSPPSSYPSPTTV 59
Query: 56 ASSPAPVV------SSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLS 109
+S+ A + ++ +R+DY SEEEFQVQLA+AISAS+S+ D SEKDQIRAATLLS
Sbjct: 60 SSTAASTLPTATSPAASNRSDYFLSEEEFQVQLALAISASNSDFRDDSEKDQIRAATLLS 119
Query: 110 LNNRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLA 169
L R+D RDK D +AE +SR+YW+YNVLDYEE+VVDGFYD+YGLSTDP QGK+PSL
Sbjct: 120 LGRHRTDSVRDK-DESAESMSRRYWDYNVLDYEEKVVDGFYDVYGLSTDPVIQGKMPSLT 178
Query: 170 HLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGG 229
LE+NLGNSGFEV++VNR ID ALEELVQVA CIALD PA +VG+LVQ+LA++V HMGG
Sbjct: 179 DLETNLGNSGFEVIVVNRRIDPALEELVQVAHCIALDCPAAEVGVLVQRLAEIVTDHMGG 238
Query: 230 PVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVK 289
PV+DANIML +WME +LR SL TS+LP+GS++IGLSRHRALLFK+LAD++ +PCRLVK
Sbjct: 239 PVRDANIMLVKWMESRKDLRTSLHTSILPVGSLSIGLSRHRALLFKILADNVGVPCRLVK 298
Query: 290 GSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPIL 349
GSHYTGVEDDAVNIIKL+ EREFLVDLM APGTLIPADILSAKD+
Sbjct: 299 GSHYTGVEDDAVNIIKLDNEREFLVDLMGAPGTLIPADILSAKDS--------------- 343
Query: 350 RTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASS 409
SSQ ST++ SLP + ++SEK ESL SF S S + G +S
Sbjct: 344 --------------------SSQTSTIENSLPQDRKASSEKIESLDSFSSSSGDTGVGTS 383
Query: 410 GISSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFA 468
IS RVTP NQSD S IG S+YKG RG NAVGDG+RMNVN+VPY Q ED K+LFA
Sbjct: 384 RISKRVTPVNQSDLRPSLAIGASVYKGSRGANAVGDGSRMNVNIVPYNQNSTEDPKNLFA 443
Query: 469 DLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEY 528
DLNPFQ+ G+ K S P E+KV+EFQ + S P
Sbjct: 444 DLNPFQMIGSSKASAQSKPMENKVDEFQREK---NSAAP--------------------- 479
Query: 529 SYMEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
+N + N++ +T++ + ++ FN S +AN + K
Sbjct: 480 ---------VNDDQNSSCNTTSMLAPSTSQFNRLSLDEDVNANYNEK------------- 517
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
+G D+ +K E+ KN E G HD RK HD FM N LR+ ES
Sbjct: 518 ------YHKDGKVFQSDMVDAAK-EHDKN----ETGLHDHRKFRHDSFMENN--LREAES 564
Query: 649 PSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKF 708
P SSVDS KVDQ+F +DV ECEIPWEDLVLGERIGLG SYGEVYH DWNGTEVAVKKF
Sbjct: 565 PCSSVDSDAGKVDQMF-EDVGECEIPWEDLVLGERIGLG-SYGEVYHGDWNGTEVAVKKF 622
Query: 709 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 768
LDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL+RILHRP
Sbjct: 623 LDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLYRILHRP 682
Query: 769 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828
CQ+DEKRRIKMALDVA+GMNCLHTS PTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKH
Sbjct: 683 SCQIDEKRRIKMALDVAKGMNCLHTSLPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKH 742
Query: 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 888
NTFLSSKSTAGTPEWMAPEVLRNE SNEKCDVYSFG+ILWELATL+LPW GMNPMQVVGA
Sbjct: 743 NTFLSSKSTAGTPEWMAPEVLRNENSNEKCDVYSFGIILWELATLRLPWSGMNPMQVVGA 802
Query: 889 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 948
VGFQNRRL+IPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQRLVIP H DQ S
Sbjct: 803 VGFQNRRLDIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQRLVIPQHLDQQSL 862
Query: 949 ALPQEIS 955
L QEIS
Sbjct: 863 TLQQEIS 869
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 960 | ||||||
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.948 | 0.976 | 0.562 | 1.1e-266 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.294 | 0.321 | 0.757 | 2.4e-179 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.298 | 0.278 | 0.714 | 1e-170 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.286 | 0.277 | 0.717 | 7.6e-161 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.281 | 0.328 | 0.644 | 3.1e-125 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.286 | 0.355 | 0.600 | 1.2e-88 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.276 | 0.360 | 0.612 | 1.1e-87 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.285 | 0.358 | 0.593 | 2.9e-87 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.263 | 0.377 | 0.621 | 1e-84 | |
| TAIR|locus:2052786 | 775 | AT2G31010 [Arabidopsis thalian | 0.261 | 0.323 | 0.480 | 3.2e-83 |
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2565 (908.0 bits), Expect = 1.1e-266, P = 1.1e-266
Identities = 541/961 (56%), Positives = 654/961 (68%)
Query: 1 MRNIFKKLHIGSNHES-NRTNETLASTTSCATDHNRXXXXXX------XXXXXXXXXXXX 53
M++IFKKLH G N E NRTN+ A+ S D NR
Sbjct: 1 MKHIFKKLHRGGNQEQQNRTND--AAPPS---DQNRIHVSANPPQATPSSVTETLPVAGA 55
Query: 54 XXXXXXXXXXXXGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL-NN 112
+R DYM+SEEE+QVQLA+AISAS+S + EK QIRAATLLSL ++
Sbjct: 56 TSSMASPAPTAASNRADYMSSEEEYQVQLALAISASNSQSSEDPEKHQIRAATLLSLGSH 115
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
+R D RD ++V A+ LSRQYWEY VLDYEE+VVD FYD+Y LSTD + QG++PSL LE
Sbjct: 116 QRMDSRRDSSEVVAQRLSRQYWEYGVLDYEEKVVDSFYDVYSLSTDSAKQGEMPSLEDLE 175
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
SN G GFE V+VNR ID +L EL+++A+CIAL T V +LVQ+LA+LV HMGG +
Sbjct: 176 SNHGTPGFEAVVVNRPIDSSLHELLEIAECIALGCSTTSVSVLVQRLAELVTEHMGGSAE 235
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
D++I+LARW E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGSH
Sbjct: 236 DSSIVLARWTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGSH 295
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTG EDDAVN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P + S
Sbjct: 296 YTGNEDDAVNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQFS 355
Query: 353 NDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGIS 412
ND PK EGSS +S + S L+ + +E+ +S S+P S S
Sbjct: 356 NDV------PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSPS 407
Query: 413 SRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNP 472
S + Q + SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLNP
Sbjct: 408 SVTSSTQLENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLNP 461
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
FQ KGA K + + V++F + NP+ GR P PMM KN + NE P++KE SY+E
Sbjct: 462 FQNKGADKLYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYIE 520
Query: 533 GILPKINREPNNNLXXXXXXXXXXENFNPHSFKPSNDANISSKDXXXXXXXXXXXXXXXX 592
+LPK++R+P ++ S + +N+ +D
Sbjct: 521 NLLPKLHRDPRYG--------NTQSSYATSSSNGAISSNVHGRDNVTFVSPVAVPSSFTS 572
Query: 593 XXXQLNGPPLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRFM-GTNLK 642
Q P +VED++ N+ +E P ++ E HD RK T D G + +
Sbjct: 573 TENQFR-PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCDPR 631
Query: 643 LRDLEXXXXXXXXXXXKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG 700
L+D E + D Q+ DD DV ECEIPW DLV+ ERIGLGS YGEVYHADW+G
Sbjct: 632 LKDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGS-YGEVYHADWHG 690
Query: 701 TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760
TEVAVKKFLDQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPRGS
Sbjct: 691 TEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGS 750
Query: 761 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 820
L+RILHRP +DE+RRIKMALDVA GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV D
Sbjct: 751 LYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGD 810
Query: 821 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 880
FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GM
Sbjct: 811 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGM 870
Query: 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940
NPMQVVGAVGFQNRRLEIPKELDP+V RII ECWQTDP+LRPSFAQLT LKPL RLV+P
Sbjct: 871 NPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVLP 930
Query: 941 S 941
+
Sbjct: 931 T 931
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1140 (406.4 bits), Expect = 2.4e-179, Sum P(2) = 2.4e-179
Identities = 215/284 (75%), Positives = 247/284 (86%)
Query: 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 726
+ + EI WEDL +GERIG+GS YGEVY A+WNGTEVAVKKFLDQDFSG AL +FK E++
Sbjct: 598 EAAKWEIMWEDLQIGERIGIGS-YGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIE 656
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
IM RLRHPNVVLFMGAVTRPPN SI+TEFLPRGSL+R+LHRP+ Q+DEKRR++MALDVA+
Sbjct: 657 IMLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAK 716
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846
GMN LHTS PT+VHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGTPEWMAP
Sbjct: 717 GMNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAP 776
Query: 847 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906
EVLRNEP+NEKCDVYSFGVILWELAT ++PW G+NPMQVVGAVGFQNRRLEIP ++D V
Sbjct: 777 EVLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTV 836
Query: 907 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 950
A+II ECWQT+P LRPSF QL +LK LQ L I + + S +
Sbjct: 837 AQIIRECWQTEPHLRPSFTQLMQSLKRLQGLNISNRANTSESLM 880
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 1.0e-170, Sum P(4) = 1.0e-170
Identities = 208/291 (71%), Positives = 249/291 (85%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREV 725
DDV +CEI WE++ +GERIGLGS YGEVY DW+GTEVAVKKFLDQD +G AL EF+ EV
Sbjct: 736 DDVSDCEILWEEITVGERIGLGS-YGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEV 794
Query: 726 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 785
+IM++LRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE+RR++MALD A
Sbjct: 795 RIMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAA 854
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 845
RGMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGT EWMA
Sbjct: 855 RGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMA 914
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
PEVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP +DP
Sbjct: 915 PEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPA 974
Query: 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP---SSALPQE 953
+A +I +CWQTD LRPSFA++ +LK LQ+ V S+ +P SS+LP E
Sbjct: 975 IADLISKCWQTDSKLRPSFAEIMASLKRLQKPVTGSNIPRPVPSSSSLPTE 1025
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1079 (384.9 bits), Expect = 7.6e-161, Sum P(2) = 7.6e-161
Identities = 201/280 (71%), Positives = 240/280 (85%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREV 725
DDV ECEI WE++ + ERIGLGS YGEVY DW+GT VAVKKF+DQD +G AL EF+ EV
Sbjct: 703 DDVAECEILWEEITVAERIGLGS-YGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEV 761
Query: 726 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 785
++MRRLRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE++R++MALD A
Sbjct: 762 RMMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAA 821
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 845
RGMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+K +T+LSSKSTAGT EWMA
Sbjct: 822 RGMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMA 881
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
PEVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP+ +DP
Sbjct: 882 PEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPG 941
Query: 906 VARIIWECWQTDPSLRPSFAQLTVALK----PLQRLVIPS 941
+A II +CWQTDP LRPSF ++ +LK P+QR +PS
Sbjct: 942 IADIIRKCWQTDPRLRPSFGEIMDSLKQLQKPIQRAAVPS 981
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 3.1e-125, Sum P(2) = 3.1e-125
Identities = 176/273 (64%), Positives = 215/273 (78%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
+ +IPW DL + E+IG GS +G V+ A+W+G++VAVK ++QDF + EF REV IM+
Sbjct: 543 DMDIPWCDLNIKEKIGAGS-FGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 601
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARG 787
RLRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA DVA+G
Sbjct: 602 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
MN LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPE
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 721
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
VLR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 722 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 781
Query: 908 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940
II CW +P RPSFA + L+PL + +P
Sbjct: 782 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 814
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 885 (316.6 bits), Expect = 1.2e-88, P = 1.2e-88
Identities = 167/278 (60%), Positives = 213/278 (76%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAAL 718
KVD D + E EI W+DL +GE++G GS G VYH W G++VAVK F Q++S +
Sbjct: 477 KVDT--DSEGLEYEILWDDLTIGEQVGQGSC-GTVYHGLWFGSDVAVKVFSKQEYSAEVI 533
Query: 719 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 778
FK+EV +M+RLRHPNV+LFMGAVT P L I++EFLPRGSLFR+L + ++D +RRI
Sbjct: 534 ESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKLDWRRRI 593
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 838
MALD+ARGMN LH +P I+HRDLKS NLLVDKNW VKV+DFGLSR+KH T+L+SKS
Sbjct: 594 HMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGK 653
Query: 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898
GTP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF ++RLEI
Sbjct: 654 GTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEI 713
Query: 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
PK++DP ++ CW +D LRP+F +L L+ LQR
Sbjct: 714 PKDIDPRWISLMESCWHSDTKLRPTFQELMDKLRDLQR 751
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 876 (313.4 bits), Expect = 1.1e-87, P = 1.1e-87
Identities = 163/266 (61%), Positives = 205/266 (77%)
Query: 671 CEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
CEI WEDL LGE +G GS + V+ WNG++VA+K + D D++ L E K+E+ IM++
Sbjct: 461 CEIRWEDLQLGEEVGRGS-FAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKK 519
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 790
LRHPNV+LFMGAV +II E++PRGSLF+ILH + +D+KRR++MALDVARGMN
Sbjct: 520 LRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRMALDVARGMNY 579
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 850
LH P IVHRDLKS NLLVDKNWNVKV DFGLS+ K+ TFLS+KS GTP+WMAPEVLR
Sbjct: 580 LHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLR 639
Query: 851 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910
+EPSNEKCDV+SFGVILWEL T +PW +N +QVVG VGF +RRL++P+ L+P +A II
Sbjct: 640 SEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPRIASII 699
Query: 911 WECWQTDPSLRPSFAQLTVALKPLQR 936
+CWQTDP+ RPSF +L + L R
Sbjct: 700 QDCWQTDPAKRPSFEELISQMMSLFR 725
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 165/278 (59%), Positives = 208/278 (74%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAAL 718
KVD D D + EI WEDL +GE+IG GS G VYH W G++VAVK F Q++S +
Sbjct: 470 KVDM--DSDCLDYEILWEDLTIGEQIGQGSC-GTVYHGLWFGSDVAVKVFSKQEYSEEII 526
Query: 719 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 778
FK+EV +M+RLRHPNV+LFMGAV P L I+TEFLPRGSLFR+L R ++D +RRI
Sbjct: 527 TSFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRI 586
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 838
MA D+ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L++
Sbjct: 587 HMASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNGR- 645
Query: 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898
GTP+WMAPEVLRNE ++EK DVYSFGV+LWEL T K+PW +N MQV+GAVGF N+RLE+
Sbjct: 646 GTPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEV 705
Query: 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
PK++DP ++ CW ++P RPSF +L L+ LQR
Sbjct: 706 PKDVDPQWIALMESCWHSEPQCRPSFQELMDKLRELQR 743
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 848 (303.6 bits), Expect = 1.0e-84, P = 1.0e-84
Identities = 159/256 (62%), Positives = 199/256 (77%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAAL 718
KVD D D E EI W+DL +GE+IG GS G VYH W G++VAVK F Q++S + +
Sbjct: 417 KVD--IDSDPLEHEILWDDLTIGEQIGRGSC-GTVYHGIWFGSDVAVKVFSKQEYSESVI 473
Query: 719 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 778
F++EV +M+RLRHPNV+LFMGAVT P L I++EF+PRGSLFR+L R ++D +RRI
Sbjct: 474 KSFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKLDWRRRI 533
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 838
MALD+ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L+SKS
Sbjct: 534 NMALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGK 593
Query: 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898
GTP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF N+RLEI
Sbjct: 594 GTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEI 653
Query: 899 PKELDPLVARIIWECW 914
PK+ DP +I CW
Sbjct: 654 PKDTDPDWISLIESCW 669
|
|
| TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 3.2e-83, Sum P(3) = 3.2e-83
Identities = 125/260 (48%), Positives = 181/260 (69%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
E +I + +L +G R+G+G +GEV+ WNGT+VA+K FL+QD + + +F E+ I+
Sbjct: 511 EWDIDFSELTVGTRVGIGF-FGEVFRGVWNGTDVAIKLFLEQDLTAENMEDFCNEISILS 569
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARG 787
R+RHPNVVLF+GA T+PP LS+ITE++ GSL+ ++H ++ RR++M D+ RG
Sbjct: 570 RVRHPNVVLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRRLRMLRDICRG 629
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
+ C+H IVHRDLKS N LVDK+W VK+ DFGLSR+ + + S+AGTPEWMAPE
Sbjct: 630 LMCIHRMK--IVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSSAGTPEWMAPE 687
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
++RN P EKCD++S GVI+WEL+TL+ PW G+ P +VV AV + RLEIP PL +
Sbjct: 688 LIRNRPFTEKCDIFSLGVIMWELSTLRKPWEGVPPEKVVFAVAHEGSRLEIPD--GPL-S 744
Query: 908 RIIWECWQTDPSLRPSFAQL 927
++I +CW +P RP+ ++
Sbjct: 745 KLIADCW-AEPEERPNCEEI 763
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9FPR3 | EDR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5846 | 0.9468 | 0.9742 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| eugene3.00130329 | SubName- Full=Putative uncharacterized protein; (967 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 960 | |||
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 4e-99 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-72 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-70 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-68 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-63 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-61 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-55 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-49 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-46 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-44 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-43 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-42 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-42 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-41 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-40 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-39 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-39 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-39 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-38 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-38 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-38 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-37 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-37 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-36 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-35 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-35 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-35 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-35 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-34 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-34 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-34 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-33 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-33 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-33 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-32 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-32 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-32 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-32 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-32 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-31 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-31 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-30 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-30 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-30 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-29 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-29 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-29 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-29 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-29 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-28 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-28 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-28 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-28 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-27 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-27 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-27 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-27 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-26 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-26 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-26 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-25 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-24 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-24 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-24 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-23 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-23 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-22 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-21 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-19 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-19 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-17 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-17 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-16 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 308 bits (792), Expect = 4e-99
Identities = 114/206 (55%), Positives = 146/206 (70%), Gaps = 6/206 (2%)
Query: 123 DVAAEVLSRQYWEYNVLDYEERVVDGFYDIYG--LSTDPSTQGKLPSLAHLES-NLGNSG 179
+AE LS +YW Y L Y++++ DGFYDIYG +D G++PSL L++ G+S
Sbjct: 1 RSSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSS 60
Query: 180 FEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLA 239
FEVV+V+R D L+EL Q+A+C+ T+ LVQ+LA LV+ HMGGPVKDA MLA
Sbjct: 61 FEVVLVDRRTDPKLKELEQLARCLVSGCG-TNTAALVQKLAGLVSDHMGGPVKDAESMLA 119
Query: 240 RWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDD 299
RW E S EL+ + V+P+GS+ IGL RHRALLFKVLADSI LPCRLVKG Y G +DD
Sbjct: 120 RWKECSNELKE--NSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYCGSDDD 177
Query: 300 AVNIIKLEEEREFLVDLMAAPGTLIP 325
A N++K ++ RE+LVDLM APGTLIP
Sbjct: 178 ASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 6e-72
Identities = 99/259 (38%), Positives = 146/259 (56%), Gaps = 14/259 (5%)
Query: 678 LVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
L LG+++G G+ +GEVY G T+VAVK L + S EF E IM++L
Sbjct: 1 LELGKKLGEGA-FGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKL 58
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
HPN+V +G T+ L I+TE++P G L L + ++ K ++MAL +A+GM L
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVL 849
+ VHRDL + N LV +N VK+SDFGLSR + K G P +WMAPE L
Sbjct: 119 ESK--NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 850 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
++ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P+ +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYE 235
Query: 909 IIWECWQTDPSLRPSFAQL 927
++ +CW DP RP+F++L
Sbjct: 236 LMLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 7e-70
Identities = 100/264 (37%), Positives = 141/264 (53%), Gaps = 17/264 (6%)
Query: 678 LVLGERIGLGSSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
L LG+++G G+ +GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGA-FGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKL 58
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
HPNVV +G T L I+ E++ G L L + ++ + AL +ARGM L
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAPEV 848
S +HRDL + N LV +N VK+SDFGLSR ++ G WMAPE
Sbjct: 119 E-SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIRWMAPES 174
Query: 849 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
L+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P P +
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELY 233
Query: 908 RIIWECWQTDPSLRPSFAQLTVAL 931
++ +CW DP RP+F++L L
Sbjct: 234 DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 2e-68
Identities = 99/259 (38%), Positives = 143/259 (55%), Gaps = 14/259 (5%)
Query: 678 LVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
L LG+++G G+ +GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGA-FGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKL 58
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNC 790
HPN+V +G T L I+ E++P G L L + + + + AL +ARGM
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 849
L S +HRDL + N LV +N VK+SDFGLSR ++ P WMAPE L
Sbjct: 119 LE-SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 850 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + + RL P P + +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYK 235
Query: 909 IIWECWQTDPSLRPSFAQL 927
++ +CW DP RP+F++L
Sbjct: 236 LMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 4e-63
Identities = 76/256 (29%), Positives = 124/256 (48%), Gaps = 18/256 (7%)
Query: 680 LGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ E++G GS +G+VY A T VA+K + + RE+KI+++L+HPN+V
Sbjct: 3 ILEKLGEGS-FGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797
L ++ E+ G LF +L + ++ E + + LH+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 798 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 857
IVHRDLK N+L+D++ +VK++DFGL+R + GTPE+MAPEVL + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLGKGYGKA 176
Query: 858 CDVYSFGVILWELATLKLPWIGMNPMQVV------GAVGFQNRRLEIPKELDPLVARIIW 911
D++S GVIL+EL T K P+ G + + + F +I E L+ +
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK--- 233
Query: 912 ECWQTDPSLRPSFAQL 927
DP R + +
Sbjct: 234 -LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 1e-61
Identities = 92/265 (34%), Positives = 137/265 (51%), Gaps = 23/265 (8%)
Query: 686 LGS-SYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
LG ++GEVY G TEVAVK L +D S +F +E ++M++L HPNVV
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ------VDEKRRIKMALDVARGMNCL 791
+G T L ++ E++ G L L RP + K + A+ +A+GM L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAPEV 848
+ VHRDL + N LV ++ VK+SDFGLSR + G WMAPE
Sbjct: 122 ASK--KFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 849 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
L++ K DV+SFGV+LWE+ TL P+ G++ +V+ + + RL P+ +
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDELY 237
Query: 908 RIIWECWQTDPSLRPSFAQLTVALK 932
++ CWQ DP RP+F++L L+
Sbjct: 238 ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 3e-60
Identities = 89/260 (34%), Positives = 136/260 (52%), Gaps = 16/260 (6%)
Query: 678 LVLGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 735
L ++G GS +G VY A GT VAVK + +RE++I+RRL HPN
Sbjct: 1 YELLRKLGSGS-FGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 795
+V + A +L ++ E+ G LF L R + E K+AL + RG+ LH++
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPS 854
I+HRDLK N+L+D+N VK++DFGL++ + S + GTP +MAPEVL
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 855 NEKCDVYSFGVILWELATLKLPW---IGMNPMQVVGAVGFQNRRLEIPKELDPLVAR--- 908
K DV+S GVIL+EL T K P+ ++ +Q++ + LE + +
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL--GPPLEFDEPKWSSGSEEAK 234
Query: 909 -IIWECWQTDPSLRPSFAQL 927
+I +C DPS RP+ ++
Sbjct: 235 DLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-59
Identities = 81/247 (32%), Positives = 123/247 (49%), Gaps = 41/247 (16%)
Query: 686 LGS-SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 742
LG +G VY A G +VA+K ++ S + L E RE++I+++L HPN+V G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 743 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 802
+L ++ E+ GSL +L ++ E +++ L + G+ LH S I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-SNG-IIHRD 117
Query: 803 LKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDV 860
LK N+L+D N VK++DFGLS+L + K+ GTP +MAPEVL + +EK D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 861 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 920
+S GVIL+EL LK +I + Q DP
Sbjct: 178 WSLGVILYELPELK---------------------------------DLIRKMLQKDPEK 204
Query: 921 RPSFAQL 927
RPS ++
Sbjct: 205 RPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 6e-55
Identities = 87/258 (33%), Positives = 133/258 (51%), Gaps = 11/258 (4%)
Query: 677 DLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734
+ GE +G GS +G VY A G +AVK S L +RE++I+ L+HP
Sbjct: 1 EWTRGELLGRGS-FGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHP 59
Query: 735 NVVLFMGA-VTRPPN-LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
N+V + G+ N L+I E++ GSL +L + ++ E K + G+ LH
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLH 118
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLR 850
++ IVHRD+K N+LVD + VK++DFG ++ + + S GTP WMAPEV+R
Sbjct: 119 SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 851 NEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARI 909
E D++S G + E+AT K PW + NPM + +G EIP+ L
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 910 IWECWQTDPSLRPSFAQL 927
+ +C + DP RP+ +L
Sbjct: 237 LRKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 5e-49
Identities = 96/263 (36%), Positives = 142/263 (53%), Gaps = 14/263 (5%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
I ++L LG IG G +G+V D+ G +VAVK D A F E +M L
Sbjct: 2 AINSKELKLGATIGKGE-FGDVMLGDYRGQKVAVKCLKDD---STAAQAFLAEASVMTTL 57
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNC 790
RHPN+V +G V + L I+TE++ +GSL L R + +++ ALDV GM
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 849
L VHRDL + N+LV ++ KVSDFGL++ S K P +W APE L
Sbjct: 118 LEEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWTAPEAL 171
Query: 850 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
R + + K DV+SFG++LWE+ + ++P+ + VV V + R+E P+ P V +
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYK 230
Query: 909 IIWECWQTDPSLRPSFAQLTVAL 931
++ +CW+ DP+ RP+F QL L
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 89/266 (33%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
EIP E L L ++G G +GEV+ WNG T+VAVK S A L+ E +IM++
Sbjct: 2 EIPRESLKLERKLGAGQ-FGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKK 57
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMALD 783
LRH +V + + I+TE++ +GSL L VD MA
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQ 111
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-E 842
+A GM L + +HRDL + N+LV +N K++DFGL+RL + +++ A P +
Sbjct: 112 IAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK 169
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 901
W APE K DV+SFG++L E+ T ++P+ GM +V+ V + R+ P
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPN 228
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQL 927
+ ++ +CW DP RP+F L
Sbjct: 229 CPEELYDLMLQCWDKDPEERPTFEYL 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 4e-46
Identities = 98/268 (36%), Positives = 147/268 (54%), Gaps = 12/268 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
E+ D+ + ++G G YGEVY W VAVK L +D + EF +E +M+
Sbjct: 2 EMERTDITMKHKLG-GGQYGEVYEGVWKKYSLTVAVKT-LKED--TMEVEEFLKEAAVMK 57
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGM 788
++HPN+V +G TR P IITEF+ G+L L + Q V+ + MA ++ M
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPE 847
L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W APE
Sbjct: 118 EYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906
L + K DV++FGV+LWE+AT + P+ G++ QV + + R+E P+ P V
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKV 234
Query: 907 ARIIWECWQTDPSLRPSFAQLTVALKPL 934
++ CWQ +PS RPSFA++ A + +
Sbjct: 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 4e-45
Identities = 79/251 (31%), Positives = 136/251 (54%), Gaps = 9/251 (3%)
Query: 680 LGERIGLGSSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
LG+ IG G+ +G VY + G VA+K+ + AL +E+ +++ L+HPN+V
Sbjct: 4 LGDLIGRGA-FGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797
++G++ +L II E+ GSL +I+ + E V +G+ LH
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLHEQ--G 119
Query: 798 IVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 856
++HRD+K+ N+L K+ VK++DFG++ +L + S GTP WMAPEV+ ++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWMAPEVIEMSGAST 178
Query: 857 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 916
D++S G + EL T P+ +NPM + + Q+ +P+ + P + + +C+Q
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQK 237
Query: 917 DPSLRPSFAQL 927
DP+LRP+ QL
Sbjct: 238 DPNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 74/253 (29%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 684 IGLGSSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
IG GS +G+VY +G +K+ + + AL EVKI+++L HPN++
Sbjct: 8 IGKGS-FGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL----NEVKILKKLNHPNII 62
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQV--DEKRRIKMALDVARGMNCLHTS 794
+ + L I+ E+ G L +I + E++ + + + + LH+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
I+HRD+K N+ + N VK+ DFG+S++ +T +K+ GTP +++PE+ +N+P
Sbjct: 123 K--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 855 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 914
N K D++S G +L+EL TLK P+ G N +++ + IP + + ++
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLL 239
Query: 915 QTDPSLRPSFAQL 927
Q DP RPS AQ+
Sbjct: 240 QKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 86/268 (32%), Positives = 133/268 (49%), Gaps = 29/268 (10%)
Query: 686 LGSS-YGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
LG +G+V ++ G +VAVK L+ +F+RE++I+R L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 739 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ G +P +L +I E+LP GSL L R Q++ KR + + + +GM+ L +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR- 129
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEP 853
+HRDL + N+LV+ VK+SDFGL+++ + + K +P W APE LR
Sbjct: 130 -YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 854 SNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGF--QNRRLEIP 899
+ DV+SFGV L+EL T L++ I M V + + RL P
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
Query: 900 KELDPLVARIIWECWQTDPSLRPSFAQL 927
V ++ CW+ +P RPSFA L
Sbjct: 249 PSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 88/263 (33%), Positives = 133/263 (50%), Gaps = 9/263 (3%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRR 730
E P E+ L ++G G +GEV+ W VA+K L D +F++EV+ ++R
Sbjct: 2 ERPREEFTLERKLGSGY-FGEVWEGLWKNRVRVAIK-ILKSD-DLLKQQDFQKEVQALKR 58
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMN 789
LRH +++ + + IITE + +GSL L P QV I MA VA GM
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
L +HRDL + N+LV ++ KV+DFGL+RL S +W APE
Sbjct: 119 YLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 850 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
+ + K DV+SFG++L+E+ T ++P+ GMN +V + R+ P + + +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYK 235
Query: 909 IIWECWQTDPSLRPSFAQLTVAL 931
I+ ECW +P RPSF L L
Sbjct: 236 IMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 84/262 (32%), Positives = 138/262 (52%), Gaps = 24/262 (9%)
Query: 675 WEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 732
+E L E+IG G +GEVY A G EVA+K + S + E++I+++ +
Sbjct: 2 FEIL---EKIGKGG-FGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCK 55
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDVARGMNCL 791
HPN+V + G+ + L I+ EF GSL +L + Q + +I + ++ +G+ L
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
H++ I+HRD+K+ N+L+ + VK+ DFGLS +T + + GTP WMAPEV+
Sbjct: 115 HSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPEVING 171
Query: 852 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV------VGAVGFQNRRLEIPKELDPL 905
+P + K D++S G+ ELA K P+ + PM+ G G +N P++
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-----PEKWSDE 226
Query: 906 VARIIWECWQTDPSLRPSFAQL 927
+ +C Q +P RP+ QL
Sbjct: 227 FKDFLKKCLQKNPEKRPTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 85/262 (32%), Positives = 130/262 (49%), Gaps = 15/262 (5%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
EI + L ++G G +GEV+ WN T VAVK +F E +IM++
Sbjct: 2 EIDRTSIQLLRKLGAGQ-FGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKK 57
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARG 787
LRHP ++ T + I+TE + GSL L ++ + I MA VA G
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL--IDMAAQVASG 115
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 846
M L +HRDL + N+LV +N KV+DFGL+R +K + + + + +W AP
Sbjct: 116 MAYLEAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
Query: 847 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
E + K DV+SFG++L E+ T ++P+ GM +V+ V Q R+ P
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKE 232
Query: 906 VARIIWECWQTDPSLRPSFAQL 927
+ I+ +CW+ DP RP+F L
Sbjct: 233 LYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 88/281 (31%), Positives = 144/281 (51%), Gaps = 24/281 (8%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E+P E + L +G GS +G VY G T VA+K ++++ S +EF E
Sbjct: 2 ELPREKITLIRELGQGS-FGMVYEGLAKGVVKGEPETRVAIKT-VNENASMRERIEFLNE 59
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP---HCQV----DEK 775
+M+ +VV +G V+ ++ E + +G L L RP + +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 776 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835
+ I+MA ++A GM L VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 836 STAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892
G P WMAPE L++ K DV+SFGV+LWE+ATL + P+ G++ +V+ V
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933
L++P+ + ++ CWQ +P +RP+F ++ +LK
Sbjct: 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 88/255 (34%), Positives = 130/255 (50%), Gaps = 15/255 (5%)
Query: 681 GERIGLGSSYGEVYHADWN---GTEVAVK--KFLDQDFSG-AALLEFKREVKIMRRLRHP 734
GE +G GS +G VY N G AVK D +G A+ + ++E+ ++ +L+HP
Sbjct: 5 GELLGSGS-FGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
N+V ++G NL I E +P GSL ++L + + E + G+ LH
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRNE- 852
VHRD+K N+LVD N VK++DFG++ K S +KS G+P WMAPEV+ +
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
D++S G + E+AT K PW + + V +G IP L I +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 913 CWQTDPSLRPSFAQL 927
C Q DPSLRP+ A+L
Sbjct: 238 CLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 81/273 (29%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKR 723
D+ P E E+IG G+S GEVY A T EVA+KK
Sbjct: 9 KDIVSEGDPRELYKNLEKIGEGAS-GEVYKATDRATGKEVAIKKM---RLRKQNKELIIN 64
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
E+ IM+ +HPN+V + + L ++ E++ GSL I+ + +++E + + +
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCRE 124
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG----LSRLKHNTFLSSKSTAG 839
V +G+ LH+ ++HRD+KS N+L+ K+ +VK++DFG L++ K S G
Sbjct: 125 VLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVVG 178
Query: 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----- 894
TP WMAPEV++ + K D++S G++ E+A + P++ P++ + F
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKGIP 234
Query: 895 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
L+ P++ P + +C DP RPS +L
Sbjct: 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 89/259 (34%), Positives = 142/259 (54%), Gaps = 14/259 (5%)
Query: 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 735
+ L LGE IG G +G V ++ G +VAVK + D + A LE E +M +L H N
Sbjct: 6 QKLTLGEIIGEGE-FGAVLQGEYTGQKVAVKN-IKCDVTAQAFLE---ETAVMTKLHHKN 60
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTS 794
+V +G + L I+ E + +G+L L R V + ++ +LDVA GM +
Sbjct: 61 LVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME--YLE 117
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
+ +VHRDL + N+LV ++ KVSDFGL+R+ +SK +W APE L+++
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKF 174
Query: 855 NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913
+ K DV+S+GV+LWE+ + + P+ M+ +V V + R+E P+ V ++ C
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSC 233
Query: 914 WQTDPSLRPSFAQLTVALK 932
W+T+P RPSF +L L+
Sbjct: 234 WETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 80/257 (31%), Positives = 125/257 (48%), Gaps = 15/257 (5%)
Query: 682 ERIGLGSSYGEVYHADW---NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
+++G GS +G V +W G VAVK L D + +F +E IM L H N+
Sbjct: 1 KKLGDGS-FGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDVARGMNCLHTST 795
+ G V P L ++TE P GSL L + + A+ +A GM L +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+HRDL + N+L+ + VK+ DFGL R + ++ + W APE LR
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 853 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
+ DV+ FGV LWE+ T + PW G++ Q++ + + RLE P+ + ++
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235
Query: 912 ECWQTDPSLRPSFAQLT 928
+CW +P+ RP+FA L
Sbjct: 236 QCWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 85/260 (32%), Positives = 134/260 (51%), Gaps = 14/260 (5%)
Query: 677 DLVLGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 735
+L + +G G +G V+ W G +VA+K + S +F E K+M +L HPN
Sbjct: 5 ELTFLKELGSGQ-FGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPN 60
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 795
+V G T+ + I+TE++ G L L ++ + + M DV M L ++
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN- 119
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
+HRDL + N LV ++ VKVSDFGL+R + + + SS+ T +W PEV
Sbjct: 120 -GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 855 NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIW 911
+ K DV+SFGV++WE+ + K+P+ + +VV +V G+ RL PK V I++
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---RLYRPKLAPTEVYTIMY 235
Query: 912 ECWQTDPSLRPSFAQLTVAL 931
CW P RP+F +L L
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 75/257 (29%), Positives = 130/257 (50%), Gaps = 10/257 (3%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
P E + E++G GS YG VY A G VA+K L E +E+ I+++
Sbjct: 1 PEEVFDILEKLGEGS-YGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQC 55
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
P +V + G+ + +L I+ E+ GS+ I+ + + E+ + +G+ L
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
H++ +HRD+K+ N+L+++ K++DFG+S +T + GTP WMAPEV++
Sbjct: 116 HSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 852 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARII 910
N K D++S G+ E+A K P+ ++PM+ + + + L P++ P +
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233
Query: 911 WECWQTDPSLRPSFAQL 927
+C DP RPS QL
Sbjct: 234 KKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 82/255 (32%), Positives = 134/255 (52%), Gaps = 9/255 (3%)
Query: 682 ERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 740
E+IG G+ +G+VY TEVAVK +F +E +I+++ HPN+V +
Sbjct: 1 EKIGKGN-FGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLI 58
Query: 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 800
G + + I+ E +P GSL L + ++ K+ ++M+LD A GM L + +H
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK--NCIH 116
Query: 801 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKSTAGTP-EWMAPEVLRNEPSNEKC 858
RDL + N LV +N +K+SDFG+SR + + S P +W APE L +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 859 DVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917
DV+S+G++LWE +L P+ GM+ Q + R+ P+ + R++ +CW D
Sbjct: 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYD 235
Query: 918 PSLRPSFAQLTVALK 932
P RPSF+++ L+
Sbjct: 236 PENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 9e-39
Identities = 85/262 (32%), Positives = 139/262 (53%), Gaps = 21/262 (8%)
Query: 680 LGERIGLGSSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
G +IG G+ +G+VY A D G +AVK+ QD + E E+K++ L+HPN+
Sbjct: 4 RGNKIGGGT-FGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-ALDVARGMNCLHTST 795
V + G + I E+ G+L +L H ++ ++ I++ L + G+ LH+
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSH- 118
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNT---FLSSKSTAGTPEWMAPEVLRN 851
IVHRD+K N+ +D N +K+ DFG + +LK+NT +S AGTP +MAPEV+
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 852 EPSNEK---CDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPK--ELDPL 905
D++S G ++ E+AT K PW + N Q++ VG ++ IP +L P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSPE 236
Query: 906 VARIIWECWQTDPSLRPSFAQL 927
+ C ++DP RP+ ++L
Sbjct: 237 GKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 88/257 (34%), Positives = 127/257 (49%), Gaps = 14/257 (5%)
Query: 676 EDLVLGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734
+DL + +G G +G V + W G +VA+K + S EF E K+M +L H
Sbjct: 4 KDLTFLKELGTGQ-FGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHE 59
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLH 792
+V G T+ + I+TE++ G L L H Q + ++M DV GM L
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ--LLEMCKDVCEGMAYLE 117
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 851
+ +HRDL + N LVD VKVSDFGLSR + + + SS + W PEVL
Sbjct: 118 SK--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY 175
Query: 852 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910
+ K DV++FGV++WE+ +L K+P+ N + V V Q RL P V I+
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIM 234
Query: 911 WECWQTDPSLRPSFAQL 927
+ CW RP+F QL
Sbjct: 235 YSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 83/269 (30%), Positives = 132/269 (49%), Gaps = 38/269 (14%)
Query: 676 EDLVLGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
E L E IG GS +GEVY A T VA+K +D + + + + ++E++ + + R
Sbjct: 1 ELFTLLECIGKGS-FGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
P + + G+ + L II E+ GS +L +P ++DE + +V G+ LH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KP-GKLDETYIAFILREVLLGLEYLHE 116
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPE 847
+HRD+K+ N+L+ + +VK++DFG+S K NTF GTP WMAPE
Sbjct: 117 EGK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF------VGTPFWMAPE 168
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
V++ +EK D++S G+ ELA + P ++PM+V+ IPK P +
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLE 219
Query: 908 RIIWE---------CWQTDPSLRPSFAQL 927
+ C DP RPS +L
Sbjct: 220 GNKFSKPFKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 94/265 (35%), Positives = 143/265 (53%), Gaps = 22/265 (8%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
EIP E L L +++G G +GEV+ WNG T+VAVK S + LE E +IM++
Sbjct: 2 EIPRESLQLIKKLGNGQ-FGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKK 57
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK------MALDV 784
LRH +V V+ P + I+TE++ +GSL L + E R +K MA V
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-----KDGEGRALKLPNLVDMAAQV 111
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EW 843
A GM + +HRDL+S N+LV K++DFGL+RL + +++ A P +W
Sbjct: 112 AAGM--AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
APE K DV+SFG++L EL T ++P+ GMN +V+ V + R+ P++
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDC 228
Query: 903 DPLVARIIWECWQTDPSLRPSFAQL 927
+ ++ +CW+ DP RP+F L
Sbjct: 229 PISLHELMLQCWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 90/286 (31%), Positives = 151/286 (52%), Gaps = 31/286 (10%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKRE 724
E+P + L LG+ +G G+ +G+V A+ G + VAVK L D + L + E
Sbjct: 8 ELPRDRLTLGKPLGEGA-FGQVVKAEAVGLDNPNETSTVAVKM-LKDDATEKDLSDLVSE 65
Query: 725 VKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP------------- 768
+++M+ + +H N++ +G T+ L ++ E+ G+L L RP
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 769 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828
+ +K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R H
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 829 NTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQV 885
+ K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEE 242
Query: 886 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931
+ + + R+E P+ + ++ +CW PS RP+F QL L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 89/256 (34%), Positives = 139/256 (54%), Gaps = 16/256 (6%)
Query: 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 735
++L L + IG G +G+V D+ G +VAVK + D + A F E +M +LRH N
Sbjct: 6 KELKLLQTIGKGE-FGDVMLGDYRGNKVAVK-CIKNDATAQA---FLAEASVMTQLRHSN 60
Query: 736 VVLFMGA-VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHT 793
+V +G V L I+TE++ +GSL L R + +K +LDV M L
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNE 852
+ VHRDL + N+LV ++ KVSDFGL++ S++ T P +W APE LR +
Sbjct: 121 NN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREK 174
Query: 853 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
+ K DV+SFG++LWE+ + ++P+ + VV V + +++ P P+V ++
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMK 233
Query: 912 ECWQTDPSLRPSFAQL 927
+CW D + RPSF QL
Sbjct: 234 QCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 84/265 (31%), Positives = 134/265 (50%), Gaps = 17/265 (6%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHAD--WNGTEVAVK--KFLDQDFSGAALLEFKREVKIMR 729
P ED L +RIG G+ YG+VY A G VA+K K D ++E+ +++
Sbjct: 1 PQEDYELIQRIGSGT-YGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLK 55
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
RHPN+V + G+ R L I+ E+ GSL I + E + + + +G+
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
LH + +HRD+K N+L+ ++ +VK++DFG+S T KS GTP WMAPEV
Sbjct: 116 YLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173
Query: 850 ---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV---GAVGFQNRRLEIPKELD 903
R + KCD+++ G+ ELA L+ P ++PM+ + F +L+ ++
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233
Query: 904 PLVARIIWECWQTDPSLRPSFAQLT 928
P+ I +C DP RP+ +L
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 85/266 (31%), Positives = 134/266 (50%), Gaps = 19/266 (7%)
Query: 673 IPWEDLVLGERIGLGSSYGEVYHADWNGT-----EVAVKKFLDQDFSGAALLEFKREVKI 727
I + + + IG G +GEV +VA+K S L+F E I
Sbjct: 1 IDPSYVTIEKVIG-GGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASI 58
Query: 728 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 787
M + HPN++ G VT+ + IITE++ GSL + L + + + M +A G
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TP-EWM 844
M L S VHRDL + N+LV+ N KVSDFGLSR ++ ++ +T G P W
Sbjct: 119 MKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS-EATYTTKGGKIPIRWT 175
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKE 901
APE + DV+SFG+++WE+ + + P+ M+ V+ AV G+ RL P +
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMD 232
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQL 927
+ +++ +CWQ D + RP+F+Q+
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 85/250 (34%), Positives = 128/250 (51%), Gaps = 10/250 (4%)
Query: 686 LGSS-YGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 743
LGS +G V+ W +VA+K + S +F E K+M +L HP +V G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 744 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803
T+ L I+TEF+ G L L + ++ + + M DV GM L + + +HRDL
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN--SFIHRDL 126
Query: 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYS 862
+ N LV VKVSDFG++R + +S S A P +W PEV + K DV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 863 FGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 921
FGV++WE+ T K+P+ + +VV + + RL PK V +++ CW P R
Sbjct: 187 FGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSCWHEKPEGR 245
Query: 922 PSFAQLTVAL 931
P+FA+L A+
Sbjct: 246 PTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 89/289 (30%), Positives = 145/289 (50%), Gaps = 32/289 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
EIP + E +G G+ +G+VY + G T VA+K L ++ EF++E
Sbjct: 1 EIPLSAVRFLEELGEGA-FGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQE 58
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIK 779
++M L+HPN+V +G T+ ++ E+L G L F + + PH V +K
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 780 MALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829
+LD +A GM L S+ VHRDL + N LV + VK+SDFGLSR ++
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
Query: 830 T-FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVV 886
+ +S + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236
Query: 887 GAVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ ++R+ L P++ V ++ ECW P+ RP F + L+
Sbjct: 237 EMI--RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 80/259 (30%), Positives = 124/259 (47%), Gaps = 18/259 (6%)
Query: 680 LGERIGLGSSYGEVY---HADWNGTEVAVKKF-LDQDFSGAA--LLEFKREVKIMRRLRH 733
G+ +G G+ +G VY D G E+AVK+ D D + + E+++++ L+H
Sbjct: 6 RGKLLGQGA-FGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
+V + G + LSI E++P GS+ L + R K + G+ LH+
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHS 122
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLK----HNTFLSSKSTAGTPEWMAPEV 848
+ IVHRD+K N+L D NVK+ DFG S RL+ T + KS GTP WM+PEV
Sbjct: 123 NM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM--KSVTGTPYWMSPEV 178
Query: 849 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
+ E K DV+S G + E+ T K PW M + + Q ++P + P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238
Query: 909 IIWECWQTDPSLRPSFAQL 927
+ + + RPS +L
Sbjct: 239 FLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 28/276 (10%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKRE 724
+ + +VL +G G+ +G+V+ + + VAVK L + S A +F+RE
Sbjct: 1 HVQRDTIVLKRELGEGA-FGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFERE 58
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR-------------PHCQ 771
+++ +H N+V F G T ++ E++ G L + L P +
Sbjct: 59 AELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 772 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 830
+ + +++A+ +A GM L ++ VHRDL + N LV + VK+ DFG+SR + T
Sbjct: 119 LTLSQLLQIAVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176
Query: 831 FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGA 888
+ P WM PE + + DV+SFGV+LWE+ T K PW G++ +V+
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 889 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 924
+ Q R L+ P+ V I+ CW+ DP R +
Sbjct: 237 IT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI 271
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 2e-35
Identities = 90/265 (33%), Positives = 142/265 (53%), Gaps = 12/265 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRR 730
EIP E L L ++G G +GEV+ WNGT VA+K S A L+ E ++M++
Sbjct: 2 EIPRESLRLEVKLGQGC-FGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKK 57
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMN 789
LRH +V V+ P + I+TE++ +GSL L + + + + MA +A GM
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM- 115
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 848
+ VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W APE
Sbjct: 116 -AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 849 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 233
Query: 908 RIIWECWQTDPSLRPSFAQLTVALK 932
++ +CW+ +P RP+F L L+
Sbjct: 234 DLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 80/249 (32%), Positives = 132/249 (53%), Gaps = 8/249 (3%)
Query: 682 ERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 740
E +G G+ +GEV+ + T VAVK +D ++F E +I+++ HPN+V +
Sbjct: 1 ELLGKGN-FGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 800
G T+ + I+ E +P G L + ++ K+ +K ALD A GM + + +H
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGM--AYLESKNCIH 116
Query: 801 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCD 859
RDL + N LV +N +K+SDFG+SR + + SS P +W APE L + + D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 860 VYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 918
V+S+G++LWE +L + P+ GM Q V + R+ P++ V +++ CW P
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKP 235
Query: 919 SLRPSFAQL 927
RP F++L
Sbjct: 236 ENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 5e-35
Identities = 86/265 (32%), Positives = 141/265 (53%), Gaps = 12/265 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
E+P E L L +++G G +GEV+ +NG T+VA+K S A L E +M++
Sbjct: 2 EVPRETLKLVKKLGAGQ-FGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA---EANLMKQ 57
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMN 789
L+HP +V VT+ P + IITE++ GSL L P ++ + I MA +A GM
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 848
+ +HRDL++ N+LV + K++DFGL+RL + +++ A P +W APE
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 849 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
+ K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233
Query: 908 RIIWECWQTDPSLRPSFAQLTVALK 932
++ CW+ P RP+F L L+
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 80/260 (30%), Positives = 129/260 (49%), Gaps = 16/260 (6%)
Query: 682 ERIGLGSSYGEVYHADW---NGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ +G G+ +G V + +G EV V K L Q+ A EF RE +M +L HP +V
Sbjct: 1 KELGHGN-FGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797
+G V + L ++ E P G L + L + ++ ++A VA GM L +
Sbjct: 60 RLIG-VCKGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKH-- 115
Query: 798 IVHRDLKSPN-LLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEP 853
VHRDL + N LLV+++ K+SDFG+SR + + + + P +W APE +
Sbjct: 116 FVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 854 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
+ K DV+S+GV LWE + P+ M +V+ + RL P+E + I+
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLS 233
Query: 913 CWQTDPSLRPSFAQLTVALK 932
CW+ P RP+F++L +
Sbjct: 234 CWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQ-----VDEKR 776
EV I+R L+HPN+V + + N L I+ E+ G L +++ + C+ ++E+
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK--CKKERKYIEEEF 106
Query: 777 RIKMALDVARGMNCLHT---STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833
++ + + H T++HRDLK N+ +D N NVK+ DFGL+++ +
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 893
+K+ GTP +M+PE L + +EK D++S G +++EL L P+ N +Q+ + +
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EG 225
Query: 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ IP + +I DP RPS +L
Sbjct: 226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-34
Identities = 87/257 (33%), Positives = 137/257 (53%), Gaps = 12/257 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRR 730
EIP E L L ++G G +GEV+ WNGT +VA+K A L+ E +IM++
Sbjct: 2 EIPRESLRLDVKLGQGC-FGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ---EAQIMKK 57
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMN 789
LRH +V V+ P + I+TEF+ +GSL L + + + + MA +A GM
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 848
+ +HRDL++ N+LV N K++DFGL+RL + +++ A P +W APE
Sbjct: 117 YIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 849 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P+ +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233
Query: 908 RIIWECWQTDPSLRPSF 924
++ CW+ DP RP+F
Sbjct: 234 ELMKLCWKKDPDERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 89/268 (33%), Positives = 141/268 (52%), Gaps = 18/268 (6%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
EIP E L L +++G G +GEV+ A +N T+VAVK S A L E +M+
Sbjct: 2 EIPRESLKLEKKLGAGQ-FGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA---EANVMKT 57
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMN 789
L+H +V VT+ P + IITEF+ +GSL L + + I + +A GM
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM- 115
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 848
+HRDL++ N+LV + K++DFGL+R+ + +++ A P +W APE
Sbjct: 116 -AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 849 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPKELDP 904
+ K DV+SFG++L E+ T ++P+ GM+ +V+ A+ G++ R E P+EL
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL-- 232
Query: 905 LVARIIWECWQTDPSLRPSFAQLTVALK 932
I+ CW+ P RP+F + L
Sbjct: 233 --YNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 84/257 (32%), Positives = 130/257 (50%), Gaps = 14/257 (5%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734
+L L + IG G +G V+ W +VA+K + S +F E ++M +L HP
Sbjct: 4 SELTLVQEIGSGQ-FGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHP 59
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
+V G T + ++ EF+ G L L + ++ + M LDV GM L +S
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK-HNTFLSSKSTAGTPEWMAPEVLRNEP 853
++HRDL + N LV +N VKVSDFG++R + + SS T +W +PEV
Sbjct: 120 --NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 854 SNEKCDVYSFGVILWEL-ATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARII 910
+ K DV+SFGV++WE+ + K P+ + +VV + GF RL P+ V ++
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---RLYKPRLASQSVYELM 234
Query: 911 WECWQTDPSLRPSFAQL 927
CW+ P RPSF+ L
Sbjct: 235 QHCWKERPEDRPSFSLL 251
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 20/270 (7%)
Query: 686 LGS-SYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
LGS ++G VY W VA+K + + S A E E +M + HP+VV
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 798
+G + + +IT+ +P G L + + + + + +A+GM+ L +
Sbjct: 74 LLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL--EEKRL 130
Query: 799 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNE 856
VHRDL + N+LV +VK++DFGL++L + G P +WMA E + +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 857 KCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 915
K DV+S+GV +WEL T P+ G+ +++ + + RL P V ++ +CW
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMVLVKCWM 249
Query: 916 TDPSLRPSFAQLT-----VALKPLQRLVIP 940
D RP+F +L +A P + LVI
Sbjct: 250 IDAESRPTFKELINEFSKMARDPQRYLVIQ 279
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 87/286 (30%), Positives = 146/286 (51%), Gaps = 30/286 (10%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVY--HADWNGTE----VAVKKFLDQDFSGAALLEFKREV 725
E+P + E +G ++G++Y H G + VA+K D + + EF++E
Sbjct: 1 ELPLSAVRFMEELG-ECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEA 58
Query: 726 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPH----CQVDEKRRIK 779
+M L HPN+V +G VT+ + ++ E+L +G L F I+ PH C DE +K
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 780 MALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829
+LD +A GM L S+ VH+DL + N+L+ + +VK+SD GLSR ++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 830 T-FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVV 886
+ + + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236
Query: 887 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
V + + L ++ P + ++ ECWQ PS RP F + L+
Sbjct: 237 EMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 83/262 (31%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHA---DWNGTEVAVK-KFLDQDFSGAALLEFKREVKI 727
EI ED+ LG IG G +G+VY ++AV K S + +F +E I
Sbjct: 2 EIQREDITLGRCIGEGQ-FGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 728 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 787
MR+ HP++V +G +T P + I+ E P G L L +D I + ++
Sbjct: 61 MRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 846
+ L + VHRD+ + N+LV VK+ DFGLSR + S P +WMAP
Sbjct: 120 LAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177
Query: 847 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
E + DV+ FGV +WE+ L P+ G+ V+G + RL +P P
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 236
Query: 906 VARIIWECWQTDPSLRPSFAQL 927
+ ++ +CW DPS RP F +L
Sbjct: 237 LYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 88/267 (32%), Positives = 142/267 (53%), Gaps = 17/267 (6%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
EIP E + L +++G G +GEV+ + N T+VAVK S A LE E +M+
Sbjct: 2 EIPRESIKLVKKLGAGQ-FGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKT 57
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMN 789
L+H +V VT+ + IITE++ +GSL L +V + I + +A GM
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM- 116
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 848
+ +HRDL++ N+LV ++ K++DFGL+R+ + +++ A P +W APE
Sbjct: 117 -AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 849 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPKELDP 904
+ K DV+SFG++L+E+ T K+P+ GM+ V+ A+ G++ R+E P EL
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL-- 233
Query: 905 LVARIIWECWQTDPSLRPSFAQLTVAL 931
I+ CW+ RP+F L L
Sbjct: 234 --YDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 21/270 (7%)
Query: 680 LGERIGLG-SSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREVKIMRRL 731
L E LG +GEV+ A G E V VK EF+RE+ + R+L
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKL 65
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE--------KRRIKMALD 783
H NVV +G +I E+ G L + L + ++ K+++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-E 842
+A GM+ H S VHRDL + N LV VKVS LS+ +N+ A P
Sbjct: 126 IALGMD--HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 901
W+APE ++ + + K DV+SFGV++WE+ T +LP+ G++ +V+ + L +P+
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQLTVAL 931
+ +++ CW +P RPSF++L AL
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 84/264 (31%), Positives = 128/264 (48%), Gaps = 16/264 (6%)
Query: 682 ERIGLGSSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
E IG G +GEV VA+K L ++ +F E IM + HPN+
Sbjct: 10 EVIGAGE-FGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ G VT+ + IITEF+ G+L L + Q + + M +A GM L S
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--SEM 125
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-----TFLSSKSTAGTPEWMAPEVLRN 851
VHRDL + N+LV+ N KVSDFGLSR + T+ SS W APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 852 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910
DV+S+G+++WE+ + + P+ M+ V+ A+ Q+ RL P + + +++
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLM 244
Query: 911 WECWQTDPSLRPSFAQLTVALKPL 934
+CWQ D + RP F Q+ L +
Sbjct: 245 LDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 93/300 (31%), Positives = 144/300 (48%), Gaps = 54/300 (18%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE------------------VAVKKFLDQDF 713
E P + L E++G G +GEV+ + +G + VAVK L D
Sbjct: 1 EFPRQPLNFVEKLGEGQ-FGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDA 58
Query: 714 SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVD 773
S A +F +EVKI+ RL PN+ +G T P L +I E++ G L + L + H
Sbjct: 59 SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK-HVAET 117
Query: 774 EKRR-----------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822
+ MA +A GM + + VHRDL + N LV KN+ +K++DFG
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMR--YLESLNFVHRDLATRNCLVGKNYTIKIADFG 175
Query: 823 LSR-LKHNTFLSSKSTAGTP-EWMAPE-VLRNEPSNEKCDVYSFGVILWELATL--KLPW 877
+SR L + + + A P WMA E VL + + K DV++FGV LWE+ TL + P+
Sbjct: 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPY 234
Query: 878 IGMNPMQVVGAVG--FQNRRLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ QV+ G F++ +I PK+ + ++ ECW+ D RP+F ++
Sbjct: 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD----IYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 28/271 (10%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVKKF------LDQDFSG-----AALLEFKREV 725
V GE IG G+ YG VY A G +AVK+ + S AL + E+
Sbjct: 4 VKGELIGKGT-YGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKAL---RSEI 59
Query: 726 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 785
+ ++ L H N+V ++G T LSI E++P GS+ L R + + +E+ V
Sbjct: 60 ETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVL 118
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEW 843
G+ LH+ I+HRDLK+ NLLVD + K+SDFG+S+ + + + ++ + G+ W
Sbjct: 119 EGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 844 MAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901
MAPEV+ + + K D++S G ++ E+ + PW + + +G + IP +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236
Query: 902 LDPLVARI----IWECWQTDPSLRPSFAQLT 928
+ ++ + + C+ +P RP+ +L
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 88/280 (31%), Positives = 145/280 (51%), Gaps = 24/280 (8%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E+ E + + +G GS +G VY G T VA+K +++ S +EF E
Sbjct: 2 EVAREKITMSRELGQGS-FGMVYEGIAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNE 59
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------K 775
+M+ +VV +G V++ +I E + RG L L RP + + K
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 776 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835
+ I+MA ++A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 120 KMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 836 STAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892
G WM+PE L++ DV+SFGV+LWE+ATL + P+ GM+ QV+ V +
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-ME 236
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
L+ P ++ ++ CWQ +P +RPSF ++ ++K
Sbjct: 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-32
Identities = 83/270 (30%), Positives = 134/270 (49%), Gaps = 33/270 (12%)
Query: 686 LGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745
L + GEV VAVKK Q + L +F+RE++I++ L+H N+V + G
Sbjct: 28 LQDNTGEV---------VAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS 76
Query: 746 P--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803
NL ++ E+LP GSL L + ++D ++ + A + +GM L + VHRDL
Sbjct: 77 AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL--GSKRYVHRDL 134
Query: 804 KSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPE-WMAPEVLRNEPSNEKCDV 860
+ N+LV+ VK+ DFGL+++ + + + +P W APE L + DV
Sbjct: 135 ATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDV 194
Query: 861 YSFGVILWELAT----------LKLPWIGMN---PMQVVGAVGF--QNRRLEIPKELDPL 905
+SFGV+L+EL T + +G + M V + N RL P
Sbjct: 195 WSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAE 254
Query: 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQ 935
+ I+ ECW DPS RPSF++L + ++ ++
Sbjct: 255 IYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 91/284 (32%), Positives = 139/284 (48%), Gaps = 31/284 (10%)
Query: 675 WEDLVLGERIGLGSSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
WED+ + IG G+ +G+V A D A+K L + S +F E++++ +
Sbjct: 1 WEDIKFEDVIGEGN-FGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDFAGELEVLCK 58
Query: 731 L-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---------------HRPHCQVDE 774
L HPN++ +GA L I E+ P G+L L H +
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 775 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834
++ ++ A DVA GM L S +HRDL + N+LV +N K++DFGLSR + +
Sbjct: 119 QQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE---VYV 173
Query: 835 KSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGF 891
K T G WMA E L K DV+SFGV+LWE+ +L P+ GM ++ +
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP- 232
Query: 892 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935
Q R+E P+ D V ++ +CW+ P RP FAQ++V L +
Sbjct: 233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 91/284 (32%), Positives = 151/284 (53%), Gaps = 33/284 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFK 722
E+P + LVLG+ +G G +G+V A+ G T+VAVK L D + L +
Sbjct: 14 EVPRDRLVLGKPLGEGC-FGQVVMAEAIGLDKEKPNRVTKVAVK-MLKSDATEKDLSDLI 71
Query: 723 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-----------HRPHC 770
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L + P
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 771 QVDEKRRIK----MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
+E+ K A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 827 KHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 883
H+ K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P+
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PV 248
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ + + + R++ P + ++ +CW PS RP+F QL
Sbjct: 249 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 71/262 (27%), Positives = 127/262 (48%), Gaps = 20/262 (7%)
Query: 681 GERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGA----ALLEFKREVKIMRRLRHP 734
G+++G G+ + Y A GT +AVK+ + + + ++E+++M RL HP
Sbjct: 5 GQQLGTGA-FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
+++ +GA + ++ E++ GS+ +L + + E I + RG++ LH +
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 795 TPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKST-----AGTPEWMAPEV 848
I+HRD+K NLL+D ++++DFG + + + GT +MAPEV
Sbjct: 123 Q--IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 849 LRNEPSNEKCDVYSFGVILWELATLKLPWIG---MNPMQVVGAVGFQNRRLEIPKELDPL 905
LR E CDV+S G ++ E+AT K PW N + ++ + IP+ L P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 906 VARIIWECWQTDPSLRPSFAQL 927
+ + C + P RP +L
Sbjct: 240 LRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 90/289 (31%), Positives = 143/289 (49%), Gaps = 45/289 (15%)
Query: 673 IPWEDLVLGERIGLGSSYGEVYHA----DWNGTEVAVKKFLD-------QDFSGAALLEF 721
+ W D+ + IG G+ +G+V A D + A+K+ + +DF+G
Sbjct: 4 LEWNDIKFQDVIGEGN-FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG------ 56
Query: 722 KREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRIL 765
E++++ +L HPN++ +GA L + E+ P G+L F I
Sbjct: 57 --ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114
Query: 766 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825
+ + ++ + A DVARGM+ L S +HRDL + N+LV +N+ K++DFGLSR
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
Query: 826 LKHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNP 882
+ + K T G WMA E L DV+S+GV+LWE+ +L P+ GM
Sbjct: 173 GQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229
Query: 883 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931
++ + Q RLE P D V ++ +CW+ P RPSFAQ+ V+L
Sbjct: 230 AELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 81/265 (30%), Positives = 128/265 (48%), Gaps = 25/265 (9%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRL 731
DL + +G GSS G VY G A+KK + LL RE+K +R
Sbjct: 1 SDLERVKVLGQGSS-GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSC 56
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
P VV GA + +SI+ E++ GSL L + ++ E +A + +G++ L
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMA 845
HT I+HRD+K NLL++ VK++DFG+S++ + NTF+ GT +M+
Sbjct: 116 HT-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMS 168
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWI---GMNPMQVVGAVGFQNRRLEIPKEL 902
PE ++ E + D++S G+ L E A K P++ + +++ A+ +E
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228
Query: 903 DPLVARIIWECWQTDPSLRPSFAQL 927
P I C Q DP RPS A+L
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 76/280 (27%), Positives = 127/280 (45%), Gaps = 31/280 (11%)
Query: 678 LVLGERIGLGSSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLR 732
L LG+ +G G +G V + + VAVK + + + EF E M+
Sbjct: 1 LKLGKILGEGE-FGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 733 HPNVVLFMG------AVTRPPNLSIITEFLPRGSLFRILHRPHCQ-----VDEKRRIKMA 781
HPNV+ +G ++ + P +I F+ G L L + + +K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGT 840
+D+A GM L S +HRDL + N ++ ++ V V+DFGLS+ ++ + A
Sbjct: 120 VDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 841 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG-----AVGFQNR 894
P +W+A E L + K DV++FGV +WE+AT G P V
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-----GQTPYPGVENHEIYDYLRHGN 232
Query: 895 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
RL+ P++ + +++ CW+ DP RP+F +L L+ +
Sbjct: 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 83/254 (32%), Positives = 131/254 (51%), Gaps = 20/254 (7%)
Query: 682 ERIGLGSSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
ERIG G+ +GEV+ + T VAVK + L D +F +E +I+++ HPN+
Sbjct: 1 ERIGRGN-FGEVFSGRLRADNTPVAVKSCRETLPPDLKA----KFLQEARILKQYSHPNI 55
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
V +G T+ + I+ E + G L ++ K I+M + A GM L +
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK-- 113
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WMAPEVLRNE 852
+HRDL + N LV + +K+SDFG+SR + + + ST G + W APE L
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--STGGMKQIPVKWTAPEALNYG 171
Query: 853 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
+ + DV+SFG++LWE +L +P+ ++ Q A+ Q RL P+ V R++
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLME 230
Query: 912 ECWQTDPSLRPSFA 925
CW+ DP RPSF+
Sbjct: 231 RCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 69/244 (28%), Positives = 117/244 (47%), Gaps = 10/244 (4%)
Query: 689 SYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746
SYG VY A+K+ S + E++I+ + HPN++ + A
Sbjct: 12 SYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71
Query: 747 PNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803
L I+ E+ P G L + + + + + E+ ++ + + RG+ LH I+HRDL
Sbjct: 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDL 129
Query: 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSF 863
KS N+L+ N VK+ D G+S++ K+ GTP +MAPEV + P + K D++S
Sbjct: 130 KSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187
Query: 864 GVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 923
G +L+E+AT P+ + MQ + + + IP + I Q P LRP+
Sbjct: 188 GCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPN 246
Query: 924 FAQL 927
++
Sbjct: 247 CDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 82/256 (32%), Positives = 127/256 (49%), Gaps = 18/256 (7%)
Query: 684 IGLGSSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
IG G +G VYH D AVK L++ + +F +E IM+ HPNV+
Sbjct: 3 IGKGH-FGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 739 FMGAVTRPPNLS-IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797
+G ++ ++ G L + K I L VA+GM L ++
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL--ASKK 118
Query: 798 IVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTP-EWMAPEVLRNEP 853
VHRDL + N ++D+++ VKV+DFGL+R K + + + A P +WMA E L+ +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 854 SNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKEL-DPLVARIIW 911
K DV+SFGV+LWEL T P+ ++ + + Q RRL P+ DPL ++
Sbjct: 179 FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLY-EVML 236
Query: 912 ECWQTDPSLRPSFAQL 927
CW P +RP+F++L
Sbjct: 237 SCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 88/291 (30%), Positives = 150/291 (51%), Gaps = 33/291 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFK 722
E P + LVLG+ +G G +G+V A+ G + VAVK L + + L +
Sbjct: 8 EFPRDRLVLGKPLGEGC-FGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLI 65
Query: 723 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILH 766
E+++M+ + +H N++ +G T+ L +I E+ +G+L F I
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125
Query: 767 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
P Q+ K + A VARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 827 KHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 883
H+ K++ G +WMAPE L + + DV+SFG+++WE+ TL P+ G+ P+
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PV 242
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ + + + R++ P + ++ ECW P+ RP+F QL AL +
Sbjct: 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 64/254 (25%), Positives = 124/254 (48%), Gaps = 7/254 (2%)
Query: 677 DLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734
D + +IG GS +G V+ + A+K+ + E E +++ +L
Sbjct: 1 DFEILNKIGKGS-FGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHT 793
++ + + L+I+ E+ G L ++L + + E + + + + G+ LH+
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 853
I+HRD+KS NL +D NVK+ D G+++L + + + GTP +++PE+ ++P
Sbjct: 120 KK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 854 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913
NEK DV++ GV+L+E T K P+ N ++ + + + + +A++I +C
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQC 236
Query: 914 WQTDPSLRPSFAQL 927
D RP QL
Sbjct: 237 LTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 88/295 (29%), Positives = 138/295 (46%), Gaps = 42/295 (14%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E P ++ IG G+ +G V+ A G T VAVK L ++ S +F+RE
Sbjct: 1 EYPRNNIEYVRDIGQGA-FGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQRE 58
Query: 725 VKIMRRLRHPNVVLFMG--AVTRPPNLSIITEFLPRGSLFRILHR--------------- 767
+M HPN+V +G AV +P + ++ E++ G L L
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 768 ------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821
+ ++ +A VA GM + S VHRDL + N LV +N VK++DF
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGM--AYLSERKFVHRDLATRNCLVGENMVVKIADF 174
Query: 822 GLSRLKHNT--FLSSKSTAGTPEWMAPE-VLRNEPSNEKCDVYSFGVILWELATLKL-PW 877
GLSR ++ + +S++ A WM PE + N + E DV+++GV+LWE+ + + P+
Sbjct: 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGMQPY 233
Query: 878 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
GM +V+ V N L P + ++ CW PS RPSFA + L+
Sbjct: 234 YGMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 86/272 (31%), Positives = 139/272 (51%), Gaps = 31/272 (11%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
+D L E IG+G++ VY A N +VA+K+ +D + ++ E ++EV+ M + H
Sbjct: 1 DDYELIEVIGVGAT-AVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNH 58
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCL 791
PNVV + + L ++ +L GSL I+ P +DE + +V +G+ L
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----------RLKHNTFLSSKSTAGTP 841
H++ +HRD+K+ N+L+ ++ +VK++DFG+S R TF GTP
Sbjct: 119 HSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF------VGTP 170
Query: 842 EWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEI 898
WMAPEV+ + K D++SFG+ ELAT P+ PM+V+ + QN LE
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-MLTLQNDPPSLET 229
Query: 899 PKELDP---LVARIIWECWQTDPSLRPSFAQL 927
+ ++I C Q DPS RP+ +L
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 71/219 (32%), Positives = 114/219 (52%), Gaps = 7/219 (3%)
Query: 720 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 779
+F E IM + HPN++ G VT+ + I+TE++ GSL L + Q + +
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG 110
Query: 780 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 839
M +A GM L S VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T G
Sbjct: 111 MLRGIASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168
Query: 840 TP---EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRR 895
W APE + DV+S+G+++WE+ + + P+ M+ V+ A+ + R
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYR 227
Query: 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
L P + + +++ +CWQ D + RP F Q+ L L
Sbjct: 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 78/263 (29%), Positives = 136/263 (51%), Gaps = 22/263 (8%)
Query: 681 GERIGLGSSYGEVY---HADWNGTEVAVKKF------LDQDFSGAALLE-FKREVKIMRR 730
G IG GS +G VY +A +G +AVK+ ++L+ RE+ +++
Sbjct: 5 GALIGSGS-FGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKE 62
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 790
L+H N+V ++G+ +L+I E++P GS+ +L+ + +E + +G+N
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNY 121
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK------STAGTPEWM 844
LH I+HRD+K N+LVD +K+SDFG+S+ LS+K S G+ WM
Sbjct: 122 LHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904
APEV++ K D++S G ++ E+ T K P+ +Q + +G +N EIP +
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISS 238
Query: 905 LVARIIWECWQTDPSLRPSFAQL 927
+ + ++ D + RP+ A+L
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 88/264 (33%), Positives = 132/264 (50%), Gaps = 26/264 (9%)
Query: 681 GERIGLGSSYGEVYHADWN-GTEVAVKKF-LDQDFSGAALLEFKR---EVKIMRRLRHPN 735
GE +G G+ YG VY N G +AVK+ LD AA E+++ EV +++ L+H N
Sbjct: 5 GEVLGKGA-YGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHT 793
+V ++G +SI EF+P GS+ IL+R P + + K LD G+ LH
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLHN 120
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--------LKHNTFLSSKSTAGTPEWMA 845
+ +VHRD+K N+++ N +K+ DFG +R H+ L KS GTP WMA
Sbjct: 121 NC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWMA 176
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 903
PEV+ K D++S G ++E+AT K P M+ + + +G +R L +P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFS 235
Query: 904 PLVARIIWECWQTDPSLRPSFAQL 927
+ C D RPS QL
Sbjct: 236 AAAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 81/270 (30%), Positives = 134/270 (49%), Gaps = 30/270 (11%)
Query: 676 EDLVLGERIGLGSSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIM 728
D+VL +G G+ +G+V+ A + + VAVK ++ S +A +F+RE +++
Sbjct: 5 RDIVLKWELGEGA-FGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELL 61
Query: 729 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR--------- 777
L+H ++V F G T L ++ E++ G L R L H P ++
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 778 ---IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FL 832
+ +A +A GM ++ ++ VHRDL + N LV + VK+ DFG+SR ++T +
Sbjct: 122 GQMLAIASQIASGM--VYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179
Query: 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 891
T WM PE + + D++SFGV+LWE+ T K PW ++ + + +
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT- 238
Query: 892 QNRRLEIPKELDPLVARIIWECWQTDPSLR 921
Q R LE P+ P V I+ CWQ +P R
Sbjct: 239 QGRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 84/275 (30%), Positives = 137/275 (49%), Gaps = 44/275 (16%)
Query: 675 WEDLVLGERIGLGSSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
WE ++GE +G G+ +G+VY A T + A K + + S L +F E+ I+ +H
Sbjct: 7 WE--IIGE-LGDGA-FGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKH 61
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
PN+V A L I+ EF G+L I+ + E + + + +N LH+
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPE 847
++HRDLK+ N+L+ + +VK++DFG+S K +TF+ GTP WMAPE
Sbjct: 122 HK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPE 173
Query: 848 VL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
V+ ++ P + K D++S G+ L ELA ++ P +NPM+V+ L+I K
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSE 224
Query: 903 DPLVAR----------IIWECWQTDPSLRPSFAQL 927
P + + + C DP RP+ A+L
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 81/277 (29%), Positives = 132/277 (47%), Gaps = 25/277 (9%)
Query: 678 LVLGERIGLGSSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 732
LG +G G +G V A D + +VAVK FS + + EF RE M+
Sbjct: 1 FTLGRMLGKGE-FGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 733 HPNVVLFMG------AVTRPPNLSIITEFLPRGSLF------RILHRPHCQVDEKRRIKM 780
HPNV+ +G A R P +I F+ G L RI P + + ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF-TLPLQTLVRF 118
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG 839
+D+A GM L S+ +HRDL + N ++++N V V+DFGLS+ + + +
Sbjct: 119 MIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 840 TP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLE 897
P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ + + RL+
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLK 235
Query: 898 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
P + V ++ +CW +P RPSF L L+ +
Sbjct: 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 77/262 (29%), Positives = 126/262 (48%), Gaps = 39/262 (14%)
Query: 683 RIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLF 739
+IG G + VY A +G VA+KK + A A + +E+ ++++L HPNV+ +
Sbjct: 9 KIGKGQ-FSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTP 796
+ + L+I+ E G L R++ Q + E+ K + + + +H+
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR- 126
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLRN 851
I+HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 -IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 852 EPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQN-RRLEIP--------K 900
N K D++S G +L+E+A L+ P+ G MN + + + + P +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-----CKKIEKCDYPPLPADHYSE 235
Query: 901 ELDPLVARIIWECWQTDPSLRP 922
EL LV+R C DP RP
Sbjct: 236 ELRDLVSR----CINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 90/297 (30%), Positives = 143/297 (48%), Gaps = 41/297 (13%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE----------------VAVKKFLDQDFSG 715
E P + L L E++G G +GEV+ + G VAVK L D +
Sbjct: 1 EFPRQQLRLKEKLGEGQ-FGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKM-LRADVTK 58
Query: 716 AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---- 771
A +F +E+KIM RL++PN++ +G L +ITE++ G L + L + +
Sbjct: 59 TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT 118
Query: 772 -------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824
V + MA+ +A GM L ++ VHRDL + N LV ++ +K++DFG+S
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 825 R-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIGM 880
R L + + A P WMA E + DV++FGV LWE+ TL + P+ +
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236
Query: 881 NPMQVVGAVG--FQNRRLEIPKELDPL----VARIIWECWQTDPSLRPSFAQLTVAL 931
+ QV+ G F+N+ +I PL V +++ CW D RP+F ++ L
Sbjct: 237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 4e-29
Identities = 87/284 (30%), Positives = 146/284 (51%), Gaps = 33/284 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFK 722
E + L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 11 EFSRDKLTLGKPLGEGC-FGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLV 68
Query: 723 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILH 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + I
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 767 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
P Q+ K + VARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 827 KHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 883
+N K+T G +WMAPE L + + DV+SFGV++WE+ TL P+ G+ P+
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PV 245
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ + + + R++ P + ++ +CW PS RP+F QL
Sbjct: 246 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 84/261 (32%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 684 IGLGSSYGEVYHADWN---GTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
IG G +GEV+ EVAV K L ++ +F E IM + H N++
Sbjct: 13 IGAGE-FGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
G VT+ IITE++ G+L + L + + + M +A GM L S V
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL--SDMNYV 129
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP---EWMAPEVLRNEPSNE 856
HRDL + N+LV+ N KVSDFGLSR+ + + +T+G W APE +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 857 KCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIWEC 913
DV+SFG+++WE+ + + P+ M+ +V+ A+ GF RL P + V +++ +C
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDCPSAVYQLMLQC 246
Query: 914 WQTDPSLRPSFAQLTVALKPL 934
WQ D + RP F + L L
Sbjct: 247 WQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 92/284 (32%), Positives = 149/284 (52%), Gaps = 33/284 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFK 722
E+ L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 8 ELSRTRLTLGKPLGEGC-FGQVVMAEAIGIDKDKPNKPVTVAVK-MLKDDATDKDLSDLV 65
Query: 723 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RP--------HCQ 771
E+++M+ + +H N++ +GA T+ L ++ E+ +G+L L RP C+
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 772 VDE-----KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
+ E K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 827 KHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 883
HN K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P+
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PV 242
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ + + + R++ P + I+ ECW PS RP+F QL
Sbjct: 243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 87/275 (31%), Positives = 132/275 (48%), Gaps = 24/275 (8%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVY-----HADWNGTEVAVK-KFLDQDFSGAALLEFKREV 725
E+P + + L +G G+ +GEVY D + E+ V K L + S +F E
Sbjct: 2 EVPRDSITLLRALGHGA-FGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 726 KIMRRLRHPNVVLFMG-AVTRPPNLSIITEFLPRGSLFRILH--RPH----CQVDEKRRI 778
IM + H N+V +G + R P I+ E + G L L RP + K +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPN-LLVDKNWN--VKVSDFGLSR-LKHNTFLSS 834
A DVA+G L + +HRD+ + N LL K K++DFG++R + ++
Sbjct: 120 FCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 835 KSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892
A P +WM PE + K DV+SFGV+LWE+ +L +P+ G +V+ V
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TG 236
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
RL+ PK V RI+ +CWQ P RP+FA +
Sbjct: 237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 81/281 (28%), Positives = 134/281 (47%), Gaps = 18/281 (6%)
Query: 682 ERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---PNVV 737
E IG G+ YG VY T V K ++ D + + +REV ++ +LR PN+
Sbjct: 7 ELIGRGA-YGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797
+ G+ + P L II E+ GS+ R L + + EK + +V + +H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGP-IAEKYISVIIREVLVALKYIHKVG-- 121
Query: 798 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NE 856
++HRD+K+ N+LV NVK+ DFG++ L + + GTP WMAPEV+ +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181
Query: 857 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRRLEIPKELDPLVARIIWECWQ 915
K D++S G+ ++E+AT P+ ++ + + + + RLE L+ + C
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKLLREFVAACLD 240
Query: 916 TDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISV 956
+P R S +L L+ I +H P S L + IS
Sbjct: 241 EEPKERLSAEEL------LKSKWIKAHSKTPVSILKELISR 275
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 83/266 (31%), Positives = 126/266 (47%), Gaps = 35/266 (13%)
Query: 686 LGS-SYGEVYHA-----DWNGTE---VAVKKF----LDQDFSGAALLEFKREVKIMRRLR 732
LGS ++GEVY G+ VAVK DQ+ EF +E +M
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-----EFLKEAHLMSNFN 57
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------VDEKRRIKMALDVAR 786
HPN+V +G II E + G L L + + K + + LDVA+
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 840
G C++ +HRDL + N LV D + VK+ DFGL+R + + + +
Sbjct: 118 G--CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 841 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 898
P WMAPE L + + DV+SFGV++WE+ TL + P+ +N +V+ V RL+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQK 234
Query: 899 PKELDPLVARIIWECWQTDPSLRPSF 924
P+ + +++ CW DPS RP+F
Sbjct: 235 PENCPDKIYQLMTNCWAQDPSERPTF 260
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 94/298 (31%), Positives = 144/298 (48%), Gaps = 42/298 (14%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE------------------VAVKKFLDQDF 713
E P + L E++G G +GEV+ + G E VAVK L +D
Sbjct: 1 EFPRKRLTFKEKLGEGQ-FGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDA 58
Query: 714 SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ 771
+ A +F +E+KIM RL+ PN++ + L +ITE++ G L + L H P
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118
Query: 772 -VDEKRR-------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823
I MA +A GM L S+ VHRDL + N LV KN+ +K++DFG+
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 824 SR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIG 879
SR L + + A P WM+ E + DV++FGV LWE+ TL + P+
Sbjct: 177 SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
Query: 880 MNPMQVVGAVG-F---QNRRLEIPKE-LDP-LVARIIWECWQTDPSLRPSFAQLTVAL 931
++ QV+ G F Q R++ +PK L P + +++ CW+ + RPSF ++ L
Sbjct: 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 86/279 (30%), Positives = 136/279 (48%), Gaps = 36/279 (12%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSG--AALLEFK 722
E P +L G+ +G G+ +G+V A G +VAVK S AL+
Sbjct: 31 EFPRNNLSFGKTLGAGA-FGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-- 87
Query: 723 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKM 780
E+KIM L H N+V +GA T + +ITE+ G L L R + + +
Sbjct: 88 -ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG 839
+ VA+GM L ++ +HRDL + N+L+ VK+ DFGL+R + +++ K A
Sbjct: 147 SYQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204
Query: 840 TP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGM-------NPMQVVGAVG 890
P +WMAPE + N + DV+S+G++LWE+ +L P+ GM ++ G
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EG 260
Query: 891 FQNRRLE-IPKELDPLVARIIWECWQTDPSLRPSFAQLT 928
++ + E P E + I+ CW DP RP+F Q+
Sbjct: 261 YRMAQPEHAPAE----IYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 86/276 (31%), Positives = 132/276 (47%), Gaps = 45/276 (16%)
Query: 690 YGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 742
+G+VY GT VA+K D+ G EFK E + RL+HPN+V +G
Sbjct: 18 FGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEAMMRSRLQHPNIVCLLGV 76
Query: 743 VTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIKMALD----------VARG 787
VT+ LS+I + L F ++ PH V D+ + +K L+ +A G
Sbjct: 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAG 136
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR---------LKHNTFLSSKSTA 838
M L S+ +VH+DL + N+LV NVK+SD GL R L N+ L +
Sbjct: 137 MEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR--- 191
Query: 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRR-L 896
WM+PE + + D++S+GV+LWE+ + L P+ G + V+ + +NR+ L
Sbjct: 192 ----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI--RNRQVL 245
Query: 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
P + V ++ ECW PS RP F + L+
Sbjct: 246 PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 88/274 (32%), Positives = 136/274 (49%), Gaps = 31/274 (11%)
Query: 673 IPWEDLVLGERIGLGSSYGEVYHAD-WNGTE------VAVKKFLDQDFSGAALLEFKREV 725
I D+VL +G G+ +G+V+ A+ +N + VAVK D AA +F+RE
Sbjct: 2 IKRRDIVLKRELGEGA-FGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREA 58
Query: 726 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ--VDEKRR---- 777
+++ L+H ++V F G L ++ E++ G L + L H P VD + R
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 778 -------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830
+ +A +A GM ++ ++ VHRDL + N LV N VK+ DFG+SR ++T
Sbjct: 119 ELGLSQMLHIASQIASGM--VYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 831 --FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVG 887
+ T WM PE + + DV+SFGVILWE+ T K PW ++ +V+
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236
Query: 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 921
+ Q R LE P+ V I+ CWQ +P R
Sbjct: 237 CIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 24/280 (8%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E+ E + L +G GS +G VY + T VAVK +++ S +EF E
Sbjct: 2 EVSREKITLLRELGQGS-FGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNE 59
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------K 775
+M+ +VV +G V++ ++ E + G L L RP + + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 776 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835
I+MA ++A GM L+ VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 120 EMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 836 STAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892
G WMAPE L++ D++SFGV+LWE+ +L + P+ G++ QV+ V
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MD 236
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
L+ P V ++ CWQ +P +RP+F ++ LK
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 83/291 (28%), Positives = 142/291 (48%), Gaps = 38/291 (13%)
Query: 677 DLVLGERIGLGSSYGEVYHA---DWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMR 729
+LVLG+ +G G +G+V A G T VAVK L ++ S + L + E +++
Sbjct: 1 NLVLGKTLGEGE-FGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLK 58
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL---FRILHRPHCQ--------------- 771
++ HP+V+ GA ++ L +I E+ GSL R +
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 772 -----VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR- 825
+ I A ++RGM L + +VHRDL + N+LV + +K+SDFGLSR
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 826 -LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPM 883
+ ++++ +WMA E L + + DV+SFGV+LWE+ TL P+ G+ P
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
++ + R+E P+ + ++ CW+ +P RP+FA ++ L+ +
Sbjct: 237 RLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 75/217 (34%), Positives = 117/217 (53%), Gaps = 9/217 (4%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 732
P ED L +RIG G+ YG+VY A + N E+A K + + G ++E+ +M+ +
Sbjct: 7 PQEDFELIQRIGSGT-YGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCK 64
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
H N+V + G+ R L I EF GSL I H + E + ++ + +G+ LH
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH 123
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL--- 849
+ +HRD+K N+L+ N +VK++DFG+S T KS GTP WMAPEV
Sbjct: 124 SKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 886
R N+ CD+++ G+ ELA L+ P ++PM+ +
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 76/231 (32%), Positives = 118/231 (51%), Gaps = 25/231 (10%)
Query: 720 EFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL------------- 765
+F E++++ +L HPN++ +GA L + E+ P G+L L
Sbjct: 41 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100
Query: 766 --HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823
+ + ++ + A DVARGM+ L S +HRDL + N+LV +N+ K++DFGL
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGL 158
Query: 824 SRLKHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGM 880
SR + + K T G WMA E L DV+S+GV+LWE+ +L P+ GM
Sbjct: 159 SRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215
Query: 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931
++ + Q RLE P D V ++ +CW+ P RPSFAQ+ V+L
Sbjct: 216 TCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 51/211 (24%), Positives = 106/211 (50%), Gaps = 4/211 (1%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMAL 782
E+ I+ L+HPN++ + L I E+ G+L+ +I+ + +E+ +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 842
+ ++ +H + I+HRD+K+ N+ + K +K+ DFG+S++ + + +++ GTP
Sbjct: 109 QIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
+M+PE+ + N K D+++ G +L+EL TLK + NP+ +V + Q +
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVY 225
Query: 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKP 933
+ ++ Q DP RP+ ++
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 5/208 (2%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKM 780
K+EV ++ +++HPN+V F + L I+ E+ G L + ++R E + +
Sbjct: 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAG 839
+ ++ G+ +H I+HRD+KS N+ + KN V K+ DFG++R +++ + + G
Sbjct: 107 FVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 899
TP +++PE+ +N P N K D++S G +L+EL TLK P+ G N Q+V + Q I
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPIS 223
Query: 900 KELDPLVARIIWECWQTDPSLRPSFAQL 927
+ +I + ++ P RPS +
Sbjct: 224 PNFSRDLRSLISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 71/245 (28%), Positives = 119/245 (48%), Gaps = 17/245 (6%)
Query: 684 IGLGSSYGEVY---HADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVV- 737
+G GS +G+V D G A+K L + + E I+ R+ HP +V
Sbjct: 1 LGKGS-FGKVLLVRKKD-TGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTSTP 796
L T L ++ E+ P G LF L + E+R R A ++ + LH+
Sbjct: 58 LHYAFQT-EEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAA-EIVLALEYLHSLG- 113
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 856
I++RDLK N+L+D + ++K++DFGL++ + + + GTPE++APEVL + +
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 857 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 916
D +S GV+L+E+ T K P+ + ++ + L P+ L P +I Q
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQK 230
Query: 917 DPSLR 921
DP+ R
Sbjct: 231 DPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 8e-27
Identities = 79/286 (27%), Positives = 140/286 (48%), Gaps = 28/286 (9%)
Query: 673 IPWEDLVLGERIGLGSSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREV 725
I ++VL +G G+ +G+V+ A+ + VAVK +D S A +F RE
Sbjct: 2 IKRHNIVLKRELGEGA-FGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREA 58
Query: 726 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH------------RPHCQVD 773
+++ L+H ++V F G L ++ E++ G L + L ++
Sbjct: 59 ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118
Query: 774 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--F 831
+ + + +A +A GM ++ ++ VHRDL + N LV +N VK+ DFG+SR ++T +
Sbjct: 119 QSQMLHIAQQIAAGM--VYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVG 890
T WM PE + + DV+S GV+LWE+ T K PW ++ +V+ +
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236
Query: 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
Q R L+ P+ V ++ CWQ +P +R + ++ L+ L +
Sbjct: 237 -QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 82/250 (32%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 697 DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI--ITE 754
D G +VAVK L + G + + K+E++I+R L H N+V + G T I I E
Sbjct: 30 DNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88
Query: 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814
FLP GSL L R +++ K+++K A+ + +GM+ L + VHRDL + N+LV+
Sbjct: 89 FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEH 146
Query: 815 NVKVSDFGLSR-LKHNT-FLSSKSTAGTPE-WMAPEVLRNEPSNEKCDVYSFGVILWELA 871
VK+ DFGL++ ++ + + + K +P W APE L DV+SFGV L+EL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 872 T------------LKLPWIGMNPMQVVGAVGF--QNRRLEIPKELDPLVARIIWECWQTD 917
T LK+ M V V + +RL P V +++ +CW+
Sbjct: 207 TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ 266
Query: 918 PSLRPSFAQL 927
PS R +F L
Sbjct: 267 PSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 77/255 (30%), Positives = 130/255 (50%), Gaps = 23/255 (9%)
Query: 682 ERIGLGSSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 740
ERIG GS +GEV+ N T+ V K +D + + + + ++E+ ++ + P V +
Sbjct: 10 ERIGKGS-FGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 800
G+ + L II E+L GS +L DE + M ++ +G++ LH+ +H
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKK--IH 124
Query: 801 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 860
RD+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 861 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA--------RIIWE 912
+S G+ ELA + P M+PM+V+ IPK P + I
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKPFKEFIDA 235
Query: 913 CWQTDPSLRPSFAQL 927
C DPS RP+ +L
Sbjct: 236 CLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/210 (30%), Positives = 113/210 (53%), Gaps = 14/210 (6%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMAL 782
E ++++ L HPN++ + L I+ E+ P G+L + R + +DE + +
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTA--- 838
+ ++ +HT I+HRDLK+ N+L+DK+ V K+ DFG+S++ LSSKS A
Sbjct: 109 QILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTV 161
Query: 839 -GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE 897
GTP +++PE+ +P N+K D+++ G +L+ELA+LK + N +V +
Sbjct: 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI-MSGTFAP 220
Query: 898 IPKELDPLVARIIWECWQTDPSLRPSFAQL 927
I P + ++I DPS RP +Q+
Sbjct: 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 10/233 (4%)
Query: 703 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 762
VA+ L S F E + + H N+V G +TR + I+TE++ G+L
Sbjct: 36 VAIHT-LRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 763 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822
L + Q+ + + M +A GM L S VH+ L + +LV+ + K+S F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 823 -LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 880
L K ++ S W APE ++ + DV+SFG+++WE+ + + P+ M
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
Query: 881 NPMQVVGAV--GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931
+ V+ AV GF RL P+ L+ +++ +CWQ + RP F+Q+ L
Sbjct: 213 SGQDVIKAVEDGF---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 76/260 (29%), Positives = 125/260 (48%), Gaps = 13/260 (5%)
Query: 686 LGS-SYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
LGS ++G VY W G V + K L++ A +EF E IM + HP++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+G V P + ++T+ +P G L +H + + + + +A+GM ++ +V
Sbjct: 75 LG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM--MYLEERRLV 131
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--EWMAPEVLRNEPSNEK 857
HRDL + N+LV +VK++DFGL+RL + G +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 858 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 916
DV+S+GV +WEL T P+ G+ P + + + + RL P V ++ +CW
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250
Query: 917 DPSLRPSFAQLTVALKPLQR 936
D RP F +L + R
Sbjct: 251 DADSRPKFKELAAEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 74/255 (29%), Positives = 131/255 (51%), Gaps = 23/255 (9%)
Query: 682 ERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 740
ERIG GS +GEVY N T EV K +D + + + + ++E+ ++ + P + +
Sbjct: 10 ERIGKGS-FGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 800
G+ + L II E+L GS +L +P ++E + ++ +G++ LH+ +H
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL-KPG-PLEETYIATILREILKGLDYLHSERK--IH 124
Query: 801 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 860
RD+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 861 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV--------ARIIWE 912
+S G+ ELA + P ++PM+V+ IPK P + +
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYSKPFKEFVEA 235
Query: 913 CWQTDPSLRPSFAQL 927
C DP RP+ +L
Sbjct: 236 CLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 75/231 (32%), Positives = 119/231 (51%), Gaps = 16/231 (6%)
Query: 680 LGERIGLGSSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRH 733
LG+ +G G+ +GEVY AD G E+AVK+ D + + + E+++++ LRH
Sbjct: 6 LGKLLGRGA-FGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 734 PNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
+V + G + P LSI E++P GS+ L + + + E + + +G++ L
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYL 122
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEV 848
H++ IVHRD+K N+L D NVK+ DFG S+ +S KS GTP WM+PEV
Sbjct: 123 HSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 849 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 899
+ E K DV+S + E+ T K PW M + + Q + +P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 83/273 (30%), Positives = 133/273 (48%), Gaps = 22/273 (8%)
Query: 678 LVLGERIGLGSSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
L LG+ +G G +G V N + VAVK + + + +F E M+ H
Sbjct: 1 LALGKTLGEGE-FGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 734 PNVVLFMGAVTRP------PNLSIITEFLPRGSL--FRILHRPHCQ---VDEKRRIKMAL 782
PNV+ +G + P+ +I F+ G L F + R + + +K
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGTP 841
D+A GM L S+ + +HRDL + N ++++N NV V+DFGLS+ +N + A P
Sbjct: 120 DIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 842 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIP 899
+W+A E L + K DV+SFGV +WE+AT + P+ G+ ++ + NR + P
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237
Query: 900 KELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
LD L + ++ CW +P RPSF L L+
Sbjct: 238 DCLDGLYS-LMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 8e-26
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 682 ERIGLGSSYGEVYHADWN---GTEVAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHP 734
E++G G+ YG VY A + G VA+KK LD + AL RE+ +++ L+HP
Sbjct: 5 EKLGEGT-YGVVYKA-RDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELKHP 58
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHT 793
N+V + + L ++ E+ L + L + + IK + + RG+ H+
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP-NLIKSIMYQLLRGLAYCHS 116
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 848
I+HRDLK N+L++++ +K++DFGL+R T E W APE+
Sbjct: 117 HR--ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEI 169
Query: 849 LRNEPS-NEKCDVYSFGVILWELATLK 874
L + D++S G I E+ T K
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 71/306 (23%), Positives = 122/306 (39%), Gaps = 66/306 (21%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFK-----RE 724
+D G+ IG GS + V A E A+K + L + E K E
Sbjct: 1 DDFKFGKIIGEGS-FSTVVLAKEKETNKEYAIKILDKRQLIK--------EKKVKYVKIE 51
Query: 725 VKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK------RR 777
+++ RL HP ++ NL + E+ P G L + + + + +DEK
Sbjct: 52 KEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAE 110
Query: 778 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--- 834
I +AL+ I+HRDLK N+L+DK+ ++K++DFG +++
Sbjct: 111 ILLALEYLHSKG--------IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
Query: 835 -----------------KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
S GT E+++PE+L +P+ + D+++ G I++++ T K P+
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
Query: 878 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937
G N + P P +I + DP R + LK
Sbjct: 223 RGSNEYLTFQKI--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK----- 275
Query: 938 VIPSHP 943
+HP
Sbjct: 276 ---AHP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 22/272 (8%)
Query: 680 LGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHP-NVV 737
+ ++G GS +GEVY A + VA+K + S + +E F RE++I+ L HP N+V
Sbjct: 4 ILRKLGEGS-FGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTST 795
+L ++ E++ GSL +L + + E + + + + LH+
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 796 PTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEV 848
I+HRD+K N+L+D++ VK+ DFGL++L + +S A GTP +MAPEV
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 849 LR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
L ++ D++S G+ L+EL T P+ G L P PL
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937
+ +A P RL
Sbjct: 240 SPSNPE----LISKAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 86/286 (30%), Positives = 138/286 (48%), Gaps = 36/286 (12%)
Query: 675 WEDLVLGERIGLGSSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
WE ++GE +G G+ +G+VY A T A K ++ S L ++ E++I+ H
Sbjct: 14 WE--IIGE-LGDGA-FGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNH 68
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGS-------LFRILHRPHCQVDEKRRIKMALDVAR 786
P +V +GA L I+ EF P G+ L R L P QV ++ ++
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE------- 121
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846
+ LH+ I+HRDLK+ N+L+ + ++K++DFG+S T S GTP WMAP
Sbjct: 122 ALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
Query: 847 EV-----LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPK 900
EV +++ P + K D++S G+ L E+A ++ P +NPM+V+ + L P
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS 239
Query: 901 ELDPLVARIIWECWQTDPSLRPSFAQL--------TVALKPLQRLV 938
+ + P RPS AQL + +PL+ LV
Sbjct: 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 20/264 (7%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK---REVKIMR 729
+DL +G G+ G V G +AVK L+ + K RE+ I+
Sbjct: 1 DDLEYLGELGAGN-SGVVSKVLHRPTGKIMAVKTIRLEIN-----EAIQKQILRELDILH 54
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
+ P +V F GA ++SI E++ GSL +IL ++ E+ K+A+ V +G+
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLT 114
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
LH I+HRD+K N+LV+ +K+ DFG+S N+ +K+ GT +MAPE +
Sbjct: 115 YLH-EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERI 171
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIG-----MNPMQVVGAVGFQNRRLEIPKELDP 904
+ + K D++S G+ L ELAT + P+ +++ + + + P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231
Query: 905 LVARIIWECWQTDPSLRPSFAQLT 928
+ C DP RPS+ +L
Sbjct: 232 DFQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 86/304 (28%), Positives = 138/304 (45%), Gaps = 54/304 (17%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE------------------VAVKKFLDQDF 713
+ P L+ E++G G +GEV+ + + VAVK L D
Sbjct: 1 KFPRGHLLFKEKLGEGQ-FGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK-ILRPDA 58
Query: 714 SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVD 773
+ A +F +EVKI+ RL+ PN++ +G L +ITE++ G L + L +D
Sbjct: 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLD 116
Query: 774 EKRR--------------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 813
+K + +AL +A GM L S+ VHRDL + N LV +N
Sbjct: 117 DKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGEN 174
Query: 814 WNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELA 871
+K++DFG+SR L + + A P WMA E + DV++FGV LWE+
Sbjct: 175 LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
Query: 872 TL--KLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWE----CWQTDPSLRPS 923
L + P+ + QV+ G F+++ ++ P + ++E CW D RPS
Sbjct: 235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS 294
Query: 924 FAQL 927
F+ +
Sbjct: 295 FSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 25/263 (9%)
Query: 680 LGERIGLGSSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRH 733
LG+ +G G+ +G VY AD G E+AVK+ + + + + E+++++ L H
Sbjct: 6 LGKLLGQGA-FGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 734 PNVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
+V + G + P LSI E +P GS+ L + + + E K + G++ L
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYL 122
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEV 848
H++ IVHRD+K N+L D NVK+ DFG S+ LS KS GTP WM+PEV
Sbjct: 123 HSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 849 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD----P 904
+ E K D++S G + E+ T K PW M + + Q +P +
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240
Query: 905 LVARIIWECWQTDPSLRPSFAQL 927
+ RI E LRPS +L
Sbjct: 241 FLKRIFVEA-----KLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 74/259 (28%), Positives = 136/259 (52%), Gaps = 15/259 (5%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLR 732
P E E+IG GS +GEV+ N T+ V K +D + + + + ++E+ ++ +
Sbjct: 2 PEELFTKLEKIGKGS-FGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
P V + G+ + L II E+L GS +L +DE + + ++ +G++ LH
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH 118
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+ +HRD+K+ N+L+ ++ VK++DFG++ +T + + GTP WMAPEV++
Sbjct: 119 SEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
+ K D++S G+ ELA + P ++PM+V+ + N P L+ ++ + E
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-----PPTLEGNYSKPLKE 231
Query: 913 ----CWQTDPSLRPSFAQL 927
C +PS RP+ +L
Sbjct: 232 FVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 81/282 (28%), Positives = 130/282 (46%), Gaps = 22/282 (7%)
Query: 686 LGS-SYGEVYHADWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
LGS ++G VY W VK K L + S A E E +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+G + + +IT+ +P G L + + + + + +A+GMN L +V
Sbjct: 75 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LV 131
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 857
HRDL + N+LV +VK++DFGL++L + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 858 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 916
DV+S+GV +WEL T P+ G+ P + ++ + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 917 DPSLRPSFAQLT-----VALKPLQRLVI----PSHPDQPSSA 949
D RP F +L +A P + LVI H P+ +
Sbjct: 251 DADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 292
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 73/255 (28%), Positives = 118/255 (46%), Gaps = 24/255 (9%)
Query: 697 DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIITE 754
D G VAVK L ++ +K+E+ I++ L H N+V + G + L +I E
Sbjct: 30 DGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88
Query: 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814
++P GSL L P +++ + + A + GM LH+ +HRDL + N+L+D +
Sbjct: 89 YVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDR 144
Query: 815 NVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 871
VK+ DFGL++ H + + W A E L+ + DV+SFGV L+EL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
Query: 872 T------------LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD-PLVARIIWE-CWQTD 917
T ++ M VV + R + +P + P I+ + CW+T+
Sbjct: 205 THCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE 264
Query: 918 PSLRPSFAQLTVALK 932
RP+F L LK
Sbjct: 265 AKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 81/243 (33%), Positives = 127/243 (52%), Gaps = 28/243 (11%)
Query: 675 WEDLVLGERIGLGSSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
WE ++GE +G G+ +G+VY A T V A K +D S L ++ E+ I+ H
Sbjct: 7 WE--IIGE-LGDGA-FGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDH 61
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRI---LHRPHCQVDEKRRIKMALDVARGMNC 790
PN+V + A NL I+ EF G++ + L RP + + K L+ +N
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNY 118
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL- 849
LH + I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 119 LHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 850 ----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
++ P + K DV+S G+ L E+A ++ P +NPM+V+ L+I K P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSEPPT 227
Query: 906 VAR 908
+A+
Sbjct: 228 LAQ 230
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 724 EVKIMR-RLRHPNVVLFMGAVTRPPNLSIITEFL---PRGSLFRILHRPHCQVDEKRRIK 779
EV I++ +LRHPN+V + L I+ + + P G F L + E+R
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 780 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH-NTFLSSKSTA 838
+ + + + LH IVHRDL N+++ ++ V ++DFGL++ K + L+S
Sbjct: 118 IFVQMVLALRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV--V 174
Query: 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNR 894
GT + PE+++NEP EK DV++FG IL+++ TL+ P+ N ++V AV
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV----- 229
Query: 895 RLEIPKELDPL--------VARIIWECWQTDPSLRPSFAQLT 928
+PL V +I C D RP Q++
Sbjct: 230 -------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 64/229 (27%), Positives = 113/229 (49%), Gaps = 22/229 (9%)
Query: 690 YGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMGAVTRP 746
YG V+ A T A+K D ++ E I+ + + P VV +
Sbjct: 6 YGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK 65
Query: 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 806
NL ++ E+LP G L +L ++ RI +A ++ + LH++ I+HRDLK
Sbjct: 66 KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSNG--IIHRDLKPD 122
Query: 807 NLLVDKNWNVKVSDFGLSRL--------KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 858
N+L+D N ++K++DFGLS++ ++ K GTP+++APEV+ + ++
Sbjct: 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTV 182
Query: 859 DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDP 904
D +S G IL+E P+ G P ++ FQN ++E P++++
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILNGKIEWPEDVEV 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 9/234 (3%)
Query: 703 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 762
VAVK + + A E RE +M++L +P +V +G + + ++ E G L
Sbjct: 25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAELGPLN 83
Query: 763 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822
+ L + V EK ++ V+ GM L + VHRDL + N+L+ K+SDFG
Sbjct: 84 KFLQKNK-HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFG 140
Query: 823 LSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWI 878
LS+ + +K+ P +W APE + + K DV+SFGV++WE + P+
Sbjct: 141 LSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200
Query: 879 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
GM +V + R+E P+ P + ++ CW RP FA + + L+
Sbjct: 201 GMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 77/269 (28%), Positives = 130/269 (48%), Gaps = 28/269 (10%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHA-DWNGTEVAVKKFLD----QDFSGAALLEFKREVKIM 728
P D L +R+G G+ YG+VY A + + E+A K + DFS ++E+ ++
Sbjct: 7 PQHDYELIQRVGSGT-YGDVYKARNLHTGELAAVKIIKLEPGDDFS-----LIQQEIFMV 60
Query: 729 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALDV 784
+ +H N+V + G+ L I E+ GSL I H Q+ + +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQI-----AYVCRET 115
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844
+G+ LH+ +HRD+K N+L+ N +VK++DFG++ T KS GTP WM
Sbjct: 116 LQGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWM 173
Query: 845 APEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEI 898
APEV +N N+ CD+++ G+ ELA L+ P ++PM+ ++ FQ +L+
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD 233
Query: 899 PKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ + +P RP+ +L
Sbjct: 234 KTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR------PHCQVDEK 775
E +I++ +RHP +V G+ NL ++ E++P G LF L + P +
Sbjct: 49 LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF--- 105
Query: 776 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSS 834
A V + LH+ IV+RDLK NLL+D + +K++DFG + R+K T+
Sbjct: 106 ----YAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--- 156
Query: 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-- 892
+ GTPE++APE++ ++ + D ++ G++++E+ P+ NP+Q+ ++
Sbjct: 157 -TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-----YEKI 210
Query: 893 -NRRLEIPKELDPLVARIIWECWQTDPSLR 921
++ P P +I Q D + R
Sbjct: 211 LEGKVRFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 81/256 (31%), Positives = 125/256 (48%), Gaps = 13/256 (5%)
Query: 681 GERIGLG-SSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
GER+ LG +YG VY A T+V A+K+ ++D L E+ + L+H N+V
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV 68
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTST 795
++G+ + I E +P GSL +L + +E+ I + G+ LH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 796 PTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
IVHRD+K N+LV+ V K+SDFG S+ +++ GT ++MAPEV+ P
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 855 --NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
D++S G + E+AT K P+I + P + VG EIP+ L I
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246
Query: 912 ECWQTDPSLRPSFAQL 927
C++ DP R S L
Sbjct: 247 RCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 45/156 (28%), Positives = 91/156 (58%), Gaps = 3/156 (1%)
Query: 720 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRI 778
E ++EV ++ ++HPN+V + + NL I+ ++ G L+ +I + E + +
Sbjct: 45 ESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 838
+ + + +H I+HRD+KS N+ + K+ +K+ DFG++R+ ++T +++
Sbjct: 105 DWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI 162
Query: 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 874
GTP +++PE+ N P N K D+++ G +L+E+ TLK
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 73/250 (29%), Positives = 130/250 (52%), Gaps = 12/250 (4%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
E+IG G+S G VY A G EVA+K+ Q L+ E+ +MR +HPN+V +
Sbjct: 25 EKIGQGAS-GTVYTAIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNY 81
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+ + L ++ E+L GSL ++ +DE + + + + + LH++ ++
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--VI 137
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSNEKC 858
HRD+KS N+L+ + +VK++DFG + S +ST GTP WMAPEV+ + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 859 DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTD 917
D++S G++ E+ + P++ NP++ + + L+ P++L + + C + D
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256
Query: 918 PSLRPSFAQL 927
R S +L
Sbjct: 257 VEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 75/256 (29%), Positives = 125/256 (48%), Gaps = 8/256 (3%)
Query: 674 PWEDLVLGERIGLGS-SYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 732
P L +IG GS + G +VAVKK +D L F EV IMR +
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKK-MDLRKQQRRELLFN-EVVIMRDYQ 74
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HPN+V + L ++ EFL G+L I+ H +++E++ + L V + ++ LH
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLH 132
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
++HRD+KS ++L+ + VK+SDFG KS GTP WMAPEV+
Sbjct: 133 AQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRLEIPKELDPLVARIIW 911
P + D++S G+++ E+ + P+ P+Q + + +L+ ++ P + +
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250
Query: 912 ECWQTDPSLRPSFAQL 927
DP+ R + A+L
Sbjct: 251 RMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 49/274 (17%)
Query: 689 SYGEVYHADWNGT------EVAVKKFLDQDFSGAALLE---FKREVKIMRRLRHPNVVLF 739
++G +++ EV VK D A+ ++ +E ++ L H N++
Sbjct: 18 TFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 740 MGAVTR---PP-------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
+ PP N + FL + L + ++ + MA+ +A GM+
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL--GEANNPQALSTQQLVHMAIQIACGMS 131
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE-----WM 844
LH ++H+D+ + N ++D+ VK++D LSR + F G E WM
Sbjct: 132 YLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNENRPVKWM 186
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE---- 897
A E L N+ + DV+SFGV+LWEL TL + P++ ++P ++ + G+ RL
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---RLAQPIN 243
Query: 898 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931
P EL ++A CW DP RPSF+QL L
Sbjct: 244 CPDELFAVMAC----CWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 6e-23
Identities = 79/266 (29%), Positives = 126/266 (47%), Gaps = 25/266 (9%)
Query: 681 GERIGLGSSYGEV---YHADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 734
G+ +G G+ +G V Y D G E+A K+ + + + + E+++++ L+H
Sbjct: 7 GKLLGQGA-FGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 735 NVVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
+V + G + L+I E++P GS+ L + + + E K + GM+ LH
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVL 849
++ IVHRD+K N+L D NVK+ DFG S+ +S +S GTP WM+PEV+
Sbjct: 124 SNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP----L 905
E K DV+S G + E+ T K PW M + + Q ++P +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241
Query: 906 VARIIWECWQTDPS----LRPSFAQL 927
+ I E PS LR FAQL
Sbjct: 242 LGCIFVEARHR-PSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 58/238 (24%), Positives = 115/238 (48%), Gaps = 12/238 (5%)
Query: 693 VYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV----LFMGAVTRPP 747
+Y +N EV ++ F L++ + E+K +RR+ N++ + V P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
LS+I E+ RG L +L + + K ++ MA+D +G+ L+ T +++L S +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNK-PYKNLTSVS 153
Query: 808 LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGV 865
LV +N+ +K+ GL ++ + K+ + + ++L + K D+YS GV
Sbjct: 154 FLVTENYKLKIICHGLEKILSSP--PFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 866 ILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 923
+LWE+ T K+P+ + ++ + +N L++P + + I+ C D RP+
Sbjct: 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPN 268
|
Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPN 735
+IG G+ YG VY A G VA+KK F + AL RE+K+++ L HPN
Sbjct: 5 GKIGEGT-YGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPN 59
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 795
++ + +L ++ EF+ L++++ + E + +G+ H+
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLR 850
I+HRDLK NLL++ +K++DFGL+R S T W APE+L
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVTRWYRAPELLL 171
Query: 851 NEPS-NEKCDVYSFGVILWELATLKLPWIGMN 881
+ + D++S G I EL + + + G +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 69/267 (25%), Positives = 124/267 (46%), Gaps = 31/267 (11%)
Query: 680 LGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
LGE G G S + N + K + D + + RE++I + + P +V +
Sbjct: 9 LGE--GAGGSVTKCRLK--NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 740 MGAVTRPP--NLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTS 794
GA ++ I E+ GSL I + + + EK K+A V +G++ LH+
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
I+HRD+K N+L+ + VK+ DFG+S N+ + + GT +MAPE ++ +P
Sbjct: 125 K--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPY 180
Query: 855 NEKCDVYSFGVILWELATLKLPWI-----GMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909
+ DV+S G+ L E+A + P+ + P++++ + + P+ D I
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELKDEPGNGI 236
Query: 910 IW---------ECWQTDPSLRPSFAQL 927
W +C + DP+ RP+ +
Sbjct: 237 KWSEEFKDFIKQCLEKDPTRRPTPWDM 263
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 86/285 (30%), Positives = 126/285 (44%), Gaps = 62/285 (21%)
Query: 680 LGERIGLGSSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN 735
L E IG G+ YG+VY H G VA+K D E K E I+R+ HPN
Sbjct: 10 LVEVIGEGT-YGKVYKARHKK-TGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPN 64
Query: 736 VVLFMGAVT--RPPN----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL------D 783
+ F GA PP L ++ E GS+ ++ + +R+K +
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR---KKGKRLKEEWIAYILRE 121
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR------LKHNTFLSSKST 837
RG+ LH + ++HRD+K N+L+ KN VK+ DFG+S + NTF+
Sbjct: 122 TLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----- 174
Query: 838 AGTPEWMAPEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 892
GTP WMAPEV+ + + + DV+S G+ ELA K P M+PM+ + F+
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK 229
Query: 893 NRRLEIPKELDPLVAR----------IIWECWQTDPSLRPSFAQL 927
IP+ P + I EC + RP +L
Sbjct: 230 -----IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 83/258 (32%), Positives = 122/258 (47%), Gaps = 30/258 (11%)
Query: 684 IGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVV 737
IG GS +G VY A T VA+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGS-FGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTI 78
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTST 795
+ G R ++ E+ GS IL H+ Q E I +G+ LH+
Sbjct: 79 EYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAI--CHGALQGLAYLHSHE 135
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVL--RN 851
+HRD+K+ N+L+ + VK++DFG + L N+F+ GTP WMAPEV+ +
Sbjct: 136 --RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMD 187
Query: 852 EPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARI 909
E + K DV+S G+ ELA K P MN M + + QN + +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSSNDWSDYFRNF 246
Query: 910 IWECWQTDPSLRPSFAQL 927
+ C Q P RPS +L
Sbjct: 247 VDSCLQKIPQDRPSSEEL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 67/248 (27%), Positives = 124/248 (50%), Gaps = 8/248 (3%)
Query: 684 IGLGSSYGEV--YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 741
+G GS YGEV +G + +KK ++ S ++E +++ +L+HPN+V +
Sbjct: 8 VGKGS-YGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 742 AVTRPPN-LSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTPTIV 799
+ L I+ F G L+ L ++ E + ++ + +A + LH I+
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--IL 124
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 859
HRDLK+ N+ + + +KV D G++R+ N + + GTP +M+PE+ N+P N K D
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSD 184
Query: 860 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 919
V++ G ++E+ATLK + + +V + + + +PK+ P + +I P
Sbjct: 185 VWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLSKRPE 243
Query: 920 LRPSFAQL 927
RPS +
Sbjct: 244 KRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 98.3 bits (244), Expect = 3e-22
Identities = 71/249 (28%), Positives = 128/249 (51%), Gaps = 10/249 (4%)
Query: 682 ERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
E+IG G+S G V+ A G EVA+K+ Q L+ E+ +M+ L++PN+V F
Sbjct: 25 EKIGQGAS-GTVFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPNIVNF 81
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+ + L ++ E+L GSL ++ C +DE + + + + + LH + ++
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTET-C-MDEAQIAAVCRECLQALEFLHANQ--VI 137
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 859
HRD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 860 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDP 918
++S G++ E+ + P++ NP++ + + L+ P++L P+ + C + D
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDV 257
Query: 919 SLRPSFAQL 927
R S +L
Sbjct: 258 EKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVL 738
++IG G + EVY A +G VA+KK D A A + +E+ ++++L HPNV+
Sbjct: 8 KKIGRGQ-FSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTST 795
+ + L+I+ E G L R++ Q + EK K + + + +H+
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLR 850
++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 --VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 851 NEPSNEKCDVYSFGVILWELATLKLPWIG 879
N K D++S G +L+E+A L+ P+ G
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 66/239 (27%), Positives = 117/239 (48%), Gaps = 9/239 (3%)
Query: 693 VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752
VY +VA+K L + + E RE +IM +L +P +V +G V L ++
Sbjct: 15 VYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG-VCEAEALMLV 72
Query: 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 812
E G L + L ++ +++ V+ GM L VHRDL + N+L+
Sbjct: 73 MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVN 130
Query: 813 NWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWE 869
K+SDFGLS+ +++ ++S P +W APE + + + DV+S+G+ +WE
Sbjct: 131 QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
Query: 870 -LATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ + P+ M +V+ + Q +RL+ P E P + ++ +CW RP+FA++
Sbjct: 191 AFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 2e-21
Identities = 77/281 (27%), Positives = 137/281 (48%), Gaps = 12/281 (4%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
E+IG G+S G VY A G EVA+K+ Q L+ E+ +MR ++PN+V +
Sbjct: 25 EKIGQGAS-GTVYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPNIVNY 81
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+ + L ++ E+L GSL ++ C +DE + + + + ++ LH++ ++
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALDFLHSNQ--VI 137
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 859
HRD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 860 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDP 918
++S G++ E+ + P++ NP++ + + L+ P+ L + + C + D
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDV 257
Query: 919 SLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 959
R S +L P +L P P +E NS+
Sbjct: 258 DRRGSAKELL--QHPFLKLAKPLSSLTPLIIAAKEAIKNSS 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-21
Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 6/188 (3%)
Query: 699 NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758
G +VAVKK +D L F EV IMR H NVV + L ++ EFL
Sbjct: 46 TGKQVAVKK-MDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103
Query: 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 818
G+L I+ H +++E++ + L V R ++ LH ++HRD+KS ++L+ + +K+
Sbjct: 104 GALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKL 159
Query: 819 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 878
SDFG KS GTP WMAPEV+ P + D++S G+++ E+ + P+
Sbjct: 160 SDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219
Query: 879 GMNPMQVV 886
P+Q +
Sbjct: 220 NEPPLQAM 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 69/261 (26%), Positives = 131/261 (50%), Gaps = 21/261 (8%)
Query: 679 VLGERIGLGSSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
+L +R+G GS +G VY A +K+ + + ++ +E +++ +L H
Sbjct: 3 ILQQRLGKGS-FGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQ--VDEKRRIKMALDVARGMNC 790
P +V F + IITE+ L ++ H + E + + + + G++
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 850
+H I+HRDLK+ N+ + N +K+ DFG+SRL + + + GTP +M+PE L+
Sbjct: 122 MHQRR--ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 851 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP----KELDPLV 906
++ + K D++S G IL+E+ L + G N + VV + + +P ++L+ ++
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQLNSIM 237
Query: 907 ARIIWECWQTDPSLRPSFAQL 927
++ DPSLRPS A++
Sbjct: 238 QSML----NKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 723 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 782
RE++IM R P +V F GA N+ + EF+ GSL RI + + + K+A+
Sbjct: 52 RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILGKIAV 110
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 842
V G+ L+ + I+HRD+K N+LV+ +K+ DFG+S N+ + + GT
Sbjct: 111 AVVEGLTYLY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTST 167
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-----------F 891
+M+PE ++ K DV+S G+ + ELA K P+ + + G
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF-AFSNIDDDGQDDPMGILDLLQQIV 226
Query: 892 QNRRLEIPKELDPLVAR-IIWECWQTDPSLRPSFAQLT 928
Q +P P R + C DP+ RP+ QL
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 76/272 (27%), Positives = 131/272 (48%), Gaps = 26/272 (9%)
Query: 686 LGSS-YGEVYHADW----NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLF 739
LGS +G V+ W + ++ V QD SG E + M L H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+G + +L ++T+ P GSL + + +D +R + + +A+GM L +V
Sbjct: 75 LG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MV 131
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTP-EWMAPEVLRNEP 853
HR+L + N+L+ + V+++DFG++ L K + S TP +WMA E +
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY----SEHKTPIKWMALESILFGR 187
Query: 854 SNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
+ DV+S+GV +WE+ + P+ GM P +V + + RL P+ V ++ +
Sbjct: 188 YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTIDVYMVMVK 246
Query: 913 CWQTDPSLRPSFAQLT-----VALKPLQRLVI 939
CW D ++RP+F +L +A P + LVI
Sbjct: 247 CWMIDENVRPTFKELANEFTRMARDPPRYLVI 278
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 74/260 (28%), Positives = 123/260 (47%), Gaps = 13/260 (5%)
Query: 686 LGS-SYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
LGS ++G VY W +G V + K L ++ S A E E +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+G + + ++T+ +P G L + ++ + + + +A+GM+ L +V
Sbjct: 75 LG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LV 131
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 857
HRDL + N+LV +VK++DFGL+RL + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 858 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 916
DV+S+GV +WEL T P+ G+ P + + + + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 917 DPSLRPSFAQLTVALKPLQR 936
D RP F +L + R
Sbjct: 251 DSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 7/230 (3%)
Query: 699 NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758
+G VAVKK +D L F EV IMR +H NVV + L ++ EFL
Sbjct: 44 SGKLVAVKK-MDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 818
G+L I+ H +++E++ + L V + ++ LH ++HRD+KS ++L+ + VK+
Sbjct: 102 GALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKL 157
Query: 819 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 878
SDFG KS GTP WMAPE++ P + D++S G+++ E+ + P+
Sbjct: 158 SDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217
Query: 879 GMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
P++ + + +L+ ++ P + + DP+ R + A+L
Sbjct: 218 NEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 682 ERIGLGSSYGEVYHADWNGTE--VAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHPN 735
+IG G+ YG+VY A T VA+KK ++ + F A+ RE+K++++LRHPN
Sbjct: 5 AQIGEGT-YGQVYKARNKKTGELVALKKIRMENEKEGFPITAI----REIKLLQKLRHPN 59
Query: 736 VVLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLH 792
+V VT SI + E++ L +L P + E + IK + G+ LH
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ-IKCYMKQLLEGLQYLH 117
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APE 847
++ I+HRD+K N+L++ + +K++DFGL+R + S T W PE
Sbjct: 118 SNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVITLWYRPPE 171
Query: 848 VLRNEPS-NEKCDVYSFGVILWELAT 872
+L + D++S G IL EL
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 50/165 (30%), Positives = 93/165 (56%), Gaps = 3/165 (1%)
Query: 714 SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV- 772
S +A+ + ++E ++ +++HPN+V F + +L I+ E+ G L + + ++
Sbjct: 38 SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF 97
Query: 773 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832
E ++ + + G+ +H ++HRD+KS N+ + +N VK+ DFG +RL +
Sbjct: 98 PEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155
Query: 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
+ + GTP ++ PE+ N P N K D++S G IL+EL TLK P+
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 3e-20
Identities = 69/249 (27%), Positives = 126/249 (50%), Gaps = 10/249 (4%)
Query: 682 ERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
E+IG G+S G VY A G EVA+++ Q L+ E+ +MR ++PN+V +
Sbjct: 26 EKIGQGAS-GTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY 82
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+ + L ++ E+L GSL ++ C +DE + + + + + LH++ ++
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALEFLHSNQ--VI 138
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 859
HRD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 860 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDP 918
++S G++ E+ + P++ NP++ + + L+ P++L + + C D
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 919 SLRPSFAQL 927
R S +L
Sbjct: 259 EKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-20
Identities = 54/158 (34%), Positives = 87/158 (55%), Gaps = 15/158 (9%)
Query: 778 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 836
I + VARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K
Sbjct: 176 ISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233
Query: 837 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 894
A P +WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + F R
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRR 288
Query: 895 -----RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
R+ P+ P + I+ +CW +P RP+F++L
Sbjct: 289 LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 50/138 (36%), Positives = 80/138 (57%), Gaps = 3/138 (2%)
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVL 849
H + ++HRD+KS N+L+ N VK+ DFG S++ T ++ GTP ++APE+
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909
R +P ++K D++S GV+L+EL TLK P+ G N M+ V R +P + P + I
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPSISPEMQEI 276
Query: 910 IWECWQTDPSLRPSFAQL 927
+ +DP RPS ++L
Sbjct: 277 VTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 71/260 (27%), Positives = 126/260 (48%), Gaps = 23/260 (8%)
Query: 677 DLVLGERIGLGSSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 733
+ + ++IG G + EVY A + VA+KK + + A + +E+ ++++L H
Sbjct: 3 NFQIEKKIGRGQ-FSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNC 790
PNV+ ++ + L+I+ E G L +++ Q + E+ K + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMA 845
+H+ ++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+
Sbjct: 122 MHSRR--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMS 174
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKE-L 902
PE + N K D++S G +L+E+A L+ P+ G MN + + Q +P E
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDYPPLPTEHY 233
Query: 903 DPLVARIIWECWQTDPSLRP 922
+ ++ C DP RP
Sbjct: 234 SEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 69/254 (27%), Positives = 117/254 (46%), Gaps = 29/254 (11%)
Query: 691 GEVYHADWNGTEVA--VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748
GE + G A V K L + L F +EV+ R L HPNV+ +G
Sbjct: 14 GEAH----RGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 749 LSIITEFLPRGSLFRILH--RPHCQVDEKRRI--KMALDVARGMNCLHTSTPTIVHRDLK 804
++ EF P G L L R ++ + +MA +VA G+ LH + +H DL
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--DFIHSDLA 127
Query: 805 SPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN------- 855
N + + +VK+ D+GL + + +++ A W+APE++ +
Sbjct: 128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQT 187
Query: 856 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK-ELD-PLVAR---I 909
+K +++S GV +WEL T P+ ++ QV+ V + + +++PK +LD R +
Sbjct: 188 KKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQLDLKYSDRWYEV 246
Query: 910 IWECWQTDPSLRPS 923
+ CW DP RP+
Sbjct: 247 MQFCW-LDPETRPT 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 78/264 (29%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 676 EDLVLG-ERIGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVKIM 728
E++ +G IG GS +G VY A + T VAVKK +SG E +EVK +
Sbjct: 20 EEIFVGLHEIGHGS-FGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFL 75
Query: 729 RRLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
++L+HPN + + G + ++ E+ L + +P +V+ AL +
Sbjct: 76 QQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---Q 132
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846
G+ LH+ ++HRD+K+ N+L+ + VK++DFG + + S GTP WMAP
Sbjct: 133 GLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAP 186
Query: 847 EVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
EV+ + K DV+S G+ ELA K P MN M + + + E
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWT 246
Query: 904 PLVARIIWECWQTDPSLRPSFAQL 927
+ C Q P RP+ A+L
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-19
Identities = 56/157 (35%), Positives = 87/157 (55%), Gaps = 5/157 (3%)
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG 839
+ VARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K +A
Sbjct: 180 SFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 840 TP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLE 897
P +WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 898 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
P+ P + RI+ CWQ DP RP+F+ L L L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 77/289 (26%), Positives = 127/289 (43%), Gaps = 62/289 (21%)
Query: 684 IGLGSSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 740
+G GS YG V H + G VA+KKFL+ + RE++++++LRH N+V +
Sbjct: 9 VGEGS-YGMVMKCKHKE-TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 800
R L ++ EF+ L + P+ +DE R K + RG+ H+ I+H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN--IIH 123
Query: 801 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT----PEWM-APEVLRNEPSN 855
RD+K N+LV ++ VK+ DFG +R L++ T W APE+L +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYTDYVATRWYRAPELLVGDTKY 178
Query: 856 EK-CDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVG------------- 890
+ D+++ G ++ E+ T P+ ++ +G
Sbjct: 179 GRAVDIWAVGCLVTEMLT-------GEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 891 --FQNRRLEIPKELDPL----------VARIIWECWQTDPSLRPSFAQL 927
F RL KE++PL V + +C + DP RPS +QL
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-19
Identities = 90/341 (26%), Positives = 148/341 (43%), Gaps = 82/341 (24%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKRE 724
E P + L LG+ +G G+ +G+V AD G + VAVK L + + + E
Sbjct: 3 EFPRDRLKLGKPLGRGA-FGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMSE 60
Query: 725 VKIMRRL-RHPNVVLFMGAVTRP--PNLSII----------------TEFLP---RGSLF 762
+KI+ + H NVV +GA T+P P + I+ EF+P + + F
Sbjct: 61 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARF 120
Query: 763 R-------------------------------ILHRPHCQVDEKRR-------------- 777
R + + V+E+
Sbjct: 121 RQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLED 180
Query: 778 -IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSK 835
I + VA+GM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K
Sbjct: 181 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238
Query: 836 STAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQN 893
A P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + +
Sbjct: 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 298
Query: 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 299 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 42/156 (26%)
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALDVARGMNCLHTSTPTIVHRD 802
+L ++ E++P G L +L R +E R + +ALD + +HRD
Sbjct: 75 HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF--------IHRD 126
Query: 803 LKSPNLLVDKNWNVKVSDFGLS-----------------------------RLKHNTFLS 833
+K N+L+D + ++K++DFGL R +
Sbjct: 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186
Query: 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 869
+ ST GTP+++APEVLR P +CD +S GVIL+E
Sbjct: 187 ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 8e-19
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 32/209 (15%)
Query: 679 VLGERIGLGSSYGEVYHA-DWN-GTEVAVKKFLDQDFSGA-------ALLEFKREVKIMR 729
G+++G G+ Y VY A D G VA+KK + A AL RE+K+++
Sbjct: 3 EKGKKLGEGT-YAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLLQ 57
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC---QVDEKRRIKMALDVAR 786
L+HPN++ + N++++ EF+ L +++ D K + M L R
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---R 113
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK----STAGTPE 842
G+ LH++ I+HRDLK NLL+ + +K++DFGL+R +F S T
Sbjct: 114 GLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR----SFGSPNRKMTHQVVTRW 167
Query: 843 WMAPEVLRNEPS-NEKCDVYSFGVILWEL 870
+ APE+L D++S G I EL
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 84/307 (27%), Positives = 123/307 (40%), Gaps = 53/307 (17%)
Query: 646 LESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGT-EVA 704
L PSSS SS+S +L RIG G+ G VY T +
Sbjct: 47 LPPPSSSSSSSSSSSAS---GSAPSAAKSLSELERVNRIGSGAG-GTVYKVIHRPTGRLY 102
Query: 705 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 764
K + + + RE++I+R + HPNVV + ++ EF+ GSL
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL--- 159
Query: 765 LHRPHCQVDEKRRIKMAL---DVAR----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 817
E I DVAR G+ LH IVHRD+K NLL++ NVK
Sbjct: 160 ---------EGTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVK 208
Query: 818 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC-----DVYSFGVILWELAT 872
++DFG+SR+ T S+ GT +M+PE + + ++ D++S GV + E
Sbjct: 209 IADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 873 LKLPWIGMNPMQVVGAVGFQ------------NRRLEIPKELDPLVARIIWECWQTDPSL 920
+ P+ VG Q ++ E P I C Q +P+
Sbjct: 269 GRFPF----------GVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAK 318
Query: 921 RPSFAQL 927
R S QL
Sbjct: 319 RWSAMQL 325
|
Length = 353 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 73/262 (27%), Positives = 121/262 (46%), Gaps = 40/262 (15%)
Query: 677 DLVLGERIGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKR------EVKIM 728
D +GE +G GS +G V A GT A+K ++ +L+ K+ E I+
Sbjct: 19 DFEMGETLGTGS-FGRVRIAKHKGTGEYYAIKCLKKRE-----ILKMKQVQHVAQEKSIL 72
Query: 729 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR-- 786
L HP +V M + + + EF+ G LF L ++ + DVA+
Sbjct: 73 MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---------RKAGRFPNDVAKFY 123
Query: 787 ------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAG 839
LH+ I++RDLK NLL+D +VKV+DFG + ++ TF + G
Sbjct: 124 HAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCG 177
Query: 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 899
TPE++APEV++++ + D ++ GV+L+E P+ P ++ + RL+ P
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAGRLKFP 235
Query: 900 KELDPLVARIIWECWQTDPSLR 921
D ++ QTD + R
Sbjct: 236 NWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 53/158 (33%), Positives = 88/158 (55%), Gaps = 3/158 (1%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
K E I+ + HP +V A L +I +FL G LF L + +E + +A
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 841
++A ++ LH+ I++RDLK N+L+D+ ++K++DFGLS+ + + S GT
Sbjct: 106 -ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 879
E+MAPEV+ + D +SFGV+++E+ T LP+ G
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 25/223 (11%)
Query: 689 SYGEVYHAD--WNGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFMGAVT 744
++G VY A G A+K D + + K E IM P V +
Sbjct: 8 AFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ 67
Query: 745 RPPNLSIITEFLPRG---SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 801
L ++ E+L G SL + L + E + +V G+ LH I+HR
Sbjct: 68 SKDYLYLVMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG--IIHR 121
Query: 802 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 861
D+K NLL+D+ ++K++DFGLSR L +K GTP+++APE + ++ D +
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKMSDWW 177
Query: 862 SFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKE 901
S G +++E P+ P V F N RR+ P+E
Sbjct: 178 SLGCVIFEFLFGYPPFHAETPDAV-----FDNILSRRINWPEE 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 83/286 (29%), Positives = 129/286 (45%), Gaps = 27/286 (9%)
Query: 656 STSKVDQIFDDDVCEC---EIPWEDLVLGERIGLGSSYGEVYHA-DWNGTEV-AVKKFLD 710
STS+ + D ++ E E P + IG GS +G VY A D EV A+KK
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGS-FGAVYFARDVRTNEVVAIKKM-- 58
Query: 711 QDFSGAALLE----FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRI 764
+SG E +EVK ++R++HPN + + G R ++ E+ L +
Sbjct: 59 -SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEV 117
Query: 765 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824
+P +V+ AL +G+ LH+ ++HRD+K+ N+L+ + VK++DFG +
Sbjct: 118 HKKPLQEVEIAAITHGAL---QGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSA 172
Query: 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMN 881
+ + S GTP WMAPEV+ + K DV+S G+ ELA K P MN
Sbjct: 173 SIAS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228
Query: 882 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
M + + E + C Q P RP+ +L
Sbjct: 229 AMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-18
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 42/215 (19%)
Query: 684 IGLGSSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
IG G+ YG V A G +VA+KK F D + L RE+K++R LRH N++
Sbjct: 8 IGSGA-YGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENII 62
Query: 738 -LFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 790
L + RPP+ I+TE + L +++ P D+ + + + RG+
Sbjct: 63 GLL--DILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFL-YQILRGLKY 118
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM------ 844
LH++ ++HRDLK N+LV+ N ++K+ DFGL+R ++
Sbjct: 119 LHSAN--VIHRDLKPSNILVNSNCDLKICDFGLAR-------GVDPDEDEKGFLTEYVVT 169
Query: 845 ----APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
APE+L + + D++S G I EL T K
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 53/201 (26%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
E ++++ + HP ++ L ++ E++P G LF L R + + A
Sbjct: 49 HNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYA 107
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 840
++ + LH+ IV+RDLK N+L+DK ++K++DFG ++ L+ T+ + GT
Sbjct: 108 SEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGT 161
Query: 841 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 900
PE++APEV++++ N+ D ++ G++++E+ P+ NP + + +LE P+
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPR 219
Query: 901 ELDPLVARIIWECWQTDPSLR 921
LD +I + D + R
Sbjct: 220 HLDLYAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 84/269 (31%), Positives = 120/269 (44%), Gaps = 35/269 (13%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRL-RHPNV 736
E IG G+ YG+VY +G+ AVK LD D E + E I++ L HPNV
Sbjct: 28 ETIGKGT-YGKVYKVTNKKDGSLAAVK-ILDPISDVDE----EIEAEYNILQSLPNHPNV 81
Query: 737 VLFMGAVTRPPNLS-----IITEFLPRGS---LFRILHRPHCQVDEKRRIKMALDVARGM 788
V F G + L ++ E GS L + L ++DE + G+
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 848
LH + I+HRD+K N+L+ VK+ DFG+S +T L ++ GTP WMAPEV
Sbjct: 142 QHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
Query: 849 LRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
+ E + +CDV+S G+ EL P M+P++ + F+ R P L
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL----FKIPRNPPPTLLH 255
Query: 904 PL-----VARIIWECWQTDPSLRPSFAQL 927
P I +C D RPS L
Sbjct: 256 PEKWCRSFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
E +I+ HP +V + ++ E+ G L+ IL R
Sbjct: 41 FSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD---------RGLFD 91
Query: 782 LDVAR--------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL-----SRLKH 828
AR LH I++RDLK NLL+D N VK+ DFG S K
Sbjct: 92 EYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT 149
Query: 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVV 886
TF GTPE++APE++ N+ + D +S G++L+EL T + P+ +PM++
Sbjct: 150 WTFC------GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY 203
Query: 887 GAVGFQNRRLEIPKELDP 904
+ N +LE P +D
Sbjct: 204 NDILKGNGKLEFPNYIDK 221
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 75/269 (27%), Positives = 130/269 (48%), Gaps = 28/269 (10%)
Query: 676 EDLVLGERIGLGSSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMR 729
+DL + E +G G+ YG V H GT +AVK+ S E KR ++ I
Sbjct: 1 DDLEVIEELGRGA-YGVVDKMRHVP-TGTIMAVKRIRATVNSQ----EQKRLLMDLDISM 54
Query: 730 RLRH-PNVVLFMGAVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALDVAR 786
R P V F GA+ R ++ I E + ++ ++ + E K+A+ + +
Sbjct: 55 RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846
+ LH S +++HRD+K N+L+++N VK+ DFG+S ++ ++ AG +MAP
Sbjct: 115 ALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAP 172
Query: 847 EVLRNEPS----NEKCDVYSFGVILWELATLKLP---WIGMNPMQVVGAVGFQNRRLEIP 899
E + E + + K DV+S G+ + ELAT + P W P Q + V + ++P
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW--KTPFQQLKQV-VEEPSPQLP 229
Query: 900 KE-LDPLVARIIWECWQTDPSLRPSFAQL 927
E P + +C + + RP++ +L
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 723 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKR----R 777
E +I++ L HP +V + N+ ++ + L G L + + + ++ +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE 108
Query: 778 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837
I +AL+ I+HRD+K N+L+D+ +V ++DF ++ L++ ST
Sbjct: 109 IVLALEYLHSKG--------IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-ST 159
Query: 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
+GTP +MAPEVL + + D +S GV +E K P+
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 7e-18
Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 37/271 (13%)
Query: 680 LGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 737
L E +G G+ YG+VY T ++A K +D +G E K+E+ ++++ H N+
Sbjct: 10 LVELVGNGT-YGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 738 LFMGAVTR--PPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNC 790
+ GA + PP + ++ EF GS+ ++ ++ I + ++ RG++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 850
LH ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 127 LHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 851 NEPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
+ + + K D++S G+ E+A P M+PM+ + IP+ P
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPR 235
Query: 906 VARIIW---------ECWQTDPSLRPSFAQL 927
+ W C + S RP+ QL
Sbjct: 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 682 ERIGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
+G G+ YG V T VA+KKF + + REVK++R+LRH N+V
Sbjct: 7 GVVGEGA-YGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
A R L ++ E++ R +L +L + + + + H+ I+
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--II 122
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEVLRNEP 853
HRD+K N+LV ++ +K+ DFG +R L ++ + T + APE+L +
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 854 SNEK-CDVYSFGVILWELAT 872
+ K DV++ G I+ EL
Sbjct: 178 NYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-18
Identities = 59/188 (31%), Positives = 99/188 (52%), Gaps = 6/188 (3%)
Query: 699 NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758
+G +VAVK +D L F EV IMR +H NVV + L ++ EFL
Sbjct: 45 SGRQVAVK-MMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102
Query: 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 818
G+L I+ + +++E++ + V + + LH+ ++HRD+KS ++L+ + VK+
Sbjct: 103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKL 158
Query: 819 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 878
SDFG KS GTP WMAPEV+ P + D++S G+++ E+ + P+
Sbjct: 159 SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218
Query: 879 GMNPMQVV 886
+P+Q +
Sbjct: 219 SDSPVQAM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-17
Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 4/198 (2%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
E ++++ RHP + + L + E+ G LF L R +++ R A +
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-E 103
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 843
+ ++ LH S +V+RDLK NL++DK+ ++K++DFGL + + K+ GTPE+
Sbjct: 104 IVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
+APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLS 220
Query: 904 PLVARIIWECWQTDPSLR 921
P ++ + DP R
Sbjct: 221 PEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 46/154 (29%), Positives = 84/154 (54%), Gaps = 3/154 (1%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
E ++++ RHP + + L + E++ G LF L R +++ R A +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-E 103
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 843
+ ++ LH+ IV+RDLK NL++DK+ ++K++DFGL + + K+ GTPE+
Sbjct: 104 IVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
+APEVL + D + GV+++E+ +LP+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 80/270 (29%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 676 EDLV-LGERIGLGSSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVK-IMRR 730
EDL LGE IG G+ +G V H +GT +AVK+ + ++ +MR
Sbjct: 4 EDLKDLGE-IGRGA-FGTVNKMLHKP-SGTIMAVKR-IRSTVDEKEQKRLLMDLDVVMRS 59
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI------KMALDV 784
P +V F GA+ R + I E L SL + + K I K+A+
Sbjct: 60 SDCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEV--LKSVIPEEILGKIAVAT 116
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844
+ +N L I+HRD+K N+L+D+N N+K+ DFG+S ++ ++ AG +M
Sbjct: 117 VKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYM 174
Query: 845 APEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRL--E 897
APE + + + + DV+S G+ L+E+AT K P+ N + Q+ V L
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS 234
Query: 898 IPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+E P I C D S RP + +L
Sbjct: 235 EEREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 5/198 (2%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
E ++++ RHP + A L + E+ G LF L R +E+ R A +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-E 103
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 843
+ + LH+ +V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE+
Sbjct: 104 IVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
+APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLS 219
Query: 904 PLVARIIWECWQTDPSLR 921
P ++ + DP R
Sbjct: 220 PEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 679 VLGERIGLGSSYGEVYHA-DWN-GTEVAVKKF---LDQDFSGAALLEFKREVKIMRRLR- 732
IG G+ YG VY A D N G VA+KK L ++ + L RE+ ++++L
Sbjct: 2 EELAEIGEGA-YGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL---REIALLKQLES 57
Query: 733 --HPNVVLFMG-----AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDV 784
HPN+V + R L+++ E + + L L + IK + +
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844
RG++ LH+ IVHRDLK N+LV + VK++DFGL+R+ +F + ++ W
Sbjct: 117 LRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWY 172
Query: 845 -APEVLRNEPSNEKCDVYSFGVILWELATLK 874
APEVL D++S G I EL +
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 45/224 (20%)
Query: 722 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKR--- 776
+ E +++ +R P +V A L +I +++ G LF L R H E R
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 777 -RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835
I +ALD LH I++RD+K N+L+D +V ++DFGLS+ FL+ +
Sbjct: 112 AEIVLALD------HLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEE 159
Query: 836 -----STAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 888
S GT E+MAPEV+R ++ D +S GV+ +EL T G +P V G
Sbjct: 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT------GASPFTVDGE 213
Query: 889 VGFQNRRLEI-----------PKELDPLVARIIWECWQTDPSLR 921
QN + EI PK + I + + DP R
Sbjct: 214 ---QNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-17
Identities = 46/144 (31%), Positives = 80/144 (55%), Gaps = 3/144 (2%)
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
+++ L+HP +V + L + +++ G LF L R C ++ + R A +VA
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVAS 107
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846
+ LH+ I++RDLK N+L+D +V ++DFGL + ++ + GTPE++AP
Sbjct: 108 AIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
Query: 847 EVLRNEPSNEKCDVYSFGVILWEL 870
EVLR EP + D + G +L+E+
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 56/165 (33%), Positives = 87/165 (52%), Gaps = 24/165 (14%)
Query: 676 EDLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
D + ++G G+ +GEVY A G VA+KK L + + RE+KI+++L+H
Sbjct: 8 RDYEILGKLGEGT-FGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 734 PNVV-LFMGAVTRPPNLSIITEFLPRGSLFRI-----------LHRPHCQVDEKRRIK-M 780
PNVV L AV RP RGS++ + L P ++ E + IK
Sbjct: 67 PNVVPLIDMAVERPDKSKRK-----RGSVYMVTPYMDHDLSGLLENPSVKLTESQ-IKCY 120
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825
L + G+N LH + I+HRD+K+ N+L+D +K++DFGL+R
Sbjct: 121 MLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-17
Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 9/156 (5%)
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTP 841
VA GM L ++ VHRDL + N+L+ + VK+ DFGL+R ++ + ++S ST
Sbjct: 248 VANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---KLPWIGMNPMQVVGAVGFQNRRLEI 898
+WMAPE + N DV+SFG++LWE+ TL P + MN Q A+ + R+
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-QFYNAIK-RGYRMAK 363
Query: 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
P + I+ +CW+ +RP F+QL + L
Sbjct: 364 PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 8e-17
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 682 ERIGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVK-------IMRRLR 732
++G G YG+V+ A T VA+K+ LL EV+ I+ +
Sbjct: 7 TQVGQGG-YGQVFLAKKKDTGEIVALKRMKKS------LLFKLNEVRHVLTERDILTTTK 59
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
+V + A L + E++P G +L+ ++ R MA ++ LH
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH 118
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+HRDLK N L+D + ++K++DFGLS+ + S G+P++MAPEVLR +
Sbjct: 119 ELG--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 885
+ D +S G +L+E P+ G P +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-17
Identities = 55/159 (34%), Positives = 88/159 (55%), Gaps = 15/159 (9%)
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTP 841
VARGM L ++ VHRDL + N+L+ + VK+ DFGL+R + + ++S ST
Sbjct: 246 VARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR-----R 895
+WMAPE + + DV+S+G++LWE+ +L P+ GM +V + F N+ R
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM----IVDST-FYNKIKSGYR 358
Query: 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ P V I+ +CW ++P RPSF L+ ++ L
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 79/279 (28%), Positives = 122/279 (43%), Gaps = 44/279 (15%)
Query: 675 WEDLVLGERIGLGSSYGEVY--HADWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRR 730
WE + E IG G+ YG+V+ NG++ AVK LD D E + E I++
Sbjct: 20 WE---IIETIGKGT-YGKVFKVLNKKNGSKAAVK-ILDPIHDIDE----EIEAEYNILKA 70
Query: 731 LR-HPNVVLFMGA-----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
L HPNVV F G V L ++ E GS+ ++ + + +A +
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 785 ARG-MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 843
M H +HRD+K N+L+ VK+ DFG+S +T L ++ GTP W
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190
Query: 844 MAPEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898
MAPEV+ E + +CDV+S G+ EL P ++PM+ + +I
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKI 241
Query: 899 PKELDPLVAR----------IIWECWQTDPSLRPSFAQL 927
P+ P + + I +C D RP+ + L
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 40/229 (17%)
Query: 689 SYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM----------RRL-----RH 733
S+G+V+ A+ GT +Q F+ AL K++V +M +R+ H
Sbjct: 7 SFGKVFLAELKGT--------NQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLAWEH 55
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLH 792
P + NL + E+L G L + H C + D R A ++ G+ LH
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLR 850
+ IV+RDLK N+L+D + ++K++DFG+ K N +K+ GTP+++APE+L
Sbjct: 114 SKG--IVYRDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 851 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 899
+ N D +SFGV+L+E+ + P+ G + ++ FQ+ R++ P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 73/250 (29%), Positives = 112/250 (44%), Gaps = 22/250 (8%)
Query: 684 IGLGSSYGEVYHA-DWNGTEV-AVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVV 737
IG GS +G VY A D +EV A+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGS-FGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 738 LFMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ G R ++ E+ L S +H+ Q E + +G+ LH+
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG--ALQGLAYLHSH-- 134
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 856
++HRD+K+ N+L+ + VK+ DFG + + + GTP WMAPEV+ +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQ 190
Query: 857 ---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913
K DV+S G+ ELA K P MN M + + + C
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 914 WQTDPSLRPS 923
Q P RP+
Sbjct: 251 LQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 46/152 (30%), Positives = 84/152 (55%), Gaps = 8/152 (5%)
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
+L + E+L G L + + DE R A ++ G+ LH I++RDLK N
Sbjct: 70 HLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDN 126
Query: 808 LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 867
+L+DK+ ++K++DFG+ + N + + GTP+++APE+L+ + NE D +SFGV+L
Sbjct: 127 VLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLL 186
Query: 868 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 899
+E+ + P+ G + ++ F + + P
Sbjct: 187 YEMLIGQSPFHGEDEDEL-----FDSILNDRP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-16
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 22/198 (11%)
Query: 684 IGLGSSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHP 734
IG GS +G+V A E AVK + A+L+ K E IM + ++HP
Sbjct: 3 IGKGS-FGKVLLARHKAEEKFYAVKVLQKK-----AILKKKEEKHIMSERNVLLKNVKHP 56
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
+V + L + +++ G LF L R C ++ + R A ++A + LH+
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSL 115
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTPEWMAPEVLRNE 852
IV+RDLK N+L+D ++ ++DFGL + ++HN ++ + GTPE++APEVL +
Sbjct: 116 N--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ 171
Query: 853 PSNEKCDVYSFGVILWEL 870
P + D + G +L+E+
Sbjct: 172 PYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPN 735
E+IG G+ YG VY A G VA+KK L+ + G A+ RE+ +++ L HPN
Sbjct: 5 EKIGEGT-YGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI----REISLLKELNHPN 59
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMAL-DVARGMNCLHT 793
+V + V L ++ EFL L + + P +D IK L + +G+ H+
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAYCHS 117
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPE----WM-A 845
++HRDLK NLL+D+ +K++DFGL+R + T+ T E W A
Sbjct: 118 HR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--------THEVVTLWYRA 167
Query: 846 PEVLRNEPS-NEKCDVYSFGVILWELATLK 874
PE+L + D++S G I E+ +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 26/200 (13%)
Query: 684 IGLGSSYGEVYHADWNGT-EV----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNV 736
+G GS +G+V A+ GT E+ +KK L D + E KR + + + HP +
Sbjct: 3 LGKGS-FGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE-KRVLALAGK--HPFL 58
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
L + E++ G L + R + DE R A ++ G+ LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERG- 116
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEVLR 850
I++RDLK N+L+D ++K++DFG+ + +TF GTP+++APE+L
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF------CGTPDYIAPEILS 169
Query: 851 NEPSNEKCDVYSFGVILWEL 870
+P D ++ GV+L+E+
Sbjct: 170 YQPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ RIG G+ +G V+ A G VA+KK + G + RE+K ++ +HP VV
Sbjct: 4 ILGRIGEGA-HGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTS 794
+ ++ E++P L +L RP + K ++M L G+ +H +
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHAN 118
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----W-MAPEVL 849
I+HRDLK NLL+ + +K++DFGL+RL F + + + W APE+L
Sbjct: 119 G--IMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQVATRWYRAPELL 172
Query: 850 RNEPS-NEKCDVYSFGVILWEL 870
+ D+++ G I EL
Sbjct: 173 YGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 6e-16
Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 11/158 (6%)
Query: 721 FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIK 779
F+ E I+ P + A NL ++ E+ P G L +L+R Q DE +
Sbjct: 48 FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY 107
Query: 780 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTA 838
+A ++ ++ +H VHRD+K N+L+D+ ++K++DFG + RL N ++SK
Sbjct: 108 LA-ELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV 164
Query: 839 GTPEWMAPEVLRNEPSNEK------CDVYSFGVILWEL 870
GTP+++APEVL + K CD +S GVI +E+
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 8e-16
Identities = 69/262 (26%), Positives = 119/262 (45%), Gaps = 30/262 (11%)
Query: 676 EDLVLGERIGLGSSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734
+D+ E +G G+ G VY A + K + D + + E++I+ + P
Sbjct: 1 QDIQYQEILGHGNG-GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI------KMALDVARGM 788
++ F GA +SI TEF+ GSL D R+I ++A+ V +G+
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGL 108
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 848
L + I+HRD+K N+LV+ VK+ DFG+S N+ +K+ GT +MAPE
Sbjct: 109 TYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPER 164
Query: 849 LRNEPSNEKCDVYSFGVILWELATLKLPWI-------GMNPMQVVGAVGFQNRRLEIPKE 901
+ E DV+S G+ ELA + P+ + P+Q++ + ++ + +
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224
Query: 902 LDPLVARIIWECWQTDPSLRPS 923
I +C + P RP+
Sbjct: 225 FSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 27/261 (10%)
Query: 691 GEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750
GEV + + +V VK+ L S ++F E + R L+H N++ +G T
Sbjct: 14 GEVN-SGYTPAQVVVKE-LRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL 71
Query: 751 IITEFLPRGSLFRILHRPHCQV------DEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 804
++ EF P G L L C+ D +MA ++A G+ LH +H DL
Sbjct: 72 LVMEFCPLGDLKGYLRS--CRKAELMTPDPTTLQRMACEIALGL--LHLHKNNFIHSDLA 127
Query: 805 SPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSN------- 855
N L+ + VK+ D+GLS K+ + +++ W+APE++ N
Sbjct: 128 LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQT 187
Query: 856 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVG-AVGFQNRRLEIPKELDPLVAR---II 910
++ +V+S GV +WEL L P+ ++ QV+ V Q +L P+ PL R ++
Sbjct: 188 KESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVM 247
Query: 911 WECWQTDPSLRPSFAQLTVAL 931
CW P RPS ++ + L
Sbjct: 248 QFCW-LQPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-16
Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 5/179 (2%)
Query: 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811
++ + IL +D + + + VA+GM+ L ++ +HRDL + N+L+
Sbjct: 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLT 248
Query: 812 KNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWE 869
K+ DFGL+R +++++ K A P +WMAPE + N + DV+S+G++LWE
Sbjct: 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 308
Query: 870 LATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ +L P+ GM + + R+ P+ + I+ CW DP RP+F Q+
Sbjct: 309 IFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 26/269 (9%)
Query: 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHP 734
E VL E +G G+ YG VY T V + K + + + + E+ I+ + P
Sbjct: 2 EIEVLDE-LGKGN-YGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSP 59
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLH 792
+V F GA + + E++ GSL ++ + E ++ V +G+ L
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRN 851
I+HRD+K N+LV+ N VK+ DFG+S N S +K+ G +MAPE +++
Sbjct: 120 EEH-NIIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 852 EPSNE------KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------EIP 899
N+ + DV+S G+ + E+A + P+ P + + Q + +P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDGDPPTLP 231
Query: 900 KELDPLVARIIWECWQTDPSLRPSFAQLT 928
+ +C P+ RP++AQL
Sbjct: 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 683 RIGLGSSYGEVYHAD--WNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPNV 736
+IG G+ +GEV+ A VA+KK L + F AL RE+KI++ L+H NV
Sbjct: 19 KIGQGT-FGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL----REIKILQLLKHENV 73
Query: 737 VLFMGAVTRPPN--------LSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVA 785
V + ++ EF L +L + + K+ +KM L+
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN-- 130
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG------ 839
G+ +H + I+HRD+K+ N+L+ K+ +K++DFGL+R F SK++
Sbjct: 131 -GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNRYTNR 183
Query: 840 --TPEWMAPEVLRNEPS-NEKCDVYSFGVILWELAT 872
T + PE+L E D++ G I+ E+ T
Sbjct: 184 VVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 682 ERIGLGSSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
E+IG G+ YG VY T VA+KK L+ + G RE+ +++ L+HPN+V
Sbjct: 6 EKIGEGT-YGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPNIVC 63
Query: 739 FMGAVTRPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMAL-DVARGMNCLHTSTP 796
+ + L +I EFL L + L P Q + +K L + +G+ H+
Sbjct: 64 LQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-N 855
++HRDLK NLL+D +K++DFGL+R T + APEVL P +
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYS 180
Query: 856 EKCDVYSFGVILWELATLK 874
D++S G I E+AT K
Sbjct: 181 TPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 45/155 (29%), Positives = 81/155 (52%), Gaps = 5/155 (3%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMAL 782
E ++++ RHP + + L + E+ G LF H +V E R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA 102
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 842
++ + LH+ +V+RDLK NL++DK+ ++K++DFGL + + + K+ GTPE
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
++APEVL + D + GV+++E+ +LP+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
KR + RHP +V ++ + E+ G L +H E R + A
Sbjct: 50 KRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYA 107
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKST-AG 839
V G+ LH + IV+RDLK NLL+D VK++DFGL K F ST G
Sbjct: 108 ACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCG 163
Query: 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 870
TPE++APEVL D + GV+++E+
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-15
Identities = 58/187 (31%), Positives = 81/187 (43%), Gaps = 19/187 (10%)
Query: 700 GTEVAVKKFLDQDFSGAALL-EFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEFLP 757
G EVA+K F+RE + RL HPN+V L P L + E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 758 RGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DK 812
+L +L + R + LD + C H IVHRDLK N++V
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD---ALACAHNQG--IVHRDLKPQNIMVSQTGV 117
Query: 813 NWNVKVSDFGLSRLKHNTFLSSKSTA-------GTPEWMAPEVLRNEPSNEKCDVYSFGV 865
+ KV DFG+ L + +T GTP + APE LR EP D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 866 ILWELAT 872
I E T
Sbjct: 178 IFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 22/198 (11%)
Query: 684 IGLGSSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHP 734
IG GS +G+V A AVK A+L+ K + IM + ++HP
Sbjct: 3 IGKGS-FGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHP 56
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
+V + L + +++ G LF L R + + R A ++A + LH+
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSL 115
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNE 852
I++RDLK N+L+D +V ++DFGL K S ++ GTPE++APEVLR +
Sbjct: 116 N--IIYRDLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 853 PSNEKCDVYSFGVILWEL 870
P + D + G +L+E+
Sbjct: 172 PYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 679 VLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN 735
+ +++G G+ +G VY A G VA+KK + +S + REVK +R+L HPN
Sbjct: 2 KVIKQLGDGT-FGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPN 59
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
+V L + E++ G+L++ + R E + + +G+ +H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPEWM-APEV-LR 850
HRDLK NLLV VK++DFGL+R + + ST W APE+ LR
Sbjct: 119 G--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST----RWYRAPEILLR 172
Query: 851 NEPSNEKCDVYSFGVILWELATLK 874
+ + D+++ G I+ EL TL+
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 22/233 (9%)
Query: 705 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 764
V K L D L F +M +L H ++V G R N+ ++ E++ G L
Sbjct: 34 VLKVLGSD--HRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVF 90
Query: 765 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------VK 817
LHR V ++ +A +A ++ L +VH ++ N+LV + +K
Sbjct: 91 LHREKNNVSLHWKLDVAKQLASALHYLEDK--KLVHGNVCGKNILVARYGLNEGYVPFIK 148
Query: 818 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN--EKCDVYSFGVILWELAT-LK 874
+SD G+ T LS + W+APE +RN ++ D +SFG L E+ + +
Sbjct: 149 LSDPGIPI----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
Query: 875 LPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
P ++ + F + +P +A +I +CW DP+ RPSF +
Sbjct: 205 EP---LSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 40/209 (19%)
Query: 684 IGLGSSYGEVYHADWN--GTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
IG G+ YG V A G +VA+KK F Q F L RE+KI+RR +H N++
Sbjct: 13 IGEGA-YGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENIIG 67
Query: 739 FMGAVTRPPNLS------IITEFLPRGSLFRI-----LHRPHCQVDEKRRIKMALDVARG 787
+ + RPP+ I+ E + L+++ L H Q + RG
Sbjct: 68 IL-DIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQY-------FLYQILRG 118
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTPE 842
+ +H++ ++HRDLK NLL++ N ++K+ DFGL+R+ H FL+ T
Sbjct: 119 LKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT--EYVATRW 174
Query: 843 WMAPEVLRNEPSNEKC-DVYSFGVILWEL 870
+ APE++ N K D++S G IL E+
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 75/271 (27%), Positives = 117/271 (43%), Gaps = 34/271 (12%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR- 732
DL IG G+ G+VY + G +AVK+ E KR I+ L
Sbjct: 15 NDLENLGEIGSGTC-GQVYKMRFKKTGHVMAVKQMRRTGNKE----ENKR---ILMDLDV 66
Query: 733 ----H--PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
H P +V G ++ I E L L ++L R + E KM + + +
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKS---TAGTPE 842
++ L ++HRD+K N+L+D + NVK+ DFG+S RL + SK+ +AG
Sbjct: 126 ALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL-----VDSKAKTRSAGCAA 179
Query: 843 WMAPEVLRNEPSNEK----CDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNR-RL 896
+MAPE + N K DV+S G+ L ELAT + P+ +V+ + + L
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ P + C D RP + +L
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 19/221 (8%)
Query: 680 LGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 737
L E +G G+ YG+VY T ++A K +D + E K E+ ++++ H N+
Sbjct: 20 LVEVVGNGT-YGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 738 LFMGAVTR--PP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNC 790
+ GA + PP L ++ EF GS+ ++ ++ I + ++ RG+
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 850
LH ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 137 LHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 851 NEPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVV 886
+ + + + D++S G+ E+A P M+PM+ +
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 56/176 (31%), Positives = 96/176 (54%), Gaps = 16/176 (9%)
Query: 700 GTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLP 757
G VA+KK + + FS L + RE+K+++ LRH N++ P ++ +TE L
Sbjct: 35 GQNVAIKKIM-KPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93
Query: 758 RGSLFRILH-RPHCQVDEKRRIK-MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 815
L R+L RP EK+ I+ + RG+ +H++ +VHRDLK N+L+++N +
Sbjct: 94 T-DLHRLLTSRPL----EKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCD 146
Query: 816 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEKCDVYSFGVILWEL 870
+K+ DFGL+R++ ST + APE+ L + + + D++S G I E+
Sbjct: 147 LKICDFGLARIQDPQMTGYVSTR---YYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 6/149 (4%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 782
E KI+ ++ +V A +L ++ + G L + I + E R I A
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTP 841
+ G+ LH IV+RDLK N+L+D + NV++SD GL+ LK K AGTP
Sbjct: 103 QIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTP 158
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWEL 870
+MAPEVL+ E + D ++ G L+E+
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 51/240 (21%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW---NGTEVAVKKF----------LDQDFSGA 716
+ ++ +ED +G GS +G V A + + VA+K+F +D FS
Sbjct: 24 KNKMKYEDFNFIRTLGTGS-FGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-- 80
Query: 717 ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR 776
E KI+ + HP V G+ L ++ EF+ G F L R KR
Sbjct: 81 -------ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR------NKR 127
Query: 777 -----------RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825
+I + + + +N IV+RDLK NLL+DK+ +K++DFG ++
Sbjct: 128 FPNDVGCFYAAQIVLIFEYLQSLN--------IVYRDLKPENLLLDKDGFIKMTDFGFAK 179
Query: 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 885
+ + + GTPE++APE+L N + D ++ G+ ++E+ P+ P+ +
Sbjct: 180 VVDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 680 LGERIGLGSSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFK------------REV 725
G +G G+ YG+V A D G VA+KK + S + + RE+
Sbjct: 13 KGAHLGEGT-YGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 726 KIMRRLRHPNVVLFMGAV---TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 782
KIM ++H N+ MG V ++++ + + L +++ R + + + + L
Sbjct: 72 KIMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-L 126
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--- 839
+ G+N LH +HRDL N+ ++ K++DFGL+R S +
Sbjct: 127 QILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 840 ------TPE----WM-APEVLRN-EPSNEKCDVYSFGVILWELATLK 874
T + W APE+L E + D++S G I EL T K
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 9/190 (4%)
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
+++ ++HP +V + L + +F+ G LF L R + + R A ++A
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIAS 107
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846
+ LH+ IV+RDLK N+L+D +V ++DFGL + ++ + GTPE++AP
Sbjct: 108 ALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
Query: 847 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906
EV+R +P + D + G +L+E+ G+ P + L P L P
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEML------YGLPPFYCRDVAEMYDNILHKPLVLRPGA 219
Query: 907 ARIIWECWQT 916
+ W +
Sbjct: 220 SLTAWSILEE 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 41/229 (17%)
Query: 684 IGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK----REVKIMRRLRHPNVV 737
+G G+ YG+V A T +VA+KK L + F A RE+++++ + H NV+
Sbjct: 23 VGSGA-YGQVCSAFDTKTGRKVAIKK-LSRPFQSA---IHAKRTYRELRLLKHMDHENVI 77
Query: 738 LFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMN 789
+ T +L ++T + L I+ CQ D+ + + + RG+
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK---CQKLSDDHIQF-LVYQILRGLK 132
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPE 847
+H++ I+HRDLK N+ V+++ +K+ DFGL+R + T T + APE
Sbjct: 133 YIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPE 185
Query: 848 VLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGA 888
++ N N+ D++S G I+ EL T K + G + M +VG
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 61/194 (31%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 683 RIGLGSSYGEVYHA-DWNGTE-VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
RIG G+ YG VY A D E VA+KK +D + G + RE+ ++ LRHPN+V
Sbjct: 14 RIGEGT-YGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVEL 71
Query: 740 MGAVT--RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797
V ++ ++ E+ + L +L E + + L + RG+ LH +
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF-- 128
Query: 798 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNE 856
I+HRDLK NLL+ +K++DFGL+R T + APE+L
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 857 KCDVYSFGVILWEL 870
D+++ G IL EL
Sbjct: 189 AIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 8e-14
Identities = 53/193 (27%), Positives = 86/193 (44%), Gaps = 41/193 (21%)
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
L +I E+LP G + +L + +E+ R +A + ++ +H +HRD+K N
Sbjct: 75 YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKLG--YIHRDIKPDN 131
Query: 808 LLVDKNWNVKVSDFGLS-------------RLKHN----------TFLSSK--------- 835
LL+D ++K+SDFGL L H +SSK
Sbjct: 132 LLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRN 191
Query: 836 ------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 889
ST GTP+++APEV N++CD +S GVI++E+ P+ NP + +
Sbjct: 192 RRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKI 251
Query: 890 GFQNRRLEIPKEL 902
L+ P E+
Sbjct: 252 INWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 4/154 (2%)
Query: 723 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 782
RE+K++ P +V F GA +SI E + GSL ++L + ++ E K+++
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISI 106
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 842
V RG+ L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT
Sbjct: 107 AVLRGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRS 163
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 876
+M+PE L+ + D++S G+ L E+A + P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 48/157 (30%), Positives = 89/157 (56%), Gaps = 11/157 (7%)
Query: 778 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 836
++ + VA+GM+ L ++ +HRD+ + N+L+ K+ DFGL+R + +++ K
Sbjct: 215 LRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 837 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM---NPMQVVGAVGF 891
A P +WMAPE + + + DV+S+G++LWE+ +L K P+ G+ + + G+
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY 332
Query: 892 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 928
Q R P P + I+ CW +P+ RP+F+Q++
Sbjct: 333 QMSR---PDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 773 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832
E R + G+ LH I++RDLK N+L+D + NV++SD GL+ +
Sbjct: 95 PEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152
Query: 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
+K AGTP +MAPE+L+ E + D ++ GV L+E+ + P+
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-13
Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 38/190 (20%)
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
NL +I EFLP G + +L + +E+ + +A + ++ +H +HRD+K N
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG--FIHRDIKPDN 131
Query: 808 LLVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------ 835
LL+D +VK+SDFGL L H+ TF ++SK
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 836 ---STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 892
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW 251
Query: 893 NRRLEIPKEL 902
L P E+
Sbjct: 252 KETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 65/254 (25%), Positives = 126/254 (49%), Gaps = 22/254 (8%)
Query: 638 GTNLKLRDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEV 693
G N + DL+ P+ ++D+ ++ ++I + + ++ ED + + IG G+ +GEV
Sbjct: 2 GLNSLVLDLDFPALRKNKNIDNFLNRYEKIVRK-IRKLQMKAEDYDVVKVIGRGA-FGEV 59
Query: 694 YHADWNGTE-VAVKKFLDQ----DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748
++ V K L + S +A F E IM P VV A
Sbjct: 60 QLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFCAFQDDKY 117
Query: 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 808
L ++ E++P G L ++ + V EK +V ++ +H+ ++HRD+K N+
Sbjct: 118 LYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNM 173
Query: 809 LVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSF 863
L+DK+ ++K++DFG ++ + + GTP++++PEVL+++ + +CD +S
Sbjct: 174 LLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 864 GVILWELATLKLPW 877
GV L+E+ P+
Sbjct: 234 GVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 14/175 (8%)
Query: 703 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 762
VA+KKF D + + RE+K++R L+ N+V A R L ++ E++ + L
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88
Query: 763 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822
+ P+ EK R + + ++ H + IVHRD+K NLL+ N +K+ DFG
Sbjct: 89 LLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFG 145
Query: 823 LSRLKHNTFLSSKSTAGTPEWMA------PEVLRNEPSNEKCDVYSFGVILWELA 871
+R LS S A E++A PE+L P + D++S G IL EL+
Sbjct: 146 FAR-----NLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-----R 776
K E I+ ++HP +V + A L +I E+L G LF L R +++
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 777 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 836
I +AL+ H I++RDLK N+L+D +VK++DFGL K + + +
Sbjct: 108 EISLALE--------HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVT 157
Query: 837 TA--GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 881
GT E+MAPE+L + D +S G +++++ T P+ N
Sbjct: 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 682 ERIGLGSSYGEVY---HADWNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHP 734
+IG GS YG V+ + + G VA+KKF+ D AL RE++++++L+HP
Sbjct: 7 SKIGEGS-YGVVFKCRNRE-TGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHP 60
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
N+V + R L ++ E+ L + P V E K+ + +N H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
+HRD+K N+L+ K +K+ DFG +R+ T + APE+L +
Sbjct: 120 N--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 855 -NEKCDVYSFGVILWELATLKLPWIG 879
DV++ G + EL T + W G
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 3/149 (2%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
E ++ ++ P +V + P L ++ F+ G LF L R D R +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAE 101
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 843
+ + LH +++RDLK N+L+D ++ + DFGL +L + + GTPE+
Sbjct: 102 LLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELAT 872
+APE+L + D ++ GV+L+E+ T
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 38/190 (20%)
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
NL +I EFLP G + +L + +E + +A + ++ +H +HRD+K N
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHRDIKPDN 131
Query: 808 LLVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------ 835
LL+D +VK+SDFGL L HN +F ++SK
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 836 ---STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 892
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW 251
Query: 893 NRRLEIPKEL 902
L P E+
Sbjct: 252 KETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 42/155 (27%), Positives = 81/155 (52%), Gaps = 9/155 (5%)
Query: 721 FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM 780
F E IM +V A L ++ E++P G L ++ + + EK
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFY 147
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAG 839
+V ++ +H+ +HRD+K N+L+DK+ ++K++DFG ++ N + + G
Sbjct: 148 TAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205
Query: 840 TPEWMAPEVLRNEPSN----EKCDVYSFGVILWEL 870
TP++++PEVL+++ + +CD +S GV L+E+
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 35/122 (28%), Positives = 74/122 (60%), Gaps = 4/122 (3%)
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 840
A ++A G+ LH+ I++RDLK N+++D ++K++DFG+ + ++++ GT
Sbjct: 107 AAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT 164
Query: 841 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 900
P+++APE++ +P + D ++FGV+L+E+ + P+ G + ++ ++ N + PK
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPK 222
Query: 901 EL 902
L
Sbjct: 223 SL 224
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 693 VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752
+ T VAVKK S L ++E+ R+L+HPN++ ++ + L ++
Sbjct: 18 LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77
Query: 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMAL---DVARGMNCLHTSTPTIVHRDLKSPNLL 809
+ + GS L + H + + +A DV ++ +H+ +HR +K+ ++L
Sbjct: 78 SPLMAYGSC-EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK--GFIHRSVKASHIL 133
Query: 810 VDKNWNVKVSDF--GLSRLKHN-----TFLSSKSTAGTPEWMAPEVLRNEPS--NEKCDV 860
+ + V +S +S +KH KS+ W++PEVL+ NEK D+
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193
Query: 861 YSFGVILWELATLKLPWIGMNPMQ 884
YS G+ ELA +P+ M Q
Sbjct: 194 YSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 782
E +I+ ++ VV A L ++ + G L F I H +E R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 842
++ G+ LH IV+RDLK N+L+D + ++++SD GL+ + + K GT
Sbjct: 110 EICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVG 166
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-E 901
+MAPEV++NE D ++ G +L+E+ + G FQ R+ +I + E
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEM--------------IAGQSPFQQRKKKIKREE 212
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937
++ LV + E + S ++ + P +RL
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 33/106 (31%), Positives = 67/106 (63%), Gaps = 2/106 (1%)
Query: 774 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833
E + A ++A G+ LH+ I++RDLK N+++D ++K++DFG+ + ++
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157
Query: 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 879
+K+ GTP+++APE++ +P + D ++FGV+L+E+ + P+ G
Sbjct: 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 47/155 (30%), Positives = 89/155 (57%), Gaps = 14/155 (9%)
Query: 748 NLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 806
+L + EFL G L F I + + D R A ++ G+ LH+ I++RDLK
Sbjct: 70 HLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLD 125
Query: 807 NLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSNEKCDVYSFG 864
N+++D++ ++K++DFG+ K N F ++++ GTP+++APE+L+ D +SFG
Sbjct: 126 NVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFG 183
Query: 865 VILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 899
V+L+E+ + P+ G + ++ F++ R++ P
Sbjct: 184 VLLYEMLIGQSPFHGDDEDEL-----FESIRVDTP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-13
Identities = 50/174 (28%), Positives = 90/174 (51%), Gaps = 4/174 (2%)
Query: 703 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 762
+ +K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 763 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822
++L ++ E+ K+++ V RG+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 92 QVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFG 149
Query: 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 876
+S ++ + S GT +M+PE L+ + + D++S G+ L ELA + P
Sbjct: 150 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 684 IGLGSSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVV 737
IG G+ YG+V+ A G VA+K+ Q L REV ++R L HPNVV
Sbjct: 9 IGEGA-YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 738 LFMGAVT-----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
T R L+++ E + + + P V + M + RG++ LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+ +VHRDLK N+LV + +K++DFGL+R+ + S T + APEVL
Sbjct: 128 SHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVVTLWYRAPEVLLQS 184
Query: 853 PSNEKCDVYSFGVILWEL 870
D++S G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-13
Identities = 68/238 (28%), Positives = 100/238 (42%), Gaps = 60/238 (25%)
Query: 684 IGLGSSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNVVLF 739
IG G GEVY + VA+KK + +D S LL+ F RE KI L HP +V
Sbjct: 10 IGKGG-MGEVYLAYDPVCSRRVALKK-IREDLSENPLLKKRFLREAKIAADLIHPGIV-- 65
Query: 740 MGAVTRPPNLSIITEFLP--------RG----SLFR------ILHRPHCQVDEKRRIKMA 781
P SI ++ P G SL + L + EK +
Sbjct: 66 -------PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL---AEKTSVGAF 115
Query: 782 L----DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--------- 828
L + + +H+ ++HRDLK N+L+ V + D+G + K
Sbjct: 116 LSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 829 ----NTFLSSKST-----AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
S T GTP++MAPE L P++E D+Y+ GVIL+++ TL P+
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 40/223 (17%)
Query: 684 IGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
IG G+ +G V W +G VA+KK + + + RE+K++ +H NV
Sbjct: 8 IGYGA-FGVV----WSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV- 61
Query: 738 LFMGA--VTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGM 788
+ A + +PP++ ++TE + + L +I+ P + +K+ L + RG+
Sbjct: 62 --LSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSD--HVKVFLYQILRGL 116
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPE 842
LH++ I+HRD+K NLLV+ N +K+ DFGL+R+ KH T T
Sbjct: 117 KYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT-----QEVVTQY 169
Query: 843 WMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 884
+ APE+L D++S G I EL ++ + +P+Q
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 43/156 (27%), Positives = 82/156 (52%), Gaps = 6/156 (3%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 782
E +I+ ++ P +V A +L ++ + G L + I + ++ +R I +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTP 841
+ G+ LH + IV+RD+K N+L+D N ++SD GL+ LK ++ + AGT
Sbjct: 103 QITCGI--LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--AGTN 158
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
+MAPE+L+ EP + D ++ G ++E+ + P+
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HP +V L + E++ G L + R +E R A +++ +N LH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH 113
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
I++RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E
Sbjct: 114 ERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 853 PSNEKCDVYSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKELDPL 905
D ++ GV+++E+ + P+ +G NP Q FQ +++ IP+ L
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231
Query: 906 VARIIWECWQTDPSLR 921
A ++ DP R
Sbjct: 232 AASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 46/215 (21%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNV 736
E IG G+ YG V A +G +VA+KK + KR E+KI+R +H N+
Sbjct: 11 ENIGSGA-YGVVCSAIDTRSGKKVAIKKIPH---AFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRI-----------LHRP-HCQVD-EKRRIKMAL- 782
+ +I P G+ F+ LH H + I+ L
Sbjct: 67 I------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY 114
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKS 836
+ RG+ +H++ ++HRDLK NLLV+++ +++ DFG++R +H F++
Sbjct: 115 QLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 837 TAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 870
T + APE+L + P D++S G I E+
Sbjct: 173 A--TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 798 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL---------------KHNTFLSSKSTAGTPE 842
IVHRDLK NLL+ ++K++DFGLS++ K K GTPE
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
++APEV+ + + D ++ G+IL+E +P+ G P ++ G V + +E P+
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISDDIEWPEGD 239
Query: 903 DPLVAR---IIWECWQTDPSLR 921
+ L A +I + +P R
Sbjct: 240 EALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 48/174 (27%), Positives = 91/174 (52%), Gaps = 4/174 (2%)
Query: 703 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 762
+ +K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 763 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822
++L + ++ E+ K+++ V +G+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 92 QVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFG 149
Query: 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 876
+S ++ + S GT +M+PE L+ + + D++S G+ L E+A + P
Sbjct: 150 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 700 GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755
G VA+KK F + + A RE+ +M+ + H N++ + T +L EF
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAY----RELVLMKLVNHKNIIGLLNVFTPQKSLE---EF 93
Query: 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVAR----------GMNCLHTSTPTIVHRDLKS 805
+ ++ CQV I+M LD R G+ LH++ I+HRDLK
Sbjct: 94 QDVYLVMELMDANLCQV-----IQMDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKP 146
Query: 806 PNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGV 865
N++V + +K+ DFGL+R +F+ + T + APEV+ E D++S G
Sbjct: 147 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGC 205
Query: 866 ILWEL 870
I+ E+
Sbjct: 206 IMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 28/201 (13%)
Query: 689 SYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVV----LFMG 741
+YG VY A T VA+KK ++++ G + RE+ I+ +L+HPN+V + +G
Sbjct: 17 TYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVKEVVVG 75
Query: 742 AVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+ + ++ E++ SL + +P Q + K + L G+ LH + I+
Sbjct: 76 --SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL---SGVAHLHDNW--IL 128
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
HRDLK+ NLL++ +K+ DFGL+R LK T T + APE+L
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-----QLVVTLWYRAPELLLGAKE 183
Query: 855 -NEKCDVYSFGVILWELATLK 874
+ D++S G I EL T K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 40/259 (15%)
Query: 691 GEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750
E+Y D V VK+ L + S EF ++ R L+HPN++ +G
Sbjct: 14 SEIY-TDTGVARVVVKE-LKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71
Query: 751 IITEFLPRGSLFRILHRPHCQVDEKRR-------IKMALDVARGMNCLHTSTPTIVHRDL 803
++ E+ G L L Q RR +MA ++A G+ +H +H DL
Sbjct: 72 LVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDL 125
Query: 804 KSPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVL-----------R 850
N + + VKV D+G+ SR K + + W+APE++ +
Sbjct: 126 ALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQ 185
Query: 851 NEPSNEKCDVYSFGVILWEL-ATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELD-PLVA 907
+PSN V++ GV LWEL P+ ++ +V+ V +++++++ K +L+ P
Sbjct: 186 TKPSN----VWALGVTLWELFENAAQPYSHLSDREVLNHV-IKDQQVKLFKPQLELPYSE 240
Query: 908 R---IIWECWQTDPSLRPS 923
R ++ CW + P R +
Sbjct: 241 RWYEVLQFCWLS-PEKRAT 258
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-12
Identities = 45/162 (27%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 721 FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM 780
F E IM P VV A L ++ E++P G L ++ + V EK
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY 147
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAG 839
+V ++ +H+ +HRD+K N+L+DK+ ++K++DFG ++ + + G
Sbjct: 148 TAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 840 TPEWMAPEVLRNEPSN----EKCDVYSFGVILWELATLKLPW 877
TP++++PEVL+++ + +CD +S GV L+E+ P+
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 25/198 (12%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
E+IG G+ YG VY A G VA+KK LD + G RE+ +++ L HPN+V
Sbjct: 6 EKIGEGT-YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVK 63
Query: 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL------DVARGMNCLH 792
+ + L ++ EFL + + I + L + +G+ H
Sbjct: 64 LLDVIHTENKLYLVFEFLHQDL------KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+ ++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 118 SHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG- 174
Query: 853 PSNEKCDVYSFGVILWEL 870
C YS V +W L
Sbjct: 175 -----CKYYSTAVDIWSL 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 43/220 (19%)
Query: 684 IGLGSSYGEVYHADW----NGTEVAVKKF-----LDQDFSGAALLEFKREVKIMRRLRHP 734
IG G+ YG VY A +G E A+KKF S +A RE+ ++R L+H
Sbjct: 8 IGRGT-YGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALLRELKHE 62
Query: 735 NVVLFMGAVTRPPNLSI-----ITEFLPRGSLFRIL--HRPH--CQVDE---KRRIKMAL 782
NVV + + S+ E L++I+ HR + K + L
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHN---TFLSSK 835
+ G++ LH++ ++HRDLK N+LV + VK+ D GL+RL +
Sbjct: 119 N---GVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 836 STAGTPEWMAPEVLRNEPSNEKC-DVYSFGVILWELATLK 874
T + APE+L K D+++ G I EL TL+
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 722 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKR--- 776
+ E +++ +R P +V A L +I +++ G LF + R + E +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 777 -RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-S 834
I +AL+ H I++RD+K N+L+D N +V ++DFGLS+ H + +
Sbjct: 112 GEIVLALE--------HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163
Query: 835 KSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 892
S GT E+MAP+++R ++ D +S GV+++EL T G +P V G Q
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT------GASPFTVDGEKNSQ 217
Query: 893 ---NRRL-----EIPKELDPLVARIIWECWQTDPSLR 921
+RR+ P+E+ L II DP R
Sbjct: 218 AEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 683 RIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLF 739
+IG G+ + EV A G A+K + + F + RE++ +RRL HPN++
Sbjct: 6 KIGEGT-FSEVLKAQSRKTGKYYAIKC-MKKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 740 MGAVTRPPN--LSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ + L+++ E L +L+ I R + EKR + + ++ +H +
Sbjct: 64 IEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRNG- 120
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--------EWM-APE 847
I HRD+K N+L+ + +K++DFG S + P W APE
Sbjct: 121 -IFHRDIKPENILIKDD-ILKLADFG----------SCRGIYSKPPYTEYISTRWYRAPE 168
Query: 848 VLRNEPS-NEKCDVYSFGVILWELATLK 874
L + K D+++ G + +E+ +L
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 8/178 (4%)
Query: 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 808
L ++ E++ G L + R +E R A ++ +N LH I++RDLK N+
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHERG--IIYRDLKLDNV 127
Query: 809 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 868
L+D + ++K++D+G+ + ++ + GTP ++APE+LR E D ++ GV+++
Sbjct: 128 LLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMF 187
Query: 869 ELATLKLPW--IGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECWQTDPSLR 921
E+ + P+ I NP FQ + + IP+ L + ++ DP R
Sbjct: 188 EMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 682 ERIGLGSSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
E++G GS Y VY + NG VA+K Q+ G RE +++ L+H N+VL
Sbjct: 11 EKLGEGS-YATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLL 68
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-------RIKMAL-DVARGMNCL 791
+ L+++ E++ H CQ +K +K+ L + RG++ +
Sbjct: 69 HDIIHTKETLTLVFEYV---------HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
H I+HRDLK NLL+ +K++DFGL+R K + + T + P+VL
Sbjct: 120 HQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 852 EPSNEKC-DVYSFGVILWELATLKLPWIGMNPMQ 884
C D++ G I E+ + GM +Q
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 684 IGLGSSYGEVYHADWN--GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 740
IG G+ YG+VY A G VA+KK LD + G + RE+KI+R+L H N+V
Sbjct: 15 IGEGT-YGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLNHRNIVNLK 72
Query: 741 GAVT----------RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 790
VT ++ E++ L +L E + G+N
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNY 131
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVL 849
H +HRD+K N+L++ +K++DFGL+RL ++ + W PE+L
Sbjct: 132 CHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELL 189
Query: 850 RNE----PSNEKCDVYSFGVILWELATLK 874
E P+ DV+S G IL EL T K
Sbjct: 190 LGEERYGPA---IDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 10/196 (5%)
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HP +V L + EF+ G L + R +E R A +++ +N LH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLH 113
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
I++RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E
Sbjct: 114 ERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 853 PSNEKCDVYSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKELDPL 905
D ++ GV+++E+ + P+ +GM NP Q FQ +++ IP+ L
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231
Query: 906 VARIIWECWQTDPSLR 921
+ ++ DP R
Sbjct: 232 ASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 38/220 (17%)
Query: 722 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR--- 776
+ E ++ +R P +V A L +I +++ G +F L+ R + DE R
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 777 -RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835
I +AL+ H IV+RD+K N+L+D +V ++DFGLS+ FLS +
Sbjct: 112 GEIILALE--------HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEE 159
Query: 836 -----STAGTPEWMAPEVLRNEPSNEKC-DVYSFGVILWELATLKLPWIGMNPMQVVGAV 889
S GT E+MAPE++R + + K D +S G++++EL T G +P + G
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT------GASPFTLEGER 213
Query: 890 GFQ---NRRL-----EIPKELDPLVARIIWECWQTDPSLR 921
Q +RR+ P + P ++ + + DP R
Sbjct: 214 NTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-11
Identities = 44/140 (31%), Positives = 78/140 (55%), Gaps = 19/140 (13%)
Query: 798 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKSTAGTPEWMAPEVLRNEPS 854
++HRDLKS N+ + +K+ DFG S+ +++ +S + S GTP ++APE+ +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 855 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------RLEIPKELDPLVA 907
++K D++S GVIL+EL TL P+ G + +++ V + + LDPL++
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308
Query: 908 RIIWECWQTDPSLRPSFAQL 927
+ +P+LRP+ QL
Sbjct: 309 K--------NPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 37/211 (17%)
Query: 684 IGLGSSYGEVYHADWNGT--EVAVKKF---LDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
IG G+ YG V A + T +VA+KK D L RE+K++R L H NV+
Sbjct: 13 IGRGA-YGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL---REIKLLRHLDHENVIA 68
Query: 739 FMGAVTRPPN------LSIITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDVAR 786
+ + PP+ + I+ E L L +I+ HCQ + R
Sbjct: 69 -IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQY-------FLYQLLR 119
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846
G+ +H++ ++HRDLK NLL++ N ++K+ DFGL+R T + AP
Sbjct: 120 GLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
Query: 847 EVLRNEPSNE---KCDVYSFGVILWELATLK 874
E+L N +E DV+S G I EL K
Sbjct: 178 ELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 679 VLGERIGLGSSYGEVYHADWNGT-EVAVKKFLD-----QDFSGAALLEFKREVKIMRRLR 732
VLG+ S+G+V A+ GT EV K L QD + KR + + +
Sbjct: 2 VLGK-----GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK-- 54
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HP + L + E++ G L + R + DE R A +V + LH
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH 113
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+++RDLK N+L+D + K++DFG+ + +++ + GTP+++APE+L+
Sbjct: 114 RHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 853 PSNEKCDVYSFGVILWEL 870
D ++ GV+++E+
Sbjct: 172 EYGPSVDWWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 34/131 (25%), Positives = 77/131 (58%), Gaps = 3/131 (2%)
Query: 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 808
L + E++ G L + + + E + + A +++ G+ LH I++RDLK N+
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNV 132
Query: 809 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 868
++D ++K++DFG+ + +++++ GTP+++APE++ +P + D +++GV+L+
Sbjct: 133 MLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLY 192
Query: 869 ELATLKLPWIG 879
E+ + P+ G
Sbjct: 193 EMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 782
E +I+ ++ VV A L ++ + G L F I + + DE+R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTP 841
++ G+ LH IV+RDLK N+L+D ++++SD GL+ + + + GT
Sbjct: 110 EITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGRVGTV 165
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPK 900
+MAPEV++NE Y+F W L L I G +P F+ R+ ++ +
Sbjct: 166 GYMAPEVVKNER-------YTFSPDWWGLGCLIYEMIEGKSP--------FRQRKEKVKR 210
Query: 901 E 901
E
Sbjct: 211 E 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 39/126 (30%), Positives = 68/126 (53%), Gaps = 4/126 (3%)
Query: 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 805
+L ++T+++ G LF L + + E R ++ + LH IV+RDLK
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKP 124
Query: 806 PNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK-CDVYSFG 864
N+L+D ++ + DFGLS+ ++ + GT E++APEVL +E K D +S G
Sbjct: 125 ENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 865 VILWEL 870
V+++E+
Sbjct: 185 VLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 684 IGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVL 738
IG+G+ YG VY A +G VA+K Q L REV +++RL HPN+V
Sbjct: 8 IGVGA-YGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 739 FMGAVT-----RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNC 790
M R ++++ E + + L L + P + + + RG++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDF 123
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 850
LH + IVHRDLK N+LV VK++DFGL+R+ ++ ++ T + APEVL
Sbjct: 124 LHANC--IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRAPEVLL 180
Query: 851 NEPSNEKCDVYSFGVILWEL 870
D++S G I E+
Sbjct: 181 QSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-10
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-- 781
E I+R + HP+++ G T +I LPR ++ +C + KR I +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPR---YKT--DLYCYLAAKRNIAICDI 184
Query: 782 ----LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----RLKHNTFLS 833
V R + LH + I+HRD+K+ N+ ++ +V + DFG + + N +
Sbjct: 185 LAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872
AGT APE+L +P D++S G++L+E+AT
Sbjct: 243 ---WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 684 IGLGSSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+G G+ YG V A G +VA+KK F + F+ A RE+++++ ++H NV+
Sbjct: 23 VGSGA-YGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMKHENVI 77
Query: 738 LFMGAVTRPPNLSIITEF---LP-----RGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
+ T +L +F +P G L + H ++ E R + + +G+
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLK 132
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
+H + I+HRDLK NL V+++ +K+ DFGL+R T T + APEV+
Sbjct: 133 YIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVI 187
Query: 850 RN-EPSNEKCDVYSFGVILWELATLK 874
N + D++S G I+ E+ T K
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPN 735
E+IG G+ YG V+ A VA+K+ LD D G +AL RE+ +++ L+H N
Sbjct: 6 EKIGEGT-YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKN 60
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 795
+V + L+++ E+ + L + + +D + + +G+ H+
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-S 854
++HRDLK NLL++KN +K++DFGL+R + T + P+VL
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 855 NEKCDVYSFGVILWELA 871
+ D++S G I ELA
Sbjct: 178 STSIDMWSAGCIFAELA 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 700 GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755
G VAVKK F +Q + A RE+ +++ + H N++ + T +L EF
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAY----RELVLLKCVNHKNIISLLNVFTPQKSLE---EF 98
Query: 756 LPRGSLFRILHRPHCQV-----DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 810
+ ++ CQV D +R + + G+ LH++ I+HRDLK N++V
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV 156
Query: 811 DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 870
+ +K+ DFGL+R F+ + T + APEV+ E D++S G I+ EL
Sbjct: 157 KSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 679 VLGERIGLGSSYGEVYHA------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 732
VLG+ S+G+V A +V K + QD + KR + + R
Sbjct: 2 VLGK-----GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-- 54
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCL 791
HP + P L + EF+ G L + H + DE R A ++ + L
Sbjct: 55 HPFLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFL 112
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
H I++RDLK N+L+D + K++DFG+ + ++ + GTP+++APE+L+
Sbjct: 113 HDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 852 EPSNEKCDVYSFGVILWEL 870
D ++ GV+L+E+
Sbjct: 171 MLYGPSVDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 723 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKM 780
RE+ +M+ L+H N+V + L ++ E++ L + + H +D
Sbjct: 47 REISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSF 105
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKST 837
+ +G+ H + ++HRDLK NLL++K +K++DFGL+R + NTF + T
Sbjct: 106 TYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVT 163
Query: 838 AGTPEWM-APEVLRNEPS-NEKCDVYSFGVILWELAT 872
W AP+VL + + D++S G I+ E+ T
Sbjct: 164 L----WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 32/204 (15%)
Query: 703 VAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVV-----LFMGAVTRPPNLSIITEF- 755
VAVKK L S L RE+KI+RRL H N+V L ++ +TE
Sbjct: 33 VAVKKIVLTDPQSVKHAL---REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 756 -------LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 808
L +L + E+ + RG+ +H++ ++HRDLK N+
Sbjct: 90 SVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANV 145
Query: 809 LVDKNWNV-KVSDFGLSRL-----KHNTFLSSKSTAGTPEWMAPEVLRNEPSN--EKCDV 860
++ V K+ DFGL+R+ H +LS T + +P +L + P+N + D+
Sbjct: 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--TKWYRSPRLLLS-PNNYTKAIDM 202
Query: 861 YSFGVILWELATLKLPWIGMNPMQ 884
++ G I E+ T K + G + ++
Sbjct: 203 WAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 67/244 (27%), Positives = 111/244 (45%), Gaps = 43/244 (17%)
Query: 703 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 45 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKSLE---EFQDV 97
Query: 759 GSLFRILHRPHCQVDEKRRIKMALDVAR----------GMNCLHTSTPTIVHRDLKSPNL 808
+ ++ CQV I+M LD R G+ LH++ I+HRDLK N+
Sbjct: 98 YLVMELMDANLCQV-----IQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 150
Query: 809 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 868
+V + +K+ DFGL+R +F+ + T + APEV+ E D++S G I+
Sbjct: 151 VVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 869 ELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 924
E+ K+ + G + + +V+ +G E K+L P V + RP +
Sbjct: 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCP--EFMKKLQPTVRNYVEN--------RPKY 259
Query: 925 AQLT 928
A LT
Sbjct: 260 AGLT 263
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMA 781
E +++ + HP+V+ + ++ LP L+ L + + + + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAG 839
+ G+ LH I+HRD+K+ N+ ++ V + D G ++ FL AG
Sbjct: 164 KQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAG 218
Query: 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 870
T E APEVL + N K D++S G++L+E+
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 79/304 (25%), Positives = 120/304 (39%), Gaps = 82/304 (26%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRHPNVV 737
E IG GS YG V A G +VA+KK D + S A RE+K++R LRHP++V
Sbjct: 6 EVIGKGS-YGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT--RILREIKLLRLLRHPDIV 62
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA------------ 785
+ + PP+ EF +F ++ QV IK D+
Sbjct: 63 E-IKHIMLPPSRR---EFKDIYVVFELMESDLHQV-----IKANDDLTPEHHQFFLYQLL 113
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 844
R + +HT+ + HRDLK N+L + + +K+ DFGL+R+ N T W
Sbjct: 114 RALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFN------DTPTAIFWTD 165
Query: 845 --------APEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------- 881
APE+ + P+ D++S G I E+ T K + G N
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222
Query: 882 -----PMQVVGAVG-------FQNRRLEIPKEL-------DPLVARIIWECWQTDPSLRP 922
+ + V + R + P DPL R++ DP RP
Sbjct: 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282
Query: 923 SFAQ 926
+ +
Sbjct: 283 TAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 29/193 (15%)
Query: 703 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 52 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIGLLNVFTPQKSLE---EFQDV 104
Query: 759 GSLFRILHRPHCQVDEKRRIKMALDVAR----------GMNCLHTSTPTIVHRDLKSPNL 808
+ ++ CQV I+M LD R G+ LH++ I+HRDLK N+
Sbjct: 105 YIVMELMDANLCQV-----IQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 157
Query: 809 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 868
+V + +K+ DFGL+R +F+ + T + APEV+ E D++S G I+
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 869 ELATLKLPWIGMN 881
E+ + + G +
Sbjct: 217 EMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 682 ERIGLGSSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
E+IG G+ YG VY A T +A+KK L+Q+ G RE+ +++ ++H N+V
Sbjct: 8 EKIGEGT-YGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVR 65
Query: 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHTSTPT 797
V L ++ E+L + P + R IK L + RG+ H+
Sbjct: 66 LQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP-RLIKTYLYQILRGIAYCHSHR-- 122
Query: 798 IVHRDLKSPNLLVDKNWN-VKVSDFGLSR---LKHNTFLSSKSTAGTPEWM-APEVLRNE 852
++HRDLK NLL+D+ N +K++DFGL+R + TF T W APE+L
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL----WYRAPEILLGS 178
Query: 853 PS-NEKCDVYSFGVILWELATLK 874
+ D++S G I E+ K
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 37/161 (22%), Positives = 82/161 (50%), Gaps = 8/161 (4%)
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
NL ++ ++ G L +L + ++ E ++ ++ +H VHRD+K N
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDN 132
Query: 808 LLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE-----KCDVY 861
+L+D N +++++DFG +L + + S GTP++++PE+L+ + +CD +
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192
Query: 862 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
S GV ++E+ + P+ + ++ G + R + P ++
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 57/247 (23%), Positives = 99/247 (40%), Gaps = 50/247 (20%)
Query: 684 IGLGSSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFM 740
IG+G+ +GEV T A+K D K E I+ + VV
Sbjct: 9 IGIGA-FGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 800
+ NL + +++P G + +L R ++ R +A ++ + +H +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMG--FIH 124
Query: 801 RDLKSPNLLVDKNWNVKVSDFGLS---RLKHN---------------------------- 829
RD+K N+L+D++ ++K++DFGL R H+
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 830 ------------TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
+ S GTP ++APEVL + CD +S GVIL+E+ + P+
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
Query: 878 IGMNPMQ 884
+ P +
Sbjct: 245 LADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 50/168 (29%)
Query: 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 808
L +I EFLP G L +L + ++ R MA + + +H +HRD+K N+
Sbjct: 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVHKLG--FIHRDIKPDNI 132
Query: 809 LVDKNWNVKVSDFGLSRLKHNTF--------------------------------LSSK- 835
L+D+ ++K+SDFGLS H +SSK
Sbjct: 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKD 192
Query: 836 --------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 869
ST GTP+++APE+ + ++CD +S G I++E
Sbjct: 193 QIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 2e-09
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 50/213 (23%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGA--ALLEFKREVKIMRRLR-HPNV 736
+++G G+ YG V+ A VA+KK D F A A F RE+ ++ L HPN+
Sbjct: 13 QKLGKGA-YGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTF-REIMFLQELGDHPNI 69
Query: 737 VLFMGAVTRPPN---LSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDVAR 786
V + V + N + ++ E++ R ++ +H KR I L A
Sbjct: 70 VKLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--------KRYIMYQLLKA- 119
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP----- 841
+ +H+ ++HRDLK N+L++ + VK++DFGL+R + + P
Sbjct: 120 -LKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENPVLTDY 172
Query: 842 ---EWM-APEVLRNEPSNEKCDVYSFGVILWEL 870
W APE+L Y+ GV +W +
Sbjct: 173 VATRWYRAPEILLGSTR------YTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 4/157 (2%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 782
E +I+ ++ VV A L ++ + G L F I + + +E+R + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 842
++ G+ LH V+RDLK N+L+D ++++SD GL+ +K S + GT
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 879
+MAPEVL N+ D + G +++E+ + P+ G
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 53/196 (27%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 682 ERIGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
+++G G+ Y VY T+ VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 DKLGEGT-YATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTL 69
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMAL-DVARGMNCLHTSTPT 797
+ +L+++ E+L + L + L C +K+ L + RG+N H
Sbjct: 70 HDIIHTEKSLTLVFEYLDK-DLKQYLD--DCGNSINMHNVKLFLFQLLRGLNYCHRRK-- 124
Query: 798 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NE 856
++HRDLK NLL+++ +K++DFGL+R K + + T + P++L +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 857 KCDVYSFGVILWELAT 872
+ D++ G I +E++T
Sbjct: 185 QIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 682 ERIGLGSSYGEVYHAD--WNGTEVAVKK-FLDQDFSG---AALLEFKREVKIMRRLRHPN 735
E+IG G+ YG+VY A G VA+KK L+ D G AL RE+ +++ L
Sbjct: 7 EKIGEGT-YGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL----REISLLQMLSESI 61
Query: 736 VVLFMGAVTR------PPNLSIITEFLPRG-SLFRILHR--PHCQVDEKRRIKMALDVAR 786
++ + V P+L ++ E+L F + P + K + +
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMA 845
G+ H ++HRDLK NLLVDK + K++D GL R S T + A
Sbjct: 122 GVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179
Query: 846 PEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 884
PEVL + D++S G I E++ + + G + +Q
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
+M+ +PN + +VT +I +++ G LF +L + + E K+ +
Sbjct: 64 LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVE 120
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTA-GTPEWM 844
+N LH I+H D+K N+L D + + D+GL ++ + S GT ++
Sbjct: 121 ALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYF 173
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATLKLP 876
+PE ++ + D ++ GV+ +EL T K P
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 33/111 (29%), Positives = 61/111 (54%), Gaps = 8/111 (7%)
Query: 799 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPS-- 854
VHRD+K N+L+D N +++++DFG S LK N + S GTP++++PE+L+
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 855 ---NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
+CD +S GV ++E+ + P+ + ++ G + R + P +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 682 ERIGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
E++G G+ Y V+ TE VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 EKLGEGT-YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTL 69
Query: 740 MGAVTRPPNLSIITEFLPR---------GSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 789
V +L+++ E+L + G++ + +K+ L + RG+
Sbjct: 70 HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-----------HNVKIFLYQILRGLA 118
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
H ++HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 119 YCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 850 RNEPS-NEKCDVYSFGVILWELAT 872
+ + D++ G I +E+A+
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 684 IGLGSSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFK-REVKIMRRLR-HPNVV 737
+G G+ YG V A T VA+KK + FS L + RE+K++R R H N+
Sbjct: 8 LGQGA-YGIVCSARNAETSEEETVAIKK-ITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 738 -LF-MGAVTRPP-NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHT 793
L+ M V N + E L L +I+ Q + + + G+ +H+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS 123
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS----KSTAGTPEWMAPEV- 848
+ ++HRDLK NLLV+ + +K+ DFGL+R + T + APE+
Sbjct: 124 AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 849 LRNEPSNEKCDVYSFGVILWELATLK 874
L + + DV+S G IL EL K
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 10/140 (7%)
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
P +V A P LS I + + G L L + H E A ++ G+ +H
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVL-R 850
+V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL +
Sbjct: 116 RF--VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 851 NEPSNEKCDVYSFGVILWEL 870
+ D +S G +L++L
Sbjct: 170 GVAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
E V +++G G+ Y V+ TE VA+K+ + GA REV +++ L+H
Sbjct: 5 ETYVKLDKLGEGT-YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKH 62
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
N+V + L+++ E+L + + + +I M + RG++ H
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM-FQLLRGLSYCHK 121
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 853
I+HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 122 RK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 854 S-NEKCDVYSFGVILWELAT 872
+ D++ G IL+E+AT
Sbjct: 180 EYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 24/201 (11%)
Query: 684 IGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVL 738
+G G+ YG V A G VAVKK L + F +++ KR E+++++ ++H NV+
Sbjct: 25 VGSGA-YGSVCAAFDTKTGLRVAVKK-LSRPFQ--SIIHAKRTYRELRLLKHMKHENVIG 80
Query: 739 FMGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLH 792
+ T +L + L L I+ CQ ++ + + RG+ +H
Sbjct: 81 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIH 137
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN- 851
++ I+HRDLK NL V+++ +K+ DFGL+R +T T + APE++ N
Sbjct: 138 SAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNW 192
Query: 852 EPSNEKCDVYSFGVILWELAT 872
N+ D++S G I+ EL T
Sbjct: 193 MHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 27/204 (13%)
Query: 684 IGLGSSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+G G+ YG V A G +VA+KK F + F+ A RE+ +++ ++H NV+
Sbjct: 23 VGSGA-YGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY----RELTLLKHMQHENVI 77
Query: 738 LFMGAVTRPPNLSIITEF---LP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
+ T + +F +P + L +I+ P + E + + + G+ +H
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLCGLKYIH 134
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN 851
++ I+HRDLK NL V+++ +K+ DFGL+R T W APEV+ N
Sbjct: 135 SAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT----RWYRAPEVILN 188
Query: 852 -EPSNEKCDVYSFGVILWELATLK 874
N+ D++S G I+ E+ T K
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 700 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 759
GT V V+ ++ + L + EV + RHPN++ T L +I+ F+ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 760 SLFRILHRPHCQVDEKRRIKMALDVA-RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 818
S +L + + I L A RG+N LH + +HR++K+ ++L+ + V +
Sbjct: 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSL 142
Query: 819 SDFGLSRL--------KHNTF--LSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVI 866
S GLS L K ST+ P W++PE+LR + N K D+YS G+
Sbjct: 143 S--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLRQDLYGYNVKSDIYSVGIT 199
Query: 867 LWELATLKLPWIGMNPMQVV 886
ELAT ++P+ M Q++
Sbjct: 200 ACELATGRVPFQDMLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 4/155 (2%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 782
E +I+ ++ VV A L ++ + G L F I + + DE+R I A
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 842
++ G+ L IV+RDLK N+L+D ++++SD GL+ ++ + + GT
Sbjct: 110 ELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVG 166
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
+MAPEV+ NE D + G +++E+ + P+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 31/109 (28%), Positives = 61/109 (55%), Gaps = 6/109 (5%)
Query: 799 VHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE- 856
VHRD+K N+L+DKN +++++DFG RL + + S GTP++++PE+L+ +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 857 ----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901
+CD +S GV ++E+ + P+ + ++ G + + P +
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 52/212 (24%)
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
NL + +++P G + +L R + R +A ++ + +H +HRD+K N
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG--FIHRDIKPDN 131
Query: 808 LLVDKNWNVKVSDFGLS---RLKHNTFLSSK----------------------------- 835
+L+D + ++K++DFGL R HN+ K
Sbjct: 132 ILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKT 191
Query: 836 ---------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 880
S GTP ++APEVL + + CD +S GVIL+E+ + P++
Sbjct: 192 LEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAP 251
Query: 881 NPMQVVGAVGFQNRRLEIPKE--LDPLVARII 910
P + V L IP + L P +I
Sbjct: 252 TPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 34/178 (19%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMA 781
E +I+ L HP + + L ++ ++ P G LFR+L R C +E R A
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----------------- 824
+V + LH IV+RDLK N+L+ ++ ++ +SDF LS
Sbjct: 111 -EVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 825 -------RLKHNTFLS-----SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 870
+ TF S S GT E++APEV+ + D ++ G++L+E+
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 54/213 (25%)
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
NL + +++P G + +L R ++ R +A ++ + +H +HRD+K N
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMG--FIHRDIKPDN 131
Query: 808 LLVDKNWNVKVSDFGL---------------------------------------SRLK- 827
+L+D++ ++K++DFGL RLK
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKP 191
Query: 828 --------HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 879
H L+ S GTP ++APEVL + CD +S GVIL+E+ + P++
Sbjct: 192 LERRAARQHQRCLA-HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 250
Query: 880 MNPMQVVGAVGFQNRRLEIPKE--LDPLVARII 910
P++ V L IP + L P + +I
Sbjct: 251 QTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-08
Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 36/186 (19%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHR---------PHCQV 772
EV +MR L+H N+V ++ N L I+ EF G L R + + H V
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 773 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-------------KNWN---- 815
D R++ AL + + ++HRDLK N+ + N N
Sbjct: 122 DITRQLLHALAYCHNLKD-GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 816 VKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELA 871
K+ DFGLS+ N + S S GTP + +PE+L +E ++K D+++ G I++EL
Sbjct: 181 AKIGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 872 TLKLPW 877
+ K P+
Sbjct: 238 SGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 10/140 (7%)
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
P +V A P L I + + G L L + H EK A ++ G+ +H
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHN 115
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVLRN 851
+V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL+
Sbjct: 116 RF--VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 852 EPS-NEKCDVYSFGVILWEL 870
+ + D +S G +L++L
Sbjct: 170 GTAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 60/248 (24%), Positives = 112/248 (45%), Gaps = 32/248 (12%)
Query: 690 YGEVYHADWNGTEVAVKKFLD---QDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746
YGE++ TEV + K LD +++S + F +M +L H ++VL G
Sbjct: 22 YGELHK-----TEV-LLKVLDKSHRNYSES----FFEAASMMSQLSHKHLVLNYGVCVCG 71
Query: 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 806
++ E++ GSL L + ++ ++++A +A ++ L + H ++ +
Sbjct: 72 DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK--GLTHGNVCAK 129
Query: 807 NLLV-----DKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEK 857
N+L+ K N +K+SD G+S T L + W+ PE + N + +
Sbjct: 130 NVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVPPECIENPQNLSLA 185
Query: 858 CDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 916
D +SFG LWE+ + P ++ + + F R ++P +A +I +C
Sbjct: 186 ADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLPAPKWTELANLINQCMDY 242
Query: 917 DPSLRPSF 924
+P RPSF
Sbjct: 243 EPDFRPSF 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 49/180 (27%), Positives = 91/180 (50%), Gaps = 23/180 (12%)
Query: 702 EVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF--- 755
+VAVKK L + F +L+ +R E+++++ ++H NV+ + T ++ E
Sbjct: 42 KVAVKK-LSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98
Query: 756 --LPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 812
L L I+ CQ ++ + + RG+ +H++ I+HRDLK N+ V++
Sbjct: 99 TNLMGADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNE 153
Query: 813 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN-EPSNEKCDVYSFGVILWEL 870
+ +++ DFGL+R + +T W APE++ N N+ D++S G I+ EL
Sbjct: 154 DCELRILDFGLARQADDEMTGYVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 8/192 (4%)
Query: 682 ERIGLGSSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
E++G GS Y VY + NG VA+K + G RE +++ L+H N+VL
Sbjct: 11 EKLGEGS-YATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLL 68
Query: 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 799
+ L+ + E++ ++ P R+ M + RG+ +H I+
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYIHGQH--IL 125
Query: 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKC 858
HRDLK NLL+ +K++DFGL+R K + S T + P+VL +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185
Query: 859 DVYSFGVILWEL 870
D++ G I E+
Sbjct: 186 DIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 27/159 (16%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
LGE SY VY G VA+K+ + GA RE +++ L+H N+
Sbjct: 12 KLGE-----GSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANI 65
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-------RRIKMAL-DVARGM 788
V + L+++ E+L Q + +++ L + RG+
Sbjct: 66 VTLHDIIHTKKTLTLVFEYL---------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827
H ++HRDLK NLL+ + +K++DFGL+R K
Sbjct: 117 AYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-06
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
E+ M +L+HPN+V +G +I E++ +L +L + +RR K+A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIG 788
Query: 784 VARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTFLSSKSTAGT 840
+A+ + LH +P +V +L +++D ++++S GL F+SS
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA----- 843
Query: 841 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 876
++APE + EK D+Y FG+IL EL T K P
Sbjct: 844 --YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 20/236 (8%)
Query: 699 NGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 757
NG E+ V K LD AL F +M ++ H ++ G R ++ EF+
Sbjct: 41 NGRELRVVLKVLDPSHRDIAL-AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVE 99
Query: 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW--- 814
G L L + +V +I +A +A ++ L +VH ++ + N+L+ +
Sbjct: 100 HGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157
Query: 815 ----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWE 869
+K+SD G+S T LS + W+APE + S + D +SFG L E
Sbjct: 158 GTSPFIKLSDPGVSF----TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 870 LA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 924
+ ++P P + F ++ +P+ +A +I +C +P+ RPSF
Sbjct: 214 ICFDGEVPLKERTPSE---KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSF 266
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 719 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 778
L F +MR++ H ++VL G R ++ EF+ G L +HR + +
Sbjct: 49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF 108
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFGLSRLKHNTF 831
K+A +A ++ L +VH ++ + N+L+ + +K+SD G+ T
Sbjct: 109 KVAKQLASALSYLEDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TV 162
Query: 832 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 870
LS + W+APE + + + + D +SFG LWE+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 681 GERIGLGSSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
G ++G G+ YG VY A + E A+K+ S +A RE+ ++R L+HPNV
Sbjct: 6 GCKVGRGT-YGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNV 60
Query: 737 VLFMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------G 787
+ + + F L+ I+ K+ +++ + + G
Sbjct: 61 IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 788 MNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTP 841
++ LH + ++HRDLK N+LV + VK++D G +RL ++ L+
Sbjct: 121 IHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 842 EWM-APEVLRNEPSNEKC-DVYSFGVILWELAT 872
W APE+L K D+++ G I EL T
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 681 GERIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
G ++G G+ YG VY A + + A+K+ S +A RE+ ++R L+HPNV
Sbjct: 6 GCKVGRGT-YGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNV 60
Query: 737 VLFMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------G 787
+ + + F L+ I+ K+ +++ + + G
Sbjct: 61 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 788 MNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTP 841
++ LH + ++HRDLK N+LV + VK++D G +RL ++ L+
Sbjct: 121 IHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 842 EWM-APEVLRNEPSNEKC-DVYSFGVILWELAT 872
W APE+L K D+++ G I EL T
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 724 EVKIMRRLRHPNVVLFM-----GAVT---RPPNLSIITEFLPRGSLFRILHRPHCQVDE- 774
E +++RRL HP V+ + G +T P S + +L G+ R L QV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL--GARLRPLGLA--QVTAV 265
Query: 775 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834
R++ A+D G I+HRD+K+ N+LV+ ++ + DFG + ++ +
Sbjct: 266 ARQLLSAIDYIHGEG--------IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317
Query: 835 --KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 871
AGT + APEVL +P D++S G++++E A
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 27/84 (32%), Positives = 48/84 (57%), Gaps = 2/84 (2%)
Query: 798 IVHRDLKSPNLLVDKNWNVKVSDFGLS-RL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 855
I+HRD+K+ N+ +D+ N + DFG + +L H +GT E +PE+L +P
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 856 EKCDVYSFGVILWELATLKLPWIG 879
K D++S G++L+E++ + G
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 39/106 (36%), Positives = 55/106 (51%), Gaps = 14/106 (13%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVK--KFLDQDFSGAALLEFK 722
E+P ++LVLG +G G+ +G V A +G +VAVK K + AL+
Sbjct: 33 EMPRDNLVLGRTLGSGA-FGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMS-- 89
Query: 723 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 767
E+KIM L H N+V +GA T+ + IITE+ G L LHR
Sbjct: 90 -ELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-05
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 48/280 (17%)
Query: 616 KNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPW 675
+++ +E H K +F + KL + E ++ +++ D+D+ P
Sbjct: 8 EDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS--PN 65
Query: 676 EDLVLGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK-REVKIMRRLR 732
+ LG IG GS +G VY A T +VA+KK L QD ++K RE+ IM+ L
Sbjct: 66 KSYKLGNIIGNGS-FGVVYEAICIDTSEKVAIKKVL-QD------PQYKNRELLIMKNLN 117
Query: 733 HPNVVL-----FMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-- 782
H N++ + + L+++ EF+P+ H + R AL
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV--------HKYMKHYARNNHALPL 169
Query: 783 --------DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRLKHNTFLS 833
+ R + +H+ I HRDLK NLL+D N + +K+ DFG ++ N
Sbjct: 170 FLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAG 224
Query: 834 SKSTA--GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 870
+S + + + APE++ + D++S G I+ E+
Sbjct: 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
N+ ++ E+L G + +LH + DE+ +K +VA ++ LH I+HRDLK N
Sbjct: 78 NVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDN 134
Query: 808 LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846
+L+ ++K++DFGLS++ N L+ TP P
Sbjct: 135 MLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 799 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 858
+HR KS N+L+ W+ + G F + + + P +MAPEV++ + EK
Sbjct: 33 LHRQAKSGNILL--TWDGLLKLDGSV-----AFKTPEQSRPDPYFMAPEVIQGQSYTEKA 85
Query: 859 DVYSFGVILWELATLKLPWIGMNPM 883
D+YS G+ L+E +LP+ +
Sbjct: 86 DIYSLGITLYEALDYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 699 NGTEVAVKKFLDQDFSGAALLEF-KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 757
G V V++ ++ + ++ F + E+ + + HPN+V + L ++T F+
Sbjct: 24 TGEYVTVRR-INLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 758 RGSLFRILHRPHCQ--VDEKRRIKMA---LDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 812
GS ++ C +D + +A V + ++ +H VHR +K+ ++L+
Sbjct: 83 YGSAKDLI----CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISV 136
Query: 813 NWNVKVSDF--GLSRLKHNTFLS-----SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSF 863
+ V +S LS + H L K + W++PEVL+ + + K D+YS
Sbjct: 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 864 GVILWELATLKLPWIGMNPMQV 885
G+ ELA +P+ M Q+
Sbjct: 197 GITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 33/148 (22%), Positives = 66/148 (44%), Gaps = 22/148 (14%)
Query: 691 GEVYHADWNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPNV----VLFM 740
E+Y D+ G + +K + + + L E +RE +IM R R V V F+
Sbjct: 10 AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV 69
Query: 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 800
P N I+ E++ L +++ ++++ ++ R + LH++ I+H
Sbjct: 70 D----PENFIIVMEYIEGEPLKDLINSN-----GMEELELSREIGRLVGKLHSA--GIIH 118
Query: 801 RDLKSPNLLVDKNWNVKVSDFGLSRLKH 828
DL + N+++ + + DFGL+
Sbjct: 119 GDLTTSNMILSGG-KIYLIDFGLAEFSK 145
|
Length = 211 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 960 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.44 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.33 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.29 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.29 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.22 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.16 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 98.14 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 98.11 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.05 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.91 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.83 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.8 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.63 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.6 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.59 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.51 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.43 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.33 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.33 | |
| PLN02236 | 344 | choline kinase | 96.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.84 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.84 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.65 | |
| COG1305 | 319 | Transglutaminase-like enzymes, putative cysteine p | 96.51 | |
| PF04473 | 153 | DUF553: Transglutaminase-like domain; InterPro: IP | 96.48 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.47 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.38 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.19 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.13 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.1 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.01 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.87 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.72 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.65 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.48 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.39 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.28 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.11 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-65 Score=530.86 Aligned_cols=199 Identities=50% Similarity=0.872 Sum_probs=189.2
Q ss_pred chHHHHHHHhhhccccccCCcccCceeeeecCCC--CC-CCCCCCCChhhhcc-cCCCCceEEEEEeccCChhHHHHHHH
Q 002146 124 VAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLST--DP-STQGKLPSLAHLES-NLGNSGFEVVIVNRTIDHALEELVQV 199 (960)
Q Consensus 124 ~~~~~~S~r~w~~~~Lsy~d~I~dGFY~i~g~~~--d~-~~~~riPsle~L~~-~~~~~~~EVIlVDr~~D~~L~~L~~~ 199 (960)
+++|.+|||||++|+|+|+||||||||+|||+.. ++ ++++|||+|++|++ ++.++++|||||||++|++|++|+++
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~ 80 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQR 80 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHH
Confidence 3789999999999999999999999999999963 44 79999999999999 57899999999999999999999999
Q ss_pred HHHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHHhCCceeEeeecccccchhhHHHHHHHhh
Q 002146 200 AQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLAD 279 (960)
Q Consensus 200 a~~l~~~l~~~~~~~~~~~lA~~V~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~pig~l~~g~~~~~a~lfk~l~d 279 (960)
|+++++++.. +.++++++||+|||++|||++.+++....+|++++++||. +++|+|||+|++|+|||||||||+|||
T Consensus 81 a~~~~~~~~~-~~~~~v~~LA~lVa~~MGG~~~~~~~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD 157 (204)
T PF14381_consen 81 AHELSKGLST-NTKELVQKLAKLVADRMGGPVSDAEDMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLAD 157 (204)
T ss_pred HHHHHhcccc-CHHHHHHHHHHHHHHHhCCCCCcchhhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHH
Confidence 9999998864 4589999999999999999999999899999999898988 799999999999999999999999999
Q ss_pred hcCCceEEeecccccCC-CCCeeEEEEecCcceeeeecccCCCccCC
Q 002146 280 SIRLPCRLVKGSHYTGV-EDDAVNIIKLEEEREFLVDLMAAPGTLIP 325 (960)
Q Consensus 280 ~~~~~~~lv~G~~y~~~-~~~a~~~v~~~~~~~y~vDlm~~pg~l~~ 325 (960)
+|||||+||||+||||+ +++|||+|++++++|||||||++||+|+|
T Consensus 158 ~iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 158 RIGLPCRLVRGCYYCGWDDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred hcCCCceEEeeccCCccCCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 99999999999999999 88999999999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=431.01 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=224.6
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChH-HHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~-~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
.+..++|++.++||+| +||+||.++. +++.||+|++++..+.+. ....++.|..||.+++||+||+++..|++.++
T Consensus 21 ~~~~~dF~~lkviGkG-~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKG-SFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred cCChhheeeeeeeecc-CCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 4567899999999999 7999999975 788999999988776543 56778999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|||+||+.||.|+.+|++.+ .++|..+..++.+|+.||.|||++| ||||||||+|||||.+|||+|+||||++...
T Consensus 100 LylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999999998765 7888888888889999999999999 9999999999999999999999999999776
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.....+.++|||++|||||++.+..|+.++||||||+++|||++|.+||.+.+..++.++|.... .+..|..++.++++
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ard 255 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARD 255 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHH
Confidence 66667778999999999999999999999999999999999999999999999999999995332 35556679999999
Q ss_pred HHHHhhhhCCCCCC
Q 002146 909 IIWECWQTDPSLRP 922 (960)
Q Consensus 909 LI~kcL~kDP~kRP 922 (960)
||.++|.+||++|.
T Consensus 256 ll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHhccCHHHhc
Confidence 99999999999996
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=434.82 Aligned_cols=271 Identities=47% Similarity=0.793 Sum_probs=248.7
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEECCcE-EEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~-VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
...+.+.+.++.+.+.||.| +||+||++.|.|+. ||||++............|.+|+.+|.+++|||||+|+|++.++
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G-~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSG-SFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred ccceecChHHhhhhhhcccC-CceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35567788888899999999 79999999999999 99999988776666678999999999999999999999999998
Q ss_pred C-ceEEEEeecCCCCHHHHhhC-CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-cEEEEecCc
Q 002146 747 P-NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGL 823 (960)
Q Consensus 747 ~-~l~LVmEY~~gGsL~dlL~k-~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-~VKL~DFGL 823 (960)
. .++|||||+++|+|.+++++ ....++...++.|+.||+.||+|||++++ ||||||||+||||+.++ ++||||||+
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCcc
Confidence 8 79999999999999999988 46789999999999999999999999986 99999999999999998 999999999
Q ss_pred cccccCCcccCCCCCCCCCccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~--g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
++.............||+.|||||++. ...|+.++||||||+++|||+||..||.+....++...+.....++.+|..
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE 270 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 998765433344478999999999999 568999999999999999999999999999998888888889999999999
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCC
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p 940 (960)
+++.+..||.+||..||.+||++.+|+..|+.+......
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999999886544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=420.57 Aligned_cols=252 Identities=32% Similarity=0.470 Sum_probs=229.3
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
..+...+++.++.||+| ..|+||++++ +++.+|+|++ .........+++.+|+++++.++|||||+|||+|..+..
T Consensus 74 ~~i~~~dle~~~~lG~G-~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSG-NGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cccCHHHhhhhhhcccC-CCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 34667788999999999 7999999987 5889999998 444567778899999999999999999999999999995
Q ss_pred -eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 749 -LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 749 -l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
++|+||||+||+|.+++.+.+ +++|..+-.|+.++++||.|||. ++ ||||||||+||||+.+|+|||||||.++.
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHH
Confidence 999999999999999997654 79999999999999999999995 76 99999999999999999999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChhHHHHHhhccccccCCCCC
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~-----~~~ei~~~I~~~~~~~~iP~~ 901 (960)
+.+. ...+++||..|||||.+.+..|+.++||||||+.++|+++|++||... +..+++..|. .+.++.+|..
T Consensus 229 lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~ 305 (364)
T KOG0581|consen 229 LVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEG 305 (364)
T ss_pred hhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcc
Confidence 8766 567899999999999999999999999999999999999999999874 6677888886 4567788886
Q ss_pred -CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 902 -LDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 902 -lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++++++||..||++||.+||++.|++++
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999999975
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=430.75 Aligned_cols=249 Identities=28% Similarity=0.445 Sum_probs=232.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..|..++.||+| .|.+||.++. +|+.||+|++.+..+. .....++.+||+|.+.|+|||||+|+++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkG-gFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKG-GFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccC-cceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 569999999999 5999999976 7999999999876543 44567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
+|+|..++|..+++++ ..++|.+++++++||+.||.|||+++ |||||||..||||+++.+|||+|||||........
T Consensus 97 LELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999999854 48999999999999999999999999 99999999999999999999999999999887767
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
...+.|||+-|+|||++....++..+||||+||+||.||.|++||...+-.+.+..|. .....+|..++.++++||.+
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~~ 251 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIRK 251 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHHH
Confidence 7888999999999999999999999999999999999999999999999999999884 45778899999999999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
||+++|.+||++++|+.+
T Consensus 252 lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 252 LLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HhcCCcccCCCHHHHhcC
Confidence 999999999999999975
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=396.43 Aligned_cols=240 Identities=25% Similarity=0.453 Sum_probs=222.5
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
...++|++++.||.| +||+|.+++. +|..||+|++.+.... ....+...+|..+|+.+.||+++++++.|.+...+
T Consensus 41 ~~l~dfe~~~tlGtG-SFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTG-SFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred cchhhhhheeeeccC-ccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 456889999999999 8999999975 7889999999876543 34556788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
||||||++||.|+.++++.+ +|++...+.++.||+.||+|||+++ |+||||||||||||.+|++||+|||+|+....
T Consensus 120 ymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999999998866 7999999999999999999999999 99999999999999999999999999998754
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
. +.+.|||+.|+|||++..++|+.++|||+|||++|||+.|.+||++.++.+++++|. .....+|..+++++++|
T Consensus 197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~--~~~v~fP~~fs~~~kdL 271 (355)
T KOG0616|consen 197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL--EGKVKFPSYFSSDAKDL 271 (355)
T ss_pred c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH--hCcccCCcccCHHHHHH
Confidence 4 457899999999999999999999999999999999999999999999999999994 56788999999999999
Q ss_pred HHHhhhhCCCCC
Q 002146 910 IWECWQTDPSLR 921 (960)
Q Consensus 910 I~kcL~kDP~kR 921 (960)
|+++|+.|-.+|
T Consensus 272 l~~LL~vD~t~R 283 (355)
T KOG0616|consen 272 LKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhhhhHhh
Confidence 999999999999
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=405.47 Aligned_cols=251 Identities=27% Similarity=0.466 Sum_probs=226.3
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..+|.+.+.||.| +|++||+|++ ++..||||.+.+..+..+.++-+..|+.||+.++|||||+|++++.+++.+|||
T Consensus 9 ~~~y~~~~~iG~G-sfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSG-SFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCc-ceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3578999999999 8999999987 688999999998888888888899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC------CcEEEEecCcccc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRL 826 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~------g~VKL~DFGLAr~ 826 (960)
||||.||+|.+||++++ .++|...+.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999998865 7999999999999999999999999 9999999999999864 4699999999999
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC-CCCCCcHH
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE-IPKELDPL 905 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~-iP~~lS~e 905 (960)
..+. ....+.||++.|||||++..+.|+.|+|+||+|+++|+|++|..||...+..+++..+.+...... ++..++..
T Consensus 165 L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~ 243 (429)
T KOG0595|consen 165 LQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNP 243 (429)
T ss_pred CCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCc
Confidence 8755 445678999999999999999999999999999999999999999999999999988866554443 45567788
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.+|+...|..+|..|.++.+.+.+
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhh
Confidence 8899999999999999888766543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=399.89 Aligned_cols=259 Identities=27% Similarity=0.486 Sum_probs=229.8
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEec-ccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG-AVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g-~f~~~~~ 748 (960)
..+..+|+|.++||.| +||+||++.+ +|..||.|.+....+..........|+.+|++|+|||||++++ .|.++..
T Consensus 15 ~~~l~~y~Il~~IG~G-sFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRG-SFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCC-cchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3455789999999999 8999999975 8999999999877777777888999999999999999999998 4666655
Q ss_pred -eEEEEeecCCCCHHHHhh---CCCCCCcHHHHHHHHHHHHHHHHHHhhCCCC--EEEeccCCCcEEEcCCCcEEEEecC
Q 002146 749 -LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPT--IVHRDLKSPNLLVDKNWNVKVSDFG 822 (960)
Q Consensus 749 -l~LVmEY~~gGsL~dlL~---k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~--IIHRDLKPeNILLd~~g~VKL~DFG 822 (960)
++||||||.+|+|..+++ +.++.++|..+|+++.|++.||+++|..-+. |+||||||.||+|+.+|.|||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 999999999999999886 3456799999999999999999999994333 9999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC-CC
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-KE 901 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP-~~ 901 (960)
|++.+........+.+|||.||+||.+.+.+|+.++|||||||++|||...+.||++.+..++..+|... .-+.+| ..
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~ 252 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEH 252 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHH
Confidence 9999887766777899999999999999999999999999999999999999999999999999999743 344566 67
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
++.++..||..|+..||+.||+...++..+.
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 8999999999999999999998555544443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=410.13 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=216.1
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEE--ECCcEEEEEEeecCCCChH-----HHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGA-----ALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak--~~g~~VAVK~i~~~~~~~~-----~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
..+.|.+.+.||.| +||.|-+|. .+|+.||||++.+...... ....+.+|++||++|+|||||+++++|+.+
T Consensus 170 ~~d~yii~~~LGsG-afg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSG-AFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCC-ceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 34668999999999 799999995 4899999999987654331 233468999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC---CcEEEEecCc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGL 823 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~---g~VKL~DFGL 823 (960)
+..||||||++||+|++.+-.++ .+.+..-..+++||+.||.|||+.| |+||||||+|||+..+ ..+||+|||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999987654 5777888889999999999999999 9999999999999865 7899999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHhhcccccc--C
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRL--E 897 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g~~---ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e-i~~~I~~~~~~~--~ 897 (960)
|+..+.. ....++|||+.|.|||++.++. +..++|||||||++|-+|+|.+||.+..... +.++|....... .
T Consensus 326 AK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 326 AKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 9998744 5678899999999999998765 3458899999999999999999998876555 666665332222 2
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 898 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 898 iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+..++.+.++||.+||..||++||++.++|++
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 345789999999999999999999999998874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=415.53 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=228.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~ 748 (960)
....+|..++.||.| +|.+|++|+. .++.||||++.+.-+. +...+-+.+|..+|.+| +||.||+|+..|+++..
T Consensus 70 k~~~DF~Fg~~lGeG-SYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEG-SYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred CChhhcchhheeccc-cceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445789999999999 8999999975 7899999998776544 33445678899999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+|+||+++|+|.++|++.+ .|++...+.++.||+.||+|||++| ||||||||+|||||++|++||+|||-|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999998865 8999999999999999999999999 9999999999999999999999999999864
Q ss_pred CCcc-----------c--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc
Q 002146 829 NTFL-----------S--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 895 (960)
Q Consensus 829 ~~~~-----------~--~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~ 895 (960)
.... . ..+++||.+|.+||++.+...+..+|||+||||+|.|+.|.+||.+.+...++++|. ...
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--ALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--Hhc
Confidence 2211 1 245899999999999999999999999999999999999999999999999999984 557
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 896 ~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~L 931 (960)
..+|..+++.+++||+++|..||.+|++..+|.+|-
T Consensus 304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 889999999999999999999999999999998763
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=405.93 Aligned_cols=265 Identities=39% Similarity=0.650 Sum_probs=235.4
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+|+|+.+++.++++||.| .||+||+|+|.| .||||++......++..+.|++|+.+|++-+|.||+-|+||+..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsG-sFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSG-SFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccc-cccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35789999999999999999 899999999998 7999999999989999999999999999999999999999999887
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
. .||+.+|+|-+|+.+|+-...+|+..+.+.|+.||++||.|||.++ |||||||..||+|.+++.|||+||||+...
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeee
Confidence 7 9999999999999999988888999999999999999999999999 999999999999999999999999999765
Q ss_pred cCC--cccCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC---CC
Q 002146 828 HNT--FLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE---IP 899 (960)
Q Consensus 828 ~~~--~~~~~t~~GT~~Y~APEvl~g~---~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~---iP 899 (960)
.-. ........|...|||||+++.+ +|++.+|||||||++|||++|.+||...+..+++..+......+. .-
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 322 1112234578899999999754 589999999999999999999999998888888777765433333 23
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 900 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
..++.++++|+..||.+++++||.|.+|+..|+.+++.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 46788999999999999999999999999999998774
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=414.27 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=226.9
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
..+..++|.++++||+| +||+|+++.. +++.||||++++..+ .++.++..+.|.+|+... +||++++++..|++.
T Consensus 363 ~~~~l~~F~~l~vLGkG-sFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRG-SFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred CcccccceEEEEEeccC-cCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 35667899999999999 8999999976 677899999998765 456778899999999998 599999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+++|+||||+.||++..+.+. ..|++..+..|+.+|+.||.|||++| |||||||.+|||||.+|++||+|||+++.
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred CeEEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999999996666554 36999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
.......+.++|||+.|||||++.+..|+.++|||+|||||||||.|+.||.+.+..+++..|. ...+.+|..++.+.
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~ea 595 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKEA 595 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHHH
Confidence 7655567889999999999999999999999999999999999999999999999999999994 55788899999999
Q ss_pred HHHHHHhhhhCCCCCCCH
Q 002146 907 ARIIWECWQTDPSLRPSF 924 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa 924 (960)
.+|++++|.++|++|...
T Consensus 596 ~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhccCcccccCC
Confidence 999999999999999865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=385.57 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=213.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++.|+.+.++|+| +||+||++++ +|+.||||+|......+...+...+|+++|++|+|||+|.++++|....+++||
T Consensus 1 MekYE~LgkvGEG-SYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEG-SYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccC-cceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 3568888899999 8999999976 799999999987766666666779999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
+|||+..-|. -|.+....+++..+..+++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+.....
T Consensus 80 FE~~dhTvL~-eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 80 FEYCDHTVLH-ELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred eeecchHHHH-HHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 9999875444 45554557899999999999999999999999 99999999999999999999999999998875545
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-------------------
Q 002146 833 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------------- 892 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~------------------- 892 (960)
..+..+.|.||+|||.+.| ..|+..+|||++||++.||++|.+.|.+....+.+..|...
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5566789999999999988 67999999999999999999999999998765544333221
Q ss_pred ccccCCC----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 NRRLEIP----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 ~~~~~iP----------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.+.+-| ..++..+.+|+++||..||.+|++.+|++.+
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0011111 1345678999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=405.45 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=222.9
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+..++|++++.||+| +||.||+++. +|..||+|++++..+- ...+..++.|..||...++|+||+|+..|++..
T Consensus 136 ~r~~~~DFe~Lk~IgkG-AfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKG-AFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred ccCCcccchhheeeccc-cceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 35678999999999999 7999999975 7999999999887654 445677899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
++||||||++||++..+|.+.+ .+++.....++.+++.||+-||++| ||||||||+|+|||..||+||+||||+..+
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999999998765 7999999889999999999999999 999999999999999999999999998642
Q ss_pred cC----------------------C-cc------------------------cCCCCCCCCCccCcccccCCCCCchhhH
Q 002146 828 HN----------------------T-FL------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDV 860 (960)
Q Consensus 828 ~~----------------------~-~~------------------------~~~t~~GT~~Y~APEvl~g~~ys~ksDI 860 (960)
.. . .. .....+|||.|||||++.+..|+..+||
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0 00 0113569999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 002146 861 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTVA 930 (960)
Q Consensus 861 WSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~--~lS~eLkdLI~kcL~kDP~kRPS---a~eILe~ 930 (960)
||||||+||||.|.+||.+.++.+...+|..-...+.+|. .+++++++||.+||. ||.+|.. ++||.++
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 9999999999999999999999999999865444566665 478999999999999 9999976 5666543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=397.16 Aligned_cols=257 Identities=32% Similarity=0.485 Sum_probs=227.5
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHHcC-CCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLR-HPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~---~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~ 746 (960)
.....|.+++.||.| +||+|+++.+ +++.||||++.+.... ......+.+|+.++++++ ||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~G-sfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSG-SFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred cccCceeeeeeecCC-CCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 345689999999999 8999999976 7899999976654221 123456778999999998 99999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC-CcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-g~VKL~DFGLAr 825 (960)
..+|+||||+.||+|++++.+ ..++.|....++++||+.|++|||++| |+||||||+|||++.+ +++||+|||++.
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999999988 558999999999999999999999999 9999999999999999 999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCC-
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEP-S-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL- 902 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~-y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~l- 902 (960)
..........+.|||+.|+|||++.+.. | +.++||||+|++||.|++|..||.+.+...+...| ......+|..+
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLL 247 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcC
Confidence 7743334567899999999999999988 8 48999999999999999999999999988888886 45578889989
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
++++++||.+||..||.+|+++.+|+ .-.-++.
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 99999999999999999999999999 4444443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=406.06 Aligned_cols=249 Identities=29% Similarity=0.474 Sum_probs=229.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+++|.+.+.||+| +||.||+|+. +.+.||||.+.+....++.++.+.+|++|++.|+|||||.++++|+...++++|
T Consensus 1 me~yhv~e~iG~G-sfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEG-SFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCC-ccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 3678899999999 8999999975 677899999998888888889999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
+||+.| +|+.+|...+ .++|..+..|+.|++.||+|||+.+ |+|||+||.|||++..|++||||||+|+.+.....
T Consensus 80 te~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 999977 9999998755 7999999999999999999999999 99999999999999999999999999998766544
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
.-....||+.|||||++.+++|+..+|+||||||+|||+.|++||+.....+++..|. ..+...|...+..+.+|++.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHH
Confidence 4556679999999999999999999999999999999999999999998888888884 44666778999999999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
+|.+||.+|.++.+++.+
T Consensus 234 LL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HhhcChhhcccHHHHhcC
Confidence 999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=399.61 Aligned_cols=263 Identities=36% Similarity=0.618 Sum_probs=236.3
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEECCc-EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~-~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
...++++.+.+++++.||+| .||.||+++|++. .||+|.++...+.. ..|.+|+++|++|+|+|||++++++..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G-~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSG-QFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred cCCeeecHHHHHHHHHhcCC-ccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 34567788889999999999 8999999999887 89999987654443 4678999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhC-CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k-~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
+.+|||||||+.|+|.++|+. .+..+...+++.|+.||++||+||++++ +|||||-.+||||+++..+||+|||||+
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccccccc
Confidence 899999999999999999987 5668999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCcccC-CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 826 LKHNTFLSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 826 ~~~~~~~~~-~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
...+..+.. ....-...|.|||.+....++.++|||||||+||||+| |+.||.++...+++..+. .+.+.+-|..|+
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP 430 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCP 430 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCC
Confidence 665544322 22223568999999999999999999999999999999 999999999999999887 667888899999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+++.+|+..||+.+|++||||+.+...|+.+...
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999999999999999999988654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=403.56 Aligned_cols=249 Identities=30% Similarity=0.473 Sum_probs=228.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecC-CCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQ-DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~-~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.-|++++.||.| .-|.|.+|++ +|+.+|||++.+. ...+.....+.+|+-||+.+.||||+++|++|+...++|+|
T Consensus 12 GpwkLgkTLG~G-stg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKG-STGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCC-CCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 347899999999 6999999987 8999999999876 55566667899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
+||++||.|++++-+++ .+++.+..++++||+.|+.|+|..+ |+||||||+|+|||..++|||+|||+|...... .
T Consensus 91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-k 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-K 166 (786)
T ss_pred EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-c
Confidence 99999999999998766 7889999999999999999999999 999999999999999999999999999876443 3
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
--.+.||.+.|.|||++.|.+| +.++||||.|||||.||+|..||.+.+...++.++ +...+++|.+++.++++||.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHH
Confidence 3456899999999999999998 68999999999999999999999999999999888 45578899999999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~L 931 (960)
+||..||.+|.|.++|++|-
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHhccCccccccHHHHhhCc
Confidence 99999999999999999873
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=378.36 Aligned_cols=262 Identities=33% Similarity=0.530 Sum_probs=217.0
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 742 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~ 742 (960)
+.++.++|+++++||.| .||.||++.+ .++.||||++... ........+.+|+.+|+.+ +|||||+++++
T Consensus 2 ~~~~~~~~~~~~~lG~G-~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHG-AFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccC-CcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 56778899999999999 6999999964 2467999988643 2334456788999999999 89999999998
Q ss_pred cccC-CceEEEEeecCCCCHHHHhhCCC----------------------------------------------------
Q 002146 743 VTRP-PNLSIITEFLPRGSLFRILHRPH---------------------------------------------------- 769 (960)
Q Consensus 743 f~~~-~~l~LVmEY~~gGsL~dlL~k~~---------------------------------------------------- 769 (960)
+... ..+++||||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 7764 45899999999999999987532
Q ss_pred ---------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCC
Q 002146 770 ---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTA 838 (960)
Q Consensus 770 ---------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~ 838 (960)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 23667788899999999999999998 9999999999999999999999999998653221 1122344
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 839 GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
++..|+|||++.+..++.++|||||||++|||++ |..||.+....+..............|..+++.+++||.+||..|
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGD 317 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6788999999999999999999999999999997 999998866444333333334455567788999999999999999
Q ss_pred CCCCCCHHHHHHHHHHhHH
Q 002146 918 PSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 918 P~kRPSa~eILe~Le~i~~ 936 (960)
|.+||++.+|++.|+.+..
T Consensus 318 p~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 318 PKERPTFSALVEILGDLLQ 336 (338)
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=383.02 Aligned_cols=257 Identities=32% Similarity=0.512 Sum_probs=220.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC--ceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~--~l~L 751 (960)
.++..++.||+| +||.||++.. +|+.+|||.+....... ...+.+|+.+|.+|+|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~G-s~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRG-SFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCc-cceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 457788999999 8999999986 47999999887653222 567899999999999999999999744444 6999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-CCcEEEEecCccccccC-
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHN- 829 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr~~~~- 829 (960)
+|||+++|+|.+++.+.+..+++..+..+++||++||.|||++| ||||||||+||||+. ++.+||+|||+++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999999999987668999999999999999999999999 999999999999999 79999999999987653
Q ss_pred --CcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHhhccccccCCCCCCcHH
Q 002146 830 --TFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 830 --~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~-~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
.......+.||+.|||||++.+. ....++|||||||++.||+||..||.. .........+......+.+|..++++
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence 11223457899999999999953 344699999999999999999999998 56666666676666667899999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+++||.+||.++|.+|||+.++|++.--.+..
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999999987654433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=370.69 Aligned_cols=246 Identities=24% Similarity=0.416 Sum_probs=217.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++.+.||.| .||.||++.. +++.||||++...... ......+.+|+.+|++++||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTG-TFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecC-CCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 468999999999 7999999986 5889999998754332 23445688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++.+.+ .+++...+.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99999999999997654 6889999999999999999999999 999999999999999999999999999865432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+. .....+|..+++.+++||++
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~ 231 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIKK 231 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHHH
Confidence 234679999999999999999999999999999999999999999988887777764 33567788889999999999
Q ss_pred hhhhCCCCCCC-----HHHHHHH
Q 002146 913 CWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPS-----a~eILe~ 930 (960)
||..||.+|++ +.+++++
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcC
Confidence 99999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=390.31 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=216.0
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCC-
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP- 747 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~- 747 (960)
.+.+++|.++++||.| +||.||+++. +|..||||++++....-+.. .-.||+.-|++|+ |||||++.+++.+.+
T Consensus 6 ~~~m~RY~~i~klGDG-TfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDG-TFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCC-cceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 3456789999999999 8999999975 78999999988766553332 2358999999998 999999999999988
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+|||||+. +|+.++..+.+.|++..++.|++||++||+|+|.+| +.|||||||||||..+..|||+|||+||.+
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccc
Confidence 89999999964 999999988889999999999999999999999999 999999999999998999999999999987
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc----------
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---------- 896 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~---------- 896 (960)
... ...+..+.|.||+|||++.. ..|+.++|||++|||++|+++-++.|.|.+..+.+.+|...-..+
T Consensus 161 ~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 161 RSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred ccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 654 23455789999999999755 568999999999999999999999999987765555543211111
Q ss_pred -------CCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 -------EIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 -------~iP-----------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+| ..++.++.+||.+||..||.+|||+.|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 2477899999999999999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=374.40 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=219.6
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
...++|++.+.||.| .||.||++++ +++.||||++...... ......+.+|+.+|++++||||+++++++.+.+.+
T Consensus 15 ~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 15 WKLSDFEMGETLGTG-SFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCchheEEEEEEEec-CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 345789999999999 7999999987 5789999998764322 23455788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+||||+.+++|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999999997654 6888889999999999999999999 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..++..+++|
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~l 245 (329)
T PTZ00263 171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDL 245 (329)
T ss_pred C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHH
Confidence 2 234679999999999999999999999999999999999999999988877777764 34567788899999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHHH
Q 002146 910 IWECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPS-----a~eILe~ 930 (960)
|.+||..||.+|++ +++|+.+
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999986 6888765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=374.20 Aligned_cols=243 Identities=24% Similarity=0.416 Sum_probs=213.2
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
+.||+| .||.||+++. +|+.||||++..... .......+.+|+.+|++++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKG-TFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeC-CCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 469999 7999999975 688999999876432 233455678999999999999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002146 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 838 (960)
Q Consensus 759 GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~ 838 (960)
++|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccccee
Confidence 99999987644 6899999999999999999999999 99999999999999999999999999976433333344567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCC
Q 002146 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 918 (960)
Q Consensus 839 GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP 918 (960)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+. .....+|..+++++++||.+||.+||
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999988777776664 33567788899999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 002146 919 SLRP-----SFAQLTVA 930 (960)
Q Consensus 919 ~kRP-----Sa~eILe~ 930 (960)
.+|| ++.+|+++
T Consensus 235 ~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 235 KQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHcCCCCCCCHHHHHcC
Confidence 9999 79998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=377.23 Aligned_cols=255 Identities=27% Similarity=0.378 Sum_probs=222.7
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEECC--cEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWNG--TEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g--~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+..++|+++++||.| .-|+||+++..+ ..+|+|++.+..+. .....+++.|.+||..++||+++.||..|+.++
T Consensus 72 ~~l~l~~f~llk~LG~G-diG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCG-DIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CccCHHHHHHHHHcCCC-CceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 45667889999999999 799999998855 78999999887654 456678899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..|++||||+||+|+.+++++ +..+++..++.++.+++.||+|||..| ||||||||+||||.++|||.|.||.|+..
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeecccccc
Confidence 999999999999999998864 457999999999999999999999999 99999999999999999999999999753
Q ss_pred cc-------C----------------------------C---------------------cccCCCCCCCCCccCccccc
Q 002146 827 KH-------N----------------------------T---------------------FLSSKSTAGTPEWMAPEVLR 850 (960)
Q Consensus 827 ~~-------~----------------------------~---------------------~~~~~t~~GT~~Y~APEvl~ 850 (960)
.. . . ......++||-+|+|||+|.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 10 0 0 01123567999999999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC--CCCcHHHHHHHHHhhhhCCCCCCC----H
Q 002146 851 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPS----F 924 (960)
Q Consensus 851 g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP--~~lS~eLkdLI~kcL~kDP~kRPS----a 924 (960)
|...+.++|||+|||++||||.|..||.|.+..+.+.+|..+ .+.+| ...+..++|||+++|.+||.+|.. +
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~--~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ--PLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC--CCcCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence 999999999999999999999999999999999999998654 44554 357889999999999999999998 6
Q ss_pred HHHHHH
Q 002146 925 AQLTVA 930 (960)
Q Consensus 925 ~eILe~ 930 (960)
.+|.++
T Consensus 387 ~eIK~H 392 (459)
T KOG0610|consen 387 AEIKRH 392 (459)
T ss_pred HHhhcC
Confidence 666654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=362.44 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=216.5
Q ss_pred EEeeccCCeeEEEEEEECCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEeccccc----CCceEEEEeec
Q 002146 682 ERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFL 756 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~----~~~l~LVmEY~ 756 (960)
..||+| .+|.||+++++|+.||||.+....... .....+.+|+.+|++++|||||++++++.+ ...+++||||+
T Consensus 26 ~~i~~g-~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKEN-DQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeC-CceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 568999 699999999999999999987654333 334678899999999999999999999876 45789999999
Q ss_pred CCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002146 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835 (960)
Q Consensus 757 ~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~ 835 (960)
++|+|.+++.+.. .+++...+.++.|++.||.|||.. + ++||||||+|||++.++.+||+|||+++..... ..
T Consensus 105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~ 178 (283)
T PHA02988 105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PF 178 (283)
T ss_pred CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhccc---cc
Confidence 9999999997654 688899999999999999999984 6 889999999999999999999999999865432 12
Q ss_pred CCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 836 STAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 836 t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
...|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..++...+.....++.+|..+++.+++||.+|
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 3568899999999977 67899999999999999999999999999888877777555566777778999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHhH
Q 002146 914 WQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~Le~i~ 935 (960)
|+.||.+||++.+|++.|+.++
T Consensus 259 l~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 259 TSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred hcCCcccCcCHHHHHHHHHHHH
Confidence 9999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=389.12 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=225.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
-+...|...++||+| +-|.||.++. +++.||||++....... .+-+.+|+.+|+..+|+|||.+++.|...+.+|
T Consensus 270 dP~~~y~~~~kigqg-aSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQG-ATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred Chhhhhcchhhhccc-cccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 345678889999999 7999999975 78889999987654332 345789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+|||||+||+|-+++... .++|.++..|+++++.||+|||.+| |||||||.+|||++.+|.|||+|||++..+...
T Consensus 347 VVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 999999999999999764 4999999999999999999999999 999999999999999999999999999988776
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC--CCCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~--iP~~lS~eLkd 908 (960)
.....+.+||++|||||++....|+.++||||||++++||+.|++||...++.+....|... ..+. .|..+++.+++
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEKLSPELKD 501 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccccCHHHHH
Confidence 66677889999999999999999999999999999999999999999999888887777633 3443 47789999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
|+.+||..|+.+|+++.+||++
T Consensus 502 FL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcC
Confidence 9999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=384.62 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=219.4
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC--Cc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 748 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~ 748 (960)
...+.|+.+++||+| +||.||+++. +|+.||+|+++.....+.......+||.||++|+|||||+|.+.+... ..
T Consensus 114 r~~~~feki~kIGeG-Tyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEG-TYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCc-chhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 344678889999999 8999999986 789999999998877777777788999999999999999999998776 67
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|||+|||+. +|.-++...+-.|++.++..|++||+.||+|+|.+| |+|||||..|||||.+|.+||+|||||+++.
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999999976 899999888888999999999999999999999999 9999999999999999999999999999765
Q ss_pred CCcc-cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--------CC
Q 002146 829 NTFL-SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--------EI 898 (960)
Q Consensus 829 ~~~~-~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--------~i 898 (960)
.... ..+..+-|.||+|||.+.|.. |+.++|+||.||||.||+.|++.|.+.+..+.++.|...-.-+ .+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 4432 245567899999999999875 9999999999999999999999999988776666553311100 11
Q ss_pred C-------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 899 P-------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 899 P-------------------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
| ..++....+|+..||..||.+|.|+.+.|+.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1 2467789999999999999999999988753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=390.78 Aligned_cols=252 Identities=37% Similarity=0.652 Sum_probs=230.1
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
..|+|+++.+.-++-||.| +.|.||+++..++.||||+++... ..+|+-|++|+|||||.|.|+|.....
T Consensus 117 e~WeiPFe~IsELeWlGSG-aQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSG-AQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred hhccCCHHHhhhhhhhccC-cccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCce
Confidence 4588999999889999999 899999999999999999865321 357888999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++||||||..|-|..+|+.. +.+....+..|..+|+.||+|||.+. |||||||.-||||..+..|||+|||-++...
T Consensus 187 yCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999999999764 47888899999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.. ...-.++||..|||||+|.+++.++|+|||||||+|||||||..||.+.+...++.-+......+..|..+++-++-
T Consensus 264 ~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 264 DK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHH
Confidence 44 34556899999999999999999999999999999999999999999999888887777667778889999999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 909 IIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
||++||+-.|..||+|.+|+.+|+-.
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 99999999999999999999999765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=373.29 Aligned_cols=249 Identities=25% Similarity=0.452 Sum_probs=224.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEE--ECCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak--~~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
..+|++.+.||+| +||+|-++. ..|+.||||.|++..+. +..+..+++|++||..|+||||+++|++|+..+.+.|
T Consensus 52 kHRyE~~etLGkG-TYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKG-TYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCC-cccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3568899999999 899999995 37999999999987765 4567789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||..+|.|++|+.+++ .+++.+...|++||+.|++|+|.++ ++|||||.+|||+|.++++||+||||+..+...
T Consensus 131 vMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 999999999999998865 7999999999999999999999999 999999999999999999999999999887654
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
..-.++||++-|.+||++.|.+| +..+|-||||++||.|..|.+||++.+...++.+|.....+. +.-+.++.-||
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLI 283 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLI 283 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHH
Confidence 34567999999999999999998 789999999999999999999999999999999886543332 22455788899
Q ss_pred HHhhhhCCCCCCCHHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~L 931 (960)
++||..+|++|.|+.+|..+-
T Consensus 284 RwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHhcCcccchhHHHHhhhh
Confidence 999999999999999998763
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=366.87 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=226.9
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
.-.+.+++|..+++||+| .||+|.+++- +++.||||+++++.+. ...+.....|-++|+..+||++..+...|+..
T Consensus 162 ~~kvTm~dFdfLKvLGkG-TFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKG-TFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred cceeccchhhHHHHhcCC-ccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 346788999999999999 8999999964 7999999999887653 44555677899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+++|+||||..||.|+-+|.+.. .+++.....+-.+|+.||.|||+.+ ||+||||.+|+|+|.+|++||+||||++.
T Consensus 241 drlCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchh
Confidence 99999999999999999998744 7888888888899999999999998 99999999999999999999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
-........++|||++|+|||++.+..|+.++|||.+|+++|||++|+.||+..+..++++.|. .....+|..+++++
T Consensus 318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~ed~kFPr~ls~eA 395 (516)
T KOG0690|consen 318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--MEDLKFPRTLSPEA 395 (516)
T ss_pred cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hhhccCCccCCHHH
Confidence 7776677889999999999999999999999999999999999999999999999999998884 44678999999999
Q ss_pred HHHHHHhhhhCCCCCC
Q 002146 907 ARIIWECWQTDPSLRP 922 (960)
Q Consensus 907 kdLI~kcL~kDP~kRP 922 (960)
+.|+..+|.+||.+|.
T Consensus 396 ktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 396 KTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHHhhcChHhhc
Confidence 9999999999999996
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=370.22 Aligned_cols=257 Identities=30% Similarity=0.441 Sum_probs=222.3
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
..+.+..++|++.+.||.| .-++||++++ .++.||||++..+.+... ++.+.+|+..|+.++|||||+++..|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G-~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVG-ASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEecc-ceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3456677899999999999 7899999987 789999999988877655 78999999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
..+|+||.||.+|++.+++.... ..++|..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||..-
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeee
Confidence 99999999999999999997532 36999999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCccc---C-CCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc---
Q 002146 826 LKHNTFLS---S-KSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--- 896 (960)
Q Consensus 826 ~~~~~~~~---~-~t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--- 896 (960)
.+...... . .+++||++|||||++.. ..|+.|+|||||||+..||.+|..||....+.+++.... ++.++
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~ 253 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLL 253 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcc
Confidence 65432211 1 56799999999999644 459999999999999999999999999999998775543 23232
Q ss_pred --CCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 --EIP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 --~iP----~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.++ +.++..++.+|..||.+||.+||++++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 112 2467789999999999999999999999874
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=366.55 Aligned_cols=243 Identities=24% Similarity=0.415 Sum_probs=211.9
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
+.||+| .||.||+++. +|..||+|++..... .......+.+|+.+++.++||||++++++|...+.+|+||||+++
T Consensus 1 ~~lG~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKG-TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeC-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 469999 7999999975 688999999876432 233455678899999999999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002146 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 838 (960)
Q Consensus 759 GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~ 838 (960)
++|..++.+.. .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence 99999887644 6899999999999999999999999 99999999999999999999999999876433323334567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCC
Q 002146 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 918 (960)
Q Consensus 839 GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP 918 (960)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++++||.+||++||
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888777766663 33456788899999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 002146 919 SLRP-----SFAQLTVA 930 (960)
Q Consensus 919 ~kRP-----Sa~eILe~ 930 (960)
.+|+ ++.+++++
T Consensus 235 ~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 235 KQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHhCCCCCCCHHHHHcC
Confidence 9998 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=349.03 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=220.3
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
+..++|++.+.||+| .||.||++.+ .+..||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 2 i~~~~~~~~~~ig~G-~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTG-RFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeeccc-CCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 456789999999999 6999999965 35689999886542 3344567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+++||||+++++|.+++.+....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999999999876567899999999999999999999998 999999999999999999999999987654
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 828 HNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 828 ~~~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
.... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......|..++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNL 236 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHH
Confidence 2221 11122345678999999999999999999999999999875 999999988877776664 33345567889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+.+++.+||..+|.+||++.+|++.|+++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.94 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=214.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.+|++++.||.| .||.||++++ +++.||||++...... ......+.+|+.+++.++||||+++++++...+.+|||
T Consensus 1 ~~y~~~~~ig~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQG-GYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeec-CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 369999999999 7999999987 5789999998765332 23345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999999997644 6889999999999999999999999 99999999999999999999999999986543
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC------CCCcHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP------KELDPLV 906 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP------~~lS~eL 906 (960)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.........| ..++.++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence 2345679999999999999999999999999999999999999999988877666554322222222 2468999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++||.+||..+|.+||++.+++++
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhC
Confidence 999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.83 Aligned_cols=241 Identities=24% Similarity=0.383 Sum_probs=210.1
Q ss_pred eeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCC
Q 002146 684 IGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
||+| .||.||++++ +++.||||++..... .......+.+|+.+|++++||||+++++++...+.+|+||||+++|+
T Consensus 1 lg~G-~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKG-SFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcC-CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 6899 6999999986 578899999875432 23445678899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCC
Q 002146 761 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 840 (960)
Q Consensus 761 L~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT 840 (960)
|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+||
T Consensus 80 L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREG-RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence 999997644 6899999999999999999999999 9999999999999999999999999998643333334456799
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCC
Q 002146 841 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 920 (960)
Q Consensus 841 ~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~k 920 (960)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..+++++++||.+||..||.+
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~ 234 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTR 234 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence 99999999999999999999999999999999999999988887777663 3466778889999999999999999999
Q ss_pred CCC---HHHHHHH
Q 002146 921 RPS---FAQLTVA 930 (960)
Q Consensus 921 RPS---a~eILe~ 930 (960)
||+ +.+++.+
T Consensus 235 R~~~~~~~e~l~h 247 (312)
T cd05585 235 RLGYNGAQEIKNH 247 (312)
T ss_pred cCCCCCHHHHHcC
Confidence 985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.89 Aligned_cols=243 Identities=24% Similarity=0.414 Sum_probs=212.7
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
+.||+| .||.||+++. +++.||||++..... .......+.+|+.+|+.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G-~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKG-TFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeC-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 469999 7999999976 688999999876432 234456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002146 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 838 (960)
Q Consensus 759 GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~ 838 (960)
|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 80 g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence 99999987643 6899999999999999999999999 99999999999999999999999999976433323334567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCC
Q 002146 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 918 (960)
Q Consensus 839 GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP 918 (960)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..+++++++||.+||.+||
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP 234 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDP 234 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCH
Confidence 9999999999999999999999999999999999999999888777766653 34556788899999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 002146 919 SLRP-----SFAQLTVA 930 (960)
Q Consensus 919 ~kRP-----Sa~eILe~ 930 (960)
.+|+ ++.+++++
T Consensus 235 ~~R~~~~~~~~~~il~h 251 (328)
T cd05593 235 NKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHcCCCCCCCHHHHhcC
Confidence 9997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.95 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=220.0
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEEC---CcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWN---GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~---g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
..+..++|++.+.||.| .||.||++.+. +..||||++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 25 ~~~~~~~y~~~~~ig~G-~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTG-SFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCChhhcEEEEEEeec-CCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 45667899999999999 79999999753 35799999875432 233455788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+|+||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++++||+|||+++.
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999999997654 6889999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+. .....+|..+++.+
T Consensus 181 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~ 255 (340)
T PTZ00426 181 VDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNNC 255 (340)
T ss_pred cCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHH
Confidence 5432 234679999999999999999999999999999999999999999988877777664 33456788899999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
+++|++||+.||.+|+ ++++++++
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999995 89998876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=352.56 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=217.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
.+|...++||+| .||.||+|++ +|+.||||+++.....+.......+|++.|+.++|+||+.++++|.+.+.+.||+
T Consensus 2 ~rY~~~~~lGEG-~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEG-TYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCc-ceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 467788999999 8999999986 7999999999887666555567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||++ .+|+..++.....+....+..|+.++++||+|||.+. |+||||||.|+||+.+|.+||+|||+|+.+......
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9995 6999999988888999999999999999999999999 999999999999999999999999999998776555
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc------C---------
Q 002146 834 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------E--------- 897 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~------~--------- 897 (960)
....+-|.||+|||.+.|.. |+..+||||.|||+.||+-|.+-|.|.+..+.+..|...-..+ .
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 55557899999999998865 8999999999999999999999999987765554432211100 0
Q ss_pred ---CC--------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 898 ---IP--------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 898 ---iP--------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+| ...++++.+|+.+||..||.+|+++.|.+++
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 1245778999999999999999999999875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=363.22 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=211.5
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHH---HcCCCceeeEecccccCCceEE
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMR---RLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk---~L~HPNIVkL~g~f~~~~~l~L 751 (960)
|++.+.||.| .||.||++++ +++.||||++..... .......+.+|++++. .++||||+++++++.....+|+
T Consensus 1 y~i~~~lg~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRG-HFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeec-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 6789999999 7999999976 688999999876432 2233456677766654 5679999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++++|..++.+. .+++..++.++.||+.||+|||+.| |+||||||+||||+.++.+||+|||+++......
T Consensus 80 v~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 99999999999988653 5899999999999999999999999 9999999999999999999999999987643333
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
......+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..++..+.+||.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~ 233 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIMR 233 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHH
Confidence 33445779999999999999999999999999999999999999999988877776664 3345678889999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHH
Q 002146 912 ECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRP-----Sa~eILe~ 930 (960)
+||..||.+|| ++.+++++
T Consensus 234 ~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 234 RLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhhC
Confidence 99999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=355.16 Aligned_cols=251 Identities=23% Similarity=0.286 Sum_probs=208.3
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++.++||.| .||.||+++. +++.||+|++...... .....+.+|+.++++++||||+++++++.+...+++|
T Consensus 4 ~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEG-TYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecC-CCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5679999999999 7999999976 6889999998654322 2234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+.+ +|.+++......+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 999975 899988776666889999999999999999999999 99999999999999999999999999986543333
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-----------------
Q 002146 833 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------------- 894 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~----------------- 894 (960)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3344578999999999876 5689999999999999999999999988776554443321000
Q ss_pred ccCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 RLEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ~~~i-----------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+ ...++.++++||.+||..||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0001 12467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=368.13 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=212.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++++.||+| .||+||+++. +++.||||++...... ......+.+|+.++.+++|+||+++++.+++...+|||
T Consensus 1 ~~y~~~~~LG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRG-AFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeC-CCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 479999999999 7999999976 5889999998764332 33445788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 831 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~- 831 (960)
|||++||+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+||||+.++++||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999999997654 6899999999999999999999999 9999999999999999999999999987542210
Q ss_pred ----------------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002146 832 ----------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877 (960)
Q Consensus 832 ----------------------------------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF 877 (960)
......+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012457999999999999999999999999999999999999999
Q ss_pred CCCChhHHHHHhhccccccCCCC--CCcHHHHHHHHHhhh--hCCCCCCCHHHHHHH
Q 002146 878 IGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQ--TDPSLRPSFAQLTVA 930 (960)
Q Consensus 878 ~~~~~~ei~~~I~~~~~~~~iP~--~lS~eLkdLI~kcL~--kDP~kRPSa~eILe~ 930 (960)
.+.+..+....+........+|. .+++++++||.+|+. .++..||++++|+++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99888887777654333444554 368999999999765 233356899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=367.23 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=216.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|.+.+.||.| .||+||+++. +++.||||++....... .....+.+|+.+|..++||||+++++++.+.+.+++|
T Consensus 1 ~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRG-AFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeC-CcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 469999999999 6999999987 48999999987654322 3455788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 831 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~- 831 (960)
|||+++++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 9999999999999875 47899999999999999999999998 9999999999999999999999999998654332
Q ss_pred ----------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Q 002146 832 ----------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 883 (960)
Q Consensus 832 ----------------------------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ 883 (960)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 1233457999999999999999999999999999999999999999998877
Q ss_pred HHHHHhhccccccCCCC--CCcHHHHHHHHHhhhhCCCCCCC-HHHHHHH
Q 002146 884 QVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS-FAQLTVA 930 (960)
Q Consensus 884 ei~~~I~~~~~~~~iP~--~lS~eLkdLI~kcL~kDP~kRPS-a~eILe~ 930 (960)
.....+........+|. .+++++++||.+||. +|.+|++ +++++++
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 77666654223334443 359999999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=350.98 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=207.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.+.||.| .||.||++++ +++.||||++............+.+|+.+++.++||||+++++++...+.+++||
T Consensus 1 ~~y~~~~~lg~g-~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEG-AYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEeccc-CCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 369999999999 7999999987 5788999998765444445567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-c
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-L 832 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~-~ 832 (960)
||++++.|..+... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99998777655443 346889999999999999999999999 9999999999999999999999999998764322 1
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-----------------c
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----------------R 895 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-----------------~ 895 (960)
......|+..|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+..... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 22345789999999999999999999999999999999999999988765443322211000 0
Q ss_pred cC-------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 LE-------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~~-------------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. ....++.++++||.+||+.||.+||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 112367889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=379.25 Aligned_cols=249 Identities=29% Similarity=0.475 Sum_probs=225.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
..|+..++||+| +||.||+|.. +++.||||++..+.. +..+..+++|+.+|.+++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrG-sfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRG-SFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhcccc-ccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 347777999999 8999999975 688999999876543 445678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|||.||++.+++.... .+.+..+..|+++++.||.|||..+ .+|||||+.|||+..+|.|||+|||.+.........
T Consensus 91 ey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999997643 5688999999999999999999999 999999999999999999999999999988777677
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
..+++||+.|||||++.+..|+.++||||||++.+||++|.+||.+..++.++..|. ...++.+...+++.+++||..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHH
Confidence 789999999999999999999999999999999999999999999999988877775 3446666668999999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~ 930 (960)
|++||+.||++.+++++
T Consensus 247 L~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKH 263 (467)
T ss_pred hhcCcccCcCHHHHhhh
Confidence 99999999999998875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=353.28 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=210.1
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
.|++.+.||+| .||.||++.+ +++.||||.+....... .....+.+|+.++++++|+||+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G-~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKG-GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecC-CCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 37889999999 6999999975 68999999987654332 22345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 754 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 754 EY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
||+++|+|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-E 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-C
Confidence 999999999887543 236889999999999999999999999 999999999999999999999999999865332 1
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhh--ccccccCCCCCCcHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~--~~~~~~~iP~~lS~eLkdLI 910 (960)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+. .......++..++.++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 2234579999999999999999999999999999999999999998765432222111 12334456778999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHHH
Q 002146 911 WECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPS-----a~eILe~ 930 (960)
.+||+.||.+||+ +++++++
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 9999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.32 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=213.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++++.||.| .||+||+++. +++.||||++...... ......+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus 1 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRG-AFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEec-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 479999999999 7999999986 6889999998764332 23445678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 80 ~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999999997654 6899999999999999999999999 99999999999999999999999999875421100
Q ss_pred --------------------------------------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC
Q 002146 833 --------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 874 (960)
Q Consensus 833 --------------------------------------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~ 874 (960)
.....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 111346999999999999999999999999999999999999
Q ss_pred CCCCCCChhHHHHHhhccccccCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 002146 875 LPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTVA 930 (960)
Q Consensus 875 ~PF~~~~~~ei~~~I~~~~~~~~iP~--~lS~eLkdLI~kcL~kDP~kRPS---a~eILe~ 930 (960)
.||.+.+..+....+........+|. .+++++++||.+||. +|.+|++ +.+++++
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999888777666643333444444 468999999999996 9999997 8888874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=349.30 Aligned_cols=257 Identities=31% Similarity=0.577 Sum_probs=220.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g-------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+..++|++.+.||.| .||.||++...+ ..||+|.+.... .......+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEG-AFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCc-cCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 456789999999999 699999997632 469999876443 33445678999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 810 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL 810 (960)
....+++|||+++++|.+++.+.. ..+++..++.++.||+.||.|||..+ |+||||||+|||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~ 157 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV 157 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE
Confidence 999999999999999999986531 35778889999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 002146 811 DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 887 (960)
Q Consensus 811 d~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~ 887 (960)
+.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....++..
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998653321 12233456889999999999899999999999999999998 999999988888777
Q ss_pred HhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 888 ~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.+. .......|..++.++.+|+.+||+.+|.+||++.+|+++|+.+
T Consensus 238 ~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 MIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 665 3334556788999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=361.23 Aligned_cols=248 Identities=21% Similarity=0.357 Sum_probs=213.9
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCC-CceeeEecccccCCceEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~H-PNIVkL~g~f~~~~~l~LV 752 (960)
+|++++.||.| .||.||++++ +++.||||++.+... .......+..|+.++..++| ++|+++++++...+.+|+|
T Consensus 1 ~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKG-SFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeec-cCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 58899999999 6999999986 467899999876432 23345677889999999976 5688999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 80 MEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999999999987644 6889999999999999999999999 99999999999999999999999999875433223
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++.++++||.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~ 234 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKG 234 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 3345679999999999999999999999999999999999999999988887777764 34566788899999999999
Q ss_pred hhhhCCCCCCCH-----HHHHHH
Q 002146 913 CWQTDPSLRPSF-----AQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa-----~eILe~ 930 (960)
||.+||.+|++. .+++++
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=363.42 Aligned_cols=243 Identities=26% Similarity=0.407 Sum_probs=210.9
Q ss_pred EEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 682 ERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~--~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
++||+| .||.||+++. .++.||||++...... ......+.+|+.+|+.++||||++++++|..++.+|+|||
T Consensus 2 ~~lg~G-~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKG-GYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeec-CCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 679999 6999999974 5788999998754321 2234467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+.+++|.+++.+.+ .+.+..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.........
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 999999999997654 6788888889999999999999999 9999999999999999999999999997643333334
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhh
Q 002146 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 914 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL 914 (960)
...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+. .....+|..+++.+++||.+||
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l 235 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKLL 235 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHc
Confidence 45679999999999999999999999999999999999999999988777776664 3356678889999999999999
Q ss_pred hhCCCCCC-----CHHHHHHH
Q 002146 915 QTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 915 ~kDP~kRP-----Sa~eILe~ 930 (960)
.++|.+|| ++.+++++
T Consensus 236 ~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 236 KRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ccCHhHcCCCCCCCHHHHhcC
Confidence 99999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.31 Aligned_cols=243 Identities=24% Similarity=0.415 Sum_probs=211.8
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
+.||+| .||.||+++. +++.||+|++...... ......+.+|+++++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G-~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKG-TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeC-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999 7999999975 6889999998765332 23455678899999999999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 759 GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
|+|..++.+.. .+++..++.++.||+.||.|||+ .| |+||||||+||||+.++.+||+|||+++............
T Consensus 80 ~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccc
Confidence 99999987644 68999999999999999999997 67 9999999999999999999999999987543332333456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..+++++.+||.+||..|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~d 234 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKD 234 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 79999999999999999999999999999999999999999988777766663 3456678889999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 002146 918 PSLRP-----SFAQLTVA 930 (960)
Q Consensus 918 P~kRP-----Sa~eILe~ 930 (960)
|.+|+ ++.+++++
T Consensus 235 P~~R~~~~~~~~~~il~h 252 (325)
T cd05594 235 PKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHhCCCCCCCHHHHhcC
Confidence 99997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=352.01 Aligned_cols=252 Identities=24% Similarity=0.412 Sum_probs=227.6
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
....++|++++.||+| -||.||+++. ++-.||+|++.+..+.. ....++.+|++|...|+||||+++|++|.+..+
T Consensus 18 ~~~l~dfeigr~Lgkg-kFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKG-KFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred ccchhhccccccccCC-ccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 3566899999999999 7999999975 56789999987765433 234578999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 749 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.||++||..+|+|+..|... ..++++.....++.|++.||.|+|.++ ||||||||+|+|++.+|.+||+|||.+...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999832 347999999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
. .....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.+.+|. ..+..+|..++.+++
T Consensus 175 p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 175 P--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--KVDLKFPSTISGGAA 250 (281)
T ss_pred C--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--HccccCCcccChhHH
Confidence 4 345667899999999999999999999999999999999999999999999889998884 457788999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||.++|.+|....|++++
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHhccCccccccHHHHhhh
Confidence 99999999999999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=372.32 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=215.5
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChH------------HHHHHHHHHHHHHHcCCCceee
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA------------ALLEFKREVKIMRRLRHPNVVL 738 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~------------~~~~~~~Ei~ILk~L~HPNIVk 738 (960)
...++|++++.||.| .||.|.+++. +++.||||++.+...... .++++.+||.||++|.|||||+
T Consensus 94 k~lNqy~l~~eiG~G-~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSG-QYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred eehhheehhhhhcCC-ccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 456899999999999 8999999986 789999999865432211 1357899999999999999999
Q ss_pred EecccccC--CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcE
Q 002146 739 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 816 (960)
Q Consensus 739 L~g~f~~~--~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~V 816 (960)
|+++..++ +.+|||+|||..|.+...= ..+..+.+.+.++|+++++.||+|||.+| ||||||||.|+||+.+|+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcE
Confidence 99998765 5799999999988876432 22223899999999999999999999999 9999999999999999999
Q ss_pred EEEecCccccccCC-----cccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 002146 817 KVSDFGLSRLKHNT-----FLSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 887 (960)
Q Consensus 817 KL~DFGLAr~~~~~-----~~~~~t~~GT~~Y~APEvl~g~~----ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~ 887 (960)
||.|||.+...... ...-...+||+-|+|||.+.++. .+.+.|||||||+||.|+.|+.||.+....+++.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999765221 11122368999999999997733 3688999999999999999999999999999999
Q ss_pred HhhccccccCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 888 AVGFQNRRLEIPKE--LDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 888 ~I~~~~~~~~iP~~--lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
+|. +.++.+|.. +..++++||.+||.+||++|.++.+|..+.=-
T Consensus 330 KIv--n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 330 KIV--NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHh--cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 994 557777755 78999999999999999999999999877543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=368.92 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=210.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|+++++||.| .||+||+++. +++.||||++.+... .......+.+|++++++++|||||+++++|.+...+|+|
T Consensus 1 ~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKG-AFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeec-CCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 478999999999 6999999976 788999999875432 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999999997643 6888899999999999999999999 99999999999999999999999999963211000
Q ss_pred -----------------------------------------------cCCCCCCCCCccCcccccCCCCCchhhHHHHHH
Q 002146 833 -----------------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGV 865 (960)
Q Consensus 833 -----------------------------------------------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGv 865 (960)
.....+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 001256999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC--CCcHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q 002146 866 ILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLR---PSFAQLTVA 930 (960)
Q Consensus 866 LLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~--~lS~eLkdLI~kcL~kDP~kR---PSa~eILe~ 930 (960)
++|||++|..||.+.+..+....+........+|. .++.++++||.+||. +|.+| +++.+++.+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999998887776666543333444554 478999999999997 66665 599998886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=359.94 Aligned_cols=248 Identities=21% Similarity=0.365 Sum_probs=214.1
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LV 752 (960)
+|.+.+.||+| .||.||++++ +++.||||++.+.... ......+..|..++..+ +|++|+++++++...+.+|+|
T Consensus 1 df~~~~~lg~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKG-SFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeC-CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 58899999999 6999999976 5678999998764322 23344567788888887 589999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++|+|.+++.+.. .+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 80 ~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 80 MEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred EcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999999999987644 6889999999999999999999998 99999999999999999999999999986443333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...+...+. .....+|..++.++++||.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 234 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKG 234 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHHH
Confidence 3445679999999999999999999999999999999999999999988888877774 34566788899999999999
Q ss_pred hhhhCCCCCCCH-----HHHHHH
Q 002146 913 CWQTDPSLRPSF-----AQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa-----~eILe~ 930 (960)
||+++|.+|++. .+++++
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhcC
Confidence 999999999984 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.61 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=210.8
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEEC------------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~------------------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP 734 (960)
++..+|++.++||+| .||.||++.+. +..||||.+.... .......+.+|+.+|.+++||
T Consensus 2 ~~~~~~~~~~~lg~G-~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEG-QFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEeccc-CCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCC
Confidence 456789999999999 69999999742 3369999886543 344556789999999999999
Q ss_pred ceeeEecccccCCceEEEEeecCCCCHHHHhhCCC------------------CCCcHHHHHHHHHHHHHHHHHHhhCCC
Q 002146 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH------------------CQVDEKRRIKMALDVARGMNCLHTSTP 796 (960)
Q Consensus 735 NIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~ 796 (960)
||+++++++.+.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++|
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 158 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN- 158 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 99999999999999999999999999999986422 23567788999999999999999999
Q ss_pred CEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--
Q 002146 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-- 872 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-- 872 (960)
|+||||||+||||+.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++
T Consensus 159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred -ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999999999999999999986533211 1223456789999999999999999999999999999986
Q ss_pred CCCCCCCCChhHHHHHhhc------cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 873 LKLPWIGMNPMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 873 G~~PF~~~~~~ei~~~I~~------~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
+..||.+....+....+.. .......+..++..+.+||.+||..+|.+||++.+|.+.|+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6788988776655443321 01112235567899999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=367.80 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=210.3
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
.|++++.||+| .||+||++++ +++.||||++..... .......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G-~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIG-AFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeec-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 58899999999 7999999976 678999999976543 2344567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC---
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--- 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~--- 830 (960)
||+++|+|.+++.+.+ .+++..+..++.||+.||+|||..| |+||||||+||||+.++++||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999997654 6888889999999999999999999 999999999999999999999999997542100
Q ss_pred --------------------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHH
Q 002146 831 --------------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVI 866 (960)
Q Consensus 831 --------------------------------------------~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvL 866 (960)
.......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000124579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHhhccccccCCCC--CCcHHHHHHHHHhh--hhCCCCCCCHHHHHHH
Q 002146 867 LWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECW--QTDPSLRPSFAQLTVA 930 (960)
Q Consensus 867 LyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~--~lS~eLkdLI~kcL--~kDP~kRPSa~eILe~ 930 (960)
+|||++|..||...+..+....+........+|. .+++++++||.+|+ ..++.+|+++.+|+.+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999998877666555543233344443 57899999999955 4555569999999886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=367.42 Aligned_cols=263 Identities=28% Similarity=0.467 Sum_probs=218.7
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEe
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 740 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~ 740 (960)
..+.++.++|++++.||+| .||.||++.+ ++..||||++..... ......+.+|+.+|+.+ +|+|||+++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G-~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAG-AFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccccHHHceehheecCC-CcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 3456778899999999999 6999999875 234799999875432 33456788999999999 899999999
Q ss_pred cccccCCceEEEEeecCCCCHHHHhhCCC---------------------------------------------------
Q 002146 741 GAVTRPPNLSIITEFLPRGSLFRILHRPH--------------------------------------------------- 769 (960)
Q Consensus 741 g~f~~~~~l~LVmEY~~gGsL~dlL~k~~--------------------------------------------------- 769 (960)
+++.....+++||||+++|+|.+++.+..
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999985421
Q ss_pred ------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 770 ------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 770 ------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
..+++..++.|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 13677888999999999999999998 9999999999999999999999999997653321
Q ss_pred c--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 832 L--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 832 ~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.........|..+++++++
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 346 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYS 346 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHH
Confidence 1 1122335678999999999999999999999999999997 999998876554443433333455566678899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
+|.+||..||.+||++.+|++.|+++.
T Consensus 347 li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 347 IMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=363.18 Aligned_cols=239 Identities=28% Similarity=0.435 Sum_probs=209.1
Q ss_pred EEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeec
Q 002146 682 ERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
+.||+| .||.||+++. +|+.||||++............+.+|+++|++++||||+++++++.....+|+||||+
T Consensus 2 ~~lg~G-~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQG-SFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeC-CCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 579999 7999999864 5789999999865444444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002146 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 836 (960)
Q Consensus 757 ~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t 836 (960)
++++|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...........
T Consensus 81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 81 RGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 9999999997643 6899999999999999999999999 999999999999999999999999999865443333445
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhh
Q 002146 837 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 916 (960)
Q Consensus 837 ~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~k 916 (960)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..+++++++||.+||+.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~ 235 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKR 235 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence 679999999999999999999999999999999999999999988777776663 335567888999999999999999
Q ss_pred CCCCCCCHHH
Q 002146 917 DPSLRPSFAQ 926 (960)
Q Consensus 917 DP~kRPSa~e 926 (960)
||.+||++.+
T Consensus 236 ~P~~R~~a~~ 245 (318)
T cd05582 236 NPANRLGAGP 245 (318)
T ss_pred CHhHcCCCCC
Confidence 9999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=355.59 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=212.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
+..++|++++.||.| .||.||++++ ++..||+|.+... ........+.+|+++|++++||||+++++++...+.++
T Consensus 2 l~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAG-NGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCC-CCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 456789999999999 7999999987 5788999988654 23445567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999999997644 6889999999999999999999852 3999999999999999999999999999765432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc-------------------
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------------------- 891 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~------------------- 891 (960)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...+..++...+..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 23346799999999999999999999999999999999999999987665444322110
Q ss_pred --------------------------cccccCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 892 --------------------------QNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 892 --------------------------~~~~~~iP-~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~L 931 (960)
....+..+ ..+++++++||.+||.+||++||++.+|+++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00111111 24678999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=360.33 Aligned_cols=237 Identities=25% Similarity=0.379 Sum_probs=207.0
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.||+| .||+||+++. +++.||||++..... .......+..|+.++..+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKG-SFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeC-CCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 369999 7999999986 578999999875432 223445677888999887 79999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+|+|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............
T Consensus 80 ~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (320)
T cd05590 80 GGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF 156 (320)
T ss_pred CchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccc
Confidence 999999987654 6899999999999999999999999 9999999999999999999999999987643333334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+|..++.++++||.+||++|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~d 234 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKN 234 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccC
Confidence 79999999999999999999999999999999999999999998888877764 3455677889999999999999999
Q ss_pred CCCCCCH
Q 002146 918 PSLRPSF 924 (960)
Q Consensus 918 P~kRPSa 924 (960)
|.+|+++
T Consensus 235 P~~R~~~ 241 (320)
T cd05590 235 PTMRLGS 241 (320)
T ss_pred HHHCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=376.48 Aligned_cols=252 Identities=24% Similarity=0.428 Sum_probs=233.1
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc-eEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~-l~L 751 (960)
+++|.++++||+| +||.++++++ ++..|++|.+......+......++|+.++.+++|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~G-afG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRG-AFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCcc-ccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 5789999999999 8999999976 67789999999888777777788999999999999999999999999998 999
Q ss_pred EEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 752 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
||+||+||+|.+.|.+.+ .-++++.++.|+.||+.|+.|||+.. |+|||||+.||+++.++.|||+|||+|+...+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999999987654 57899999999999999999999888 999999999999999999999999999998877
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
.....+.+||+.||+||++.+.+|+.++|||||||++|||++-+++|...+...+..+|... .-.++|..++.+++.||
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-LYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc-cCCCCCccccHHHHHHH
Confidence 55677889999999999999999999999999999999999999999999999998888633 35678899999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
+.||.++|..||++.+||.+
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999987
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.64 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=220.6
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|.+.+.||.| .||.||++.+ +++.|++|.+............+.+|+.++++++||||+++++++...+.+++|||
T Consensus 1 ~~~~~~~l~~g-~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKG-SFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCC-CCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58889999999 6999999976 68899999988766666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 755 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|+++++|.+++... ...+++..++.++.|++.||.|||+.| |+||||||+||+++.++.++|+|||+++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999999998764 457889999999999999999999998 999999999999999999999999999876544333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..++++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHH
Confidence 345578999999999999999999999999999999999999999888766665554 3334556667889999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~ 930 (960)
|+.+|++||++.+++++
T Consensus 237 l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 237 LTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCCcccCcCHHHHhhC
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=365.53 Aligned_cols=261 Identities=29% Similarity=0.456 Sum_probs=215.6
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEec
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 741 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g 741 (960)
.+.++.++|+++++||+| .||.||++.+ ++..||||+++.... ......+.+|+.+|+.+ +|||||++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G-~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAG-AFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeehhheecCC-ccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 456677899999999999 6999999964 355799998865432 23345788999999999 8999999999
Q ss_pred ccccCCceEEEEeecCCCCHHHHhhCCC----------------------------------------------------
Q 002146 742 AVTRPPNLSIITEFLPRGSLFRILHRPH---------------------------------------------------- 769 (960)
Q Consensus 742 ~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------------------------------------------- 769 (960)
++......++||||+++|+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986422
Q ss_pred ----------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 770 ----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 770 ----------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceec
Confidence 13677888999999999999999998 999999999999999999999999999865
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 828 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 828 ~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
..... ......++..|+|||++.+..++.++|||||||++|||++ |..||.................+...|...+.
T Consensus 265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (375)
T cd05104 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS 344 (375)
T ss_pred cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCH
Confidence 43211 1122335678999999999999999999999999999998 89999876544333333223334455667789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
++++||.+||+.||.+||++.+|++.|++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=355.64 Aligned_cols=242 Identities=25% Similarity=0.424 Sum_probs=207.9
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
++||.| .||.||++++ +++.||||+++.... .......+..|..++..+ +||||+++++++.....+|+||||++
T Consensus 1 ~~lG~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKG-SFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeC-CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 469999 7999999986 577899999876432 223344556777777765 89999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+|+|..++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++............
T Consensus 80 gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 156 (316)
T cd05592 80 GGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156 (316)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccc
Confidence 999999987654 6899999999999999999999998 9999999999999999999999999998654333334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+. ...+.+|..++.++.+||.+||..+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~ 234 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERD 234 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999999998887777663 3456778889999999999999999
Q ss_pred CCCCCCHH-HHHH
Q 002146 918 PSLRPSFA-QLTV 929 (960)
Q Consensus 918 P~kRPSa~-eILe 929 (960)
|.+||++. ++++
T Consensus 235 P~~R~~~~~~l~~ 247 (316)
T cd05592 235 PTKRLGVDGDIRQ 247 (316)
T ss_pred HHHcCCChHHHHc
Confidence 99999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=338.75 Aligned_cols=251 Identities=33% Similarity=0.558 Sum_probs=215.4
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..++|++.+.||.| .||.||++++. +..||+|.+...... ...+.+|+.+|++++||||+++++++.....+++|
T Consensus 2 ~~~~~~~~~~lg~G-~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 2 NPSELTFMKELGSG-QFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred CHHHcEEeeEecCC-cCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 34679999999999 69999999874 458999987654333 34678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++|+|.+++......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999999999765556889999999999999999999999 99999999999999999999999999986533222
Q ss_pred c-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 833 S-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 833 ~-~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
. .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.. ..+...|...+..+.+|+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li 234 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVM 234 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHH
Confidence 1 122335668999999999899999999999999999999 9999999888777777653 334455667788999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~L 931 (960)
.+||..+|.+||++.+|++.|
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.50 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=202.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++.+.||.| .||.||+++. +++.||||++....... ....+.+|+.+++.++||||+++++++.+...+++|
T Consensus 4 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEG-SYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEec-CCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3679999999999 7999999986 68899999987543222 233567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+. ++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 99995 6888888766567889999999999999999999999 99999999999999999999999999976543323
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHhhccccc---------------
Q 002146 833 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRR--------------- 895 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e-i~~~I~~~~~~--------------- 895 (960)
......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+..... ....+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 33456789999999998764 58899999999999999999999998764321 11111100000
Q ss_pred ----c--CCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 896 ----L--EIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 896 ----~--~iP---------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
. ..+ ..+++++++||.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 001 123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=359.20 Aligned_cols=243 Identities=22% Similarity=0.339 Sum_probs=210.5
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
++||+| .||.||++++ +++.||||++..... .......+..|++++..+ +||||++++++|...+.+|+||||++
T Consensus 1 ~~lG~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKG-SFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccC-CCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 369999 7999999987 477899999876432 233445677899999877 89999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|..++.+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............
T Consensus 80 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05591 80 GGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156 (321)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCcccccc
Confidence 999999887644 6889999999999999999999999 9999999999999999999999999997643333334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ....+|..++.++.+||.+||.+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ll~~~L~~d 234 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--DDVLYPVWLSKEAVSILKAFMTKN 234 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhccC
Confidence 799999999999999999999999999999999999999999988888777643 345567778999999999999999
Q ss_pred CCCCC-------CHHHHHHH
Q 002146 918 PSLRP-------SFAQLTVA 930 (960)
Q Consensus 918 P~kRP-------Sa~eILe~ 930 (960)
|.+|+ ++.+++++
T Consensus 235 p~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 235 PNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHcCCCCCCCCCHHHHhcC
Confidence 99999 77888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=356.11 Aligned_cols=247 Identities=29% Similarity=0.408 Sum_probs=205.8
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
...+|+++++||.| .||.||++++ +++.||||++.... .......+.+|+++|+.++|+||+++++++...+.+++
T Consensus 72 ~~~~~~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSG-AGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCC-CCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 45678888999999 6999999986 58899999986543 33445678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++++|.... ...+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 150 v~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999999986532 3567788899999999999999999 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH---HHHHhhccccccCCCCCCc
Q 002146 832 LSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g-----~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e---i~~~I~~~~~~~~iP~~lS 903 (960)
.......||..|+|||++.. ...+.++|||||||++|||++|..||....... ....+. .......+..++
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 301 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATAS 301 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccC
Confidence 33445679999999999843 234578999999999999999999997433222 222222 233455667889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.++++||.+||..||.+||++.+|+++
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999986
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=361.11 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=215.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|.+.+.||.| .||+||+++. +++.||||++..... .......+.+|+.+++.++|+||+++++++.+...+++|
T Consensus 1 ~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRG-HFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEec-cCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 468999999999 7999999976 688999999886543 233455688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++.+....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999999876567999999999999999999999999 99999999999999999999999999986543221
Q ss_pred -cCCCCCCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC--CCc
Q 002146 833 -SSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELD 903 (960)
Q Consensus 833 -~~~t~~GT~~Y~APEvl~------g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~--~lS 903 (960)
......||+.|+|||++. +..++.++|||||||++|+|++|..||...+..+....+........+|. .++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 223357999999999987 45678999999999999999999999998887777666643333344443 578
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.++++||.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 999999999997 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=366.65 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=218.7
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
...+..++|++.++||.| .||.||+++. +++.||||++...... ......+.+|+.+++.++||||+++++++.+.
T Consensus 37 ~~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRG-AFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred cCCCCHHHcEEEEEEeeC-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 455677899999999999 7999999976 6889999998754322 22334577899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999999998753 4788889999999999999999999 99999999999999999999999999986
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC-
Q 002146 827 KHNTF-LSSKSTAGTPEWMAPEVLRNE----PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK- 900 (960)
Q Consensus 827 ~~~~~-~~~~t~~GT~~Y~APEvl~g~----~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~- 900 (960)
..... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+........+|.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 54322 223456799999999998764 378999999999999999999999999888777777754444455555
Q ss_pred -CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 002146 901 -ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 930 (960)
Q Consensus 901 -~lS~eLkdLI~kcL~kDP~k--RPSa~eILe~ 930 (960)
.++.++++||.+||+.+|.+ |+++.+++++
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 57899999999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=338.85 Aligned_cols=257 Identities=30% Similarity=0.538 Sum_probs=219.4
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
|++..++|+++++||.| .||.||++.. ++..||+|.+.... .....+.+|+.++++++|+||+++++.+......
T Consensus 1 ~~~~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 1 WEIPRESIKLVKKLGAG-QFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred CcCchHHeEEeeecCCc-CCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 45778899999999999 6999999976 56779999876432 2345788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++|||+++++|.+++.+. ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecC
Confidence 9999999999999998753 346788889999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 829 NTFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 829 ~~~~~-~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ..+...+..++.++
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRMENCPDEL 233 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHH
Confidence 33211 122345678999999999889999999999999999998 9999998877776666542 23344455688999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.+||.+||..+|++||++++|++.|+++
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=339.01 Aligned_cols=257 Identities=36% Similarity=0.626 Sum_probs=221.4
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
+++...+|.+.+.||.| .||.||++.+ .++.||+|++.... .....+.+|++++++++|+||+++++++.....
T Consensus 1 ~~~~~~~~~~~~~ig~g-~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 1 WEMERTDITMKHKLGGG-QYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 76 (263)
T ss_pred CCCchHHeEEeeecCCc-ccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC
Confidence 45677889999999999 7999999976 58889999876432 234578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
+++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 999999999999999987533 35888999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcccC-CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 828 HNTFLSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 828 ~~~~~~~-~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+. .......+..++.+
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPK 233 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHH
Confidence 4432211 12234668999999999999999999999999999998 999999888777666654 33455677889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+.++|.+||..+|.+||++.++++.|+.+
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=366.53 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=210.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.+|++++.||+| .||.||+++. +++.||||++...... ......+.+|+.+|+.++|+||+++++.|.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G-~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIG-AFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeC-CCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 369999999999 7999999976 6889999998654322 22345678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC--
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 830 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~-- 830 (960)
|||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||++..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999997654 6888889999999999999999999 999999999999999999999999997532100
Q ss_pred -----------------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHH
Q 002146 831 -----------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 869 (960)
Q Consensus 831 -----------------------------------------~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyE 869 (960)
.......+||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 001123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHhhccccccCCC--CCCcHHHHHHHHHhhhhCCCCCC---CHHHHHHH
Q 002146 870 LATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRP---SFAQLTVA 930 (960)
Q Consensus 870 LLTG~~PF~~~~~~ei~~~I~~~~~~~~iP--~~lS~eLkdLI~kcL~kDP~kRP---Sa~eILe~ 930 (960)
|++|..||.+.+..+....+........+| ..+++++.+||.+|+ .+|.+|+ ++.+++++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999988776655553322233333 357899999999977 5999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=365.93 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=210.0
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
.|+++++||+| .||.||+++. +++.||||++..... .......+.+|+.+|++++|||||++++.|.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G-~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIG-AFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeC-CCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 58899999999 7999999986 678899999876432 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC---
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--- 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~--- 830 (960)
||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+||||+.+|++||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999999997653 6888999999999999999999999 999999999999999999999999997532100
Q ss_pred --------------------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHH
Q 002146 831 --------------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVI 866 (960)
Q Consensus 831 --------------------------------------------~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvL 866 (960)
.......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHhhccccccCCC--CCCcHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 002146 867 LWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPS---FAQLTVA 930 (960)
Q Consensus 867 LyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP--~~lS~eLkdLI~kcL~kDP~kRPS---a~eILe~ 930 (960)
+|||++|..||.+.+..+....+........+| ..+++++++||.+|+ .+|.+|++ +.+++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999999988776666654333334444 457899999999976 59999987 8888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=338.31 Aligned_cols=257 Identities=24% Similarity=0.449 Sum_probs=215.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.+|++.+.||.| .||.||++++ +++.||||.+..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~~i~~~l~~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRG-QFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccC-CCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 579999999999 7999999976 789999998865433 344456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 753 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 753 mEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988753 2345788999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHhhccccccCCCCCCcHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~--~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+.....+...+..++..++
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 33223345688999999999988899999999999999999999999976532 3444444322222222345778999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
+||.+||..+|.+||++.++++.++.++
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=342.35 Aligned_cols=257 Identities=29% Similarity=0.548 Sum_probs=218.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+++++|++.+.||+| .||+||++.+ .+..||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g-~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGEC-AFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeecccc-CCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 466889999999999 6999999974 45689999886543 334456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCC----------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH----------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 810 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~----------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL 810 (960)
...|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 99999999999999999985321 24778888999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 002146 811 DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 887 (960)
Q Consensus 811 d~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~ 887 (960)
+.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.....+..
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998653321 11233446778999999998889999999999999999998 999999887766666
Q ss_pred HhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 888 ~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.+. .......+..+++.++++|.+||+.+|.+||++.+|++.|+.+
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 238 MVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 554 2334556778899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.81 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=207.8
Q ss_pred CeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCc
Q 002146 677 DLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~--~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~ 748 (960)
+|++++.||+| .||.||+++. +++.||+|++.+.... ......+..|+.+|+.+ +|+||+++++++...+.
T Consensus 1 ~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTG-AYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeec-CCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 58899999999 6999999875 5788999998754321 22345678899999999 59999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999987643 6889999999999999999999999 9999999999999999999999999998653
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHhhccccccCCCCCC
Q 002146 829 NTF-LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 829 ~~~-~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~----~ei~~~I~~~~~~~~iP~~l 902 (960)
... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ..+...+ ....+.+|..+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFI 234 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCC
Confidence 321 2233467999999999998764 78999999999999999999999975322 2222222 23455677889
Q ss_pred cHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 002146 903 DPLVARIIWECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
++.+++||.+||..||.+|| ++.+++++
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999999999 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=367.55 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=227.4
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|.+.+.||.| .|..|-++++ +|+.||||++.+..+.......+..|++.|+.++|||||++|++...+..+|||+|.
T Consensus 20 YDLekTlG~G-HFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRG-HFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCC-ceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 6778899999 8999999986 899999999999988887778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecCccccccCCcccC
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
-.+|+|++||-++...+.|....+++.||+.|+.|+|+.. +|||||||+|+++- +-|-|||+|||++..+... ..-
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL 175 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKL 175 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc-chh
Confidence 9999999999998889999999999999999999999998 99999999998876 5799999999999877554 445
Q ss_pred CCCCCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 835 KSTAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys-~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
.+.||...|-|||++.|..|+ +++||||||+|||.|.+|++||...+..+.+..| ....+.+|..++.++++||..|
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHHHHH
Confidence 678999999999999999985 6899999999999999999999999999888887 5668889999999999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTV 929 (960)
Q Consensus 914 L~kDP~kRPSa~eILe 929 (960)
|..||.+|.+.++|..
T Consensus 254 LvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVS 269 (864)
T ss_pred HhcCchhhccHHHHhc
Confidence 9999999999888764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=373.85 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=221.9
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
...+...++|++.+.||.| .||+||++++ +++.||||++............+.+|+.+|..++|+||+++++.+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G-~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSG-ATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred ccccccCCCEEEEEEEecC-CCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 3344556799999999999 7999999976 789999999987766666677889999999999999999998876543
Q ss_pred C--------ceEEEEeecCCCCHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc
Q 002146 747 P--------NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 815 (960)
Q Consensus 747 ~--------~l~LVmEY~~gGsL~dlL~k~---~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~ 815 (960)
+ .+++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCC
Confidence 2 378999999999999998642 346889999999999999999999998 999999999999999999
Q ss_pred EEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 002146 816 VKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 893 (960)
Q Consensus 816 VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~ 893 (960)
+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. .
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~ 260 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-G 260 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-C
Confidence 9999999998654321 123456799999999999999999999999999999999999999999888777766543 3
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....+|..+++++++||.+||..+|.+||++.+++++
T Consensus 261 ~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 3445778899999999999999999999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=337.67 Aligned_cols=256 Identities=32% Similarity=0.540 Sum_probs=219.6
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
..++|++.+.||+| .||.||+|.+. ...||||.+.... .......+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~~~lg~g-~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGG-EFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCC-ccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 35679999999999 69999999873 3479999876543 34445678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
.++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999999999876667899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 829 NTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 829 ~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSA 236 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 221 11122334678999999999999999999999999999998 999998887777766664 22344556778999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+.+|+.+||+.+|.+||++.+|++.|+++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.64 Aligned_cols=248 Identities=36% Similarity=0.634 Sum_probs=210.9
Q ss_pred EEEEEeeccCCeeEEEEEEEC------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 679 VLGERIGLGSSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 679 ~i~k~LG~GGsFG~Vy~ak~~------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.+.+.||.| .||.||+|.+. +..|+||.+.. .........+.+|+++|++++||||+++++++.....+++|
T Consensus 2 ~~~~~ig~G-~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEG-SFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEE-SSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccC-CCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 578899999 89999999887 67899999854 33445577899999999999999999999999988889999
Q ss_pred EeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC-
Q 002146 753 TEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 830 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~- 830 (960)
|||+++|+|.++|... ...+++..++.|+.||+.||.|||+++ |+||||+++|||++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 9999999999999876 557999999999999999999999998 999999999999999999999999999876221
Q ss_pred -cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 831 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 831 -~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..++...+. ...+..++..++..+.+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK-QGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-TTEETTSBTTSBHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccceeccchhHHHHH
Confidence 112233446779999999999999999999999999999999 789999998888877773 55566778889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~L 931 (960)
+|.+||..+|.+||++.+|++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.25 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=206.8
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
++||.| .||.||++++ +|+.||||++...... ......+..|..++..+ +||||+++++++.+.+.+|+||||+.
T Consensus 1 ~~lg~G-~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKG-SFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeC-CCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 469999 7999999987 6789999998764321 22344567788888765 89999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|..++.+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............
T Consensus 80 ~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05620 80 GGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF 156 (316)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceecc
Confidence 999999987643 6889999999999999999999999 9999999999999999999999999987543222233456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+. ...+.+|..++.++++||.+||..|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~d 234 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERD 234 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999999988877777663 3356677889999999999999999
Q ss_pred CCCCCCHH-HHH
Q 002146 918 PSLRPSFA-QLT 928 (960)
Q Consensus 918 P~kRPSa~-eIL 928 (960)
|.+|+++. +++
T Consensus 235 P~~R~~~~~~~~ 246 (316)
T cd05620 235 PTRRLGVVGNIR 246 (316)
T ss_pred HHHcCCChHHHH
Confidence 99999974 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=351.69 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=200.7
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC-----Cce
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 749 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~-----~~l 749 (960)
+|++.++||.| .||.||++.. +++.||||++............+.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKG-SYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeec-CCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 58999999999 7999999975 688999999875433333445788999999999999999999987543 348
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+||||+. ++|.+++.+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 99999995 68999887644 6899999999999999999999999 99999999999999999999999999986432
Q ss_pred Cc---ccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc-------------
Q 002146 830 TF---LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------------- 891 (960)
Q Consensus 830 ~~---~~~~t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~------------- 891 (960)
.. .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 21 11234579999999999876 6789999999999999999999999987654332211100
Q ss_pred -------------cccccCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 892 -------------QNRRLEI---PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 892 -------------~~~~~~i---P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
......+ ...+++.+.+||.+||..||.+||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 12467889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=355.34 Aligned_cols=243 Identities=23% Similarity=0.388 Sum_probs=210.9
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.||.| .||+||++++ +++.||||++.+... .......+.+|+.+++.+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKG-SFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeC-CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 469999 6999999987 577899999876532 223455677899999888 79999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|..++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............
T Consensus 80 ~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (318)
T cd05570 80 GGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF 156 (318)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccce
Confidence 999999987654 6899999999999999999999999 9999999999999999999999999997543332333456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..++..+++||.+||..|
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~d 234 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKN 234 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999999888877776663 3355678889999999999999999
Q ss_pred CCCCCCH-----HHHHHH
Q 002146 918 PSLRPSF-----AQLTVA 930 (960)
Q Consensus 918 P~kRPSa-----~eILe~ 930 (960)
|.+||++ .+++++
T Consensus 235 P~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 235 PEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 9999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=354.80 Aligned_cols=242 Identities=21% Similarity=0.370 Sum_probs=209.8
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~LV 752 (960)
+|+..+.||.| .||.||+++. +++.||||++.+... .......+..|+.+++.+. |++|+++++++.+.+.+|+|
T Consensus 1 ~f~~~~~lg~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKG-SFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEec-CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 47788999999 7999999976 688999999876432 2334456778999998885 57888999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999999999987644 6899999999999999999999999 99999999999999999999999999976433323
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+. .....+|..++.++++|+.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~ 234 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKG 234 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHHH
Confidence 3445679999999999999999999999999999999999999999988887777764 34556788899999999999
Q ss_pred hhhhCCCCCCCH
Q 002146 913 CWQTDPSLRPSF 924 (960)
Q Consensus 913 cL~kDP~kRPSa 924 (960)
||.++|.+|++.
T Consensus 235 ~l~~~p~~R~~~ 246 (323)
T cd05615 235 LMTKHPSKRLGC 246 (323)
T ss_pred HcccCHhhCCCC
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.63 Aligned_cols=251 Identities=30% Similarity=0.487 Sum_probs=217.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~---~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
+.|.+.+.||.| .||.||++.. +++.||+|.+....... .....+.+|+.++++++||||+++++++.....++
T Consensus 2 ~~~~~~~~lg~g-~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQG-AFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCC-CceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 468899999999 7999999975 68999999987543322 23457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+++++|.+++.+.. .+++.....++.|++.||.|||..| |+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999999987643 5888999999999999999999999 999999999999999999999999999765332
Q ss_pred ccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 831 FLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 831 ~~~---~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
... .....|+..|+|||++.+..++.++||||||+++|+|++|..||...........+........+|..++..+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence 111 12356888999999999999999999999999999999999999887776665555545556677888999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++|.+||.++|.+||++.+++++
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.29 Aligned_cols=256 Identities=33% Similarity=0.555 Sum_probs=218.9
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
++..++|++.+.||.| .||.||++.+ +++.||||.+...... ...+.+|+.++++++||||+++++++.....++
T Consensus 2 ~~~~~~~~~~~~lg~g-~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 2 EIDRTSIQLLRKLGAG-QFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred ccchhheeeEEEeccc-CCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 5667889999999999 6999999976 5567999988654332 346889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
+||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999999997643 46889999999999999999999998 99999999999999999999999999987653
Q ss_pred Cccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 830 TFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 830 ~~~~-~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.... ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+. .......+..++..+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELY 234 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 2211 111223457999999999999999999999999999999 999999988777766664 2334455677889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+++.+||+.+|.+||++.+|++.|+.+
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.42 Aligned_cols=238 Identities=26% Similarity=0.413 Sum_probs=203.3
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHH-HHHHcCCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~-ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.||+| .||+||++++ +|+.||||++...... ......+..|.. +++.++||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKG-SFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeC-CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 469999 7999999987 6889999998754322 222344555555 4577899999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|..++.+.+ .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............
T Consensus 80 ~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccc
Confidence 999999987644 6889999999999999999999999 9999999999999999999999999997643333334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+. .....++..++..+.+||.+||++|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~ 234 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKD 234 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 79999999999999999999999999999999999999999988877777664 3345567778999999999999999
Q ss_pred CCCCCCHH
Q 002146 918 PSLRPSFA 925 (960)
Q Consensus 918 P~kRPSa~ 925 (960)
|.+||++.
T Consensus 235 p~~R~~~~ 242 (323)
T cd05575 235 RTKRLGAK 242 (323)
T ss_pred HHhCCCCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=355.04 Aligned_cols=252 Identities=19% Similarity=0.326 Sum_probs=212.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++.+.||+| .||.||++++ +++.||||++.+... .......+.+|+.++..++|+||+++++++.+.+.+|+|
T Consensus 1 d~y~i~~~lG~G-~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRG-AFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeC-CCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 479999999999 6999999986 578899999875322 223345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||++||+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999999875557899999999999999999999999 99999999999999999999999999976543321
Q ss_pred -cCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC---CCc
Q 002146 833 -SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK---ELD 903 (960)
Q Consensus 833 -~~~t~~GT~~Y~APEvl~g-----~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~---~lS 903 (960)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....+..+|. .++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 237 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVS 237 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCC
Confidence 2233579999999999876 4578899999999999999999999999888777777654444445554 368
Q ss_pred HHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSL--RPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~k--RPSa~eILe~ 930 (960)
.++++||.+||..++.+ |+++++++++
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 99999999999876654 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=356.93 Aligned_cols=243 Identities=22% Similarity=0.377 Sum_probs=205.4
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
++||+| .||.||++++ +++.||||+++..... ......+.+|+.+++.+ +||||++++++|.+...+|+||||++
T Consensus 1 ~~lG~G-~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRG-SYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeC-CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 469999 7999999986 6889999999865433 33455688999999999 79999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............
T Consensus 80 ~g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (329)
T cd05588 80 GGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF 156 (329)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCccccc
Confidence 999999887643 6899999999999999999999999 9999999999999999999999999997533322334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------hHHHHHhhccccccCCCCCCcHHHHH
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---------MQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~---------~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+ ......+|..++.++++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASS 234 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHH
Confidence 899999999999999999999999999999999999999964221 1122223 33455678889999999
Q ss_pred HHHHhhhhCCCCCCC------HHHHHHH
Q 002146 909 IIWECWQTDPSLRPS------FAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPS------a~eILe~ 930 (960)
||.+||+.||.+|++ +.+++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=337.71 Aligned_cols=252 Identities=34% Similarity=0.560 Sum_probs=215.8
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEECCc-EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~g~-~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..++|++++.||.| .||.||++++.+. .||||.+...... ...+.+|+.++++++||||+++++++.....+++|
T Consensus 2 ~~~~~~~~~~lg~G-~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 2 DPKDLTFLKELGTG-QFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred ChHHeEEeeEecCc-ccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 45689999999999 6999999987544 5999987654333 34688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+.+++|.+++......+++..++.++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999999999775557899999999999999999999999 99999999999999999999999999886543221
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 833 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 833 -~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
......++..|++||++.+..++.++|||||||++|+|++ |..||...+..+....+. ...+...+...+..+++++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 234 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIM 234 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHH
Confidence 1122335678999999998889999999999999999998 999999888777666664 3344455667889999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~Le 932 (960)
.+||..+|.+||++.+|++.|+
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=361.39 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=211.8
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++++.||.| .||+||+++. +++.||||++..... .......+.+|+.++..++||||+++++.+.+.+.+|+|
T Consensus 1 ~~f~~~~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRG-AFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeC-CCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 478999999999 7999999976 688999999875432 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 831 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~- 831 (960)
|||++||+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999997644 6899999999999999999999999 9999999999999999999999999987542110
Q ss_pred ----------------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002146 832 ----------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877 (960)
Q Consensus 832 ----------------------------------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF 877 (960)
......+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0012457999999999999999999999999999999999999999
Q ss_pred CCCChhHHHHHhhccccccCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 002146 878 IGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTVA 930 (960)
Q Consensus 878 ~~~~~~ei~~~I~~~~~~~~iP~--~lS~eLkdLI~kcL~kDP~kRPS---a~eILe~ 930 (960)
.+.+.......+........+|. .++.++++||.+|+ .+|.+|++ +.+++++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 99888877766653333444554 36899999999987 59999985 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.15 Aligned_cols=241 Identities=25% Similarity=0.378 Sum_probs=203.0
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHH-HHHHcCCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~-ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.||.| .||+||++++ +++.||+|++...... ......+..|.. +++.++||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G-~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKG-SFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeC-CCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 469999 6999999986 5778999998754321 122234444444 5677899999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|.+++.+.+ .+.+..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++............
T Consensus 80 ~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccc
Confidence 999999997644 5778888889999999999999999 9999999999999999999999999997643333334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....++..++..++++|.+||+++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~ 234 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKD 234 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccC
Confidence 79999999999999999999999999999999999999999988877776663 2345566788999999999999999
Q ss_pred CCCCCCHHHHH
Q 002146 918 PSLRPSFAQLT 928 (960)
Q Consensus 918 P~kRPSa~eIL 928 (960)
|.+|+++.+.+
T Consensus 235 p~~R~~~~~~~ 245 (325)
T cd05602 235 RTKRLGAKDDF 245 (325)
T ss_pred HHHCCCCCCCH
Confidence 99999876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.45 Aligned_cols=259 Identities=31% Similarity=0.536 Sum_probs=221.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
|.+++|.+.+.||.| .||.||++.. ++..||+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G-~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEG-AFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCc-CCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 567889999999999 6999999974 2456899987643 23445678999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCC------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPH------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 813 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~ 813 (960)
...+++||||+++++|.+++...+ ..+++..++.++.||+.||+|||++| |+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC
Confidence 999999999999999999986432 24899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhh
Q 002146 814 WNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 890 (960)
Q Consensus 814 g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~ 890 (960)
+.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998653321 11223345778999999999999999999999999999998 999999888777776664
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 891 ~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
. ......+..++.++.+|+.+||..+|.+||++.++++.|+++.+.
T Consensus 237 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 Q-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred c-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 3 334455667889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.96 Aligned_cols=264 Identities=32% Similarity=0.537 Sum_probs=223.2
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceee
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 738 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVk 738 (960)
..+++..++|.+++.||+| .||.||++++. ...||+|.+.... ......++.+|+.+++.+ +||||++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G-~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEG-CFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CcceeehHHeEEeeeeccC-CCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 3567778899999999999 69999999752 2469999887542 344456788999999999 8999999
Q ss_pred EecccccCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 739 L~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
+++++...+..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dl 166 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDL 166 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccc
Confidence 9999999999999999999999999997532 24788899999999999999999998 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~~~--~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999999999765432111 111234568999999999999999999999999999998 89999887
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
...++...+. .......+..++.++++||.+||..+|.+||++.++++.|+++...
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 247 PVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 7766666554 3335566778899999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=338.18 Aligned_cols=256 Identities=33% Similarity=0.594 Sum_probs=221.0
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
....+|+++++||.| .||.||++.+ .+..||+|++..... .....+.+|+.+++.++|+||+++++++.....+++
T Consensus 3 ~~~~~y~~~~~ig~g-~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 3 RPREEFTLERKLGSG-YFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred CcHHHHHHhhhhccC-CCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 345679999999999 6999999986 567899998865432 234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 752 ITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
||||+++++|.+++.+. +..+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999999763 346889999999999999999999998 999999999999999999999999999876443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
........++..|++||++.+..++.++||||||+++|+|++ |..||.+.+..+....+. ...+...+..++..+.++
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHH
Confidence 322333446778999999999899999999999999999998 899999888777776665 334556677889999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 910 IWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
|.+||+.+|.+||++.+|++.|+.+
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 237 MLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHcCCCchhCcCHHHHHHHHhcC
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=354.11 Aligned_cols=242 Identities=24% Similarity=0.398 Sum_probs=206.6
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.||+| .||+||++++ +++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+++||||++
T Consensus 1 ~~lG~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKG-SFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeC-CCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 469999 7999999986 577899999876432 122344566788888765 99999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+|+|.+++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++............
T Consensus 80 ~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05619 80 GGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156 (316)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeee
Confidence 999999997643 6888899999999999999999998 9999999999999999999999999997543222233456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.. ..+.+|..++.++++||.+||..+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~ 234 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVRE 234 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccC
Confidence 799999999999999999999999999999999999999999888877776643 345567788999999999999999
Q ss_pred CCCCCCHH-HHHH
Q 002146 918 PSLRPSFA-QLTV 929 (960)
Q Consensus 918 P~kRPSa~-eILe 929 (960)
|.+||++. ++++
T Consensus 235 P~~R~~~~~~l~~ 247 (316)
T cd05619 235 PERRLGVKGDIRQ 247 (316)
T ss_pred HhhcCCChHHHHc
Confidence 99999996 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=363.10 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=216.1
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+..++|++.++||.| .||.||++++ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.++.
T Consensus 38 ~~~~~~~y~~~~~lG~G-~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 38 LQMKAEDYDVVKVIGRG-AFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred cCCCHHHCeEEEEEEec-CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34556789999999999 7999999987 578899999865332 2233446788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999999999754 4888999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC--
Q 002146 828 HNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-- 900 (960)
Q Consensus 828 ~~~~-~~~~t~~GT~~Y~APEvl~g~~----ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~-- 900 (960)
.... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+........+|.
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 4322 2234567999999999997653 78899999999999999999999999888777777654444455555
Q ss_pred CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 930 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~k--RPSa~eILe~ 930 (960)
.++..++++|.+||..++.+ |+++.+++++
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 46899999999999865544 8899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.96 Aligned_cols=252 Identities=37% Similarity=0.636 Sum_probs=219.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+..++|++.+.||.| .||.||++...|+.||||.+..... ...++.+|+.+++.++|+||+++++++......++|
T Consensus 3 ~~~~~~~~~~~ig~g-~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 3 INSKELKLGATIGKG-EFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred cChhhccceeeeecC-CCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 456789999999999 7999999999999999999865432 456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 753 TEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
|||+++++|.+++.... ..+++..++.++.|++.||.|||..+ |+||||||+||+++.++.+||+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999997643 25899999999999999999999999 9999999999999999999999999998763221
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
....++..|+|||++.+..++.++||||||+++|+|++ |..||......++...+. ...+...+..+++.+.+||
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHH
Confidence 12345668999999998889999999999999999997 999998887776665553 2334556777899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 911 WECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.+||..+|.+||++.++++.|+++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.83 Aligned_cols=250 Identities=23% Similarity=0.304 Sum_probs=210.6
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChH-HHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~-~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
.|++.++||.| .||.||++.. +++.||||++........ ....+.+|+.+++.++||||+++++.+...+.+++||
T Consensus 1 ~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKG-GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecC-CCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 37899999999 7999999976 688999999876443322 2345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 754 EFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++...... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-E 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCC-C
Confidence 9999999998886533 46899999999999999999999998 999999999999999999999999999865432 2
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhh--ccccccCCCCCCcHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~--~~~~~~~iP~~lS~eLkdLI 910 (960)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+. .......++..++..+++||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 2234578999999999999999999999999999999999999998865533222211 12334456677899999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHHH
Q 002146 911 WECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
.+||..||.+|| ++++++++
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999 88899776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=343.48 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=202.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc---CCCceeeEecccc-----
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT----- 744 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~---~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L---~HPNIVkL~g~f~----- 744 (960)
++|++.+.||.| .||.||++++ .++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G-~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEG-AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccC-CCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 368999999999 7999999976 367899998876543333334556777777766 6999999999874
Q ss_pred cCCceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
....+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 3456999999996 5899888653 335889999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc-------
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------- 896 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~------- 896 (960)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+......+
T Consensus 157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 157 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 9865433 23345678999999999999999999999999999999999999999887665554442110000
Q ss_pred ------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 ------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 ------------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+...++..+++||.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0113467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.90 Aligned_cols=257 Identities=32% Similarity=0.546 Sum_probs=215.2
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
++..++|++.+.||+| .||.||++.+. +..||||++.... ......++.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G-~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQG-SFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccc-cCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4456789999999999 69999998753 3579999875433 2234457889999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCC---------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 815 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~---------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~ 815 (960)
.....++||||+++++|.+++.+.+ ..++...+..++.|++.||.|||+.+ ++||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence 9999999999999999999986532 13567788899999999999999998 999999999999999999
Q ss_pred EEEEecCccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcc
Q 002146 816 VKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 892 (960)
Q Consensus 816 VKL~DFGLAr~~~~~~~~--~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~ 892 (960)
+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+. .
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-E 236 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-c
Confidence 999999999765332111 112345778999999999999999999999999999999 789999888776666554 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 893 ~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
.....++..++..+++||.+||+.+|.+||++.++++.|++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 33455677889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.61 Aligned_cols=251 Identities=33% Similarity=0.565 Sum_probs=214.7
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
...+|++.+.||.| .||.||++++. +..+|||++....... ..+.+|+.++++++||||+++++++......++|
T Consensus 2 ~~~~~~~~~~lg~G-~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 2 DPSELTFLKELGSG-QFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred ChHHcchhhhhccC-CCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 34678899999999 79999999874 4579999886544332 3677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999999999765557899999999999999999999999 99999999999999999999999999986543221
Q ss_pred c-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 833 S-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 833 ~-~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ...+...+..++.++.+|+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 234 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIM 234 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHH
Confidence 1 112224468999999999999999999999999999999 899998887777666654 3335566777899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~L 931 (960)
.+||..+|.+||++.++++.|
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.47 Aligned_cols=259 Identities=27% Similarity=0.493 Sum_probs=217.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCc----EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~----~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+...+|++.+.||+| .||.||++.+ +++ .||||.+... .......++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSG-AFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecC-CCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 345679999999999 6999999976 333 4899987643 2334456788999999999999999999998764
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..++|+||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccc
Confidence 578999999999999999876667889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 827 KHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 827 ~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. .......+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICT 237 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCC
Confidence 643221 1122334678999999999999999999999999999997 999999887766554433 334455567788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.++.++|.+||..+|.+||++.+++..|.++.+.
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 9999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.55 Aligned_cols=238 Identities=27% Similarity=0.406 Sum_probs=202.9
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHH-HHHHcCCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~-ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
++||.| .||.||++++ +++.||||++.+.... ......+..|+. +++.++||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKG-SFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeC-CCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 469999 7999999987 6889999998754322 223344555554 5788899999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|..++.+.. .+.+..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++............
T Consensus 80 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccc
Confidence 999999887643 6888889999999999999999998 9999999999999999999999999987643332334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+. .....+|...+..+.++|.+||+++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~ 234 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKD 234 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999999988777776663 3456677888999999999999999
Q ss_pred CCCCCCHH
Q 002146 918 PSLRPSFA 925 (960)
Q Consensus 918 P~kRPSa~ 925 (960)
|.+|+++.
T Consensus 235 p~~R~~~~ 242 (321)
T cd05603 235 QRRRLGAK 242 (321)
T ss_pred HhhcCCCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.14 Aligned_cols=251 Identities=33% Similarity=0.589 Sum_probs=216.6
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccc-ccCCceEE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLSI 751 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f-~~~~~l~L 751 (960)
+.+++|++.+.||.| .||.||++...|..||+|.+.... ....+.+|+.++++++|+||+++++++ ......++
T Consensus 3 ~~~~~~~~~~~lg~g-~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 3 LNMKELKLLQTIGKG-EFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred ccHHhCeeeeeeccc-CCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 566789999999999 699999999999999999875432 234688999999999999999999875 45567999
Q ss_pred EEeecCCCCHHHHhhCCCC-CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 752 ITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~-~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
||||+++++|.+++.+... .+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999999876443 4788999999999999999999998 999999999999999999999999998765332
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
. ....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..++...+.. ......+..+++.+++|
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV 231 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHH
Confidence 1 23345678999999999999999999999999999997 9999998887777666642 33455667889999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 910 IWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
|.+||+.+|.+||++.++++.|+++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.87 Aligned_cols=258 Identities=31% Similarity=0.543 Sum_probs=220.1
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 743 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f 743 (960)
+++..++|++.+.||.| .||.||++.+. +..||+|.+.... .......+.+|+.+|+.++||||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 1 WELPREKITLIRELGQG-SFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred CccchHHeeEEeEecCC-CCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 35677899999999999 69999999763 2679999875443 333455788999999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHhhCCC---------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC
Q 002146 744 TRPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL~dlL~k~~---------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g 814 (960)
......++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~ 156 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDL 156 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCC
Confidence 99999999999999999999986422 23677889999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhc
Q 002146 815 NVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 891 (960)
Q Consensus 815 ~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~ 891 (960)
.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~- 235 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI- 235 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-
Confidence 999999999986543221 1233456789999999998889999999999999999998 999999888777776665
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 892 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 892 ~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
......+|..++.++.+||.+||+.+|.+||++.+|++.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 444566788889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=352.31 Aligned_cols=252 Identities=20% Similarity=0.342 Sum_probs=212.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++.++||+| .||.||++++ .++.||+|++.+... .......+..|+.++..++|+||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~lG~G-~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRG-AFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeC-CCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 479999999999 7999999987 567899999865322 223344578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 831 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~- 831 (960)
|||+++|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999999875557899999999999999999999999 9999999999999999999999999987643221
Q ss_pred ccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC---CCc
Q 002146 832 LSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK---ELD 903 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~---~lS 903 (960)
......+||+.|+|||++. ...++.++|||||||++|||++|..||...+..+....+.....+..+|. .++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 1223457999999999986 34578999999999999999999999999888887777754444444443 578
Q ss_pred HHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSL--RPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~k--RPSa~eILe~ 930 (960)
+++++||.+||..++.+ |+++.+++++
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 99999999999665544 6899999888
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.29 Aligned_cols=256 Identities=31% Similarity=0.574 Sum_probs=218.4
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
++|..++|+++++||.| .||.||++.. +++.||+|.+...... ...+.+|+.++++++|+||+++++++. .+..
T Consensus 1 ~~~~~~~~~~~~~ig~G-~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 1 WEVPRETLKLVKKLGAG-QFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred CccchHHceeeeeeccC-ccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 45677899999999999 6999999976 6788999988755433 346889999999999999999999875 4578
Q ss_pred EEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++|||+.+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999999999998653 346888999999999999999999998 9999999999999999999999999997664
Q ss_pred CCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 829 NTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 829 ~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+. ...+...+..++.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 2221 1223346778999999999989999999999999999998 999999888777766654 233455667788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+++|.+||+.+|.+||++++|+..|+.+
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=353.78 Aligned_cols=252 Identities=25% Similarity=0.296 Sum_probs=214.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc--cCCceE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLS 750 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~--~~~~l~ 750 (960)
.++|+.+++|++| +||.||+++. +++.||+|+++.....+.....-.+||.+|.+++|||||.+-+++. .-+.+|
T Consensus 75 v~efe~lnrI~EG-tyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEG-TYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccC-cceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4679999999999 8999999976 7889999999876544433445679999999999999999988764 345699
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
||||||+. +|..++......|...+...++.|++.||+|||.+. |+|||||++|+|++..|.+||+|||+|+.+...
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99999965 999999988778999999999999999999999999 999999999999999999999999999999888
Q ss_pred cccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc---------------
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------------- 894 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~--------------- 894 (960)
.......+-|.||+|||.+.|.+ |+.++||||+|||+.||+++.+-|.|....+.+..|...-.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 77677788899999999999865 89999999999999999999999999776554444322100
Q ss_pred --------------ccCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 --------------RLEIPKE-LDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 --------------~~~iP~~-lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+..|+.. ++....+|+..+|..||.+|.|+.+.|++
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0111112 56788999999999999999999999875
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.84 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=216.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.+.||.| .||.||++++ ++..||+|.+..... ......+.+|+.+++.++|+||+++++.+.+.+.+|++||
T Consensus 1 ~y~~~~~lg~g-~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEG-SFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeecc-CCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58899999999 7999999976 688999999865432 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhC-CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 755 FLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k-~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|+++++|.+++.. ....+++...+.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999999998864 3345789999999999999999999998 999999999999999999999999999866543333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+++||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHH
Confidence 344678999999999999999999999999999999999999999887776666554 3334456778899999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~ 930 (960)
|+.+|.+||++.+|+..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=362.30 Aligned_cols=266 Identities=32% Similarity=0.474 Sum_probs=220.8
Q ss_pred CccccCcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceee
Q 002146 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVL 738 (960)
Q Consensus 667 ~~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVk 738 (960)
....++++.++|+++++||.| .||.||++.+. +..||||++.... .......+.+|+.+|+++. |||||+
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G-~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSG-AFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred CCCceeccccceehhheecCC-CCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeee
Confidence 345677888999999999999 69999999752 2469999886542 3334567899999999995 999999
Q ss_pred EecccccCCceEEEEeecCCCCHHHHhhCCC-------------------------------------------------
Q 002146 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH------------------------------------------------- 769 (960)
Q Consensus 739 L~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~------------------------------------------------- 769 (960)
+++++.....+|||||||++|+|.+++.+..
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 9999999999999999999999999886421
Q ss_pred ----------------------------------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 770 ----------------------------------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 770 ----------------------------------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
..+++..++.++.||+.||.|||..+ |+||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~di 263 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDL 263 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCC
Confidence 13667788899999999999999998 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 9999999999999999999998653321 12223456788999999999999999999999999999997 99999876
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
..............+...+..++.++++||.+||..+|.+||++.+|.+.|+++.+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 54433333323344555677889999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.04 Aligned_cols=261 Identities=31% Similarity=0.564 Sum_probs=222.4
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEec
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 741 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g 741 (960)
.+++..++|++.+.||+| .||.||++.+. ...||+|.+.... .......+.+|+.+++++ +|+||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g-~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEG-AFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEeccc-ccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 466778899999999999 69999999763 2568999886543 334456788999999999 8999999999
Q ss_pred ccccCCceEEEEeecCCCCHHHHhhCC---------------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCC
Q 002146 742 AVTRPPNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 806 (960)
Q Consensus 742 ~f~~~~~l~LVmEY~~gGsL~dlL~k~---------------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPe 806 (960)
++.....++++|||+++++|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~ 161 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAAR 161 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cccccccee
Confidence 999999999999999999999998632 246888999999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChh
Q 002146 807 NLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 883 (960)
Q Consensus 807 NILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ 883 (960)
|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999999987643321 1122235678999999999999999999999999999997 99999988877
Q ss_pred HHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 884 ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
+....+. .......+..++..+.+|+.+||..+|.+||++.++++.|+.+.
T Consensus 242 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 7766654 33445567778899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=360.18 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=215.8
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+..++|++.+.||.| .||.||++++ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 38 ~~~~~~~y~i~~~lG~G-~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 38 LRMKAEDYEVVKVIGRG-AFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred cCcchhhcEEEEEEeec-CCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 45667899999999999 7999999987 678899999865332 2233445788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999999999754 4888889999999999999999999 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC--
Q 002146 828 HNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-- 900 (960)
Q Consensus 828 ~~~~-~~~~t~~GT~~Y~APEvl~g~~----ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~-- 900 (960)
.... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+........+|.
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 4322 2234567999999999997643 78999999999999999999999999888777777754443444443
Q ss_pred CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSL--RPSFAQLTVAL 931 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~k--RPSa~eILe~L 931 (960)
.++..+++||.+||..++.+ |+++.+|+++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 68999999999999844443 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=350.58 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=208.8
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
+..++|++.++||.| .||.||++.+ ++..||+|++... ........+.+|+++|++++||||++++++|...+.++
T Consensus 2 l~~~~y~~~~~lg~g-~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAG-NGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCC-CCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 456789999999999 7999999987 5778999987654 23445567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
+||||+++++|.+++.+.+ .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999999997644 588899999999999999999974 6 99999999999999999999999999976533
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhh-------------------
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------------------- 890 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~------------------- 890 (960)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||......++...+.
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 2 2234579999999999999999999999999999999999999998655433321110
Q ss_pred ------------------------ccccccCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 891 ------------------------FQNRRLEIPK-ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 891 ------------------------~~~~~~~iP~-~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.....+.++. .++.++++||.+||++||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0111111221 357889999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.20 Aligned_cols=255 Identities=31% Similarity=0.535 Sum_probs=217.3
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
...+|.+.+.||.| .||.||++++. ++.||||.+.... .......+.+|+++|+.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g-~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEG-AFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhcccc-CCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 45678899999999 69999999752 4679999886543 233456889999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCC-------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH-------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 813 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~-------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~ 813 (960)
...++||||+++++|.+++...+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 99999999999999999986532 34788899999999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhh
Q 002146 814 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 890 (960)
Q Consensus 814 g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~ 890 (960)
+.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999976432211 1223446789999999999999999999999999999998 999999888877776664
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 891 ~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
.......+..++..+++||.+||..+|.+||++.++++.|++
T Consensus 239 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 -QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 333444566789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=361.67 Aligned_cols=248 Identities=19% Similarity=0.248 Sum_probs=195.1
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC------CceeeEeccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH------PNVVLFMGAV 743 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H------PNIVkL~g~f 743 (960)
++...+|+++++||+| .||+||++.+ .++.||||+++... .....+..|+.+++.++| .+|++++++|
T Consensus 125 ~~~~~~y~i~~~lG~G-~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 125 DVSTQRFKILSLLGEG-TFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccCCCcEEEEEEEEec-cCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3455789999999999 7999999976 67889999986432 223345667777777754 4588999888
Q ss_pred ccC-CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCC-------
Q 002146 744 TRP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW------- 814 (960)
Q Consensus 744 ~~~-~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g------- 814 (960)
... ..+++|||++ |++|.+++.+.+ .+++..+..|+.||+.||.|||+ .| ||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccccc
Confidence 765 4688999988 778998887643 68999999999999999999997 58 99999999999998765
Q ss_pred ---------cEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 002146 815 ---------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 885 (960)
Q Consensus 815 ---------~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei 885 (960)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998864322 23456899999999999999999999999999999999999999988776544
Q ss_pred HHHhhccccc-------------------------cCC-C--------------CCCcHHHHHHHHHhhhhCCCCCCCHH
Q 002146 886 VGAVGFQNRR-------------------------LEI-P--------------KELDPLVARIIWECWQTDPSLRPSFA 925 (960)
Q Consensus 886 ~~~I~~~~~~-------------------------~~i-P--------------~~lS~eLkdLI~kcL~kDP~kRPSa~ 925 (960)
...+...... +.. + ...++.+.+||.+||++||.+||+++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 3332111000 000 0 01135678999999999999999999
Q ss_pred HHHHH
Q 002146 926 QLTVA 930 (960)
Q Consensus 926 eILe~ 930 (960)
|++++
T Consensus 434 e~L~H 438 (467)
T PTZ00284 434 QMTTH 438 (467)
T ss_pred HHhcC
Confidence 99973
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=352.15 Aligned_cols=252 Identities=21% Similarity=0.342 Sum_probs=211.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++++.||+| .||.||+++. +++.||||++.+... .......+.+|+.+++.++|+||++++++|.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRG-AFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEec-CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 479999999999 7999999986 588999999875322 233445688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999999999875567899999999999999999999999 99999999999999999999999999876543222
Q ss_pred -cCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC---CCc
Q 002146 833 -SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK---ELD 903 (960)
Q Consensus 833 -~~~t~~GT~~Y~APEvl~g-----~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~---~lS 903 (960)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+........++. .++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 237 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS 237 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCC
Confidence 2223469999999999973 4578899999999999999999999998887777666654333344433 478
Q ss_pred HHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSL--RPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~k--RPSa~eILe~ 930 (960)
..+++||.+||..++.+ |+++.+++++
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999998764444 7899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.92 Aligned_cols=246 Identities=28% Similarity=0.480 Sum_probs=211.1
Q ss_pred EeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 683 RIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
.||+| .||.||++.+ ++..||||++............+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 2 ~lg~G-~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSG-NFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCc-CCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 58999 6999999964 56789999887655445556788999999999999999999998764 567899999999
Q ss_pred CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc---CC
Q 002146 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SK 835 (960)
Q Consensus 759 GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~---~~ 835 (960)
++|.+++.+.. .+++..+..++.||+.||+|||++| |+||||||.|||++.++.+||+|||+++........ ..
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 99999997643 6899999999999999999999999 999999999999999999999999999865433211 11
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhh
Q 002146 836 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 914 (960)
Q Consensus 836 t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL 914 (960)
...++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+.. ...+..|..+++++++||.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~~ 235 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLCW 235 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHh
Confidence 2234578999999988889999999999999999998 9999998888777776653 3456678889999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHh
Q 002146 915 QTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 915 ~kDP~kRPSa~eILe~Le~i 934 (960)
+.||.+||++.+|.+.|+++
T Consensus 236 ~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 236 TYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ccCchhCcCHHHHHHHHhcc
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=342.14 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=203.3
Q ss_pred eeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCC
Q 002146 684 IGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
||.| .||+||++.+ +++.||||++....... .....+..|+.+|+.++|+||+++++++.....+++||||+++|+
T Consensus 1 lg~G-~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKG-GFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCC-CceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 6889 6999999976 68899999987544322 234567889999999999999999999999999999999999999
Q ss_pred HHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 761 LFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 761 L~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
|..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 9988743 2346899999999999999999999999 9999999999999999999999999997654433333456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~----ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+ ......++..++..+++|+.+|
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccCCCCcccCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999865432 222222 2234456777899999999999
Q ss_pred hhhCCCCCC-----CHHHHHHH
Q 002146 914 WQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 914 L~kDP~kRP-----Sa~eILe~ 930 (960)
|+.||.+|| ++++++++
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcC
Confidence 999999999 67888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.22 Aligned_cols=250 Identities=27% Similarity=0.447 Sum_probs=214.9
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc-CCceEEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIIT 753 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-~~~l~LVm 753 (960)
+|++.+.||.| .||.||++.. +++.||+|++............+.+|++++++++|+||+++++.+.. ...++++|
T Consensus 1 ~y~~~~~lg~g-~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKG-SYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCC-CCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999 7999999976 67889999987665555566678899999999999999999998764 44689999
Q ss_pred eecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 754 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 754 EY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
||+++++|.+++... ...+++.+++.++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999998753 335899999999999999999999999 99999999999999999999999999987644333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+. ....+.++..+++.+.+||.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHH
Confidence 3345578999999999999999999999999999999999999998877666555543 233345667789999999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
||..+|.+||++.+++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HhccCcccCCCHHHHhcC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=340.89 Aligned_cols=258 Identities=33% Similarity=0.580 Sum_probs=216.4
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~--~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l 749 (960)
|++|++.+.||.| .||.||++.. ++. .+++|.++.. ........+.+|+.++.++ +||||+++++++.....+
T Consensus 1 ~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 1 WEDIKFEDVIGEG-NFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred CccceeeeeecCC-CcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 5789999999999 6999999975 333 4688876532 2333456788999999999 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC
Q 002146 750 SIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g 814 (960)
++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENL 156 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCC
Confidence 99999999999999996532 24788899999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccc
Q 002146 815 NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 893 (960)
Q Consensus 815 ~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~ 893 (960)
.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ..
T Consensus 157 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~ 234 (297)
T cd05089 157 ASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QG 234 (297)
T ss_pred eEEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cC
Confidence 9999999998643221 11111223557999999999999999999999999999997 999999988877776664 23
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 894 ~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
.....+..++..+++||.+||..+|.+||+++++++.|+.+....
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 345567778999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=353.66 Aligned_cols=262 Identities=31% Similarity=0.506 Sum_probs=216.2
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 742 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~ 742 (960)
|+++.++|++.+.||.| +||.||++.+ +++.||+|++.... .......+.+|+.+++++ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G-~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRG-AFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccC-cCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 67788899999999999 7999999964 24679999886443 334456778999999999 89999999998
Q ss_pred ccc-CCceEEEEeecCCCCHHHHhhCCC----------------------------------------------------
Q 002146 743 VTR-PPNLSIITEFLPRGSLFRILHRPH---------------------------------------------------- 769 (960)
Q Consensus 743 f~~-~~~l~LVmEY~~gGsL~dlL~k~~---------------------------------------------------- 769 (960)
+.. ...++++|||+++++|.+++....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 754 456889999999999999885421
Q ss_pred --------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCC
Q 002146 770 --------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAG 839 (960)
Q Consensus 770 --------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~G 839 (960)
..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...... .......+
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 25788889999999999999999998 9999999999999999999999999998653221 11223446
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCC
Q 002146 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 918 (960)
Q Consensus 840 T~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP 918 (960)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+..............|..+++++.+++.+||+.+|
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCCh
Confidence 778999999999999999999999999999998 9999987654443333322334455567788999999999999999
Q ss_pred CCCCCHHHHHHHHHHhHH
Q 002146 919 SLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 919 ~kRPSa~eILe~Le~i~~ 936 (960)
.+||++.+|+++|+++..
T Consensus 318 ~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 318 EDRPTFSELVEILGDLLQ 335 (337)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=370.36 Aligned_cols=269 Identities=32% Similarity=0.559 Sum_probs=239.7
Q ss_pred CccccCcCCCCeEEEEEeeccCCeeEEEEEEE--C-C--cE-EEEEEeec-CCCChHHHHHHHHHHHHHHHcCCCceeeE
Q 002146 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADW--N-G--TE-VAVKKFLD-QDFSGAALLEFKREVKIMRRLRHPNVVLF 739 (960)
Q Consensus 667 ~~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~-g--~~-VAVK~i~~-~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL 739 (960)
....|++..++..+.++||+| +||.||+|+. . + .. ||||..+. .......+.++.+|.++|++++|||||+|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeG-aFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEG-AFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred cccccEEeccCccccceeecc-cccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 455688888999999999999 8999999976 2 2 23 89998875 34667888899999999999999999999
Q ss_pred ecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 740 ~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
||+......+++|||+|.||+|.++|.+.+..++..++..++++.+.||+|||+++ +|||||-.+|||++.++.+||+
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999999999998777999999999999999999999999 9999999999999999999999
Q ss_pred ecCccccccCCcccCC-CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccC
Q 002146 820 DFGLSRLKHNTFLSSK-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 897 (960)
Q Consensus 820 DFGLAr~~~~~~~~~~-t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~ 897 (960)
|||+++..... .... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+....++..+|.....+..
T Consensus 305 DFGLs~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 305 DFGLSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP 383 (474)
T ss_pred ccccccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence 99999865311 1111 1123569999999999999999999999999999999 8899999999999999977888889
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhC
Q 002146 898 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 939 (960)
Q Consensus 898 iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~ 939 (960)
+|...+.++..++.+||..+|++||++.++.+.|+.+.....
T Consensus 384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 999999999999999999999999999999999999976543
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=328.89 Aligned_cols=246 Identities=34% Similarity=0.595 Sum_probs=216.5
Q ss_pred EEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeec
Q 002146 682 ERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
+.||.| .||.||++.+. +..|+||.+....... ....+.+|+++++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g-~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEG-AFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccC-CceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 468999 69999999874 7789999987654333 4678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCC--------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 757 PRGSLFRILHRP--------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 757 ~gGsL~dlL~k~--------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccccccc
Confidence 999999999875 467899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 829 NTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 829 ~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......++...+.. ......+..++.+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDE 235 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChH
Confidence 432 22334567889999999998889999999999999999999 6999999988877777653 4456677888999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
+.+++.+||+.+|.+||++.+++++|+
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 236 LYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=329.77 Aligned_cols=256 Identities=25% Similarity=0.469 Sum_probs=216.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++.+.||.| .||.||++.. +|+.||+|.++..... ......+.+|++++++++|+||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKG-QFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccC-CceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 579999999999 7999999986 6899999988754333 33466789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 753 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 753 mEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|||+++++|..++.. ....+++.+++.++.||+.||.|||+.| |+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998863 2345889999999999999999999998 99999999999999999999999999876544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHhhccccccCCCC-CCcHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPK-ELDPLV 906 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~--~~ei~~~I~~~~~~~~iP~-~lS~eL 906 (960)
.........|+..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+.. ......|. .++..+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEEL 237 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHH
Confidence 3333344568899999999999999999999999999999999999996643 2233333322 22333444 678899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
+++|.+||..+|.+||++.+|++.|+.+.
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=354.21 Aligned_cols=239 Identities=26% Similarity=0.387 Sum_probs=203.4
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHHcCCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~-ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.||.| .||+||++++ +|+.||||++..... .......+..|.. +++.++||||+++++++...+.+|+||||+.
T Consensus 1 ~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKG-SFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeC-CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999 7999999976 688999999875432 2233445566655 4677899999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|..++.+.. .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............
T Consensus 80 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccc
Confidence 999999887644 6899999999999999999999999 9999999999999999999999999997643333334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+.. ....++...+..+.++|.+||.++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ll~~~ 234 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLEKD 234 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHHHHHHHHHhccC
Confidence 799999999999999999999999999999999999999999888777776642 344556678999999999999999
Q ss_pred CCCCCCHHH
Q 002146 918 PSLRPSFAQ 926 (960)
Q Consensus 918 P~kRPSa~e 926 (960)
|.+||++.+
T Consensus 235 p~~R~~~~~ 243 (325)
T cd05604 235 RQRRLGAKE 243 (325)
T ss_pred HHhcCCCCC
Confidence 999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=353.22 Aligned_cols=243 Identities=23% Similarity=0.379 Sum_probs=204.0
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.||+| .||+||+++. +++.||+|++.+.... ......+.+|+.++.++ +||||+++++++...+.+++||||++
T Consensus 1 ~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRG-SYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeC-CCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 469999 6999999976 6788999998865332 33455678899999887 89999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|..++.+.. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............
T Consensus 80 ~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (329)
T cd05618 80 GGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 156 (329)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccc
Confidence 999999887643 6899999999999999999999999 9999999999999999999999999997643332334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------h-hHHHHHhhccccccCCCCCCcHHHHH
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------P-MQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~--------~-~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
+||..|+|||++.+..++.++|||||||++|+|++|..||.... . ..+...+ ......+|..++..+++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAAS 234 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHHH
Confidence 79999999999999999999999999999999999999995321 1 1122222 33456688889999999
Q ss_pred HHHHhhhhCCCCCCC------HHHHHHH
Q 002146 909 IIWECWQTDPSLRPS------FAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPS------a~eILe~ 930 (960)
||.+||+.||.+|++ +.+++++
T Consensus 235 ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 235 VLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999998 4676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=367.13 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=213.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--C-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--N-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..|.+.+.||+| .||.||++.. + ++.||+|.+.... ......+.+|+.+|+.++|||||+++++|...+.+|||
T Consensus 67 ~~y~~~~~lg~G-~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRN-PTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeC-CCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 449999999999 6999999975 3 6778888764332 33345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 753 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 753 mEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999998753 2336889999999999999999999998 99999999999999999999999999987643
Q ss_pred Cc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 830 TF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 830 ~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+... ....+|..++.+++
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMK 300 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHH
Confidence 22 1234567999999999999999999999999999999999999999998887777766533 23456778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||.++|.+||++.+++.+
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhC
Confidence 99999999999999999998753
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=332.70 Aligned_cols=253 Identities=30% Similarity=0.511 Sum_probs=210.8
Q ss_pred eEEEEEeeccCCeeEEEEEEEC--Cc--EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC------C
Q 002146 678 LVLGERIGLGSSYGEVYHADWN--GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 747 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~--g~--~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------~ 747 (960)
|.++++||.| .||.||++.+. +. .||||.+............+.+|+.+++.++|+||+++++++... .
T Consensus 1 ~~i~~~ig~G-~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEG-EFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcc-cCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3467889999 79999999863 32 589998876555556677889999999999999999999875422 3
Q ss_pred ceEEEEeecCCCCHHHHhhC-----CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecC
Q 002146 748 NLSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k-----~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFG 822 (960)
..+++|||+.+|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCC
Confidence 47899999999999988742 2235789999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCC
Q 002146 823 LSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 899 (960)
Q Consensus 823 LAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP 899 (960)
+++....... ......+++.|++||.+.+..++.++|||||||++|+|++ |..||.+....++...+.. ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 236 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-GNRLKQP 236 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence 9987643221 1122346778999999999999999999999999999999 8999988877777666643 3344556
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 900 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
..++..++++|.+||..+|.+||++.+|++.|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 77889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=330.68 Aligned_cols=246 Identities=32% Similarity=0.566 Sum_probs=209.1
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 759 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gG 759 (960)
+.||.| .||.||++.+ +++.||+|.+... ........+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g-~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRG-NFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcc-cCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 358999 6999999976 7889999987643 33445567899999999999999999999999999999999999999
Q ss_pred CHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC--CCC
Q 002146 760 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KST 837 (960)
Q Consensus 760 sL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~--~t~ 837 (960)
+|.+++.+.+..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......... ...
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999999776667899999999999999999999998 9999999999999999999999999987644321111 111
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhh
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 916 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~k 916 (960)
.++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. ...+...+..++..+.+|+.+||..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 235 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEY 235 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCC
Confidence 23457999999999999999999999999999997 999998877666555543 2334566778899999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 002146 917 DPSLRPSFAQLTVALK 932 (960)
Q Consensus 917 DP~kRPSa~eILe~Le 932 (960)
+|.+||++.++++.|+
T Consensus 236 ~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 236 DPGQRPSFSTVHQELQ 251 (252)
T ss_pred ChhhCcCHHHHHHHHh
Confidence 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=340.48 Aligned_cols=257 Identities=29% Similarity=0.498 Sum_probs=217.0
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+...+|.+.+.||.| .||.||++.+. +..||||++.... .......+.+|+.++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G-~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGED-RFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCC-CCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 445678889999999 69999999763 4679999987443 33345678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCC---------------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE
Q 002146 746 PPNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 810 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~---------------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL 810 (960)
....++++||+.+++|.+++... ...+++..++.++.|++.||.|||++| |+||||||+|||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~ 157 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLV 157 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEe
Confidence 99999999999999999998521 124778888999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 002146 811 DKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 887 (960)
Q Consensus 811 d~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~ 887 (960)
+.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....++..
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999886533211 1223446789999999998889999999999999999998 889999988877777
Q ss_pred HhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 888 ~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.+.. .....++..++.++.+|+.+||+.+|.+||++++|+..|+++
T Consensus 238 ~i~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 238 MIRN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred HHHc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 7653 234456778999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=342.51 Aligned_cols=265 Identities=31% Similarity=0.546 Sum_probs=223.6
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE---------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceee
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 738 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~---------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVk 738 (960)
.++.++.++|.++++||+| .||.||+++. ....||+|++.... .......+.+|+.+++++ +||||++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G-~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEG-CFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred ccccccHHHeeeeeeecCC-CcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 3466778899999999999 6999999974 23468999876543 344566788999999999 6999999
Q ss_pred EecccccCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 739 L~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
+++++.....+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++| |+||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dl 160 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDL 160 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence 9999999999999999999999999986532 24788889999999999999999998 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCcccC--CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~~~~--~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+|||++.++.+||+|||+++......... ....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred cceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654322111 12234467999999999999999999999999999999 89999988
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
...+....+. ......++..++.++++||.+||..+|.+||++.++++.|+++....
T Consensus 241 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 241 PVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 8777776664 33345567788899999999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.36 Aligned_cols=255 Identities=34% Similarity=0.577 Sum_probs=216.8
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
|++..++|++.++||.| .||.||++.+ .+..||+|.+....... ..+.+|+.++++++|+||+++++++.. ...
T Consensus 1 ~~~~~~~~~~~~~ig~g-~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05070 1 WEIPRESLQLIKKLGNG-QFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPI 75 (260)
T ss_pred CCCchHHhhhhheeccc-cCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC-CCc
Confidence 35677889999999999 6999999976 56789999887654432 468899999999999999999998854 568
Q ss_pred EEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 8999999999999998753 335889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 829 NTFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 829 ~~~~~-~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.. ......+...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCPQDCPISL 232 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHH
Confidence 32211 122335668999999999899999999999999999999 8999998887777766642 33555677789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
++|+.+||.++|.+||++.++.+.|+.
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.04 Aligned_cols=253 Identities=28% Similarity=0.505 Sum_probs=214.8
Q ss_pred eEEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc----
Q 002146 678 LVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN---- 748 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~---- 748 (960)
|.+++.||.| .||.||++.+. +..||||++............+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G-~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEG-EFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcC-CCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5678899999 79999999752 3679999987665555666789999999999999999999998765544
Q ss_pred --eEEEEeecCCCCHHHHhhCC-----CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEec
Q 002146 749 --LSIITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821 (960)
Q Consensus 749 --l~LVmEY~~gGsL~dlL~k~-----~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DF 821 (960)
.+++|||+++++|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCc
Confidence 79999999999999987432 235888999999999999999999998 999999999999999999999999
Q ss_pred CccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCC
Q 002146 822 GLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 822 GLAr~~~~~~~~--~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~i 898 (960)
|+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+. .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 236 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQ 236 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 999865432211 112235678999999999999999999999999999999 999999888877776664 3345567
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
|..++..+.++|.+||+.||.+||++.++++.|+++
T Consensus 237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 788999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=329.02 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=219.8
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.+.||.| .||.||.++. +++.|++|.+............+.+|+.++++++|+||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g-~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKG-AFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEeccc-CCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 48899999999 7999988875 68899999987766666667788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 755 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|+++++|.+++.+. ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999999999764 346899999999999999999999998 999999999999999999999999999876444323
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+... .....+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG-NYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-CCCCCccccCHHHHHHHHHH
Confidence 34567899999999999888999999999999999999999999988877777666433 23344567889999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~ 930 (960)
|..+|.+||++.+++++
T Consensus 237 l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 237 LQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCcccCCCHHHHhhC
Confidence 99999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=334.17 Aligned_cols=259 Identities=27% Similarity=0.482 Sum_probs=217.4
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCc----EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~----~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+..++|++.++||.| .||+||++++ ++. .||||.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G-~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSG-AFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCC-CCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 345789999999999 6999999986 444 48999876543 33445678899999999999999999998875
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
...++++||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceee
Confidence 4578999999999999999876567899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 827 KHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 827 ~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
...... ......++..|++||.+.+..++.++|||||||++|||++ |..||.......+...+. .......+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICT 237 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCC
Confidence 643211 1122234678999999999999999999999999999998 999998877666655543 333455567789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.++.++|.+||..||.+||++.++++.|+++...
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 9999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=329.32 Aligned_cols=257 Identities=32% Similarity=0.574 Sum_probs=219.5
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+++..++|++.++||.| .||.||++.. ++..||||.+...... ...+.+|+.++++++|+||+++++++......
T Consensus 1 ~~~~~~~~~i~~~ig~g-~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 1 WEIPRESLKLERKLGAG-QFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred CccchhheeeeeeeccC-cceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 35677899999999999 6999999976 4567999988754433 34688999999999999999999999998999
Q ss_pred EEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+|+.++.+||+|||++....
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceecc
Confidence 99999999999999997643 46889999999999999999999998 9999999999999999999999999997654
Q ss_pred CCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 829 NTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 829 ~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+.......+. .......+...+.++
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEEL 233 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 3211 1112234568999999999999999999999999999998 999999888777666664 233445566778999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
++++.+||..+|.+||+++++++.|+.+
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 234 YDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=339.95 Aligned_cols=263 Identities=31% Similarity=0.532 Sum_probs=223.5
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE---------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeE
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 739 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~---------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL 739 (960)
.+++..++|.+++.||.| .||.||++++ ++..||+|++... ........+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEG-CFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeecc-CCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhe
Confidence 456778899999999999 6999999974 2346999987643 2344556789999999999 89999999
Q ss_pred ecccccCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccC
Q 002146 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 804 (960)
Q Consensus 740 ~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLK 804 (960)
++++......++||||+++++|.+++.+.. ..++...+..++.||+.||.|||++| |+|||||
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 164 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLA 164 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccc
Confidence 999999999999999999999999987532 24677888999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002146 805 SPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 881 (960)
Q Consensus 805 PeNILLd~~g~VKL~DFGLAr~~~~~~~~--~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~ 881 (960)
|+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876432211 222345678999999999999999999999999999998 889999888
Q ss_pred hhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 882 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 882 ~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
..++...+. ...+...+..++.++++||.+||..+|.+||++.++++.|+++...
T Consensus 245 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 877777664 3334556778899999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.25 Aligned_cols=257 Identities=25% Similarity=0.461 Sum_probs=215.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++.+.||.| .||.||++.+ +++.||||.+...... ......+.+|+.+++.++||||+++++++...+.++++
T Consensus 2 ~~y~~~~~ig~g-~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRG-QFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhccc-CCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 578889999999 7999999985 7889999988764432 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 753 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 753 mEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.| |+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998863 2346889999999999999999999999 99999999999999999999999999876644
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHhhccccccCCCCCCcHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~--~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.........|+..|+|||++.+..++.++|+||||+++|+|++|..||.+... ......+.........+..++..++
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 33223345789999999999999899999999999999999999999976543 2333333222212222345788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
++|.+||..+|.+||++.+|++.++++.
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=337.45 Aligned_cols=259 Identities=33% Similarity=0.533 Sum_probs=219.5
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+...+|.+.+.||.| .||.||++++ ++..|++|.+.... ......+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g-~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEG-AFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeeccc-CCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 456789999999999 6999999974 23458888875432 3334578899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 810 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL 810 (960)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||.++ |+||||||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~ 156 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV 156 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE
Confidence 999999999999999999986532 24788999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 002146 811 DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 887 (960)
Q Consensus 811 d~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~ 887 (960)
+.++.++|+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+...
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999997653321 11233456789999999999999999999999999999998 999998888777666
Q ss_pred HhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 888 ~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+. .......+..++..+.+|+.+||.++|.+||++.++++.|+++.+.
T Consensus 237 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 553 3334445667889999999999999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.60 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=207.0
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
.+++|.+.+.||.| .||.||+++. +++.||||++...... .....+.+|+.++++++||||+++++++..++.+++
T Consensus 4 ~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEG-TYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEeccc-CCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 35789999999999 6999999976 6788999998754322 223356789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++ +|..++...+..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9999975 888888776667889999999999999999999999 9999999999999999999999999997654333
Q ss_pred ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc----------------
Q 002146 832 LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------------- 894 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~---------------- 894 (960)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 33344568999999999875 4589999999999999999999999988776544333211000
Q ss_pred -ccC-----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 895 -RLE-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 895 -~~~-----------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
... ....++.++++||.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 11246789999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.38 Aligned_cols=249 Identities=29% Similarity=0.463 Sum_probs=222.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~L 751 (960)
..|++++.||.| .||.||+++. +|+.||+|.+.+..... .....+.+|+.||+++. |||||+++++|++...+++
T Consensus 35 ~~Y~l~~~lG~G-~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 35 EKYELGRELGRG-QFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred ccEEehhhhCCC-CceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 569999999999 8999999976 68999999998776543 24567899999999997 9999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC----CCcEEEEecCccccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLK 827 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~----~g~VKL~DFGLAr~~ 827 (960)
|||+|.||.|++.+.+. .+++.....++.|++.+++|||+.| |+||||||+|||+.. ++.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999998775 3999999999999999999999999 999999999999963 357999999999987
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC--CCCCCcHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPL 905 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~--iP~~lS~e 905 (960)
.. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+.......+........ ....++..
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 66 4556778999999999999999999999999999999999999999999998888887765443222 23567899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++||..||..||.+|+++.++|++
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999999999999999999996
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=332.61 Aligned_cols=255 Identities=30% Similarity=0.510 Sum_probs=216.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--C---CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--N---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~---g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
..+|++.+.||.| .||.||++.+ + +..||+|.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAG-EFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeeccc-CCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4678999999999 6999999975 2 3369999876533 344556889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++||||+++++|.+++.+....+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999999876667899999999999999999999999 99999999999999999999999999987543
Q ss_pred CcccC---CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 830 TFLSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 830 ~~~~~---~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
..... ....++..|++||.+.+..++.++|+|||||++|++++ |..||.+....+....+.. ..+...+..++..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCCCCCCCCHH
Confidence 22111 11223568999999999899999999999999999886 9999998877666665542 2344455678899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+.+++.+||+++|.+||++.++++.|+++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=334.11 Aligned_cols=249 Identities=35% Similarity=0.516 Sum_probs=207.5
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|++++.||+| .||+||+++. +++.||+|++..............+|+.++++++||||+++++++.+...+++||||
T Consensus 1 y~~~~~lg~G-~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSG-GFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEE-SSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeC-CCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 7899999999 7999999987 566899999987765555444556799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~ 835 (960)
+.+++|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...........
T Consensus 80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 80 CPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp ETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccc-ccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc
Confidence 999999999983 346899999999999999999999999 99999999999999999999999999976423223344
Q ss_pred CCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH---HHHHhhccccccCC--CCCCcHHHHHH
Q 002146 836 STAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEI--PKELDPLVARI 909 (960)
Q Consensus 836 t~~GT~~Y~APEvl~-g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e---i~~~I~~~~~~~~i--P~~lS~eLkdL 909 (960)
...++..|+|||++. +..++.++||||||+++|+|++|..||......+ .............. .......+.+|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 567899999999998 8889999999999999999999999999873322 22222111111111 11234899999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
|.+||+.||.+||++.+++++
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=358.51 Aligned_cols=264 Identities=32% Similarity=0.476 Sum_probs=221.1
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeE
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLF 739 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL 739 (960)
...++++.++|.++++||+| +||.||++++. ++.||||++.... .......+.+|+.+|.++. |||||++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G-~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSG-AFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred CCcceecHHHeehhhhccCC-CceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 34578888999999999999 79999999864 3579999987543 2333457889999999997 9999999
Q ss_pred ecccccCCceEEEEeecCCCCHHHHhhCCC--------------------------------------------------
Q 002146 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPH-------------------------------------------------- 769 (960)
Q Consensus 740 ~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~-------------------------------------------------- 769 (960)
++++.....+++||||+++|+|.+++++.+
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 999999999999999999999999986532
Q ss_pred -----------------------------------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEec
Q 002146 770 -----------------------------------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 802 (960)
Q Consensus 770 -----------------------------------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRD 802 (960)
..+++..++.|+.||+.||.|||+.+ |+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrd 264 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRD 264 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCccc
Confidence 12456677889999999999999998 99999
Q ss_pred cCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 002146 803 LKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIG 879 (960)
Q Consensus 803 LKPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~ 879 (960)
|||+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999998643221 12223457889999999999999999999999999999998 8999987
Q ss_pred CChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 880 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 880 ~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
....+..........++..|..++.++.+|+.+||..+|.+||++.+|++.|+++.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 345 LPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 66555443333344456677788999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=329.67 Aligned_cols=251 Identities=32% Similarity=0.518 Sum_probs=213.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++.+.||.| .||.||++.+ +++.|++|++...... ....+.+|+.++++++||||+++++++.....++++
T Consensus 2 ~~~~~~~~~l~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSG-TYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCC-CceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 4689999999999 7999999986 5788999998755322 456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999999999876457899999999999999999999998 99999999999999999999999999987654332
Q ss_pred cCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc---CCCCCCcHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---EIPKELDPLV 906 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~---~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~---~iP~~lS~eL 906 (960)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+....... ..+..++.++
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 33456789999999999877 78999999999999999999999999877665554443221111 1233467889
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++||.+||..+|.+||++.+|+.+
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=350.05 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=202.1
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----- 747 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~----- 747 (960)
.++|++.+.||.| .||.||++.. +|+.||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSG-AQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecC-CCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4789999999999 7999999975 6889999998765444455567889999999999999999999886543
Q ss_pred -ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 -NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 -~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 47999999965 66666643 4788889999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc--------------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------- 892 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-------------- 892 (960)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 173 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 5332 2233457899999999999999999999999999999999999999877643322111000
Q ss_pred ------ccccC--------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 ------NRRLE--------------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 ------~~~~~--------------------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+. .....+.++++||.+||..||.+||++.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 112246789999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=331.48 Aligned_cols=255 Identities=33% Similarity=0.575 Sum_probs=214.8
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
++...+|++.++||.| .||.||++++. ...||||++...... ...+.+|+.++++++||||+++++.+.. ...+
T Consensus 2 ~~~~~~~~~~~~lg~g-~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 2 EIPRESLRLEVKLGQG-CFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCChHHeeEeeecCCC-CCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 4666789999999999 69999999873 457999988754432 2467899999999999999999998754 5689
Q ss_pred EEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
+||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999999999753 335788999999999999999999998 99999999999999999999999999976543
Q ss_pred Cccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 830 TFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 830 ~~~~-~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.... .....++..|++||++.+..++.++|||||||++|+|++ |..||.+....+....+.. ......+..++..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 233 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLH 233 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCccccCHHHH
Confidence 3211 123346678999999999999999999999999999999 8999988877766665532 223445667889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+||.+||+++|.+||++.++++.|+.+
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=333.97 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=214.7
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
++..++|.+.+.||.| .||.||++.+. +..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g-~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 2 EVPRDSITLLRALGHG-AFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred CCCHHHcEeeeECCCC-CCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 3456789999999999 69999999873 4678899775432 3334457889999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCC------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC---c
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---N 815 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g---~ 815 (960)
+....++||||+++++|.+++...+ ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcc
Confidence 9999999999999999999987543 25788999999999999999999998 99999999999998654 5
Q ss_pred EEEEecCccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcc
Q 002146 816 VKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 892 (960)
Q Consensus 816 VKL~DFGLAr~~~~~~~~--~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~ 892 (960)
+||+|||+++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+. .
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~ 236 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-G 236 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-c
Confidence 999999999865322111 112234568999999999999999999999999999997 999999887777665554 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 893 ~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
..+..+|..++..+.+|+.+||+.+|.+||++.+|+++|+
T Consensus 237 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 3455667888999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=334.78 Aligned_cols=257 Identities=26% Similarity=0.479 Sum_probs=215.5
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCc----EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~----~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
...+|++++.||.| .||+||++.+ +++ .|++|.+... .......++..|+.++++++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G-~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 5 KETELRKLKLLGSG-VFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CHhhceeccccCcc-CCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 45688999999999 6999999987 454 4777776432 223345678889999999999999999998754 5
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
..++++||+++|+|.+++......+++..++.|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 678999999999999999876667899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 828 HNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 828 ~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
.... .......++..|++||.+.+..++.++|||||||++|||++ |..||.+.........+. ....+..+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTI 238 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCCCCH
Confidence 3221 12223456778999999999999999999999999999998 999999887766554443 3345555667888
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
++.+++.+||..+|.+||++.++++.|..+.+
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.35 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=208.6
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
...+|++++.||.| .||.||+++. +++.||+|++..... .....+.+|+.++++++||||+++++++.....+++
T Consensus 7 ~~~~y~~~~~lg~g-~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSG-TYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecC-CCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 34679999999999 7999999986 678899998865432 233467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999999987543 6889999999999999999999998 9999999999999999999999999998664333
Q ss_pred ccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc---CCCCCCcHH
Q 002146 832 LSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---EIPKELDPL 905 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~---~iP~~lS~e 905 (960)
.......|+..|+|||.+. ...++.++|||||||++|+|++|+.||....+.+....+....... ..+..++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 3334457899999999985 3447889999999999999999999998766544333322111111 112346789
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~L 931 (960)
+.+||.+||..+|.+||++++|+++|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 99999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=341.12 Aligned_cols=259 Identities=32% Similarity=0.596 Sum_probs=216.3
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcE--EEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~--VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
.+.+++|++.+.||.| .||.||++.+ ++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G-~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEG-NFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCC-CCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 3567899999999999 7999999976 4443 577765432 2344456788999999999 899999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd 811 (960)
+.+|+||||+++++|.+++.+.+ ..+++..++.++.||+.||+|||++| |+||||||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~ 158 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 158 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec
Confidence 99999999999999999987532 25788899999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhh
Q 002146 812 KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 890 (960)
Q Consensus 812 ~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~ 890 (960)
.++.+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred CCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 9999999999998643221 11122234668999999998889999999999999999998 999999888777666553
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 891 ~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.......+..++.++.+||.+||+.+|.+||++.++++.|+.+..
T Consensus 238 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 238 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222444566788999999999999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.35 Aligned_cols=243 Identities=22% Similarity=0.378 Sum_probs=204.6
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.||+| .||+||+++. +++.||||++...... ......+.+|+.++.++ +||||+++++++.....+|+||||++
T Consensus 1 ~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRG-SYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeC-CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 369999 7999999976 6788999999865432 33456688999999998 69999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|..++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............
T Consensus 80 ~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (327)
T cd05617 80 GGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF 156 (327)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecc
Confidence 999999887543 6899999999999999999999999 9999999999999999999999999997543322334457
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hhH-HHHHhhccccccCCCCCCcHHHHHHH
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN------PMQ-VVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~------~~e-i~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+ ....+ ......+|..++..+.++|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--HhCCCCCCCCCCHHHHHHH
Confidence 89999999999999999999999999999999999999996421 122 22222 2345567888999999999
Q ss_pred HHhhhhCCCCCCC------HHHHHHH
Q 002146 911 WECWQTDPSLRPS------FAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPS------a~eILe~ 930 (960)
.+||++||.+|++ +.+++++
T Consensus 235 ~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 235 KGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 9999999999997 4566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=377.89 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=215.7
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE-C-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecc-ccc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW-N-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA-VTR 745 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~-f~~ 745 (960)
.+++...+++|.++|-+|| |+.||++.. . |..||+|++... .+..+..+++|+.+|+.| .|+|||.|++. ...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGG-Fa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGG-FAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EEEECCEEEEEEEEEccCC-cEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 3456667899999999995 999999987 3 389999988655 456677899999999999 59999999993 211
Q ss_pred ------CCceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEE
Q 002146 746 ------PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 818 (960)
Q Consensus 746 ------~~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL 818 (960)
...++|.||||.||.|-++|+++ ...|+|.++++|+.|+++|+.+||.+.++|||||||-|||||+.+|++||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 23478999999999999998743 23599999999999999999999999999999999999999999999999
Q ss_pred EecCccccccCCcccCC---------CCCCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 002146 819 SDFGLSRLKHNTFLSSK---------STAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 886 (960)
Q Consensus 819 ~DFGLAr~~~~~~~~~~---------t~~GT~~Y~APEvl---~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~ 886 (960)
||||.|.-......... ...-|+.|+|||+| .+.+.++|+|||+|||+||-|+....||.+.....+
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI- 266 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI- 266 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-
Confidence 99999875432211100 11258999999987 677889999999999999999999999988755433
Q ss_pred HHhhccccccCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 887 GAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 887 ~~I~~~~~~~~iP~--~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
....+.||. .++..+++||..||..||.+||++.|+++.+-++...
T Consensus 267 -----lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 267 -----LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -----EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 344555654 6899999999999999999999999999999988553
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=326.17 Aligned_cols=250 Identities=28% Similarity=0.475 Sum_probs=216.9
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--CCceEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSII 752 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~--~~~l~LV 752 (960)
+|++.+.||.| .||.||++.+ +++.||+|.+............+.+|+.++++++|+||+++++++.. ...++++
T Consensus 1 ~y~~~~~lg~g-~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKG-SFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccC-CCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999 6999999975 67889999988766666667788999999999999999999997753 4568999
Q ss_pred EeecCCCCHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHh-----hCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 753 TEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLH-----TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~---~~~lse~~~~~Ia~QIa~AL~YLH-----s~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
|||+++++|.+++... ...+++..++.++.||+.||.||| ..+ |+||||||+||+++.++.+||+|||++
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999998653 447899999999999999999999 777 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
..............|+..|+|||++.+..++.++|+||||+++|+|++|..||...+..++...+. ......++..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSS 236 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCH
Confidence 876544332344578999999999999889999999999999999999999999888766666554 2334456778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+.+++.+||..+|.+||++.+|+++
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhC
Confidence 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=339.36 Aligned_cols=261 Identities=30% Similarity=0.467 Sum_probs=218.9
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEec
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 741 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g 741 (960)
.+.+..++|.+.+.||+| .||.||++.+ .+..||||++.... .......+.+|+.+++++ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G-~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAG-AFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeecc-CCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 456777899999999999 6999999964 24479999876543 233456788999999999 8999999999
Q ss_pred ccccCCceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEe
Q 002146 742 AVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 820 (960)
Q Consensus 742 ~f~~~~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~D 820 (960)
++...+.+++||||+.+++|.+++.... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECC
Confidence 9999999999999999999999997533 34899999999999999999999998 99999999999999999999999
Q ss_pred cCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccC
Q 002146 821 FGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 897 (960)
Q Consensus 821 FGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~ 897 (960)
||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+...............+..
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 264 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA 264 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC
Confidence 999986533211 1223346788999999999999999999999999999998 9999988766544433332333444
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 898 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 898 iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.+...+.++++|+.+||.++|++||++.++++.|+++
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 5667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.56 Aligned_cols=254 Identities=33% Similarity=0.570 Sum_probs=213.9
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
++..++|++.+.||.| .||.||++.+. +..||+|.+...... ...+.+|+.++++++|+||+++++++.. +..+
T Consensus 2 ~~~~~~~~~~~~ig~g-~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 2 EIPRESLRLDVKLGQG-CFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred cCChHHeeeeeeecCc-CCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 4556789999999999 69999999874 457999987654322 3467889999999999999999998754 5688
Q ss_pred EEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 9999999999999997533 35788899999999999999999998 99999999999999999999999999976543
Q ss_pred Ccc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 830 TFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 830 ~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. .......+..++..++
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHH
Confidence 221 1122345678999999999999999999999999999999 999999887776666554 2334455677899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
+||.+||.++|.+||++++|++.|+.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=348.01 Aligned_cols=248 Identities=23% Similarity=0.290 Sum_probs=203.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------ 746 (960)
.++|++.+.||.| .||.||++.. .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSG-AQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecC-CCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4789999999999 7999999975 688899999876544445556788999999999999999999987543
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+|+||||+++ +|..++.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 357999999965 77777753 4788889999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-------------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 893 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~------------- 893 (960)
.... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 176 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 5433 22334678999999999999999999999999999999999999998877654443321100
Q ss_pred -------cccC--------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 -------RRLE--------------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 -------~~~~--------------------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.++. .....+..+++||.+||..||.+||++.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 011134678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.19 Aligned_cols=255 Identities=31% Similarity=0.537 Sum_probs=215.3
Q ss_pred CeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 677 DLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+|++.+.||+| .||.||++... ...|++|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g-~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEG-EFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCc-CCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47888999999 69999999752 2468888876443 334456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCC-----------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCC
Q 002146 750 SIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 806 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~-----------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPe 806 (960)
+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~ 156 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAAR 156 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhh
Confidence 99999999999999986421 24778889999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChh
Q 002146 807 NLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 883 (960)
Q Consensus 807 NILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ 883 (960)
|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+..+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999976432211 1223346778999999999999999999999999999998 99999988887
Q ss_pred HHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 884 ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
++...+. .......+..++.++++||.+||+.+|.+||++.++++.|+++..
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 7766554 223445677889999999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.65 Aligned_cols=264 Identities=31% Similarity=0.525 Sum_probs=222.5
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceee
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 738 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVk 738 (960)
.++++...+|++++.||.| .||.||++++. ...||+|.+... ........+.+|+.+++++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G-~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEG-CFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccc-cCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 4567777889999999999 69999999752 236899987643 3344567889999999999 8999999
Q ss_pred EecccccCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 739 L~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
+++++.....++++|||+++++|.+++.+.. ..+....++.++.||+.||.|||.+| |+||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dl 160 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDL 160 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccc
Confidence 9999999999999999999999999987532 24677888899999999999999998 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~~~--~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999999999865432211 122234568999999999999999999999999999998 89999988
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+..+....+. .......+..++.++.+||.+||..+|.+||++.+|++.|+++...
T Consensus 241 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 241 PVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred CHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 8777766654 3334556777889999999999999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.67 Aligned_cols=260 Identities=30% Similarity=0.512 Sum_probs=216.5
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 743 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f 743 (960)
|++..++|++.++||.| .||.||++... +..||+|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G-~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 1 WEVSREKITLLRELGQG-SFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred CcccHHHceeeeeecCC-CCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 35667889999999999 79999998642 4479999876443 223344678899999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHhhCCC---------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC
Q 002146 744 TRPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL~dlL~k~~---------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g 814 (960)
.+....++||||+++|+|.+++.+.. ..+....+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~ 156 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDF 156 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCC
Confidence 99999999999999999999996422 23456778889999999999999999 99999999999999999
Q ss_pred cEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhc
Q 002146 815 NVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 891 (960)
Q Consensus 815 ~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~ 891 (960)
.+||+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+....+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~- 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM- 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986533211 1122345678999999999999999999999999999998 789999888777666554
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 892 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 892 ~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
.......+..+++.+++++.+||+.+|.+||++.++++.|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 23344566778899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=349.01 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=208.1
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc-----CCc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-----~~~ 748 (960)
..|..++.||.| +||.|+.+.. +|+.||||++..........++..+|+++|+.++|+||+.+++.+.. -..
T Consensus 22 ~~y~~~~~iG~G-AyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRG-AYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCc-ceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 445668999999 8999999975 78999999998665566667788999999999999999999998865 345
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+|+|+| +.+|..+++... .+++.....+++||+.||+|+|+.+ |+||||||.|+|++.+..+||||||+|+...
T Consensus 101 vYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeecc
Confidence 99999999 679999997643 5999999999999999999999999 9999999999999999999999999999875
Q ss_pred CC--cccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--------------
Q 002146 829 NT--FLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------- 891 (960)
Q Consensus 829 ~~--~~~~~t~~GT~~Y~APEvl~-g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~-------------- 891 (960)
.. ....+..+.|.||+|||++. ...|+.++||||+||||.||++|++-|.|.+...-+..|..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 32 12234567899999999975 45699999999999999999999999998765432222111
Q ss_pred ----------cccccCC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 892 ----------QNRRLEI-----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 892 ----------~~~~~~i-----P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....+.. -++.++.+.+|+++||..||.+|+|++|.|++
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111 13678999999999999999999999999886
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=351.73 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=205.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----ce
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NL 749 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~-----~l 749 (960)
+|++++.||.| .||.||++.. +++.||||++............+.+|+.+|+.++||||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYG-AFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeC-CCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47889999999 7999999985 7899999988654334445567889999999999999999999998776 78
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+||||+. ++|..++.... .+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999996 57888776543 6899999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc---------------
Q 002146 830 TF-LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 892 (960)
Q Consensus 830 ~~-~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~--------------- 892 (960)
.. .......++..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 21 1223346899999999998754 799999999999999999999999887765544333110
Q ss_pred --------c-cc------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 --------N-RR------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 --------~-~~------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. .. ..+....++++.+||.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 00 01234467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.52 Aligned_cols=257 Identities=30% Similarity=0.511 Sum_probs=217.7
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCc---EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGT---EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~---~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
|..++|+..+.||.| .||.||++.. ++. .||||++... ........+.+|++++++++|+||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g-~~g~vy~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAG-EFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCC-CCccEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 445688999999999 6999999975 333 6899987543 23444567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
..++||||+++++|.+++.+....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999999999876567899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccC---CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 828 HNTFLSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 828 ~~~~~~~---~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
....... .....+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.. ......+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~ 236 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCP 236 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCC
Confidence 4322111 11223457999999998889999999999999999997 9999988877777766643 23444556688
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
..+++|+.+||..+|.+||++.+|++.|+++
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.17 Aligned_cols=250 Identities=24% Similarity=0.454 Sum_probs=218.7
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.+.||.| .||.||+++. +++.||||.+............+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~y~~~~~lg~g-~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEG-SFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccC-CceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 48899999999 7999999975 68899999987655555556688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 755 FLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|+.+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999999987533 35788999999999999999999998 999999999999999999999999999876543333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+. .......+..++.+++++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHH
Confidence 334568899999999999999999999999999999999999999887777766654 3334456778899999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~ 930 (960)
|+.+|.+||++.+++++
T Consensus 237 l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 237 FKRNPRDRPSVNSILEK 253 (256)
T ss_pred hhCChhhCcCHHHHhhC
Confidence 99999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=358.79 Aligned_cols=247 Identities=25% Similarity=0.322 Sum_probs=198.6
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC----
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP---- 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~---- 746 (960)
....+|+++++||+| .||.||++.+ +++.||||++.... ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G-~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNG-SFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeC-CCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 345689999999999 7999999976 67899999885432 1235799999999999999998876432
Q ss_pred ----CceEEEEeecCCCCHHHHhh---CCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-cEEE
Q 002146 747 ----PNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKV 818 (960)
Q Consensus 747 ----~~l~LVmEY~~gGsL~dlL~---k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-~VKL 818 (960)
..+++||||+++ +|.+++. +....+++..++.++.||+.||.|||+++ ||||||||+||||+.++ .+||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceee
Confidence 247799999975 7776664 23446899999999999999999999999 99999999999999664 7999
Q ss_pred EecCccccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc----
Q 002146 819 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---- 893 (960)
Q Consensus 819 ~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~---- 893 (960)
+|||+++..... .......||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+....+.+..+....
T Consensus 213 ~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 213 CDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred eccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999999866433 223346789999999998765 58999999999999999999999999876654443332100
Q ss_pred -----------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 -----------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 -----------------------~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....+|...+.++++||.+||.+||.+||++.+++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0112345577899999999999999999999999865
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.52 Aligned_cols=259 Identities=31% Similarity=0.546 Sum_probs=218.5
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEECC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g-----~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
++..++|.+.++||.| .||.||++.+.. ..||||.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 2 EIQREDITLGRCIGEG-QFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred eechhhceeeeeeCCc-cceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 3556789999999999 699999997632 368999875432 24445678999999999999999999998876
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
...++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeee
Confidence 4578999999999999999876657899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 827 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 827 ~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. ...+...+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 235 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCH
Confidence 543321 1122334568999999998889999999999999999986 999999887776665554 3345566778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.+.+||.+||..+|.+||++.++++.|+.+..
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.46 Aligned_cols=245 Identities=26% Similarity=0.465 Sum_probs=207.8
Q ss_pred eeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCC
Q 002146 684 IGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 759 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gG 759 (960)
||.| .||.||++.+ ++..||||++... ........+.+|+.++++++||||+++++++.. ...++||||++++
T Consensus 3 ig~G-~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSG-NFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred cCCC-CcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 8999 6999999975 3456999987654 234445678999999999999999999998864 5789999999999
Q ss_pred CHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc---CCC
Q 002146 760 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKS 836 (960)
Q Consensus 760 sL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~---~~t 836 (960)
+|.+++......+++..++.++.||+.||.|||.+| |+||||||+|||++.++.+||+|||+++........ ...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999999765567899999999999999999999998 999999999999999999999999999765332111 111
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhh
Q 002146 837 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 915 (960)
Q Consensus 837 ~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~ 915 (960)
..++..|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. ...+..+|..+++++.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcC
Confidence 223578999999998889999999999999999996 999999988777666554 334566778889999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHh
Q 002146 916 TDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 916 kDP~kRPSa~eILe~Le~i 934 (960)
.+|++||++.+|++.|+.+
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CChhhCcCHHHHHHHHhhh
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.65 Aligned_cols=255 Identities=33% Similarity=0.540 Sum_probs=216.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+.+.+|.+.++||+| .||.||+++. ++..||+|.+... .......+.+|+++++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEG-AFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCc-cCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 456789999999999 6999999963 3557899986543 34445678999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCC--------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPH--------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~--------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd 811 (960)
....+++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~ 156 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG 156 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc
Confidence 999999999999999999987543 24788999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 002146 812 KNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 888 (960)
Q Consensus 812 ~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~ 888 (960)
+++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 999999999999975532211 1222345788999999999999999999999999999998 9999988877766665
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 889 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 889 I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
+. .......+..+++.+++||.+||..||.+||++.+|++.|++
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 IT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 54 233455677889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.79 Aligned_cols=253 Identities=30% Similarity=0.466 Sum_probs=213.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
.+.+.|+++++||.| .||.||+++. ++..|++|++... .......+.+|+.+++.++||||+++++.+..+..++
T Consensus 9 ~~~~~y~i~~~lg~g-~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDG-AFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCC-CCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 344679999999999 7999999986 5788999998654 3444667889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+++++|..++.+....+++..++.++.||+.+|.|||..+ |+||||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999999999988765567899999999999999999999998 999999999999999999999999998765433
Q ss_pred cccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-ccCCCCCCcH
Q 002146 831 FLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDP 904 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-~~~iP~~lS~ 904 (960)
........++..|+|||++. ...++.++|||||||++|+|++|..||...+..+....+..... ....+..++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 33334456889999999985 34578899999999999999999999988776655544432211 2233566888
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++.+||.+||..+|.+||++.+++++
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=333.96 Aligned_cols=249 Identities=27% Similarity=0.362 Sum_probs=199.4
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc---CCCceeeEeccccc-----C
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTR-----P 746 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L---~HPNIVkL~g~f~~-----~ 746 (960)
+|++.+.||.| .||+||+++. +++.||||.+............+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g-~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVG-AYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeec-CCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48899999999 7999999976 688999998875433322223455677777665 79999999998764 3
Q ss_pred CceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
..+++||||+.+ +|.+++.+.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccc
Confidence 458999999974 8888886533 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc---c-------
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---R------- 895 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~---~------- 895 (960)
..... .......||..|+|||++.+..++.++|||||||++|+|++|.+||.+....+....+..... .
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 66433 222345689999999999999999999999999999999999999988766544433221000 0
Q ss_pred ---------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ---------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ---------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+...++..+++||.+||..||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00113467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=377.16 Aligned_cols=265 Identities=32% Similarity=0.563 Sum_probs=232.0
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEe
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 740 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~ 740 (960)
....+|+..+.+..+.||+| .||+||+++. ....||||.++... ......+|++|+++|..|+|||||+|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGeg-aFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEG-AFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred cceeEechhheeehhhhcCc-hhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 34456788889999999999 8999999975 34569999876543 444677999999999999999999999
Q ss_pred cccccCCceEEEEeecCCCCHHHHhhCC-------------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCc
Q 002146 741 GAVTRPPNLSIITEFLPRGSLFRILHRP-------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807 (960)
Q Consensus 741 g~f~~~~~l~LVmEY~~gGsL~dlL~k~-------------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeN 807 (960)
|+|..++.++||+|||..|+|.++|... ...++..+.+.|+.||+.||.||-++. +|||||-.+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRN 633 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRN 633 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhh
Confidence 9999999999999999999999998631 123788999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCccccccCCcccC-C-CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhH
Q 002146 808 LLVDKNWNVKVSDFGLSRLKHNTFLSS-K-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQ 884 (960)
Q Consensus 808 ILLd~~g~VKL~DFGLAr~~~~~~~~~-~-t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~e 884 (960)
+||.++..|||+||||++.+-...+.. . ...-.++||+||.|...+|+.++||||+||+|||+++ |..||++....+
T Consensus 634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 999999999999999999765433221 1 2233579999999999999999999999999999998 999999999999
Q ss_pred HHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 885 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 885 i~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+++.|.... .+.-|.+++.++.+|+..||+.+|.+||+|++|-..|+.+...
T Consensus 714 VIe~i~~g~-lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 VIECIRAGQ-LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHcCC-cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 999997544 4778999999999999999999999999999999999998643
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.05 Aligned_cols=255 Identities=32% Similarity=0.550 Sum_probs=216.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEEC--C---cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~~--g---~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
..+|++.+.||.| .||.||++.+. + ..||||++... ........+..|+.++++++||||+++++++.....+
T Consensus 3 ~~~~~~~~~lg~g-~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAG-EFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCC-CCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4578999999999 69999999762 3 35999987643 3455567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++||||+++++|.+++......+++..++.++.|++.||.|||++| ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999999999876667899999999999999999999998 99999999999999999999999999876543
Q ss_pred Cccc--CCCCC---CCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 830 TFLS--SKSTA---GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 830 ~~~~--~~t~~---GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
.... ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. ...+...+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 237 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCP 237 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCC
Confidence 2111 01111 2457999999999999999999999999999886 999999888777766664 333445566788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
..+.+++.+||..+|.+||++.+|+..|+++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.41 Aligned_cols=256 Identities=31% Similarity=0.567 Sum_probs=217.2
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
|++..++|++.++||+| .||.||++++ .+..||+|.+... ......+.+|+.++++++|+||+++++.+.+ ...
T Consensus 1 ~~~~~~~~~~~~~lg~g-~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 1 WEIPRESLKLEKKLGAG-QFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred CcccccceeEEeEecCc-cceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 46778899999999999 6999999986 5667999987643 2234578899999999999999999999887 788
Q ss_pred EEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++|||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999999999763 346788889999999999999999998 9999999999999999999999999997654
Q ss_pred CCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 829 NTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 829 ~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
.... ......++..|+|||++.+..++.++|+|||||++|++++ |..||.+.+..+....+. .......+...+.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHH
Confidence 3221 1122345678999999998889999999999999999998 999999887776666554 333445566788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.+++.+||+.+|.+||++.++++.|+.+
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=343.60 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=220.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
+.|++.+.||+| .|..||++-+ +|+.+|+|++....+.....+++.+|++|.+.|+|||||++++.+......|||+
T Consensus 11 d~y~l~e~igkG-~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccC-chHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 568888999999 8999999855 7999999998877776667788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc---CCCcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd---~~g~VKL~DFGLAr~~~~~ 830 (960)
|++.|++|+.-|-.+ ..++|...-.+++||+++|.|+|..+ |||||+||+|+|+- ...-|||+|||+|......
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 999999997655433 46899999999999999999999999 99999999999995 3456999999999988733
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC--CCCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~--iP~~lS~eLkd 908 (960)
.....++||+.|||||++...+|+..+|||+.|+++|-|+.|++||.+.+...+++.|........ .+.+++++.++
T Consensus 167 -~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 167 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred -cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 444568899999999999999999999999999999999999999999999999999975544333 34678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe 929 (960)
||++||..||.+|.|+.|.|+
T Consensus 246 LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHhccChhhhccHHHHhC
Confidence 999999999999999987764
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=350.49 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=202.5
Q ss_pred eeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc---CCCceeeEecccccCCceEEEEeecC
Q 002146 684 IGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L---~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
||+| .||+||++++ +++.||||++...... ......+..|..++..+ +||||+++++++.....+|+||||+.
T Consensus 1 lG~G-~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKG-TFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCC-CceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 6899 7999999976 5889999998654322 22344556677777765 69999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+|+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............
T Consensus 80 ~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 80 GGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred CChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCc
Confidence 999999987644 6899999999999999999999999 9999999999999999999999999997643333334456
Q ss_pred CCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC-CCcHHHHHHHHHhhh
Q 002146 838 AGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARIIWECWQ 915 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~-~lS~eLkdLI~kcL~ 915 (960)
+||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... ...+|. .+++++++||.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPKNVLSDEGRQFVKGLLN 234 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCCCCccCCHHHHHHHHHHcC
Confidence 899999999999765 4799999999999999999999999998888777776533 233443 478999999999999
Q ss_pred hCCCCCC----CHHHHHHH
Q 002146 916 TDPSLRP----SFAQLTVA 930 (960)
Q Consensus 916 kDP~kRP----Sa~eILe~ 930 (960)
.||.+|| ++.+++++
T Consensus 235 ~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCHHHCCCCCCCHHHHhcC
Confidence 9999998 56777663
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.99 Aligned_cols=250 Identities=27% Similarity=0.319 Sum_probs=204.1
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.+.||.| .||.||+++. ++..||||++............+.+|+.++++++||||+++++++..+..+++|||
T Consensus 1 ~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEG-TYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEeccc-CceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58899999999 6999999986 68899999987554333344577899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 755 FLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~--~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 997 58888876432 46899999999999999999999998 99999999999999999999999999976543323
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-------------------
Q 002146 833 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------------- 892 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~------------------- 892 (960)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 33345678999999998764 4789999999999999999999999876543322211000
Q ss_pred --------ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 --------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 --------~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.........+++++++||.+||..||.+||++.+|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00001123478899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.20 Aligned_cols=247 Identities=30% Similarity=0.517 Sum_probs=209.6
Q ss_pred EEeeccCCeeEEEEEEE--C---CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeec
Q 002146 682 ERIGLGSSYGEVYHADW--N---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~---g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
++||+| .||.||++.+ . +..||+|.+...... .....+.+|+.+++.+.|+|||++++++. ....++||||+
T Consensus 1 ~~ig~G-~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHG-NFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCcc-CceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 469999 6999999976 2 267999988765443 44567889999999999999999999876 45689999999
Q ss_pred CCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC--
Q 002146 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS-- 834 (960)
Q Consensus 757 ~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~-- 834 (960)
++++|.+++.+.. .+++..++.++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 78 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 78 PLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 9999999998755 6899999999999999999999998 9999999999999999999999999998664332111
Q ss_pred -CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 835 -KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 835 -~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+..++..+++||.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHH
Confidence 11223568999999999999999999999999999998 999999888777766664 333456677889999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHhH
Q 002146 913 CWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~Le~i~ 935 (960)
||..+|.+||++.+|++.|+++.
T Consensus 234 cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 234 CWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HhcCChhhCcCHHHHHHHHHhcc
Confidence 99999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.37 Aligned_cols=262 Identities=31% Similarity=0.499 Sum_probs=213.9
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 742 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~ 742 (960)
|+++.++|++++.||.| +||+||++.+ .++.||||+++... .......+.+|+.+|.++ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G-~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRG-AFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCC-ccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 56777899999999999 7999999963 46789999986543 233455788999999999 78999999998
Q ss_pred cccC-CceEEEEeecCCCCHHHHhhCCC----------------------------------------------------
Q 002146 743 VTRP-PNLSIITEFLPRGSLFRILHRPH---------------------------------------------------- 769 (960)
Q Consensus 743 f~~~-~~l~LVmEY~~gGsL~dlL~k~~---------------------------------------------------- 769 (960)
+... ..+++||||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 7544 56889999999999999986421
Q ss_pred --------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc--c
Q 002146 770 --------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--S 833 (960)
Q Consensus 770 --------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~--~ 833 (960)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 13567788889999999999999998 99999999999999999999999999976532211 1
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||.+...................|..+++++.+++.+
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 317 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 122345678999999999999999999999999999997 9999987654333333222334555666788999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 913 CWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
||..+|.+||++.+|+++|+.+..
T Consensus 318 cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 318 CWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.68 Aligned_cols=251 Identities=33% Similarity=0.559 Sum_probs=214.8
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
...+|++.+.||.| .||.||++.+ ++..+|+|.+....... ..+.+|++++++++||||+++++++......++|
T Consensus 2 ~~~~~~~~~~ig~g-~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 2 HPSELTLVQEIGSG-QFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred ChhHeEEEeeecCc-ccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 34689999999999 6999999987 47889999886554432 3678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++......+++..++.++.|++.+|+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999999999999765556889999999999999999999998 99999999999999999999999999876533221
Q ss_pred c-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 833 S-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 833 ~-~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......+...+.. ..+...+...+..+.+|+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPRLASQSVYELM 234 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCCCCCCHHHHHHH
Confidence 1 122335678999999998889999999999999999998 9999988877777766642 224444666789999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~L 931 (960)
.+||..+|.+||++.++++.|
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.64 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=219.1
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEEC------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
.+..++|++.+.||+| .||.||++.+. +..|++|.+... ........+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g-~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 2 AISRDRVTLSDLLQEG-TFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred ccchhheEEeeeeccc-CCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3566889999999999 69999999863 477899987533 345556778899999999999999999998655
Q ss_pred -CCceEEEEeecCCCCHHHHhhCCC-------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEE
Q 002146 746 -PPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 817 (960)
Q Consensus 746 -~~~l~LVmEY~~gGsL~dlL~k~~-------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VK 817 (960)
....++++||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEE
Confidence 577899999999999999986532 35889999999999999999999998 99999999999999999999
Q ss_pred EEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcccc
Q 002146 818 VSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR 894 (960)
Q Consensus 818 L~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~ 894 (960)
|+|||+++....... ......++..|+|||++.+..++.++|||||||++||+++ |..||...+..++...+.. ..
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~ 236 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GY 236 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CC
Confidence 999999986532211 1122346778999999999999999999999999999998 9999998887777665542 33
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 895 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 895 ~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+..+..+++++.+++.+||..+|.+||++.++++.|+.+.+.
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 4444566789999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.31 Aligned_cols=257 Identities=32% Similarity=0.508 Sum_probs=213.4
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEEC------------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~------------------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP 734 (960)
+...+|++++.||.| .||.||+++.. +..||+|.+.... .......+.+|++++++++||
T Consensus 2 ~~~~~~~~~~~lg~G-~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 2 FPRQPLNFVEKLGEG-QFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred CchhhCcccccccCC-CCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCC
Confidence 345789999999999 69999998752 2458999876543 334566789999999999999
Q ss_pred ceeeEecccccCCceEEEEeecCCCCHHHHhhCCC----------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccC
Q 002146 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 804 (960)
Q Consensus 735 NIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~----------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLK 804 (960)
||+++++++......+++|||+.+++|.+++.+.. ..+++..++.++.|++.||.|||+++ |+|||||
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlk 157 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLA 157 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccc
Confidence 99999999999999999999999999999987643 25889999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 002146 805 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGM 880 (960)
Q Consensus 805 PeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT--G~~PF~~~ 880 (960)
|+||+++.++.++|+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ +..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999999997653321 11223456789999999998889999999999999999998 78899887
Q ss_pred ChhHHHHHhhcc------ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 881 NPMQVVGAVGFQ------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 881 ~~~ei~~~I~~~------~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
...+....+... ......+..++.++.+||.+||..+|.+||++.+|++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 766665544321 11122345677899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=381.14 Aligned_cols=260 Identities=31% Similarity=0.544 Sum_probs=229.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE---CCc----EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW---NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~---~g~----~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
++.+..++...||+| .||.||.|.. ++. .||||.+... .+.....+|.+|..+|..++|||||+++|++.+
T Consensus 689 v~~~~v~l~~~lG~G-~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKG-AFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccc-cccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 557788999999999 8999999976 333 4899987543 456677899999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCC------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 746 PPNLSIITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
....+|++|||.||+|..+|++. ...+....++.++.||++|++||++++ +|||||-.+|+||++...|||+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEc
Confidence 99999999999999999999986 557889999999999999999999998 9999999999999999999999
Q ss_pred ecCccccccCCccc-CCCC-CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcccccc
Q 002146 820 DFGLSRLKHNTFLS-SKST-AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 896 (960)
Q Consensus 820 DFGLAr~~~~~~~~-~~t~-~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~ 896 (960)
|||+|+.+....+. .... .--.+|||||.+....++.++|||||||++||+|+ |..||.+.+..++........ ++
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 99999965433222 2222 22359999999999999999999999999999999 999999999999888665444 99
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 897 ~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
..|..|+..+.++|.+||+.+|++||+|..|++.+..+..-
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 99999999999999999999999999999999999888554
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.68 Aligned_cols=256 Identities=31% Similarity=0.494 Sum_probs=215.7
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
++.++|++.+.||.| .||.||++.+ ++..||||++.... .......+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQG-AFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceeccccccc-ccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 456789999999999 6999999975 35789999876432 33445678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCC---------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccC
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPH---------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 804 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~---------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLK 804 (960)
...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||..+ ++|||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~ 157 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLA 157 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccccc
Confidence 999999999999999999986421 24678888999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002146 805 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 881 (960)
Q Consensus 805 PeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~ 881 (960)
|.|||++.++.+||+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987543221 11122335668999999999999999999999999999997 889999888
Q ss_pred hhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 882 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 882 ~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
..+....+.. ......+..++.++.+||.+||+.+|.+||++.||++.|++
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEEVIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 8777766643 22334566788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.64 Aligned_cols=249 Identities=22% Similarity=0.267 Sum_probs=209.4
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChH-HHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~-~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
|+..+.||.| .||+||++.+ +++.||+|++........ ....+.+|+.+|+.++|+||+.+++++...+.+++|||
T Consensus 2 ~~~~~~lg~G-~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKG-GFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecC-CCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 7788999999 6999999976 688999999876543322 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 755 FLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cc
Confidence 999999998886532 36899999999999999999999999 999999999999999999999999999765322 12
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--cccccCCCCCCcHHHHHHHH
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~--~~~~~~iP~~lS~eLkdLI~ 911 (960)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.. ......++..++.++.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 2345789999999999999999999999999999999999999988765433322211 22234456778899999999
Q ss_pred HhhhhCCCCCCC-----HHHHHHH
Q 002146 912 ECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPS-----a~eILe~ 930 (960)
+||..+|.+||+ +.+++.+
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcC
Confidence 999999999999 7788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.89 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=209.7
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|++.+.||.| .||.||++.+ ++..+++|.+... .......+.+|+.+++.++||||+++++++......++||||
T Consensus 7 ~~i~~~lg~g-~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDG-AFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccC-CCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 6788999999 6999999987 4677899987543 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~ 835 (960)
+++++|..++.+....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 9999999988765557899999999999999999999998 99999999999999999999999999976544333334
Q ss_pred CCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cccCCCCCCcHHHHHH
Q 002146 836 STAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARI 909 (960)
Q Consensus 836 t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~~iP~~lS~eLkdL 909 (960)
...|+..|+|||++. +..++.++|||||||++|+|++|.+||...+..+....+.... .....|..++.++++|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 567899999999984 4557889999999999999999999999887766555543221 1223456788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
|.+||..+|.+||++.+++++
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.37 Aligned_cols=248 Identities=24% Similarity=0.317 Sum_probs=202.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------ 746 (960)
.++|++.+.||.| .||.||++.. .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSG-AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeec-CCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4789999999999 6999999975 688999999876544455566788999999999999999999987643
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+|+||||+++ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999965 67776653 4788899999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc--------------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------- 892 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-------------- 892 (960)
.... .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 169 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 5433 2234467899999999999999999999999999999999999999887644332211100
Q ss_pred ------ccc--------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 ------NRR--------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 ------~~~--------------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
... ...+...+.++++||.+||..||.+||++.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 00112235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=333.34 Aligned_cols=251 Identities=30% Similarity=0.472 Sum_probs=214.8
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++.+.||.| .||.||++.+ ++..||+|.+... .......+.+|+.++++++||||+++++++.....+|+|
T Consensus 4 ~~~~~i~~~l~~g-~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDG-AFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCC-CCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 4679999999999 7999999986 5788999988643 334456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++.+....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999999999876667999999999999999999999999 99999999999999999999999999876544333
Q ss_pred cCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-ccCCCCCCcHHH
Q 002146 833 SSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLV 906 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-~~~iP~~lS~eL 906 (960)
......|+..|++||++. +..++.++|+||||+++|+|++|..||...+..+....+..... ....+..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 334457899999999985 34567899999999999999999999998877666655532211 223356788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.++|.+||..+|.+||++.+++++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcC
Confidence 999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.89 Aligned_cols=258 Identities=31% Similarity=0.502 Sum_probs=211.8
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEECC----------------cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG----------------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 735 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g----------------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN 735 (960)
+++..+|++.++||+| .||.||++++.+ ..||||.+... ........+.+|+++|++++|+|
T Consensus 1 ~~~~~~~~~~~~lg~G-~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 1 EFPRQQLRLKEKLGEG-QFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred CCchHhCeehhccCCC-CCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCC
Confidence 3566789999999999 699999986522 24899988654 33445567899999999999999
Q ss_pred eeeEecccccCCceEEEEeecCCCCHHHHhhCCC-----------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccC
Q 002146 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 804 (960)
Q Consensus 736 IVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~-----------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLK 804 (960)
|+++++++......++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ |+|||||
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlk 156 (295)
T cd05097 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLA 156 (295)
T ss_pred cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccC
Confidence 9999999999999999999999999999986432 13678888999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 002146 805 SPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGM 880 (960)
Q Consensus 805 PeNILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT--G~~PF~~~ 880 (960)
|+|||++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++ +..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999976533211 1122345678999999999999999999999999999998 67899887
Q ss_pred ChhHHHHHhhc------cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 881 NPMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 881 ~~~ei~~~I~~------~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
...+....+.. .......+..+++.+++||.+||..+|.+||++.+|++.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 76665544321 111123355678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=321.14 Aligned_cols=246 Identities=32% Similarity=0.578 Sum_probs=209.9
Q ss_pred EEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCC
Q 002146 682 ERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
++||.| .||.||++.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++......++||||+++++
T Consensus 1 ~~ig~g-~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKG-NFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCC-CCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 368999 6999999975 57789999876543 34444578899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC-CCCCC
Q 002146 761 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS-KSTAG 839 (960)
Q Consensus 761 L~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~-~t~~G 839 (960)
|.+++......+++..++.++.|++.+|.|||+.| ++||||||+||+++.++.+||+|||++.......... ....+
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 99999765556889999999999999999999998 9999999999999999999999999997643322211 12234
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCC
Q 002146 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 918 (960)
Q Consensus 840 T~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP 918 (960)
+..|+|||++.+..++.++||||||+++|+|++ |..||.+.........+. ...+...+..++..+.+|+.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 567999999999889999999999999999998 999999887776666554 333455677789999999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 002146 919 SLRPSFAQLTVALK 932 (960)
Q Consensus 919 ~kRPSa~eILe~Le 932 (960)
.+||++.++++.|.
T Consensus 236 ~~Rp~~~~l~~~l~ 249 (250)
T cd05085 236 ENRPKFSELQKELA 249 (250)
T ss_pred ccCCCHHHHHHHhc
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.49 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=202.4
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.+.||.| .||.||++++ +|+.||+|.+............+.+|+.++++++||||+++++++.+...+++|+|
T Consensus 1 ~y~~~~~l~~g-~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEG-TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEeccc-CCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999 7999999987 68899999987544333334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+. ++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 996 5788887665557899999999999999999999999 9999999999999999999999999998654433333
Q ss_pred CCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHhhcc------------------cc
Q 002146 835 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQ------------------NR 894 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~-~~~~ei~~~I~~~------------------~~ 894 (960)
....++..|+|||++.+.. ++.++|||||||++|+|++|..||.. .+..+....+... ..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 3456789999999987754 78999999999999999999888644 3322222221100 00
Q ss_pred cc---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 RL---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ~~---------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. .....+++++++||.+||..||.+||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 1113467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.44 Aligned_cols=246 Identities=26% Similarity=0.452 Sum_probs=216.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++.+.||.| .||.||++.+ +++.||||++...... ......+.+|+++|++++||||+++++++.....+++|
T Consensus 1 ~~y~~~~~ig~g-~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTG-SFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecC-CCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 479999999999 6999999986 6789999998764332 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++.+.. .+++..+..++.||+.||.|||+.| |+||||+|.||||+.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 99999999999997753 7899999999999999999999998 999999999999999999999999999876443
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+. .....+|..++..++++|.+
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~ 231 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRN 231 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHH
Confidence 334578999999999998889999999999999999999999999887666666553 34566788889999999999
Q ss_pred hhhhCCCCCC-----CHHHHHHH
Q 002146 913 CWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRP-----Sa~eILe~ 930 (960)
||..+|.+|+ ++++++++
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcC
Confidence 9999999999 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.18 Aligned_cols=249 Identities=30% Similarity=0.503 Sum_probs=213.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++.++||.| .||.||++.+ ++..|++|.+.... ....+.+|++++++++|+||+++++.+.....+|++
T Consensus 2 ~~~y~~~~~i~~g-~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEG-SYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCC-CCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 4679999999999 7999999987 37889999886432 156889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
+||+.+++|.+++......+++..++.++.|++.||.|||..+ |+||||+|.||+++.++.+||+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999999999876667899999999999999999999998 99999999999999999999999999987654432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-ccccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-~~~~~iP~~lS~eLkdLI~ 911 (960)
......|+..|+|||++.+..++.++||||||+++|+|++|..||......+....+... ......+..++.++.++|.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 334456889999999999999999999999999999999999999887665544433211 1122234567889999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||..+|.+||++.+++++
T Consensus 235 ~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHhcChhhCcCHHHHhcC
Confidence 9999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=333.95 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=212.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++.+.||.| .||.||++.. +++.||||.+....... .....+.+|+++++.++|+||+++++.+......++|
T Consensus 1 ~~y~~~~~ig~g-~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKG-DVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCC-ccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 478999999999 6999999986 57899999998765443 3456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 753 TEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
|||+.+++|.+++.+. ...+++..++.++.||+.||.|||..| |+||||||+||+|+.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999998753 346899999999999999999999998 9999999999999999999999999987542210
Q ss_pred -----------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 002146 832 -----------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 882 (960)
Q Consensus 832 -----------------------------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~ 882 (960)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 111234688999999999999999999999999999999999999998887
Q ss_pred hHHHHHhhccccccCCCC--CCcHHHHHHHHHhhhhCCCCCCC----HHHHHHH
Q 002146 883 MQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS----FAQLTVA 930 (960)
Q Consensus 883 ~ei~~~I~~~~~~~~iP~--~lS~eLkdLI~kcL~kDP~kRPS----a~eILe~ 930 (960)
......+... ...++. .++..+++||.+||..+|.+||+ +++++.+
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DETFSNILKK--EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHhcC--CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 7666555322 333333 36899999999999999999999 7777774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.45 Aligned_cols=249 Identities=28% Similarity=0.434 Sum_probs=206.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccC------
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP------ 746 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~------ 746 (960)
..|++.+.||.| .||.||++.+ .++.||||++..... ....+.+|+.+++++ +|+||+++++++...
T Consensus 6 ~~y~~~~~lg~g-~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNG-TYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeec-CCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 458888999999 7999999976 678899999865432 234678899999998 799999999998653
Q ss_pred CceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
..+|+||||+.+++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4589999999999999998764 346889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
.............|+..|+|||++. +..++.++|||||||++|+|++|..||...........+.....+...+.
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 6543333344567899999999986 34578899999999999999999999987766555444432222333345
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.++.++++||.+||..+|.+||++.+++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 678899999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.14 Aligned_cols=244 Identities=21% Similarity=0.297 Sum_probs=198.6
Q ss_pred eeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCC
Q 002146 684 IGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
||.| .||.||+++. +|+.||+|++....... .....+..|++++++++||||+++++++.....+++||||++|++
T Consensus 1 lg~G-~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKG-GFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCC-CceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 6889 6999999975 58999999986543322 123345679999999999999999999999999999999999999
Q ss_pred HHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCC
Q 002146 761 LFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 839 (960)
Q Consensus 761 L~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~G 839 (960)
|.+++.... ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++...... .......|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccCC
Confidence 998876433 35888889999999999999999999 999999999999999999999999999765433 22234568
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHhhccccccCCCCCCcHHHHHHHHHhhh
Q 002146 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 915 (960)
Q Consensus 840 T~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~----ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~ 915 (960)
+..|+|||++.+..++.++|||||||++|+|++|..||.+.... ++...+. ..........++.++++||.+||+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-ccccccccccCCHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999865432 2222221 111111224688999999999999
Q ss_pred hCCCCCCCHHHHHHHHH
Q 002146 916 TDPSLRPSFAQLTVALK 932 (960)
Q Consensus 916 kDP~kRPSa~eILe~Le 932 (960)
+||.+||++.++++.+.
T Consensus 236 ~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 236 KKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCHhhCCCCccchhhhh
Confidence 99999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.39 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=206.7
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
..++|++.++||.| .||.||++++ +++.||+|.+....... ....+.+|+.+++.++||||+++++++.....+++
T Consensus 4 ~~~~y~~~~~lg~g-~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEG-TYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccC-cCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999 7999999976 57889999886543222 23356789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+. ++|..++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 999996 5899988776667889999999999999999999998 9999999999999999999999999997654332
Q ss_pred ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-----------------
Q 002146 832 LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------- 893 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~----------------- 893 (960)
.......++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 333345678999999998764 47899999999999999999999998876554433221100
Q ss_pred cccCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 894 RRLEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 894 ~~~~i-----------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
....+ ...+++++++||.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00011 1346888999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.85 Aligned_cols=252 Identities=27% Similarity=0.324 Sum_probs=211.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc-eeeEecccccCC----
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPP---- 747 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN-IVkL~g~f~~~~---- 747 (960)
...|..+++||+| +||+||+|+. +|+.||+|+++.....+.......+|+.+|+.|+|+| ||.+++++.+..
T Consensus 10 ~~~~~~~eklGeG-tyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEG-TYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCC-CceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 4557777889999 8999999975 7899999999876443334456789999999999999 999999998877
Q ss_pred --ceEEEEeecCCCCHHHHhhCCC---CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecC
Q 002146 748 --NLSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822 (960)
Q Consensus 748 --~l~LVmEY~~gGsL~dlL~k~~---~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFG 822 (960)
.++|||||++ -+|..++.... ..++...++.+++||+.||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccc
Confidence 8999999995 59999998755 35777899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc-----
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----- 896 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~----- 896 (960)
+|+.+.-........++|.+|+|||++.|. .|+..+||||+|||++||+++++.|.+....+....|...-..+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 999776555555667899999999999998 58999999999999999999999999987765555543211111
Q ss_pred -----------CCC------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 -----------EIP------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 -----------~iP------------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.++ +..+++..+++.+||+.+|.+|.+++..+++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 1223578999999999999999999999886
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.40 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=206.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.+.||.| .||.||++.+ +++.||+|++............+.+|+.++++++|+||+++++++.....+++||
T Consensus 1 ~~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEG-SYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred Cceeeeeeeccc-CCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 468999999999 7999999986 5889999988754433333346789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||++++.|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 9999988888775543 6899999999999999999999998 999999999999999999999999999876544323
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-----------------c
Q 002146 834 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----------------R 895 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-----------------~ 895 (960)
.....++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+..... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 334568889999999876 4578999999999999999999999988765443332211000 0
Q ss_pred cCC------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 LEI------------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~~i------------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
... ...++..+.+||.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 12457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=321.49 Aligned_cols=249 Identities=26% Similarity=0.463 Sum_probs=216.4
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.+.||.| .||.||++.. +++.||||.+............+.+|+.+|++++||||+++++.+.....+++|||
T Consensus 1 ~y~~~~~lg~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRG-AFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEeccc-CceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58899999999 6999999875 68889999988766666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC-CcEEEEecCccccccCCcc
Q 002146 755 FLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-g~VKL~DFGLAr~~~~~~~ 832 (960)
|+++++|.+++.... ..+++..++.++.|++.+|+|||+++ |+||||||+||+++.+ +.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999997643 35889999999999999999999998 9999999999999854 468999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. .....++..++.+++++|.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHH
Confidence 22345688999999999998899999999999999999999999988877666655542 33445677789999999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
||..+|.+||++.+++.+
T Consensus 236 ~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HccCChhhCCCHHHHhhC
Confidence 999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=328.40 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=205.3
Q ss_pred CeEEEEEeeccCCeeEEEEEEE------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC--Cc
Q 002146 677 DLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 748 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~ 748 (960)
.|++.+.||.| .||+||++.+ ++..||+|.+.... .......+.+|+++|++++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 5 YLKKIRVLGEG-HFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hceeceecccC-CCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 35899999999 7999988653 56789999886543 233455788999999999999999999987653 45
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++||||+++++|.+++... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccC
Confidence 88999999999999999764 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--HH------------HHHhhc
Q 002146 829 NTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QV------------VGAVGF 891 (960)
Q Consensus 829 ~~~~~---~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~--ei------------~~~I~~ 891 (960)
..... .....++..|+|||++.+..++.++||||||+++|+|++|..||...... +. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 32111 12234566799999999888999999999999999999999998653321 00 000111
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 892 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 892 ~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
.......+..++..+++|+.+||..+|.+||++++|++.|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 12233446678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.16 Aligned_cols=257 Identities=30% Similarity=0.506 Sum_probs=210.7
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEEC------------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~------------------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP 734 (960)
++.++|++.++||.| .||.||++++. +..||+|++.... .......+.+|+.+|+.++|+
T Consensus 2 ~~~~~~~~~~~lg~G-~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~ 79 (296)
T cd05095 2 FPRKRLTFKEKLGEG-QFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDP 79 (296)
T ss_pred CChhhceeeeeccCC-CCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCC
Confidence 456789999999999 69999998542 3358999876542 334456789999999999999
Q ss_pred ceeeEecccccCCceEEEEeecCCCCHHHHhhCCC----------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccC
Q 002146 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 804 (960)
Q Consensus 735 NIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~----------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLK 804 (960)
||+++++++...+..++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlk 157 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLA 157 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCC
Confidence 99999999999999999999999999999987532 23667789999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 002146 805 SPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGM 880 (960)
Q Consensus 805 PeNILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT--G~~PF~~~ 880 (960)
|+|||++.++.++|+|||+++....... ......++..|++||+..+..++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999986533211 1122334678999999988889999999999999999998 78999887
Q ss_pred ChhHHHHHhhc------cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 881 NPMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 881 ~~~ei~~~I~~------~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
...+....... .......+..+++.+++||.+||+.||.+||++.+|++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 76665543311 111223355678999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=330.20 Aligned_cols=250 Identities=31% Similarity=0.482 Sum_probs=207.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++.+.||.| .||.||++.+ +++.||+|++.... ......+.+|+.+++.++||||+++++.+...+.+++|
T Consensus 8 ~~~~~~~~~lg~g-~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSG-TYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCC-CCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3578888999999 6999999976 68899999886543 22344678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++...+ .+++.+++.++.|++.||.|||..| |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999999987654 6899999999999999999999999 99999999999999999999999999876544333
Q ss_pred cCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC-C--CCCCcHHH
Q 002146 833 SSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE-I--PKELDPLV 906 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~-i--P~~lS~eL 906 (960)
......|+..|+|||++. ...++.++|+|||||++|+|++|..||....+.............+. . ...++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 334567999999999974 45588999999999999999999999987665444333221211111 1 12467889
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++|.+||..+|++||++++|+++
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcC
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.21 Aligned_cols=249 Identities=31% Similarity=0.524 Sum_probs=211.6
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-------HHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-------~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
.|.+++.||.| .||.||++.. +++.||+|.+....... .....+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g-~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSG-SFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecC-CCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 36778899999 7999999975 67899999886543221 22356889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999999997653 6888999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 828 HNTFL------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 828 ~~~~~------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
..... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+. ....+.++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSN 235 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcc
Confidence 42211 1123458899999999999889999999999999999999999999876655554443 2335567778
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++..++++|.+||+.+|.+||++.+|+++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 89999999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.27 Aligned_cols=258 Identities=28% Similarity=0.506 Sum_probs=219.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCc----EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~----~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+...+|++.+.||.| .||+||++.+ +|+ .||+|.+..... ......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g-~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSG-AFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCC-CCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 445789999999999 6999999975 333 589998765432 4445678899999999999999999999887
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
...++||||+++|+|.+++.+....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCccccc
Confidence 7899999999999999999876667899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 827 KHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 827 ~~~~~~~--~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
....... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+....++...+. .......|..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICT 237 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCC
Confidence 5432211 111223568999999988889999999999999999998 999999988877776664 334556677788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
..+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus 238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 238 IDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=321.07 Aligned_cols=246 Identities=32% Similarity=0.573 Sum_probs=210.2
Q ss_pred EEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCC
Q 002146 682 ERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
++||.| .||.||++.+. ++.||+|++...... .....+.+|++++++++|+||+++++++......++||||+.+++
T Consensus 1 ~~lg~g-~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKG-NFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccC-CCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999 69999999864 899999988765433 445678999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC--CCCC
Q 002146 761 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTA 838 (960)
Q Consensus 761 L~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~--~t~~ 838 (960)
|.+++.+....+++..++.++.+++.+|.|||+.+ |+||||||+||||+.++.+||+|||++.......... ....
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99999775557889999999999999999999998 9999999999999999999999999997654221111 1223
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 839 GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.. ......+..++.++.+||.+||..+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 235 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYD 235 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccC
Confidence 4567999999999899999999999999999998 8999988877666665542 2344567788999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 002146 918 PSLRPSFAQLTVALK 932 (960)
Q Consensus 918 P~kRPSa~eILe~Le 932 (960)
|.+||++.+|++.|+
T Consensus 236 p~~Rp~~~ell~~l~ 250 (251)
T cd05041 236 PENRPSFSEIYNELQ 250 (251)
T ss_pred hhhCcCHHHHHHHhh
Confidence 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=322.90 Aligned_cols=250 Identities=30% Similarity=0.513 Sum_probs=205.7
Q ss_pred EEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc-cCCceEEEEee
Q 002146 682 ERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNLSIITEF 755 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~-~~~~l~LVmEY 755 (960)
+.||.| .||.||++.+ .+..||||.+.... .......+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 1 ~~lg~g-~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKG-HFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred Cccccc-CCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 358999 6999999975 23469999875332 2344567889999999999999999999764 45568899999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc----
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF---- 831 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~---- 831 (960)
+.+++|.+++.+....+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999999875556777888899999999999999998 9999999999999999999999999997653221
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
.......++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+....+. ....+..+..++..+.+++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 235 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVM 235 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHH
Confidence 11123346778999999998899999999999999999999 567787777666665553 3334455667789999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 911 WECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.+||..+|.+||++.+|++.|+++..
T Consensus 236 ~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 236 LSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.65 Aligned_cols=246 Identities=32% Similarity=0.561 Sum_probs=211.7
Q ss_pred EEeeccCCeeEEEEEEEC---Cc--EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeec
Q 002146 682 ERIGLGSSYGEVYHADWN---GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~---g~--~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
++||.| .||.||++.+. ++ .||||.+...... .....+.+|+.++++++||||+++++.+.. ..+++||||+
T Consensus 1 ~~ig~g-~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDG-SFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCcc-CcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999 69999999762 22 5899998766543 556788999999999999999999999988 8899999999
Q ss_pred CCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc---
Q 002146 757 PRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--- 832 (960)
Q Consensus 757 ~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~--- 832 (960)
++++|.+++.+.. ..+++..++.++.|++.||.|||..+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999999997654 46899999999999999999999998 99999999999999999999999999987643211
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..++...+.........+..++..+.+++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence 1123457789999999999999999999999999999998 999999888887777665444455566778899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~Le 932 (960)
+||+.+|.+||++.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=324.29 Aligned_cols=249 Identities=31% Similarity=0.471 Sum_probs=210.4
Q ss_pred CeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCC----ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDF----SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~----~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
+|++++.||.| .||.||++.. +++.||||.+..... .......+.+|+.+|++++|+||+++++++.+...+++
T Consensus 1 ~~~~~~~ig~g-~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKG-AYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEecc-CCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 47888999999 7999999976 788899998765432 12334568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC-
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 830 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~- 830 (960)
||||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999997644 5789999999999999999999998 999999999999999999999999998764211
Q ss_pred -----cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-ccccCCCCCCcH
Q 002146 831 -----FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDP 904 (960)
Q Consensus 831 -----~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-~~~~~iP~~lS~ 904 (960)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... ...+.++..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11122356899999999999999999999999999999999999999876655443333222 233456778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
++.++|.+||..+|.+||++.++++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=332.86 Aligned_cols=258 Identities=29% Similarity=0.531 Sum_probs=215.6
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCc----EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~----~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
...+|++.+.||.| .||.||++.+ ++. .||+|.+.... ......++.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G-~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSG-AFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccC-CCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45678999999999 6999999976 444 47888776433 233345788999999999999999999998754
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
..++++||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccc
Confidence 567999999999999999876667889999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 828 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 828 ~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTI 238 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence 43211 1223345778999999999999999999999999999997 999998877665554443 3344555667889
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+.+++.+||..+|.+||++.++++.|+.+.+.
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=350.91 Aligned_cols=244 Identities=23% Similarity=0.278 Sum_probs=197.5
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
+....|++++.||.| .||.||++.. +++.||||... ...+.+|+++|++|+|||||+++++|......+
T Consensus 89 ~~~~~y~~~~~lg~G-~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPG-AEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCC-CCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 455789999999999 7999999976 68899999642 124678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+|||++. ++|..++.... .+++..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 160 lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9999995 68888886543 6889999999999999999999998 999999999999999999999999999754321
Q ss_pred -cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------hHHHHHhhc-----------
Q 002146 831 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVGF----------- 891 (960)
Q Consensus 831 -~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-------~ei~~~I~~----------- 891 (960)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+..
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1223346799999999999999999999999999999999999988764321 000000000
Q ss_pred ---------------c-cccc-CCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 892 ---------------Q-NRRL-EIP-----KELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 892 ---------------~-~~~~-~iP-----~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
. ...+ ..+ ..++.++.+||.+||..||.+||++.|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000 000 124668999999999999999999999986
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=322.90 Aligned_cols=250 Identities=30% Similarity=0.488 Sum_probs=210.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHHcCCCceeeEecccccC--Cc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~---~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~ 748 (960)
.+|++++.||.| .||.||++.. +++.||||++..... .......+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g-~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQG-AFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecC-CceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 579999999999 6999999975 688999998764321 223456788999999999999999999988764 46
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++++|||+++++|.+++.+.. .+++...+.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 889999999999999987643 5788889999999999999999999 9999999999999999999999999997653
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 829 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 829 ~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
... .......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+......+.+|..++..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence 211 11233568899999999999889999999999999999999999998876665555554344455567778889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.++|.+||. +|.+||++++|+++
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 9999999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.89 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=206.7
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
|++.+.||+| .||.||++.+ +++.||||.+....... .....+.+|+.++++++|+||+.+++.+.+.+.+++|||
T Consensus 2 f~~~~~ig~G-~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKG-GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecC-CCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 6788999999 6999999976 68899999887654332 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 755 FLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCC-cc
Confidence 999999999885432 35889999999999999999999998 999999999999999999999999998765332 12
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+. ......++..+++++++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 23457999999999999999999999999999999999999999875432 1111111 1123345677899999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHH
Q 002146 911 WECWQTDPSLRPS-----FAQLTV 929 (960)
Q Consensus 911 ~kcL~kDP~kRPS-----a~eILe 929 (960)
.+||+.||.+||+ +.++++
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHc
Confidence 9999999999999 889888
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.91 Aligned_cols=249 Identities=34% Similarity=0.587 Sum_probs=212.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+...+|++.+.||.| .||.||++...++.||+|.+.... ....+.+|+.++++++||||+++++++... ..++|
T Consensus 3 ~~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 3 LNLQKLTLGEIIGEG-EFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred ccHHHceeeeeeccC-CCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 345779999999999 699999999999999999876432 234688999999999999999999998764 57999
Q ss_pred EeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 753 TEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
|||+.+++|.+++.... ..+++..++.++.|++.||.|||+.| ++||||||+|||++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 99999999999997543 35789999999999999999999998 999999999999999999999999998764322
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
......+..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+.. ..+...+..++..+++||
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLM 230 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHH
Confidence 122334568999999998899999999999999999997 9999998887776665543 334455667889999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
.+||+.+|.+||++++|++.|++
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 231 TSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHcCCChhhCcCHHHHHHHHcc
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=325.20 Aligned_cols=254 Identities=31% Similarity=0.532 Sum_probs=205.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--CC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PP 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~--~~ 747 (960)
.+|++.+.||.| .||.||++.+ ++..||||++... .......+.+|+++|++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKG-NFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCC-CCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 578999999999 6999999874 4778999987654 23445678899999999999999999987643 34
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+++||||+++++|.+++.+....+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 689999999999999999765557899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHH---------------HHHh
Q 002146 828 HNTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV---------------VGAV 889 (960)
Q Consensus 828 ~~~~~~---~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei---------------~~~I 889 (960)
...... .....++..|+|||++.+..++.++|||||||++|||++|..++........ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 432111 1112234569999999999999999999999999999998777644321100 0011
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 890 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 890 ~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.........+..++.++.+||.+||..+|.+||++.+|++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 112223344567889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=325.18 Aligned_cols=248 Identities=32% Similarity=0.588 Sum_probs=206.3
Q ss_pred EEeeccCCeeEEEEEEE--CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeec
Q 002146 682 ERIGLGSSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~--~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
+.||.| .||.||++.+ ++. .+++|.+... ........+.+|+.+++++ +||||+++++++.....+++||||+
T Consensus 1 ~~lg~g-~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEG-NFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCC-CCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 358999 6999999986 333 4688876532 2334455788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEec
Q 002146 757 PRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821 (960)
Q Consensus 757 ~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DF 821 (960)
++++|.+++.+.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCC
Confidence 9999999987532 24778899999999999999999998 999999999999999999999999
Q ss_pred CccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 822 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 822 GLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
|++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.. ......+.
T Consensus 157 gl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~ 234 (270)
T cd05047 157 GLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPL 234 (270)
T ss_pred CCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCC
Confidence 998643221 11112234567999999999999999999999999999997 9999998877776666542 23445566
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
.++.++.+|+.+||..+|.+||++.+++..|+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 78899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=319.78 Aligned_cols=249 Identities=34% Similarity=0.532 Sum_probs=215.1
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~---~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
+|+..+.||.| .||.||++.. +++.|++|.+..... .......+.+|+.+++.++|+||+++++++.....+++
T Consensus 1 ~~~~~~~ig~g-~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSG-SFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred Cccccceeeec-CCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 36677899999 6999999976 688999998865432 23455678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
++||+++++|.+++.+.. .+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999999997654 5889999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
......|+..|++||.+.... ++.++|+||||+++|+|++|..||......+....+........++..+++.+++|+
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence 234466899999999998776 899999999999999999999999887766655555443455667778899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||..+|.+||++.+++++
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHhhcCcccCcCHHHHhcC
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=324.55 Aligned_cols=250 Identities=29% Similarity=0.488 Sum_probs=210.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHHcCCCceeeEeccccc--CCc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~---~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~--~~~ 748 (960)
.+|++.+.||+| .||.||++.. ++..||+|++...... ......+.+|+.++++++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g-~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQG-AFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCC-CCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 368899999999 7999999975 6889999988654322 2345578899999999999999999998865 356
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++++|||+++++|.+++.+.. .+++...+.++.||+.||.|||..+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 889999999999999997644 5888999999999999999999998 9999999999999999999999999997653
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 829 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 829 ~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
... .......++..|+|||++.+..++.++|||||||++|+|++|..||......+....+......+.+|..+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence 221 11123458899999999999989999999999999999999999998877666555554444456677788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++|| +||..+|.+||++++|+++
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhcC
Confidence 99999 6888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.05 Aligned_cols=249 Identities=38% Similarity=0.662 Sum_probs=213.0
Q ss_pred eEEEEEeeccCCeeEEEEEEECC------cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 678 LVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~g------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
+++++.||.| .||.||++++.. ..||+|++.... .......+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEG-AFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccC-CCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 3577889999 699999998743 789999986543 22245688899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCC-CcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 752 ITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~-lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+|||+++++|.+++...... +++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999999765434 899999999999999999999998 999999999999999999999999999876443
Q ss_pred cccCC-CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 831 FLSSK-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~-t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
..... ...++..|+|||.+.+..++.++|||+||+++|+|++ |..||...+..+....+.. ......+..++.++.+
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEIYK 235 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHH
Confidence 11111 2236789999999988889999999999999999998 8999988877777766653 3345566778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~L 931 (960)
++.+||+.+|.+||++.++++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=332.86 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=207.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.++||.| .||.||++.+ ++..||+|.+... .......++.+|++++++++||||++++++|..++.+++||
T Consensus 1 ~~~~~~~~lg~G-~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAG-NGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCC-CCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 468999999999 7999999986 5778999987643 23445567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 999999999999765 368899999999999999999997 57 9999999999999999999999999987654332
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc--------------------
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------- 892 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-------------------- 892 (960)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 23467899999999999888999999999999999999999999765544333222110
Q ss_pred ---------------ccccCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 ---------------NRRLEIPK-ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 ---------------~~~~~iP~-~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+.+|. .++.++++||.+||..+|.+||++.+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112222 367889999999999999999999999887
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=326.36 Aligned_cols=248 Identities=30% Similarity=0.472 Sum_probs=214.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.+.||.| .||.||++.+ +++.||+|.+.... .......+.+|+.+++.++|+||+++++++.+...+++|+
T Consensus 1 ~~y~~~~~lg~g-~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKG-SFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCC-CCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 368888999999 6999999976 68899999887543 2334557889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++........
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 79 EYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 999999999999764 6899999999999999999999998 999999999999999999999999999877544333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCC-CcHHHHHHHHH
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE-LDPLVARIIWE 912 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~-lS~eLkdLI~k 912 (960)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.. ...+.++.. ++.++.++|.+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ 233 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDFVSL 233 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHHHHH
Confidence 4456789999999999998899999999999999999999999988776666555432 233444444 88999999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
||..+|.+||++.+++++
T Consensus 234 ~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 234 CLNKDPKERPSAKELLKH 251 (274)
T ss_pred HhhCChhhCcCHHHHhhC
Confidence 999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=326.83 Aligned_cols=243 Identities=28% Similarity=0.403 Sum_probs=203.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.++||.| .||.||++.+ +++.||||.+.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g-~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHG-NGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccC-CCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 468889999999 6999999975 68889999886542 3344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...... .
T Consensus 79 e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~ 149 (279)
T cd06619 79 EFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--I 149 (279)
T ss_pred ecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--c
Confidence 999999997653 4678888999999999999999999 999999999999999999999999999865433 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-------HHHHHhhccccccCC-CCCCcHH
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-------QVVGAVGFQNRRLEI-PKELDPL 905 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-------ei~~~I~~~~~~~~i-P~~lS~e 905 (960)
....+|+..|+|||++.+..++.++|+|||||++|+|++|..||...... .....+. ......+ ....+++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 228 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEK 228 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHH
Confidence 33467999999999999999999999999999999999999999764321 2222221 1112222 2357889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++||.+||..+|.+||++.+++++
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcC
Confidence 9999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=341.49 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=202.1
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------ 746 (960)
.++|++++.||.| .||+||++.. +++.||||++............+.+|+.+|++++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSG-AYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccC-CCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4679999999999 7999999975 678899999875443334455678999999999999999999987543
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+|+++|++ +++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCcccee
Confidence 3478999988 7899988864 35899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc------------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------ 893 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~------------ 893 (960)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 168 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 168 ADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred cCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 234678999999999987 568999999999999999999999998766544333321100
Q ss_pred ---------cccCCC--------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ---------RRLEIP--------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ---------~~~~iP--------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....++ ...++.+.+||.+||..||.+||++.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000111 2356778999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=330.75 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=211.4
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..+|++.+.||.| .||.||++.. +++.||+|.+....... ...+.+|+.+++.++|+||+++++.|......++|
T Consensus 19 ~~~y~~~~~lg~g-~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQG-ASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCC-CCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999 7999999975 68899999887654332 35678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++... .+++.++..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999999998653 4788999999999999999999999 99999999999999999999999999876543322
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-ccccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-~~~~~iP~~lS~eLkdLI~ 911 (960)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... ......+..++..+.+||.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 233457899999999999988999999999999999999999999887664433322211 1122345668899999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||.++|.+||++.+|+++
T Consensus 252 ~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHCcCCcccCcCHHHHhhC
Confidence 9999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.80 Aligned_cols=250 Identities=28% Similarity=0.471 Sum_probs=213.8
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
....|++++.||.| .||.||++.. +++.||||.+...... ....+.+|+.+++.++||||+++++++.....+++
T Consensus 17 ~~~~y~~~~~lg~g-~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQG-ASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CcceEEEEEEEecC-CCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 44679999999999 7999999974 7889999988654332 24567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
|+||+++++|..++.+. .+++.++..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999999998753 5899999999999999999999999 9999999999999999999999999988654433
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-ccccCCCCCCcHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARII 910 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-~~~~~iP~~lS~eLkdLI 910 (960)
.......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+... ......+..+++.+++||
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 3333457899999999999998999999999999999999999999987765544443221 112334667889999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||..+|.+||++.+|+++
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHhhcChhhCCCHHHHhhC
Confidence 99999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=328.27 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=209.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.+.||.| .||.||++.+ .+..||+|.+... ........+.+|+.++++++|+||+++++.+...+.+++||
T Consensus 1 ~~~~~~~~ig~g-~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKG-NYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred Chhhhhhhhccc-CCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 468899999999 7999999987 5889999988654 34445567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~--~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
||+++++|..++... ...+++..+..++.||+.||.|||. ++ |+||||||+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999998763 2368999999999999999999996 57 999999999999999999999999999765332
Q ss_pred cccCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--cccccCCCCCC
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIPKEL 902 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~------ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~--~~~~~~iP~~l 902 (960)
......|+..|+|||++.+.. ++.++|||||||++|+|++|..||...........+.. ......++..+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 223356888999999985543 57899999999999999999999987655444333211 23345567779
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.++++||.+||..+|.+||++.+++.+
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 9999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=325.13 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=207.7
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccc---
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVT--- 744 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~--- 744 (960)
+....++|++.+.||.| .||.||++.. +++.||+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g-~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKG-TYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccC-CCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34456889999999999 6999999976 678999998754321 224677899999999 7999999999873
Q ss_pred --cCCceEEEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 745 --RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 745 --~~~~l~LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
....+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEc
Confidence 44679999999999999998752 2346888999999999999999999998 9999999999999999999999
Q ss_pred ecCccccccCCcccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-
Q 002146 820 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN- 893 (960)
Q Consensus 820 DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g-----~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~- 893 (960)
|||+++.............|+..|+|||++.. ..++.++|||||||++|+|++|..||...........+....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence 99999876443333344578999999999853 447889999999999999999999998876654443332111
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 894 ~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~L 931 (960)
.....+..++..+.+||.+||..+|.+||++.+|+++.
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 12223556788999999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.70 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=199.3
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
...+|++++.||.| .||.||++.. .++.||||.+.... .+.+|+.+|++++|||||+++++|.....+
T Consensus 90 ~~~~y~i~~~Lg~G-~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPG-SEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCC-CCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34579999999999 7999999965 35679999865431 346899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++....
T Consensus 162 ~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999995 688888854 347899999999999999999999999 99999999999999999999999999976543
Q ss_pred Ccc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH---HHHHhhc-------------
Q 002146 830 TFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGF------------- 891 (960)
Q Consensus 830 ~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e---i~~~I~~------------- 891 (960)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .+..+..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 221 2234679999999999999999999999999999999999999998754321 0100000
Q ss_pred ------------ccccc--CCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 892 ------------QNRRL--EIP-----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 892 ------------~~~~~--~iP-----~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+. .+| ..++.++++||.+||..||.+||++.+++.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00011 111 2346789999999999999999999999986
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=324.22 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=208.7
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.+.||.| .||.||++.+ +|+.||||++............+.+|+.++++++||||+++++++.....+++|||
T Consensus 1 ~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEG-AHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccC-CCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58899999999 7999999986 68899999988765545556678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc-c
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-S 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~-~ 833 (960)
|+ +++|.+++......+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 99 99999998766567999999999999999999999999 99999999999999999999999999987644321 1
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-----------------
Q 002146 834 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------------- 895 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~----------------- 895 (960)
.....|+..|+|||++.+.. ++.++|||||||++|+|++|.+||.+.........+......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 23456899999999987644 689999999999999999999988876654433322110000
Q ss_pred c-----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 L-----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~-----------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. .+....+..+.+||.+||..+|.+||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0112456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=348.89 Aligned_cols=261 Identities=35% Similarity=0.532 Sum_probs=208.6
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc-eEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~-l~L 751 (960)
..++|.-..+||+| .||.||+|... |+.||||++....... ..+|.+|+.+|.+++|||+|+|+|||.+.+. .+|
T Consensus 73 AT~~Fs~~~~ig~G-gfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 73 ATNNFSESNLIGEG-GFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HHhCCchhcceecC-CCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 34677778899999 49999999875 4899999876554332 3469999999999999999999999999984 999
Q ss_pred EEeecCCCCHHHHhhCCCC-CCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 752 ITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~-~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+|||+.|+|.++|+.... .++|..+++|+.++++||+|||.. .++|||||||+.|||||++.+.||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999988666 889999999999999999999984 44799999999999999999999999999976543
Q ss_pred CcccCCCC-CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHH---hhccc-----cccC
Q 002146 830 TFLSSKST-AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGA---VGFQN-----RRLE 897 (960)
Q Consensus 830 ~~~~~~t~-~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~---~~ei~~~---I~~~~-----~~~~ 897 (960)
........ .||..|+|||.+..+..+.++||||||+++.||++|+.+..... ...+..+ ..... ..+.
T Consensus 230 ~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 230 GDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred cccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 11112222 79999999999999889999999999999999999998887532 1112221 11010 0111
Q ss_pred CC-CCCc--HH---HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 898 IP-KELD--PL---VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 898 iP-~~lS--~e---LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+. ..++ .. +..+..+|++.+|.+||++.|+++.|+.+...
T Consensus 310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 11 2222 22 56677899999999999999999999776544
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.06 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=215.8
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
..++|++.+.||.| .||.||++++ ....|++|.+.... .......+.+|+++|++++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRG-EFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeeccc-ceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 45689999999999 6999999985 24568999775432 233456789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCC--------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEE
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH--------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 818 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~--------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL 818 (960)
...++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEE
Confidence 99999999999999999987543 15889999999999999999999999 999999999999999999999
Q ss_pred EecCccccccCC-cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcccccc
Q 002146 819 SDFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 896 (960)
Q Consensus 819 ~DFGLAr~~~~~-~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~ 896 (960)
+|||+++..... ........++..|++||.+.+..++.++||||||+++|+|++ |..||.+....+....+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 999998754322 112233456778999999998889999999999999999998 889998887777776665444344
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 897 ~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
..+..++..+.++|.+||..+|.+||++.+++..|.+
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 4566788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=319.57 Aligned_cols=250 Identities=32% Similarity=0.469 Sum_probs=212.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++++.||.| .||+||++.+ ++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.....+++||
T Consensus 1 ~~y~~~~~lg~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVG-ATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCC-CCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 479999999999 6999999986 67889999987554433 5668899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 754 EFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~--~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||+++++|.+++.... ..+++..+..++.||+.||.|||+.| |+||||||+||++++++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999997642 36899999999999999999999998 9999999999999999999999999987654332
Q ss_pred cc----CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC-----CC
Q 002146 832 LS----SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-----KE 901 (960)
Q Consensus 832 ~~----~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP-----~~ 901 (960)
.. .....|+..|++||++... .++.++|+|||||++|+|++|..||...+..+....+... ....++ ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKK 235 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCcccccc
Confidence 21 2344689999999998877 7899999999999999999999999988776655544322 122222 25
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++..+++|+.+||..+|.+||++.+|+++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 67899999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=326.54 Aligned_cols=254 Identities=31% Similarity=0.511 Sum_probs=208.1
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC--C
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--P 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~ 747 (960)
.-|++.+.||+| .||.||++++ .+..||+|.+.... .......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEG-HFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCC-CceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 347889999999 6999999974 47789999886443 334456789999999999999999999988775 5
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
..++||||+++++|.+++.+....+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCcccccc
Confidence 689999999999999999765556899999999999999999999999 999999999999999999999999999875
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------hhHHHHHh
Q 002146 828 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------------PMQVVGAV 889 (960)
Q Consensus 828 ~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~---------------~~ei~~~I 889 (960)
..... ......++..|+|||++.+..++.++|||||||++|+|++++.|+.... .......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 43211 1123457778999999998889999999999999999999876653211 01111111
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 890 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 890 ~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
........+..++..+.+||.+||+.+|.+||++.++++.|+.+
T Consensus 240 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 -EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 12233445667899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=325.77 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=206.5
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEeccccc-----
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----- 745 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~----- 745 (960)
+...|++.+.||.| .||.||++++ .++.||+|++... ......+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g-~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNG-TYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccC-CCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 44678999999999 6999999986 6788999987543 23345678899999999 79999999999853
Q ss_pred -CCceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 746 -PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 746 -~~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
...++++|||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcc
Confidence 45789999999999999998753 235788889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i 898 (960)
+..............|+..|+|||++. +..++.++|||||||++|+|++|..||....+......+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 247 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence 876543323334567899999999986 345788999999999999999999999887665544433222222223
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+..++.++.+||.+||..||.+||++.+|+++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 34678999999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.40 Aligned_cols=248 Identities=32% Similarity=0.540 Sum_probs=210.9
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.+.||.| .||.||++.. +++.|++|.+............+.+|+.++++++|+||+++++.+.....+++|+|
T Consensus 1 ~y~~~~~lg~G-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGG-TFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecC-CCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 48899999999 7999999976 68899999988766555567789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 999999999997653 5788899999999999999999999 9999999999999999999999999998764332211
Q ss_pred ----CCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhccccccCCCCCC--cH
Q 002146 835 ----KSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKEL--DP 904 (960)
Q Consensus 835 ----~t~~GT~~Y~APEvl~g~~---ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~~~~~~~iP~~l--S~ 904 (960)
....++..|++||++.+.. ++.++|||+||+++|+|++|+.||..... ......+. ....+.+|... +.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSP 235 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccCH
Confidence 1356788999999998776 88999999999999999999999977633 23333332 23344555544 89
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
.+.+||.+||+.+|.+||++.+++.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=318.75 Aligned_cols=250 Identities=28% Similarity=0.490 Sum_probs=214.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|.+.+.||.| .||.||++.+ +|..||+|.+............+.+|+.+++.++|+||+++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEG-SFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCC-CcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 48899999999 6999999976 67889999987654444455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-cEEEEecCccccccCCcc
Q 002146 755 FLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-~VKL~DFGLAr~~~~~~~ 832 (960)
|+++++|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++ .+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999999987643 35789999999999999999999998 99999999999999876 469999999987654332
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+. ......++..++.+++++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHH
Confidence 3334568999999999998889999999999999999999999998877776665553 223334556678899999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
||..+|.+||++.+++++
T Consensus 237 ~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 237 LFKVSPRDRPSITSILKR 254 (257)
T ss_pred HhccChhhCcCHHHHhhC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=344.02 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=220.7
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEECC--cEEEEEEeecCCCCh-HHHHHHHHHHHHHHHc-CCCceeeEecccccCC
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG--TEVAVKKFLDQDFSG-AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 747 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g--~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~ 747 (960)
.|...+|..+.+||+| +||+|.+++.+| +.||||++++..+.+ +..+-...|.++|... +-|++++++..|++-+
T Consensus 345 ~i~~tDFnFl~VlGKG-SFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKG-SFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ceeecccceEEEeccC-ccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 4666889999999999 899999998754 569999988765433 3333446788888776 6789999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
++|+||||+.||+|--+|+..+ ++-|..+..++.+|+-||-+||++| ||+||||..|||++.+|+|||+|||+++.-
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred heeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999999998765 6788888889999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
......+.++|||+.|+|||++..++|+.++||||+|++||||+.|++||.+.+..++++.|. .....+|+.++.++.
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--ehnvsyPKslSkEAv 578 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--EHNVSYPKSLSKEAV 578 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HccCcCcccccHHHH
Confidence 555667788999999999999999999999999999999999999999999999999999994 557889999999999
Q ss_pred HHHHHhhhhCCCCCCCH
Q 002146 908 RIIWECWQTDPSLRPSF 924 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa 924 (960)
++++.+|.++|.+|...
T Consensus 579 ~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLGC 595 (683)
T ss_pred HHHHHHhhcCCccccCC
Confidence 99999999999999643
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=323.49 Aligned_cols=255 Identities=32% Similarity=0.515 Sum_probs=211.3
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEEC------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--C
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--P 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~~------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~--~ 746 (960)
.++|++.+.||.| .||.||+++++ +..||||++...... .....+.+|+++++.++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g-~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEG-HFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccC-CCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3568888999999 69999999863 678999998755432 345688999999999999999999999877 5
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
...++||||+++++|.+++.+....+++..++.++.||+.||+|||++| |+||||||+|||++.++.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 6799999999999999999876667999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH---------------HHHH
Q 002146 827 KHNTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------------VVGA 888 (960)
Q Consensus 827 ~~~~~~~---~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e---------------i~~~ 888 (960)
....... .....++..|++||.+.+..++.++||||||+++|||++|..||....... +...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532111 112234567999999998899999999999999999999999987642211 1111
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 889 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 889 I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+. ...+...+..++.++.+|+.+||+.+|.+||++.+|++.|+++
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 21 2233344566788999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=320.88 Aligned_cols=251 Identities=31% Similarity=0.469 Sum_probs=207.5
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCC---
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP--- 747 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~--- 747 (960)
..++|++.+.||.| .||.||++.. +++.|++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEG-TYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCC-CCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45789999999999 7999999987 577899998875432 345788999999999 7999999999986644
Q ss_pred ---ceEEEEeecCCCCHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEec
Q 002146 748 ---NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821 (960)
Q Consensus 748 ---~l~LVmEY~~gGsL~dlL~k~---~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DF 821 (960)
.+++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCC
Confidence 489999999999999988653 357899999999999999999999999 999999999999999999999999
Q ss_pred CccccccCCcccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-c
Q 002146 822 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-R 895 (960)
Q Consensus 822 GLAr~~~~~~~~~~t~~GT~~Y~APEvl~g-----~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-~ 895 (960)
|++..............|+..|+|||++.. ..++.++|||||||++|+|++|..||...........+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 999866544333345668999999999854 3467899999999999999999999987765555444432211 1
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+..++.++++||.+||..||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 12233477899999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=371.11 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=209.6
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--C
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--P 746 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~--~ 746 (960)
.+....+|++++.||.| .||+||++++ .+..||+|++............+..|+.+|++|+|||||+++++|.. .
T Consensus 8 ge~~l~~YeIl~kLG~G-gFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNG-RFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecC-CCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34556799999999999 7999999986 57789999988776666667788999999999999999999998854 4
Q ss_pred CceEEEEeecCCCCHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHhhCC-----CCEEEeccCCCcEEEcC------
Q 002146 747 PNLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTST-----PTIVHRDLKSPNLLVDK------ 812 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~---~~~lse~~~~~Ia~QIa~AL~YLHs~g-----~~IIHRDLKPeNILLd~------ 812 (960)
..+||||||+++++|.++|... ...+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5699999999999999998652 246899999999999999999999854 34999999999999964
Q ss_pred -----------CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002146 813 -----------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIG 879 (960)
Q Consensus 813 -----------~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF~~ 879 (960)
.+.+||+|||++...... ......+||+.|+|||++.+ ..++.++||||||||||+|++|..||..
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 345999999999865433 22334679999999999865 4488999999999999999999999987
Q ss_pred CChhHHHHHhhccccccCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 880 MNPMQVVGAVGFQNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 880 ~~~~ei~~~I~~~~~~~~iP-~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+....+...... .+.+| ..++.++.+||..||..+|.+||++.++|.+
T Consensus 246 ~~~~~qli~~lk~--~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNFSQLISELKR--GPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcHHHHHHHHhc--CCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 6544333222111 22232 4578999999999999999999999999954
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.48 Aligned_cols=250 Identities=29% Similarity=0.496 Sum_probs=221.0
Q ss_pred CeEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|.+.+.||.| .||.||++.+. +..|++|++............+.+|+++++.++|+|++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKG-SFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccC-CCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999 69999999874 8899999988766555666788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 755 FLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 755 Y~~gGsL~dlL~k~---~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
|+++++|.+++.+. ...+++..++.++.+++.||.|||+.| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998764 357899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
.......|++.|+|||.+.+..++.++|+|+||+++|+|++|..||...+..++...+. ......++..++..+.++|.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHH
Confidence 23344578999999999999999999999999999999999999998888777666654 33355667788999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||..+|.+||++.+++++
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 237 SLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHcCCChhhCcCHHHHhcC
Confidence 9999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=334.85 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=201.9
Q ss_pred EEEEeeccC-CeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeec
Q 002146 680 LGERIGLGS-SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 680 i~k~LG~GG-sFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
++++||+|+ .|++||++.. +|+.||||++............+.+|+.+++.++||||++++++|..++.+++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 457799983 3789999975 6899999998766555555667888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc---
Q 002146 757 PRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--- 832 (960)
Q Consensus 757 ~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~--- 832 (960)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999998653 235889999999999999999999999 99999999999999999999999986544321110
Q ss_pred ----cCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-----------
Q 002146 833 ----SSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 895 (960)
Q Consensus 833 ----~~~t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~----------- 895 (960)
......++..|+|||++.+ ..++.++|||||||++|||++|..||......+...........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1122356778999999976 45899999999999999999999999876543332221100000
Q ss_pred ---------------------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 002146 896 ---------------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 935 (960)
Q Consensus 896 ---------------------------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--Le~i~ 935 (960)
..+...+++.+++||.+||+.||.+||++.+++++ ++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00112356789999999999999999999999873 55543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.84 Aligned_cols=247 Identities=30% Similarity=0.488 Sum_probs=213.7
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.|+..++||.| .||.||++.+ ++..||||++..... ......+.+|+.++++++|+||+++++.+.+....++|||
T Consensus 5 ~y~~~~~lg~g-~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKG-SFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccC-CCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 47788899999 6999999976 578999998875432 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 99999999998753 5888899999999999999999998 9999999999999999999999999997765433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhh
Q 002146 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 914 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL 914 (960)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......+. ....+.++..++..+.+||.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHc
Confidence 44568899999999999889999999999999999999999999887766655442 23344556678889999999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 002146 915 QTDPSLRPSFAQLTVA 930 (960)
Q Consensus 915 ~kDP~kRPSa~eILe~ 930 (960)
..+|.+||++.+++++
T Consensus 238 ~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 238 NKDPSFRPTAKELLKH 253 (277)
T ss_pred ccCcccCcCHHHHHhC
Confidence 9999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.29 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=206.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
+..+.+.....||+| .||.||++++ ++..||+|.+.... ......+.+|+.++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKG-TYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecC-CceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 344455555689999 6999999975 56789999876543 234457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCC--cHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-CCcEEEEecCccccc
Q 002146 751 IITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLK 827 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~l--se~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr~~ 827 (960)
+|+||+++++|.+++......+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. .+.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999997643344 78888899999999999999998 999999999999986 679999999998765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHhhccccccCCCCCCcH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~--ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e-i~~~I~~~~~~~~iP~~lS~ 904 (960)
...........|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||....... ....+......+.+|..+++
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 43322233456889999999987644 7899999999999999999999997654322 22222222344567788899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++++|+.+||..+|.+||++.+++++
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=325.21 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=206.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.++||.| .||.||++.+ .++.||+|++............+.+|+++++.++||||+++++++.....+++||
T Consensus 1 ~~y~~~~~lg~g-~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEG-SYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccC-CCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 468999999999 6999999987 5789999987655443334456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||++++.|..+..... .+++..++.++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 9999999988876543 5899999999999999999999998 999999999999999999999999999876443333
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc------------------
Q 002146 834 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------ 894 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~------------------ 894 (960)
.....++..|+|||++.+. .++.++||||||+++|+|++|.+||......+....+.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 3445688999999998764 478899999999999999999999977654333222211000
Q ss_pred --cc---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 --RL---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 --~~---------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+ .....++..+++|+.+||..+|.+||++.+|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 0123567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=357.52 Aligned_cols=267 Identities=30% Similarity=0.472 Sum_probs=230.1
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
|.-++.||.| +||.||.+++ +.+.||||++....- ..+.+..+..|+..|++++|||+|.+-|+|..+...|||||
T Consensus 28 f~dLrEIGHG-SFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHG-SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHhcCC-ccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 5556779999 8999999975 788899999887653 35677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|| -|+-.|++.-.+..+.+.++..|+.+.+.||.|||+++ .||||||..|||+++.|.|||+|||.|.... ..
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----PA 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMA----PA 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcC----ch
Confidence 99 56888888776778999999999999999999999999 9999999999999999999999999997653 34
Q ss_pred CCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC-CCCcHHHHHHH
Q 002146 835 KSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-KELDPLVARII 910 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP-~~lS~eLkdLI 910 (960)
++++|||+|||||+|. .+.|+-++|||||||+..||...++|++.++.+..+-.|. ++..+.++ ..++..+++||
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-QNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-hcCCCCCCCchhHHHHHHHH
Confidence 6799999999999985 3569999999999999999999999999999988888887 34455554 46889999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHH------------------------------HHhHHhhCCCCCCCCCCCCCCc
Q 002146 911 WECWQTDPSLRPSFAQLTVAL------------------------------KPLQRLVIPSHPDQPSSALPQE 953 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~L------------------------------e~i~~~~~p~~P~~p~~~~~~~ 953 (960)
..||++-|.+||+.++++++- +++.+.++...|+-|-..++++
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTKdaVrELDNlqYrKMkKilf~e~~ng~~ae~~e~ 331 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQEAPNGPGAEGPEE 331 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHHHHHHHhhhhhHHHHHHHHhhccCCCCCCCCCch
Confidence 999999999999999887653 3445566777777666655544
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.90 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=211.4
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..+|++.+.||.| .||.||++.. +++.||||.+...... ....+.+|+.+++.++|+||++++++|.....+++|
T Consensus 18 ~~~y~~~~~lg~g-~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQG-ASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccC-CCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3679999999999 7999999975 6899999998754332 235678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred ecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999999998753 4788899999999999999999998 99999999999999999999999999976544333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-ccccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-~~~~~iP~~lS~eLkdLI~ 911 (960)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+... ......+..++..+++||.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 333457899999999999998999999999999999999999999876654433222211 1122345678899999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||..+|.+||++.+|+++
T Consensus 251 ~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=327.06 Aligned_cols=247 Identities=27% Similarity=0.471 Sum_probs=211.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.|++.+.||.| .||.||++.+ +++.||||.+..... ......+.+|+.++++++||||+++++++.....+++|||
T Consensus 5 ~y~~~~~l~~g-~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKG-SFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCC-CCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 35667789999 7999999976 578899998765432 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999999999865 35889999999999999999999998 9999999999999999999999999997664433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhh
Q 002146 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 914 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL 914 (960)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+. ....+.++..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 34568899999999999999999999999999999999999998776665554442 22344455667889999999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 002146 915 QTDPSLRPSFAQLTVA 930 (960)
Q Consensus 915 ~kDP~kRPSa~eILe~ 930 (960)
..+|.+||++.+++++
T Consensus 238 ~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 238 NKDPRFRPTAKELLKH 253 (277)
T ss_pred cCCcccCcCHHHHHHh
Confidence 9999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=321.36 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=212.3
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
+|++.+.||.| .||.||++++ +++.||+|++....... .....+.+|++++++++||||+++++.+.....+++|+
T Consensus 1 ~y~~~~~i~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKG-AFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccC-CCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 48899999999 6999999987 48899999987654432 45678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||+.+++|.+++.+. ..+++..+..++.||+.||.|||.++ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 155 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-L 155 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-c
Confidence 999999999999775 46889999999999999999999999 9999999999999999999999999998764432 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~---~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ....... ......+|..++..+.++|
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAI 233 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHH
Confidence 3345688999999999998899999999999999999999999998763 3333322 1145667788899999999
Q ss_pred HHhhhhCCCCCCCH--HHHH
Q 002146 911 WECWQTDPSLRPSF--AQLT 928 (960)
Q Consensus 911 ~kcL~kDP~kRPSa--~eIL 928 (960)
.+||..+|.+||++ .+++
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHccCChhHcCCccHHHHh
Confidence 99999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.58 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=207.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.+.||.| .||.||++.+ +++.||||++............+.+|++++++++|+||+++++++...+.+++||
T Consensus 1 ~~y~~~~~i~~g-~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEG-AYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEeccc-CCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 368999999999 6999999986 5789999988765444444567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 832 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~- 832 (960)
||++++.|..++.+. ..+++..++.++.||+.||.|||..+ |+||||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 999987777666543 45899999999999999999999998 99999999999999999999999999987654432
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-------------------
Q 002146 833 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------------- 892 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~------------------- 892 (960)
......++..|+|||++.+. .++.++||||||+++|+|++|.+||.+....+....+...
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 23345688999999999888 7899999999999999999999999876544332221100
Q ss_pred c-c----------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 N-R----------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 ~-~----------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. . ...++..++.++++||.+||..+|.+||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0 001233458899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.49 Aligned_cols=249 Identities=31% Similarity=0.485 Sum_probs=215.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.+.||.| .||.||++.. +++.|+||++...... .....+.+|+.++.+++|+||+++++++.....+++||
T Consensus 1 ~~~~~~~~i~~g-~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQG-SSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred Ccceeeeeeeec-CCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 368899999999 6999999976 5889999998765432 44567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
||+++++|.+++... ..+++..++.++.||+.||.|||+ .+ ++||||+|+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999999999765 468999999999999999999999 88 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHhhccccccCCCCC-CcHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRLEIPKE-LDPLVAR 908 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~---~~ei~~~I~~~~~~~~iP~~-lS~eLkd 908 (960)
......++..|+|||.+.+..++.++|+|+||+++|+|++|..||.... ..+....+. ......++.. ++..+.+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHH
Confidence 3334568899999999999999999999999999999999999998773 444444443 3334455566 8899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
+|.+||..+|.+||++.+++++
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=355.19 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=226.3
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
...|.+.+.||+| .|++|.++++ ++..||||.+.+..........+.+|+++|+.|+|||||+++.+.+.+..+|+|
T Consensus 55 vg~y~i~~tig~g-~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKG-NFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccc-eeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3568999999999 8999999986 799999999998888777777799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+.+|.+++++.+.+ ...+.....++.|++.|++|||+++ |||||||.+||||+.+.++||+|||++..+... .
T Consensus 134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDYG-L 209 (596)
T ss_pred EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeeccc-c
Confidence 99999999999999877 4555888899999999999999999 999999999999999999999999999987643 4
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
...++||++.|.|||++.+..| ++.+|+|+||+++|.|+.|..||.+.+...+....... +..+|..++.++.+||+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--k~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--KYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--eecccceeechhHHHHH
Confidence 4677999999999999999987 68999999999999999999999998887777666433 55667779999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
++|..+|.+|+++++|.++
T Consensus 288 k~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred HhhccCccccCCHHHhhhh
Confidence 9999999999999999875
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.75 Aligned_cols=246 Identities=27% Similarity=0.447 Sum_probs=222.2
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|.++++||+| +||.||++.+ .|..||||++... ..+.++..|+.||++++.|+||++||.|.....+|+||||
T Consensus 35 FDi~~KLGEG-SYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEG-SYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCC-cchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 6678899999 8999999965 7999999987543 3466889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~ 835 (960)
|..|++.++++.+...+.+.++..+++..++||+|||... -||||||..|||++.+|+.||+|||.|..+.......+
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9999999999988889999999999999999999999987 89999999999999999999999999998877777778
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC--CCCCcHHHHHHHHHh
Q 002146 836 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARIIWEC 913 (960)
Q Consensus 836 t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i--P~~lS~eLkdLI~kc 913 (960)
+..||+.|||||++..-.|+.++||||||++..||..|++||.+..+.....-|.. +.++.| |..++.++.+||++|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-CCCCCCCChHhhhhHHHHHHHHH
Confidence 88999999999999999999999999999999999999999999988877666642 223333 566889999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~L 931 (960)
|.+.|++|.++.+++++-
T Consensus 267 LiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHT 284 (502)
T ss_pred hcCCHHHHHHHHHHhhhh
Confidence 999999999999998863
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.40 Aligned_cols=250 Identities=24% Similarity=0.301 Sum_probs=206.0
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~---~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
+|++++.||.| .||.||++.+ +++.||||++...... ......+..|+.++++++|+||+++++++.+...+++
T Consensus 1 ~y~~~~~lg~g-~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEG-TYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred Cceeeeeeeec-cccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 47889999999 6999999986 5889999998765443 2334467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+ +++|.+++......+++..++.++.||+.||.|||.+| |+||||||+|||++.++.+||+|||+++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 99999 89999999775557899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc----------------
Q 002146 832 LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------------- 894 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~---------------- 894 (960)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+....+....+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 33334457889999999865 4578999999999999999999888887665443333211000
Q ss_pred -----ccC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 -----RLE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 -----~~~-----iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
... .....+..+.+||.+||.++|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 113456789999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.92 Aligned_cols=254 Identities=25% Similarity=0.347 Sum_probs=210.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++.+.||.| .||.||++.+ .++.||||.+...... ......+.+|+.+++.++||||+++++.+.....+++|
T Consensus 1 ~~y~~~~~l~~g-~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNG-AYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecC-CCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 468999999999 7999999986 5778999988765332 23455788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC--
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 830 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~-- 830 (960)
|||++|++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999999997654 6889999999999999999999998 999999999999999999999999998742110
Q ss_pred -------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-c
Q 002146 831 -------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-L 896 (960)
Q Consensus 831 -------------~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~-~ 896 (960)
........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+....++...+...... +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 00112345788999999999988999999999999999999999999988877776665432211 2
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 897 ~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
..+..++.++++||.+||.++|.+||++.++++.|+.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 2223578999999999999999999996655555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=321.49 Aligned_cols=248 Identities=30% Similarity=0.460 Sum_probs=210.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.+.||.| .||.||++.+ +++.||+|.+..... .....++.+|++++++++||||+++++.+.....+++++
T Consensus 1 ~~~~~~~~ig~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAG-NSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCC-CCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 367888999999 7999999987 488999998876533 345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
||+++++|.+++......+++..+..++.|++.||+|||+ .+ ++||||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999999998754578999999999999999999999 88 99999999999999999999999999876543321
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHhhccccccCCCCC-CcHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-----PMQVVGAVGFQNRRLEIPKE-LDPLV 906 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~-----~~ei~~~I~~~~~~~~iP~~-lS~eL 906 (960)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+. ....+.++.. ++.++
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDF 233 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHH
Confidence 12678899999999999999999999999999999999999997652 223333332 2234445554 88999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++||.+||..+|.+||++.+++.+
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhC
Confidence 999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.58 Aligned_cols=243 Identities=27% Similarity=0.368 Sum_probs=197.4
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----ce
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NL 749 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~-----~l 749 (960)
.|...+++|.| +||.||.+.. +++.||||+.....-- -.+|+.+|+.++|||||+++.+|.... ++
T Consensus 25 ~~~~~~liG~G-sFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSG-SFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeec-ccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 47788999999 8999999976 6789999987654321 137999999999999999998875322 45
Q ss_pred EEEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-CCcEEEEecCccc
Q 002146 750 SIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSR 825 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr 825 (960)
.+||||++. +|.++++. .+..++...++-+.+||++||.|||..| |+||||||.|||||. .|.+||||||.|+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 689999965 89988873 2456888888889999999999999998 999999999999995 4999999999999
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc----------
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------- 894 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~---------- 894 (960)
...... ...+...|..|+|||.+.|.. |+.+.||||.||++.||+-|++-|.|.+..+.+..|...-.
T Consensus 175 ~L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 175 VLVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 876543 335567799999999998865 89999999999999999999999999766544333221000
Q ss_pred --c------c---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 --R------L---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 --~------~---------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. + .+....++++.+|+.++|..+|.+|.++.|++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 0 0234578999999999999999999999988854
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=347.27 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=215.3
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHH-HHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAA-LLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~-~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+..+.|..-++||+|| ||.||-++. +|+.||+|++.+..+.... ..-..+|..||.+++.++||.+-.+|++.+
T Consensus 180 qpvt~n~F~~~RvlGkGG-FGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGG-FGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hhccccceeeeEEEeccc-ccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 356778899999999995 999999864 8999999988766554332 224578999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+++||..|+||+|.-+|.+.+ ..|++.+++.++.+|+.||++||+.+ ||+|||||+|||+|+.|+|+|.|+|||..
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999999999887654 47999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHhhccccccCCCCCC
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~----ei~~~I~~~~~~~~iP~~l 902 (960)
+... ......+||.+|||||++.++.|+...|||+|||+||||+.|+-||...... ++-+.+ ......+|..+
T Consensus 337 i~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--~~~~~ey~~kF 413 (591)
T KOG0986|consen 337 IPEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--LEDPEEYSDKF 413 (591)
T ss_pred cCCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--hcchhhccccc
Confidence 7554 3344568999999999999999999999999999999999999999764332 232333 34566788999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFA 925 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~ 925 (960)
++++++|.+.+|.+||.+|....
T Consensus 414 S~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccCC
Confidence 99999999999999999998654
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=311.69 Aligned_cols=248 Identities=31% Similarity=0.564 Sum_probs=218.3
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.+.||.| .||.||++.. .++.|+||.+............+.+|++++++++|+||+++++++.....++++||
T Consensus 1 ~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRG-AFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEccc-CCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 47889999999 7999999976 57889999998776655667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+++++|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 99999999998765 46899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhh
Q 002146 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 914 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL 914 (960)
....++..|+|||.+.+..++.++|||+||+++|+|++|..||...+.......+. ......++..++..++++|.+||
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 235 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCF 235 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHH
Confidence 44578999999999988888999999999999999999999998877655555443 33455677788999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 002146 915 QTDPSLRPSFAQLTV 929 (960)
Q Consensus 915 ~kDP~kRPSa~eILe 929 (960)
..+|++||++.+++.
T Consensus 236 ~~~p~~R~~~~~~l~ 250 (254)
T cd06627 236 QKDPNLRPTAKQLLK 250 (254)
T ss_pred hCChhhCcCHHHHhc
Confidence 999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=330.92 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=211.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF------SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~------~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
..|.-.+.||.| .-..|.++.+ +|..+|+|++..... .....+...+|+.||+++ .||+|++++++|+.+
T Consensus 17 ~~y~pkeilgrg-vss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 17 AKYEPKEILGRG-VSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred hhcChHHHhccc-chhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456667789999 4667766643 788999998864321 122345567899999999 899999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+++|+|.|+.|.|+|+|... -.++|+...+|++|+++|++|||..+ ||||||||+|||++++.++||.|||++..
T Consensus 96 sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceeec
Confidence 9999999999999999999764 37999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC--
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-- 898 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g------~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i-- 898 (960)
+... ..-...|||++|+|||.+.. ..|+..+|+|++|+|+|.|+.|.+||......-++..|...+....-
T Consensus 173 l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 173 LEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred cCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 7554 33456899999999999854 34788999999999999999999999998877777777544333222
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.+++...++||.+||..||.+|.|++|.|.+
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 35688999999999999999999999999875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.33 Aligned_cols=246 Identities=31% Similarity=0.523 Sum_probs=206.7
Q ss_pred EeeccCCeeEEEEEEECC--------cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 683 RIGLGSSYGEVYHADWNG--------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~~g--------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.||.| .||.||++++.. ..||||.+... ........+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~lg~g-~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSG-AFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccc-cceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 58999 699999997632 57999987543 223345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCC------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-----cEEEEecCc
Q 002146 755 FLPRGSLFRILHRP------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-----NVKVSDFGL 823 (960)
Q Consensus 755 Y~~gGsL~dlL~k~------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-----~VKL~DFGL 823 (960)
|+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++ .+||+|||+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999998642 234788899999999999999999998 99999999999999877 899999999
Q ss_pred cccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 824 SRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 824 Ar~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+. .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 236 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPE 236 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCcc
Confidence 976532211 1122345788999999999999999999999999999998 999998887777666654 334556677
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
.++..+.+||.+||..+|.+||++.+|++.|++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 789999999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.50 Aligned_cols=253 Identities=26% Similarity=0.335 Sum_probs=206.9
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC--Cce
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 749 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~l 749 (960)
..++|++.+.||.| .||.||++.. +|+.||+|++............+.+|+.++++++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g-~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEG-TYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeec-CCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 45789999999999 7999999976 688999999875543333333566899999999999999999998654 568
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++||||+.+ +|.+++......+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999999964 888888765567899999999999999999999999 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc--------------
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------- 894 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-------------- 894 (960)
.........++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 3222333446888999999876 4578999999999999999999999998877665544321100
Q ss_pred ---ccCCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 ---RLEIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ---~~~iP-----------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...++ ...++++.+||.+||..||.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00011 1257889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.91 Aligned_cols=242 Identities=23% Similarity=0.337 Sum_probs=186.9
Q ss_pred EEEeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--CCceEEEEe
Q 002146 681 GERIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIITE 754 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~--~~~l~LVmE 754 (960)
+++||+| .||+||++++ .++.||||.+...... ..+.+|+.+|++++||||+++++++.. ...++++||
T Consensus 6 ~~~lG~G-~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRG-TYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccC-CCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 4679999 7999999975 4578999988654332 246789999999999999999998854 456899999
Q ss_pred ecCCCCHHHHhhCC--------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE----cCCCcEEEEecC
Q 002146 755 FLPRGSLFRILHRP--------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFG 822 (960)
Q Consensus 755 Y~~gGsL~dlL~k~--------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL----d~~g~VKL~DFG 822 (960)
|+. ++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+|||+ +..+.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 995 5888877531 125888999999999999999999999 9999999999999 456889999999
Q ss_pred ccccccCCcc---cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChh---------HHHHHh
Q 002146 823 LSRLKHNTFL---SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------QVVGAV 889 (960)
Q Consensus 823 LAr~~~~~~~---~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---------ei~~~I 889 (960)
+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||...... .....+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 9987643321 22346789999999999874 5899999999999999999999999753321 001100
Q ss_pred hc-cccc-----------c------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 890 GF-QNRR-----------L------------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 890 ~~-~~~~-----------~------------------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. ...+ + ......+..+.+||.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000 0 0001234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.24 Aligned_cols=245 Identities=27% Similarity=0.445 Sum_probs=196.1
Q ss_pred EeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 683 RIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
.||+| .||.||++.. ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+.+...+++||||+++
T Consensus 2 ~lg~G-~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNG-WFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCcc-CCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999 7999999964 23468888765432 334455788999999999999999999999999999999999999
Q ss_pred CCHHHHhhCCCC----CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc--c
Q 002146 759 GSLFRILHRPHC----QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--L 832 (960)
Q Consensus 759 GsL~dlL~k~~~----~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~--~ 832 (960)
|+|.+++..... ..++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999875432 3467778899999999999999999 9999999999999999999999999987543221 1
Q ss_pred cCCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcccc----ccCCCC
Q 002146 833 SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR----RLEIPK 900 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g-------~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~----~~~iP~ 900 (960)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+..... .+.++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 1223446778999999743 356889999999999999999 7889988776655444322211 123345
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
.++..+.+++..|| .||.+||++++|++.|.
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 67889999999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.88 Aligned_cols=253 Identities=29% Similarity=0.515 Sum_probs=210.2
Q ss_pred eEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----
Q 002146 678 LVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----- 747 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~----- 747 (960)
|.+.+.||+| .||.||++.+ ++..||||++...........++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g-~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKG-EFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCC-CCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 5678899999 6999999975 3678999998766555666778899999999999999999999875432
Q ss_pred -ceEEEEeecCCCCHHHHhhCC-----CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEec
Q 002146 748 -NLSIITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821 (960)
Q Consensus 748 -~l~LVmEY~~gGsL~dlL~k~-----~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DF 821 (960)
..++++||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECcc
Confidence 247889999999999886421 124788889999999999999999998 999999999999999999999999
Q ss_pred CccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCC
Q 002146 822 GLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 822 GLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~i 898 (960)
|+++....... ......++..|++||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.. ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 236 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-GNRLKQ 236 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCcCCC
Confidence 99986543211 1222345678999999999999999999999999999999 8999988877766655542 233445
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+..++..+.+++.+||..+|.+||++.++++.|+.+
T Consensus 237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 566789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.07 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=217.1
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.++||.| .||.||++++ +++.||||.+...........++.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~y~~~~~i~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKG-SYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCC-CceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 48899999999 7999999976 67889999988766556666788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 755 FLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 755 Y~~gGsL~dlL~k~---~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
|+++++|.+++.+. ...+++..++.++.|++.||.|||+.| ++||||+|.||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999988652 246888999999999999999999999 999999999999999999999999999876544
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+. ......++..++.+++++|.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHH
Confidence 2234568899999999999999999999999999999999999999888776665553 33344556678899999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||..+|.+||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 235 SMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHcCCCcccCCCHHHHhcC
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=357.93 Aligned_cols=248 Identities=29% Similarity=0.458 Sum_probs=218.9
Q ss_pred CeEEEEEeeccCCeeEEEEEEECCc--EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~g~--~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.|.|+..||.| +||+||++..... ..|.|+|... .++.+..+.-||.||..+.||+||+|+++|..++.++|+.|
T Consensus 33 ~WeIiGELGDG-AFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDG-AFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCc-cchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 46777889999 8999999976433 3466776433 35667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
||.||-+..++-.-+..+.+.++..+++|++.||.|||+.+ |||||||..|||++-+|.|+|+|||.+..........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999998888889999999999999999999999999 9999999999999999999999999986654444556
Q ss_pred CCCCCCCCccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC--CCCCCcHHHH
Q 002146 835 KSTAGTPEWMAPEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVA 907 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl-----~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~--iP~~lS~eLk 907 (960)
.++.||++|||||++ .+.+|++++||||||++|.||..+.+|-...+++.++-+|.... ++. -|..++..++
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-PPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTLLQPSHWSRSFS 266 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-CCcccCcchhhhHHH
Confidence 779999999999986 55789999999999999999999999999999999998886433 333 3778999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+|+++||.+||..||++.+|+++
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhhC
Confidence 99999999999999999999875
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=309.39 Aligned_cols=250 Identities=34% Similarity=0.549 Sum_probs=217.4
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC--CceEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSII 752 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~l~LV 752 (960)
+|.+.+.||.| .+|.||++.. +++.|++|++............+.+|+.++++++|+||+++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRG-SFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeec-CceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 47888999999 6999999987 488999999877655455677889999999999999999999999888 889999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
+||+++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 99999999999998754 7899999999999999999999998 99999999999999999999999999987654432
Q ss_pred --cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 833 --SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 833 --~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~-~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
......++..|++||.+.+..++.++|+|+||+++|+|++|..||.... .......+........+|..++..+++|
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 1344568999999999999889999999999999999999999998876 3333333333345566788889999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
|.+||..+|.+||++.+++++
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHhCcCChhhCCCHHHHhhC
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.71 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=207.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC--CceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~l~L 751 (960)
++|++.+.||.| .||.||++.+ +++.||||.+............+.+|+.++++++||||+++++++... ..+|+
T Consensus 5 ~~y~~~~~lg~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEG-TYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCC-CCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 578899999999 6999999987 578899999876544433344667899999999999999999998877 88999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||++ ++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999997 4999998775557899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc------------------
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------------ 892 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~------------------ 892 (960)
.......++..|+|||.+.+.. ++.++||||||+++|+|++|.+||......+....+...
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 3333456788999999987654 689999999999999999999999887665444332110
Q ss_pred -----------ccccCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 -----------NRRLEIPKE-LDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 -----------~~~~~iP~~-lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.....++.. +++.+++||.+||+.+|++||++.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001112333 58889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=308.13 Aligned_cols=247 Identities=31% Similarity=0.527 Sum_probs=212.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|.+.+.||.| .+|.||++.. +++.|++|++..... .....+.+|+.++++++|+||+++++.+......++++|
T Consensus 1 ~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKG-GFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccC-CceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 57889999999 6999999987 488999999876543 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+++++|.+++......+++..+..++.|++.||.|||..+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence 99999999999876557899999999999999999999988 99999999999999999999999999987654322 3
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC--CCcHHHHHHHHH
Q 002146 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWE 912 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~--~lS~eLkdLI~k 912 (960)
....|+..|++||.+.+..++.++|+||||+++|+|++|..||...+.......+.. .....++. .++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHH
Confidence 456789999999999988899999999999999999999999988765555444432 22223332 248899999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
||..||.+||++.+++++
T Consensus 234 ~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HccCChhhCCCHHHHhcC
Confidence 999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.59 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=204.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++++.||.| .||.||+++. +++.||||++............+.+|++++++++||||+++++++.+.+.+++|||
T Consensus 1 ~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEG-TYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCC-CceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999 7999999976 68899999887554333344578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 755 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|+. ++|..++... ...+++..++.++.||+.||+|||..+ |+||||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 996 5888888653 346889999999999999999999998 999999999999999999999999998765433222
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc------------------
Q 002146 834 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------ 894 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~------------------ 894 (960)
.....++..|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 33445788999999987654 58899999999999999999999987665433322211000
Q ss_pred ---------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 ---------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ---------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+...++++++++|.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 001123467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.95 Aligned_cols=250 Identities=28% Similarity=0.507 Sum_probs=209.1
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~----~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
+|+.++.||+| .||.||+++. +++.||+|++...... ......+.+|+.++++++|+||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g-~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTG-AFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCc-CceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 47788999999 7999999975 7889999998754321 223567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-cEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-~VKL~DFGLAr~~~~ 829 (960)
+||||+++++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+||+++.++ .+||+|||++.....
T Consensus 80 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999999997643 6889999999999999999999998 99999999999998776 599999999977643
Q ss_pred Ccc----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHhhccccccCCCCCC
Q 002146 830 TFL----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 830 ~~~----~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---ei~~~I~~~~~~~~iP~~l 902 (960)
... ......|+..|+|||.+.+..++.++|+|+||+++|+|++|..||...... .....+........++..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 311 122346888999999999988999999999999999999999999754432 2222222233445667778
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++++.+++.+||..+|.+||++.+++++
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 9999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.96 Aligned_cols=248 Identities=28% Similarity=0.475 Sum_probs=199.1
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHH-HHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~I-Lk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++.+.||.| .||.||++.+ +|+.||||++........ ..++..|+.+ ++.++||||+++++++.....+|++
T Consensus 1 ~~~~~~~~ig~g-~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRG-AYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEeccc-CCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 478999999999 7999999986 689999999876543333 2345556665 5666999999999999999999999
Q ss_pred EeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 753 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 753 mEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
|||++ ++|.+++.. ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99996 688777653 234689999999999999999999986 7 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHhhccccccCCC-CCC
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIP-KEL 902 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g----~~ys~ksDIWSLGvLLyELLTG~~PF~~~~-~~ei~~~I~~~~~~~~iP-~~l 902 (960)
.. .......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.... ..+....+. ......++ ..+
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (283)
T cd06617 156 DS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKF 233 (283)
T ss_pred cc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCcccc
Confidence 32 12233568899999999865 446889999999999999999999997532 222222222 22233343 357
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.++++||.+||..+|.+||++.+|+++
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.11 Aligned_cols=241 Identities=26% Similarity=0.393 Sum_probs=209.9
Q ss_pred eeccCCeeEEEEEEEC--CcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCC
Q 002146 684 IGLGSSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
||.| .||.||+++.. ++.||||++...... ......+.+|+.+++.++||||+++++.+.++..+++||||+++++
T Consensus 1 lg~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVG-GFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCC-CceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 6889 69999999875 889999998765433 2345678999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCC
Q 002146 761 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 840 (960)
Q Consensus 761 L~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT 840 (960)
|.+++.+.. .+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||+++...... ......|+
T Consensus 80 L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~ 155 (262)
T cd05572 80 LWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGT 155 (262)
T ss_pred HHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCC
Confidence 999997654 5889999999999999999999998 9999999999999999999999999998765432 23345789
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCC
Q 002146 841 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 918 (960)
Q Consensus 841 ~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~--~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP 918 (960)
..|++||.+.+..++.++|+|+||+++|+|++|..||.... ..+....+........+|..++.+++++|.+||..+|
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 99999999998889999999999999999999999998877 5566665543455667787889999999999999999
Q ss_pred CCCCC-----HHHHHH
Q 002146 919 SLRPS-----FAQLTV 929 (960)
Q Consensus 919 ~kRPS-----a~eILe 929 (960)
.+||+ ++|+++
T Consensus 236 ~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 236 EERLGNLKGGIKDIKK 251 (262)
T ss_pred hhCcCCcccCHHHHhc
Confidence 99999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=376.75 Aligned_cols=256 Identities=23% Similarity=0.376 Sum_probs=225.8
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
...+..++|.|+++||+| +||.|.++++ +++.||+|++.+-..- .....-|..|..||-.-+.+=||+++.+|+++
T Consensus 69 ~lrl~~~DfeilKvIGrG-aFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRG-AFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhCCHHhhHHHHHhccc-ccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 345667899999999999 8999999987 6788999988764322 33344578899999988999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.++||||||++||+|-.+|.+.+ .+++..++.|+.+|+.||.-||+.| +|||||||+|||||..|||||+|||.+..
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHh
Confidence 99999999999999999999877 8999999999999999999999999 99999999999999999999999999877
Q ss_pred cc-CCcccCCCCCCCCCccCccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC-
Q 002146 827 KH-NTFLSSKSTAGTPEWMAPEVLR----N-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP- 899 (960)
Q Consensus 827 ~~-~~~~~~~t~~GT~~Y~APEvl~----g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP- 899 (960)
+. +....+...+|||.|++||++. + +.|+..+|||||||++||||.|..||+.......+.+|......+.||
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 65 4445567789999999999984 3 568999999999999999999999999999999999998887888898
Q ss_pred -CCCcHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 002146 900 -KELDPLVARIIWECWQTDPSLRPS---FAQLTVA 930 (960)
Q Consensus 900 -~~lS~eLkdLI~kcL~kDP~kRPS---a~eILe~ 930 (960)
..++.++++||.+++ -+|..|.. +++|..|
T Consensus 305 ~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 468999999999988 56777877 8888765
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.87 Aligned_cols=251 Identities=29% Similarity=0.408 Sum_probs=210.0
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
+..++|++.+.||+| .||+||++.+ +++.||+|++.... .......+.+|+++++.++||||+++++++.....++
T Consensus 2 l~~~~~~~~~~ig~g-~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAG-NGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCC-CCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 345789999999999 6999999987 48899999876543 2344567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
+||||+++++|.+++.+.+ .+++.....++.+++.+|.|||+ ++ |+||||||+||+++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999999999987644 68899999999999999999997 57 99999999999999999999999999875432
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-----------HHHHHhhccccccCC
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVGFQNRRLEI 898 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-----------ei~~~I~~~~~~~~i 898 (960)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||...... +....+. ....+.+
T Consensus 157 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (284)
T cd06620 157 S--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRL 233 (284)
T ss_pred h--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCC
Confidence 2 123457899999999998888999999999999999999999999875542 2222222 1222333
Q ss_pred CCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 899 PKE-LDPLVARIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 899 P~~-lS~eLkdLI~kcL~kDP~kRPSa~eILe~L 931 (960)
+.. ++.++.+||.+||..||.+||++.+++++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 333 778999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=317.63 Aligned_cols=245 Identities=26% Similarity=0.411 Sum_probs=195.5
Q ss_pred EeeccCCeeEEEEEEEC----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 683 RIGLGSSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~~----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
.||+| .||.||++.+. +..+|+|.+..... ......+.+|+.++++++||||+++++++.+...+++||||+++
T Consensus 2 ~lg~G-~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNG-WFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred ccccc-CCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 58999 69999999752 35689998765542 23345788899999999999999999999999999999999999
Q ss_pred CCHHHHhhCCC----CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc--
Q 002146 759 GSLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-- 832 (960)
Q Consensus 759 GsL~dlL~k~~----~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~-- 832 (960)
|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++++||+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999986422 23566777889999999999999999 99999999999999999999999999975433211
Q ss_pred cCCCCCCCCCccCcccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcc-cc---ccCCCC
Q 002146 833 SSKSTAGTPEWMAPEVLRNE-------PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ-NR---RLEIPK 900 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~-------~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~-~~---~~~iP~ 900 (960)
......|+..|+|||++.+. .++.++||||||+++|||++ |..||......+........ .. .+.+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 12234578899999998643 35789999999999999996 99999887666544332111 11 112223
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
..++.+++++.+|| .+|.+||++++|+..|+
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 56788999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=319.17 Aligned_cols=247 Identities=27% Similarity=0.484 Sum_probs=213.6
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
-|++.++||.| .||.||++.+ +++.||||++..... ......+.+|+.++++++||||+++++++.....+++|||
T Consensus 5 ~~~~~~~ig~G-~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKG-SFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeec-CCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 36788899999 6999999975 678999998765432 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+++++|.+++... .+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 83 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 99999999998753 5889999999999999999999998 9999999999999999999999999987664433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhh
Q 002146 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 914 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL 914 (960)
....|+..|++||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 44568899999999998889999999999999999999999998877766665553 23344566778899999999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 002146 915 QTDPSLRPSFAQLTVA 930 (960)
Q Consensus 915 ~kDP~kRPSa~eILe~ 930 (960)
..+|.+||++.+++++
T Consensus 238 ~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 238 NKEPSFRPTAKELLKH 253 (277)
T ss_pred cCChhhCcCHHHHHhC
Confidence 9999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.50 Aligned_cols=250 Identities=31% Similarity=0.501 Sum_probs=206.9
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC--------hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS--------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~--------~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+|.+.+.||.| .||.||++.. +++.||||.+...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g-~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKG-TYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceeccc-CceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 47888999999 6999999965 6889999987642211 11234678899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+++||||+++++|.+++.+.+ .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 99999999999999999997754 6888999999999999999999998 99999999999999999999999999976
Q ss_pred ccCCc--ccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC---
Q 002146 827 KHNTF--LSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--- 899 (960)
Q Consensus 827 ~~~~~--~~~~t~~GT~~Y~APEvl~g~~--ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP--- 899 (960)
..... .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+........++
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 53321 1123346889999999987765 7899999999999999999999998766554444333232233333
Q ss_pred -CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 900 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 900 -~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..++.+++++|.+||..+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3468899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.07 Aligned_cols=243 Identities=20% Similarity=0.292 Sum_probs=194.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..+|++++.||.| .||.||++++ +++.||+|+.... ....|+.++++++||||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPG-SEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCC-CCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3579999999999 7999999987 4668999974322 234689999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+. ++|.+++.+....+++..++.|+.||+.||.|||.++ ||||||||+|||++.++.+||+|||+++..... .
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-P 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccC-c
Confidence 99995 6888888776667999999999999999999999999 999999999999999999999999999754322 2
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-----------HHHHHhhc-cccccCCC-
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVGF-QNRRLEIP- 899 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-----------ei~~~I~~-~~~~~~iP- 899 (960)
......||..|+|||++.+..++.++|||||||++|||+++..++....+. .+...+.. ......++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 233467999999999999999999999999999999999865555332111 01110100 00001111
Q ss_pred -----------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 900 -----------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 900 -----------------------------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..++.++.+||.+||+.||.+||++.|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1346677889999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=352.13 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=230.8
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEECCcE--EEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~--VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
++...+++++..||-| .||.|-+++.+++. +|+|++++..+.+ .....+..|.+||..++.|+||++|..|.+..+
T Consensus 416 ~v~l~dl~~iaTLGvG-gFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVG-GFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred ccchhhhhhhhhcccC-ccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 4556788889999999 59999999887666 8999988765543 345568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+||+||-|-||.|+.+|.+++ .|++.....++..+++|++|||++| ||+|||||+|+|++.+|.+||.|||+|+.+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999999998866 6888888888999999999999999 9999999999999999999999999999887
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.. ..+.++|||++|.|||++.++..+.++|+|+||+++|||++|.+||.+.++++.+..|...-....+|+.++....+
T Consensus 572 ~g-~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 572 SG-RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred cC-CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 65 45678999999999999999999999999999999999999999999999999999998888889999999999999
Q ss_pred HHHHhhhhCCCCCCC-----HHHHHHH
Q 002146 909 IIWECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPS-----a~eILe~ 930 (960)
||+++.+.+|.+|.. +.+|.+|
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhh
Confidence 999999999999986 5666655
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=314.82 Aligned_cols=250 Identities=30% Similarity=0.488 Sum_probs=212.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCC---CChHHHHHHHHHHHHHHHcCCCceeeEecccccC--Cc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~---~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~ 748 (960)
.+|.+.+.||+| .||.||++.. ++..||+|.+.... ........+.+|+.++++++|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRG-AFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccC-CCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 479999999999 6999999975 68899999875432 1234456788999999999999999999998664 45
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++++|||+++++|.+++...+ .+++...+.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 889999999999999987644 4788999999999999999999999 9999999999999999999999999998653
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 829 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 829 ~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.....++.+|..+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence 321 11223568999999999999889999999999999999999999999877666666655455566778899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++++|.+||. +|.+||++.+++.+
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhcC
Confidence 9999999999 57999999988864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=358.39 Aligned_cols=265 Identities=32% Similarity=0.527 Sum_probs=239.5
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
.+|......|.++||.| .||+|+.|+. +...||||.++ ....+....+|+.|..||.++.||||++|.|++..
T Consensus 624 kEId~s~i~Ie~VIGaG-EFGEVc~GrLk~pgkre~~VAIKTLK-~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAG-EFGEVCSGRLKLPGKREITVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecc-cccceecccccCCCCcceeEEEeeec-cCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 36777889999999999 8999999975 34569999875 45677778899999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
...+.||+|||+.|.|+.+|+++..+|+..++..|++.|+.||+||-..+ +|||||-.+||||+.+-..|+.||||++
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEecccccee
Confidence 99999999999999999999998889999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCcccCCCCC-C--CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 826 LKHNTFLSSKSTA-G--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 826 ~~~~~~~~~~t~~-G--T~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
.+.+......+.. | ..+|.|||.|...+++.++||||+||+|||.+. |..||-++...+++..|. ++.+++-|.+
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmD 858 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMD 858 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCC
Confidence 8765543333333 3 369999999999999999999999999999776 999999999999999887 6778888999
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCC
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p 940 (960)
++..+.+|+..||++|-.+||.|.||+..|+++.+....
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 999999999999999999999999999999999887543
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.33 Aligned_cols=239 Identities=22% Similarity=0.371 Sum_probs=194.8
Q ss_pred EEeeccCCeeEEEEEEEC--------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 682 ERIGLGSSYGEVYHADWN--------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~--------------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
+.||+| .||.||++++. ...|++|.+.... ......+..|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G-~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRG-TRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccC-CcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999 69999999752 2258888765432 233456788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc-------EEEEe
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------VKVSD 820 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~-------VKL~D 820 (960)
..++||||+++++|..++.+....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +|++|
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999999998776667899999999999999999999998 999999999999987664 89999
Q ss_pred cCccccccCCcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChhHHHHHhhccccccCC
Q 002146 821 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 821 FGLAr~~~~~~~~~~t~~GT~~Y~APEvl~-g~~ys~ksDIWSLGvLLyELL-TG~~PF~~~~~~ei~~~I~~~~~~~~i 898 (960)
||++..... .....++..|+|||++. +..++.++|||||||++|||+ .|..||......+..... ......
T Consensus 156 ~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~ 228 (262)
T cd05077 156 PGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCML 228 (262)
T ss_pred CCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCccC
Confidence 999865432 22356788999999987 466899999999999999997 588998876544432211 112223
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
....+.++++||.+||+.||.+||++.+|++.|+
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 3345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=320.31 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=200.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++.+.||.| .||.||++.. +++.||||.+...... .....+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~g-~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEG-SYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeec-CCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999 7999999976 6889999998654322 1223467899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+.+ +|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 999975 999998776667899999999999999999999998 99999999999999999999999999876533222
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHhhc-------------------
Q 002146 833 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGF------------------- 891 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~-~~ei~~~I~~------------------- 891 (960)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.. ..+....+..
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 2233457889999999876 458899999999999999999999997665 2221111100
Q ss_pred ccccc---------CCCCCCc--HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 892 QNRRL---------EIPKELD--PLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 892 ~~~~~---------~iP~~lS--~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..... .....++ .++.++|.+||..+|.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 0001233 788999999999999999999998863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.06 Aligned_cols=237 Identities=24% Similarity=0.405 Sum_probs=194.8
Q ss_pred EEeeccCCeeEEEEEEECCc------------EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 682 ERIGLGSSYGEVYHADWNGT------------EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~g~------------~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+.||.| .||.||++.+... .|++|.+..... ....+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G-~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQG-TFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred Cccccc-ccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 468999 6999999987432 377776654321 15678899999999999999999999887 778
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-------cEEEEecC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFG 822 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-------~VKL~DFG 822 (960)
++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999999876557899999999999999999999998 99999999999999887 89999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCC
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 899 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g~--~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP 899 (960)
++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+......... .....+
T Consensus 154 ~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~~ 226 (259)
T cd05037 154 IPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLP 226 (259)
T ss_pred ccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCCC
Confidence 9986543 2234577889999999887 78999999999999999999 688887775444333322 122223
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 900 KELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
......+.+||.+||..+|.+||++.++++.|+
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 227 MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 223478999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.36 Aligned_cols=251 Identities=31% Similarity=0.466 Sum_probs=206.7
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccC----
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP---- 746 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~---- 746 (960)
..++|.+.+.||.| .||.||++.. +++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g-~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKG-TYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecC-CCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 35789999999999 7999999976 68899999876432 2234677899999999 899999999988654
Q ss_pred -CceEEEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecC
Q 002146 747 -PNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822 (960)
Q Consensus 747 -~~l~LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFG 822 (960)
..+++||||+++++|.++++. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeecc
Confidence 358999999999999998863 3346889999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-ccc
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRL 896 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~-----ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~ 896 (960)
+++.............|+..|+|||++.... ++.++|||||||++|+|++|..||......+....+.... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 9987654333334457899999999986543 6789999999999999999999999877655554443211 112
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 ~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+..+...+.+||.+||..+|.+||++.+|+++
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2344567889999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=315.03 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=210.5
Q ss_pred CeEEEEEeeccCCeeEEEEEEEC---CcEEEEEEeecCC--------CChHHHHHHHHHHHHHHH-cCCCceeeEecccc
Q 002146 677 DLVLGERIGLGSSYGEVYHADWN---GTEVAVKKFLDQD--------FSGAALLEFKREVKIMRR-LRHPNVVLFMGAVT 744 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~---g~~VAVK~i~~~~--------~~~~~~~~~~~Ei~ILk~-L~HPNIVkL~g~f~ 744 (960)
+|++.+.||.| .||.||++.+. ++.||||.+.... .......++.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G-~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 1 EYAVLEHLGSG-AFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred CchhhhhhcCC-CCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 47788999999 69999999873 5789999876432 223345567889998876 69999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEe
Q 002146 745 RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSD 820 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~D 820 (960)
..+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||. .+ |+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988742 34468999999999999999999996 66 99999999999999999999999
Q ss_pred cCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 821 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 821 FGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
||++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|..||...+.......+......+....
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 99998754432 23445689999999999998899999999999999999999999988777666655543222222223
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
.+++.+.+||.+||..||.+||++.++..+++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 57899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.37 Aligned_cols=239 Identities=22% Similarity=0.371 Sum_probs=198.2
Q ss_pred EEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 682 ERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+.||.| .||.||++.+. ...||+|.+.... ......+..|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G-~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQG-TFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcc-cchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 358999 69999999752 2347888764332 23345788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc--------EEEEecCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLS 824 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~--------VKL~DFGLA 824 (960)
|||+++|+|..++...+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++++|||++
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999999876667899999999999999999999999 999999999999987664 699999998
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHhhccccccCCCCCC
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG-~~PF~~~~~~ei~~~I~~~~~~~~iP~~l 902 (960)
..... .....++..|+|||++.+. .++.++||||||+++|+|++| ..||........... ......+|...
T Consensus 156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 228 (258)
T cd05078 156 ITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---YEDRHQLPAPK 228 (258)
T ss_pred cccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---HHccccCCCCC
Confidence 65432 2235688899999999874 578999999999999999998 567766655443322 22345667777
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
+.++.+||.+||+.+|.+||++.+|++.|+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=341.30 Aligned_cols=256 Identities=22% Similarity=0.305 Sum_probs=214.5
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 747 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~ 747 (960)
-+.+....|+++++||.|| -..||++.. +.+.||+|++.........+.-+.+|+.+|.+| .|.+||+|++|-..++
T Consensus 355 ~i~Vkg~~Yeilk~iG~GG-SSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGG-SSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eEEECcchhhHHHhhcCCC-cceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 3456778899999999996 799999986 567789988777767778888999999999999 6999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+||||||- ..+|..+|++.....+.-.++.+..||+.+++++|++| |||.||||.|+|+ -.|.+||+|||+|..+
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLl-VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLL-VKGRLKLIDFGIANAI 509 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEE-EeeeEEeeeechhccc
Confidence 999999986 56999999987766665688889999999999999999 9999999999999 5679999999999877
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCCC-----------CchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHhhccc
Q 002146 828 HNTF--LSSKSTAGTPEWMAPEVLRNEPS-----------NEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQN 893 (960)
Q Consensus 828 ~~~~--~~~~t~~GT~~Y~APEvl~g~~y-----------s~ksDIWSLGvLLyELLTG~~PF~~~~-~~ei~~~I~~~~ 893 (960)
.... ......+||+-||+||.+....+ ++++||||||||||+|+.|++||.... ....+..|.--+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 5432 23456789999999999865443 478999999999999999999997754 333444454333
Q ss_pred cccCCCCCCcHH-HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 RRLEIPKELDPL-VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ~~~~iP~~lS~e-LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+||..-+.. +.++++.||..||.+||++.+||++
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 455666655444 9999999999999999999999875
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.24 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=203.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.+.||.| .+|+||++++ +++.||||++............+.+|++++++++||||+++++++......++||
T Consensus 2 ~~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEG-TYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCC-CCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999 7999999976 6789999988655443344457789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-CCcEEEEecCccccccCCc
Q 002146 754 EFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr~~~~~~ 831 (960)
||++ ++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||++.......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9996 57877775433 34678888899999999999999998 999999999999985 5679999999997654332
Q ss_pred ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc----------------
Q 002146 832 LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------------- 894 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~---------------- 894 (960)
.......++..|+|||.+.+. .++.++|||||||++|+|++|..||......+....+.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 233345678999999998764 578999999999999999999999988765544333211000
Q ss_pred ---cc--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 ---RL--------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ---~~--------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+ .....++++++++|.+||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0123467889999999999999999999999874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=349.54 Aligned_cols=244 Identities=27% Similarity=0.312 Sum_probs=203.8
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-C-----CceeeEecccccCCc
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-----PNVVLFMGAVTRPPN 748 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-H-----PNIVkL~g~f~~~~~ 748 (960)
+|.|.+.||+| +||.|.+|.. +++.||||+++.. .....+...|+.||..|+ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkG-tFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKG-SFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEeccc-ccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 78999999999 8999999965 7899999998754 334456678999999996 4 389999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC--CCcEEEEecCccc
Q 002146 749 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSR 825 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~--~g~VKL~DFGLAr 825 (960)
+|||+|.+ ..+|+++|+.++ ..++...++.|+.||+.||..||+.+ |||+|||||||||.. ...|||+|||.+.
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999999 569999998654 46899999999999999999999999 999999999999974 3479999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc------------
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------ 893 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~------------ 893 (960)
......+ +.+.+..|+|||+|.|.+|+.+.||||||||++||++|.+.|.|.+..+.+..|....
T Consensus 340 ~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 340 FESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred ccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 7765543 5778899999999999999999999999999999999999999877655443322100
Q ss_pred --------------------------------------cccCCCC-----------CCcHHHHHHHHHhhhhCCCCCCCH
Q 002146 894 --------------------------------------RRLEIPK-----------ELDPLVARIIWECWQTDPSLRPSF 924 (960)
Q Consensus 894 --------------------------------------~~~~iP~-----------~lS~eLkdLI~kcL~kDP~kRPSa 924 (960)
.....|. .-...+.+||++||..||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0000120 122468999999999999999999
Q ss_pred HHHHHH
Q 002146 925 AQLTVA 930 (960)
Q Consensus 925 ~eILe~ 930 (960)
.+.+++
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=315.21 Aligned_cols=249 Identities=27% Similarity=0.456 Sum_probs=215.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~L 751 (960)
++|.+.+.||.| .||.||++.. ++..||+|++..... .......+.+|+.++++++ |+||+++++++...+..++
T Consensus 1 ~~y~~~~~lg~g-~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEG-SFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCC-CceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 479999999999 6999999976 689999999876443 2334567889999999998 9999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+.+++|.+++.+.+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999999999998754 6999999999999999999999999 9999999999999999999999999998654322
Q ss_pred --------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 002146 832 --------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF 891 (960)
Q Consensus 832 --------------------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~ 891 (960)
.......|+..|++||++.+..++.++|+|+||+++|+|++|..||...........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~- 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL- 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-
Confidence 12233467899999999998889999999999999999999999999887666655553
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCH----HHHHHH
Q 002146 892 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSF----AQLTVA 930 (960)
Q Consensus 892 ~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa----~eILe~ 930 (960)
.....+|..+++.+.+||.+||+.+|.+||++ .+++++
T Consensus 236 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 236 -KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 34556778889999999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=316.93 Aligned_cols=247 Identities=28% Similarity=0.478 Sum_probs=208.5
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC---CCceeeEecccccCCceEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~---HPNIVkL~g~f~~~~~l~L 751 (960)
.|++.+.||.| .||.||++.+ +++.||||.+.... .......+.+|+.++++++ ||||+++++++......++
T Consensus 2 ~y~~~~~l~~g-~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRG-AYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheecc-CCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 47778899999 6999999986 68899999886543 2334557889999999996 9999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++++|.+++... .+++..++.++.|++.||.|||+.| |+||||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999998663 6889999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC-CCcHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARI 909 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~-~lS~eLkdL 909 (960)
.......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+.. ...+.++. .++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNGYSKLLREF 234 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCcccCCHHHHHH
Confidence 33344578999999999875 4468999999999999999999999988776555443321 22333443 378899999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
+.+||+.+|.+||++.+++++
T Consensus 235 i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 235 VAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHcCCCcccCcCHHHHhhC
Confidence 999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=323.39 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=185.8
Q ss_pred EEEeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc--cCCceEEEEe
Q 002146 681 GERIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSIITE 754 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~--~~~~l~LVmE 754 (960)
+++||.| .||+||+++. ++..||+|.+...... ..+.+|+.+|+.++||||+++++++. ....+++|||
T Consensus 6 g~~lG~G-~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRG-TYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccC-CCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4679999 6999999985 3467999988654322 35678999999999999999999874 4567899999
Q ss_pred ecCCCCHHHHhhC--------CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE----cCCCcEEEEecC
Q 002146 755 FLPRGSLFRILHR--------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFG 822 (960)
Q Consensus 755 Y~~gGsL~dlL~k--------~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL----d~~g~VKL~DFG 822 (960)
|+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 996 478777642 1225788899999999999999999999 9999999999999 567899999999
Q ss_pred ccccccCCcc---cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChh----------HHHHH
Q 002146 823 LSRLKHNTFL---SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM----------QVVGA 888 (960)
Q Consensus 823 LAr~~~~~~~---~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~----------ei~~~ 888 (960)
+++....... ......||..|+|||++.+. .++.++|||||||++|||++|.+||...... +....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 9987643321 22345689999999999774 5799999999999999999999999753321 00000
Q ss_pred hhccc-----------cc------------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 889 VGFQN-----------RR------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 889 I~~~~-----------~~------------------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.... .. .......+..+++||.+||..||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 00 00011235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=318.89 Aligned_cols=251 Identities=24% Similarity=0.275 Sum_probs=201.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCc----
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN---- 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~---- 748 (960)
++|++.+.||.| .||.||++.+ +++.||||++............+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g-~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEG-TYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEeccc-CCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 468999999999 6999999986 688999998765433333345678899999999 56999999999877665
Q ss_pred -eEEEEeecCCCCHHHHhhCC----CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-CCcEEEEecC
Q 002146 749 -LSIITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFG 822 (960)
Q Consensus 749 -l~LVmEY~~gGsL~dlL~k~----~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-~g~VKL~DFG 822 (960)
+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||..+ |+||||||+||+++. ++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 788887643 235799999999999999999999998 999999999999998 8999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-------
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------- 894 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~------- 894 (960)
+++.............+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 99865433222333457889999999865 4578999999999999999999999988765544332211000
Q ss_pred ---------------cc----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 ---------------RL----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ---------------~~----~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. .....++.++.+||.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0013477889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=317.66 Aligned_cols=249 Identities=25% Similarity=0.317 Sum_probs=203.7
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|++.+.||.| .+|.||++.+ +|+.||||++............+.+|+.+++.++||||+++++++.+....+++|||
T Consensus 1 y~~~~~l~~g-~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEG-TYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCC-CCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 5678899999 7999999976 689999999876544333345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 756 LPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 756 ~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
++ ++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 95 68999887643 36899999999999999999999998 9999999999999999999999999997654332222
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc--------------------
Q 002146 835 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------------- 893 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-------------------- 893 (960)
....++..|+|||++.+. .++.++||||||+++|+|++|.+||...+.......+....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578899999988765 47899999999999999999999998776543332221100
Q ss_pred -------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 -------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 -------~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
........++..+.++|.+||+.+|.+||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0001124567899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=319.07 Aligned_cols=250 Identities=30% Similarity=0.499 Sum_probs=213.0
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
..+.|++.+.||.| .||.||++.+ .+..|++|++..... ....+.+|+++++.++|+||+++++.+......++
T Consensus 17 ~~~~~~~~~~l~~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEG-ASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCC-CCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 44668888999999 6999999987 488999999875433 45578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
|+||+++++|.+++......+++..++.++.|++.||.|||+.| |+|+||+|+||+++.++.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999999876547899999999999999999999998 9999999999999999999999999987654332
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-ccCCCCCCcHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARII 910 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-~~~iP~~lS~eLkdLI 910 (960)
.......++..|++||++.+..++.++|+||||+++|+|++|..||...+.......+..... ....+..++.++++||
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 223345688899999999998899999999999999999999999998777655554432221 1122334788999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe 929 (960)
.+||..+|.+||++.++++
T Consensus 251 ~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHhccChhhCcCHHHHhh
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=352.02 Aligned_cols=243 Identities=30% Similarity=0.506 Sum_probs=213.1
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 759 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gG 759 (960)
-+||+| +||+||.++. +...+|||.+...+. ....-++.|+.+.++|+|.|||+++|.+.+++.+-|+||.++||
T Consensus 581 vVLGKG-TYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKG-TYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecC-ceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 469999 8999999986 455689998765432 23446889999999999999999999999999999999999999
Q ss_pred CHHHHhhCCCCCC--cHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecCccccccCCcccCCC
Q 002146 760 SLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKS 836 (960)
Q Consensus 760 sL~dlL~k~~~~l--se~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLAr~~~~~~~~~~t 836 (960)
+|.++|...=+.+ +|..+-.+.+||++||.|||... |||||||-.|+||+ -.|.+||.|||-++....-..-+.+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9999998765566 88999999999999999999998 99999999999997 5899999999999887655455678
Q ss_pred CCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 837 TAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 837 ~~GT~~Y~APEvl~g~~--ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
+.||..|||||+|..++ |+.++|||||||++.||.||++||..... .....++..-...+++|..++.+++.||.+|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 89999999999997765 89999999999999999999999988653 4445556656678889999999999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTV 929 (960)
Q Consensus 914 L~kDP~kRPSa~eILe 929 (960)
+..+|.+||++.++|+
T Consensus 816 Fepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCcccCccHHHhcc
Confidence 9999999999999986
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.77 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=203.7
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|++.++||.| .+|.||+++. +|+.||||++..... ......+.+|+.++++++|+||+++++++...+.+++|||
T Consensus 1 ~y~~~~~l~~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEG-TYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccC-CceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58899999999 6999999987 688999999875432 2233466789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 755 FLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~--~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 9975 8888876543 45899999999999999999999998 99999999999999999999999999976544322
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc----------------cc
Q 002146 833 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------RR 895 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~----------------~~ 895 (960)
......++..|++||++.+. .++.++|||+|||++|+|++|..||.+.+..+....+.... ..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 33345678999999998664 47899999999999999999999998876554433321100 00
Q ss_pred cC-----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 LE-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~~-----------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. +...++..++++|.+||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 01 112457789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.54 Aligned_cols=253 Identities=24% Similarity=0.296 Sum_probs=201.0
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC----
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP---- 747 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~---- 747 (960)
..++|++.++||.| .||.||++.. +++.||||++............+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g-~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQG-TFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecC-CCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34679999999999 7999999986 6889999988755433333345678999999999999999999876543
Q ss_pred ----ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 748 ----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 748 ----~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
..++||||+. ++|.+++.+....+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999996 5888888766557899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcc----cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc---
Q 002146 824 SRLKHNTFL----SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--- 895 (960)
Q Consensus 824 Ar~~~~~~~----~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~--- 895 (960)
+........ ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 986543221 112345788999999987654 788999999999999999999999887654433222110000
Q ss_pred --------------cCCC-------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 --------------LEIP-------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 --------------~~iP-------------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..++ ...+..+++||.+||..||.+||++++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0011 1235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=319.59 Aligned_cols=238 Identities=22% Similarity=0.369 Sum_probs=195.1
Q ss_pred EeeccCCeeEEEEEEEC--------------------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCce
Q 002146 683 RIGLGSSYGEVYHADWN--------------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~~--------------------------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNI 736 (960)
+||+| +||.||++.+. ...|++|.+.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G-~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQG-TRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcc-cccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCe
Confidence 58999 79999998641 1348888875432 2234567889999999999999
Q ss_pred eeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC--
Q 002146 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-- 814 (960)
Q Consensus 737 VkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-- 814 (960)
+++++++.+....++||||+++++|..++.+....+++..+..++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999999999776667899999999999999999999998 99999999999997643
Q ss_pred -----cEEEEecCccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCChhHHHH
Q 002146 815 -----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVG 887 (960)
Q Consensus 815 -----~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELL-TG~~PF~~~~~~ei~~ 887 (960)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred cCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999988643221 22457888999999876 56899999999999999985 6999998876655433
Q ss_pred HhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 888 ~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
.. .....+|....+.+.+||.+||..+|.+||++.+|++.|+
T Consensus 233 ~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 FY---EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 22 1233455556788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=361.58 Aligned_cols=258 Identities=25% Similarity=0.356 Sum_probs=211.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.+|+++++||+| .||.||++.+ +++.||||++...... .....++.+|++++++++||||+++++++.+.+..++|
T Consensus 2 grYeIi~~LGkG-gfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKG-GMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecC-CCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 579999999999 6999999976 5889999998754322 33456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCC----------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecC
Q 002146 753 TEFLPRGSLFRILHRP----------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~----------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFG 822 (960)
|||++|++|.+++... ....+...++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999988631 123455677889999999999999998 9999999999999999999999999
Q ss_pred ccccccCC------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH
Q 002146 823 LSRLKHNT------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 884 (960)
Q Consensus 823 LAr~~~~~------------------~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e 884 (960)
+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99865211 011123569999999999999999999999999999999999999998865544
Q ss_pred HHHHhhccccccCC--CCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhHHh
Q 002146 885 VVGAVGFQNRRLEI--PKELDPLVARIIWECWQTDPSLRP-SFAQLTVALKPLQRL 937 (960)
Q Consensus 885 i~~~I~~~~~~~~i--P~~lS~eLkdLI~kcL~kDP~kRP-Sa~eILe~Le~i~~~ 937 (960)
+..... ....... ...+++.+.+++.+||..||.+|+ +++++++.|+.+...
T Consensus 239 i~~~~~-i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYRDV-ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhh-ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 432221 1111111 235788999999999999999996 578888888887553
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=324.43 Aligned_cols=247 Identities=29% Similarity=0.416 Sum_probs=207.5
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.|.....||.| .||.||++.. ++..||||++.... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 23 ~~~~~~~lg~g-~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEG-STGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCC-CCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 34556779999 6999999975 68899999875432 2345568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++..........
T Consensus 100 ~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 99999999998653 5888999999999999999999998 9999999999999999999999999987654333333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-ccccCCCCCCcHHHHHHHHHh
Q 002146 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-~~~~~iP~~lS~eLkdLI~kc 913 (960)
....|+..|+|||.+.+..++.++||||||+++|||++|..||...+.......+... .........++..++++|.+|
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 4456899999999999988999999999999999999999999987776555444211 111122335788999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~ 930 (960)
|..+|.+||++++++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.97 Aligned_cols=248 Identities=29% Similarity=0.425 Sum_probs=208.0
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
.+.|.+.+.||.| .||+||++.. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~y~~~~~lg~g-~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHG-SFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred chhhhhheeecCC-CCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3568899999999 7999999976 688999999865433 33445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+. |+|.+++......+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 999996 5777777654456899999999999999999999998 999999999999999999999999998754322
Q ss_pred ccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
....|+..|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.........+..++..+++
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 2456888999999984 3557899999999999999999999999887766555443222222223457889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..+|.+||++.+|+.+
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcC
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.11 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=198.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
.+|++.+.||.| .||.||++.. +++.||||++...... .....+.+|+.+++.++|+||+++++++......++||
T Consensus 5 ~~y~~~~~ig~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEG-SYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEec-CCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 679999999999 7999999975 6889999998654322 22235678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||+. ++|..++......+.+..+..++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9995 6777776554446788888899999999999999998 999999999999999999999999999865433223
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHhhc-c---------------c--
Q 002146 834 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGF-Q---------------N-- 893 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-ei~~~I~~-~---------------~-- 893 (960)
.....++..|+|||++.+. .++.++||||||+++|+|++|..||.+.... +....+.. . .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 3445678999999998764 4788999999999999999999999875432 11111100 0 0
Q ss_pred ---cccCCC-------C--CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ---RRLEIP-------K--ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ---~~~~iP-------~--~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.....+ . ..+..+.+|+.+||..||.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000 0 125689999999999999999999998863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=326.57 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=202.0
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------ 746 (960)
.++|++.+.||.| .||.||++.. +++.||||++............+.+|+.++++++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSG-AQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccC-CCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4679999999999 6999999975 788999999865444444456778899999999999999999987644
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
...|+||||+. ++|.+++... +++..+..++.||+.||+|||..| |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999995 5888887643 888999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-------------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 893 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~------------- 893 (960)
..... ......++..|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 168 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 64432 2334568899999999999999999999999999999999999998765433222211000
Q ss_pred -------ccc--------------CC-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 -------RRL--------------EI-------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 -------~~~--------------~i-------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+. .+ +...+..+++||.+||+.||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00 11345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=344.50 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=197.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
...|.+.+.||.| .||.||++.+ .++.||||.... ..+.+|+++|++|+|+|||++++++......++|
T Consensus 168 ~~gy~i~~~Lg~G-~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPG-SEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccC-CCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999 7999999987 578899995321 2356899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+. ++|..++......+++..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99995 6888888765557999999999999999999999999 99999999999999999999999999986533211
Q ss_pred --cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hhHHHHHhhccccc-cCCC--
Q 002146 833 --SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------PMQVVGAVGFQNRR-LEIP-- 899 (960)
Q Consensus 833 --~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~--------~~ei~~~I~~~~~~-~~iP-- 899 (960)
.....+||..|+|||++.+..++.++|||||||++|||++|..|+.... ..++...+...... ..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1224579999999999999999999999999999999999876654322 12222222111000 0000
Q ss_pred -----------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 900 -----------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 900 -----------------------------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..++.++.+||.+||+.||.+||++.|+|++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1245689999999999999999999999975
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.30 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=199.0
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccC--CceEEE
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP--PNLSII 752 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~--~~l~LV 752 (960)
|++.+.||.| .||.||++.. +++.||||+++........ ....+|+.+++++ +|+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g-~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEG-TFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeecccc-ccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999 7999999976 6889999988754322222 2345789999998 499999999999887 889999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||++ ++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||+++. +.+||+|||+++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 99997 5888887765557899999999999999999999998 999999999999999 999999999998764332
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc----------------ccc
Q 002146 833 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------------NRR 895 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~----------------~~~ 895 (960)
......++..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2233568899999998654 55788999999999999999999999887765443333110 001
Q ss_pred cCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 LEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~~i-----------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+ ...++..+++||.+||.++|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 111 12467899999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.33 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=209.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..+|.+.+.||.| .||.||++.. ++..||+|.+..... .....+.+|+.+++.++||||+++++.+......|+|
T Consensus 18 ~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQG-ASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCC-CCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 4689999999999 6999999965 678899998764332 2345678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
+||+++++|.+++.+. .+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999999764 4788889999999999999999999 99999999999999999999999999876544333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~~iP~~lS~eLkdLI~ 911 (960)
......|++.|++||.+.+..++.++|+||||+++|+|++|..||...+.......+.... .....+..++..+++||.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 3344568899999999998889999999999999999999999998776544433322111 111223456788999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||..+|.+||++.+++.+
T Consensus 251 ~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=322.91 Aligned_cols=246 Identities=28% Similarity=0.416 Sum_probs=207.9
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|.....||.| .||.||++.. +++.||||++...... ....+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 23 ~~~~~~ig~g-~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEG-STGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCC-CceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 4445579999 6999999975 6889999998654322 235678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~ 835 (960)
+++++|..++... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...........
T Consensus 100 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 100 LQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 9999999988653 5889999999999999999999999 99999999999999999999999999976544333334
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cccCCCCCCcHHHHHHHHHhh
Q 002146 836 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWECW 914 (960)
Q Consensus 836 t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~~iP~~lS~eLkdLI~kcL 914 (960)
...|+..|+|||++.+..++.++|||||||++|||++|..||......+....+.... .....+..++..+.++|.+||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 5678999999999999899999999999999999999999998877665555443211 112224467889999999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 002146 915 QTDPSLRPSFAQLTVA 930 (960)
Q Consensus 915 ~kDP~kRPSa~eILe~ 930 (960)
+.+|.+||++.+|+++
T Consensus 256 ~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 256 TREPQERATAQELLDH 271 (297)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.75 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=207.1
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|++.+.||.| .+|.||++.. +++.|++|.+............+.+|+.+|++++|+||+++++++.....+++||||
T Consensus 1 y~~~~~i~~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEG-TYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecC-CCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 5677889999 6999999976 688899999876554444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~ 835 (960)
+++ +|.+++......+++..++.++.||+.||.|||..+ |+|+||||+||+++.++.+||+|||++...........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 975 888888775567899999999999999999999999 99999999999999999999999999987655432233
Q ss_pred CCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-------------------
Q 002146 836 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------- 895 (960)
Q Consensus 836 t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~------------------- 895 (960)
...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 45688899999999877 7899999999999999999999999887654443332111000
Q ss_pred ---------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ---------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ---------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
......++.++++||.+||..||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00122467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.28 Aligned_cols=246 Identities=29% Similarity=0.431 Sum_probs=208.4
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.|...+.||.| .+|.||++.. +++.|+||++.... ......+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEG-STGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccC-CCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 45556899999 7999999975 67889999876432 2334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+.+++|.+++.. ..+++..+..++.||+.||+|||++| |+||||+|+||+++.++.++|+|||++..........
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 97 FLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 9999999999877 35889999999999999999999999 9999999999999999999999999887654332233
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC--CCCCcHHHHHHHHH
Q 002146 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARIIWE 912 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i--P~~lS~eLkdLI~k 912 (960)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... ....+ +..++..+.+||.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHH
Confidence 3456899999999999988999999999999999999999999888776666555322 11222 33478899999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
||..+|.+||++.+++++
T Consensus 252 ~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 252 MLVRDPAQRATAAELLNH 269 (285)
T ss_pred HcccChhhCcCHHHHccC
Confidence 999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.80 Aligned_cols=243 Identities=27% Similarity=0.436 Sum_probs=206.5
Q ss_pred eeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCC
Q 002146 684 IGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
||.| .||.||++++ +|+.|++|.+...... ......+.+|++++++++||||+++++.+.....+|++|||+.+++
T Consensus 1 lg~g-~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKG-AYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCC-CceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 5788 7999999987 4899999998765432 3445678899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc--------
Q 002146 761 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-------- 832 (960)
Q Consensus 761 L~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~-------- 832 (960)
|.+++.+.+ .+++..++.++.||+.||.|||..+ |+||||+|+||+++.++.++|+|||++........
T Consensus 80 L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 999997754 7899999999999999999999998 99999999999999999999999999876433211
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCC--cHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL--DPLVARII 910 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~l--S~eLkdLI 910 (960)
......++..|++||.+.+..++.++||||||+++|+|++|..||......+....+.. .....+..+ +..+.+||
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHHH
Confidence 22345688899999999988899999999999999999999999998888777766643 234444444 89999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~Le 932 (960)
.+||+.+|.+||++..+.+.|+
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhc
Confidence 9999999999999955554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.34 Aligned_cols=240 Identities=27% Similarity=0.361 Sum_probs=200.9
Q ss_pred eeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCC
Q 002146 684 IGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
||.| .||+||++.. +|+.||+|.+....... .....+.+|+.+|++++||||+++++.+...+.+|+||||+++++
T Consensus 1 lg~g-~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKG-GFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCC-CceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 6889 6999999975 68899999987643322 223456789999999999999999999999999999999999999
Q ss_pred HHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCC
Q 002146 761 LFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 839 (960)
Q Consensus 761 L~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~G 839 (960)
|.+++.+.. ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++...... .......+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccC
Confidence 999987644 36899999999999999999999999 999999999999999999999999998765432 22334567
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHhhccccccCCCCCCcHHHHHHHHHhhh
Q 002146 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 915 (960)
Q Consensus 840 T~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~----~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~ 915 (960)
+..|++||++.+..++.++||||||+++|+|++|..||..... .++...+ ......++..+++.++++|.+||.
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~ 234 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--LEMAVEYPDKFSPEAKDLCEALLQ 234 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--ccccccCCccCCHHHHHHHHHHcc
Confidence 8899999999988899999999999999999999999987654 2222222 233455677789999999999999
Q ss_pred hCCCCCC-----CHHHHHH
Q 002146 916 TDPSLRP-----SFAQLTV 929 (960)
Q Consensus 916 kDP~kRP-----Sa~eILe 929 (960)
.+|.+|| ++.+++.
T Consensus 235 ~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 235 KDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CChhHccCCCcccHHHHHh
Confidence 9999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.17 Aligned_cols=249 Identities=29% Similarity=0.412 Sum_probs=199.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~L 751 (960)
.++|+..+.||.| .||.||++.+ +++.||||++...... .....+.+|+.++.++. |+||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~G-~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRG-AFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCC-CceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3567778889999 7999999976 6789999998754433 44567889999999995 9999999999999999999
Q ss_pred EEeecCCCCHHHHh---hC-CCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 752 ITEFLPRGSLFRIL---HR-PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 752 VmEY~~gGsL~dlL---~k-~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+|||+.. +|.++. .. ....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 9999854 555543 21 234689999999999999999999974 7 99999999999999999999999999976
Q ss_pred ccCCcccCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHhhccccccCC----
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEI---- 898 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~---~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-ei~~~I~~~~~~~~i---- 898 (960)
..... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||...... +....+. ....+.+
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (288)
T cd06616 158 LVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSE 235 (288)
T ss_pred hccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcC
Confidence 54332 22334689999999999876 6899999999999999999999999775421 1222221 1112222
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+..++.++.+||.+||.++|.+||++++|+++
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 23478899999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=310.38 Aligned_cols=245 Identities=22% Similarity=0.383 Sum_probs=194.7
Q ss_pred EeeccCCeeEEEEEEE-CCc---EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 683 RIGLGSSYGEVYHADW-NGT---EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~-~g~---~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
.||+| .||.||++++ ++. .+++|.+.... .......+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus 2 ~lg~G-~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNG-WFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCC-cCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 58999 7999999975 332 45666654432 233456789999999999999999999999999999999999999
Q ss_pred CCHHHHhhCCC---CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc--cc
Q 002146 759 GSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LS 833 (960)
Q Consensus 759 GsL~dlL~k~~---~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~--~~ 833 (960)
|+|.+++.+.. ....+..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999997532 24566778889999999999999998 9999999999999999999999999986432211 12
Q ss_pred CCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccc----cccCCCCC
Q 002146 834 SKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN----RRLEIPKE 901 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g-------~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~----~~~~iP~~ 901 (960)
....+|+..|+|||++.+ ..++.++|||||||++|||++ |..||......+....+.... .++.++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence 234568899999999853 235789999999999999997 577888777666555443221 12334456
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
+++.+.+++..|| .+|.+||++.+|++.|.
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 7889999999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.69 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=211.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+.|...+.||.| .||.||++++ ++..||||++..... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~f~~~~~lg~G-~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHG-SFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhheeccC-CCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 447788999999 7999999986 678999999875433 334456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+.| +|.+++......+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 999975 788877655557899999999999999999999998 99999999999999999999999999875432
Q ss_pred cCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||...+.......+.........+..++..+++|
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 23456889999999974 45688999999999999999999999988876666655543333333345678899999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 910 IWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
|.+||+.+|.+||++.++++++-.+
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhh
Confidence 9999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.34 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=204.2
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC----
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP---- 747 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~---- 747 (960)
..++|++.+.||.| .||.||++.+ +++.||||++............+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEG-TYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeeccc-CCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45689999999999 7999999987 5889999998765433333446778999999999999999999887655
Q ss_pred ------ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEec
Q 002146 748 ------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821 (960)
Q Consensus 748 ------~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DF 821 (960)
.+++|+||+++ +|..++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999976 777777765557899999999999999999999998 999999999999999999999999
Q ss_pred CccccccCCcc-cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc---
Q 002146 822 GLSRLKHNTFL-SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--- 896 (960)
Q Consensus 822 GLAr~~~~~~~-~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--- 896 (960)
|++........ ......++..|+|||++.+. .++.++|||||||++|+|++|++||...+..+....+.......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99986643321 12223467889999988654 47899999999999999999999998766544433322110000
Q ss_pred -------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 -------------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 -------------------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.....++..+.+||.+||..+|.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0122467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=349.37 Aligned_cols=248 Identities=33% Similarity=0.506 Sum_probs=214.8
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc--eE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN--LS 750 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~--~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~--l~ 750 (960)
.++...+||+| +|-+||+|-+ +|..||--.++..+. ......+|..|+.+|+.|+|||||+||.+|.+..+ +.
T Consensus 41 y~k~~evLGrG-afKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 41 YLKFDEVLGRG-AFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred eeehhhhcccc-cceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 35567889999 8999999965 677777543333222 34556889999999999999999999999987766 88
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLAr~~~~ 829 (960)
+|+|.+..|+|..|+.+.+ ..+.+.+..|++||++||.|||++.|+|||||||-+||+|+ ..|.|||+|+|||..+..
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999999998754 79999999999999999999999999999999999999998 569999999999998765
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~-~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.. .....|||+|||||++. ..|++.+||||||+++.||.|+..||.. .++.+++.++.....+..+.+--++++++
T Consensus 199 s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~ 275 (632)
T KOG0584|consen 199 SH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVRE 275 (632)
T ss_pred cc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHH
Confidence 43 33478999999999998 7799999999999999999999999976 57889999887666666666777899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||.. ..+|+++.+||++
T Consensus 276 fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 276 FIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHhcC-chhccCHHHHhhC
Confidence 99999999 9999999999874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=339.14 Aligned_cols=262 Identities=28% Similarity=0.514 Sum_probs=230.2
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE----CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW----NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 742 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~----~g~--~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~ 742 (960)
.++++..+.+++.++||.| .||.||+|.+ +|+ .||||..+. +...+..+.|..|..+|+.++|||||+++|+
T Consensus 382 rnyel~Re~Itl~r~iG~G-qFGdVy~gvYt~~~kge~iaVAvKtCK~-d~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEG-QFGDVYKGVYTDPEKGERIAVAVKTCKT-DCTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CcceeehhhccHHHhhcCC-cccceeeeEecccccCcceeeeeehhcc-CCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 4566677778888999999 8999999976 233 488897654 3455567889999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecC
Q 002146 743 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822 (960)
Q Consensus 743 f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFG 822 (960)
+.+ ...|||||.++-|.|..||+.++..++...+..+++||..||.|||+.. .|||||-.+|||+....-|||+|||
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccc
Confidence 976 4789999999999999999998888999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 823 LSRLKHNTFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 823 LAr~~~~~~~~-~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
|++.+....+. .....-...|||||-+.-..++.++|||.||+++||++. |..||.+....+++..+. ++.+++.|+
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~ 615 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPP 615 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCC
Confidence 99988655433 222233568999999999999999999999999999776 999999999888888776 667899999
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
+|++.+..|+.+||..+|.+||.|.+|...|..+..
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999999987743
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=311.95 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=203.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--CCceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~--~~~l~L 751 (960)
++|+..++||.| .||.||++.. +++.||+|.+..... ......+.+|++++++++||||++++++|.. ...+++
T Consensus 1 ~~~~~~~~lg~g-~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEG-AGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccC-CceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 468999999999 7999999986 678899998875432 2445678899999999999999999998754 346899
Q ss_pred EEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 752 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999988653 3346888999999999999999999999 9999999999999999999999999987654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHhhccccccCCC----
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-----PMQVVGAVGFQNRRLEIP---- 899 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~-----~~ei~~~I~~~~~~~~iP---- 899 (960)
... .....++..|++||.+.+..++.++|||+|||++|+|++|..||.... ..+....+.. ...+.++
T Consensus 157 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (287)
T cd06621 157 NSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPG 233 (287)
T ss_pred ccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCC
Confidence 321 123467889999999999999999999999999999999999998652 2333333321 1112221
Q ss_pred --CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 900 --KELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 900 --~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
..+++.+++||.+||..+|.+||++.|+++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 234678999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.41 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=198.8
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHH-HcCCCceeeEecccccCCceEEEEeecC
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk-~L~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.||.| .||.||++.. +++.||||.+...... ......+..|..++. .++|+||+++++++...+.+|+||||++
T Consensus 2 ~~l~~g-~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKG-AFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcC-CCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 568999 7999999976 6789999998765432 222334455655544 4489999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||+|.||+++.++.+||+|||+++.... ....
T Consensus 81 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~ 153 (260)
T cd05611 81 GGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKF 153 (260)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccC
Confidence 999999997644 6889999999999999999999998 99999999999999999999999999875432 2345
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc--ccCCCCCCcHHHHHHHHHhhh
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLVARIIWECWQ 915 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~--~~~iP~~lS~eLkdLI~kcL~ 915 (960)
.|+..|++||.+.+..++.++||||||+++|+|++|..||...+..+....+..... ....+..++.++.++|.+||.
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence 688999999999998899999999999999999999999998887776665532221 222344678999999999999
Q ss_pred hCCCCCCCHHHHHHH
Q 002146 916 TDPSLRPSFAQLTVA 930 (960)
Q Consensus 916 kDP~kRPSa~eILe~ 930 (960)
.+|.+||++.++.+.
T Consensus 234 ~~p~~R~~~~~~~~~ 248 (260)
T cd05611 234 MDPAKRLGANGYQEI 248 (260)
T ss_pred CCHHHccCCCcHHHH
Confidence 999999976544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=312.50 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=213.4
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
...|.-++|++.+.||+|| |..||+++. ++..||+|++.-.. .+.+...++|++..++++||||++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGG-fsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGG-FSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred cEEEcCceEEEeeeecCCC-ceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 3456778899999999995 999999985 78899999987654 455678899999999999999999999865444
Q ss_pred c-----eEEEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 748 N-----LSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 748 ~-----l~LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
. .||++.|...|+|.+.+.+ .+..++|.+.+.|+.+|++||++||...++++||||||.|||+.+.+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 4 9999999999999998864 3457999999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCccc---------CCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 002146 820 DFGLSRLKHNTFLS---------SKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 887 (960)
Q Consensus 820 DFGLAr~~~~~~~~---------~~t~~GT~~Y~APEvl~g~---~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~ 887 (960)
|||.+....-.... -.....|..|+|||.+.-+ ..++++|||||||++|+|+.|.-||...-..----
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 99998764211100 0112368899999998654 45899999999999999999999996432110001
Q ss_pred HhhccccccCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 888 AVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 888 ~I~~~~~~~~iP~--~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
.+........+|. .++..+.+||+.||+.||.+||++.+++.+++.+.
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1122333444443 38899999999999999999999999999998764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=322.91 Aligned_cols=254 Identities=26% Similarity=0.370 Sum_probs=205.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC-----Cc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~-----~~ 748 (960)
.+|.+.+.||.| .||+||+++. +++.||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G-~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRG-AYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccC-CCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 579999999999 6999999976 688999999875433333445677899999999999999999987654 34
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+||||+. ++|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999995 68998887644 6899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc---------------
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 892 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~--------------- 892 (960)
..........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 43223344568899999999865 45889999999999999999999999876543222111100
Q ss_pred -----------ccc---cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHh
Q 002146 893 -----------NRR---LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 934 (960)
Q Consensus 893 -----------~~~---~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--Le~i 934 (960)
... ......+++++++||.+||+.+|.+||++.+++++ ++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 01124578899999999999999999999999988 6665
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=312.95 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=194.8
Q ss_pred EeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChH-HHHHHHHHHHHHHH---cCCCceeeEecccccCCceEEEEeec
Q 002146 683 RIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRR---LRHPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~-~~~~~~~Ei~ILk~---L~HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
.||+| .||.||++.. +++.||||.+........ ....+.+|..+++. .+||||+.+++++...+..++||||+
T Consensus 1 ~lg~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRG-GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccC-CCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 38999 7999999976 578999998876543222 12223444444433 47999999999999999999999999
Q ss_pred CCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002146 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 836 (960)
Q Consensus 757 ~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t 836 (960)
++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ....
T Consensus 80 ~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 154 (279)
T cd05633 80 NGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHA 154 (279)
T ss_pred CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccC
Confidence 9999999987644 6899999999999999999999999 999999999999999999999999998755332 1233
Q ss_pred CCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH--HHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 837 TAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--VVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 837 ~~GT~~Y~APEvl~-g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e--i~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
..|+..|+|||.+. +..++.++|||||||++|+|++|..||....... ...... ......+|..++.+++++|.+|
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHH
Confidence 56899999999986 4568999999999999999999999997653321 111111 2234556778899999999999
Q ss_pred hhhCCCCCC-----CHHHHHHH
Q 002146 914 WQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 914 L~kDP~kRP-----Sa~eILe~ 930 (960)
|+.||.+|+ ++++++++
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhC
Confidence 999999999 59999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=319.13 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=210.3
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----ce
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NL 749 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~-----~l 749 (960)
+|++.+.||.| .||.||+++. +++.||||++............+.+|+.+++.++|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSG-AYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCC-CCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 48899999999 6999999986 5789999998765433445567889999999999999999999998875 79
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+||||++ ++|.+++.+.. .+++..++.++.||+.||+|||+.| |+||||||.|||++.++.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999997 58999887654 7899999999999999999999999 99999999999999999999999999987654
Q ss_pred Cc---ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc----------
Q 002146 830 TF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---------- 895 (960)
Q Consensus 830 ~~---~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~---------- 895 (960)
.. .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+....+......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 32 122345678999999999888 7899999999999999999999999887765544333211000
Q ss_pred -------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 002146 896 -------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 935 (960)
Q Consensus 896 -------------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--Le~i~ 935 (960)
..+...++.++.+||.+||.++|.+||++.+++.+ ++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00123367889999999999999999999999985 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=315.85 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=197.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEE----CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccC--Cce
Q 002146 677 DLVLGERIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 749 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~l 749 (960)
.|.+.++||.| .||.||++.+ .++.||||.+...... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g-~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRG-TYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccC-CcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 47889999999 6999999986 5689999998764311 22234667899999999999999999999988 789
Q ss_pred EEEEeecCCCCHHHHhhCC----CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC----CCcEEEEec
Q 002146 750 SIITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDF 821 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~----~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~----~g~VKL~DF 821 (960)
++||||+++ +|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 999999965 677766421 236889999999999999999999999 999999999999999 999999999
Q ss_pred CccccccCCcc---cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhH-------------
Q 002146 822 GLSRLKHNTFL---SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ------------- 884 (960)
Q Consensus 822 GLAr~~~~~~~---~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e------------- 884 (960)
|++........ ......++..|+|||++.+. .++.++|||||||++|+|++|++||.+.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987543321 23345688999999988764 57899999999999999999999998654321
Q ss_pred HHHHhh--------------------ccccccCCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 885 VVGAVG--------------------FQNRRLEIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 885 i~~~I~--------------------~~~~~~~iP-----------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++..+. .......++ ...+.++.++|.+||..||.+||++.+++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 000001111 1456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.45 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=213.7
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
.+....++++++..||.| +.|.|+++++ .|...|||.+....-. +..+++...+.++... .+|+||+++|+|..+
T Consensus 86 r~~~dindl~~l~dlGsG-tcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSG-TCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred ccccChHHhhhHHhhcCC-CccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 345566778888899999 8999999987 5689999999877644 4456777777777666 489999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
...++.||.| ...+++++.+-+..++|..+-++...++.||.||..+. +|||||+||+|||+|+.|+|||||||++..
T Consensus 164 ~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 164 TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccce
Confidence 9999999998 55778888777778999999999999999999998653 499999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHhhccccccCCCC--
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPK-- 900 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g---~~ys~ksDIWSLGvLLyELLTG~~PF~~~~-~~ei~~~I~~~~~~~~iP~-- 900 (960)
+... .......|.+.|||||.+.- ..|+.++||||||++++||.||+.||.+.+ ..+++..+. ...++.+|.
T Consensus 242 lvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-n~ePP~L~~~~ 319 (391)
T KOG0983|consen 242 LVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-NEEPPLLPGHM 319 (391)
T ss_pred eecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-hcCCCCCCccc
Confidence 7554 23345679999999999854 469999999999999999999999999854 345555554 355565654
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+++++.+|+..||.+|+.+||.+.+++++
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 479999999999999999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=314.27 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=205.8
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
.+.+..++|++.+.||.| .||.||++.+. ++.||||.+....... ....+..|+.++.++ .||||+++++++.+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g-~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSG-TCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeecc-CCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 456677899999999999 79999999885 8899999987654332 344566777777777 599999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
..+|+||||+. +.|.+++......+++..+..++.||+.||+|||+ .+ |+||||+|+||+++.++.+||+|||++.
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccch
Confidence 99999999985 57888776645578999999999999999999997 57 9999999999999999999999999997
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhccccccCCC-
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIP- 899 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~----ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~~~~~~~iP- 899 (960)
...... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||..... .+....+.. .....++
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (296)
T cd06618 164 RLVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-EEPPSLPP 241 (296)
T ss_pred hccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc-CCCCCCCC
Confidence 654332 222345788999999997654 78899999999999999999999976433 233333321 2222233
Q ss_pred -CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 900 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 900 -~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..++.++++||.+||..+|.+||++.+++++
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2478899999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=313.56 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=200.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------ 746 (960)
.++|++.++||.| .||.||++.+ +++.||||++............+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g-~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEG-TFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccC-CCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 5789999999999 6999999986 588999998876543333334567899999999999999999887443
Q ss_pred --CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 747 --PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 747 --~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
..+++||||+.+ +|..++......+++..++.++.||++||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccc
Confidence 347999999964 777777665567999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcc-----------cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc
Q 002146 825 RLKHNTFL-----------SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 892 (960)
Q Consensus 825 r~~~~~~~-----------~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~ 892 (960)
+....... ......|++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 86532211 11223568889999988764 4789999999999999999999999887765544332110
Q ss_pred ccc---------------------cCCC-------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 NRR---------------------LEIP-------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 ~~~---------------------~~iP-------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
... ...+ ..+.+.+.+||.+||..+|.+||++.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000 0001 2344678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.89 Aligned_cols=250 Identities=24% Similarity=0.300 Sum_probs=200.7
Q ss_pred eEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecC
Q 002146 678 LVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.+++.+|.| .++.|++++.+++.||||++............+.+|+.++++++|+||+++++++.....++++|||++
T Consensus 4 ~~i~~~~~~~-~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDL-MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCC-ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 3455666666 477777777789999999998765556667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc----
Q 002146 758 RGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---- 832 (960)
Q Consensus 758 gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~---- 832 (960)
+++|.+++.+. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999999753 336889999999999999999999999 99999999999999999999999998875432111
Q ss_pred ---cCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc--------------
Q 002146 833 ---SSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------- 893 (960)
Q Consensus 833 ---~~~t~~GT~~Y~APEvl~g~--~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-------------- 893 (960)
......++..|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 12234577889999998764 57899999999999999999999998765443321110000
Q ss_pred ------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ------------------~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.....+..++.++.+||.+||..||.+||++++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0001122345789999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.19 Aligned_cols=249 Identities=26% Similarity=0.349 Sum_probs=203.7
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC--CceEEEE
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIIT 753 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~l~LVm 753 (960)
|++.+.||.| .||.||++++ +++.||+|++............+.+|+.++++++|+||+++++++... ...++||
T Consensus 1 y~~~~~l~~g-~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEG-TYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccC-CCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 6788999999 6999999987 468999999986643333445678999999999999999999999888 8899999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 832 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~- 832 (960)
||+++ +|..++.+....+++..++.++.||+.||+|||..+ ++|+||||+|||++.++.+||+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 99974 899988776557899999999999999999999998 99999999999999999999999999987644321
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc----------------
Q 002146 833 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---------------- 895 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~---------------- 895 (960)
......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+......
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 12234578899999987754 5789999999999999999999999887765444332210000
Q ss_pred -------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 -------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 -------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+...++..+.++|.+||..+|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111137889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.96 Aligned_cols=240 Identities=24% Similarity=0.341 Sum_probs=195.7
Q ss_pred EeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHH-HHHHHHHH---HHHHHcCCCceeeEecccccCCceEEEEeec
Q 002146 683 RIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAA-LLEFKREV---KIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~-~~~~~~Ei---~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
.||.| .||.||+++. +++.||||++......... ...+..|. .+++...||||+++++++...+.+++||||+
T Consensus 1 ~ig~g-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRG-GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccC-CCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 37999 7999999975 5789999998765433211 11233333 3444558999999999999999999999999
Q ss_pred CCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002146 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 836 (960)
Q Consensus 757 ~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t 836 (960)
.|++|.+++.+.. .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 154 (278)
T cd05606 80 NGGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHA 154 (278)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcC
Confidence 9999999887643 6899999999999999999999998 999999999999999999999999998765332 2234
Q ss_pred CCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 837 TAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 837 ~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~---~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
..|+..|+|||++.+. .++.++||||||+++|+|++|..||.+... ......+ ......+|..++.++.++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHH
Confidence 5799999999999754 689999999999999999999999987632 2222222 223456777789999999999
Q ss_pred hhhhCCCCCC-----CHHHHHHH
Q 002146 913 CWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRP-----Sa~eILe~ 930 (960)
||..+|.+|| ++.+++++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhC
Confidence 9999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=344.03 Aligned_cols=260 Identities=32% Similarity=0.547 Sum_probs=228.5
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEEC---Cc--EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWN---GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 742 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~---g~--~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~ 742 (960)
..++-|..+++.+.|+||.| +||.|+.+.|+ |+ .||||+++...... ....|++|+.+|.+|+|||+|+|||+
T Consensus 102 ~lkclIpee~i~l~e~LG~G-sFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 102 DLKCLIPEEQIKLYELLGEG-SFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred CcceeccHHHHHHHHHhcCc-ceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeee
Confidence 34567788889999999999 89999999994 33 58999998765544 67799999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHHHHhhC-CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEec
Q 002146 743 VTRPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821 (960)
Q Consensus 743 f~~~~~l~LVmEY~~gGsL~dlL~k-~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DF 821 (960)
+.+ ..+.||||.+++|+|.+.|++ ....|....+..++.||+.||.||..++ +|||||-.+||||-....||||||
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DF 256 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDF 256 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecc
Confidence 988 678899999999999999987 4456888899999999999999999998 999999999999998889999999
Q ss_pred CccccccCCcccC---CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccC
Q 002146 822 GLSRLKHNTFLSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 897 (960)
Q Consensus 822 GLAr~~~~~~~~~---~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~ 897 (960)
||.+.+....... ....--.-|+|||.++...++.++|+|++||+|||||+ |..||.+....++++.|. ..+++.
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLp 335 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLP 335 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCC
Confidence 9999875432211 11122457999999999999999999999999999998 899999999999999998 778888
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 898 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 898 iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
-|+.|+.++.+++..||..+|.+||+|..|.+.+-.
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 999999999999999999999999999999865543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.87 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=204.5
Q ss_pred CeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCc
Q 002146 677 DLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~--~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~ 748 (960)
+|++.+.||.| .||.||+++. +|+.||+|++...... ......+.+|+.+++++ +|+||+++++.|+....
T Consensus 1 ~y~~~~~lg~G-~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTG-AYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccC-CcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 47899999999 7999999975 6789999998754321 12345678899999999 69999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999999987643 6888999999999999999999998 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHhhccccccCCCCC
Q 002146 829 NTF-LSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 829 ~~~-~~~~t~~GT~~Y~APEvl~g~--~ys~ksDIWSLGvLLyELLTG~~PF~~~~~----~ei~~~I~~~~~~~~iP~~ 901 (960)
... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... ..+...+ ......+|..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCcc
Confidence 321 122345689999999998763 467899999999999999999999975332 2222222 2234456778
Q ss_pred CcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 002146 902 LDPLVARIIWECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
+++.+.+|+.+||..+|.+|| ++.+++.+
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 899999999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=305.71 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=207.4
Q ss_pred CeEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecC---CCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQ---DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~---~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
+|.+.+.||.| .||.||++++. +..+++|.++.. .........+..|+.+++.++||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g-~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKG-SFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCC-CCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 48889999999 69999999763 344666655432 2233334467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 752 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
||||+++++|.+++.+ ....+++..++.++.|++.||.|||+.| ++|+||||+||+++. +.+||+|||+++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998863 3346899999999999999999999998 999999999999975 569999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
..........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+. ....+.++..++.++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNS 235 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHH
Confidence 44333445568899999999988889999999999999999999999998776666555543 23344566778899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
+|.+||..+|.+||++.+++++
T Consensus 236 li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 236 IMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHhcCChhhCcCHHHHhhC
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=334.87 Aligned_cols=259 Identities=35% Similarity=0.613 Sum_probs=230.1
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
.+|++...++.+..+||.| -||.||.+.|+ .-.||||.++... ..+.+|+.|..+|+.++|||+|+|+|+|..+
T Consensus 260 DkWEmeRtdItMkhKLGGG-QYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGG-QYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCC-cccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 4577777889999999988 89999999884 5679999876432 3467899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCC-CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~-~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
..+|||+|||..|+|.+||++..+ .++...+++|+.||..||+||..++ +|||||-.+|+|+.++..||++||||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999999987543 5778888999999999999999998 9999999999999999999999999999
Q ss_pred cccCCcccCCC-CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 826 LKHNTFLSSKS-TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 826 ~~~~~~~~~~t-~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
++....+.... ..-.+.|.|||-+....++.++|||+||++|||+.| |--||.+.+..+++..+. .+.+..-|..|+
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGCP 492 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGCP 492 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCCC
Confidence 98655443221 123568999999999999999999999999999998 889999999999888775 567888899999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+.+.+|+..||+..|..||+|.+|-+.|+.+
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 9999999999999999999999999999887
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=371.70 Aligned_cols=249 Identities=31% Similarity=0.455 Sum_probs=215.9
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+++-+..||.| .||.||-+.. +|+..|+|.++.+.........+.+|+.+|..|+|||+|+++|+-.+.+.++|.||
T Consensus 1236 rWqrg~~Ig~G-~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGG-TFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCc-ceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 34556789999 8999999975 78899999988776666666778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc--
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-- 832 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~-- 832 (960)
||+||+|.+++.. ++..+|.....+..|++.|+.|||++| ||||||||+||+|+.+|.+|++|||.|+.+.+...
T Consensus 1315 yC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999999999976 346778888888899999999999999 99999999999999999999999999988755421
Q ss_pred --cCCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHhhccccccCCCCCCcHHH
Q 002146 833 --SSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 833 --~~~t~~GT~~Y~APEvl~g~~---ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
.-+...||+-|||||+|.+.. ...+.|||||||++.||+||+.||...+.. ++...+. .+..+++|..++.+-
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSSEG 1470 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhHhH
Confidence 123567999999999997754 578999999999999999999999886543 3333333 567899999999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++||.+||..||.+|+++.||+++
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHh
Confidence 999999999999999999998875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.94 Aligned_cols=237 Identities=28% Similarity=0.433 Sum_probs=207.4
Q ss_pred eeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCC
Q 002146 684 IGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
||.| .||.||++.+ +++.||+|.+...... ......+..|+.++++++|+||+++++.++.....++||||+++++
T Consensus 1 lg~G-~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKG-SFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCC-CceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6889 6999999987 4889999998765443 2356678999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCC
Q 002146 761 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 840 (960)
Q Consensus 761 L~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT 840 (960)
|.+++.... .+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++..............++
T Consensus 80 L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 999997654 5899999999999999999999998 9999999999999999999999999998765432334456789
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCC
Q 002146 841 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 920 (960)
Q Consensus 841 ~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~k 920 (960)
..|++||.+.+...+.++|+|+||+++|+|++|..||...+..+....+.. ....+|..++..+.++|.+||..||.+
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~ 234 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTK 234 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence 999999999988899999999999999999999999988877666666543 456778888999999999999999999
Q ss_pred CCCHHH
Q 002146 921 RPSFAQ 926 (960)
Q Consensus 921 RPSa~e 926 (960)
||++.+
T Consensus 235 R~~~~~ 240 (250)
T cd05123 235 RLGSGG 240 (250)
T ss_pred CCCccc
Confidence 999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.88 Aligned_cols=248 Identities=27% Similarity=0.326 Sum_probs=201.3
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc---CCCceeeEecccccCCc----
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPN---- 748 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L---~HPNIVkL~g~f~~~~~---- 748 (960)
|++.+.||.| .||.||++++ +++.||||++............+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g-~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEG-AYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEeccc-CceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999 7999999987 478999999875443333334566788887776 59999999999988777
Q ss_pred -eEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 749 -LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 749 -l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
++++|||+.+ +|.+++.+.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999974 8988887643 36899999999999999999999998 99999999999999999999999999977
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc------------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------ 894 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~------------ 894 (960)
..... ......++..|+|||++.+..++.++|||||||++|+|++|.+||.+....+....+.....
T Consensus 157 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 64332 22334578899999999999999999999999999999999999998776655444321100
Q ss_pred --ccCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 --RLEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 --~~~i-----------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+ ...++..+.+||.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 11345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.92 Aligned_cols=245 Identities=29% Similarity=0.439 Sum_probs=206.3
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
|...++||.| .||+||+++. +++.|+||++..... .......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 23 ~~~~~~lg~g-~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHG-SFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccC-CCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 6667889999 7999999976 688999999875433 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+. ++|.+++......+++..++.++.||+.||.|||..| |+||||||+||+++.++.+||+|||++.... ..
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~ 174 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PA 174 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccC----CC
Confidence 995 5788887665557899999999999999999999998 9999999999999999999999999986432 22
Q ss_pred CCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 835 KSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
....|+..|+|||++. +..++.++|||||||++|+|++|..||...+.......+............++..+++||.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 3467899999999984 4568889999999999999999999999887766665554333222233457788999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||+.+|.+||++.+++.+
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 255 YCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=320.62 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=202.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc----CCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~----~~~l 749 (960)
++|++.+.||.| .||.||++.. +++.||+|++............+.+|+.+|++++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g-~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSG-AYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecC-CCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 679999999999 6999999975 68899999987654333445677889999999999999999998763 3468
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++||||+. ++|.+++...+ .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999995 68999987654 5899999999999999999999998 99999999999999999999999999976543
Q ss_pred Ccc----cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc-------------
Q 002146 830 TFL----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------------- 891 (960)
Q Consensus 830 ~~~----~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~------------- 891 (960)
... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 221 1123478999999999866 4588999999999999999999999987654332221110
Q ss_pred -----------cccccCC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 892 -----------QNRRLEI-----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 892 -----------~~~~~~i-----P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....... ....+.+++++|.+||+.+|.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0001111 13467899999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=329.43 Aligned_cols=260 Identities=31% Similarity=0.503 Sum_probs=221.9
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEECC-cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g-~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
.+++...+.++++||+| .||+|.+++..+ ..||||.++..... .....|.+|+++|.+|+|||||.++++|..++.+
T Consensus 533 ~EfPRs~L~~~ekiGeG-qFGEVhLCeveg~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEG-QFGEVHLCEVEGPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhcchhheehhhhhcCc-ccceeEEEEecCceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 46677889999999999 899999999876 89999998765443 3457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCC-CcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~-lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+||+||++.|+|..++.++... ........|+.||+.||+||.+.+ +|||||-+.|||++.++++||+|||+++.+.
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999999886533 356677789999999999999999 9999999999999999999999999999654
Q ss_pred CCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChhHHHHHhhcc------ccccCC
Q 002146 829 NTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMNPMQVVGAVGFQ------NRRLEI 898 (960)
Q Consensus 829 ~~~~~--~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT--G~~PF~~~~~~ei~~~I~~~------~~~~~i 898 (960)
...+. ....+-.++|||||.|...+++.++|+|+||+++||+++ ...||......++++..... ..-+..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 33221 223344679999999999999999999999999999765 78999999888887765321 112234
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
|.-++..+.++|.+||+.+-.+||+|++|...|...
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 678999999999999999999999999999988753
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.17 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=200.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC-----Cc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~-----~~ 748 (960)
++|++.++||.| .||.||++.+ +|+.||||++.... .......+.+|+.++++++|+||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G-~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEG-AYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEec-CCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 579999999999 6999999976 68899999886432 223345678899999999999999999876543 35
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++|+||+. ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 899999996 5888887653 5899999999999999999999999 9999999999999999999999999997653
Q ss_pred CCcc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc-------------
Q 002146 829 NTFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------------- 891 (960)
Q Consensus 829 ~~~~---~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~------------- 891 (960)
.... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3211 1123568999999998765 5689999999999999999999999987654322211100
Q ss_pred --c---------ccccC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 002146 892 --Q---------NRRLE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 935 (960)
Q Consensus 892 --~---------~~~~~-----iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--Le~i~ 935 (960)
. ..... .....+.++.+||.+||+.+|.+||++.+++++ ++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 00000 112457789999999999999999999999998 66553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.93 Aligned_cols=253 Identities=17% Similarity=0.218 Sum_probs=189.4
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCCh--HH-H------HHHHHHHHHHHHcCCCcee
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSG--AA-L------LEFKREVKIMRRLRHPNVV 737 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~--~~-~------~~~~~Ei~ILk~L~HPNIV 737 (960)
++...+|++.++||+| .||+||++.+. +..+|+|+........ +. . .....++..+..+.|+||+
T Consensus 8 ~i~~~~y~i~~~LG~G-~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCG-GFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecC-CCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 3455789999999999 69999999874 3356777543222111 00 0 0122334445567899999
Q ss_pred eEecccccCC----ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC
Q 002146 738 LFMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 813 (960)
Q Consensus 738 kL~g~f~~~~----~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~ 813 (960)
++++++.... ..++++|++. .++.+++... ...++..++.|+.|++.||.|||+++ |+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC
Confidence 9998765443 3467888874 4677766543 24678888999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccccCCc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHH
Q 002146 814 WNVKVSDFGLSRLKHNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQV 885 (960)
Q Consensus 814 g~VKL~DFGLAr~~~~~~-------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei 885 (960)
+.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 999999999998653211 112234699999999999999999999999999999999999999988732 222
Q ss_pred H--------HHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 886 V--------GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 886 ~--------~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
. ..+. .... ....+++++.+++..||..+|.+||++.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKRLH--EGKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHHhh--hhhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 1111 1111 23457899999999999999999999999998763
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.53 Aligned_cols=240 Identities=19% Similarity=0.341 Sum_probs=194.6
Q ss_pred CCeEEEEEe--eccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceE
Q 002146 676 EDLVLGERI--GLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 676 ~dy~i~k~L--G~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~ 750 (960)
++|.+.+.+ |.| .||.||++.. ++..+|+|.+........ |+.+...+ +||||+++++.|...+.++
T Consensus 14 ~~~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDG-KFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCC-CceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 345555555 999 7999999975 688899998865433221 22222222 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-cEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-~VKL~DFGLAr~~~~ 829 (960)
+||||+++++|.+++.+.. .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999999999997754 7899999999999999999999999 99999999999999988 999999999876543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHH--HHHhhccccccCCCCCCcHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--VGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei--~~~I~~~~~~~~iP~~lS~eLk 907 (960)
. ....|+..|+|||++.+..++.++||||||+++|+|++|..||........ .............+..+++.++
T Consensus 163 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 163 P----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN 238 (267)
T ss_pred C----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence 2 235689999999999999999999999999999999999999986543321 1111112334455667899999
Q ss_pred HHHHHhhhhCCCCCCC-HHHHHHH
Q 002146 908 RIIWECWQTDPSLRPS-FAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPS-a~eILe~ 930 (960)
+||.+||+.+|.+|++ +++++++
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcC
Confidence 9999999999999996 6988853
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=341.81 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=187.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEEC---CcEEEEEEe--------------ec-CCCChHHHHHHHHHHHHHHHcCCCce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADWN---GTEVAVKKF--------------LD-QDFSGAALLEFKREVKIMRRLRHPNV 736 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~~---g~~VAVK~i--------------~~-~~~~~~~~~~~~~Ei~ILk~L~HPNI 736 (960)
.++|+++++||+| .||+||++.+. +..+++|.+ .+ ..........+.+|+.+|++++||||
T Consensus 147 ~~~Y~ii~~LG~G-~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAG-AFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCC-CCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999 79999998642 222222211 10 11112234467899999999999999
Q ss_pred eeEecccccCCceEEEEeecCCCCHHHHhhCCC----CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC
Q 002146 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 812 (960)
Q Consensus 737 VkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~----~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~ 812 (960)
|++++++...+..|+|+|++. ++|..++.... .......+..|+.||+.||.|||++| ||||||||+||||+.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence 999999999999999999995 57777764321 12345667789999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CC--h-hHHHH
Q 002146 813 NWNVKVSDFGLSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MN--P-MQVVG 887 (960)
Q Consensus 813 ~g~VKL~DFGLAr~~~~~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~-~~--~-~ei~~ 887 (960)
++.+||+|||+++.+.... ......+||..|+|||++.+..++.++|||||||++|||++|..++.+ .. . .++..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999998764332 223346799999999999999999999999999999999998754432 21 1 11111
Q ss_pred Hhhccc-cccCCC----------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 888 AVGFQN-RRLEIP----------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 888 ~I~~~~-~~~~iP----------------------------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+.... ....+| ..++.++.++|.+||..||.+||++.|++.+
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111000 000000 1245678888999999999999999999874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.47 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=207.1
Q ss_pred CeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCc
Q 002146 677 DLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~--~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~ 748 (960)
+|++.+.||.| .||.||+++. +++.||||++...... ......+.+|+.++.++ +||||+++++.+.....
T Consensus 1 ~~~~~~~ig~G-~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTG-AYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccC-CCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 48899999999 7999999864 5678999998754322 22345678999999999 69999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++||||+.+++|.+++.+.. .+++..+..++.|++.+|.|||+.+ ++||||||.||+++.++.++|+|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999999987643 6888999999999999999999998 9999999999999999999999999987654
Q ss_pred CCcc-cCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHhhccccccCCCCC
Q 002146 829 NTFL-SSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 829 ~~~~-~~~t~~GT~~Y~APEvl~g~~--ys~ksDIWSLGvLLyELLTG~~PF~~~~~----~ei~~~I~~~~~~~~iP~~ 901 (960)
.... ......|+..|++||.+.+.. .+.++|+||||+++|+|++|..||..... .++...+ .......|..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKT 234 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCcc
Confidence 3321 123356899999999987765 68899999999999999999999964332 2222222 2234556777
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
++..++++|.+||..+|.+||++.++.+.|+..
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 899999999999999999999988777666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=315.29 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=201.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----- 747 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~----- 747 (960)
.++|++.+.||.| .||.||++.. ++..||||++............+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSG-AYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeec-CCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4679999999999 7999999975 6889999988654433444557889999999999999999999887654
Q ss_pred -ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 -NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 -~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 7799988865 35889999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-----------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------- 894 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~----------- 894 (960)
.... .....++..|++||++.+ ..++.++|+||||+++|+|++|..||.+.+.......+.....
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 168 TDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 5432 233567899999999876 4578999999999999999999999987665433322211000
Q ss_pred ------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 895 ------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 895 ------------------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
...+...+++.+.++|.+||..||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00112457788999999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.55 Aligned_cols=248 Identities=28% Similarity=0.416 Sum_probs=206.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+.|...+.||.| .||.||+++. ++..||||.+..... .......+.+|+++++.++|+||+++++++......++|
T Consensus 15 ~~~~~~~~lg~g-~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHG-SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeC-CCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 447778889999 7999999986 678899998865322 334456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+. ++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 99996 5888877654556899999999999999999999998 999999999999999999999999998765332
Q ss_pred cCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
....|+..|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.........+..++..+++|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 3456889999999985 34578899999999999999999999988776555544432222222344688899999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~L 931 (960)
|.+||..+|.+||++.+++++-
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCc
Confidence 9999999999999999999774
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.63 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=205.0
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|++.+.||.| .||.||+++. +++.||+|++............+..|+.++++++|+||+++++++.....+++||||
T Consensus 1 y~~~~~ig~g-~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEG-TYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred Ceeehccccc-CcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 5677889999 6999999986 588999999876543333445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~ 835 (960)
++ ++|.+++.+....+++..++.++.|++.||.|||..+ |+||||+|+||+++.++.+||+|||+++..........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 97 5899999876457899999999999999999999998 99999999999999999999999999987654332333
Q ss_pred CCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc----------------cccC-
Q 002146 836 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------RRLE- 897 (960)
Q Consensus 836 t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~----------------~~~~- 897 (960)
...++..|+|||.+.+. .++.++|||||||++|||++|..||.+.+..+....+.... ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 44567889999998776 78999999999999999999999998876544433221100 0000
Q ss_pred ----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 898 ----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 898 ----------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....++..+.++|.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 011346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.89 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=198.6
Q ss_pred Eeecc-CCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCC
Q 002146 683 RIGLG-SSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 759 (960)
Q Consensus 683 ~LG~G-GsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gG 759 (960)
.||.| |.||+||++++ +|+.||||++..........+.+.+|+.+++.++||||++++++|...+.+++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45555 25899999987 7899999998766555566678899999999999999999999999999999999999999
Q ss_pred CHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc-----
Q 002146 760 SLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS----- 833 (960)
Q Consensus 760 sL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~----- 833 (960)
+|.+++.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999987643 35889999999999999999999998 999999999999999999999999865432211110
Q ss_pred --CCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc----------------
Q 002146 834 --SKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------------- 893 (960)
Q Consensus 834 --~~t~~GT~~Y~APEvl~g~--~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~---------------- 893 (960)
.....++..|++||++.+. .++.++|||||||++|+|++|..||.+.........+....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 1112346679999999774 47899999999999999999999998765443322211000
Q ss_pred -----------------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhHH
Q 002146 894 -----------------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQR 936 (960)
Q Consensus 894 -----------------------------~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--Le~i~~ 936 (960)
.....+..+++.+++||.+||..||.+||++.+++++ ++.+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0011123466789999999999999999999999754 444433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.88 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=201.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccC--Cce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP--PNL 749 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~--~~l 749 (960)
.++|++.+.||.| .||.||++.+ +++.||||++............+.+|+.+++++ +||||++++++|... ..+
T Consensus 6 ~~~y~~~~~lg~g-~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKG-AYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCC-CCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3578899999999 6999999976 578999998865433334445677899999999 999999999987654 358
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+||||++ ++|..++... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999997 5999988764 6788889999999999999999998 99999999999999999999999999986543
Q ss_pred Ccc-----cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc----------
Q 002146 830 TFL-----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------- 893 (960)
Q Consensus 830 ~~~-----~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~---------- 893 (960)
... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 1223568999999998865 457899999999999999999999998765443332221100
Q ss_pred ----------------cc---cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ----------------RR---LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ----------------~~---~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. ......++.++.+||.+||+.+|.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 01112368899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.45 Aligned_cols=243 Identities=29% Similarity=0.429 Sum_probs=204.5
Q ss_pred EEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 681 GERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
..+||.| .||.||++.. +++.||||++.... ......+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 25 ~~~lg~g-~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEG-STGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCC-CCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 4679999 7999999976 68899999875432 23455688999999999999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002146 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 838 (960)
Q Consensus 759 GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~ 838 (960)
++|.+++... .+++..++.++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++..............
T Consensus 102 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 102 GALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 9999988653 5788999999999999999999998 99999999999999999999999999876543322233456
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cccCCCCCCcHHHHHHHHHhhhhC
Q 002146 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 839 GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
|+..|++||.+.+..++.++|+||||+++|+|++|..||.+....+....+.... ........++..+.++|.+||..+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 8999999999988889999999999999999999999998877665554442111 111223457889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 002146 918 PSLRPSFAQLTVA 930 (960)
Q Consensus 918 P~kRPSa~eILe~ 930 (960)
|.+||++.+++++
T Consensus 258 P~~R~~~~~ll~~ 270 (292)
T cd06657 258 PAQRATAAELLKH 270 (292)
T ss_pred cccCcCHHHHhcC
Confidence 9999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=314.12 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=200.9
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC-----
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP----- 746 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~----- 746 (960)
..++|++.+.||.| .||.||++.. +++.||||++............+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G-~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSG-AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeec-CCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 34789999999999 7999999974 688999999876433333445678899999999999999999987543
Q ss_pred -CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 747 -PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 747 -~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
...|++++++ +++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478888887 78999888653 5889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc----------
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------- 894 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~---------- 894 (960)
..... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 169 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 169 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 65322 234568899999999876 5688999999999999999999999987665443322211000
Q ss_pred -----------ccCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 -----------RLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 -----------~~~i--------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+ ....++++++||.+||+.||.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0001 12357889999999999999999999999977
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=316.85 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=202.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC------
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~------ 747 (960)
.+|.+.+.||.| .||.||++.+ +|+.||||++............+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g-~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSG-AYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeec-CCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 579999999999 7999999975 6889999998764433334456789999999999999999999886543
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+++|+||+. .+|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4689999996 47777663 25888999999999999999999999 999999999999999999999999999764
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-------------
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 893 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~------------- 893 (960)
... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 168 DAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 322 234567889999999876 458899999999999999999999999876544333221100
Q ss_pred --------cccCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 002146 894 --------RRLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 935 (960)
Q Consensus 894 --------~~~~i--------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--Le~i~ 935 (960)
..+.+ ....+..+.+||.+||+.||.+||++.+++.+ ++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00001 12467789999999999999999999999966 77664
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=314.47 Aligned_cols=247 Identities=24% Similarity=0.308 Sum_probs=198.6
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHH------------HHHHHHHHHHHHHcCCCceeeEeccc
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAA------------LLEFKREVKIMRRLRHPNVVLFMGAV 743 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~------------~~~~~~Ei~ILk~L~HPNIVkL~g~f 743 (960)
+.+.+.||.| .||+||++.. .++.||||++......... ...+.+|+.++++++|+||+++++++
T Consensus 11 ~~~~~~ig~G-~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (335)
T PTZ00024 11 IQKGAHLGEG-TYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY 89 (335)
T ss_pred hhhhhcccCC-CceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence 3456789999 6999999975 6889999988654322210 12467899999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 744 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
...+..++||||+. ++|.+++.... .+++.....++.||+.||+|||++| |+||||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 90 VEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred ecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCccc
Confidence 99999999999996 58999886543 6889999999999999999999999 99999999999999999999999999
Q ss_pred cccccCC--------------cccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 002146 824 SRLKHNT--------------FLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 888 (960)
Q Consensus 824 Ar~~~~~--------------~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~ 888 (960)
+...... ........++..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9765411 11112234688999999987654 68999999999999999999999998876554443
Q ss_pred hhcccccc--------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 889 VGFQNRRL--------------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 889 I~~~~~~~--------------------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
+......+ .....++.++.++|.+||+.+|.+||++++++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 32100000 011245788999999999999999999999996
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.50 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=217.3
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
+-+...+|.++.+||+| +|.+|.++++ +.+.||+|+++++-.. ++.++-++.|..+..+. +||++|-++.+|+++
T Consensus 245 ~~l~l~df~ll~vigrg-syakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRG-SYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred cccccccceeeeeecCc-chhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 34566889999999999 8999999976 6788999999876554 34566778899999888 899999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.++++|.||++||+|--++++.. ++++..+..+..+|..||+|||+.| ||+||||..|+|||..|++||+|+|+++.
T Consensus 324 srlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999988887654 7888888889999999999999999 99999999999999999999999999997
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CChhHHHHHhhccccccCCC
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-------MNPMQVVGAVGFQNRRLEIP 899 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~-------~~~~ei~~~I~~~~~~~~iP 899 (960)
-......+.++|||+.|+|||++.|..|...+|||+||++++||+.|+.||.- .+..+.+.++. ......+|
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-lekqirip 479 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-LEKQIRIP 479 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-hhhccccc
Confidence 66666778899999999999999999999999999999999999999999963 23333333332 44567789
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCC
Q 002146 900 KELDPLVARIIWECWQTDPSLRPS 923 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRPS 923 (960)
..++-.+..+++..|++||.+|..
T Consensus 480 rslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhcC
Confidence 999999999999999999999964
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.82 Aligned_cols=242 Identities=25% Similarity=0.408 Sum_probs=201.5
Q ss_pred CCeEEE-EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEeccccc----CC
Q 002146 676 EDLVLG-ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PP 747 (960)
Q Consensus 676 ~dy~i~-k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~----~~ 747 (960)
++|.+- ++||-| .-|+|..+.+ +++++|+|++... .+.++|+++.-.. .|||||.++++|+. ..
T Consensus 61 edY~is~qvLG~G-inGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 61 EDYSISWQVLGAG-INGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhheehhhhhccc-cCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 455553 789999 7899999865 7999999987543 2456788876666 79999999998753 46
Q ss_pred ceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecCc
Q 002146 748 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGL 823 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFGL 823 (960)
++.+|||.|+||.|+.-++.++ ..|+|.++..|++||..|+.|||+.+ |.||||||+|+|... +..+||+|||+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccc
Confidence 7899999999999999988654 46999999999999999999999999 999999999999974 56799999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHhhccccccCCC
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIP 899 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~----ei~~~I~~~~~~~~iP 899 (960)
|+..... ..-.+.|-|++|.|||++..++|+..+|+|||||++|-|++|.+||+..... .+..+|. .....||
T Consensus 211 AK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~--~gqy~FP 287 (400)
T KOG0604|consen 211 AKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR--TGQYEFP 287 (400)
T ss_pred ccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh--ccCccCC
Confidence 9876433 3455678999999999999999999999999999999999999999876432 2334443 2344454
Q ss_pred ----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 900 ----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 900 ----~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..++...+++|+.+|+.+|.+|.|+.+++.+
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 3478899999999999999999999999875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=315.36 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=203.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc----
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN---- 748 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~---- 748 (960)
.++|++.+.||.| .||.||++++ +++.||||++............+.+|+.++++++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g-~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSG-AYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccC-CceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4679999999999 6999999987 57889999886544334445567889999999999999999998876654
Q ss_pred --eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 749 --LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 749 --l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+++|+||+ +++|.+++... .+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 67999998753 5899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc----------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---------- 895 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~---------- 895 (960)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 168 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred cccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 5432 2345688999999998663 5789999999999999999999999887665544433211000
Q ss_pred ----------------c---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ----------------L---EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ----------------~---~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. .....++..+.+||.+||+.+|.+||++.+|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0112458899999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.35 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=199.1
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEEEEe
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~LVmE 754 (960)
|++.+.||.| .||.||+|.. +++.|+||++...... .......+|+..+++++ |+||+++++++...+..++|||
T Consensus 1 y~~~~~ig~g-~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDG-TFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccC-CceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999 6999999987 5788999988654322 22234457999999998 9999999999999999999999
Q ss_pred ecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 755 FLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|+ +++|.+++.... ..+++..+..++.|++.+|.|||+++ |+|+||+|.||+++.++.++|+|||++....... .
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-P 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-C
Confidence 99 789998887643 46899999999999999999999999 9999999999999999999999999998664332 2
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-----------------c
Q 002146 834 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----------------R 895 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-----------------~ 895 (960)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|++||......+....+..... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999998854 4578999999999999999999999987665433322210000 0
Q ss_pred c-----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 L-----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~-----------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. .+....+..+++||.+||..+|.+||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 0111236789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=339.82 Aligned_cols=147 Identities=28% Similarity=0.448 Sum_probs=132.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
+++|.++++||+| .||+||++.+. ++.||||++..... .......+.+|+.+++.++||||+++++++.....+||
T Consensus 3 ~~~y~i~~~LG~G-~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRG-AFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecC-CCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 5789999999999 79999999874 88999999876543 33445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
||||+.+++|.+++...+ .+++..++.|+.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999997644 5888899999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.27 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=196.6
Q ss_pred CeEEEEEeeccCCeeEEEEEEEC----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccc----cCC
Q 002146 677 DLVLGERIGLGSSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVT----RPP 747 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~----~~~ 747 (960)
+|++.+.||.| .||.||+++.. +..||||++............+.+|+.+++++ +||||+++++.+. ...
T Consensus 1 ~y~~~~~lg~G-~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQG-AYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEcccc-CCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 48899999999 69999999874 66899998865433333445678899999999 5999999998643 224
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+++||+. ++|..++... ..+++..++.++.||+.||.|||..| |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 5788999985 6899988654 36899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcc----cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc-----------
Q 002146 828 HNTFL----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF----------- 891 (960)
Q Consensus 828 ~~~~~----~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~----------- 891 (960)
..... ......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43211 1233568999999998766 5689999999999999999999999987654332221110
Q ss_pred ---------------cccccC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 892 ---------------QNRRLE---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 892 ---------------~~~~~~---iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...... .....+..+++||.+||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000011 112357899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=308.69 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=199.8
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc-CCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-~~~l~L 751 (960)
.++|++.+.||.| .||.||++.. +++.||||++.+..........+.+|+.+++.++||||++++++|.. ...+++
T Consensus 9 ~~~y~~~~~ig~g-~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMG-AFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeeccc-CCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4679999999999 6999999975 68899999886544333444567899999999999999999998865 567899
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+ +++|..++... .+++.....++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred Eeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 99999 56899888653 4788888889999999999999999 999999999999999999999999999754322
Q ss_pred ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc-------------------
Q 002146 832 LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------------------- 891 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~------------------- 891 (960)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 233567889999999866 5689999999999999999999999987654322111100
Q ss_pred -----cccccCC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 892 -----QNRRLEI-----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 892 -----~~~~~~i-----P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....... ...++..++++|.+||+.+|.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000111 13467899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.43 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=197.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC-------
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------- 746 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------- 746 (960)
.+|.+.+.||.| .||.||++.. +++.||+|++..... .....+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g-~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCG-SNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCC-CCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 679999999999 6999999976 688999999876543 3345678999999999999999999876554
Q ss_pred -------CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEE
Q 002146 747 -------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKV 818 (960)
Q Consensus 747 -------~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL 818 (960)
..+++||||++ ++|.+++... .+++..++.++.||+.||.|||+.| |+||||||+||+++ .++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 5898888643 5889999999999999999999999 99999999999998 4567999
Q ss_pred EecCccccccCCcc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc--
Q 002146 819 SDFGLSRLKHNTFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-- 892 (960)
Q Consensus 819 ~DFGLAr~~~~~~~---~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-- 892 (960)
+|||+++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999976533211 1122357889999998755 55789999999999999999999999877654433322110
Q ss_pred ---------------------cccc-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 ---------------------NRRL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 ---------------------~~~~-----~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.... .+...++.++++||.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 0123577889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=327.90 Aligned_cols=242 Identities=27% Similarity=0.381 Sum_probs=208.7
Q ss_pred EEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCC
Q 002146 681 GERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~g 758 (960)
.++||.| -||+||-+++ +|+.||||+|.+..+.......+++|+.||+++.||.||.|...|++.+++++|||-+.|
T Consensus 569 devLGSG-QFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSG-QFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCC-cceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 4789999 7999999975 799999999998877666667899999999999999999999999999999999999987
Q ss_pred CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecCccccccCCcccCC
Q 002146 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNTFLSSK 835 (960)
Q Consensus 759 GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFGLAr~~~~~~~~~~ 835 (960)
.-|+-+|...+.++++.....++.||+.||.|||-++ |+|+||||+|||+.. --.+||||||+|+.+.... ...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRr 724 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRR 724 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh-hhh
Confidence 7777778777778999999999999999999999999 999999999999964 3569999999999987653 345
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc--cccCCCCCCcHHHHHHHHHh
Q 002146 836 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--RRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 836 t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~--~~~~iP~~lS~eLkdLI~kc 913 (960)
+.+||+.|+|||++.++.|+..-||||.|+|+|--+.|.+||.... ++..+|.... .++..+..+++++.+||..+
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence 6889999999999999999999999999999999999999997643 2333332111 23333467899999999999
Q ss_pred hhhCCCCCCCHHHHH
Q 002146 914 WQTDPSLRPSFAQLT 928 (960)
Q Consensus 914 L~kDP~kRPSa~eIL 928 (960)
|+..-.+|.+.+.-+
T Consensus 803 LqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHhcchHhhc
Confidence 999999999987543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=311.87 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=197.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE----C--CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc-CCc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW----N--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~----~--g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-~~~ 748 (960)
..|++++.||+| +||.||++.. + ...+|||+|+.+.-....-....+|+.+++.|+|||||.+..+|.. +..
T Consensus 24 ~~ye~ig~Ig~G-TYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRG-TYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceeccc-ccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 568999999999 8999999943 1 3469999998663222222356799999999999999999999887 788
Q ss_pred eEEEEeecCCCCHHHHhhC----CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC----CcEEEEe
Q 002146 749 LSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----WNVKVSD 820 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k----~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~----g~VKL~D 820 (960)
++|++||.+. +|+.+|+- ....++...+..|++||+.|++|||+.. |+||||||.||||..+ |.|||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999976 88888752 2246889999999999999999999999 9999999999999876 9999999
Q ss_pred cCccccccCCcc---cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCh-------------h
Q 002146 821 FGLSRLKHNTFL---SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNP-------------M 883 (960)
Q Consensus 821 FGLAr~~~~~~~---~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~-------------~ 883 (960)
||+++.+.+... .....+-|.+|+|||.+.|.. |+.++|||++|||+.||++..+.|.+... .
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999999876533 334556799999999999876 89999999999999999999888876321 1
Q ss_pred HHHHHhhccc--ccc---CCC--------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 884 QVVGAVGFQN--RRL---EIP--------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 884 ei~~~I~~~~--~~~---~iP--------------------------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+++.+..-. ..+ .+| +.-++...+|+.+||..||.+|.|+++.+++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1111111000 000 001 1123457899999999999999999998765
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.79 Aligned_cols=241 Identities=27% Similarity=0.409 Sum_probs=204.2
Q ss_pred EEEeeccCCeeEEEEEE--ECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecC
Q 002146 681 GERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak--~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
.+.||+| +|+.|--+. .+|..||||++.+. ......++.+|++++.++ .|+||++++++|+++.++|||||-|.
T Consensus 83 ~e~LGeG-AyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEG-AYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCc-cceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 3679999 899998885 48999999998776 334566889999999999 69999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC---cEEEEecCccccccCCc---
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLKHNTF--- 831 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g---~VKL~DFGLAr~~~~~~--- 831 (960)
||.|..+|+++. -|+|.+..++..+|+.||.+||.+| |.||||||+|||..... -||||||.|...+....
T Consensus 160 GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred CchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999999998754 6899999999999999999999999 99999999999997544 48999999987543211
Q ss_pred ----ccCCCCCCCCCccCcccc---cC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------hhHHHH
Q 002146 832 ----LSSKSTAGTPEWMAPEVL---RN--EPSNEKCDVYSFGVILWELATLKLPWIGMN---------------PMQVVG 887 (960)
Q Consensus 832 ----~~~~t~~GT~~Y~APEvl---~g--~~ys~ksDIWSLGvLLyELLTG~~PF~~~~---------------~~ei~~ 887 (960)
..-.+.+|+.+|||||+. .+ ..|+.++|.||||+|+|-||.|++||.+.- ...+++
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 112356799999999985 33 358999999999999999999999997642 235566
Q ss_pred HhhccccccCCCC----CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 888 AVGFQNRRLEIPK----ELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 888 ~I~~~~~~~~iP~----~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
.| +....+||. .++.+.++||..+|..++.+|.++.+++.
T Consensus 317 sI--QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SI--QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HH--hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 66 566777774 58899999999999999999999998887
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=334.88 Aligned_cols=261 Identities=33% Similarity=0.573 Sum_probs=226.4
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeE
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 739 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL 739 (960)
.+++..+++.+.+.||.| .||.|+++... ...||||.++..... .....+..|+++|+.+ .|+|||.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g-~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEG-AFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecc-cccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 788888999999999999 89999999631 346999987765444 6677899999999999 69999999
Q ss_pred ecccccCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccC
Q 002146 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 804 (960)
Q Consensus 740 ~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLK 804 (960)
+|++.+...+++|+||+..|+|..++.+.+ ..+....++.+++||+.||+||++.. +|||||-
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLA 445 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLA 445 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhh
Confidence 999999999999999999999999998765 34888999999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCc-ccCCCCCC--CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 805 SPNLLVDKNWNVKVSDFGLSRLKHNTF-LSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 805 PeNILLd~~g~VKL~DFGLAr~~~~~~-~~~~t~~G--T~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
.+||||.++..+||+|||+++...... +......| -..|||||.+....|+.++||||+|+++||+++ |..||.+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999999654332 22222233 346999999999999999999999999999999 88999986
Q ss_pred C-hhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 881 N-PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 881 ~-~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
. ..++...+ ..+.+...|..+++++.+|++.||+.+|++||+|.++.+.|+.+.
T Consensus 526 ~~~~~l~~~l-~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 526 PPTEELLEFL-KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CcHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 6 55565544 467788999999999999999999999999999999999999953
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=328.70 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=218.3
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEE--ECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEeccccc----
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR---- 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak--~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~---- 745 (960)
.+.+-|++++.||.| .||.||+++ ++++.+|||+.......+ ++++.|.+||+.+ .|||++.++++|..
T Consensus 16 dp~d~~ei~evig~G-tygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNG-TYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeec-cceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 344669999999999 899999996 489999999876543332 4678899999998 79999999999854
Q ss_pred -CCceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 746 -PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 746 -~~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
++++|||||||.||+.-|+++.. +..+.|..+.+|++.++.||.|||... +||||||-.|||++.+|.|||+|||+
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeee
Confidence 46799999999999999998753 557999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g~~-----ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i 898 (960)
+..+........+..||+.|||||++...+ |+..+|+||||++..||--|.+|+.++.+...+..|... .++.+
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkL 248 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKL 248 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccc
Confidence 998887777788899999999999996543 678999999999999999999999999999888887533 22222
Q ss_pred --CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 899 --PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 899 --P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
|..++.++.+||..||.+|-.+||+..+++++
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 56788999999999999999999999988754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=308.65 Aligned_cols=253 Identities=35% Similarity=0.639 Sum_probs=210.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc--CCCceeeEecccccCC----ce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL--RHPNVVLFMGAVTRPP----NL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L--~HPNIVkL~g~f~~~~----~l 749 (960)
.++++.+.||+| .||+||+|+|.|+.||||+|...+. ..+.+|.+|++.. +|+||+.|+++-..+. ++
T Consensus 211 rqI~L~e~IGkG-RyGEVwrG~wrGe~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKG-RFGEVWRGRWRGEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred heeEEEEEecCc-cccceeeccccCCceEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 568899999999 8999999999999999999865432 3567888888875 9999999998865443 59
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh------CCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT------STPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs------~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
|||++|.+.|+|+|||.+ ..++....+++++.++.||+|||. ..|+|.|||||..||||..+|...|+|+||
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999987 369999999999999999999996 235799999999999999999999999999
Q ss_pred cccccCC----cccCCCCCCCCCccCcccccCCCC------CchhhHHHHHHHHHHHHhC----------CCCCCCCCh-
Q 002146 824 SRLKHNT----FLSSKSTAGTPEWMAPEVLRNEPS------NEKCDVYSFGVILWELATL----------KLPWIGMNP- 882 (960)
Q Consensus 824 Ar~~~~~----~~~~~t~~GT~~Y~APEvl~g~~y------s~ksDIWSLGvLLyELLTG----------~~PF~~~~~- 882 (960)
|...... ....+..+||.+|||||++...-. -..+||||||+++||+... ++||++..+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9865332 233556789999999999865431 2568999999999998752 589987543
Q ss_pred ----hHHHHHhhccccccCCCCCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 883 ----MQVVGAVGFQNRRLEIPKELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 883 ----~ei~~~I~~~~~~~~iP~~lS-----~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.++..-+.....++.+|..+. ..+.+|++.||..+|.-|.++-.|.+.|.++.+
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 455555666777888876543 346789999999999999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=321.88 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=203.1
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
+....-|..++.||-| +||+|.+++. +...||+|.+++.+. .......++.|..||.....+-||+||..|++.++
T Consensus 625 KMdKSmFvkik~iGvG-AFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVG-AFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hccccceEEEeeeccc-ccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 4455669999999999 8999999975 556799999877553 34455678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+||+|++||++-.+|-+.+ .|.|..++.++.++.+|+++.|..| +|||||||.|||||.+|+|||+||||+.-+.
T Consensus 704 LYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999999887755 6888888888889999999999999 9999999999999999999999999996421
Q ss_pred ---CC---------------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHH
Q 002146 829 ---NT---------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVI 866 (960)
Q Consensus 829 ---~~---------------------------------------~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvL 866 (960)
+. .......+||+.|+|||++....|+..+|||+.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 00 011123469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHhhccccccCC--CCCCcHHHHHHHHHhhhhCCCCCC
Q 002146 867 LWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARIIWECWQTDPSLRP 922 (960)
Q Consensus 867 LyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i--P~~lS~eLkdLI~kcL~kDP~kRP 922 (960)
||||+.|++||....+.+...++..=...+.+ ..++++++.+||.+++ .+++.|.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 99999999999988776665554321122333 3579999999998765 4566665
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=285.48 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=209.6
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+|.-.++||+| +||+||+++. +++.||+|.++..+-.+.......+|+-+|+.++|.|||++++....++.+.+|+|
T Consensus 3 ~ydkmekigeg-tygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEG-TYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCC-cceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35556789999 8999999975 67889999998776666666778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
||. .+|..+.....+.++......++.|+++||.++|+++ +.||||||.|+||+.+|++||+|||+++.++-...-.
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 995 5899888776667899999999999999999999999 9999999999999999999999999999887664444
Q ss_pred CCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcccccc----------------
Q 002146 835 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL---------------- 896 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~---------------- 896 (960)
...+-|.+|.+|.++.|.+ |+...|+||.|||+.|+.. |++.|.+.+-.+.+.+|...-..+
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 4567799999999998876 8999999999999999997 778888877665555543311111
Q ss_pred --CCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 --EIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 --~iP---------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+| +.++..-++|++++|.-+|.+|.+++..+++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 011 1233456899999999999999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=290.79 Aligned_cols=218 Identities=21% Similarity=0.262 Sum_probs=182.6
Q ss_pred cCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCCHHHH
Q 002146 687 GSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 764 (960)
Q Consensus 687 GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGsL~dl 764 (960)
| .||.||+++. +++.||+|.+.... .+.+|...+....||||+++++++......++||||+++++|.++
T Consensus 4 g-~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 G-VIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred c-ccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 5 7999999976 78899999986542 223455555666899999999999999999999999999999999
Q ss_pred hhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCcc
Q 002146 765 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844 (960)
Q Consensus 765 L~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~ 844 (960)
+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....++..|+
T Consensus 76 l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~ 149 (237)
T cd05576 76 ISKFL-NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYC 149 (237)
T ss_pred HHHhc-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCcccc
Confidence 87643 5889999999999999999999998 999999999999999999999999988665432 22345677899
Q ss_pred CcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 002146 845 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 924 (960)
Q Consensus 845 APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa 924 (960)
|||.+.+..++.++|+||||+++|+|++|..||...... .. ......+|..+++.+++||.+||+.||.+|+++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN-----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc-----cccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 999998888999999999999999999999887643211 11 112345677789999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=339.84 Aligned_cols=243 Identities=31% Similarity=0.465 Sum_probs=195.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--------
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-------- 745 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-------- 745 (960)
.+|+.++.||+| .||.||+++. +|+.||||+|.... ......++.+|+.+|.+|+|||||+++.+|.+
T Consensus 479 ~DFEEL~lLGkG-GFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKG-GFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCC-CCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 567888999999 5999999975 89999999998765 66677789999999999999999998754300
Q ss_pred --------------------------------------------------------------------------------
Q 002146 746 -------------------------------------------------------------------------------- 745 (960)
Q Consensus 746 -------------------------------------------------------------------------------- 745 (960)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC
Q 002146 746 -----------------------P--------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794 (960)
Q Consensus 746 -----------------------~--------~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~ 794 (960)
+ ..+||-||||+...|.+++.+++..-.....|+++++|++||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 237889999999888888887663335788999999999999999999
Q ss_pred CCCEEEeccCCCcEEEcCCCcEEEEecCcccccc------------------CCcccCCCCCCCCCccCcccccCCC---
Q 002146 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH------------------NTFLSSKSTAGTPEWMAPEVLRNEP--- 853 (960)
Q Consensus 795 g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~------------------~~~~~~~t~~GT~~Y~APEvl~g~~--- 853 (960)
| ||||||||.||++++++.|||+|||+|.... ......+..+||.-|+|||++.+..
T Consensus 717 g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 G--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred c--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9 9999999999999999999999999998611 0011234567999999999997765
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHhhccccccCCCCC------CcHHHHHHHHHhhhhCCCCCCCHHH
Q 002146 854 SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKE------LDPLVARIIWECWQTDPSLRPSFAQ 926 (960)
Q Consensus 854 ys~ksDIWSLGvLLyELLTG~~PF~~-~~~~ei~~~I~~~~~~~~iP~~------lS~eLkdLI~kcL~kDP~kRPSa~e 926 (960)
|+.|+|||||||+||||+. ||.. +....++..+. .+.+|.. .-+.-+.+|++||+.||.+|||+.|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR----~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR----KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc----cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 9999999999999999995 5543 23333444432 3333322 2245678999999999999999999
Q ss_pred HHH
Q 002146 927 LTV 929 (960)
Q Consensus 927 ILe 929 (960)
+|.
T Consensus 868 LL~ 870 (1351)
T KOG1035|consen 868 LLN 870 (1351)
T ss_pred Hhh
Confidence 985
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=326.40 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=203.0
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC------ce
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------NL 749 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~------~l 749 (960)
+...+.||+| +||.||++++ +|+.||||.++... .....+...+|+++|++|+|+|||++++.-++.. ..
T Consensus 15 W~~~e~LG~G-a~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKG-AFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCC-ccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4456789999 6999999985 79999999987754 2334567789999999999999999998865543 46
Q ss_pred EEEEeecCCCCHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc--CCC--cEEEEecCc
Q 002146 750 SIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNW--NVKVSDFGL 823 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~--~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd--~~g--~VKL~DFGL 823 (960)
.+|||||.||+|...|++.. ..+++.+++.++.+++.||.|||.+| ||||||||.||++- ++| ..||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 78999999999999998643 47999999999999999999999999 99999999999994 323 479999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH----HHHHhhc-------
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVGF------- 891 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e----i~~~I~~------- 891 (960)
|+...... ...+++||..|++||++.. +.|+..+|.|||||++|+++||..||......+ +...+..
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 99886653 5677899999999999984 889999999999999999999999997643331 2222111
Q ss_pred ------ccccc------CCCCCCcHH----HHHHHHHhhhhCCCCCC--CHHHHHHHHHHhHHh
Q 002146 892 ------QNRRL------EIPKELDPL----VARIIWECWQTDPSLRP--SFAQLTVALKPLQRL 937 (960)
Q Consensus 892 ------~~~~~------~iP~~lS~e----LkdLI~kcL~kDP~kRP--Sa~eILe~Le~i~~~ 937 (960)
.+.+. ++|-.++.. +-..+..+|..+|++|. .+.+....+..|.+.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 01111 123334433 44566678899999999 888888888877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=322.96 Aligned_cols=238 Identities=23% Similarity=0.335 Sum_probs=201.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~L 751 (960)
.++|.+...+|.| +|+.|..+.. +++.+++|++.+... ...+|+.++... +||||+++++.+.+....|+
T Consensus 321 ~~~y~~~~~~~~g-s~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEG-SFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCC-Cccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 3567777789999 8999999875 788899999876521 234677666666 79999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE-cCCCcEEEEecCccccccCC
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-DKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL-d~~g~VKL~DFGLAr~~~~~ 830 (960)
|||++.|+.|.+-+.... ....++..|+.+|+.|+.|||.+| ||||||||+|||+ +..|+++|||||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999888776543 222777789999999999999998 9999999999999 69999999999999876544
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHhhccccccCCCCCCcHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
..+.|-|..|.|||++....|++++||||||++||+||+|+.||...... ++...+ ..+.+...+|.++++|
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKdL 542 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKDL 542 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHHH
Confidence 34557789999999999999999999999999999999999999876544 444444 2455557899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
|++||+.||.+|+++.++..+
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHhccCChhhCcChhhhccC
Confidence 999999999999999998865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.26 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=208.4
Q ss_pred CccccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEeccc
Q 002146 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 743 (960)
Q Consensus 667 ~~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f 743 (960)
+...+++..++++-...||.| +||+|++-.+ .|+..|||+++.... +....+++.|.+..++- +.||||+|||+.
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G-~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNG-AFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred cccccccccchHHHHHHhcCC-cchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 334556667778888889999 8999999876 688999999987765 45566888888887776 789999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHhhC----CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 744 TRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL~dlL~k----~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
..++..||.||.| ..+|..+... ....++|..+-.|....+.||.||... .+|||||+||+||||+..|.||||
T Consensus 133 F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 133 FSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred hcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeee
Confidence 9999999999999 4577665432 334689999999999999999999764 249999999999999999999999
Q ss_pred ecCccccccCCcccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHhhcccccc
Q 002146 820 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL 896 (960)
Q Consensus 820 DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-ei~~~I~~~~~~~ 896 (960)
|||++..+... .......|...|||||.+.. ..|+.++|+||||++|||+.||.+|+++++.. +.+..+. .+.++
T Consensus 211 DFGIcGqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-~gdpp 288 (361)
T KOG1006|consen 211 DFGICGQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-IGDPP 288 (361)
T ss_pred cccchHhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-cCCCC
Confidence 99999876544 23344678999999999954 35899999999999999999999999997652 1222222 22233
Q ss_pred CC--CC---CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 EI--PK---ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 ~i--P~---~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+ +. +++..+..+|.-||.+|-..||.+.+++++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22 22 378899999999999999999999998864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=272.96 Aligned_cols=235 Identities=31% Similarity=0.491 Sum_probs=198.2
Q ss_pred eeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCCHHHHhhC
Q 002146 690 YGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 767 (960)
Q Consensus 690 FG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k 767 (960)
||.||++.+ +++.||+|++........ ...+.+|++++++++|+||+++++.+......++++||+.+++|..++..
T Consensus 2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 2 FGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred ceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 899999987 468999999876543322 56889999999999999999999999999999999999999999999876
Q ss_pred CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcc
Q 002146 768 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847 (960)
Q Consensus 768 ~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APE 847 (960)
.. .+++..++.++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||++....... ......++..|++||
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE 156 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPE 156 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHH
Confidence 44 3889999999999999999999998 9999999999999999999999999998765432 334566889999999
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHhhccccccCCCCC-CcHHHHHHHHHhhhhCCCCCCCHH
Q 002146 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKE-LDPLVARIIWECWQTDPSLRPSFA 925 (960)
Q Consensus 848 vl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~-~~~~ei~~~I~~~~~~~~iP~~-lS~eLkdLI~kcL~kDP~kRPSa~ 925 (960)
.+.+..++.++|||+||+++|+|++|..||.. .+...+...+............ ++.++.+++.+||..+|.+||++.
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 236 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE 236 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence 99988899999999999999999999999988 4555554444322111111111 788999999999999999999999
Q ss_pred HHHH
Q 002146 926 QLTV 929 (960)
Q Consensus 926 eILe 929 (960)
++++
T Consensus 237 ~~~~ 240 (244)
T smart00220 237 EALQ 240 (244)
T ss_pred HHhh
Confidence 9987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=303.87 Aligned_cols=254 Identities=32% Similarity=0.507 Sum_probs=210.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc--CCCceeeEecccccCC----ce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL--RHPNVVLFMGAVTRPP----NL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L--~HPNIVkL~g~f~~~~----~l 749 (960)
..+++.++||+| .||.||+|..+++.||||+|.. .....+++|.+|+... +|+||++|+++-.... .+
T Consensus 210 ~pl~l~eli~~G-rfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRG-RFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcC-ccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 456778889999 7999999999999999999753 4456788888888775 8999999999877666 79
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC-------CCCEEEeccCCCcEEEcCCCcEEEEecC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-------TPTIVHRDLKSPNLLVDKNWNVKVSDFG 822 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~-------g~~IIHRDLKPeNILLd~~g~VKL~DFG 822 (960)
+||+||.+.|+|.+||..+ ..++....+|+.-|++||+|||.. +++|+|||||..||||..+++..|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999999874 599999999999999999999973 3479999999999999999999999999
Q ss_pred ccccccCCc--ccCCCCCCCCCccCcccccCCCC------CchhhHHHHHHHHHHHHhCC------------CCCC----
Q 002146 823 LSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPS------NEKCDVYSFGVILWELATLK------------LPWI---- 878 (960)
Q Consensus 823 LAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~y------s~ksDIWSLGvLLyELLTG~------------~PF~---- 878 (960)
||..+.... ......+||.+|||||++.|... =.+.||||+|.++|||++.. +||.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 998875332 22334689999999999977542 24689999999999999864 3332
Q ss_pred -CCChhHHHHHhhccccccCCCCCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 879 -GMNPMQVVGAVGFQNRRLEIPKELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 879 -~~~~~ei~~~I~~~~~~~~iP~~lS-----~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.....++...+.....++.+|..+- .-+++.++.||..||+.|.|+.=+.+.+..+...
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 1233456666666778888886532 4589999999999999999999999999888655
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=336.42 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=192.1
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.|...+.||+| .||.||+|++ ++..||||++...... ...|++++++++|||||++++++.+....|+|||
T Consensus 691 ~~~~~~~ig~G-~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRG-KKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccC-CCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 45667789999 7999999985 7889999987643321 1356889999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|+++|+|.++++. +++..+..|+.||+.||+|||.. .++|+||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999999999963 78899999999999999999943 2349999999999999998888875 666543321
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHhh--cccc------ccCC-----
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVG--FQNR------RLEI----- 898 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~--~ei~~~I~--~~~~------~~~i----- 898 (960)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+..... .... .+.+
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 2234688999999999999999999999999999999999999954211 11111100 0000 0111
Q ss_pred -CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 899 -PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 899 -P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+.....++.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 111223578899999999999999999999999998653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=315.31 Aligned_cols=253 Identities=30% Similarity=0.546 Sum_probs=221.6
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CC----cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NG----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g----~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
++..++||.| +||+||+|.| .| .+||||++.... ....-.++.+|.-+|.+|+|||++++++++.... +.|
T Consensus 698 lkk~kvLGsg-AfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSG-AFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccc-cceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4557899999 8999999987 33 468999876543 3344568899999999999999999999998876 889
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
|++|+++|.|.+|++.++..+-.+.++.|.+||++||.|||.+. ++||||-.+||||..-.+||+.|||+++......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999999988888999999999999999999999988 9999999999999999999999999999876543
Q ss_pred ccCCCCCC--CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 832 LSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 832 ~~~~t~~G--T~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.......| -+.|||=|.+....|+.++|||||||++||||| |..|+.+....++...+. ...++.-|+.++-++..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTIDVYM 931 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHHHHH
Confidence 33322223 468999999999999999999999999999998 999999999888877665 45568889999999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
++.+||..|+..||+|+++...+.++.+
T Consensus 932 ~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 9999999999999999999999988854
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=292.79 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=204.0
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------ 746 (960)
...|+-..+||+| .||+||+++. .|+.||+|++..+...........+|+.+|..|+|+|++.+++.|...
T Consensus 16 ~~~yek~~kigqG-tfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQG-TFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCc-hHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3456667889999 8999999975 678899987665443333344567999999999999999999887432
Q ss_pred --CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 747 --PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 747 --~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
..+||||.+|+. +|+-+|.....+++..++.+++.+++.||.|+|+.. |+|||+|++|+||+.+|.+||+|||++
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccc
Confidence 348999999965 999999888778999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCc----ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc--c--
Q 002146 825 RLKHNTF----LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--R-- 895 (960)
Q Consensus 825 r~~~~~~----~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~--~-- 895 (960)
+.+.... ......+-|.+|++||.+.|.. |+.+.|||+.||++.||.++.+-|.+....+.++.|...-. .
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 8754221 1233456799999999998865 89999999999999999999999998877665554432100 0
Q ss_pred ----------------cCCC-------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 896 ----------------LEIP-------------KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 896 ----------------~~iP-------------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~L 931 (960)
.++| ..-+++..+|+.++|..||.+|+++.+++.+.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0011 12345788999999999999999999988763
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=298.91 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=203.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCC-CChHH----HHHHHHHHHHHHHcCCCceeeEecccc-cC
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQD-FSGAA----LLEFKREVKIMRRLRHPNVVLFMGAVT-RP 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~-~~~~~----~~~~~~Ei~ILk~L~HPNIVkL~g~f~-~~ 746 (960)
-++|.++.+||+|| |..||++-. ..+.||||+-.... ..++. .+...+|.+|.+.|.||.||++|++|. +.
T Consensus 462 n~RYLlLhLLGrGG-FSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGG-FSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHhcccc-HHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 35688899999995 999999954 67789999654332 22222 234678999999999999999999986 45
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc---CCCcEEEEecCc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGL 823 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd---~~g~VKL~DFGL 823 (960)
+.+|-|+|||+|.+|..||...+ .++++++..|+.||+.||.||....++|||-||||.|||+- .-|.|||+||||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 56889999999999999997654 78999999999999999999999999999999999999995 458899999999
Q ss_pred cccccCCccc-------CCCCCCCCCccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhc
Q 002146 824 SRLKHNTFLS-------SKSTAGTPEWMAPEVLRNE----PSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGF 891 (960)
Q Consensus 824 Ar~~~~~~~~-------~~t~~GT~~Y~APEvl~g~----~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~ 891 (960)
++.+....+. +....||.||++||++.=. +.+.++||||+|||||.++.|+.||..... .++++....
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9987544322 3456799999999997433 358899999999999999999999976533 334333211
Q ss_pred -cccccCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 892 -QNRRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 892 -~~~~~~iP--~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
......|| +.++.++++||++||...-+.|.+..+|..
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 22344455 358899999999999999999999888764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=303.88 Aligned_cols=249 Identities=18% Similarity=0.216 Sum_probs=171.0
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--C----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc---
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--N----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA--- 742 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~--- 742 (960)
.+..++|++.++||+| .||.||++.+ + +..||||++......+ ....| .++...+.+++.++..
T Consensus 128 ~~~~~~y~l~~~LG~G-~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEG-AFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeC-CCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhc
Confidence 3456889999999999 6999999986 4 6789999875432111 11111 1222223333333322
Q ss_pred ---cccCCceEEEEeecCCCCHHHHhhCCCCC-------------------CcHHHHHHHHHHHHHHHHHHhhCCCCEEE
Q 002146 743 ---VTRPPNLSIITEFLPRGSLFRILHRPHCQ-------------------VDEKRRIKMALDVARGMNCLHTSTPTIVH 800 (960)
Q Consensus 743 ---f~~~~~l~LVmEY~~gGsL~dlL~k~~~~-------------------lse~~~~~Ia~QIa~AL~YLHs~g~~IIH 800 (960)
......++|||||+.+++|.+++...... ..+..+..|+.||+.||+|||+++ |||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 24566799999999999999998754311 123345678999999999999998 999
Q ss_pred eccCCCcEEEcC-CCcEEEEecCccccccCC-cccCCCCCCCCCccCcccccCCC----------------------CCc
Q 002146 801 RDLKSPNLLVDK-NWNVKVSDFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNEP----------------------SNE 856 (960)
Q Consensus 801 RDLKPeNILLd~-~g~VKL~DFGLAr~~~~~-~~~~~t~~GT~~Y~APEvl~g~~----------------------ys~ 856 (960)
|||||+||||+. ++.+||+|||+++..... ......++|++.|+|||++.... ++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999999985 689999999999865322 12234568999999999764322 345
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-------------ccc------CCCCCCcHHHHHHHHHhhhhC
Q 002146 857 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------RRL------EIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 857 ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-------------~~~------~iP~~lS~eLkdLI~kcL~kD 917 (960)
++|||||||++|||+++..++... .......+.... ... .+........++||.+||++|
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 679999999999999977765432 111111110000 000 001112234568999999999
Q ss_pred CCCCCCHHHHHHH
Q 002146 918 PSLRPSFAQLTVA 930 (960)
Q Consensus 918 P~kRPSa~eILe~ 930 (960)
|.+||++.+++++
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=286.30 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=197.9
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-C-C----ceeeEeccccc
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-P----NVVLFMGAVTR 745 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-H-P----NIVkL~g~f~~ 745 (960)
...+|.+.+.+|+| +||.|..+.. .+..||||+++.- ....+..+-|+++|+++. + | -+|++.+||..
T Consensus 87 l~~Ry~i~~~lGeG-tFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEG-TFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCC-cccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 35789999999999 8999999854 4678999988643 223345567999999993 3 3 38899999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC------------
Q 002146 746 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK------------ 812 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~------------ 812 (960)
.++.+||+|.+ |-+++++|..+ ...++...+..|++||++++++||+.+ ++|-||||+|||+-.
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999998 77999999874 457899999999999999999999999 999999999999932
Q ss_pred --------CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH
Q 002146 813 --------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 884 (960)
Q Consensus 813 --------~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e 884 (960)
+..|||+|||.|+..+.. ....+.|..|+|||++.+-.|+..+||||+||||+||++|...|+..+..+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 345999999999876543 245778999999999999999999999999999999999999998876544
Q ss_pred HH---HHhhc----------------cccccCCCC-------------------------CCcHHHHHHHHHhhhhCCCC
Q 002146 885 VV---GAVGF----------------QNRRLEIPK-------------------------ELDPLVARIIWECWQTDPSL 920 (960)
Q Consensus 885 i~---~~I~~----------------~~~~~~iP~-------------------------~lS~eLkdLI~kcL~kDP~k 920 (960)
.+ +.|.- ...++..|. ....++.+||++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 22 22210 000111110 01135899999999999999
Q ss_pred CCCHHHHHHH
Q 002146 921 RPSFAQLTVA 930 (960)
Q Consensus 921 RPSa~eILe~ 930 (960)
|+|+.|++.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=244.39 Aligned_cols=211 Identities=38% Similarity=0.636 Sum_probs=185.6
Q ss_pred eeccCCeeEEEEEEEC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCCH
Q 002146 684 IGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 761 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGsL 761 (960)
||.| .+|.||++... ++.+++|++....... ....+.+|+.+++.+.|++|+++++++......+++|||+.+++|
T Consensus 1 l~~g-~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEG-GFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcC-CceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6788 79999999886 8999999987654322 345788999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-CCcEEEEecCccccccCCcccCCCCCCC
Q 002146 762 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGT 840 (960)
Q Consensus 762 ~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr~~~~~~~~~~t~~GT 840 (960)
.+++......++...++.++.+++.+|.|||..+ ++|+||+|.||+++. ++.++|+|||.+..............+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 9999875446889999999999999999999998 999999999999999 8999999999998765432223345678
Q ss_pred CCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCC
Q 002146 841 PEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 919 (960)
Q Consensus 841 ~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~ 919 (960)
..|++||.+... .++.+.|+|+||+++++| ..+.+++.+||..+|.
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~ 203 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPE 203 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcc
Confidence 899999999887 788999999999999999 6789999999999999
Q ss_pred CCCCHHHHHHHH
Q 002146 920 LRPSFAQLTVAL 931 (960)
Q Consensus 920 kRPSa~eILe~L 931 (960)
+||++.++++++
T Consensus 204 ~R~~~~~l~~~~ 215 (215)
T cd00180 204 KRPSAKEILEHL 215 (215)
T ss_pred cCcCHHHHhhCC
Confidence 999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=289.22 Aligned_cols=256 Identities=18% Similarity=0.196 Sum_probs=183.7
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE------------------CCcEEEEEEeecCCCCh--H----------HHHHH
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW------------------NGTEVAVKKFLDQDFSG--A----------ALLEF 721 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~------------------~g~~VAVK~i~~~~~~~--~----------~~~~~ 721 (960)
.+..++|.+.++||+| .||+||++.+ .++.||||++....... . .....
T Consensus 141 r~~~d~F~i~~~LG~G-gFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 141 RWSSDDFQLRDKLGGG-NFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CccccCceEeeEeecC-CCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3457889999999999 6999999853 35679999986432110 0 01123
Q ss_pred HHHHHHHHHcCCCce-----eeEeccccc--------CCceEEEEeecCCCCHHHHhhCCCC------------------
Q 002146 722 KREVKIMRRLRHPNV-----VLFMGAVTR--------PPNLSIITEFLPRGSLFRILHRPHC------------------ 770 (960)
Q Consensus 722 ~~Ei~ILk~L~HPNI-----VkL~g~f~~--------~~~l~LVmEY~~gGsL~dlL~k~~~------------------ 770 (960)
..|+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 457777888876654 567776643 3568999999999999999864211
Q ss_pred -----CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc-cCCCCCCCCCcc
Q 002146 771 -----QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SSKSTAGTPEWM 844 (960)
Q Consensus 771 -----~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~-~~~t~~GT~~Y~ 844 (960)
.+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++....... ......+|+.|+
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 2345677889999999999999998 99999999999999999999999999976533211 111223588999
Q ss_pred CcccccCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCChhHH---------HHHhhcc
Q 002146 845 APEVLRNEP--------------------S--NEKCDVYSFGVILWELATLKL-PWIGMNPMQV---------VGAVGFQ 892 (960)
Q Consensus 845 APEvl~g~~--------------------y--s~ksDIWSLGvLLyELLTG~~-PF~~~~~~ei---------~~~I~~~ 892 (960)
|||++.... | ..+.||||+||++|+|++|.. ||.+...... .......
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 999986432 1 124799999999999999875 7764321111 1111111
Q ss_pred ccccCC--CCCCcHHHHHHHHHhhhhCC---CCCCCHHHHHHH
Q 002146 893 NRRLEI--PKELDPLVARIIWECWQTDP---SLRPSFAQLTVA 930 (960)
Q Consensus 893 ~~~~~i--P~~lS~eLkdLI~kcL~kDP---~kRPSa~eILe~ 930 (960)
.....+ ....++..++|+.+||.++| .+|++++|+|+|
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 122222 34578899999999999876 689999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-31 Score=301.20 Aligned_cols=251 Identities=30% Similarity=0.496 Sum_probs=219.8
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
-+.++|+++.++|.| +||.||+++. .++..|||+++..- .+.+.-++.|+-+++..+|||||.+++.+...+.++
T Consensus 12 nP~ddyellqrvgsg-TygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSG-TYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCC-cccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 356789999999999 8999999975 78899999987653 233456789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
++||||.||+|.++.+-.+ .+++.++.+++++.+.||+|||+.| -+|||||-.|||+++.|.|||+|||.+..+...
T Consensus 89 icMEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999999999987655 7999999999999999999999998 899999999999999999999999999887776
Q ss_pred cccCCCCCCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC---CCCCCcH
Q 002146 831 FLSSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE---IPKELDP 904 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl---~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~---iP~~lS~ 904 (960)
......+.||++|||||+. +...|...+|||++|++..||-.-++|..+.-+++...........+. -+..+++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 6667789999999999986 445699999999999999999999999999888887766544333222 2345788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
.+.+|++.+|.++|++||+++.+|.
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhhee
Confidence 9999999999999999999998775
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=260.78 Aligned_cols=224 Identities=29% Similarity=0.469 Sum_probs=183.5
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
.++++-+++.-+..||+| +||.|-+.++ +|+..|+|.+.... .....+++.+|+.+..+. .+|++|.|||.+.+.
T Consensus 40 ~~eV~ad~L~~i~elGrG-ayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRG-AYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred ccccchhhhhhhhhhcCC-ccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 367777888889999999 7999988765 89999999987654 344566788899988877 799999999999999
Q ss_pred CceEEEEeecCCCCHHHHhh---CCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 747 PNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~---k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
...++.||.| ..+|..+.. +.+...+|..+-+|+..++.||.|||++= .|||||+||.||||+..|+||+||||+
T Consensus 118 gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 118 GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEccccc
Confidence 9999999999 468877654 35668999999999999999999999852 499999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHhhccccccCC
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g----~~ys~ksDIWSLGvLLyELLTG~~PF~~~-~~~ei~~~I~~~~~~~~i 898 (960)
+..+.+.. ......|...|||||.+.. ..|+.++||||||++++||.+++.||... ++.+.+.++. ....+.+
T Consensus 196 sG~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV-eep~P~L 273 (282)
T KOG0984|consen 196 SGYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV-EEPSPQL 273 (282)
T ss_pred ceeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh-cCCCCCC
Confidence 98775542 2223568889999999854 36899999999999999999999999875 4555555553 3333344
Q ss_pred C
Q 002146 899 P 899 (960)
Q Consensus 899 P 899 (960)
|
T Consensus 274 p 274 (282)
T KOG0984|consen 274 P 274 (282)
T ss_pred c
Confidence 4
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=263.28 Aligned_cols=243 Identities=20% Similarity=0.327 Sum_probs=196.1
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCC--ce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP--NL 749 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~--~l 749 (960)
.++|++++++|+| .|++||.|.. ++++++||+++ ....+.+.+|+.||+.|. |||||++++...++. ..
T Consensus 37 ~ddYeivrk~GRG-KYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRG-KYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCc-cHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4689999999999 7999999974 88899999875 345668899999999995 999999999998764 47
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-CCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr~~~ 828 (960)
.||+||++..+...+.. .++...+..++.+++.||.|+|+.| |+|||+||.|++||. .-.++|+|||||.+.+
T Consensus 111 aLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 79999998887776654 4888899999999999999999999 999999999999994 5679999999999887
Q ss_pred CCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC-C-hhHHHH------------Hhhcc-
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGM-N-PMQVVG------------AVGFQ- 892 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~-~-~~ei~~------------~I~~~- 892 (960)
.. ...+..+.+..|..||.+.+.. |+..-|+|||||++..|++.+-||... + ..+++. .+..-
T Consensus 185 p~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 185 PG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred CC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 65 3345567788999999997754 899999999999999999999888642 2 222221 11000
Q ss_pred -ccccC----------------CC---C-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 -NRRLE----------------IP---K-ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 -~~~~~----------------iP---~-~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+. ++ . -.++++.+|+.++|..|-.+|+|++|.+.+
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00000 01 1 135899999999999999999999998764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=287.85 Aligned_cols=250 Identities=20% Similarity=0.249 Sum_probs=202.4
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC------CceeeEeccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH------PNVVLFMGAV 743 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H------PNIVkL~g~f 743 (960)
++.-..|.+....|+| .|++|..|+. .|..||||+|..... ..+.=+.|++||++|+. -|+++|+..|
T Consensus 428 E~LD~RY~V~~~~GkG-vFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKG-VFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhcceeEEEeccccc-eeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 4455779999999999 8999999975 678999999986543 23345689999999952 3899999999
Q ss_pred ccCCceEEEEeecCCCCHHHHhhCCCC--CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC-CcEEEEe
Q 002146 744 TRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSD 820 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL~dlL~k~~~--~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-g~VKL~D 820 (960)
...+++|||+|-+ ..+|.++|.+.+. .+....+..++.||+.||.+|..+| |+|.||||.||||++. ..+||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeecc
Confidence 9999999999988 5699999987554 5788899999999999999999999 9999999999999964 6799999
Q ss_pred cCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC---
Q 002146 821 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--- 897 (960)
Q Consensus 821 FGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~--- 897 (960)
||.|........ ..+.-+..|.|||+|.|.+|+...|+||+||+||||+||+..|.|.+..+++....-...+++
T Consensus 581 fGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 581 FGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred Cccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 999987655432 223456789999999999999999999999999999999999999877665543211000000
Q ss_pred -------------------------------------CC-----------CCCc-------HHHHHHHHHhhhhCCCCCC
Q 002146 898 -------------------------------------IP-----------KELD-------PLVARIIWECWQTDPSLRP 922 (960)
Q Consensus 898 -------------------------------------iP-----------~~lS-------~eLkdLI~kcL~kDP~kRP 922 (960)
-| +.++ ..+++|+.+||..||.+|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 01 0111 3588999999999999999
Q ss_pred CHHHHHHH
Q 002146 923 SFAQLTVA 930 (960)
Q Consensus 923 Sa~eILe~ 930 (960)
+..|.|++
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99998865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=299.77 Aligned_cols=240 Identities=28% Similarity=0.421 Sum_probs=188.4
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecCCC
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRG 759 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~gG 759 (960)
.+++|.|..-+.||+|.+.|+.||||.+..+ ......+|+.+|+.- +|||||++++.-++...+||.+|.|. .
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 3568888445678999999999999987543 234567999999998 79999999999999999999999995 5
Q ss_pred CHHHHhhCCCC--CC-cHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---C--CcEEEEecCccccccCCc
Q 002146 760 SLFRILHRPHC--QV-DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---N--WNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 760 sL~dlL~k~~~--~l-se~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~--g~VKL~DFGLAr~~~~~~ 831 (960)
+|.+++..... .. .....+.++.|++.||+|||+.+ ||||||||.||||+. + ..++|.|||+++......
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999987411 11 11345678899999999999998 999999999999975 3 468999999999875432
Q ss_pred ---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHhhcccccc-CCCCCCcHHH
Q 002146 832 ---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRL-EIPKELDPLV 906 (960)
Q Consensus 832 ---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG-~~PF~~~~~~ei~~~I~~~~~~~-~iP~~lS~eL 906 (960)
....+..||-+|+|||++.....+.++|||||||++|+.++| ..||.+.-..+. .|...+... .+......++
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHH
Confidence 223456799999999999999889999999999999999886 899976543322 222122111 1212222389
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++||.+|++.+|..||++.+++.|
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCC
Confidence 999999999999999999999753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=287.10 Aligned_cols=199 Identities=27% Similarity=0.410 Sum_probs=174.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChH------HHHHHHHHHHHHHHcC---CCceeeEeccc
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLR---HPNVVLFMGAV 743 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~------~~~~~~~Ei~ILk~L~---HPNIVkL~g~f 743 (960)
+.+|..++.+|.| +||.|+++.+ +...|+||.|.++.+-.+ .+-.+-.|++||..|+ |+||++++++|
T Consensus 560 ~s~yttlq~lG~G-AyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEG-AYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cccceeeeecccc-ccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4579999999999 8999999976 466799998877654222 2234667999999997 99999999999
Q ss_pred ccCCceEEEEeec-CCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecC
Q 002146 744 TRPPNLSIITEFL-PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822 (960)
Q Consensus 744 ~~~~~l~LVmEY~-~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFG 822 (960)
++++.+||+||-. +|.+|+++|..+ ..++|.+...|++|++.|+++||+.| |||||||-+|++++.+|-+||+|||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeecc
Confidence 9999999999975 467999999764 47999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIG 879 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~ 879 (960)
.+....+. ....++||..|.|||++.|.+| +..-|||+||+++|.++....||+.
T Consensus 716 saa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99876544 3457899999999999999998 7788999999999999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=268.42 Aligned_cols=265 Identities=26% Similarity=0.404 Sum_probs=222.8
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEe
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 740 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~ 740 (960)
..+..+...++++..++-+| .||.||.|.|. .+.|.+|.++.. ..+.....+..|--+|..+.|||+..+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEG-tFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEG-TFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcC-chhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 34455666778888889999 89999999763 234666765433 3455667788999999999999999999
Q ss_pred cccc-cCCceEEEEeecCCCCHHHHhh-----C--CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC
Q 002146 741 GAVT-RPPNLSIITEFLPRGSLFRILH-----R--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 812 (960)
Q Consensus 741 g~f~-~~~~l~LVmEY~~gGsL~dlL~-----k--~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~ 812 (960)
++.. +....++++.++.-|+|..++. + .-..++..++..++.|++.||+|||.++ |||.||-.+|++||+
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDD 431 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehh
Confidence 8754 4556788899999999999997 2 1235677888999999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccCCcccCC--CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHh
Q 002146 813 NWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 889 (960)
Q Consensus 813 ~g~VKL~DFGLAr~~~~~~~~~~--t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I 889 (960)
.-.|||+|=.+++..-...+.+- ..-....||+||.+.+..|+.++|+||||+++|||+| |+.|+...++.++...+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 99999999999997644433221 1223568999999999999999999999999999999 99999999999999888
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 890 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 890 ~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
. .+.+...|.+|++++..++.-||...|++||+++|+...|.++...
T Consensus 512 k-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 512 K-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred h-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 6 5678888999999999999999999999999999999999988654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=268.11 Aligned_cols=246 Identities=24% Similarity=0.309 Sum_probs=197.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC------
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~------ 747 (960)
.+|.-.+.+|.| .- .|..+.+ .+++||+|++-.........++..+|..++..++|+||++++.+|.-..
T Consensus 17 ~Ry~nL~p~~~g-~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSG-AQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCC-Cc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 467777889999 44 5555543 7999999987665444445667889999999999999999999986543
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
..|+|||||. .+|...+.. .++...+.+|++|++.|++|||+.| |+||||||+||++..++.+||+|||+|+..
T Consensus 95 e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhccc
Confidence 4899999995 588888763 5788999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc--------------
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------- 893 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-------------- 893 (960)
... ......+.|..|.|||++.+..|...+||||+||++.||++|...|.|.+..+-..++...-
T Consensus 169 ~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 169 DTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred Ccc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 554 34556788999999999999999999999999999999999999998866433222211100
Q ss_pred ------ccc---------CCCC-----------CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ------RRL---------EIPK-----------ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ------~~~---------~iP~-----------~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.++ .+|. .-...+++|+.+||..+|++|.++.++|.+
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 0111 112458999999999999999999999876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=272.04 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=196.2
Q ss_pred EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----ceEEEEe
Q 002146 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLSIITE 754 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~-----~l~LVmE 754 (960)
+.||-| +||.||.+.+ +|+.||+|++..-...-..-+++.+|+++|.-++|.|++..++..+-.. .+|+++|
T Consensus 59 RPIGYG-AFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYG-AFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred Cccccc-ceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 459999 8999999975 7999999998765444455678899999999999999999887765432 4778999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-cc
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LS 833 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~-~~ 833 (960)
.|. .+|.++|-... .++...+.-+++||++||+|||+.+ |.||||||.|+|++.+..+||||||+++...... ..
T Consensus 138 LmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 995 58888886654 6788888889999999999999999 9999999999999999999999999999754322 22
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc--------------------
Q 002146 834 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------- 892 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-------------------- 892 (960)
....+-|.+|+|||++.|.. |+.++||||.|||+.||+..+..|...++.+.++.|...
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 33345688999999999865 899999999999999999999999888776554433210
Q ss_pred ----ccccCCC--------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 893 ----NRRLEIP--------KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 893 ----~~~~~iP--------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~L 931 (960)
...+.++ ..-..+...++.++|..||++|.+.++.+.++
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0111111 12345788899999999999999999888765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=237.69 Aligned_cols=209 Identities=34% Similarity=0.548 Sum_probs=177.6
Q ss_pred eEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|.+.+.||.| .+|.||++... ++.||||.+...... .....+.+|++.+++++|+||+++++++......++++||
T Consensus 1 ~~~~~~i~~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEG-AFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecC-CCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 5678899999 69999999873 689999998765433 2456788999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-ccC
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LSS 834 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~-~~~ 834 (960)
+++++|.+++......+++..++.++.+++.+|.+||.++ ++|+||+|.||+++.++.++|+|||++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999999765433889999999999999999999998 9999999999999999999999999998765432 122
Q ss_pred CCCCCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChh-HHHHHhh
Q 002146 835 KSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPM-QVVGAVG 890 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl-~g~~ys~ksDIWSLGvLLyELLTG~~PF~~-~~~~-ei~~~I~ 890 (960)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++. .+...+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 345688899999998 667788899999999999999999999987 4444 5555553
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-26 Score=257.82 Aligned_cols=131 Identities=21% Similarity=0.284 Sum_probs=109.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-----C---CceeeEecccc
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----H---PNVVLFMGAVT 744 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-----H---PNIVkL~g~f~ 744 (960)
..+|.+.++||+| .|.+||++.. ..+.||+|+.+.. +...+....||++|++++ | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWG-HFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWG-HFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEecccc-ccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 3579999999999 8999999965 6778999987643 233345679999999983 3 36999999986
Q ss_pred c----CCceEEEEeecCCCCHHHHhhC-CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc
Q 002146 745 R----PPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811 (960)
Q Consensus 745 ~----~~~l~LVmEY~~gGsL~dlL~k-~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd 811 (960)
. +.+++||+|++ |.+|..+|.+ ..+.++...+..|++||+.||.|||..- +|||-||||+|||+.
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLC 222 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeee
Confidence 4 45799999999 7788888765 4567999999999999999999999753 499999999999993
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-24 Score=220.94 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=204.3
Q ss_pred eEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChH-HHHHHHHHHHHHHHcCCC-ceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHP-NVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~-~~~~~~~Ei~ILk~L~HP-NIVkL~g~f~~~~~l~LVmEY 755 (960)
|.+.+.||.| .||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......+++++|
T Consensus 2 ~~~~~~l~~g-~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEG-SFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCC-CCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 7788999999 68999999877 8899998876554432 566889999999999888 799999999877778999999
Q ss_pred cCCCCHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-cEEEEecCccccccCCcc
Q 002146 756 LPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 756 ~~gGsL~dlL~k~~--~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-~VKL~DFGLAr~~~~~~~ 832 (960)
+.+++|.+++.... ..+.+.....++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||+++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999998877654 26889999999999999999999999 99999999999999988 799999999986543321
Q ss_pred ------cCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHhhccccc-c--
Q 002146 833 ------SSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRR-L-- 896 (960)
Q Consensus 833 ------~~~t~~GT~~Y~APEvl~g---~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~----~ei~~~I~~~~~~-~-- 896 (960)
......|+..|++||.+.+ ..+....|+|++|++++++++|..||..... ......+...... .
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 2356789999999999988 5788999999999999999999999887763 3444444322222 1
Q ss_pred CCCCCC----cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 EIPKEL----DPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 ~iP~~l----S~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...... ...+.+++..|+..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111 2578999999999999999998887775
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=282.80 Aligned_cols=195 Identities=21% Similarity=0.202 Sum_probs=144.3
Q ss_pred HcCC-CceeeEeccc-------ccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEe
Q 002146 730 RLRH-PNVVLFMGAV-------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 801 (960)
Q Consensus 730 ~L~H-PNIVkL~g~f-------~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHR 801 (960)
.++| +||++++++| .....++++|||+ +++|.++|......+++.+++.|++||+.||+|||++| ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 4445 5777888877 3345678889988 66999999876667999999999999999999999999 9999
Q ss_pred ccCCCcEEEcCCCc-------------------EEEEecCccccccCCc----------------ccCCCCCCCCCccCc
Q 002146 802 DLKSPNLLVDKNWN-------------------VKVSDFGLSRLKHNTF----------------LSSKSTAGTPEWMAP 846 (960)
Q Consensus 802 DLKPeNILLd~~g~-------------------VKL~DFGLAr~~~~~~----------------~~~~t~~GT~~Y~AP 846 (960)
||||+||||+..|. +||+|||+++...... ......+||++||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999965444 5555666554321000 001124589999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 002146 847 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 926 (960)
Q Consensus 847 Evl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~e 926 (960)
|++.+..|+.++|||||||++|||++|.+||..... ....+.....++... ...+...+++.+||.++|.+||++.+
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcChHH
Confidence 999999999999999999999999999988764321 122221111111111 12456778999999999999999999
Q ss_pred HHHH
Q 002146 927 LTVA 930 (960)
Q Consensus 927 ILe~ 930 (960)
++++
T Consensus 262 il~h 265 (793)
T PLN00181 262 LLQS 265 (793)
T ss_pred Hhhc
Confidence 9864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=222.08 Aligned_cols=164 Identities=23% Similarity=0.279 Sum_probs=132.5
Q ss_pred CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002146 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 838 (960)
Q Consensus 759 GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~ 838 (960)
|+|.+++...+..+++.+++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++..... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999876667999999999999999999999986 999999999999999 9999865432 236
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHhhcccccc-----CCCCCCcH--HHHHHH
Q 002146 839 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL-----EIPKELDP--LVARII 910 (960)
Q Consensus 839 GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-ei~~~I~~~~~~~-----~iP~~lS~--eLkdLI 910 (960)
||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+....... ..+..++. +++++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999999999999999999999999999999999765432 2222221111111 11222333 699999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 911 WECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+||..+|.+||++.++++++..+...
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999887554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=241.26 Aligned_cols=244 Identities=22% Similarity=0.348 Sum_probs=187.1
Q ss_pred CCeEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEec-ccccCCceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG-AVTRPPNLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g-~f~~~~~l~L 751 (960)
+.|.|.+.||+| .||.+.+++++ .+.+++|-+.... ..+.+|.+|..---.| .|.|||.-|+ +|+..+.+.+
T Consensus 24 d~y~I~k~lgeG-~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEG-RFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhccc-ceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 569999999999 89999999884 5679999877653 3355788887655555 6899998776 5888898999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc--CCCcEEEEecCccccccC
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd--~~g~VKL~DFGLAr~~~~ 829 (960)
++||++.|+|..-+... .+.|....+++.|++.||.|+|+++ +||||||.+||||- +...|||||||+.+..+.
T Consensus 100 ~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999999988664 4888889999999999999999999 99999999999995 345899999999986654
Q ss_pred CcccCCCCCCCCCccCcccccCC---C--CCchhhHHHHHHHHHHHHhCCCCCCCCChh--HHHHHhhc-cccccCCCC-
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNE---P--SNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGF-QNRRLEIPK- 900 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~---~--ys~ksDIWSLGvLLyELLTG~~PF~~~~~~--ei~~~I~~-~~~~~~iP~- 900 (960)
.... .--+..|.+||.+... . ..+.+|+|.||+++|.+|+|.+||...... .......+ ....+..|+
T Consensus 176 tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 176 TVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred eehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 3221 2235579999986433 2 367899999999999999999999853211 11111111 222334454
Q ss_pred --CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 901 --ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 901 --~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
-+++.+..+.++.|..++++|-...+..+.
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 367889999999999999999554444443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=234.30 Aligned_cols=255 Identities=17% Similarity=0.245 Sum_probs=213.4
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~ 750 (960)
..-.|.++++||+| +||..+.|+. +++.||||.-..... .-+++.|.+.++.| ..++|.+.|.+.+.+.+-.
T Consensus 26 VG~hyrVGkKIGeG-sFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEG-SFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccC-cceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 34579999999999 8999999974 899999996543322 23677889999988 5799999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-----CCcEEEEecCccc
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSR 825 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-----~g~VKL~DFGLAr 825 (960)
||||.+ |.+|+|+..-++++|+.+.+..++.||+.-++|+|.+. +|+|||||+|+||.. ...|.|+|||+|+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 999998 88999999888889999999999999999999999999 999999999999974 3459999999999
Q ss_pred cccCC-------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHhhccccc
Q 002146 826 LKHNT-------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRR 895 (960)
Q Consensus 826 ~~~~~-------~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~---~ei~~~I~~~~~~ 895 (960)
...+. ........||.+||+--...|.+.+.+.|+-|||.+|+++|-|..||.+... .+.+++|......
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 75432 2344567799999999999999999999999999999999999999999654 4455556433222
Q ss_pred cC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 896 LE---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 896 ~~---iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.. +..+++.++..-++-.-+.+-.+-|+++-+...+..+..
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 22 345688899888888888999999999988888877754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=246.13 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=192.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCc
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~ 748 (960)
.+.|.++++||.| +|+.||++.. ..+.||+|.+...... .++.+|+++|..+ .+.||+++.+++...+.
T Consensus 35 ~~~~~~v~kigeG-sFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEG-SFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhcccccc-chhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4678999999999 8999999953 5678999988665432 3688999999999 69999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecCccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLAr~~ 827 (960)
..+||||++.....+++.. ++...+..+++.++.||.|+|..| ||||||||.|+|.+ ..+.-.|+|||||...
T Consensus 110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHH
Confidence 9999999999988888864 678888999999999999999999 99999999999998 5688999999999720
Q ss_pred c---------------C-C------------------cc----------cCCCCCCCCCccCcccccCCC-CCchhhHHH
Q 002146 828 H---------------N-T------------------FL----------SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYS 862 (960)
Q Consensus 828 ~---------------~-~------------------~~----------~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWS 862 (960)
. . . .+ ..-...||++|.|||++...+ .+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 0 0 0 00 011235999999999987765 688999999
Q ss_pred HHHHHHHHHhCCCCCCCCChh-----HHH---------------HH----------------hhcccc------------
Q 002146 863 FGVILWELATLKLPWIGMNPM-----QVV---------------GA----------------VGFQNR------------ 894 (960)
Q Consensus 863 LGvLLyELLTG~~PF~~~~~~-----ei~---------------~~----------------I~~~~~------------ 894 (960)
.|+|+..+++++.||...... ++. .. +.+...
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 999999999999999653211 000 00 000000
Q ss_pred -cc-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 -RL-EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 -~~-~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. .....++..+.+|+.+||..||.+|.++++.|++
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 0012234588999999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-23 Score=232.31 Aligned_cols=255 Identities=22% Similarity=0.261 Sum_probs=201.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEECC---cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC----CceeeEeccc-ccCCc
Q 002146 677 DLVLGERIGLGSSYGEVYHADWNG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----PNVVLFMGAV-TRPPN 748 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~g---~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H----PNIVkL~g~f-~~~~~ 748 (960)
.|.+.++||+| .||.||++.... ..+|+|........... .+..|+.+|..+.. .++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G-~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEG-GFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeecccc-CCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 89999999999 699999998643 46899976654322211 56788889988862 6899999999 57788
Q ss_pred eEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC-----CcEEEEecC
Q 002146 749 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-----WNVKVSDFG 822 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-----g~VKL~DFG 822 (960)
-||||+.+ |.+|.++..... ..++......|+.|++.+|++||+.| +|||||||.|+++... ..+.|.|||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99999988 889999886544 68999999999999999999999999 9999999999999854 469999999
Q ss_pred ccc--cccCCc-------cc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc
Q 002146 823 LSR--LKHNTF-------LS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 892 (960)
Q Consensus 823 LAr--~~~~~~-------~~-~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~ 892 (960)
+++ ...... .. ...+.||.+|+++.+..+...+.+.|+||++.++.+|+.|..||.+.........+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 321111 11 23456999999999999999999999999999999999999999886643222222211
Q ss_pred ccccC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 893 NRRLE---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 893 ~~~~~---iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
..... +....+.++.++...+-..+...+|.+..+...|+.+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11111 2334567788888777789999999999999998887554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-25 Score=252.72 Aligned_cols=225 Identities=28% Similarity=0.404 Sum_probs=192.1
Q ss_pred eeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEEEEeecC
Q 002146 684 IGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+|.| +||.|++++. .|.-||+|+.++.............|..++..++ ||++|+++.+|+.+..++++++|..
T Consensus 2 lg~g-~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQG-SYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcC-CCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6889 8999998853 5677999988766544333335667899999996 9999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
||+|+..+.+.. .+++.....+...++.+++++|+.+ |+|||+|++||+++.+|++++.|||+++....... .
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----A 153 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----c
Confidence 999999887655 4666666667779999999999999 99999999999999999999999999987654422 2
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 917 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kD 917 (960)
|||..|||||+++ ....++|+|+||+++|||++|..||.. ++...| ....+.+|..++..+++++..++.++
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKRN 225 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhhC
Confidence 9999999999999 567899999999999999999999998 444445 34467889999999999999999999
Q ss_pred CCCCCCH
Q 002146 918 PSLRPSF 924 (960)
Q Consensus 918 P~kRPSa 924 (960)
|..|...
T Consensus 226 p~nrLg~ 232 (612)
T KOG0603|consen 226 PENRLGA 232 (612)
T ss_pred HHHHhcc
Confidence 9999765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=212.68 Aligned_cols=255 Identities=20% Similarity=0.249 Sum_probs=208.1
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC-CceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H-PNIVkL~g~f~~~~~ 748 (960)
.+....|.++++||.| +||.+|++.. .|+.||||+-....-. -.+..|..+.+.|++ ..|..+..++.+...
T Consensus 11 ~iv~gky~lvrkiGsG-SFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSG-SFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCC-chhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 3556789999999999 8999999975 8999999975443222 256788999999965 788888888888889
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecCccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSR 825 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFGLAr 825 (960)
-.|||+.+ |.+|+++.+-..+.++.++.+.++-||+.-++|+|.++ +|||||||+|+|..- ...+.|+||||++
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchh
Confidence 99999998 88999998877778999999999999999999999999 999999999999973 4569999999998
Q ss_pred cccC-------CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH---HHHHhhcccc-
Q 002146 826 LKHN-------TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNR- 894 (960)
Q Consensus 826 ~~~~-------~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e---i~~~I~~~~~- 894 (960)
..-+ .........||.+|.+--...+...+...|+-|+|.++.++.-|..||.+..... ..+.|.....
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 7532 2234456779999999888888888999999999999999999999999976543 3333421111
Q ss_pred --ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 895 --RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 895 --~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
...+.+.++.++.-.+.-|-...-.+-|++.-|-+.++-+
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 1123467889999999999998889999988777766655
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=222.42 Aligned_cols=257 Identities=29% Similarity=0.610 Sum_probs=217.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
|...++.++-+|... .-|+.|+++|.|..+++|++.........-+.|..|.-.|+-+.||||+.+++++..+.++.++
T Consensus 187 id~~~lnl~tkl~e~-hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 187 IDVSSLNLITKLAES-HSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred cchhhhhhhhhhccC-CCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 445566667778887 6899999999999999999887776666666888999999989999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCC-CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 753 TEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~-~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
..||+.|+|+.+++.... ..+..+..+++.+|++|+.|||+..+-|----|....++||++.+.+|. .+-+++.
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs---- 340 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS---- 340 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee----
Confidence 999999999999987543 5677889999999999999999988544444689999999998776663 1212211
Q ss_pred ccCCCCCCCCCccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~y---s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.......-.+.||+||.+..++. -.++|+|||++++|||-|...||.+..+.+.--+|..++.+..+|+.++..+..
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~k 420 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNK 420 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHH
Confidence 11122334678999999988774 367999999999999999999999999999988998899999999999999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
|+.-|++.||.+||.|+.|+-.|++++
T Consensus 421 lm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 421 LMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999999999999999999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=250.19 Aligned_cols=246 Identities=25% Similarity=0.334 Sum_probs=191.7
Q ss_pred EEEEEeeccCCeeEEEEEEE--CCcEEEEEEeec---CCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 679 VLGERIGLGSSYGEVYHADW--NGTEVAVKKFLD---QDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 679 ~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~---~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.-..++|.| +||.|+.... ..+.++.|.++. ..... .....+..|+-+-..|.|+||+..+..+++....+-+
T Consensus 321 ~~~~~~g~g-a~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSG-AYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred Cccceeeec-ccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 356779999 8997777754 444455554431 11222 2222377788888889999999998888888777777
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 831 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~- 831 (960)
||||++ +|+.++...+ ++...++..++.|++.|++|||..| |.|||||++||++..+|.+||+|||.+..+....
T Consensus 400 mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999999 9999997753 6888888899999999999999999 9999999999999999999999999998765432
Q ss_pred ---ccCCCCCCCCCccCcccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChhHHH-HHhhc------cccccCCCC
Q 002146 832 ---LSSKSTAGTPEWMAPEVLRNEPSNE-KCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGF------QNRRLEIPK 900 (960)
Q Consensus 832 ---~~~~t~~GT~~Y~APEvl~g~~ys~-ksDIWSLGvLLyELLTG~~PF~~~~~~ei~-~~I~~------~~~~~~iP~ 900 (960)
......+|+..|+|||++.+..|+. .+||||.|++++.|++|+.||......+.. ..... ......+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 2345678999999999999999965 689999999999999999999765443221 11111 111112234
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
.++.+.+.+|.+||+.+|.+|.++++|++
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhh
Confidence 57788999999999999999999999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=223.35 Aligned_cols=166 Identities=18% Similarity=0.165 Sum_probs=129.0
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE---CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHHcCCCceee-Eeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW---NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVL-FMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~---~g~~VAVK~i~~~~~---~~~~~~~~~~Ei~ILk~L~HPNIVk-L~g~f~~ 745 (960)
...++|.+.+.||+| .||+||++.+ +++.||||++..... .......+.+|+++|++++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G-~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 15 ALSARFVETAVLKRD-VFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred cccCCceEccEEeec-CcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345789999999999 6999999976 467789998653311 2334557899999999999999985 5543
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc-CCCcEEEcCCCcEEEEecCcc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL-KPeNILLd~~g~VKL~DFGLA 824 (960)
+..||||||++|++|... .. .. ...++.|++.+|.|||+.| |+|||| ||+|||++.++.+||+|||++
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 458999999999999732 11 11 1457889999999999999 999999 999999999999999999999
Q ss_pred ccccCCccc--------CCCCCCCCCccCcccccCCC
Q 002146 825 RLKHNTFLS--------SKSTAGTPEWMAPEVLRNEP 853 (960)
Q Consensus 825 r~~~~~~~~--------~~t~~GT~~Y~APEvl~g~~ 853 (960)
+........ -....++..|+|||.+.-..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 875432211 12456888999999986543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=234.02 Aligned_cols=248 Identities=19% Similarity=0.205 Sum_probs=186.6
Q ss_pred CeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCC--CChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~--~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
++...+.||.+ .|-+|.+++++...|+||++-+.+ +.-....+...|++ ...++|||++.|..+-...+..|||-+
T Consensus 24 e~~~~~~LGst-RFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGST-RFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCch-hhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 67788999999 899999999877779999987654 23333444445555 556699999999999888889999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc----CC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH----NT 830 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~----~~ 830 (960)
|.. -+|+|.+..+ .++...+++.|+.||+.||..+|..| |+|||||.+||||+.-+-+.|+||.--+..- ++
T Consensus 102 yvk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 994 5999988764 47888999999999999999999999 9999999999999999999999997665421 11
Q ss_pred ---cccCCCCCCCCCccCcccccCCC-----------CCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccc
Q 002146 831 ---FLSSKSTAGTPEWMAPEVLRNEP-----------SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR 895 (960)
Q Consensus 831 ---~~~~~t~~GT~~Y~APEvl~g~~-----------ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~ 895 (960)
.+...+......|+|||.+.... .+++.||||+||+++||++ |+++|.- .+++....-....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAYRSGNADD 254 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhHhccCccC
Confidence 01112223345899999985421 4678999999999999998 7888842 2222221110000
Q ss_pred cC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 002146 896 LE--IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 933 (960)
Q Consensus 896 ~~--iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~ 933 (960)
++ +...-+..+++||..|++.||.+|.++++.|+..+.
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 00 111234579999999999999999999999988443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-21 Score=230.07 Aligned_cols=205 Identities=29% Similarity=0.442 Sum_probs=156.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
.+|..+|.|-.| +||.||+++++ .+++|+| +.++.+.. ++ ||.....|++|
T Consensus 83 ~df~~Iklisng-Aygavylvrh~~trqrfa~k-iNkq~lil------Rn---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNG-AYGAVYLVRHKETRQRFAMK-INKQNLIL------RN---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccC-CCCceeeeeccccccchhhc-ccccchhh------hc---cccccCCccee----------------
Confidence 578899999999 89999999874 7889995 44332211 11 44444556655
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc-----
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH----- 828 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~----- 828 (960)
|+-..++...+ .++. +++.+++|||+.| |+|||+||+|+||+.-|++|++|||+.+...
T Consensus 136 -----gDc~tllk~~g-~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG-PLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -----chhhhhcccCC-CCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 34444444322 2221 3488999999999 9999999999999999999999999987521
Q ss_pred ----------CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cccC
Q 002146 829 ----------NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLE 897 (960)
Q Consensus 829 ----------~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~~ 897 (960)
.........|||++|+|||++..+.|+..+|||+||+|+||++-|..||++.++.+++..+.... ..++
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 01122345689999999999999999999999999999999999999999999999987764221 1122
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCC
Q 002146 898 IPKELDPLVARIIWECWQTDPSLRPS 923 (960)
Q Consensus 898 iP~~lS~eLkdLI~kcL~kDP~kRPS 923 (960)
-..-++++++++|.++|+.+|..|..
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 22347899999999999999999953
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-20 Score=201.80 Aligned_cols=192 Identities=23% Similarity=0.366 Sum_probs=148.4
Q ss_pred CCCceeeEeccccc---------------------------CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHH
Q 002146 732 RHPNVVLFMGAVTR---------------------------PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784 (960)
Q Consensus 732 ~HPNIVkL~g~f~~---------------------------~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QI 784 (960)
+|||||+++++|.+ +..+|+||...+ -+|..|+-.++ .+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence 69999999988743 245889998875 48988887654 5556666688899
Q ss_pred HHHHHHHhhCCCCEEEeccCCCcEEEc--CC--CcEEEEecCccccccCC------cccCCCCCCCCCccCcccccCCC-
Q 002146 785 ARGMNCLHTSTPTIVHRDLKSPNLLVD--KN--WNVKVSDFGLSRLKHNT------FLSSKSTAGTPEWMAPEVLRNEP- 853 (960)
Q Consensus 785 a~AL~YLHs~g~~IIHRDLKPeNILLd--~~--g~VKL~DFGLAr~~~~~------~~~~~t~~GT~~Y~APEvl~g~~- 853 (960)
++|+.|||++| |.|||||.+||||. ++ -.+.|+|||.+---... .......-|...-||||+....+
T Consensus 351 LEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 351 LEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999 99999999999994 33 35899999987532221 11222345788999999986543
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 002146 854 -----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 928 (960)
Q Consensus 854 -----ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eIL 928 (960)
.-.+.|.|+.|.+.||++....||++.....+-.....+...+.+|..+++.+++|+..+|+.||.+|++..-..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 236899999999999999999999996554333333334556778999999999999999999999998865433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-20 Score=188.57 Aligned_cols=140 Identities=21% Similarity=0.231 Sum_probs=106.8
Q ss_pred EEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHH------------------------HHHHHHHHHHHHHcCCCc
Q 002146 681 GERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAA------------------------LLEFKREVKIMRRLRHPN 735 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~------------------------~~~~~~Ei~ILk~L~HPN 735 (960)
.+.||.| .||.||++.. +|+.||||+++........ .....+|+.+|.++.+++
T Consensus 2 ~~~ig~G-~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTG-KEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccc-cceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 4579999 7999999986 6999999998754221110 112345999999998776
Q ss_pred eeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHH-hhCCCCEEEeccCCCcEEEcCCC
Q 002146 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 736 IVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YL-Hs~g~~IIHRDLKPeNILLd~~g 814 (960)
|........ ...+|||||++|++|...+.+. ..+++.....++.|++.+|.|| |..| |+||||||+|||++ ++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CC
Confidence 643222211 2238999999988776553332 3688899999999999999999 6888 99999999999998 47
Q ss_pred cEEEEecCccccc
Q 002146 815 NVKVSDFGLSRLK 827 (960)
Q Consensus 815 ~VKL~DFGLAr~~ 827 (960)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=192.96 Aligned_cols=175 Identities=13% Similarity=0.101 Sum_probs=136.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChH-HHHH------HHHHHHHHHHcCCCceeeEeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLE------FKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~-~~~~------~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+...+|+++++||.| .||.||+.+.++..+|||++........ .... +.+|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~-~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNI-DDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCC-CceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 345789999999999 5999999988888999999876543332 2223 5789999999999999998887553
Q ss_pred C--------CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEE
Q 002146 746 P--------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 817 (960)
Q Consensus 746 ~--------~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VK 817 (960)
. ...+|+|||++|.+|.++.. +++. .+.+++.+|..||..| |+||||||.||+++.+| ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EE
Confidence 3 35889999999999988742 3332 3559999999999999 99999999999999988 99
Q ss_pred EEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 002146 818 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872 (960)
Q Consensus 818 L~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT 872 (960)
|+|||..+....... ....+....|+.+.|+|+||+++..+..
T Consensus 175 liDfg~~~~~~e~~a------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 175 IIDLSGKRCTAQRKA------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEECCCcccccchhh------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 999998865421100 0113445557789999999999876653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=185.69 Aligned_cols=187 Identities=17% Similarity=0.175 Sum_probs=143.2
Q ss_pred EEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChH--HHHHHHHHHHHHHHcC-CCceeeEecccccCCceEEEEeec
Q 002146 680 LGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGA--ALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~--~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
+...|+.| .||+|+.+...+.+|+.+.+........ ....+.+|+++|++|. |++|++++++ ...+++|||+
T Consensus 6 ~~~~l~~~-~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSD-TFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCC-CcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 56789999 6999999988899999887654433111 1225789999999995 5889999886 4579999999
Q ss_pred CCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc-CCCcEEEcCCCcEEEEecCccccccCCccc--
Q 002146 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-- 833 (960)
Q Consensus 757 ~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL-KPeNILLd~~g~VKL~DFGLAr~~~~~~~~-- 833 (960)
.|.+|...+.. . ...++.|++.+|.++|.+| |+|||| ||+|||++.+|.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999765421 1 1346779999999999999 999999 799999999999999999999865432210
Q ss_pred -----------CCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002146 834 -----------SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMN 881 (960)
Q Consensus 834 -----------~~t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF~~~~ 881 (960)
......++.|+.|+...- .+.-...+|++.|+-+|.++|+..++.+.+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 001125788888886433 233367899999999999999998876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-19 Score=179.98 Aligned_cols=140 Identities=21% Similarity=0.243 Sum_probs=108.6
Q ss_pred EEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHHHcCCCc
Q 002146 681 GERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSG------------------------AALLEFKREVKIMRRLRHPN 735 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~------------------------~~~~~~~~Ei~ILk~L~HPN 735 (960)
.+.||.| +||.||++.. +|+.||||+++...... .....+..|...+.++.|++
T Consensus 2 ~~~ig~G-~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTG-KEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecC-CCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 4679999 7999999986 59999999987642110 00123467999999999988
Q ss_pred eeeEecccccCCceEEEEeecCCCCHHHH-hhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCC
Q 002146 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRI-LHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKN 813 (960)
Q Consensus 736 IVkL~g~f~~~~~l~LVmEY~~gGsL~dl-L~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~ 813 (960)
|.....+... ..+|||||++|+++... +.. ..+++.....++.|++.+|.+||. .| |+||||||+|||++ +
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C
Confidence 7543333222 24899999998755433 433 357788889999999999999999 88 99999999999999 8
Q ss_pred CcEEEEecCcccccc
Q 002146 814 WNVKVSDFGLSRLKH 828 (960)
Q Consensus 814 g~VKL~DFGLAr~~~ 828 (960)
+.++|+|||+++...
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=189.66 Aligned_cols=232 Identities=22% Similarity=0.275 Sum_probs=151.6
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCC----------CceeeEecc-
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH----------PNVVLFMGA- 742 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~H----------PNIVkL~g~- 742 (960)
.+..++.||.| .++.||.+.+ +|+.+|||++..... ....++++++|.-....+.+ -.++..++.
T Consensus 13 ~l~~~~~i~~g-~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKG-GFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEE-TTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccC-CceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 46778999999 6999999998 579999998875542 23356677776655544322 112211111
Q ss_pred --------cccC---C-----ceEEEEeecCCCCHHHHhh---CCC---CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEE
Q 002146 743 --------VTRP---P-----NLSIITEFLPRGSLFRILH---RPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVH 800 (960)
Q Consensus 743 --------f~~~---~-----~l~LVmEY~~gGsL~dlL~---k~~---~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIH 800 (960)
+... . +.+++|+-+ .++|.+++. ... ..+....+..+..|+++.+++||..| |+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence 1111 1 246778877 468888754 111 12444566677799999999999999 999
Q ss_pred eccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCC--------CCCchhhHHHHHHHHHHHHh
Q 002146 801 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE--------PSNEKCDVYSFGVILWELAT 872 (960)
Q Consensus 801 RDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~--------~ys~ksDIWSLGvLLyELLT 872 (960)
+||||+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|.+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999999987765443221 2345779999986442 47899999999999999999
Q ss_pred CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCC
Q 002146 873 LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 921 (960)
Q Consensus 873 G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kR 921 (960)
+..||........... ......+++..++.||.++|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999987654322221 122223678899999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=211.07 Aligned_cols=249 Identities=21% Similarity=0.244 Sum_probs=186.7
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC---CCceeeEeccccc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTR 745 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~---HPNIVkL~g~f~~ 745 (960)
.+++..+.|.|-+.||.| +||.||+|.. +|+.||+|+-+.....+.. --.+++.+|+ -+-|..+..++..
T Consensus 692 ~~~~~~~~~~I~~e~G~g-~y~~vy~a~~~~~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEG-SYGSVYVATHSNGKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccc-cceEEEEeecCCCcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcchHHHHHHHcc
Confidence 456667889999999999 7999999975 6899999987655443321 1123344444 3456677777777
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-------CCcEEE
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-------NWNVKV 818 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-------~g~VKL 818 (960)
.+.-+||+||.+.|+|.++++.. ..+++...+.++.||+.-+++||..+ |||+||||+|+||.. .--++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEE
Confidence 88899999999999999999843 47899999999999999999999999 999999999999942 345999
Q ss_pred EecCcccccc--CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc
Q 002146 819 SDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 896 (960)
Q Consensus 819 ~DFGLAr~~~--~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~ 896 (960)
+|||.+..+. .........++|-.+-.+|+..|++|++.+|.|.|+.+++-||+|+.- +....- ......
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q~~~g~-~~~~~~ 914 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------EVKNGS-SWMVKT 914 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------HhcCCc-ceeccc
Confidence 9999987542 122234556789999999999999999999999999999999998742 100000 000111
Q ss_pred CCCCCCcHH-HHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 897 EIPKELDPL-VARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 897 ~iP~~lS~e-LkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
.+++.+..+ ..+|+..+|+.|-..=|.+.+|...|+.+.
T Consensus 915 ~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 915 NFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred cchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 234444444 456888889866555688888888887763
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.1e-18 Score=173.07 Aligned_cols=136 Identities=23% Similarity=0.410 Sum_probs=114.8
Q ss_pred EEeeccCCeeEEEEEEECCcEEEEEEeecCCCChH------HHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 682 ERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~------~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
+.||+| .+|.||++.+.|..|+||+......... ....+.+|+.++..+.|++|+....++......+++|||
T Consensus 2 ~~l~~G-~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRG-AEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccC-ceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 568999 7999999999999999998664332211 224578899999999999887766666677788999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
++|++|.+++.... . ....++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 2 77789999999999999999 99999999999999 78999999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=193.61 Aligned_cols=209 Identities=33% Similarity=0.525 Sum_probs=168.0
Q ss_pred HHHcCCCceeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCc
Q 002146 728 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807 (960)
Q Consensus 728 Lk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeN 807 (960)
|+.+.|.|+.+|+|.+.++..+++|.+||..|+|.|.+......++......++++|+.||.|||.... ..|+.|+..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecccc
Confidence 456889999999999999999999999999999999999877789999999999999999999998762 3999999999
Q ss_pred EEEcCCCcEEEEecCccccccCC--cccCCCCCCCCCccCcccccCCC-------CCchhhHHHHHHHHHHHHhCCCCCC
Q 002146 808 LLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEP-------SNEKCDVYSFGVILWELATLKLPWI 878 (960)
Q Consensus 808 ILLd~~g~VKL~DFGLAr~~~~~--~~~~~t~~GT~~Y~APEvl~g~~-------ys~ksDIWSLGvLLyELLTG~~PF~ 878 (960)
++++....+||.|||+....... ........-..-|.|||.+.+.. .+.+.|+||+|++++|+++..-||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998776321 01111112345799999998752 3567999999999999999999997
Q ss_pred CC----ChhHHHHHhhcccc---ccCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 879 GM----NPMQVVGAVGFQNR---RLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 879 ~~----~~~ei~~~I~~~~~---~~~iP~--~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.. .+.++...+..... ++.++. ...+++..++.+||..+|.+||++++|-..++.+.+.
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 62 23345555443122 222221 3455799999999999999999999999999888654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=172.94 Aligned_cols=134 Identities=19% Similarity=0.244 Sum_probs=103.8
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-----CCCceeeEecccccCC---ceE-E
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-----RHPNVVLFMGAVTRPP---NLS-I 751 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-----~HPNIVkL~g~f~~~~---~l~-L 751 (960)
.+.||+| +||.||.-..++.. +||++...... ....+.+|+.+++.+ .||||++++++++++. .++ +
T Consensus 7 ~~~LG~G-~~~~Vy~hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTG-RHRKCYAHPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCC-CceEEEECCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4679999 79999973234444 68887654322 345789999999999 5799999999998874 333 7
Q ss_pred EEee--cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHH-HHHhhCCCCEEEeccCCCcEEEcC----CCcEEEEecCcc
Q 002146 752 ITEF--LPRGSLFRILHRPHCQVDEKRRIKMALDVARGM-NCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLS 824 (960)
Q Consensus 752 VmEY--~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL-~YLHs~g~~IIHRDLKPeNILLd~----~g~VKL~DFGLA 824 (960)
|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ ||||||||+|||++. ++.++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 5579999999763 35555 34577888888 9999999 999999999999974 347999995544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=168.50 Aligned_cols=132 Identities=22% Similarity=0.373 Sum_probs=107.9
Q ss_pred eeccCCeeEEEEEEECCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecC
Q 002146 684 IGLGSSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~------~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
||+| .||.||++.+++..|++|+........ ....++.+|++++..+.|+++.....++......++||||++
T Consensus 2 ig~G-~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKG-AEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCC-ceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 7999 799999999999999999865432211 123567889999999988865544444455667899999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
|++|.+++..... .++.+++.+|.+||+.| ++|||++|.|||++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998765321 67889999999999999 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=170.75 Aligned_cols=143 Identities=24% Similarity=0.226 Sum_probs=110.7
Q ss_pred CeEEEEEeeccCCeeEEEEEE---ECCcEEEEEEeecCCCCh----------------------HHHHHHHHHHHHHHHc
Q 002146 677 DLVLGERIGLGSSYGEVYHAD---WNGTEVAVKKFLDQDFSG----------------------AALLEFKREVKIMRRL 731 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak---~~g~~VAVK~i~~~~~~~----------------------~~~~~~~~Ei~ILk~L 731 (960)
.|.+.+.||.| .||.||+|. .+|+.||||++....... .....+.+|+.+++++
T Consensus 29 ~~~i~~~Lg~G-~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 29 LSAIGGCISTG-KEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred hHHhCCeeccC-cceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 37788999999 799999997 379999999987542110 0112467899999999
Q ss_pred CCC--ceeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEE
Q 002146 732 RHP--NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 809 (960)
Q Consensus 732 ~HP--NIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNIL 809 (960)
.+. .+.+++++ ...++||||++|++|..++.... .+.......++.||+.+|.+||..| .|+||||||+||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIl 181 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNIL 181 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEE
Confidence 653 34445543 23589999999988877653322 4566667889999999999999876 5999999999999
Q ss_pred EcCCCcEEEEecCccccc
Q 002146 810 VDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 810 Ld~~g~VKL~DFGLAr~~ 827 (960)
++ ++.++|+|||++...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998644
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=186.99 Aligned_cols=136 Identities=20% Similarity=0.337 Sum_probs=113.3
Q ss_pred eEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 678 LVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~------~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
|...+.||+| .||+||++.+.+..+++|+........ .....+.+|+++++.++|++|+..+.++......++
T Consensus 335 ~~~~~~iG~G-~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 335 KIPDHLIGKG-AEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred cCccceeccC-CcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 4567889999 799999999988887777543322211 123468899999999999999887777777778899
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999999885 34568899999999999999 9999999999999 678999999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.1e-16 Score=160.00 Aligned_cols=137 Identities=21% Similarity=0.227 Sum_probs=107.2
Q ss_pred eEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCCh--------------------HHHHHHHHHHHHHHHcCCC--
Q 002146 678 LVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSG--------------------AALLEFKREVKIMRRLRHP-- 734 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~--------------------~~~~~~~~Ei~ILk~L~HP-- 734 (960)
|.+.+.||.| .||.||++.+ +|+.||||++....... .....+..|+.++..+.|+
T Consensus 17 ~~~~~~i~~G-~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVG-KESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccC-cceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 6777889999 7999999987 69999999876432100 0112367899999999777
Q ss_pred ceeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC
Q 002146 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 735 NIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g 814 (960)
.++..++. ...++||||++|++|..+... .....++.+++.++.++|..| |+||||||+||+|++++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCC
Confidence 44444442 356899999999999876431 234567889999999999998 99999999999999999
Q ss_pred cEEEEecCcccccc
Q 002146 815 NVKVSDFGLSRLKH 828 (960)
Q Consensus 815 ~VKL~DFGLAr~~~ 828 (960)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-16 Score=181.38 Aligned_cols=169 Identities=23% Similarity=0.326 Sum_probs=128.8
Q ss_pred CceEEEEeecCCCCHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 747 PNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~--~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
.++||.|++|...+|.+||.++ ....+......++.|++.|++| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 3588999999999999999643 3456778888999999999999 66 999999999999999999999999999
Q ss_pred ccccCCc------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccC
Q 002146 825 RLKHNTF------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 897 (960)
Q Consensus 825 r~~~~~~------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~ 897 (960)
....... ......+||.+||+||+|.+..|+.++|||+||+|++||+. =...|.... .+..+.....++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhhcCCCChH
Confidence 7654332 12344579999999999999999999999999999999997 233332211 1122211111111
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 002146 898 IPKELDPLVARIIWECWQTDPSLRPSF 924 (960)
Q Consensus 898 iP~~lS~eLkdLI~kcL~kDP~kRPSa 924 (960)
+..+ .++-..|+.+||.+.|.+||++
T Consensus 481 ~~~d-~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 481 FLQD-YPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred Hhhc-CcHHHHHHHHhcCCCcccCchH
Confidence 2222 2455689999999999999943
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.7e-15 Score=141.56 Aligned_cols=134 Identities=19% Similarity=0.186 Sum_probs=112.5
Q ss_pred EEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC--CceeeEecccccCCceEEEEeecC
Q 002146 680 LGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H--PNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
+.+.||.| .++.||++...+..++||.+..... ...+.+|+.+++.+.| .++++++.++...+..+++|||++
T Consensus 2 ~~~~i~~g-~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGG-LTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccc-cccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 45779999 7999999999888999998765432 3468899999999976 589999999888889999999999
Q ss_pred CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCC-CCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 758 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 758 gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g-~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
++.+..+ +......++.+++.+|.+||... .+++|+||+|+|||++..+.++++|||+++.
T Consensus 77 g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777654 44555667889999999999842 2399999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.9e-17 Score=194.60 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=196.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~---~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~L 751 (960)
..|.+.+.||+| +|+.|-.... ....+|+|.+............+..|..+-+.+. |.|++.+++...+....++
T Consensus 20 ~~~~~~~~ig~g-s~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKG-SFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccc-ccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 456677779999 8999988854 3445677766554433344456667888888886 9999999999999999999
Q ss_pred EEeecCCCCHHHHh-hCCCCCCcHHHHHHHHHHHHHHHHHHh-hCCCCEEEeccCCCcEEEcCCC-cEEEEecCcccccc
Q 002146 752 ITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKH 828 (960)
Q Consensus 752 VmEY~~gGsL~dlL-~k~~~~lse~~~~~Ia~QIa~AL~YLH-s~g~~IIHRDLKPeNILLd~~g-~VKL~DFGLAr~~~ 828 (960)
+++|..|+++++.+ .......+......++.|+..++.|+| ..+ +.||||||+|.+++..+ .+|+.|||+|....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999998 443325666667778899999999999 887 99999999999999999 99999999998764
Q ss_pred C-C--cccCCCCCC-CCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHH--HHhhcccc-ccCCCC
Q 002146 829 N-T--FLSSKSTAG-TPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV--GAVGFQNR-RLEIPK 900 (960)
Q Consensus 829 ~-~--~~~~~t~~G-T~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~--~~I~~~~~-~~~iP~ 900 (960)
. . .......+| ++.|+|||...+.. .....|+||+|+++..+++|..||......... ..+..... ....+.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 4 2 223345678 99999999999964 478899999999999999999999765443321 11111111 233456
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
.++....+++.+++..+|..|.+.+++..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccc
Confidence 78889999999999999999999887754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.2e-15 Score=149.80 Aligned_cols=137 Identities=23% Similarity=0.221 Sum_probs=98.0
Q ss_pred EEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHH----------------------HHHHHHHHHHcCCCc--
Q 002146 681 GERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLE----------------------FKREVKIMRRLRHPN-- 735 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~----------------------~~~Ei~ILk~L~HPN-- 735 (960)
++.||+| .||+||++... ++.||||++............ ...|...+.++.+..
T Consensus 2 ~~~lg~G-~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTG-KEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred Ccccccc-cceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 4679999 79999999874 999999998754322111111 145677777774432
Q ss_pred eeeEecccccCCceEEEEeecCCCCHHH-HhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCC
Q 002146 736 VVLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKN 813 (960)
Q Consensus 736 IVkL~g~f~~~~~l~LVmEY~~gGsL~d-lL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~ 813 (960)
+.++++. ...++||||++++.+.. .+.... . ......++.+++.++.++|. .+ |+||||||+||+++ +
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-D 150 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-C
Confidence 4445543 24689999999854321 121111 1 15567889999999999999 88 99999999999999 8
Q ss_pred CcEEEEecCcccccc
Q 002146 814 WNVKVSDFGLSRLKH 828 (960)
Q Consensus 814 g~VKL~DFGLAr~~~ 828 (960)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=153.99 Aligned_cols=136 Identities=16% Similarity=0.263 Sum_probs=103.6
Q ss_pred EEee-ccCCeeEEEEEEECCcEEEEEEeecCCC-----------ChHHHHHHHHHHHHHHHcCCCce--eeEecccccCC
Q 002146 682 ERIG-LGSSYGEVYHADWNGTEVAVKKFLDQDF-----------SGAALLEFKREVKIMRRLRHPNV--VLFMGAVTRPP 747 (960)
Q Consensus 682 k~LG-~GGsFG~Vy~ak~~g~~VAVK~i~~~~~-----------~~~~~~~~~~Ei~ILk~L~HPNI--VkL~g~f~~~~ 747 (960)
..|| .| ..|+||.++..+..++||.+..... .......+.+|+.++.+|.|++| +..+++.....
T Consensus 37 ~~lg~~~-g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAK-GRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCC-CCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4466 44 4778888888899999998854221 11233467889999999998775 66666543322
Q ss_pred c----eEEEEeecCC-CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecC
Q 002146 748 N----LSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822 (960)
Q Consensus 748 ~----l~LVmEY~~g-GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFG 822 (960)
. .++||||++| .+|.+++... .+++.. +.+|+.+|.+||..| |+||||||.|||++.++.++|+|||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 3599999997 6999988653 344433 568999999999999 9999999999999998999999999
Q ss_pred cccc
Q 002146 823 LSRL 826 (960)
Q Consensus 823 LAr~ 826 (960)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.3e-14 Score=163.10 Aligned_cols=246 Identities=23% Similarity=0.189 Sum_probs=187.3
Q ss_pred eEEEEEeec--cCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceE
Q 002146 678 LVLGERIGL--GSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 678 y~i~k~LG~--GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~ 750 (960)
+.+.+.+|. | .+|.||.++. .+..+|+|.-+...-.......=.+|+.-.+.+ .|+|.++.+..++..+.++
T Consensus 116 ~~~~~~~g~~~g-~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 116 FPISSRTGSLPG-SKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred cccccccccCCC-CCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 556677898 9 7999999876 577799987433222111111224566666777 5999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHH----HHHHHhhCCCCEEEeccCCCcEEEcCC-CcEEEEecCccc
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR----GMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR 825 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~----AL~YLHs~g~~IIHRDLKPeNILLd~~-g~VKL~DFGLAr 825 (960)
+-+|+| +.+|..+.+.....+++..++.++.+... ||.++|..+ |+|-|+||.||++..+ ...+++|||+..
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeE
Confidence 999999 57999999888778999999999999999 999999999 9999999999999988 889999999999
Q ss_pred cccCCcccCC-----CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 826 LKHNTFLSSK-----STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 826 ~~~~~~~~~~-----t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
.+........ ...|...|++||.+.+. ++.+.|+|+||.++.+..++..++.......+.+ +.......++-.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cccccCchhhhc
Confidence 8765542222 22688899999998776 7899999999999999998766554331111111 100111223334
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
..+..+...+.+|++.+|..|+++..+..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 45667777999999999999998876654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-13 Score=167.53 Aligned_cols=251 Identities=22% Similarity=0.257 Sum_probs=195.7
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
+....+.+.+++-+-.| +++.++.++- .|...++|+...... .......+..+-.++...++|.++.....+....
T Consensus 799 yrsS~d~~~i~~p~qS~-sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSG-SPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred ccCCCccceecccccCC-CCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC
Confidence 56778899999988888 8999998864 344455554433221 1122334555666666667888988877777778
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.++|+++|+.+++|...|+..+. .++.....++..++.+++|||... ++|||++|.|+|+..+|+.++.|||.....
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccccc
Confidence 89999999999999999988763 444444455668999999999987 999999999999999999999999844321
Q ss_pred cCC-------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002146 828 HNT-------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 876 (960)
Q Consensus 828 ~~~-------------------------------~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~P 876 (960)
.-. ........||+.|.+||.+.+......+|||++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 0112344689999999999999999999999999999999999999
Q ss_pred CCCCChhHHHHHhhcccccc-CCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 002146 877 WIGMNPMQVVGAVGFQNRRL-EIPKELDPLVARIIWECWQTDPSLRPSFA 925 (960)
Q Consensus 877 F~~~~~~ei~~~I~~~~~~~-~iP~~lS~eLkdLI~kcL~kDP~kRPSa~ 925 (960)
|....+.++++.|......+ .-+...++++++++...|..+|.+|..+.
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999998885433222 23556889999999999999999998765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.5e-11 Score=144.83 Aligned_cols=166 Identities=19% Similarity=0.247 Sum_probs=126.9
Q ss_pred EECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHH
Q 002146 697 DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR 776 (960)
Q Consensus 697 k~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~ 776 (960)
+.++.+|.|+.+....- .....+.+-++.|+.|+||||+++++.++..+.+|||+|.+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHH
Confidence 34788888887765443 334456788899999999999999999999999999999984 57777765 33667
Q ss_pred HHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCc
Q 002146 777 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 856 (960)
Q Consensus 777 ~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ 856 (960)
....++||+.||.+||..+ .++|++|.-.-|+|++.|++||++|.++..............---.|..|+.+.... .
T Consensus 106 v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--c
Confidence 7778899999999998543 499999999999999999999999998865432211111111222456666543332 5
Q ss_pred hhhHHHHHHHHHHHHhC
Q 002146 857 KCDVYSFGVILWELATL 873 (960)
Q Consensus 857 ksDIWSLGvLLyELLTG 873 (960)
..|.|.|||++++++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 67999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.4e-12 Score=125.90 Aligned_cols=129 Identities=16% Similarity=0.126 Sum_probs=95.8
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCce-eeEecccccCCceEEEEeecCCC
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPRG 759 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNI-VkL~g~f~~~~~l~LVmEY~~gG 759 (960)
++.|+.| .++.||+++..+..|++|....... ....+.+|+.+++.+.+.++ .+++.+.. ...++||||++|.
T Consensus 3 ~~~l~~G-~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGG-MTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCc-ccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 4568888 7999999999999999998654321 12245788999998855443 45555433 3457999999998
Q ss_pred CHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCC---CEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 760 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP---TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 760 sL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~---~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
++.... . ....++.+++.+|..||..+. .++|+|++|.||+++ ++.++|+|||.+.
T Consensus 77 ~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 876430 1 112356789999999999862 259999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-11 Score=143.94 Aligned_cols=141 Identities=24% Similarity=0.252 Sum_probs=96.9
Q ss_pred EEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHH----------------------------H----------HHHH
Q 002146 682 ERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAA----------------------------L----------LEFK 722 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~----------------------------~----------~~~~ 722 (960)
+.||.| ++|.||+|+. +|+.||||+.+........ . ..+.
T Consensus 123 ~plasa-SigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAA-SIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeee-ehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 569999 8999999986 7999999987543110000 0 0244
Q ss_pred HHHHHHHHcC-----CCceeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHH-HHHHHhhCCC
Q 002146 723 REVKIMRRLR-----HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR-GMNCLHTSTP 796 (960)
Q Consensus 723 ~Ei~ILk~L~-----HPNIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~-AL~YLHs~g~ 796 (960)
+|...+.++. +++|.-..-+.......+|||||++|++|.++........ ....++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC-
Confidence 5666665552 3443221112223345789999999999988765321122 23345556665 468889988
Q ss_pred CEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++|+|+||.||+++.+|.++|+|||++....
T Consensus 278 -~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 -FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.2e-11 Score=139.94 Aligned_cols=143 Identities=17% Similarity=0.186 Sum_probs=89.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE-C-CcEEEEEEeecCCC---------------------------Ch-----HHHHH
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW-N-GTEVAVKKFLDQDF---------------------------SG-----AALLE 720 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~-~-g~~VAVK~i~~~~~---------------------------~~-----~~~~~ 720 (960)
+.+|.. +.||.| ++|.||+++. + |+.||||+++..-. .. +....
T Consensus 119 F~~fd~-~Plasa-SiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 119 FDDFDI-KPLASA-SIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHhcCh-hhhcCC-CccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 345665 789999 8999999986 4 89999999864310 00 11112
Q ss_pred ------HHHHHHHHHHcC----CCceeeEeccc-ccCCceEEEEeecCCCCHHHH--hhCCCC---CCcHHHHHHHHHHH
Q 002146 721 ------FKREVKIMRRLR----HPNVVLFMGAV-TRPPNLSIITEFLPRGSLFRI--LHRPHC---QVDEKRRIKMALDV 784 (960)
Q Consensus 721 ------~~~Ei~ILk~L~----HPNIVkL~g~f-~~~~~l~LVmEY~~gGsL~dl--L~k~~~---~lse~~~~~Ia~QI 784 (960)
+.+|...+.+++ +.+.+.+-.++ ......+|||||+.|+.|.++ +...+. .+.+.....++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 333443333331 22222221111 113345699999999999875 322221 23333334444444
Q ss_pred HHHHHHHhhCCCCEEEeccCCCcEEEcCCC----cEEEEecCcccccc
Q 002146 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKH 828 (960)
Q Consensus 785 a~AL~YLHs~g~~IIHRDLKPeNILLd~~g----~VKL~DFGLAr~~~ 828 (960)
+..| ++|+|+||.||+++.+| .++++|||++....
T Consensus 277 -------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3467 99999999999999888 99999999987553
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-11 Score=136.05 Aligned_cols=200 Identities=23% Similarity=0.344 Sum_probs=142.5
Q ss_pred HHHHHcCCCceeeEecccccCC-----ceEEEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCC
Q 002146 726 KIMRRLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPT 797 (960)
Q Consensus 726 ~ILk~L~HPNIVkL~g~f~~~~-----~l~LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~ 797 (960)
.-|-++.|.|||+++.||.+.+ +..+++||+.-|+|..+|++ .+..+..+...+|+-||+.||.|||+..++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455567999999999987654 47889999999999999875 344688888899999999999999999999
Q ss_pred EEEeccCCCcEEEcCCCcEEEEecCccccccCCcc-----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 002146 798 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872 (960)
Q Consensus 798 IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~-----~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT 872 (960)
|+|+++...-|++..+|-||+.--- -...+.... ......+-++|.+||.=.....+-++|||+||....+|.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999988874211 111111111 1112246678999998766667889999999999999987
Q ss_pred CCCC-CCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 873 LKLP-WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 873 G~~P-F~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~L 931 (960)
+..- -.+.........+. .....+ -...-+.+|.+||+..|..||++..++-+.
T Consensus 278 lEiq~tnseS~~~~ee~ia--~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIA--NVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeehhhhhh--hheeec---cCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 6532 11111111111111 001111 122346789999999999999999887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-11 Score=144.87 Aligned_cols=248 Identities=21% Similarity=0.214 Sum_probs=184.7
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCce
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~---~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l 749 (960)
...+|..+..||.| .|+.|+.+.. ++..|++|.+.+..........-..|+.+...+ -|.+++.++..|....+.
T Consensus 263 ~~~df~~v~~i~~~-~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDG-NFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCC-ccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 44678889999999 7999998754 577899998766544433323335677777777 599999999999888899
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC-CcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-g~VKL~DFGLAr~~~ 828 (960)
|+-.|||+++++...+. ....+++..++++..|++.++.++|+.. ++|+|+||.||++..+ +..++.|||+...+.
T Consensus 342 ~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccc
Confidence 99999999998876652 2235788889999999999999999998 9999999999999875 788999999986432
Q ss_pred CCcccCCCCCCCCCcc--CcccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 829 NTFLSSKSTAGTPEWM--APEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~--APEvl~g~~ys~ksDIWSLGvLLyELLTG~~-PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
.. .....+.-+++ +++......+..+.|+++||..+.+.+++.. ++.+.....+. .+..+..+ ....+
T Consensus 419 ~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~-----~~~~p~~~-~~~~~ 489 (524)
T KOG0601|consen 419 FS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR-----SGDTPNLP-GLKLQ 489 (524)
T ss_pred ee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee-----cccccCCC-chHHh
Confidence 11 11223333444 5666677778999999999999999999864 33332222111 12122233 33478
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
+..+.+.+...++..||.+.++..+.+..
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 88899999999999999998887766544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.7e-10 Score=115.38 Aligned_cols=141 Identities=21% Similarity=0.262 Sum_probs=107.0
Q ss_pred EEeeccCCeeEEEEEEECC-cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC--CceeeEecccccC---CceEEEEee
Q 002146 682 ERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRP---PNLSIITEF 755 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~g-~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H--PNIVkL~g~f~~~---~~l~LVmEY 755 (960)
+.|+.| .++.||+++..+ +.|++|+....... .....+..|..+++.+.+ .++.+++.+.... +..++||||
T Consensus 4 ~~l~~G-~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGG-QSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCC-ccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568888 799999998765 89999986543321 123467899999999965 3456677766553 367899999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST---------------------------------------- 795 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g---------------------------------------- 795 (960)
++|.+|.+.+.. ..+++.....++.+++.+|.+||+..
T Consensus 82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 999988876532 24677777778888888888888521
Q ss_pred --------------CCEEEeccCCCcEEEcC--CCcEEEEecCcccc
Q 002146 796 --------------PTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRL 826 (960)
Q Consensus 796 --------------~~IIHRDLKPeNILLd~--~g~VKL~DFGLAr~ 826 (960)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24899999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.5e-10 Score=117.67 Aligned_cols=137 Identities=19% Similarity=0.172 Sum_probs=96.7
Q ss_pred EEeeccCCeeEEEEEEEC--------CcEEEEEEeecCCC--Ch------------------HHHHH----HHHHHHHHH
Q 002146 682 ERIGLGSSYGEVYHADWN--------GTEVAVKKFLDQDF--SG------------------AALLE----FKREVKIMR 729 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~--------g~~VAVK~i~~~~~--~~------------------~~~~~----~~~Ei~ILk 729 (960)
..||.| -=+.||.+... +..+|||+++.... .. ..... .++|.+.|+
T Consensus 3 g~i~~G-KEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 3 GCISTG-KESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CccccC-cceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 458888 57899999643 37899997753210 00 00112 348999999
Q ss_pred HcCC--CceeeEecccccCCceEEEEeecCCCCHHH-HhhCCCCCCcHHHHHHHHHHHHHHHHHH-hhCCCCEEEeccCC
Q 002146 730 RLRH--PNVVLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKS 805 (960)
Q Consensus 730 ~L~H--PNIVkL~g~f~~~~~l~LVmEY~~gGsL~d-lL~k~~~~lse~~~~~Ia~QIa~AL~YL-Hs~g~~IIHRDLKP 805 (960)
++.. -++.+.+++ ..-+|||||+.++.+.. .+.. ..+++.....+..+++.+|..| |..| |||+||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 9843 355666654 46789999997654432 2222 1345556667788999999999 8888 99999999
Q ss_pred CcEEEcCCCcEEEEecCcccccc
Q 002146 806 PNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 806 eNILLd~~g~VKL~DFGLAr~~~ 828 (960)
.|||++ ++.+.|+|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.9e-09 Score=111.32 Aligned_cols=132 Identities=25% Similarity=0.367 Sum_probs=100.9
Q ss_pred EeeccCCeeEEEEEEECCcEEEEEEeecCCCChHH------HHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEeec
Q 002146 683 RIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAA------LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~------~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
.+++| +=..++.+.|-|.++++|.-....+.... ..+..+|..+|.+++--.|..-+=++.+++...|+|||+
T Consensus 3 ~i~~G-AEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQG-AEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCC-cceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 46778 78899999998888888854333332222 235678999999986545444344455677888999999
Q ss_pred CCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 757 ~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+|..|.+++... ...++..+-.-+.-||..| |||+||.++||++...+ +.++||||+..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888764 2456677778888899999 99999999999997765 99999999963
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=2e-08 Score=110.00 Aligned_cols=133 Identities=20% Similarity=0.162 Sum_probs=95.2
Q ss_pred eEEEEEEECCcEEEEEEeecCCCChH---------HHHHHHHHHHHHHHcCCCce--eeEeccccc-----CCceEEEEe
Q 002146 691 GEVYHADWNGTEVAVKKFLDQDFSGA---------ALLEFKREVKIMRRLRHPNV--VLFMGAVTR-----PPNLSIITE 754 (960)
Q Consensus 691 G~Vy~ak~~g~~VAVK~i~~~~~~~~---------~~~~~~~Ei~ILk~L~HPNI--VkL~g~f~~-----~~~l~LVmE 754 (960)
..|+...+.|+.|.||.......... ....+.+|...+.+|..-+| +..++++.. ...-+||||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 34667788899999997643331110 01136788888888843332 223333322 235789999
Q ss_pred ecCCC-CHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-------CCcEEEEecCccc
Q 002146 755 FLPRG-SLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-------NWNVKVSDFGLSR 825 (960)
Q Consensus 755 Y~~gG-sL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-------~g~VKL~DFGLAr 825 (960)
++++. +|.+++... ....++.....++.+++..+.-||..| |+|+||++.||||+. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99876 799987531 224556677789999999999999999 999999999999975 4689999999775
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=8.9e-08 Score=110.80 Aligned_cols=210 Identities=16% Similarity=0.204 Sum_probs=149.6
Q ss_pred eEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc----CCceEEEEeecCC-CCHHH
Q 002146 691 GEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFLPR-GSLFR 763 (960)
Q Consensus 691 G~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~----~~~l~LVmEY~~g-GsL~d 763 (960)
.+.|++.. +|..|++|+++-...... .....-+++|+++.|.|||+|.++|.. +..+++|++|.++ ++|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 46677753 899999999843322111 112244788999999999999999873 3458899999875 57776
Q ss_pred HhhC--------------CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 764 ILHR--------------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 764 lL~k--------------~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
+... .+.+.+|..+|.++.||..||.++|+.| +..+-|.+.+||++.+.+|+|...|+-.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5421 2235778999999999999999999999 88899999999999998999987776655433
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChhHH-HHHhhccccccCCCCCCcHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQV-VGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~-PF~~~~~~ei-~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.. + |.+.+ ..+-|.=.||.+++.|.||.. -|......+. ... +-..++.+++
T Consensus 446 d~-------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D~r 499 (655)
T KOG3741|consen 446 DP-------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTDLR 499 (655)
T ss_pred CC-------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHHHH
Confidence 21 0 11222 356789999999999999853 2222222222 222 2345788899
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~L 931 (960)
++|.-+...++++ -++.+++.++
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHHH
Confidence 9999999888886 5677666544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.1e-08 Score=108.41 Aligned_cols=247 Identities=18% Similarity=0.266 Sum_probs=160.7
Q ss_pred EEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceee--------EecccccCCceE
Q 002146 680 LGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL--------FMGAVTRPPNLS 750 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVk--------L~g~f~~~~~l~ 750 (960)
.+..||+|| -+.+|-.---+..|| |+++........ .-+..|... .||-+-. ++|.- ....+.
T Consensus 15 ~gr~LgqGg-ea~ly~l~e~~d~VA-KIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iG 86 (637)
T COG4248 15 PGRPLGQGG-EADLYTLGEVRDQVA-KIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIG 86 (637)
T ss_pred CCccccCCc-cceeeecchhhchhh-eeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeE
Confidence 456799995 677776543333344 777654322111 112334333 5654322 22221 223377
Q ss_pred EEEeecCCCC-HHHHhh-----CCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 751 IITEFLPRGS-LFRILH-----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 751 LVmEY~~gGs-L~dlL~-----k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
++|..+.|.. +.++++ +.....++..+++.++.|+.+.+-||.+| .+-+|+.++|+|+.+++.|.|+|-..-
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccce
Confidence 8888887653 233332 12234778999999999999999999999 999999999999999999999986543
Q ss_pred ccccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-------hhH--HHHH-
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATL-KLPWIGMN-------PMQ--VVGA- 888 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG-~~PF~~~~-------~~e--i~~~- 888 (960)
.. +.........+|..+|.+||... +..-+...|.|.||+++|+|+.| +.||.+.. +.+ +..-
T Consensus 165 qi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 165 QI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 22 22223344567999999999854 44457889999999999999886 99998742 111 1000
Q ss_pred --------hhccccccCCC-CCCcHHHHHHHHHhhhh--CCCCCCCHHHHHHHHHHhHHh
Q 002146 889 --------VGFQNRRLEIP-KELDPLVARIIWECWQT--DPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 889 --------I~~~~~~~~iP-~~lS~eLkdLI~kcL~k--DP~kRPSa~eILe~Le~i~~~ 937 (960)
......+..+| ..+++.+..|..+|+.. ++.-||+++.++..|..+...
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 00000111122 24688999999999953 367899999888888776443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.9e-08 Score=102.63 Aligned_cols=144 Identities=18% Similarity=0.245 Sum_probs=104.6
Q ss_pred EEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 680 LGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~------~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
....|-+| +-+.|+++.+.|+...||.-....+.. -...+..+|.++|.++.--.|.--.-+|.+...-.|+|
T Consensus 11 ~l~likQG-AEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQG-AEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeecc-ceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 45667788 789999999999999988533322221 12346788999999885444433333455566677999
Q ss_pred eecCC-CCHHHHhhCCCCC-CcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC---cEEEEecCcccc
Q 002146 754 EFLPR-GSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRL 826 (960)
Q Consensus 754 EY~~g-GsL~dlL~k~~~~-lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g---~VKL~DFGLAr~ 826 (960)
||++| .++.+++...... ..+.....++.+|-..+.-||..+ |||+||..+||+|..+| .+.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4777877653322 333344778899999999999999 99999999999996543 358999999854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.3e-08 Score=100.05 Aligned_cols=127 Identities=28% Similarity=0.315 Sum_probs=82.7
Q ss_pred EEEEEEE-CCcEEEEEEeecCC--CCh----------------------HHHHHHHHHHHHHHHcCCC--ceeeEecccc
Q 002146 692 EVYHADW-NGTEVAVKKFLDQD--FSG----------------------AALLEFKREVKIMRRLRHP--NVVLFMGAVT 744 (960)
Q Consensus 692 ~Vy~ak~-~g~~VAVK~i~~~~--~~~----------------------~~~~~~~~Ei~ILk~L~HP--NIVkL~g~f~ 744 (960)
.||.|.. +|..+|||..+... +.. .......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3888875 78899999774321 110 1123568899999999765 456666542
Q ss_pred cCCceEEEEeecC--CCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHH-HhhCCCCEEEeccCCCcEEEcCCCcEEEEec
Q 002146 745 RPPNLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC-LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821 (960)
Q Consensus 745 ~~~~l~LVmEY~~--gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~Y-LHs~g~~IIHRDLKPeNILLd~~g~VKL~DF 821 (960)
.-.|||||++ |..+..+.... ++......++.+++..+.. +|..| |||+||.+.|||++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 3469999998 66666554431 2234455667788886655 57888 9999999999999887 8999999
Q ss_pred Ccccccc
Q 002146 822 GLSRLKH 828 (960)
Q Consensus 822 GLAr~~~ 828 (960)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.7e-08 Score=120.05 Aligned_cols=145 Identities=19% Similarity=0.278 Sum_probs=108.7
Q ss_pred HHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-ccCC--------CCCCCCCccCcccccCCC
Q 002146 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LSSK--------STAGTPEWMAPEVLRNEP 853 (960)
Q Consensus 783 QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~-~~~~--------t~~GT~~Y~APEvl~g~~ 853 (960)
+++.||.|+|..- ++||+.|.|++|.++++|.+||+.|+++....... +... ...-...|.|||.+.+..
T Consensus 107 ~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 5669999999864 69999999999999999999999999987654311 1110 112456899999999988
Q ss_pred CCchhhHHHHHHHHHHHH-hCCCCCCCCChhHHHHH--hhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 002146 854 SNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGA--VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 928 (960)
Q Consensus 854 ys~ksDIWSLGvLLyELL-TG~~PF~~~~~~ei~~~--I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eIL 928 (960)
.+.++|+||||+++|.++ .|.+-+...+....... .........++..++.++++-+.+++..++..||++..++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 899999999999999999 56666655433222211 1112223345678899999999999999999999666553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.4e-07 Score=99.04 Aligned_cols=127 Identities=27% Similarity=0.284 Sum_probs=90.8
Q ss_pred EECCcEEEEEEeecCCCCh-----HHHHHHHHHHHHHHHcCCCc--eeeEecccccC----CceEEEEeecCCC-CHHHH
Q 002146 697 DWNGTEVAVKKFLDQDFSG-----AALLEFKREVKIMRRLRHPN--VVLFMGAVTRP----PNLSIITEFLPRG-SLFRI 764 (960)
Q Consensus 697 k~~g~~VAVK~i~~~~~~~-----~~~~~~~~Ei~ILk~L~HPN--IVkL~g~f~~~----~~l~LVmEY~~gG-sL~dl 764 (960)
+..++.|.+|.+....... ....+..+|...+..|..-. +++.+++.+.. ...+||+|++++. +|.++
T Consensus 29 ~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 29 DLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred cccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHH
Confidence 4566677777543221111 22346778888888874322 23334443332 3458999999874 79999
Q ss_pred hhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC---cEEEEecCcccc
Q 002146 765 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRL 826 (960)
Q Consensus 765 L~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g---~VKL~DFGLAr~ 826 (960)
+.... ..+......++.+++..+.-||..| |+|+|+++.||||+.++ .+.|+||+-++.
T Consensus 109 ~~~~~-~~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWE-QLDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhc-ccchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 87633 2667778889999999999999999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.2e-06 Score=87.08 Aligned_cols=140 Identities=18% Similarity=0.226 Sum_probs=82.6
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC--ceeeEeccc---ccCCceEEEEee
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGAV---TRPPNLSIITEF 755 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP--NIVkL~g~f---~~~~~l~LVmEY 755 (960)
++.|+.| ..+.||++...+..+++|..... .....+.+|..+++.+... .+.+++... ......+++|+|
T Consensus 2 i~~l~~G-~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGG-FSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEES-SSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCC-CeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 4678988 78999999988889999986433 3455778899999888422 345565532 233347899999
Q ss_pred cCCCCHHH----------------Hhh---CC---CCCCcH-H--------HHHHH------------HHHHHH-HHHHH
Q 002146 756 LPRGSLFR----------------ILH---RP---HCQVDE-K--------RRIKM------------ALDVAR-GMNCL 791 (960)
Q Consensus 756 ~~gGsL~d----------------lL~---k~---~~~lse-~--------~~~~I------------a~QIa~-AL~YL 791 (960)
++|..+.. ++. .. ...+.. . ..... ...+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99988777 111 11 000000 0 00000 011222 23333
Q ss_pred hh-----CCCCEEEeccCCCcEEEc-CCCcEEEEecCccc
Q 002146 792 HT-----STPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 825 (960)
Q Consensus 792 Hs-----~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLAr 825 (960)
+. ....++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 223599999999999999 67777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.8e-06 Score=94.23 Aligned_cols=135 Identities=24% Similarity=0.273 Sum_probs=95.0
Q ss_pred EEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCC--C------------------hHHHHHHHHHHHHHHHcCCC--c
Q 002146 679 VLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDF--S------------------GAALLEFKREVKIMRRLRHP--N 735 (960)
Q Consensus 679 ~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~--~------------------~~~~~~~~~Ei~ILk~L~HP--N 735 (960)
.++..||-| -=+.||.+.. .|.++|||.-+.-.. . .......++|.++|.+|... .
T Consensus 94 ~iG~~IGvG-KEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVG-KESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccC-ccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 467889999 5899999976 699999994321100 0 11123568899999999554 6
Q ss_pred eeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc
Q 002146 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 815 (960)
Q Consensus 736 IVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~ 815 (960)
|.+.+++ ++-.+||||++|..|...-- +....-.++..|++-+..+-..| |||+|+.+-|||++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 7776654 45679999999977776431 22222233444445444444667 999999999999999999
Q ss_pred EEEEecCcccc
Q 002146 816 VKVSDFGLSRL 826 (960)
Q Consensus 816 VKL~DFGLAr~ 826 (960)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976653
|
|
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=98.33 E-value=8e-07 Score=76.36 Aligned_cols=54 Identities=30% Similarity=0.248 Sum_probs=46.3
Q ss_pred cccccchhhHHHHHHHhhhcCCceEEeeccccc---------CCCCCeeEEEEecCcceeeeec
Q 002146 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYT---------GVEDDAVNIIKLEEEREFLVDL 316 (960)
Q Consensus 262 l~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~y~---------~~~~~a~~~v~~~~~~~y~vDl 316 (960)
-+.|.|.++|.||..|+..+|||||+|.|..-. ....|+|++|.+ +++||.+|-
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~-~~~W~~~D~ 66 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYL-EGGWVPVDP 66 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEE-CCCeEEEeC
Confidence 368999999999999999999999999994322 245699999999 588999994
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.3e-06 Score=88.66 Aligned_cols=135 Identities=21% Similarity=0.200 Sum_probs=82.9
Q ss_pred EEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc--eeeEecccccCCceEEEEeecCCC
Q 002146 682 ERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSIITEFLPRG 759 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN--IVkL~g~f~~~~~l~LVmEY~~gG 759 (960)
..||.| ..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G-~t~~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEG-GNGESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCC-CCcceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 468989 68999984 36678889875432 2234678999999885332 466777777777888999999986
Q ss_pred C-HHHH---------------------hhCC---CCCCcHHHHHHHHH----------HHHHH-HHHH--hhCCCCEEEe
Q 002146 760 S-LFRI---------------------LHRP---HCQVDEKRRIKMAL----------DVARG-MNCL--HTSTPTIVHR 801 (960)
Q Consensus 760 s-L~dl---------------------L~k~---~~~lse~~~~~Ia~----------QIa~A-L~YL--Hs~g~~IIHR 801 (960)
. +... ++.. ...+... ...+.. .+... ..+| +.....++|+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 3 2111 1111 1011100 000100 00111 1222 2223358999
Q ss_pred ccCCCcEEEcCCCcEEEEecCccc
Q 002146 802 DLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 802 DLKPeNILLd~~g~VKL~DFGLAr 825 (960)
|+.|.||++++++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.6e-06 Score=86.57 Aligned_cols=139 Identities=17% Similarity=0.101 Sum_probs=100.5
Q ss_pred eccCCeeEEEEEEECCcEEEEEEeecCC---CC-hHHHHHHHHHHHHHHHcCCC--ceeeEeccc--cc--CCceEEEEe
Q 002146 685 GLGSSYGEVYHADWNGTEVAVKKFLDQD---FS-GAALLEFKREVKIMRRLRHP--NVVLFMGAV--TR--PPNLSIITE 754 (960)
Q Consensus 685 G~GGsFG~Vy~ak~~g~~VAVK~i~~~~---~~-~~~~~~~~~Ei~ILk~L~HP--NIVkL~g~f--~~--~~~l~LVmE 754 (960)
|+|| .+-|+.....|..|-+|.-.... .. .-....|.+|+..|++|..- .+.+..... .. ..+-+||+|
T Consensus 27 ~rgG-~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNG-MSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCC-cceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 4564 67788888888889999653110 00 12345789999999998432 244444221 11 223679999
Q ss_pred ecCC-CCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc--EEEEecCcccc
Q 002146 755 FLPR-GSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRL 826 (960)
Q Consensus 755 Y~~g-GsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~--VKL~DFGLAr~ 826 (960)
-+.| .+|.+++.... ...++..+..++.+++..|.-||..| +.|+|+.+.|||++.+|. |+++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7753 58998886532 25678888899999999999999999 999999999999986667 99999986654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.5e-06 Score=87.52 Aligned_cols=140 Identities=16% Similarity=0.178 Sum_probs=94.6
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChH-HHHH------HHHHHHHHHHcC---CCceeeEecc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLE------FKREVKIMRRLR---HPNVVLFMGA 742 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~-~~~~------~~~Ei~ILk~L~---HPNIVkL~g~ 742 (960)
+...+|.+.+++-.. ....|.+.+.+|+.+.+|..+......+ .... ..+++..+.+++ ...+..++.+
T Consensus 28 i~~~~~~~~kv~k~~-~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNT-KRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCC-CccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 345678888888877 5788888889999999998765432222 1111 233444444442 2233332222
Q ss_pred -----cccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEE
Q 002146 743 -----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 817 (960)
Q Consensus 743 -----f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VK 817 (960)
+.-....+|+|||++|..|.++.. +++ .++..|+++|.-||..| +.|+|.+|.|+++..++ ++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EE
Confidence 222344678999999988877642 222 23456778899999999 99999999999998655 99
Q ss_pred EEecCccc
Q 002146 818 VSDFGLSR 825 (960)
Q Consensus 818 L~DFGLAr 825 (960)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-05 Score=85.92 Aligned_cols=137 Identities=20% Similarity=0.235 Sum_probs=84.3
Q ss_pred eeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEeecCCCCHH
Q 002146 684 IGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 762 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmEY~~gGsL~ 762 (960)
|-.|.+-..||+....+..++||...... ...+.+|+++++.+ .+--+.+++++....+..++||||++|..|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 44453458899998777788888764332 23566889998888 3444567787777667789999999988775
Q ss_pred HHh-------------------hCC---CCCCcHH--HHHHH-----------------------HHHHHHHHHHHh--h
Q 002146 763 RIL-------------------HRP---HCQVDEK--RRIKM-----------------------ALDVARGMNCLH--T 793 (960)
Q Consensus 763 dlL-------------------~k~---~~~lse~--~~~~I-----------------------a~QIa~AL~YLH--s 793 (960)
... +.. ...+... ..... +.++...|.... .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 110 0011100 00000 111111111110 1
Q ss_pred CCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 794 ~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12349999999999999998778999998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=7e-06 Score=97.53 Aligned_cols=142 Identities=21% Similarity=0.206 Sum_probs=91.1
Q ss_pred EEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCCh---------------------------H-HHH----------HHH
Q 002146 682 ERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSG---------------------------A-ALL----------EFK 722 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~---------------------------~-~~~----------~~~ 722 (960)
+.|+.+ +-|.||+|+.. |+.||||+.+..-... . ..+ .+.
T Consensus 131 ~PiAsA-SIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASA-SIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred Cchhhh-hHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 458888 89999999984 9999999864321100 0 000 134
Q ss_pred HHHHHHHHcC-----CCceeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCC
Q 002146 723 REVKIMRRLR-----HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797 (960)
Q Consensus 723 ~Ei~ILk~L~-----HPNIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~ 797 (960)
+|...+.+++ .++|.--.=+++....-.|+|||++|..+.++........+.+.+.....+++- ..+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~~dg-- 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLLRDG-- 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHHhcC--
Confidence 4555555542 344332222334445677999999999999884332234554443333222222 2222357
Q ss_pred EEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 798 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 798 IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++|.|.+|.||+++.+|.+.+.|||+.....
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987654
|
|
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.3e-06 Score=98.83 Aligned_cols=53 Identities=28% Similarity=0.543 Sum_probs=45.5
Q ss_pred ccccchhhHHHHHHHhhhcCCceEEeecccccCC---------CCCeeEEEEecCcceeeeeccc
Q 002146 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGV---------EDDAVNIIKLEEEREFLVDLMA 318 (960)
Q Consensus 263 ~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~y~~~---------~~~a~~~v~~~~~~~y~vDlm~ 318 (960)
--+||..||.|||.||..+||||.+|+| |-+. .+||||+|++.| +||+||.--
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIeg--f~k~~~~~~~~~~iNHaWN~VkiD~-~yy~VDtTw 269 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEG--FLKSPIYYTRDININHAWNIVKIDN-EYYLVDTTW 269 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEee--cccccccccCCccccceeeEEEECC-eEEEEeeec
Confidence 4589999999999999999999999999 5332 249999999955 899999754
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.4e-06 Score=80.14 Aligned_cols=53 Identities=25% Similarity=0.270 Sum_probs=43.6
Q ss_pred ccccchhhHHHHHHHhhhcCCceEEeeccccc----------CCCCCeeEEEEecCcceeeee
Q 002146 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYT----------GVEDDAVNIIKLEEEREFLVD 315 (960)
Q Consensus 263 ~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~y~----------~~~~~a~~~v~~~~~~~y~vD 315 (960)
+.|.|.++|.||..|+..+|||||+|.|.... +...|+||.|.+.+++|+.+|
T Consensus 50 ~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D 112 (113)
T PF01841_consen 50 GRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD 112 (113)
T ss_dssp EEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred CCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence 46999999999999999999999999994331 123399999999888999998
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.7e-07 Score=104.82 Aligned_cols=183 Identities=21% Similarity=0.214 Sum_probs=135.9
Q ss_pred EEEeeccCCeeEEEEEEECCcE-EEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc-eeeEecccccCCceEEEEeecCC
Q 002146 681 GERIGLGSSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIITEFLPR 758 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~-VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN-IVkL~g~f~~~~~l~LVmEY~~g 758 (960)
-.-+++| +++++++.+-..+. ...+.+... ....-++++|.+++||| .+..++-++.++..+++++|+.+
T Consensus 247 fh~fvK~-altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 247 FHNFVKG-ALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHH-HhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3447888 89999998753332 224443322 24456889999999999 78888888888899999999987
Q ss_pred C-CHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 759 G-SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 759 G-sL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
+ +-...+......+.+.+...+.+.-+++++|||+.- =+||| ||+..+ +..|+.||+....+.... ..++.
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~ 390 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTA 390 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-ccccC
Confidence 7 332222222223555566677777888999999874 48998 777755 689999999887765543 45667
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 879 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~ 879 (960)
.+++.|+|||++....+....|.|++|.--.++--|-+|-..
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 899999999999999999999999999877777777766543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.5e-05 Score=79.95 Aligned_cols=74 Identities=15% Similarity=0.151 Sum_probs=46.9
Q ss_pred EEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC---ceeeEecccccC---CceEEEEee
Q 002146 682 ERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVTRP---PNLSIITEF 755 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP---NIVkL~g~f~~~---~~l~LVmEY 755 (960)
+.|+.||.-..||+. +..+++|...... ....+.+|.++|..|... -+.++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777666678876 3467778644321 234678899999888421 344455544332 235789999
Q ss_pred cCCCCHH
Q 002146 756 LPRGSLF 762 (960)
Q Consensus 756 ~~gGsL~ 762 (960)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=76.38 Aligned_cols=127 Identities=28% Similarity=0.416 Sum_probs=90.9
Q ss_pred CCeEEEEEeeccCCe-eEEEEEEECCcEEEEEEeec---CC-------CCh---------HHHHHHHHHHHHHHHcC---
Q 002146 676 EDLVLGERIGLGSSY-GEVYHADWNGTEVAVKKFLD---QD-------FSG---------AALLEFKREVKIMRRLR--- 732 (960)
Q Consensus 676 ~dy~i~k~LG~GGsF-G~Vy~ak~~g~~VAVK~i~~---~~-------~~~---------~~~~~~~~Ei~ILk~L~--- 732 (960)
.+++.++.||.| .- |.||+++.+|+.||+|++.. .. ... ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g-~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHG-SHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCC-CceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 689999999999 68 99999999999999998322 11 110 11234778888888874
Q ss_pred CCce--eeEecccccC------------------CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHh
Q 002146 733 HPNV--VLFMGAVTRP------------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792 (960)
Q Consensus 733 HPNI--VkL~g~f~~~------------------~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLH 792 (960)
+.++ |+++||+.-. ....||.||++... .+... -+.+|.+-|.-+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHH
Confidence 4566 9999986211 12457778776533 12222 2347777888899
Q ss_pred hCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 793 s~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
..| |+-+|+++.|.. .-||+|||.+
T Consensus 182 k~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCC--eeeccCcccccc-----CCEEEecccC
Confidence 999 999999999987 3589999854
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00013 Score=91.72 Aligned_cols=78 Identities=17% Similarity=0.198 Sum_probs=55.4
Q ss_pred EEEeeccCCeeEEEEEEECC----cEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCce--eeEecccccC---CceE
Q 002146 681 GERIGLGSSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV--VLFMGAVTRP---PNLS 750 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g----~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNI--VkL~g~f~~~---~~l~ 750 (960)
++.|+.| .++.+|+.+..+ ..+++|+....... .....+.+|.++|+.+. |.+| .+++.++.+. +..|
T Consensus 43 v~~l~gG-~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHG-QSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCC-CcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 4668878 789999987754 46778865432211 12346789999999995 6665 7777777664 4678
Q ss_pred EEEeecCCCC
Q 002146 751 IITEFLPRGS 760 (960)
Q Consensus 751 LVmEY~~gGs 760 (960)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00021 Score=75.50 Aligned_cols=73 Identities=19% Similarity=0.282 Sum_probs=47.8
Q ss_pred EEEeeccCCeeEEEEEEEC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEEEEeec
Q 002146 681 GERIGLGSSYGEVYHADWN---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~---g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
++.|..| ....+|++... +..|++|+...... ......+|+.+++.+. +.-++++++.+.. .++|||+
T Consensus 3 i~~l~gG-~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGG-ITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCc-ccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4567767 78899999765 57899997653211 1123357888998884 3334555554432 3799999
Q ss_pred CCCCH
Q 002146 757 PRGSL 761 (960)
Q Consensus 757 ~gGsL 761 (960)
+|..+
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.0002 Score=77.86 Aligned_cols=137 Identities=22% Similarity=0.201 Sum_probs=89.8
Q ss_pred EEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHH----------------------HHHHHHHHHHHHcC--CCce
Q 002146 682 ERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAAL----------------------LEFKREVKIMRRLR--HPNV 736 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~----------------------~~~~~Ei~ILk~L~--HPNI 736 (960)
-.|..| --..||+|.. ++..||||+++.....-..+ .-..+|+.-|+++. +=.+
T Consensus 54 g~istG-KEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTG-KEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCC-cceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 356677 5789999874 68999999886543221111 12456777777773 2233
Q ss_pred eeEecccccCCceEEEEeecCCCCH-HHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCC
Q 002146 737 VLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 737 VkL~g~f~~~~~l~LVmEY~~gGsL-~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g 814 (960)
.+-+.+. .-.|||||+....+ .-.|.. ..+...+...+..++++.+.-|-. .+ +||+||..-|||+. ++
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CC
Confidence 3334332 34689999954311 111111 123333566677788888887766 66 99999999999999 88
Q ss_pred cEEEEecCcccccc
Q 002146 815 NVKVSDFGLSRLKH 828 (960)
Q Consensus 815 ~VKL~DFGLAr~~~ 828 (960)
.+.|+|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999887654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00034 Score=73.05 Aligned_cols=101 Identities=21% Similarity=0.271 Sum_probs=80.5
Q ss_pred HHHHHHHHHcCC-CceeeEecccccCCceEEEEeecCCCCHHHH---hhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCC-
Q 002146 722 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRI---LHRPHCQVDEKRRIKMALDVARGMNCLHTSTP- 796 (960)
Q Consensus 722 ~~Ei~ILk~L~H-PNIVkL~g~f~~~~~l~LVmEY~~gGsL~dl---L~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~- 796 (960)
..|.-+|+.+++ +++++++|+|-+ ++|+||...+++... +.. ....++..+.+|+.++++.+++|+..-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888999966 799999999843 679999987766532 111 1247899999999999999999987211
Q ss_pred CEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+...|++++|+-|+++|++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 2888999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0002 Score=90.21 Aligned_cols=201 Identities=16% Similarity=0.126 Sum_probs=142.0
Q ss_pred HHHHHHHHHHHHHHHcCCCceeeEecccccCCc----eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHH
Q 002146 716 AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791 (960)
Q Consensus 716 ~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~----l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YL 791 (960)
..+.....|+..+..+.|+|++.++.|...... +.+..|||.+.++..+++... ..+....+.+..++++||.|+
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHH
Confidence 344556678888888999999999888544332 234458899999998887654 567777778889999999999
Q ss_pred hhCCCCEEEeccCCC---cEEEcCCCcEEEE--ecCccccccCCcccCCCCCCCCCccCcccccCCCCCch--hhHHHHH
Q 002146 792 HTSTPTIVHRDLKSP---NLLVDKNWNVKVS--DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK--CDVYSFG 864 (960)
Q Consensus 792 Hs~g~~IIHRDLKPe---NILLd~~g~VKL~--DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~k--sDIWSLG 864 (960)
|... ..|.-|... +--++..+.+.+. ||+..+........ ....-...|.++|......+..+ .|+|.+|
T Consensus 303 h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 303 HSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred HHhc--cceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 9986 555555554 4445566777777 99888776554322 22334557788888877776554 7999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 002146 865 VILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 865 vLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~L 931 (960)
.++..+..|..+-...-. . ..-++......+.++..+|+..++++|+.+.+++.+.
T Consensus 380 ll~~~~~~~~~i~~~~~~--~---------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV--P---------VSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHHhhhhhcCcccccccc--h---------hhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999999987654211100 0 0011112222788899999999999999999998765
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00069 Score=75.43 Aligned_cols=79 Identities=15% Similarity=-0.013 Sum_probs=55.8
Q ss_pred eEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-C--CceeeEeccccc---CCceEE
Q 002146 678 LVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H--PNVVLFMGAVTR---PPNLSI 751 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-H--PNIVkL~g~f~~---~~~l~L 751 (960)
..-.+.||.| ..+.||.....+..+++|..+. ... ...+..|...|+.|. + -.|.++++++.. .+..+|
T Consensus 16 ~~~~~~i~~G-~~~~vy~~~~~~~~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 16 LSRVECISEQ-PYAALWALYDSQGNPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred hheeeecCCc-cceeEEEEEcCCCCEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3445679999 7999999976555677787432 111 236778999998884 2 356777776643 466899
Q ss_pred EEeecCCCCH
Q 002146 752 ITEFLPRGSL 761 (960)
Q Consensus 752 VmEY~~gGsL 761 (960)
|||+++|+.+
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00024 Score=76.60 Aligned_cols=135 Identities=16% Similarity=0.146 Sum_probs=77.0
Q ss_pred eeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc-eeeEecccccCCceEEEEeecCCCCHH
Q 002146 684 IGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIITEFLPRGSLF 762 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN-IVkL~g~f~~~~~l~LVmEY~~gGsL~ 762 (960)
+..| ..+.+|+...++..+++|......... . ....+|..+++.+..-. ..+++.... -++||||++|..+.
T Consensus 4 ~~~G-~tn~~y~~~~~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGG-LTNRSWRIEHPGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCc-CcCCeEEEEeCCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 3445 788999998888899999754321110 0 13467888998884322 234444332 36899999986653
Q ss_pred H--------------H---hhCC---CCCCcHH-HHHHHHHHH---------HHHHHHHhhC------CCCEEEeccCCC
Q 002146 763 R--------------I---LHRP---HCQVDEK-RRIKMALDV---------ARGMNCLHTS------TPTIVHRDLKSP 806 (960)
Q Consensus 763 d--------------l---L~k~---~~~lse~-~~~~Ia~QI---------a~AL~YLHs~------g~~IIHRDLKPe 806 (960)
. . ++.. ...++.. .+..+..++ ...+..+-.. ...++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 1 1111 1111111 111111111 1112222111 224899999999
Q ss_pred cEEEcCCCcEEEEecCcccc
Q 002146 807 NLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 807 NILLd~~g~VKL~DFGLAr~ 826 (960)
|||+++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=1.2e-05 Score=102.18 Aligned_cols=190 Identities=15% Similarity=0.121 Sum_probs=132.6
Q ss_pred eEEEEEEECC---cEEEEEEeecCCC---ChHHHHHHHHHHHHHHHcCCCceeeEecccc--cCCceEEEEeecCCCCHH
Q 002146 691 GEVYHADWNG---TEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSIITEFLPRGSLF 762 (960)
Q Consensus 691 G~Vy~ak~~g---~~VAVK~i~~~~~---~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~--~~~~l~LVmEY~~gGsL~ 762 (960)
+.-++++|-+ ..+-+|+++.-++ .+..++-...|+..++...|+++.....-.. .....|.+++|+.+|.++
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 3345565522 2345565544332 2233334456666777778999887655443 334578899999999999
Q ss_pred HHhhCCCCC---CcHHHHHHHHHHHHHHHHHHhhC---CCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002146 763 RILHRPHCQ---VDEKRRIKMALDVARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 836 (960)
Q Consensus 763 dlL~k~~~~---lse~~~~~Ia~QIa~AL~YLHs~---g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t 836 (960)
+.|-+.-.. +++........+.+.+..-+|+. |-..+|++||+-|.+|..+..+|+.++|+.+..+........
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl 1399 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGL 1399 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhh
Confidence 998653222 22222222223336666665542 234899999999999999999999999999966555445556
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002146 837 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 880 (960)
Q Consensus 837 ~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~ 880 (960)
.++++.|+.|++...-.++.++|+|..|+.+|++-.|..+|...
T Consensus 1400 ~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~f 1443 (2724)
T KOG1826|consen 1400 ELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFF 1443 (2724)
T ss_pred hhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHH
Confidence 77899999999999999999999999999999999998888543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00027 Score=73.37 Aligned_cols=132 Identities=22% Similarity=0.253 Sum_probs=92.5
Q ss_pred CeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCcee-eEecccccCCceEEEEee
Q 002146 677 DLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIV-kL~g~f~~~~~l~LVmEY 755 (960)
...+.+.|++| .++.||++.|.|..+|+|+-+.. .....+..|.++|..+.-.++. +++.+..+ ++.|||
T Consensus 23 ~~~v~~~L~KG-~~s~Vyl~~~~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 23 ELRVEKELAKG-TTSVVYLGEWRGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhhhcc-cccEEEEeeccCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 34556779999 79999999999999999975433 3345788999999999766654 45555333 355999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccC-CCcEEEcCCCcEEEEecCccccc
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLK-PeNILLd~~g~VKL~DFGLAr~~ 827 (960)
+.|-.|.++... .+.++++ .+++.-.-|-..| |-|+.|. |..++|-.++.+.|+||.-|+..
T Consensus 94 i~G~~L~~~~~~----~~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIG----GDRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhc----ccHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 999888877542 1233333 4555544566667 9999886 44444444558999999988743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00034 Score=83.55 Aligned_cols=141 Identities=18% Similarity=0.168 Sum_probs=86.7
Q ss_pred EEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCCh--HHH---------------------------H------HHHHHH
Q 002146 682 ERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSG--AAL---------------------------L------EFKREV 725 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~--~~~---------------------------~------~~~~Ei 725 (960)
+.||.- +.|.||+++. +|+.||||+-+..-... ..+ + .|.+|.
T Consensus 167 ~piaaA-SlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAA-SLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhc-chhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568988 8999999986 78999999764321111 000 0 133333
Q ss_pred HHHHHc----CCCc------eeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCC
Q 002146 726 KIMRRL----RHPN------VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 795 (960)
Q Consensus 726 ~ILk~L----~HPN------IVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g 795 (960)
+...++ .|-+ |.++|- .....-.|+||||+|..+.|+-.-....++...+..-+.+...-+ |=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcC
Confidence 333332 3444 333332 223456799999999888765332222355554443333332222 22246
Q ss_pred CCEEEeccCCCcEEEcC----CCcEEEEecCccccccC
Q 002146 796 PTIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 796 ~~IIHRDLKPeNILLd~----~g~VKL~DFGLAr~~~~ 829 (960)
++|+|=+|.||++.. ++.+.|.|||+......
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999983 67899999999976543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00094 Score=70.57 Aligned_cols=130 Identities=18% Similarity=0.243 Sum_probs=88.5
Q ss_pred EEeeccCCeeEEEEEEECCcEEEEEEeecCC--------------CChHHHHHHHHHHHHHHHcC------CCceeeEec
Q 002146 682 ERIGLGSSYGEVYHADWNGTEVAVKKFLDQD--------------FSGAALLEFKREVKIMRRLR------HPNVVLFMG 741 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~--------------~~~~~~~~~~~Ei~ILk~L~------HPNIVkL~g 741 (960)
..||.| ..-.||.-- .+....||+..... .......+..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G-~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQG-GERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccC-CCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 358889 577777643 34456678776554 01112345667777666665 789999999
Q ss_pred ccccCCceEEEEeecCC------CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC--
Q 002146 742 AVTRPPNLSIITEFLPR------GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-- 813 (960)
Q Consensus 742 ~f~~~~~l~LVmEY~~g------GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-- 813 (960)
+.+++..+.+|+|.+.. .+|.+++.+.. +++ .....+. +-..||-.++ |+.+||+|.||++...
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHH---HHHHHHHHcC--CeecCCCcccEEEEecCC
Confidence 99999999999998642 36888886543 555 4443333 3345666777 9999999999999632
Q ss_pred C--cEEEEec
Q 002146 814 W--NVKVSDF 821 (960)
Q Consensus 814 g--~VKL~DF 821 (960)
+ .+.|+|-
T Consensus 157 ~~~~lvlIDG 166 (199)
T PF10707_consen 157 GEFRLVLIDG 166 (199)
T ss_pred CceEEEEEeC
Confidence 2 4777774
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.001 Score=73.30 Aligned_cols=73 Identities=22% Similarity=0.320 Sum_probs=46.7
Q ss_pred EEeeccCCeeEEEEEEEC--------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC-ceeeEecccccCCceEEE
Q 002146 682 ERIGLGSSYGEVYHADWN--------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP-NVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~--------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP-NIVkL~g~f~~~~~l~LV 752 (960)
+.|..| .-..||++... ++.|++|+..... .......+|..++..+... -..++++++.. .+|
T Consensus 4 ~~l~gG-ltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGG-LTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCc-ccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 445556 67899998764 4789999865432 1123456888888888432 23455655542 358
Q ss_pred EeecCCCCHH
Q 002146 753 TEFLPRGSLF 762 (960)
Q Consensus 753 mEY~~gGsL~ 762 (960)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00095 Score=73.11 Aligned_cols=139 Identities=19% Similarity=0.137 Sum_probs=83.0
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC--ceeeEecc------cccCCceEEE
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGA------VTRPPNLSII 752 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP--NIVkL~g~------f~~~~~l~LV 752 (960)
++.|..| .-..+|+...++..+++|++... . ...+..|+.++..|.+. .+.+++.. ....+..++|
T Consensus 19 i~~i~~G-~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAG-IENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCc-cccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 4567767 67899999877788999987541 1 23566788888887432 24454432 1234567899
Q ss_pred EeecCCCCHHH-----------Hh---hCC--C--C------CCcHHHH----------HHHHHHHHHHHHHHhh-----
Q 002146 753 TEFLPRGSLFR-----------IL---HRP--H--C------QVDEKRR----------IKMALDVARGMNCLHT----- 793 (960)
Q Consensus 753 mEY~~gGsL~d-----------lL---~k~--~--~------~lse~~~----------~~Ia~QIa~AL~YLHs----- 793 (960)
++|++|..+.. .+ +.. . . ...+... ......+..++.++..
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99999876521 11 110 0 0 0000000 0011112233444432
Q ss_pred CCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 794 ~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
....+||+|+.|.|||++.++.+.|+||+.+.
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 11249999999999999988777999998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0015 Score=72.56 Aligned_cols=144 Identities=17% Similarity=0.141 Sum_probs=83.9
Q ss_pred CeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC--ceeeEeccc------ccCCc
Q 002146 677 DLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGAV------TRPPN 748 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP--NIVkL~g~f------~~~~~ 748 (960)
....++.++.| ....+|+.+.++..+++|+..... . ...+..|++++..|... .|.+++... ...+.
T Consensus 23 ~~~~i~~~~~G-~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 23 ELLSLKGIAEG-VENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred CceeccccCCc-cccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 34456777777 568899988767788899765421 1 22445677777777322 244444321 22456
Q ss_pred eEEEEeecCCCCHH-----------HH---hhCCCCCC----------c-HHHHH------------HHHHHHHHHHHHH
Q 002146 749 LSIITEFLPRGSLF-----------RI---LHRPHCQV----------D-EKRRI------------KMALDVARGMNCL 791 (960)
Q Consensus 749 l~LVmEY~~gGsL~-----------dl---L~k~~~~l----------s-e~~~~------------~Ia~QIa~AL~YL 791 (960)
.+++|||++|..+. .. +++....+ . +.... .....+...+++|
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999885431 11 11100000 0 00000 0011233345555
Q ss_pred hh-----CCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 792 HT-----STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 792 Hs-----~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
.. ...++||+|+++.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 32 12359999999999999988877899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0025 Score=70.77 Aligned_cols=139 Identities=17% Similarity=0.128 Sum_probs=75.3
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-----CCceeeEe-c--ccccCCceEEE
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----HPNVVLFM-G--AVTRPPNLSII 752 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-----HPNIVkL~-g--~f~~~~~l~LV 752 (960)
.+.|+.| ....+|+.+.++..+++|++. .... ..+..|+.+++.|. .|.++.-. | +....+..+++
T Consensus 27 ~~~l~~G-~~n~~y~v~t~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 27 LKGIAEG-IENSNFFLTTTQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred cchhccc-cccceEEEEeCCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 4556667 677899998777789999875 2222 23334556665552 23333211 0 11234567899
Q ss_pred EeecCCCCHH-----------HHh---hCCCC----------CCcH-HHHH------------HHHHH-HHHHHHHHhh-
Q 002146 753 TEFLPRGSLF-----------RIL---HRPHC----------QVDE-KRRI------------KMALD-VARGMNCLHT- 793 (960)
Q Consensus 753 mEY~~gGsL~-----------dlL---~k~~~----------~lse-~~~~------------~Ia~Q-Ia~AL~YLHs- 793 (960)
+||++|..+. ..+ +.... .+.. .... ..+.+ +...+..+..
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 9999987431 111 11000 0000 0000 01111 1111222221
Q ss_pred ----CCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 794 ----STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 794 ----~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
...++||+|+++.|||++.+...-|+||+.+.
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12249999999999999866556899999875
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0088 Score=68.06 Aligned_cols=142 Identities=17% Similarity=0.255 Sum_probs=80.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEEC------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC-CceeeEecccccCCc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H-PNIVkL~g~f~~~~~ 748 (960)
+.+.+.. |-.| -...+|++.+. ++.|++|+..... ...+ ...+|..+++.+.. ---.++++.+...
T Consensus 37 ~~~~i~~-l~gG-lTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 37 EALQVIP-LKGA-MTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcEEEEE-cCCc-ccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 3444444 4336 67899998752 3678999765432 2112 23678899988843 3334556665432
Q ss_pred eEEEEeecCCCCHHHH-----------------hhCCC---CC-C-cHHHHHHHHHHH-----------------HHHHH
Q 002146 749 LSIITEFLPRGSLFRI-----------------LHRPH---CQ-V-DEKRRIKMALDV-----------------ARGMN 789 (960)
Q Consensus 749 l~LVmEY~~gGsL~dl-----------------L~k~~---~~-l-se~~~~~Ia~QI-----------------a~AL~ 789 (960)
.|+||+++..|... ++... .. + ...++.+++.++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 58999987665311 11111 00 1 112222222111 11111
Q ss_pred HH----hh--CCCCEEEeccCCCcEEEcC-CCcEEEEecCcccc
Q 002146 790 CL----HT--STPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 826 (960)
Q Consensus 790 YL----Hs--~g~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr~ 826 (960)
.| .. ....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 11 1224999999999999986 47899999998853
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.024 Score=66.09 Aligned_cols=77 Identities=17% Similarity=0.050 Sum_probs=52.1
Q ss_pred EEEeeccCCeeEEEEEEECC--cEEEEEEeecCCC---C--hHHHHHHHHHHHHHHHcC---CCceeeEecccccCCceE
Q 002146 681 GERIGLGSSYGEVYHADWNG--TEVAVKKFLDQDF---S--GAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g--~~VAVK~i~~~~~---~--~~~~~~~~~Ei~ILk~L~---HPNIVkL~g~f~~~~~l~ 750 (960)
.+.||.| .+..||++...+ +.|+||.-..... . .....+...|.+.|+.+. ..++++++.+ +....+
T Consensus 31 ~~elggG-n~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 31 AREIGDG-NLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeEcCCC-ceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 3568888 899999998743 4899997431100 0 123456677888888862 2467778776 345678
Q ss_pred EEEeecCCCC
Q 002146 751 IITEFLPRGS 760 (960)
Q Consensus 751 LVmEY~~gGs 760 (960)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.011 Score=66.89 Aligned_cols=142 Identities=18% Similarity=0.244 Sum_probs=79.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEECC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCce-eeEecccccCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~g-----~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNI-VkL~g~f~~~~~l 749 (960)
+++++....| | -...+|+....+ ..|++|+..... . ....-.+|..+++.+..-++ .++++++..+
T Consensus 15 ~~i~i~~l~g-G-lTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G--- 86 (330)
T PLN02421 15 SDFSVERISG-G-ITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG--- 86 (330)
T ss_pred CceEEEEeCC-c-ccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEeCCc---
Confidence 4555555544 6 678899887543 378899765421 1 12233578889988854333 4566655322
Q ss_pred EEEEeecCCCCHHH--------------H---hhCCC----CCCc-HHHHHHHHH-------------------------
Q 002146 750 SIITEFLPRGSLFR--------------I---LHRPH----CQVD-EKRRIKMAL------------------------- 782 (960)
Q Consensus 750 ~LVmEY~~gGsL~d--------------l---L~k~~----~~ls-e~~~~~Ia~------------------------- 782 (960)
+|.+|++|..|.. . ++... ..++ ...+..+..
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5899988765521 1 11111 0011 111211211
Q ss_pred HHHHHHHHHh-hCC--CCEEEeccCCCcEEEcC-CCcEEEEecCcccc
Q 002146 783 DVARGMNCLH-TST--PTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 826 (960)
Q Consensus 783 QIa~AL~YLH-s~g--~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr~ 826 (960)
+.+..+..+. ..+ ...+|+||.+.|||+++ ++.++|+||..|..
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1111222221 111 24899999999999975 57899999998854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.022 Score=64.45 Aligned_cols=149 Identities=18% Similarity=0.212 Sum_probs=83.3
Q ss_pred CeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC--CceeeEecccccCC--ceEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPP--NLSII 752 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H--PNIVkL~g~f~~~~--~l~LV 752 (960)
...+++.+-.|-++-+ |....++++++++ .......-.......+|+.+|+.+.- --+...++.+.++. ..|.|
T Consensus 26 ~~~~v~~~~~G~sn~t-~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 26 GLLIVEEISGGWSNDT-FRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CCceeeeccCCcccce-EEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3445555644523334 4444458888888 33212222344566788889988742 23344555555554 67999
Q ss_pred EeecCCCCHHHHhhCCC-------------------------------CCCcHHHHHHHHHHH--------------HHH
Q 002146 753 TEFLPRGSLFRILHRPH-------------------------------CQVDEKRRIKMALDV--------------ARG 787 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~-------------------------------~~lse~~~~~Ia~QI--------------a~A 787 (960)
|+|++|..+...+.... ..+...++..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 99998843322211100 000111111111111 122
Q ss_pred HHHHhhCCC------CEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 788 MNCLHTSTP------TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 788 L~YLHs~g~------~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
..+|+.+-+ .++|+|+.+.||+|+.++.+=++||+++..-
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 334443322 3999999999999999888999999998753
|
|
| >COG1305 Transglutaminase-like enzymes, putative cysteine proteases [Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0032 Score=68.64 Aligned_cols=50 Identities=30% Similarity=0.383 Sum_probs=42.9
Q ss_pred cccchhhHHHHHHHhhhcCCceEEeecccccCCC--------------CCeeEEEEecCcceeeee
Q 002146 264 IGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVE--------------DDAVNIIKLEEEREFLVD 315 (960)
Q Consensus 264 ~g~~~~~a~lfk~l~d~~~~~~~lv~G~~y~~~~--------------~~a~~~v~~~~~~~y~vD 315 (960)
.|+|+|.|-||=.||-.+|||||+|.| |+... .|+|.+|-+..-.|+-+|
T Consensus 194 ~G~C~d~a~l~val~Ra~GIpAR~V~G--y~~~~~~~~~~~~~~~~~~~Haw~ev~~~~~gW~~~D 257 (319)
T COG1305 194 RGVCRDFAHLLVALLRAAGIPARYVSG--YLGAEVEPLSGRPLVRNDDAHAWAEVYLPGRGWVPLD 257 (319)
T ss_pred CcccccHHHHHHHHHHHcCCcceeeec--cccCCCCcccccccccCcccceeeeeecCCCccEeec
Confidence 899999999999999999999999999 43333 299999999554588887
|
|
| >PF04473 DUF553: Transglutaminase-like domain; InterPro: IPR007562 This entry represents a transglutaminase-like domain found in a family of uncharacterised archaeal proteins that had previously been called DUF553 and UPF0252 | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.0043 Score=63.13 Aligned_cols=54 Identities=13% Similarity=0.185 Sum_probs=46.3
Q ss_pred cccccchhhHHHHHHHhhhcCCceEEeecccccCCCCCeeEEEEecCcceeeeec
Q 002146 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEEEREFLVDL 316 (960)
Q Consensus 262 l~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~y~~~~~~a~~~v~~~~~~~y~vDl 316 (960)
.+.|+|+.+|+|...|.-..|+.-.-|-+-.+.+..+|||+.|++ ||++|++|-
T Consensus 73 ~k~GiC~DYA~Lta~lLl~~g~~~~yi~~~~~~~~~~Haa~aV~i-ng~~yvlDq 126 (153)
T PF04473_consen 73 YKKGICGDYAILTAALLLNMGYSPVYILHIEFDNDPGHAAVAVKI-NGKYYVLDQ 126 (153)
T ss_pred cCCeeeHHHHHHHHHHHHHCCCCceEEEEEecCCCCCeEEEEEEE-CCEEEEEeC
Confidence 468999999999999999999877555566667766899999999 889999993
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.028 Score=61.88 Aligned_cols=28 Identities=29% Similarity=0.406 Sum_probs=24.9
Q ss_pred CEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
++||+|+.+.|||++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 5999999999999987 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.024 Score=63.34 Aligned_cols=76 Identities=21% Similarity=0.187 Sum_probs=47.9
Q ss_pred eEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC---CCceeeEecccccCCceEEEEe
Q 002146 678 LVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~---HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.+-.+.|+.| ....+|+.+.+++.+.||+-.... ...|..|..-|+.|. --.+.+.+++....+.-+||||
T Consensus 19 i~~~~~v~GG-~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 19 ITSIEPVSGG-DINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp --EEEEE--S-SSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeeeEecCCC-ChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 3445778877 899999999889999999865221 225677888888883 3457788888877777799999
Q ss_pred ecCCC
Q 002146 755 FLPRG 759 (960)
Q Consensus 755 Y~~gG 759 (960)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.058 Score=59.67 Aligned_cols=30 Identities=23% Similarity=0.491 Sum_probs=25.1
Q ss_pred CEEEeccCCCcEEEcCCCc-EEEEecCcccc
Q 002146 797 TIVHRDLKSPNLLVDKNWN-VKVSDFGLSRL 826 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~-VKL~DFGLAr~ 826 (960)
.++|+|+++.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.012 Score=61.72 Aligned_cols=30 Identities=33% Similarity=0.572 Sum_probs=21.5
Q ss_pred CEEEeccCCCcEEE-cCCCcEEEEecCcccc
Q 002146 797 TIVHRDLKSPNLLV-DKNWNVKVSDFGLSRL 826 (960)
Q Consensus 797 ~IIHRDLKPeNILL-d~~g~VKL~DFGLAr~ 826 (960)
.++|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 49999999999999 8889999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.051 Score=60.58 Aligned_cols=30 Identities=20% Similarity=0.307 Sum_probs=27.3
Q ss_pred CEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
++||+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.078 Score=62.04 Aligned_cols=76 Identities=16% Similarity=0.010 Sum_probs=51.1
Q ss_pred EEEEeeccCCeeEEEEEEECCcEEEEEEeecCCC-Ch----HHHHHHHHHHHHHHHcC---CCceeeEecccccCCceEE
Q 002146 680 LGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDF-SG----AALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~-~~----~~~~~~~~Ei~ILk~L~---HPNIVkL~g~f~~~~~l~L 751 (960)
..+.||.| .-..||+....+..|+||.-..... .. ....+...|...|+.+. ..++.+++.++. +..++
T Consensus 36 ~~~eiggG-n~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDG-NLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCC-ceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 35668988 7899999987777899996541111 00 12334455677776663 247888888876 45678
Q ss_pred EEeecCC
Q 002146 752 ITEFLPR 758 (960)
Q Consensus 752 VmEY~~g 758 (960)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.047 Score=62.65 Aligned_cols=76 Identities=22% Similarity=0.218 Sum_probs=57.0
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+....|++|++. |+.|...- .-...+...|+++.+.-++-|.. ..+.-|||+...||||+ +|+|.|+||-++
T Consensus 297 e~~y~yl~~kdh-gt~is~ik-----~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISIIK-----ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeeeee-----cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence 344577888876 66665432 23456777788888877766654 34699999999999999 999999999999
Q ss_pred cccc
Q 002146 825 RLKH 828 (960)
Q Consensus 825 r~~~ 828 (960)
+...
T Consensus 369 Rl~~ 372 (488)
T COG5072 369 RLSY 372 (488)
T ss_pred eccc
Confidence 8543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.013 Score=66.19 Aligned_cols=135 Identities=19% Similarity=0.202 Sum_probs=89.3
Q ss_pred eEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCC-------h----------H---HHHHHHHHHHHHHHc-CCCc
Q 002146 678 LVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFS-------G----------A---ALLEFKREVKIMRRL-RHPN 735 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~-------~----------~---~~~~~~~Ei~ILk~L-~HPN 735 (960)
+.+++.||-| --..||++-. .|++.++|.-+.-... . + ......+|...|+.| .|-+
T Consensus 94 ~svGnqIGVG-KESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVG-KESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccc-cccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4567889999 5789999865 5888888842211100 0 0 012346788888888 3432
Q ss_pred -eeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC
Q 002146 736 -VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 736 -IVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g 814 (960)
|.+.++ .++-++|||++.|-.|...-+- .+...+. ..+..-+--|-.+| +||+|..-=||+|++++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly---~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV----EDPPTLY---DDLMGLIVRLANHG--LIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec----CChHHHH---HHHHHHHHHHHHcC--ceecccchheeEEecCC
Confidence 334443 3567899999998777654321 2233332 33444445566778 99999999999999999
Q ss_pred cEEEEecCcccc
Q 002146 815 NVKVSDFGLSRL 826 (960)
Q Consensus 815 ~VKL~DFGLAr~ 826 (960)
.++++||--...
T Consensus 240 ~i~vIDFPQmvS 251 (465)
T KOG2268|consen 240 KIVVIDFPQMVS 251 (465)
T ss_pred CEEEeechHhhc
Confidence 999999986544
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.078 Score=57.66 Aligned_cols=76 Identities=20% Similarity=0.180 Sum_probs=54.9
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc---CCCceeeEecccccCCceEEEEeecC
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L---~HPNIVkL~g~f~~~~~l~LVmEY~~ 757 (960)
.+.+-.| ..-..|.......+|.||+-. ......|..|+.-|+.| +.=.|.+.+.+....+..|+||||++
T Consensus 21 r~~v~gG-~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 21 REEVSGG-DINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred ccccCCc-cccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 3445545 566778888888899999732 23344567777777666 34567788999999999999999998
Q ss_pred CCCHH
Q 002146 758 RGSLF 762 (960)
Q Consensus 758 gGsL~ 762 (960)
-+.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 76554
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.086 Score=60.66 Aligned_cols=140 Identities=22% Similarity=0.265 Sum_probs=88.9
Q ss_pred EEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCC----------------------h-HH-HHHHHHHHHHHHHcCCC
Q 002146 680 LGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFS----------------------G-AA-LLEFKREVKIMRRLRHP 734 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~----------------------~-~~-~~~~~~Ei~ILk~L~HP 734 (960)
|-.+|..| --.-||.+.. +|..+|||+++..-+. . .. ..-...|++-|++|+..
T Consensus 148 inGCiSTG-KEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTG-KEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccC-ccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 33567778 5788999964 8899999977432110 0 11 12346789999998655
Q ss_pred ceeeEecccccCCceEEEEeecCCCCHHH-HhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcC
Q 002146 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDK 812 (960)
Q Consensus 735 NIVkL~g~f~~~~~l~LVmEY~~gGsL~d-lL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~ 812 (960)
.|..---... ..-.|||+|+.+....- .|. ...++...+..+-.|++.-|.-|.+ ++ +||.||.-=|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-
Confidence 4432110000 23468999995322111 121 1245555566666788888877754 55 99999999999995
Q ss_pred CCcEEEEecCccccc
Q 002146 813 NWNVKVSDFGLSRLK 827 (960)
Q Consensus 813 ~g~VKL~DFGLAr~~ 827 (960)
+|.+.|+|-+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 568999999887643
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.11 Score=59.33 Aligned_cols=132 Identities=18% Similarity=0.274 Sum_probs=76.7
Q ss_pred eeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc------eeeE----ecccccCCceEEEEeecCCC
Q 002146 690 YGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN------VVLF----MGAVTRPPNLSIITEFLPRG 759 (960)
Q Consensus 690 FG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN------IVkL----~g~f~~~~~l~LVmEY~~gG 759 (960)
-..||+....+..+++|+.... ... .++..|+..|..|.-.. |..+ +..+....+.+-+++|++|.
T Consensus 38 eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 38 ENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred cCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 4568888887777799987765 333 35667788888873211 2222 22222223777899999988
Q ss_pred CHHH-H-----------h---h---CCC-----C---CCcHH-------------HHHHHHHHHHHHHHHHhhC------
Q 002146 760 SLFR-I-----------L---H---RPH-----C---QVDEK-------------RRIKMALDVARGMNCLHTS------ 794 (960)
Q Consensus 760 sL~d-l-----------L---~---k~~-----~---~lse~-------------~~~~Ia~QIa~AL~YLHs~------ 794 (960)
.+.. . + + +.. . ...+. .-.....++...+..+...
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7762 1 1 1 000 0 01111 0001122333333333331
Q ss_pred CCC--EEEeccCCCcEEEcCCCc-EEEEecCccc
Q 002146 795 TPT--IVHRDLKSPNLLVDKNWN-VKVSDFGLSR 825 (960)
Q Consensus 795 g~~--IIHRDLKPeNILLd~~g~-VKL~DFGLAr 825 (960)
..+ |||+|+.|.|||++.+.. +.++|||.+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 112 999999999999998875 9999999774
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.14 Score=59.07 Aligned_cols=73 Identities=19% Similarity=0.108 Sum_probs=46.7
Q ss_pred EeeccCCeeEEEEEEECC--cEEEEEEeecC-----CCChHHHHHHHHHHHHHHHcC--CC-ceeeEecccccCCceEEE
Q 002146 683 RIGLGSSYGEVYHADWNG--TEVAVKKFLDQ-----DFSGAALLEFKREVKIMRRLR--HP-NVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~~g--~~VAVK~i~~~-----~~~~~~~~~~~~Ei~ILk~L~--HP-NIVkL~g~f~~~~~l~LV 752 (960)
.||.| ....||++...+ +.|+||.-..- ....-...+..-|...|+... .| .++++|.+ ++....+|
T Consensus 2 EigdG-nlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 2 EVGDG-NLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred cCCCC-ceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 37878 789999998643 57999964311 111223445567788887763 24 56666644 44566799
Q ss_pred EeecCC
Q 002146 753 TEFLPR 758 (960)
Q Consensus 753 mEY~~g 758 (960)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.2 Score=58.28 Aligned_cols=78 Identities=17% Similarity=0.188 Sum_probs=46.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEECC---cE-----EEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWNG---TE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRP 746 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~g---~~-----VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~ 746 (960)
+++++.. |..| --..+|++...+ .. |.++..-. .......-.+|+.+++.|. +-.-.++++.|..
T Consensus 51 ~~i~i~~-l~gG-LTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~- 124 (383)
T PTZ00384 51 EFIEIKK-MNNG-ITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD- 124 (383)
T ss_pred ccEEEEE-eCCc-ccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence 4455554 4336 678999986532 22 33333211 1111123357899999995 4445567777653
Q ss_pred CceEEEEeecCCCCHH
Q 002146 747 PNLSIITEFLPRGSLF 762 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~ 762 (960)
++|.||++|..|.
T Consensus 125 ---g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 ---FTIQEWVEGNTMG 137 (383)
T ss_pred ---EEEEEEeccccCC
Confidence 5999999987663
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 960 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-99 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-98 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-40 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-39 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-39 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-38 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-37 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-37 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-37 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-37 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-37 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-37 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-37 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-36 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-36 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-36 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-36 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-36 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-36 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-36 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-36 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-36 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-36 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-36 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-36 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-36 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-36 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-36 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-35 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-35 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-35 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-35 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-35 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-35 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-35 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-35 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-35 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-35 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-35 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-35 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-34 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-34 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-33 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-33 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-31 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-31 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-30 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-30 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-30 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-30 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-30 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-30 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-30 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-30 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-30 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-30 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-30 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-30 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-30 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-30 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-30 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-30 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-30 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-30 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-30 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-30 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-30 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-29 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-29 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-29 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-29 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-29 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-29 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-29 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-29 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-29 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-29 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-29 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-29 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-29 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-29 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-29 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-29 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-29 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-29 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-29 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-29 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-29 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-29 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-29 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-28 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-28 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-28 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-28 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-28 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-28 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-28 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-28 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-28 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-28 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-28 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-27 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-27 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-27 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-27 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-27 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-27 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-27 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-27 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-27 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-27 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-27 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-27 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-27 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-27 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-27 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-27 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-27 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-27 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-27 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-27 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-27 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-27 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-27 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-27 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-27 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-27 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-27 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-27 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-27 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-27 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-27 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-27 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-27 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-27 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-26 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-26 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-26 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-26 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-26 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-26 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-26 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-26 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-26 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-26 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-26 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-26 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-26 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-26 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-26 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-26 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-26 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-26 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-26 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-26 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-26 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-26 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-26 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-26 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-26 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-26 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-26 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-26 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-26 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-26 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-26 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-25 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-25 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-25 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-25 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-25 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-25 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-25 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-25 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-24 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-24 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-24 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-24 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-24 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-24 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-24 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-24 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-24 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-24 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-24 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-24 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-24 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-24 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-24 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-24 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-24 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-24 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-24 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-24 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-23 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-23 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-23 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-23 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-23 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-23 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-23 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-23 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-23 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-23 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-23 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-23 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-23 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-22 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-22 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-22 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-22 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-22 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-22 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-22 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-22 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-22 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-22 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-22 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-21 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-21 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-20 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-20 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-20 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-20 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-20 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-20 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-20 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-20 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-20 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-20 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-20 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-20 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-20 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-19 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-19 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-19 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-19 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-19 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-19 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-19 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-19 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-19 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-19 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-18 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-18 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-18 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-18 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-18 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-17 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-17 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-17 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-17 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-16 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 960 | |||
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-163 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-144 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-142 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-141 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-141 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-139 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-136 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-135 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-131 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-117 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-116 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-113 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-110 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-107 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-101 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-71 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-68 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-66 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 6e-66 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-66 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-66 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-65 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-65 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-65 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-65 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-65 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-65 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-64 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-64 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-63 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-63 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-63 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-63 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-63 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-63 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 7e-63 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-62 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-62 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-62 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-62 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-62 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-62 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-62 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-62 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-62 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-61 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-61 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-61 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-61 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-61 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-61 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-60 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-60 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-60 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-60 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-60 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-60 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-60 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-60 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-59 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-59 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-59 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-59 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-59 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 8e-59 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 8e-59 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-57 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 9e-53 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-52 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-52 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 7e-52 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-51 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-51 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-48 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-48 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-48 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-47 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-47 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 8e-46 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-45 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 4e-45 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-44 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-44 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-43 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-43 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-43 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-43 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-43 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-43 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-43 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-42 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-42 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-42 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-42 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-42 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-41 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-41 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-41 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 5e-41 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 7e-41 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-40 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-39 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-39 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-39 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-39 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-39 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 9e-38 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-37 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-37 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-37 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-37 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-37 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-37 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-37 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-37 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-36 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-36 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-36 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-36 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-36 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-36 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 8e-36 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-36 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-35 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-35 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-35 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-35 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-35 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-35 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-34 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-34 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-34 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-34 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 6e-34 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 7e-34 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-34 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-33 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-33 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-33 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-33 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-33 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-33 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-33 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-33 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-33 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-33 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-33 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-33 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 8e-33 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 9e-33 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-32 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-32 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-32 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-32 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-32 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-32 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-31 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-31 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-31 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-31 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-31 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-30 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-30 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-30 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-29 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-28 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-26 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 7e-25 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-24 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-24 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-24 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 7e-24 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-24 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 9e-24 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-23 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-23 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 8e-23 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 9e-23 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 6e-22 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-21 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-21 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-21 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-21 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-21 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-21 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-21 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 6e-21 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 8e-21 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 9e-21 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-20 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-20 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-20 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-20 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-20 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-20 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-19 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-19 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-19 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-19 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 7e-19 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-18 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-18 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-18 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-18 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 4e-18 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 9e-18 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-17 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-17 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-17 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-17 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-17 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-17 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-16 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 9e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-06 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-09 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-07 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 7e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-05 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-04 |
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 479 bits (1236), Expect = e-163
Identities = 181/303 (59%), Positives = 224/303 (73%), Gaps = 4/303 (1%)
Query: 641 LKLRDLESPSSSVDSSTSKVDQIFD-DDVCECEIPWEDLVLGERIGLGSSYGEVYHADWN 699
+K P S D T++ D + +IPW DL + E+IG GS +G V+ A+W+
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGS-FGTVHRAEWH 59
Query: 700 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 759
G++VAVK ++QDF + EF REV IM+RLRHPN+VLFMGAVT+PPNLSI+TE+L RG
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 760 SLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 817
SL+R+LH+ Q+DE+RR+ MA DVA+GMN LH P IVHR+LKSPNLLVDK + VK
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 818 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877
V DFGLSRLK +TFLSSKS AGTPEWMAPEVLR+EPSNEK DVYSFGVILWELATL+ PW
Sbjct: 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239
Query: 878 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937
+NP QVV AVGF+ +RLEIP+ L+P VA II CW +P RPSFA + L+PL +
Sbjct: 240 GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
Query: 938 VIP 940
+P
Sbjct: 300 AVP 302
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 429 bits (1106), Expect = e-144
Identities = 81/271 (29%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
I ++ L ++ GE++ W G ++ VK +D+S +F E +R
Sbjct: 6 GIDFKQLNFLTKLNENH-SGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 732 RHPNVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGM 788
HPNV+ +GA PP + ++IT ++P GSL+ +LH VD+ + +K ALD+ARGM
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 848
LHT P I L S ++++D++ ++S + S P W+APE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEA 179
Query: 849 LRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
L+ +P + D++SF V+LWEL T ++P+ ++ M++ V + R IP + P
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
V++++ C DP+ RP F + L+ +Q
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 424 bits (1093), Expect = e-142
Identities = 98/274 (35%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMR 729
EI + +L L E IG+G +G+VY A W G EVAVK + + ++E K+
Sbjct: 3 EIDFAELTLEEIIGIGG-FGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
L+HPN++ G + PNL ++ EF G L R+L ++ + A+ +ARGMN
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMN 119
Query: 790 CLHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSDFGLSRLKHNTFLSSKSTAGT 840
LH I+HRDLKS N+L+ + N +K++DFGL+R H T + S AG
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGA 177
Query: 841 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 900
WMAPEV+R ++ DV+S+GV+LWEL T ++P+ G++ + V V L IP
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
A+++ +CW DP RPSF + L +
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 422 bits (1087), Expect = e-141
Identities = 93/315 (29%), Positives = 150/315 (47%), Gaps = 23/315 (7%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEV 703
+L S+ + IF E +IP+E L +GE IG G +G+VYH W+G EV
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQ---EWDIPFEQLEIGELIGKGR-FGQVYHGRWHG-EV 58
Query: 704 AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFR 763
A++ + + L FKREV R+ RH NVVLFMGA PP+L+IIT +L+
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 764 ILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823
++ +D + ++A ++ +GM LH I+H+DLKS N+ D N V ++DFGL
Sbjct: 119 VVRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGL 175
Query: 824 SRLKHNTFLSSKST-----AGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWE 869
+ + G +APE++R P ++ DV++ G I +E
Sbjct: 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235
Query: 870 LATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 929
L + P+ ++ +G + + ++ I+ CW + RP+F +L
Sbjct: 236 LHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295
Query: 930 ALKPLQRLVI-PSHP 943
L+ L + SHP
Sbjct: 296 MLEKLPKRNRRLSHP 310
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 420 bits (1083), Expect = e-141
Identities = 100/280 (35%), Positives = 156/280 (55%), Gaps = 14/280 (5%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREV 725
D + EIP + +G+RIG GS +G VY W+G +VAVK + L FK EV
Sbjct: 14 DAADDWEIPDGQITVGQRIGSGS-FGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 71
Query: 726 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 785
++R+ RH N++LFMG T P L+I+T++ SL+ LH + + K+ I +A A
Sbjct: 72 GVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEW 843
RGM+ LH +I+HRDLKS N+ + ++ VK+ DFGL+ K S + G+ W
Sbjct: 131 RGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 844 MAPEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRR---L 896
MAPEV+R + SN + DVY+FG++L+EL T +LP+ +N Q++ VG +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
++ + R++ EC + RPSF ++ ++ L R
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 408 bits (1050), Expect = e-136
Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 22/279 (7%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALL-----EFKRE 724
+ ++ ++IG G +G V+ + + VA+K + D G + EF+RE
Sbjct: 15 TLADNEIEYEKQIGKGG-FGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
V IM L HPN+V G + PP ++ EF+P G L+ L + ++++ LD+
Sbjct: 74 VFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLKHNTFLSSKSTAG 839
A G+ + P IVHRDL+SPN+ + KV+DFGLS+ ++ G
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLG 188
Query: 840 TPEWMAPEVL--RNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRR 895
+WMAPE + E EK D YSF +IL+ + T + P+ + ++ + + + R
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
IP++ P + +I CW DP RP F+ + L L
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 407 bits (1048), Expect = e-135
Identities = 90/293 (30%), Positives = 128/293 (43%), Gaps = 18/293 (6%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
DL+ GE +G G +G+ T + F F +EVK+MR
Sbjct: 4 HRIFRPSDLIHGEVLGKGC-FGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
L HPNV+ F+G + + L+ ITE++ G+L I+ Q +R+ A D+A GM
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--------------KHNTFLSSK 835
LH+ I+HRDL S N LV +N NV V+DFGL+RL K
Sbjct: 123 YLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 836 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNR 894
+ G P WMAPE++ +EK DV+SFG++L E+ P + +
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240
Query: 895 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPS 947
P P I C DP RPSF +L L+ L+ + P P
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-131
Identities = 82/282 (29%), Positives = 135/282 (47%), Gaps = 15/282 (5%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
I ++++ + E +G G+ +G V A W +VA+K+ + F E++ + R+
Sbjct: 4 MIDYKEIEVEEVVGRGA-FGVVCKAKWRAKDVAIKQIESESERK----AFIVELRQLSRV 58
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMN 789
HPN+V GA P + ++ E+ GSL+ +LH P + L ++G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 790 CLHTSTPT-IVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
LH+ P ++HRDLK PNLL+ V K+ DFG + ++K G+ WMAPE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPE 173
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLV 906
V +EKCDV+S+G+ILWE+ T + P+ + P + R + K L +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 907 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 948
++ CW DPS RPS ++ + L R +
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-117
Identities = 91/342 (26%), Positives = 146/342 (42%), Gaps = 59/342 (17%)
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHA 696
G +L+ +S SS S + Q + + + ++IG G YGEV+
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQ---------RTIAKQIQMVKQIGKGR-YGEVWMG 56
Query: 697 DWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTRP----PNLS 750
W G +VAVK F + + + RE +I +RH N++ F+ A + L
Sbjct: 57 KWRGEKVAVKVFFTTEEA-----SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111
Query: 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------PTIVHRDLK 804
+IT++ GSL+ L +D K +K+A G+ LHT P I HRDLK
Sbjct: 112 LITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 805 SPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVL------RNEPS 854
S N+LV KN ++D GL+ + + + GT +M PEVL + S
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229
Query: 855 NEKCDVYSFGVILWELAT----------LKLPWIGMNPMQ-----VVGAVGFQNRRLEIP 899
D+YSFG+ILWE+A +LP+ + P + V + R P
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289
Query: 900 K-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
E + +++ ECW +P+ R + ++ L +
Sbjct: 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-116
Identities = 84/301 (27%), Positives = 134/301 (44%), Gaps = 50/301 (16%)
Query: 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRH 733
D+ L E +G G YGEV+ W G VAVK F +D + RE ++ LRH
Sbjct: 8 RDITLLECVGKGR-YGEVWRGSWQGENVAVKIFSSRDEK-----SWFRETELYNTVMLRH 61
Query: 734 PNVVLFMGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
N++ F+ + L +IT + GSL+ L +D +++ L +A G+
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLA 119
Query: 790 CLHT------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----LSSKSTAG 839
LH P I HRDLKS N+LV KN ++D GL+ + + + + G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 840 TPEWMAPEVLRNEP------SNEKCDVYSFGVILWELAT----------LKLPWIGMNP- 882
T +MAPEVL S ++ D+++FG++LWE+A K P+ + P
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 883 ----MQVVGAVGFQNRRLEIPKELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKP 933
+ V +R IP +A+++ ECW +PS R + ++ L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 934 L 934
+
Sbjct: 300 I 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 344 bits (883), Expect = e-110
Identities = 97/341 (28%), Positives = 151/341 (44%), Gaps = 59/341 (17%)
Query: 638 GTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHAD 697
GT LK + +S S + Q +VL E IG G +GEV+
Sbjct: 13 GTTLKDLIYDMTTSGSGSGLPLLVQ---------RTIARTIVLQESIGKGR-FGEVWRGK 62
Query: 698 WNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTR----PPNLSI 751
W G EVAVK F ++ + RE +I LRH N++ F+ A + L +
Sbjct: 63 WRGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117
Query: 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------PTIVHRDLKS 805
++++ GSLF L+R V + IK+AL A G+ LH P I HRDLKS
Sbjct: 118 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 806 PNLLVDKNWNVKVSDFGLSRLKHNT----FLSSKSTAGTPEWMAPEVLRNE------PSN 855
N+LV KN ++D GL+ + ++ GT +MAPEVL + S
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 856 EKCDVYSFGVILWELATL----------KLPWIGMNPM-----QVVGAVGFQNRRLEIPK 900
++ D+Y+ G++ WE+A +LP+ + P ++ V Q R IP
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 295
Query: 901 -----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
E ++A+I+ ECW + + R + ++ L L +
Sbjct: 296 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 335 bits (860), Expect = e-107
Identities = 85/331 (25%), Positives = 126/331 (38%), Gaps = 57/331 (17%)
Query: 647 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVK 706
SS VD T L L E G +G V+ A VAVK
Sbjct: 6 HHHSSGVDLGTE-----------NLYFQSMPLQLLEVKARGR-FGCVWKAQLLNEYVAVK 53
Query: 707 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIITEFLPRGSLF 762
F QD + + EV + ++H N++ F+GA R + L +IT F +GSL
Sbjct: 54 IFPIQDKQS---WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLS 110
Query: 763 RILHRPHCQVDEKRRIKMALDVARGMNCLHT--------STPTIVHRDLKSPNLLVDKNW 814
L V +A +ARG+ LH P I HRD+KS N+L+ N
Sbjct: 111 DFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168
Query: 815 NVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVIL 867
++DFGL+ + + GT +MAPEVL + + D+Y+ G++L
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228
Query: 868 WELATLKLPWIGMNP----------------MQVVGAVGFQNRRLEIPKELDP-----LV 906
WELA+ G + V + +R + ++
Sbjct: 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288
Query: 907 ARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937
I ECW D R S + + +QRL
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 319 bits (818), Expect = e-101
Identities = 84/332 (25%), Positives = 126/332 (37%), Gaps = 61/332 (18%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
E + ++L L E IG G YG VY + VAVK F + F E I R
Sbjct: 7 EPSLDLDNLKLLELIGRGR-YGAVYKGSLDERPVAVKVFSFANRQ-----NFINEKNIYR 60
Query: 730 --RLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 782
+ H N+ F+ R ++ E+ P GSL + L D ++A
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAH 118
Query: 783 DVARGMNCLHTST-------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--- 832
V RG+ LHT P I HRDL S N+LV + +SDFGLS L
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 833 -----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELA---TLKLPW 877
++ S GT +MAPEVL E + ++ D+Y+ G+I WE+ T P
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 878 IGMNPMQV---------------VGAVGFQNRRLEIPKELDP------LVARIIWECWQT 916
+ Q+ V + +R + P+ + I +CW
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 917 DPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 948
D R + + L + + P++
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 7e-71
Identities = 78/256 (30%), Positives = 122/256 (47%), Gaps = 13/256 (5%)
Query: 680 LGERIGLGSSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
IG GS + VY D EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 30 FDIEIGRGS-FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 738 LFMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
F + V + ++TE + G+L L R + K + +G+ LHT
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 794 STPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
TP I+HRDLK N+ + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEK 205
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGFQNRRLEIPKELDPLVARIIW 911
+E DVY+FG+ + E+AT + P+ + V + K P V II
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 912 ECWQTDPSLRPSFAQL 927
C + + R S L
Sbjct: 265 GCIRQNKDERYSIKDL 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-68
Identities = 83/272 (30%), Positives = 139/272 (51%), Gaps = 10/272 (3%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKI 727
+ + EDLVLGE+IG G+ +GEV+ T VAVK + +F +E +I
Sbjct: 108 KWVLNHEDLVLGEQIGRGN-FGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARI 165
Query: 728 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 787
+++ HPN+V +G T+ + I+ E + G L ++ K ++M D A G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMA 845
M L + +HRDL + N LV + +K+SDFG+SR + + ++ P +W A
Sbjct: 226 MEYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA 283
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904
PE L + + DV+SFG++LWE +L P+ ++ Q V + RL P+
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPD 342
Query: 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
V R++ +CW +P RPSF+ + L+ +++
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 4e-66
Identities = 90/286 (31%), Positives = 145/286 (50%), Gaps = 19/286 (6%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFS 714
S + D+ + + ++L L + IG G +G+V D+ G +VAVK +
Sbjct: 3 GSVAAQDEFYRS---GWALNMKELKLLQTIGKGE-FGDVMLGDYRGNKVAVKCIKN---- 54
Query: 715 GAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRILH-RPHCQV 772
A F E +M +LRH N+V +G + L I+TE++ +GSL L R +
Sbjct: 55 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114
Query: 773 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832
+K +LDV M L VHRDL + N+LV ++ KVSDFGL++ +T
Sbjct: 115 GGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172
Query: 833 SSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVG 890
+ K P +W APE LR + + K DV+SFG++LWE+ + ++P+ + VV V
Sbjct: 173 TGK----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
Query: 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
+ +++ P P V ++ CW D ++RPSF QL L+ ++
Sbjct: 229 -KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 6e-66
Identities = 83/313 (26%), Positives = 139/313 (44%), Gaps = 26/313 (8%)
Query: 650 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG-----TEVA 704
+ + + + + I L+LG+ +G G +G V + +VA
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGE-FGSVMEGNLKQEDGTSLKVA 66
Query: 705 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNLSIITEFLPRG 759
VK + S + EF E M+ HPNV+ +G P +I F+ G
Sbjct: 67 VKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG 126
Query: 760 SLFRIL--HRPHCQVDE---KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814
L L R + +K +D+A GM L S +HRDL + N ++ +
Sbjct: 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDM 184
Query: 815 NVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872
V V+DFGLS+ ++ + P +W+A E L + K DV++FGV +WE+AT
Sbjct: 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
Query: 873 L-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931
P+ G+ ++ + RL+ P++ + I++ CW+TDP RP+F+ L + L
Sbjct: 245 RGMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303
Query: 932 KPLQRLVIPSHPD 944
+ L + S PD
Sbjct: 304 EKL----LESLPD 312
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 7e-66
Identities = 79/268 (29%), Positives = 129/268 (48%), Gaps = 10/268 (3%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
I +L + IG G +G V+ W +VA+K + + +F E ++M +
Sbjct: 4 VIDPSELTFVQEIGSGQ-FGLVHLGYWLNKDKVAIKT-IREGAMSEE--DFIEEAEVMMK 59
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 790
L HP +V G + ++TEF+ G L L + + M LDV GM
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 849
L ++HRDL + N LV +N +KVSDFG++R + +S + P +W +PEV
Sbjct: 120 L--EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 177
Query: 850 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 236
Query: 909 IIWECWQTDPSLRPSFAQLTVALKPLQR 936
I+ CW+ P RP+F++L L +
Sbjct: 237 IMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 8e-66
Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 23/295 (7%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKRE 724
+ IP + LG +G G +G V A +VAVK + + + EF RE
Sbjct: 17 DVLIPEQQFTLGRMLGKGE-FGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 725 VKIMRRLRHPNVVLFMGAVTR------PPNLSIITEFLPRGSLFRIL--HRPH---CQVD 773
M+ HP+V +G R P +I F+ G L L R +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 774 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833
+ ++ +D+A GM L S+ +HRDL + N ++ ++ V V+DFGLSR ++
Sbjct: 136 LQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193
Query: 834 SKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVG 890
+ A P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ +
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253
Query: 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 945
RL+ P E V ++++CW DP RPSF L + L+ + + Q
Sbjct: 254 -GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-65
Identities = 86/268 (32%), Positives = 139/268 (51%), Gaps = 10/268 (3%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
E+ E++ L + +G G +G V W G +VAVK + + EF +E + M +
Sbjct: 4 ELKREEITLLKELGSGQ-FGVVKLGKWKGQYDVAVKM-IKEGSMSED--EFFQEAQTMMK 59
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 790
L HP +V F G ++ + I+TE++ G L L ++ + ++M DV GM
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 849
L + +HRDL + N LVD++ VKVSDFG++R + S P +W APEV
Sbjct: 120 L--ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 850 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
+ K DV++FG+++WE+ +L K+P+ +VV V Q RL P + +
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQ 236
Query: 909 IIWECWQTDPSLRPSFAQLTVALKPLQR 936
I++ CW P RP+F QL +++PL+
Sbjct: 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-65
Identities = 82/274 (29%), Positives = 125/274 (45%), Gaps = 13/274 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKRE 724
+ I ED+VL +G G +GEVY + VAVK +D + +F E
Sbjct: 6 QYGIAREDVVLNRILGEGF-FGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKFMSE 63
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
IM+ L HP++V +G + P II E P G L L R + + +L +
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EW 843
+ M L + VHRD+ N+LV VK+ DFGLSR + S P +W
Sbjct: 123 CKAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
M+PE + DV+ F V +WE+ + K P+ + V+G + + RL P
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLC 239
Query: 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
P++ ++ CW DPS RP F +L +L + +
Sbjct: 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-65
Identities = 90/288 (31%), Positives = 146/288 (50%), Gaps = 15/288 (5%)
Query: 663 IFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEF 721
++D E E+P E L L ER+G G +GEV+ +NG T+VAVK L Q F
Sbjct: 3 WWED---EWEVPRETLKLVERLGAGQ-FGEVWMGYYNGHTKVAVKS-LKQGSMSPD--AF 55
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKM 780
E +M++L+H +V VT+ P IITE++ GSL L ++ + + M
Sbjct: 56 LAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 840
A +A GM + +HRDL++ N+LV + K++DFGL+RL + +++ A
Sbjct: 115 AAQIAEGMAFI--EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172
Query: 841 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 898
P +W APE + K DV+SFG++L E+ T ++P+ GM +V+ + + R+
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVR 231
Query: 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 946
P + +++ CW+ P RP+F L L+ + QP
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-65
Identities = 81/268 (30%), Positives = 125/268 (46%), Gaps = 10/268 (3%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
EI +DL + +G G +G V + W G +VA+K + + EF E K+M
Sbjct: 20 EIDPKDLTFLKELGTGQ-FGVVKYGKWRGQYDVAIKM-IKEGSMSED--EFIEEAKVMMN 75
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 790
L H +V G T+ + IITE++ G L L + ++ ++M DV M
Sbjct: 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 849
L + +HRDL + N LV+ VKVSDFGLSR + +S + P W PEVL
Sbjct: 136 L--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 193
Query: 850 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYT 252
Query: 909 IIWECWQTDPSLRPSFAQLTVALKPLQR 936
I++ CW RP+F L + +
Sbjct: 253 IMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 5e-65
Identities = 90/305 (29%), Positives = 150/305 (49%), Gaps = 28/305 (9%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E+ E + + +G GS +G VY G T VA+K +++ S +EF E
Sbjct: 21 EVAREKITMSRELGQGS-FGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNE 78
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQVDEKRR----- 777
+M+ +VV +G V++ +I E + RG L + RP +
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 778 --IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835
I+MA ++A GM L + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 139 KMIQMAGEIADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 836 STAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892
G P WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-ME 255
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ----RLVIPSHPDQPSS 948
L+ P ++ ++ CWQ +P +RPSF ++ ++K R V + ++
Sbjct: 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKL 315
Query: 949 ALPQE 953
P+E
Sbjct: 316 PEPEE 320
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 7e-65
Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 15/275 (5%)
Query: 671 CEIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 724
+ + + +G G+ +G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGA-FGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDE 67
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
+M + +P+V +G + +IT+ +P G L + + + + + +
Sbjct: 68 AYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-E 842
A+GMN L +VHRDL + N+LV +VK++DFGL++ L P +
Sbjct: 127 AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 901
WMA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPI 243
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
V I+ +CW D RP F +L + + R
Sbjct: 244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-64
Identities = 86/294 (29%), Positives = 141/294 (47%), Gaps = 19/294 (6%)
Query: 667 DVCECEIP--WEDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALL 719
+V + IP IG G +G VYH ++ + A+K L + +
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGH-FGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQQVE 67
Query: 720 EFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 778
F RE +MR L HPNV+ +G + P ++ ++ G L + + P K I
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKS 836
L VARGM L + VHRDL + N ++D+++ VKV+DFGL+R + + +
Sbjct: 128 SFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185
Query: 837 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 893
P +W A E L+ K DV+SFGV+LWEL T P+ ++P + + Q
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QG 244
Query: 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH-PDQP 946
RRL P+ + +++ +CW+ DP++RP+F L ++ + ++ H P
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-64
Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 31/296 (10%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAAL 718
+ I D+VL +G G+ +G+V+ A+ VAVK +D + AA
Sbjct: 5 SGIHVQHIKRRDIVLKRELGEGA-FGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAAR 61
Query: 719 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKR 776
+F+RE +++ L+H ++V F G L ++ E++ G L + L H P +
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 777 R-------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823
+ + +A +A GM L ++ VHRDL + N LV N VK+ DFG+
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 824 SRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 880
SR ++T P WM PE + + DV+SFGVILWE+ T K PW +
Sbjct: 180 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
+ +V+ + Q R LE P+ V ++ CWQ +P R + ++ L L +
Sbjct: 240 SNTEVIECIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-63
Identities = 85/301 (28%), Positives = 135/301 (44%), Gaps = 29/301 (9%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E+P +++ L +G G+ +GEVY +G +VAVK L + S L+F E
Sbjct: 26 EVPRKNITLIRGLGHGA-FGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLME 83
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRI 778
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSK 835
+A D+A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 144 HVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 836 STAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 260
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQ 952
R++ PK V RI+ +CWQ P RP+FA + ++ + PD ++ALP
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-----DPDVINTALPI 315
Query: 953 E 953
E
Sbjct: 316 E 316
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-63
Identities = 87/272 (31%), Positives = 125/272 (45%), Gaps = 14/272 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALL-EFKR 723
C I +DL L E++G GS +G V +W+ VAVK S + +F R
Sbjct: 12 TCLIGEKDLRLLEKLGDGS-FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
EV M L H N++ G V PP + ++TE P GSL L + + A+
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P 841
VA GM L + +HRDL + NLL+ VK+ DFGL R P
Sbjct: 130 VAEGMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 842 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIP 899
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247
Query: 900 KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931
++ + ++ +CW P RP+F L L
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-63
Identities = 84/301 (27%), Positives = 134/301 (44%), Gaps = 16/301 (5%)
Query: 653 VDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKK 707
+D S + + + E IG G +G VYH AVK
Sbjct: 2 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGH-FGCVYHGTLLDNDGKKIHCAVKS 60
Query: 708 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILH 766
L++ + +F E IM+ HPNV+ +G R + ++ ++ G L +
Sbjct: 61 -LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 119
Query: 767 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
K I L VA+GM L ++ VHRDL + N ++D+ + VKV+DFGL+R
Sbjct: 120 NETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177
Query: 827 KHNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMN 881
++ + T P +WMA E L+ + K DV+SFGV+LWEL T P+ +N
Sbjct: 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237
Query: 882 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 941
+ + Q RRL P+ + ++ +CW +RPSF++L + + I
Sbjct: 238 TFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
Query: 942 H 942
H
Sbjct: 297 H 297
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 4e-63
Identities = 97/325 (29%), Positives = 150/325 (46%), Gaps = 31/325 (9%)
Query: 636 FMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYH 695
MG+ L E S + + Q F D C I D+VL +G G+ +G+V+
Sbjct: 2 AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDA-CVHHIKRRDIVLKWELGEGA-FGKVFL 59
Query: 696 ADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748
A+ + VAVK ++ S +A +F+RE +++ L+H ++V F G T
Sbjct: 60 AECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117
Query: 749 LSIITEFLPRGSLFRIL--HRPHCQVDEKRR------------IKMALDVARGMNCLHTS 794
L ++ E++ G L R L H P ++ + +A VA GM L +
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--A 175
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNE 852
VHRDL + N LV + VK+ DFG+SR ++T P WM PE +
Sbjct: 176 GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR 235
Query: 853 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
+ DV+SFGV+LWE+ T K PW ++ + + + Q R LE P+ P V I+
Sbjct: 236 KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMR 294
Query: 912 ECWQTDPSLRPSFAQLTVALKPLQR 936
CWQ +P R S + L+ L +
Sbjct: 295 GCWQREPQQRHSIKDVHARLQALAQ 319
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 5e-63
Identities = 96/271 (35%), Positives = 144/271 (53%), Gaps = 14/271 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKI 727
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +
Sbjct: 7 KWEMERTDITMKHKLGGGQ-YGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAV 62
Query: 728 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVA 785
M+ ++HPN+V +G TR P IITEF+ G+L L +V + MA ++
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQIS 121
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 844
M L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W
Sbjct: 122 SAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
APE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238
Query: 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
V ++ CWQ +PS RPSFA++ A + +
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 7e-63
Identities = 82/274 (29%), Positives = 124/274 (45%), Gaps = 13/274 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKRE 724
+ EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 9 DYEIQRERIELGRCIGEGQ-FGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQE 66
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
MR+ HP++V +G +T P II E G L L +D I A +
Sbjct: 67 ALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EW 843
+ + L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +W
Sbjct: 126 STALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
MAPE + DV+ FGV +WE+ P+ G+ V+G + RL +P
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 242
Query: 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
P + ++ +CW DPS RP F +L L +
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 213 bits (546), Expect = 7e-63
Identities = 84/289 (29%), Positives = 123/289 (42%), Gaps = 30/289 (10%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
EI + E +G +G+VY G VA+K L G EF+ E
Sbjct: 5 EISLSAVRFMEELGEDR-FGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHE 62
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR----- 777
+ RL+HPNVV +G VT+ LS+I + G L L PH V
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 778 --------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829
+ + +A GM L S+ +VH+DL + N+LV NVK+SD GL R +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 830 TFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVV 886
P WMAPE + + D++S+GV+LWE+ + P+ G + VV
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 887 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935
+ + L P + V ++ ECW PS RP F + L+
Sbjct: 241 EMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-62
Identities = 85/303 (28%), Positives = 135/303 (44%), Gaps = 29/303 (9%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E+P +++ L +G G+ +GEVY +G +VAVK L + S L+F E
Sbjct: 67 EVPRKNITLIRGLGHGA-FGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLME 124
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRI 778
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSK 835
+A D+A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 185 HVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 836 STAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 301
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQ 952
R++ PK V RI+ +CWQ P RP+FA + ++ + PD ++ALP
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-----DPDVINTALPI 356
Query: 953 EIS 955
E
Sbjct: 357 EYG 359
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-62
Identities = 69/296 (23%), Positives = 127/296 (42%), Gaps = 20/296 (6%)
Query: 671 CEIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 724
+L + +G G +G V+ W V +K ++ +
Sbjct: 8 RIFKETELRKLKVLGSGV-FGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDH 65
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
+ + L H ++V +G L ++T++LP GSL + + + + + + +
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-E 842
A+GM L +VHR+L + N+L+ V+V+DFG++ L + TP +
Sbjct: 125 AKGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 901
WMA E + + DV+S+GV +WEL T P+ G+ +V + + RL P+
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQI 241
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALPQ 952
V ++ +CW D ++RP+F +L + R LVI + P+
Sbjct: 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPE 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-62
Identities = 84/295 (28%), Positives = 141/295 (47%), Gaps = 20/295 (6%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 725
EI + + IG G +GEVY VA+K L ++ ++F E
Sbjct: 40 EIHPSCVTRQKVIGAGE-FGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEA 97
Query: 726 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 785
IM + H N++ G +++ + IITE++ G+L + L + + + M +A
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-E 842
GM L + VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+G P
Sbjct: 158 AGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 901
W APE + DV+SFG+++WE+ T + P+ ++ +V+ A+ RL P +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 274
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALP 951
+ +++ +CWQ + + RP FA + L L R + + S LP
Sbjct: 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLP 329
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 4e-62
Identities = 74/296 (25%), Positives = 130/296 (43%), Gaps = 19/296 (6%)
Query: 671 CEIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 724
+ + + +G G+ +G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGA-FGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDE 67
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
+M + +P+V +G + +IT+ +P G L + + + + + +
Sbjct: 68 AYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-E 842
A+GMN L +VHRDL + N+LV +VK++DFGL++ L P +
Sbjct: 127 AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 901
WMA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPI 243
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL----QRLVIPSHPDQPSSALPQE 953
V I+ +CW D RP F +L + + QR ++ ++ P +
Sbjct: 244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 299
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 5e-62
Identities = 88/273 (32%), Positives = 140/273 (51%), Gaps = 20/273 (7%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVK--KFLDQDFSGAALLEFKREVKI 727
+ ++L L + IG G +G+V D+ G +VAVK K + A F E +
Sbjct: 187 GWALNMKELKLLQTIGKGE-FGDVMLGDYRGNKVAVKCIK------NDATAQAFLAEASV 239
Query: 728 MRRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVA 785
M +LRH N+V +G + L I+TE++ +GSL L R + +K +LDV
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 299
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 844
M L VHRDL + N+LV ++ KVSDFGL++ +T + K P +W
Sbjct: 300 EAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWT 353
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
APE LR + + K DV+SFG++LWE+ + ++P+ + VV V + +++ P
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 412
Query: 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
P V ++ CW D + RP+F QL L+ ++
Sbjct: 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-62
Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 38/311 (12%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQ 711
++ + + + E P ++ IG G+ +G V+ A G T VAVK L +
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVRDIGEGA-FGRVFQARAPGLLPYEPFTMVAVKM-LKE 87
Query: 712 DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPH 769
+ S +F+RE +M +PN+V +G + ++ E++ G L L PH
Sbjct: 88 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 147
Query: 770 CQVDEKRR---------------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNL 808
+ +A VA GM L S VHRDL + N
Sbjct: 148 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNC 205
Query: 809 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVI 866
LV +N VK++DFGLSR ++ P WM PE + + DV+++GV+
Sbjct: 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 265
Query: 867 LWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFA 925
LWE+ + P+ GM +V+ V L P+ + ++ CW P+ RPSF
Sbjct: 266 LWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 926 QLTVALKPLQR 936
+ L+ +
Sbjct: 325 SIHRILQRMCE 335
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 5e-62
Identities = 84/306 (27%), Positives = 135/306 (44%), Gaps = 16/306 (5%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG-----TE 702
+ + +D S + + + E IG G +G VYH
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGH-FGCVYHGTLLDNDGKKIH 119
Query: 703 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSL 761
AVK L++ + +F E IM+ HPNV+ +G R + ++ ++ G L
Sbjct: 120 CAVKS-LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 762 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821
+ K I L VA+GM L ++ VHRDL + N ++D+ + VKV+DF
Sbjct: 179 RNFIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADF 236
Query: 822 GLSRLKHNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLP 876
GL+R ++ T P +WMA E L+ + K DV+SFGV+LWEL T P
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
Query: 877 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
+ +N + + Q RRL P+ + ++ +CW +RPSF++L + +
Sbjct: 297 YPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355
Query: 937 LVIPSH 942
I H
Sbjct: 356 TFIGEH 361
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 6e-62
Identities = 87/295 (29%), Positives = 148/295 (50%), Gaps = 14/295 (4%)
Query: 656 STSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFS 714
+SK + ++ D EIP E L L +++G G +GEV+ A +N T+VAVK
Sbjct: 170 MSSKPQKPWEKD--AWEIPRESLKLEKKLGAGQ-FGEVWMATYNKHTKVAVKTMKP---G 223
Query: 715 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVD 773
++ F E +M+ L+H +V VT+ P IITEF+ +GSL L +
Sbjct: 224 SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQP 282
Query: 774 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833
+ I + +A GM + +HRDL++ N+LV + K++DFGL+R+ + +
Sbjct: 283 LPKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340
Query: 834 SKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 891
++ A P +W APE + K DV+SFG++L E+ T ++P+ GM+ +V+ A+
Sbjct: 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE- 399
Query: 892 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 946
+ R+ P+ + I+ CW+ P RP+F + L + + P
Sbjct: 400 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 8e-62
Identities = 95/317 (29%), Positives = 160/317 (50%), Gaps = 36/317 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFK 722
E+P + LVLG+ +G G+ +G+V A+ G T+VAVK L D + L +
Sbjct: 65 ELPRDRLVLGKPLGEGA-FGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLI 122
Query: 723 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILH 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + H
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 767 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
P Q+ K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 827 KHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 883
H+ K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 943
++ + + R++ P + ++ +CW PS RP+F QL ++ L R+V +
Sbjct: 301 ELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL---VEDLDRIVALTSN 356
Query: 944 DQPSSALPQEISVNSTP 960
+ P
Sbjct: 357 QEMGYYHHHHHHDYDIP 373
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-61
Identities = 89/291 (30%), Positives = 148/291 (50%), Gaps = 33/291 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFK 722
E P + L LG+ +G G+ +G+V A+ G VAVK L D + L +
Sbjct: 31 EFPRDKLTLGKPLGEGA-FGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLV 88
Query: 723 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHC--------- 770
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L RP
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 771 ----QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
Q+ K + +ARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 827 KHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 883
+N K+T G P +WMAPE L + + DV+SFGV++WE+ TL P+ G+
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
++ + + R++ P + ++ +CW PS RP+F QL L +
Sbjct: 267 ELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 2e-61
Identities = 92/286 (32%), Positives = 143/286 (50%), Gaps = 16/286 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIM 728
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M
Sbjct: 178 AWEIPRESLRLEVKLGQGC-FGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVM 233
Query: 729 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVAR 786
++LRH +V V+ P I+TE++ +GSL L + + + MA +A
Sbjct: 234 KKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIAS 291
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 845
GM + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W A
Sbjct: 292 GMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904
PE K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 408
Query: 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 950
+ ++ +CW+ +P RP+F L L+ QP L
Sbjct: 409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 452
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-61
Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 15/272 (5%)
Query: 670 ECEIPWEDLVLGERIGLGS-SYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKRE 724
E + + L L ++ LGS ++G V + VAVK ++ A E E
Sbjct: 10 EVYLDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
+M++L +P +V +G + ++ E G L + L + + V +K I++ V
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQV 126
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 841
+ GM L VHRDL + N+L+ K+SDFGLS+ K+ P
Sbjct: 127 SMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 900
+W APE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPA 243
Query: 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
+ ++ CW D RP FA + + L+
Sbjct: 244 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 5e-61
Identities = 88/296 (29%), Positives = 143/296 (48%), Gaps = 38/296 (12%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E P ++LVLG+ +G G +G+V A T VAVK L ++ S + L + E
Sbjct: 19 EFPRKNLVLGKTLGEGE-FGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLLSE 76
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR----- 777
+++++ HP+V+ GA ++ L +I E+ GSL L R
Sbjct: 77 FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 778 ----------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821
I A +++GM L + +VHRDL + N+LV + +K+SDF
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 822 GLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWI 878
GLSR + K + G P +WMA E L + + DV+SFGV+LWE+ TL P+
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 879 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
G+ P ++ + R+E P + R++ +CW+ +P RP FA ++ L+ +
Sbjct: 255 GIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 6e-61
Identities = 88/274 (32%), Positives = 130/274 (47%), Gaps = 14/274 (5%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVK 726
EI + + + IG G GEV + VA+K L ++ +F E
Sbjct: 45 EIEASRIHIEKIIGSGD-SGEVCYGRLRVPGQRDVPVAIKA-LKAGYTERQRRDFLSEAS 102
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
IM + HPN++ G VTR I+TE++ GSL L Q + + M V
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EW 843
GM L S VHRDL + N+LVD N KVSDFGLSR+ + ++ +T G P W
Sbjct: 163 GMRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
APE + + DV+SFGV++WE+ + P+ M V+ +V + RL P
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGC 279
Query: 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
+ +++ +CW D + RP F+Q+ L L R
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 7e-61
Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 33/294 (11%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKR 723
+ L +++G G+ +G V ++ VAVKK L + L +F+R
Sbjct: 4 PTQFEERHLKFLQQLGKGN-FGSVEMCRYDPLQDNTGEVVAVKK-LQHS-TEEHLRDFER 60
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLS--IITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
E++I++ L+H N+V + G + +I E+LP GSL L + ++D + ++
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG- 839
+ +GM L T +HRDL + N+LV+ VK+ DFGL++ L + G
Sbjct: 121 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 840 TP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNP 882
+P W APE L + DV+SFGV+L+EL T M
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 883 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
++ + N RL P + I+ ECW + + RPSF L + + ++
Sbjct: 239 FHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-60
Identities = 95/331 (28%), Positives = 159/331 (48%), Gaps = 41/331 (12%)
Query: 637 MGTNLKLRDLESPSSSVDS-----STSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYG 691
M +N L + + SS S+ + D E P + L LG+ +G G +G
Sbjct: 40 MNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW---EFPRDKLTLGKPLGEGC-FG 95
Query: 692 EVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 741
+V A+ G VAVK L D + L + E+++M+ + +H N++ +G
Sbjct: 96 QVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154
Query: 742 AVTRPPNLSIITEFLPRGSL--FRILHRPHC-------------QVDEKRRIKMALDVAR 786
A T+ L +I E+ +G+L + RP Q+ K + +AR
Sbjct: 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWM 844
GM L ++ +HRDL + N+LV +N +K++DFGL+R +N K+T G P +WM
Sbjct: 215 GMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 272
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
APE L + + DV+SFGV++WE+ TL P+ G+ ++ + + R++ P
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCT 331
Query: 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ ++ +CW PS RP+F QL L +
Sbjct: 332 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-60
Identities = 89/303 (29%), Positives = 148/303 (48%), Gaps = 19/303 (6%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVK 726
E+ ++ + + +G G +GEV VA+K L ++ +F E
Sbjct: 41 ELDATNISIDKVVGAGE-FGEVCSGRLKLPSKKEISVAIKT-LKVGYTEKQRRDFLGEAS 98
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
IM + HPN++ G VT+ + I+TE++ GSL L + Q + + M +A
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EW 843
GM L S VHRDL + N+L++ N KVSDFGL R+ + ++ +T G P W
Sbjct: 159 GMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
+PE + DV+S+G++LWE+ + + P+ M+ V+ AV + RL P +
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDC 275
Query: 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALPQEISVN 957
+ +++ +CWQ D + RP F Q+ L L R +I S +PS+ L + +V+
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVD 335
Query: 958 STP 960
T
Sbjct: 336 ITT 338
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-60
Identities = 93/273 (34%), Positives = 144/273 (52%), Gaps = 14/273 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKI 727
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +
Sbjct: 214 KWEMERTDITMKHKLGGGQ-YGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAV 269
Query: 728 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVA 785
M+ ++HPN+V +G TR P IITEF+ G+L L +V + MA ++
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQIS 328
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWM 844
M L +HR+L + N LV +N VKV+DFGLSR + +T+ + +W
Sbjct: 329 SAMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
APE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 445
Query: 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
V ++ CWQ +PS RPSFA++ A + + +
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-60
Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 31/286 (10%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKI 727
+ W D+ + IG G+ +G+V A + A+K+ + + S +F E+++
Sbjct: 21 VLDWNDIKFQDVIGEGN-FGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEV 78
Query: 728 MRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR------- 777
+ +L HPN++ +GA L + E+ P G+L L R
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 778 ------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831
+ A DVARGM+ L S +HRDL + N+LV +N+ K++DFGLSR +
Sbjct: 139 LSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY- 195
Query: 832 LSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGA 888
K T G P WMA E L DV+S+GV+LWE+ +L P+ GM ++
Sbjct: 196 --VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 889 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ Q RLE P D V ++ +CW+ P RPSFAQ+ V+L +
Sbjct: 254 LP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-60
Identities = 82/291 (28%), Positives = 129/291 (44%), Gaps = 31/291 (10%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREV 725
L +G G +G+V + G +VAVK L + G + + K+E+
Sbjct: 17 HFEKRFLKRIRDLGEGH-FGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEI 74
Query: 726 KIMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
+I+R L H N+V + G T + +I EFLP GSL L + +++ K+++K A+
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P 841
+ +GM+ L + VHRDL + N+LV+ VK+ DFGL++ P
Sbjct: 135 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 842 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPMQV 885
W APE L DV+SFGV L EL T M ++
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 886 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
V + + +RL P V +++ +CW+ PS R SF L + L +
Sbjct: 253 VNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-60
Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 33/292 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 725
+ L +++G G+ +G V ++ VAVKK Q + L +F+RE+
Sbjct: 37 QFEERHLKFLQQLGKGN-FGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREI 93
Query: 726 KIMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
+I++ L+H N+V + G L +I E+LP GSL L + ++D + ++
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-TP 841
+ +GM L T +HRDL + N+LV+ VK+ DFGL++ L + G +P
Sbjct: 154 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 842 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNPMQ 884
W APE L + DV+SFGV+L+EL T M
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 885 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
++ + N RL P + I+ ECW + + RPSF L + + ++
Sbjct: 272 LIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 5e-60
Identities = 68/270 (25%), Positives = 123/270 (45%), Gaps = 15/270 (5%)
Query: 672 EIPWEDLVLGE-RIGLGSSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVK 726
+ ++L++ + +G G+ +G V + +VA+K L Q A E RE +
Sbjct: 5 FLKRDNLLIADIELGCGN-FGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQ 62
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
IM +L +P +V +G + ++ E G L + L ++ ++ V+
Sbjct: 63 IMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 121
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EW 843
GM L VHRDL + N+L+ K+SDFGLS+ + + P +W
Sbjct: 122 GMKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902
APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 238
Query: 903 DPLVARIIWECWQTDPSLRPSFAQLTVALK 932
P + ++ +CW RP F + ++
Sbjct: 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 6e-60
Identities = 89/326 (27%), Positives = 140/326 (42%), Gaps = 38/326 (11%)
Query: 642 KLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG- 700
+L+ ++ SS + + ++ D+ + E P E+L G+ +G G+ +G+V +A G
Sbjct: 12 QLQMVQVTGSSDNEYFYVDFREYEYDL-KWEFPRENLEFGKVLGSGA-FGKVMNATAYGI 69
Query: 701 ------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 753
+VAVK L + + E+K+M +L H N+V +GA T + +I
Sbjct: 70 SKTGVSIQVAVKM-LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128
Query: 754 EFLPRGSLFRIL--HRPHCQVDEKRR--------------------IKMALDVARGMNCL 791
E+ G L L R DE + A VA+GM L
Sbjct: 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVL 849
+ VHRDL + N+LV VK+ DFGL+R + P +WMAPE L
Sbjct: 189 --EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 246
Query: 850 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
K DV+S+G++LWE+ +L P+ G+ + +++ P +
Sbjct: 247 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI 306
Query: 909 IIWECWQTDPSLRPSFAQLTVALKPL 934
I+ CW D RPSF LT L
Sbjct: 307 IMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-59
Identities = 86/291 (29%), Positives = 139/291 (47%), Gaps = 33/291 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E P + L LG+ +G G+ +G+V AD G VAVK L + + + E
Sbjct: 23 EFPRDRLKLGKPLGRGA-FGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMSE 80
Query: 725 VKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRIL--HRPHC---------- 770
+KI+ + H NVV +GA T+P L +I EF G+L L R
Sbjct: 81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 771 ---QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827
+ + I + VA+GM L ++ +HRDL + N+L+ + VK+ DFGL+R
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 828 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM-NPM 883
+ + P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ + + R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 259 EFCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-59
Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 32/291 (10%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E P L G+ +G G+ +G+V A G VAVK L E
Sbjct: 19 EFPRNRLSFGKTLGAGA-FGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSE 76
Query: 725 VKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPH------------ 769
+K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 770 ---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
+D + + + VA+GM L ++ +HRDL + N+L+ K+ DFGL+R
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 827 KHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 883
N P +WMAPE + N + DV+S+G+ LWEL +L P+ GM
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ + R+ P+ + I+ CW DP RP+F Q+ ++
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-59
Identities = 82/272 (30%), Positives = 123/272 (45%), Gaps = 13/272 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVK 726
EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 386 EIQRERIELGRCIGEGQ-FGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEAL 443
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
MR+ HP++V +G +T P II E G L L +D I A ++
Sbjct: 444 TMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 845
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +WMA
Sbjct: 503 ALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904
PE + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 619
Query: 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
+ ++ +CW DPS RP F +L L +
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-59
Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 33/284 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFK 722
+I EDL+ E +G G+ + +++ TEV +K LD+ F
Sbjct: 4 KIRNEDLIFNESLGQGT-FTKIFKGVRREVGDYGQLHETEVLLKV-LDKA-HRNYSESFF 60
Query: 723 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 782
+M +L H ++VL G ++ EF+ GSL L + ++ ++++A
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLSRLKHNTFLSS 834
+A M+ L T++H ++ + N+L+ + + +K+SD G+S +
Sbjct: 121 QLAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----VLP 173
Query: 835 KSTAGTP-EWMAPEVLRNEPS-NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 891
K W+ PE + N + N D +SFG LWE+ + P ++ + +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE- 232
Query: 892 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935
+L PK +A +I C +P RPSF + L L
Sbjct: 233 DRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 5e-59
Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 33/293 (11%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKR 723
L +G G +G+V ++ VAVK L D +K+
Sbjct: 25 PTVFHKRYLKKIRDLGEGH-FGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQ 82
Query: 724 EVKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
E+ I+R L H +++ + G +L ++ E++P GSL L R + + + A
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFA 140
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG- 839
+ GM LH +HRDL + N+L+D + VK+ DFGL++ + G
Sbjct: 141 QQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 840 TP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPM 883
+P W APE L+ DV+SFGV L+EL T + M +
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
++ + + RL P + V ++ CW+T+ S RP+F L LK +
Sbjct: 259 RLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 8e-59
Identities = 92/286 (32%), Positives = 143/286 (50%), Gaps = 16/286 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIM 728
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M
Sbjct: 261 AWEIPRESLRLEVKLGQGC-FGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVM 316
Query: 729 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVAR 786
++LRH +V V+ P I+TE++ +GSL L + + + MA +A
Sbjct: 317 KKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIAS 374
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 845
GM + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W A
Sbjct: 375 GMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904
PE K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 491
Query: 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 950
+ ++ +CW+ +P RP+F L L+ QP L
Sbjct: 492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 535
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 8e-59
Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 30/288 (10%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKRE 724
E P +L G+ +G G+ +G+V A G +VAVK L E
Sbjct: 42 EFPRNNLQFGKTLGAGA-FGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMSE 99
Query: 725 VKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR---- 777
+KIM L +H N+V +GA T + +ITE+ G L L + D
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 778 -------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830
+ + VA+GM L ++ +HRD+ + N+L+ K+ DFGL+R N
Sbjct: 160 TASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 831 FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG-MNPMQVV 886
P +WMAPE + + + DV+S+G++LWE+ +L P+ G + +
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 887 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
V ++ P + I+ CW +P+ RP+F Q+ L+
Sbjct: 278 KLVK-DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-57
Identities = 78/314 (24%), Positives = 132/314 (42%), Gaps = 37/314 (11%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKR 723
L ++G G+ +G V ++ VAVK+ Q +F+R
Sbjct: 17 PTIFEERHLKYISQLGKGN-FGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQR 73
Query: 724 EVKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
E++I++ L +V + G P +L ++ E+LP G L L R ++D R + +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAG 839
+ +GM L + VHRDL + N+LV+ +VK++DFGL++L + +
Sbjct: 134 SQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 840 TP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF------ 891
+P W APE L + + + DV+SFGV+L+EL T +
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 892 -------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL-------KPLQRL 937
+ +RL P V ++ CW P RPSF+ L L + +
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311
Query: 938 VIPSHPDQPSSALP 951
+HP+ +L
Sbjct: 312 AFTAHPEGKHHSLS 325
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 9e-53
Identities = 67/272 (24%), Positives = 124/272 (45%), Gaps = 15/272 (5%)
Query: 670 ECEIPWEDLVLGE-RIGLGSSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKRE 724
+ + ++L++ + +G G+ +G V + +VA+K L Q A E RE
Sbjct: 329 KLFLKRDNLLIADIELGCGN-FGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMRE 386
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
+IM +L +P +V +G + ++ E G L + L ++ ++ V
Sbjct: 387 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 445
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 841
+ GM L VHR+L + N+L+ K+SDFGLS+ + + P
Sbjct: 446 SMGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 900
+W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPP 562
Query: 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
E P + ++ +CW RP F + ++
Sbjct: 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-52
Identities = 61/255 (23%), Positives = 128/255 (50%), Gaps = 7/255 (2%)
Query: 676 EDLVLGERIGLGSSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
E V ++IG GS +G+ +G + +K+ S E +REV ++ ++H
Sbjct: 24 EKYVRLQKIGEGS-FGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLH 792
PN+V + + +L I+ ++ G LF+ + + E + + + + + +H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
I+HRD+KS N+ + K+ V++ DFG++R+ ++T +++ GTP +++PE+ N+
Sbjct: 143 DRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
P N K D+++ G +L+EL TLK + + +V + + + ++ +
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQ 259
Query: 913 CWQTDPSLRPSFAQL 927
++ +P RPS +
Sbjct: 260 LFKRNPRDRPSVNSI 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 70/262 (26%), Positives = 121/262 (46%), Gaps = 12/262 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
ED + IG GS YG +G + K+ + A EV ++R L+H
Sbjct: 6 EDYEVLYTIGTGS-YGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 734 PNVVLFMGAVTRPPN--LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGM 788
PN+V + + N L I+ E+ G L ++ + +DE+ +++ + +
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 789 NCLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 845
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
PE + NEK D++S G +L+EL L P+ + ++ G + + + IP
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDE 243
Query: 906 VARIIWECWQTDPSLRPSFAQL 927
+ II RPS ++
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEI 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-52
Identities = 71/293 (24%), Positives = 118/293 (40%), Gaps = 20/293 (6%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHA-DW-NGT 701
+ + D+ + + E + R+G GS +GEV+ D G
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGS-FGEVHRMKDKQTGF 84
Query: 702 EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 761
+ AVKK + F E+ L P +V GAV P ++I E L GSL
Sbjct: 85 QCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137
Query: 762 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSD 820
+++ + + E R + G+ LHT I+H D+K+ N+L+ + + D
Sbjct: 138 GQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCD 194
Query: 821 FGLSR-----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 875
FG + + L+ GT MAPEV+ +P + K D++S ++ +
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
Query: 876 PWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
PW + + + EIP PL A+ I E + +P R S +L
Sbjct: 255 PWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-51
Identities = 66/261 (25%), Positives = 124/261 (47%), Gaps = 13/261 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHA-DW-NGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLR 732
+ + ++IG G + EVY A +G VA+KK + A + +E+ ++++L
Sbjct: 32 ANFRIEKKIGRGQ-FSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMN 789
HPNV+ + + L+I+ E G L R++ + + E+ K + + +
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
+H+ ++HRD+K N+ + VK+ D GL R + ++ S GTP +M+PE +
Sbjct: 151 HMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKE-LDPLV 906
N K D++S G +L+E+A L+ P+ G MN + + Q +P + +
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPLPSDHYSEEL 267
Query: 907 ARIIWECWQTDPSLRPSFAQL 927
+++ C DP RP +
Sbjct: 268 RQLVNMCINPDPEKRPDVTYV 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-51
Identities = 75/282 (26%), Positives = 136/282 (48%), Gaps = 15/282 (5%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHA-DW-NGTEVAVKKFLDQD 712
S S + + D+ E + +++ +G G+ YG VY D N +A+K+ ++D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGT-YGIVYAGRDLSNQVRIAIKEIPERD 59
Query: 713 FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH--C 770
+ L E+ + + L+H N+V ++G+ + + I E +P GSL +L
Sbjct: 60 SRYSQPLH--EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL 117
Query: 771 QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHN 829
+ +E+ + G+ LH + IVHRD+K N+L++ + +K+SDFG S+
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 830 TFLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFG-VILWELATLKLPWIGM-NPMQV 885
+++ GT ++MAPE++ P + D++S G I+ E+AT K P+ + P
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAA 234
Query: 886 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ VG EIP+ + I +C++ DP R L
Sbjct: 235 MFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 44/286 (15%)
Query: 676 EDLVLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
D +G G+ +G+V A + A+KK + L EV ++ L H
Sbjct: 6 SDFEEIAVLGQGA-FGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNH 61
Query: 734 PNVVLFMGAVTRPPNLS-------------IITEFLPRGSLFRILHRPHCQVDEKRRIKM 780
VV + A N I E+ G+L+ ++H + ++
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-- 838
+ ++ +H+ I+HRDLK N+ +D++ NVK+ DFGL++ H + K +
Sbjct: 122 FRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 839 ------------GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQV 885
GT ++A EVL NEK D+YS G+I +E+ + GM + +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVNI 237
Query: 886 VGAVGFQNRRLEIPKELD----PLVARIIWECWQTDPSLRPSFAQL 927
+ + ++ +E P + D + +II DP+ RP L
Sbjct: 238 LKKL--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 55/265 (20%), Positives = 109/265 (41%), Gaps = 23/265 (8%)
Query: 680 LGERIGLGSSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--V 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + +
Sbjct: 13 ILKQIGSGG-SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ + ++ E L L + +D R ++ ++ +H
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 855 -----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKEL 902
+ K DV+S G IL+ + K P+ + N + + A+ N +E P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 903 DPLVARIIWECWQTDPSLRPSFAQL 927
+ + ++ C + DP R S +L
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-48
Identities = 55/265 (20%), Positives = 109/265 (41%), Gaps = 23/265 (8%)
Query: 680 LGERIGLGSSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--V 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + +
Sbjct: 32 ILKQIGSGG-SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ + ++ E L L + +D R ++ ++ +H
Sbjct: 91 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 855 -----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKEL 902
+ K DV+S G IL+ + K P+ + N + + A+ N +E P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 903 DPLVARIIWECWQTDPSLRPSFAQL 927
+ + ++ C + DP R S +L
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 60/273 (21%), Positives = 120/273 (43%), Gaps = 39/273 (14%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLR 732
D E IG G +G+V+ A +G +K+ + + + +REVK + +L
Sbjct: 11 MDFKEIELIGSGG-FGQVFKAKHRIDGKTYVIKRVKYNNE-------KAEREVKALAKLD 62
Query: 733 HPNVVLFMGA----------------VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEK 775
H N+V + G ++ L I EF +G+L + + R ++D+
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 776 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSS 834
+++ + +G++ +H+ +++RDLK N+ + VK+ DFGL LK++
Sbjct: 123 LALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 894
+ GT +M+PE + ++ ++ D+Y+ G+IL EL + + R
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF-TDLR 232
Query: 895 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
I D ++ + P RP+ +++
Sbjct: 233 DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-47
Identities = 54/265 (20%), Positives = 108/265 (40%), Gaps = 23/265 (8%)
Query: 680 LGERIGLGSSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--V 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + +
Sbjct: 60 ILKQIGSGG-SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ + ++ E L L + +D R ++ ++ +H
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
IVH DLK N L+ +K+ DFG++ T + S G +M PE +++ S
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 855 N-----------EKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKEL 902
+ K DV+S G IL+ + K P+ + N + + A+ N +E P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 903 DPLVARIIWECWQTDPSLRPSFAQL 927
+ + ++ C + DP R S +L
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-46
Identities = 73/289 (25%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734
++G G +G+VY +G +VA+K+ + S + EF+ E++ + RHP
Sbjct: 43 HKFLIGH----GV-FGKVYKGVLRDGAKVALKR-RTPE-SSQGIEEFETEIETLSFCRHP 95
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCL 791
++V +G + +I +++ G+L R L+ P + ++R+++ + ARG++ L
Sbjct: 96 HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVL 849
HT I+HRD+KS N+L+D+N+ K++DFG+S+ + ST GT ++ PE
Sbjct: 156 HT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------RRLEIPK 900
EK DVYSFGV+L+E+ + + N ++ +
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVLC------ARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 901 ELDPL------------VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937
+DP +C RPS + L+ RL
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 69/325 (21%), Positives = 110/325 (33%), Gaps = 30/325 (9%)
Query: 609 NSKDENPKNVE--DHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDD 666
+ + V+ + + + R L+SP S Q F
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQ- 60
Query: 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKRE 724
R+G GS YGEV+ +G AVK+ + E
Sbjct: 61 -------------RLSRLGHGS-YGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAE 106
Query: 725 VKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
V ++ +HP V A L + TE SL + + E + D
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 843
+ LH+ +VH D+K N+ + K+ DFGL + T + + G P +
Sbjct: 166 TLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRY 222
Query: 844 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKEL 902
MAPE+L DV+S G+ + E+A G Q + Q E L
Sbjct: 223 MAPELL-QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGL 277
Query: 903 DPLVARIIWECWQTDPSLRPSFAQL 927
+ ++ + DP LR + L
Sbjct: 278 SSELRSVLVMMLEPDPKLRATAEAL 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-45
Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 44/276 (15%)
Query: 690 YGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748
+G+VY +GT VAVK+ L ++ + L+F+ EV+++ H N++ G P
Sbjct: 43 FGKVYKGRLADGTLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101
Query: 749 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDLK 804
++ ++ GS+ L +D +R ++AL ARG+ LH P I+HRD+K
Sbjct: 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161
Query: 805 SPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYS 862
+ N+L+D+ + V DFGL++L +T +++ GT +APE L S+EK DV+
Sbjct: 162 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEKTDVFG 220
Query: 863 FGVILWELATLKLPWIGMNPMQVVGAVG-------------FQNRRLEIPKEL-DPL--- 905
+GV+L EL T G + + ++LE L D
Sbjct: 221 YGVMLLELIT------GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---ALVDVDLQG 271
Query: 906 ------VARIIW---ECWQTDPSLRPSFAQLTVALK 932
V ++I C Q+ P RP +++ L+
Sbjct: 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-44
Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 24/288 (8%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHAD-WNGTEVAVKKFLDQDF 713
SS S D++ + + +G G+ G + + ++ +VAVK+ L + F
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGA-EGTIVYRGMFDNRDVAVKRILPECF 61
Query: 714 SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV 772
S A REV+++R HPNV+ + I E +L + +
Sbjct: 62 SFA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAH 115
Query: 773 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSRL- 826
I + G+ LH+ IVHRDLK N+L+ +SDFGL +
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 827 --KHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATL-KLPWIGM 880
++F GT W+APE+L + D++S G + + + + P+
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233
Query: 881 NPMQVVGAVG-FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
Q +G L K D + +I + DP RPS +
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 61/295 (20%), Positives = 110/295 (37%), Gaps = 33/295 (11%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
+ + +++G G + V +G A+K+ L + E +RE + R H
Sbjct: 29 KHYLFIQKLGEGG-FSYVDLVEGLHDGHFYALKRILCHEQQ--DREEAQREADMHRLFNH 85
Query: 734 PNVVLFMGAVTRPPN----LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVAR 786
PN++ + R ++ F RG+L+ + + E + + + L + R
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-------- 838
G+ +H HRDLK N+L+ + D G S+
Sbjct: 146 GLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 839 -GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLP--WIGMNPMQVVGAVGFQ 892
T + APE+ + +E+ DV+S G +L+ + + P + V AV
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--- 260
Query: 893 NRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 945
+L IP+ + +++ DP RP L L+ LQ H Q
Sbjct: 261 QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQ 315
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 24/272 (8%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFK 722
D+ + P E + E++G GS YG VY A G VA+K+ ++ D E
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGS-YGSVYKAIHKETGQIVAIKQVPVESDLQ-----EII 72
Query: 723 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 782
+E+ IM++ P+VV + G+ + +L I+ E+ GS+ I+ + + E +
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ 132
Query: 783 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKS 836
+G+ LH +HRD+K+ N+L++ + K++DFG++ K NT +
Sbjct: 133 STLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI---- 186
Query: 837 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-R 895
GTP WMAPEV++ N D++S G+ E+A K P+ ++PM+ + +
Sbjct: 187 --GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT 244
Query: 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
P+ + +C P R + QL
Sbjct: 245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-43
Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 23/281 (8%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
+ ER+G G +G V G +VA+K+ Q+ S + E++IM++L HPNV
Sbjct: 17 EMKERLGTGG-FGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 737 V-LF-----MGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGM 788
V + + + E+ G L + L++ C + E + D++ +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWM 844
LH + I+HRDLK N+++ K+ D G ++ L GT +++
Sbjct: 135 RYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYL 190
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904
APE+L + D +SFG + +E T P++ + + E D
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDD 249
Query: 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 945
L + + P+ L+ + ++ H Q
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILA--GKLERWLQCMLMWHQRQ 288
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 56/297 (18%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
+L + +G G+ V+ G A+K F + + RE +++++L H N+
Sbjct: 12 LLSDILGQGA-TANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 737 V-LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNC 790
V LF A+ T + +I EF P GSL+ +L P + E + + DV GMN
Sbjct: 70 VKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 791 LHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 845
L + IVHR++K N++ D K++DFG +R L+ + S GT E++
Sbjct: 128 LREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLH 183
Query: 846 PEVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ------------- 884
P++ + D++S GV + AT LP+ +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 885 ----VVGAVGFQNRRLE----------IPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ G +N ++ + + L L+ ++ + D F Q
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 57/274 (20%), Positives = 98/274 (35%), Gaps = 39/274 (14%)
Query: 681 GERIGLGSSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 736
E+IG G +G V+ +G A+K+ REV L +H +V
Sbjct: 16 LEKIGSGE-FGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMNCLHT 793
V + A ++ I E+ GSL + +R E + L V RG+ +H+
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 794 STPTIVHRDLKSPNLLVDKN-------------------WNVKVSDFGLSRLKHNTFLSS 834
+ +VH D+K N+ + + K+ D G +
Sbjct: 134 MS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---- 187
Query: 835 KSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 893
+ G ++A EVL+ N K D+++ + + A + + + Q
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI----RQG 243
Query: 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
R IP+ L ++ DP RPS L
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 77/274 (28%), Positives = 134/274 (48%), Gaps = 45/274 (16%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
P E E+IG GS +GEV+ + VA+K +D + + + + ++E+ ++ +
Sbjct: 20 PEELFTKLEKIGKGS-FGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQC 77
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
P V + G+ + L II E+L GS +L +DE + + ++ +G++ L
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYL 135
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMA 845
H+ +HRD+K+ N+L+ ++ VK++DFG++ ++K NTF GTP WMA
Sbjct: 136 HSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VGTPFWMA 187
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP- 904
PEV++ + K D++S G+ ELA + P ++PM+V+ IPK P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPT 238
Query: 905 -----------LVARIIWECWQTDPSLRPSFAQL 927
V C +PS RP+ +L
Sbjct: 239 LEGNYSKPLKEFVEA----CLNKEPSFRPTAKEL 268
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 8e-43
Identities = 68/328 (20%), Positives = 130/328 (39%), Gaps = 51/328 (15%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHA--DWNGT 701
+ LE + +++ E+ +D +G G+ G V+ +G
Sbjct: 2 KKLEELELD-EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGN-GGVVFKVSHKPSGL 59
Query: 702 EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 761
+A K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 60 VMARKL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 118
Query: 762 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821
++L + ++ E+ K+++ V +G+ L I+HRD+K N+LV+ +K+ DF
Sbjct: 119 DQVLKKAG-RIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDF 176
Query: 822 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 881
G+S ++ + S GT +M+PE L+ + + D++S G+ L E+A + P +
Sbjct: 177 GVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234
Query: 882 PMQVVGAVGFQNRRLE---------------------------------IPKELDPLVAR 908
++ G Q I E P +
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
Query: 909 IIW---------ECWQTDPSLRPSFAQL 927
++ +C +P+ R QL
Sbjct: 295 GVFSLEFQDFVNKCLIKNPAERADLKQL 322
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-43
Identities = 73/265 (27%), Positives = 118/265 (44%), Gaps = 22/265 (8%)
Query: 690 YGEVYHADWNGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747
+G VY N T VAVKK + +F +E+K+M + +H N+V +G +
Sbjct: 44 FGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD 103
Query: 748 NLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 805
+L ++ ++P GSL L R K+A A G+N LH +HRD+KS
Sbjct: 104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKS 161
Query: 806 PNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLRNEPSNEKCDVYSF 863
N+L+D+ + K+SDFGL+R + ++ GT +MAPE LR E K D+YSF
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSF 220
Query: 864 GVILWELATLKLPWIGMNPMQ--VVGAVGFQNRRLEIPKELDPL-----------VARII 910
GV+L E+ T Q + ++ I +D + +
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA 280
Query: 911 WECWQTDPSLRPSFAQLTVALKPLQ 935
+C + RP ++ L+ +
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 73/299 (24%), Positives = 130/299 (43%), Gaps = 32/299 (10%)
Query: 645 DLESPSSSVDSSTSKV--DQIFD--DDVCECEIPWEDLVLGERIGLGSSYGEVYHA--DW 698
++ + ++ + V +Q V + P L +IG GS G V A
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGS-TGIVCLAREKH 68
Query: 699 NGTEVAVKKF---LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755
+G +VAVK Q EV IMR +H NVV + L ++ EF
Sbjct: 69 SGRQVAVKMMDLRKQQRRE-----LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 815
L G+L I+ +++E++ + V + + LH ++HRD+KS ++L+ +
Sbjct: 124 LQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGR 179
Query: 816 VKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 869
VK+SDFG K + GTP WMAPEV+ + D++S G+++ E
Sbjct: 180 VKLSDFGFCAQISKDVPKRKSL------VGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
Query: 870 LATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ + P+ +P+Q + + +L+ ++ P++ + DP R + +L
Sbjct: 234 MVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-42
Identities = 71/310 (22%), Positives = 119/310 (38%), Gaps = 38/310 (12%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV 736
+ + G + VY A +G E A+K+ L + +EV M++L HPN+
Sbjct: 32 VRRVLAEGG-FAFVYEAQDVGSGREYALKRLLSNEEE--KNRAIIQEVCFMKKLSGHPNI 88
Query: 737 VLFMGAVTRPPNLS-------IITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARG 787
V F A + S ++ L +G L L + +K+ R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--------- 838
+ +H P I+HRDLK NLL+ +K+ DFG + + S S
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 839 ---GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 892
TP + PE++ N P EK D+++ G IL+ L + P+ +++V
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV------ 262
Query: 893 NRRLEIPKELD--PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 950
N + IP + +I Q +P R S A++ L+ + + + L
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELL 322
Query: 951 PQEISVNSTP 960
Q S
Sbjct: 323 EQNGGYGSAT 332
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 62/297 (20%), Positives = 110/297 (37%), Gaps = 42/297 (14%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
D + +G G +G V+ A + A+K+ + A + REVK + +L H
Sbjct: 5 TDFEPIQCLGRGG-FGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEH 62
Query: 734 PNVVLFMGA------------VTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIK 779
P +V + A + L I + + +L ++ + + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 780 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA- 838
+ L +A + LH+ ++HRDLK N+ + VKV DFGL
Sbjct: 123 IFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 839 -----------GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 887
GT +M+PE + + K D++S G+IL+EL M ++ +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLT 238
Query: 888 AVGFQNRRLEIPKELD---PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 941
V R L+ P P ++ + P RP + + + L P
Sbjct: 239 DV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI-IENAVFEDLDFPG 290
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 7e-42
Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 11/254 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLR 732
ED +G +G G +G VY A + +A+K A + +REV+I LR
Sbjct: 9 EDFEIGRPLGKGK-FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HPN++ G + +I E+ P G+++R L + + DE+R ++A ++ H
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH 126
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+ ++HRD+K NLL+ +K++DFG S H GT +++ PE++
Sbjct: 127 SKR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISR 240
Query: 913 CWQTDPSLRPSFAQ 926
+ +PS RP +
Sbjct: 241 LLKHNPSQRPMLRE 254
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 70/271 (25%), Positives = 130/271 (47%), Gaps = 24/271 (8%)
Query: 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKR 723
+ P + E+IG G+ G VY A G EVA+++ L Q
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGA-SGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIIN 66
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
E+ +MR ++PN+V ++ + L ++ E+L GSL ++ +DE + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRE 124
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKST 837
+ + LH++ ++HRD+KS N+L+ + +VK++DFG + K +T
Sbjct: 125 CLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------ 176
Query: 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RL 896
GTP WMAPEV+ + K D++S G++ E+ + P++ NP++ + + L
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ P++L + + C + D R S +L
Sbjct: 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-41
Identities = 55/299 (18%), Positives = 121/299 (40%), Gaps = 44/299 (14%)
Query: 680 LGERIGLGSSYGEVYHADWNGTEVAVK---------------KFLDQDFSGAALLEFKRE 724
+ + G + ++ + + A+K D+ + +FK E
Sbjct: 35 IIRTLNQGK-FNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
++I+ +++ + G +T + II E++ S+ + +D+ + + V
Sbjct: 94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQV 152
Query: 785 AR--------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 836
+ + +H + I HRD+K N+L+DKN VK+SDFG S + + K
Sbjct: 153 IKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KG 209
Query: 837 TAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLP-WIGMNPMQVVGAVGFQN 893
+ GT E+M PE NE + K D++S G+ L+ + +P + ++ +++ + +
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI--RT 267
Query: 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ------LTVALKPLQRLVIP---SHP 943
+ +E P + + + + + + + L P +R+ H
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK--NPAERITSEDALKHE 324
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-41
Identities = 67/308 (21%), Positives = 121/308 (39%), Gaps = 56/308 (18%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
L + +G G+ V+ G A+K F + + RE +++++L H N+V
Sbjct: 13 LSDILGQGA-TANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 738 -LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCL 791
LF A+ T + +I EF P GSL+ +L P + E + + DV GMN L
Sbjct: 71 KLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 792 HTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 846
+ IVHR++K N++ D K++DFG +R L+ + S GT E++ P
Sbjct: 129 REN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHP 184
Query: 847 EVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-------------- 884
++ + D++S GV + AT LP+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 885 ---VVGAVGFQNRRLE----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 931
+ G +N ++ + + L L+ ++ + D F Q
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 932 KPLQRLVI 939
+ ++
Sbjct: 305 SDILHRMV 312
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 62/254 (24%), Positives = 115/254 (45%), Gaps = 11/254 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLR 732
+D +G +G G +G VY A N +A+K + +RE++I LR
Sbjct: 14 DDFDIGRPLGKGK-FGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HPN++ + ++ EF PRG L++ L + H + DE+R ++A ++ H
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH 131
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
++HRD+K NLL+ +K++DFG S + ++ GT +++ PE++ +
Sbjct: 132 ERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMCGTLDYLPPEMIEGK 187
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
+EK D++ GV+ +E P+ + + + N L+ P L +I +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--VNVDLKFPPFLSDGSKDLISK 245
Query: 913 CWQTDPSLRPSFAQ 926
+ P R
Sbjct: 246 LLRYHPPQRLPLKG 259
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR 723
+ V P E + +G G+ +G+VY A G A K ++ S L ++
Sbjct: 9 EHVRRDLDPNEVWEIVGELGDGA-FGKVYKAKNKETGALAAAKV-IETK-SEEELEDYIV 65
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 783
E++I+ HP +V +GA L I+ EF P G++ I+ + E + +
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKST 837
+ +N LH+ I+HRDLK+ N+L+ +++++DFG+S K ++F+
Sbjct: 126 MLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----- 178
Query: 838 AGTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF- 891
GTP WMAPEV+ E + K D++S G+ L E+A ++ P +NPM+V+
Sbjct: 179 -GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL----LK 233
Query: 892 --QNR--RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
++ L P + + +P RPS AQL
Sbjct: 234 IAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-41
Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 47/288 (16%)
Query: 673 IPWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 730
I +D L E IG G+ V A +VA+K+ ++ + ++ E +E++ M +
Sbjct: 12 INRDDYELQEVIGSGA-TAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQ 69
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR------IKMAL-D 783
HPN+V + + L ++ + L GS+ I+ + + K I L +
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-----------RLKHNTFL 832
V G+ LH + +HRD+K+ N+L+ ++ +V+++DFG+S TF
Sbjct: 130 VLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF- 186
Query: 833 SSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF 891
GTP WMAPEV+ + + K D++SFG+ ELAT P+ PM+V+
Sbjct: 187 -----VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL----M 237
Query: 892 ---QNR--RLEIPKELDPLVAR-------IIWECWQTDPSLRPSFAQL 927
QN LE + ++ + +I C Q DP RP+ A+L
Sbjct: 238 LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-40
Identities = 76/298 (25%), Positives = 118/298 (39%), Gaps = 36/298 (12%)
Query: 647 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHA--DWNGTEVA 704
+ ++ + P + IG GS +G VY A N VA
Sbjct: 25 AMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGS-FGAVYFARDVRNSEVVA 83
Query: 705 VKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFR 763
+KK S + +EV+ +++LRHPN + + G R ++ E+ GS
Sbjct: 84 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD 142
Query: 764 ILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823
+L + E + +G+ LH+ ++HRD+K+ N+L+ + VK+ DFG
Sbjct: 143 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGS 200
Query: 824 S--RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPWI 878
+ N+F GTP WMAPEV+ + K DV+S G+ ELA K P
Sbjct: 201 ASIMAPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254
Query: 879 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW---------ECWQTDPSLRPSFAQL 927
MN M + I + P + W C Q P RP+ L
Sbjct: 255 NMNAMSAL---------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-39
Identities = 61/309 (19%), Positives = 111/309 (35%), Gaps = 25/309 (8%)
Query: 661 DQIFDDDVCECEIPWEDLVLGERIGLG-SSYGEVYHA--DWNGTEVAVKKFLDQDFSGAA 717
+ ++ + L IG G V A G V V++ + S
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM 69
Query: 718 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR 777
+ + E+ + + HPN+V + L ++T F+ GS ++ +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA 129
Query: 778 IKMAL-DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNT 830
I L V + ++ +H VHR +K+ ++L+ + V +S + +
Sbjct: 130 IAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 831 -FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 887
K + W++PEVL+ + K D+YS G+ ELA +P+ M Q++
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML- 246
Query: 888 AVGFQNRRLEIPKELDP-LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 946
LE P L+ + S S A ++ PS+ D P
Sbjct: 247 --------LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298
Query: 947 SSALPQEIS 955
S + S
Sbjct: 299 SHPYHRTFS 307
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 51/303 (16%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQD 712
+S S + + D+ P L E +G G+ YG+VY G A+K D
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGT-YGQVYKGRHVKTGQLAAIKV---MD 58
Query: 713 FSGAALLEFKREVKIMRRL-RHPNVVLFMGA------VTRPPNLSIITEFLPRGSLFRIL 765
+G E K+E+ ++++ H N+ + GA L ++ EF GS+ ++
Sbjct: 59 VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 766 HRPHCQVDEKRRIKMAL-DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824
++ I ++ RG++ LH ++HRD+K N+L+ +N VK+ DFG+S
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 825 ------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELATL 873
+ NTF GTP WMAPEV+ + + + K D++S G+ E+A
Sbjct: 177 AQLDRTVGRRNTF------IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 874 KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW---------ECWQTDPSLRPSF 924
P M+PM+ + F IP+ P + W C + S RP+
Sbjct: 231 APPLCDMHPMRAL----FL-----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT 281
Query: 925 AQL 927
QL
Sbjct: 282 EQL 284
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 69/260 (26%), Positives = 111/260 (42%), Gaps = 27/260 (10%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPN 735
G +G G + + + A K + + E+ I R L H +
Sbjct: 19 RGRFLGKGG-FAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------G 787
VV F G + ++ E R SL + KRR + AR G
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLG 127
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
LH + ++HRDLK NL ++++ VK+ DFGL+ K GTP ++APE
Sbjct: 128 CQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
VL + + + DV+S G I++ L K P+ + + + IPK ++P+ A
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAA 243
Query: 908 RIIWECWQTDPSLRPSFAQL 927
+I + QTDP+ RP+ +L
Sbjct: 244 SLIQKMLQTDPTARPTINEL 263
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 69/285 (24%), Positives = 122/285 (42%), Gaps = 46/285 (16%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEF---------- 721
L + IG GS YG V A + + T A+K K + Q
Sbjct: 16 TLKDEIGKGS-YGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 722 ---------KREVKIMRRLRHPNVV-LF--MGAVTRPPNLSIITEFLPRGSLFRILHRPH 769
+E+ I+++L HPNVV L + +L ++ E + +G + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKP 133
Query: 770 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--K 827
D+ R D+ +G+ LH I+HRD+K NLLV ++ ++K++DFG+S
Sbjct: 134 LSEDQARFY--FQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQ 884
+ L +T GTP +MAPE L + DV++ GV L+ + P++ M
Sbjct: 190 SDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 885 VVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQL 927
+ + +++ LE P ++ + +I +P R ++
Sbjct: 248 LHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 44/281 (15%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-M 728
E+ +DL +G G+ YG V +G +AVK+ + + ++ I M
Sbjct: 3 EVKADDLEPIMELGRGA-YGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISM 60
Query: 729 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVA 785
R + P V F GA+ R ++ I E + SL + + + + E K+A+ +
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGT 840
+ + LH S +++HRD+K N+L++ VK+ DFG+S + + AG
Sbjct: 120 KALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------AGC 172
Query: 841 PEWMAPEVLRNEPS----NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRR 895
+MAPE + E + + K D++S G+ + ELA L+ P+ P Q +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ------- 225
Query: 896 LEIPKELDPLVARIIW---------ECWQTDPSLRPSFAQL 927
+ +E P + + +C + + RP++ +L
Sbjct: 226 --VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-38
Identities = 81/342 (23%), Positives = 134/342 (39%), Gaps = 75/342 (21%)
Query: 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLE 720
D + E P + L LG+ +G G ++G+V AD G K L + + +
Sbjct: 13 DASKWEFPRDRLKLGKPLGRG-AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 721 FKREVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRP---------- 768
E+KI+ + H NVV +GA T+P L +I EF G+L L
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
Query: 769 ------------HCQVDEKRRIKM-----------ALDVARGMNCLHTSTPTIVHRDLKS 805
VD KRR+ ++ + P +++D +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 806 PNLLVDKNWNV------------------------------KVSDFGLSR-LKHNTFLSS 834
L+ ++ V K+ DFGL+R + +
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251
Query: 835 KSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892
K A P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + +
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 69/260 (26%), Positives = 111/260 (42%), Gaps = 27/260 (10%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPN 735
G +G G + + + A K + + E+ I R L H +
Sbjct: 45 RGRFLGKGG-FAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------G 787
VV F G + ++ E R SL + KRR + AR G
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLG 153
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
LH + ++HRDLK NL ++++ VK+ DFGL+ K GTP ++APE
Sbjct: 154 CQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
VL + + + DV+S G I++ L K P+ + + + IPK ++P+ A
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAA 269
Query: 908 RIIWECWQTDPSLRPSFAQL 927
+I + QTDP+ RP+ +L
Sbjct: 270 SLIQKMLQTDPTARPTINEL 289
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 63/251 (25%), Positives = 110/251 (43%), Gaps = 8/251 (3%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNV 736
+G +G GS + VY A G EVA+K + A +++ + EVKI +L+HP++
Sbjct: 15 VGNLLGKGS-FAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ + ++ E G + R L E + GM LH+
Sbjct: 74 LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG- 132
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 856
I+HRDL NLL+ +N N+K++DFGL+ + GTP +++PE+
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 857 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 916
+ DV+S G + + L + P+ + V E+P L +I + +
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLIHQLLRR 249
Query: 917 DPSLRPSFAQL 927
+P+ R S + +
Sbjct: 250 NPADRLSLSSV 260
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 71/253 (28%), Positives = 117/253 (46%), Gaps = 14/253 (5%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
L + IG G+ + +V A G EVA+K + +L + REV+IM+ L HPN+V
Sbjct: 19 LLKTIGKGN-FAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ L +I E+ G +F ++ + E R + + H
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK--FRQIVSAVQYCHQKR- 134
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 855
IVHRDLK+ NLL+D + N+K++DFG S L + G P + APE+ + + +
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYD 191
Query: 856 -EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 914
+ DV+S GVIL+ L + LP+ G N ++ V + IP + ++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRFL 249
Query: 915 QTDPSLRPSFAQL 927
+P R + Q+
Sbjct: 250 VLNPIKRGTLEQI 262
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 76/275 (27%), Positives = 114/275 (41%), Gaps = 44/275 (16%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
W+ L + +G G+ YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGA-YGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKML 62
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVAR---- 786
H NVV F G + E+ G LF RI I M A+
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFH 112
Query: 787 ----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTA 838
G+ LH I HRD+K NLL+D+ N+K+SDFGL+ + L
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMC 168
Query: 839 GTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQ----VVGAVGFQ 892
GT ++APE+L+ E DV+S G++L + +LPW + Q +
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
N +I L+ +I+ +PS R + +
Sbjct: 229 NPWKKIDSAPLALLHKIL----VENPSARITIPDI 259
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 73/258 (28%), Positives = 127/258 (49%), Gaps = 23/258 (8%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNV 736
LG+ +G+G+ +G+V G +VAVK Q ++ KRE++ ++ RHP++
Sbjct: 15 LGDTLGVGT-FGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCL 791
+ ++ P + ++ E++ G LF I + E RR I A+D
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD------YC 127
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLR 850
H +VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 128 HRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVIS 183
Query: 851 NEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909
+ + D++S GVIL+ L LP+ + + + + IP+ L+ VA +
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVATL 241
Query: 910 IWECWQTDPSLRPSFAQL 927
+ Q DP R + +
Sbjct: 242 LMHMLQVDPLKRATIKDI 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 71/279 (25%), Positives = 122/279 (43%), Gaps = 36/279 (12%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-M 728
+ EDL IG G+ YG V +G +AVK+ + + ++ + M
Sbjct: 18 DFTAEDLKDLGEIGRGA-YGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVVM 75
Query: 729 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----VDEKRRIKMALDV 784
R P +V F GA+ R + I E + S + + + E+ K+ L
Sbjct: 76 RSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844
+ +N L I+HRD+K N+L+D++ N+K+ DFG+S ++ ++ AG +M
Sbjct: 135 VKALNHLK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYM 192
Query: 845 APEVLRNEPSNE----KCDVYSFGVILWELATLKLPWIGMNPM-----QVVGAVGFQNRR 895
APE + S + + DV+S G+ L+ELAT + P+ N + QVV +
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV--------K 244
Query: 896 LEIPKELDPLVAR-------IIWECWQTDPSLRPSFAQL 927
+ P+ + + C D S RP + +L
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 57/286 (19%), Positives = 113/286 (39%), Gaps = 16/286 (5%)
Query: 652 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFL 709
S SS + + + DL +G G+ G+V+ G +AVK+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQ-RYQAEINDLENLGEMGSGT-CGQVWKMRFRKTGHVIAVKQ-M 58
Query: 710 DQDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 768
+ + ++ + ++ P +V G ++ I E + +
Sbjct: 59 RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118
Query: 769 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828
+ E+ KM + + + + L ++HRD+K N+L+D+ +K+ DFG+S
Sbjct: 119 GP-IPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNP- 882
+ + +AG +MAPE + + + DV+S G+ L ELAT + P+
Sbjct: 177 DD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
Query: 883 MQVVGA-VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+V+ + + L + +C D RP + +L
Sbjct: 236 FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 14/195 (7%)
Query: 680 LGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ E +G G+ + V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 10 VKEELGKGA-FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
++ ++ + + G LF I+ R E + + H++
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN-- 124
Query: 797 TIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNE 852
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKD 182
Query: 853 PSNEKCDVYSFGVIL 867
P ++ D+++ GVIL
Sbjct: 183 PYSKPVDIWACGVIL 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 60/274 (21%), Positives = 115/274 (41%), Gaps = 45/274 (16%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRH 733
++G+ +G GS YG+V AVK L + K+E++++RRLRH
Sbjct: 8 LMGDLLGEGS-YGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 734 PNVV-LF--MGAVTRPPNLSIITEFLPRGS--LF-RILHRPHCQVDEKRRIKMALDVAR- 786
NV+ L + + ++ E+ G + + + + + A
Sbjct: 66 KNVIQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPVCQAHG 113
Query: 787 -------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSK 835
G+ LH+ IVH+D+K NLL+ +K+S G++ + +
Sbjct: 114 YFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--R 169
Query: 836 STAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 893
++ G+P + PE+ S K D++S GV L+ + T P+ G N ++ +
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GK 227
Query: 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
IP + P ++ ++ + +P+ R S Q+
Sbjct: 228 GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 15/194 (7%)
Query: 680 LGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
E +G G+ + EV+ T A+K + LE E+ ++++++H N+V
Sbjct: 13 FMEVLGSGA-FSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIV 69
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ ++ + + G LF RIL R EK + V + LH +
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENG- 126
Query: 797 TIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 853
IVHRDLK NLL ++N + ++DFGLS+++ N + + GTP ++APEVL +P
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVLAQKP 183
Query: 854 SNEKCDVYSFGVIL 867
++ D +S GVI
Sbjct: 184 YSKAVDCWSIGVIT 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 76/275 (27%), Positives = 114/275 (41%), Gaps = 44/275 (16%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
W+ L + +G G+ YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGA-YGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKML 62
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVAR---- 786
H NVV F G + E+ G LF RI I M A+
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFH 112
Query: 787 ----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTA 838
G+ LH I HRD+K NLL+D+ N+K+SDFGL+ + L
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMC 168
Query: 839 GTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQ----VVGAVGFQ 892
GT ++APE+L+ E DV+S G++L + +LPW + Q +
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
N +I L+ +I+ +PS R + +
Sbjct: 229 NPWKKIDSAPLALLHKIL----VENPSARITIPDI 259
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRH 733
+GE +G G + V G E A K + G + E +REV I+R++ H
Sbjct: 16 IGEELGSGQ-FAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLH 792
NV+ ++ +I E + G LF + + + E+ + G+N LH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH 132
Query: 793 TSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 847
T I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 848 VLRNEPSNEKCDVYSFGVIL 867
++ EP + D++S GVI
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 15/195 (7%)
Query: 680 LGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ +G GS +GEV T E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGS-FGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ + I+ E G LF I+ R E ++ V G+ +H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH-- 140
Query: 797 TIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNE 852
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-G 197
Query: 853 PSNEKCDVYSFGVIL 867
+EKCDV+S GVIL
Sbjct: 198 TYDEKCDVWSAGVIL 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-36
Identities = 64/284 (22%), Positives = 108/284 (38%), Gaps = 45/284 (15%)
Query: 679 VLGERIGLGSSYGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 736
V + +G GS G V + G VAVK+ L A E+K++ HPNV
Sbjct: 18 VSEKILGYGS-SGTVVFQGSFQGRPVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNV 71
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHR-----PHCQVDEKRRIKMALDVARGMNC 790
+ + + T L I E +L + + E I + +A G+
Sbjct: 72 IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 791 LHTSTPTIVHRDLKSPNLLVD-------------KNWNVKVSDFGLSRL----KHNTFLS 833
LH+ I+HRDLK N+LV +N + +SDFGL + + + +
Sbjct: 131 LHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 834 SKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ- 884
+ +GT W APE+L D++S G + + + + K P+ +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 885 --VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 926
+ G + + L +I + DP RP+ +
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRH 733
+GE +G G + V G E A K + L G + E +REV I+R +RH
Sbjct: 9 MGEELGSGQ-FAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLH 792
PN++ ++ +I E + G LF + + + E + + G++ LH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLH 125
Query: 793 TSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 847
+ I H DLK N+++ N +K+ DFG++ ++ K+ GTPE++APE
Sbjct: 126 SKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPE 181
Query: 848 VLRNEPSNEKCDVYSFGVIL 867
++ EP + D++S GVI
Sbjct: 182 IVNYEPLGLEADMWSIGVIT 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRH 733
GE +G G + V G + A K + G + + +REV I++ ++H
Sbjct: 15 TGEELGSGQ-FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLH 792
PNV+ ++ +I E + G LF + + + E+ + + G+ LH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLH 131
Query: 793 TSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 847
+ I H DLK N+++ +K+ DFGL+ + K+ GTPE++APE
Sbjct: 132 SLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 848 VLRNEPSNEKCDVYSFGVIL 867
++ EP + D++S GVI
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 14/195 (7%)
Query: 680 LGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ E +G G+ + V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 33 VKEELGKGA-FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
++ ++ + + G LF I+ R E + + H++
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN-- 147
Query: 797 TIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNE 852
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKD 205
Query: 853 PSNEKCDVYSFGVIL 867
P ++ D+++ GVIL
Sbjct: 206 PYSKPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 680 LGERIGLGSSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
L E +G G+ + V E A + S + +RE +I R L+HPN+V
Sbjct: 15 LFEELGKGA-FSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+++ + +I + + G LF I+ R + E + + H
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQM-- 129
Query: 797 TIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 853
+VHR+LK NLL+ K VK++DFGL+ + AGTP +++PEVLR +P
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 854 SNEKCDVYSFGVIL 867
+ D+++ GVIL
Sbjct: 190 YGKPVDLWACGVIL 203
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 27/261 (10%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVK-----KFL-DQDFSGAALLEFKREVKIMRR 730
+G G+ +G V+ A EV VK K L D L + E+ I+ R
Sbjct: 27 STMSPLGSGA-FGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGS-LF-RILHRPHCQVDEKRRIKMALDVARGM 788
+ H N++ + ++ E G LF I P I + +
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI--FRQLVSAV 143
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPE 847
L I+HRD+K N+++ +++ +K+ DFG + + + GT E+ APE
Sbjct: 144 GYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPE 199
Query: 848 VLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906
VL P + +++S GV L+ L + P+ + + V A + P + +
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEA------AIHPPYLVSKEL 251
Query: 907 ARIIWECWQTDPSLRPSFAQL 927
++ Q P R + +L
Sbjct: 252 MSLVSGLLQPVPERRTTLEKL 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRH 733
+GE +G G + V G E A K + G E +REV I+R++ H
Sbjct: 16 IGEELGSGQ-FAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLH 792
PN++ ++ +I E + G LF + + + E+ + G+N LH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH 132
Query: 793 TSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 847
T I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 848 VLRNEPSNEKCDVYSFGVIL 867
++ EP + D++S GVI
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 24/253 (9%)
Query: 625 YHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI 684
+H + NL + + S ++S T+ + + D + + + +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 685 GLGSSYGEVYHADWNGT--EVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
G G+ VY GT A+K K +D+ + E+ ++ RL HPN++
Sbjct: 62 GRGA-TSIVYRCKQKGTQKPYALKVLKKTVDKK-------IVRTEIGVLLRLSHPNIIKL 113
Query: 740 MGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 798
P +S++ E + G LF RI+ + + E+ + + LH + I
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENG--I 169
Query: 799 VHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
VHRDLK NLL + +K++DFGLS+ ++H + K+ GTP + APE+LR
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAY 227
Query: 855 NEKCDVYSFGVIL 867
+ D++S G+I
Sbjct: 228 GPEVDMWSVGIIT 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 14/199 (7%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHP 734
L E IG G + V G + AVK G + + KRE I L+HP
Sbjct: 28 LCEVIGKGP-FSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVD--EKRRIKMALDVARGMNCL 791
++V + + L ++ EF+ L I+ R E + +
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 792 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 848
H + I+HRD+K +L+ + + VK+ FG++ + L + GTP +MAPEV
Sbjct: 147 HDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 849 LRNEPSNEKCDVYSFGVIL 867
++ EP + DV+ GVIL
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 75/262 (28%), Positives = 124/262 (47%), Gaps = 32/262 (12%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLR 732
+ E +G GS +G+V A +VA+K D +RE+ ++ LR
Sbjct: 13 IRETLGEGS-FGKVKLATHYKTQQKVALKFISRQLLKKSDMHM----RVEREISYLKLLR 67
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARG 787
HP+++ +T P ++ ++ E+ G LF I+ + DE RR I A++
Sbjct: 68 HPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIE---- 122
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAP 846
H IVHRDLK NLL+D N NVK++DFGLS + FL K++ G+P + AP
Sbjct: 123 --YCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAP 176
Query: 847 EVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
EV+ + + + DV+S G++L+ + +LP+ + V + +P L P
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPG 234
Query: 906 VARIIWECWQTDPSLRPSFAQL 927
+I DP R + ++
Sbjct: 235 AQSLIRRMIVADPMQRITIQEI 256
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 61/289 (21%), Positives = 109/289 (37%), Gaps = 33/289 (11%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLR 732
+G +G G +G VY + VA+K + EV +++++
Sbjct: 46 QVGPLLGSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 733 H--PNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRRIKMALDVARGM 788
V+ + RP + +I E P LF I R Q + R V +
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAV 162
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
H ++HRD+K N+L+D N +K+ DFG L +T GT + PE
Sbjct: 163 RHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPE 218
Query: 848 VLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906
+R V+S G++L+++ +P+ +++ ++ + +
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQRVSSEC 270
Query: 907 ARIIWECWQTDPSLRPSFAQ------LTVALKPLQRLVIPSHPDQPSSA 949
+I C PS RP+F + + L P + I H P +
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 13/197 (6%)
Query: 679 VLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PN 735
+ + +G G + V G E A K + E E+ ++ + P
Sbjct: 32 LTSKELGRGK-FAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
V+ + +I E+ G +F L V E I++ + G+ LH +
Sbjct: 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 795 TPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLR 850
IVH DLK N+L+ ++K+ DFG+SR + H L + GTPE++APE+L
Sbjct: 151 N--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILN 206
Query: 851 NEPSNEKCDVYSFGVIL 867
+P D+++ G+I
Sbjct: 207 YDPITTATDMWNIGIIA 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVK-------KFLDQDFSGAALLEFKREVKIMRR 730
E +G G V E AVK + +EV I+R+
Sbjct: 21 PKEILGRGV-SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 731 L-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGM 788
+ HPN++ ++ + + +G LF + + + EK K+ + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVI 137
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 847
LH IVHRDLK N+L+D + N+K++DFG S L L + GTP ++APE
Sbjct: 138 CALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPE 193
Query: 848 VLRNEPS------NEKCDVYSFGVIL 867
++ + ++ D++S GVI+
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 9e-34
Identities = 49/321 (15%), Positives = 101/321 (31%), Gaps = 52/321 (16%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRR 730
LV G +G A G V + A+ + K EV +R
Sbjct: 76 RPRTLVRGTVLGQED-PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 731 LR----------------------HPNVVLFMGAVTRPPNLSIITEFLPR-------GSL 761
LR P + ++ +++ F +
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 762 FRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 818
+L H + R+++ L V R + LH +VH L+ ++++D+ V +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFL 252
Query: 819 SDFGLSRLKHNTFLSSKSTA-GTPEWMAPEVLRNEPSNEK-----CDVYSFGVILWELAT 872
+ F + +S PE A +L + D ++ G+ ++ +
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 873 LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL--TVA 930
LP + + F++ + IP+ + L+ + + R Q T
Sbjct: 313 ADLPNTDDAALGGSEWI-FRSCK-NIPQPVRALLEGFL----RYPKEDRLLPLQAMETPE 366
Query: 931 LKPLQRLVIPSHPDQPSSALP 951
+ L+ + + P + P
Sbjct: 367 YEQLRTELSAALPLYQTDGEP 387
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 79/302 (26%), Positives = 132/302 (43%), Gaps = 50/302 (16%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGT--EVAV 705
+P + S + +++ +++G G+ YGEV T E A+
Sbjct: 23 TPGMFITSKKGHLSEMYQ--------------RVKKLGSGA-YGEVLLCRDKVTHVERAI 67
Query: 706 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RI 764
K S ++ + EV +++ L HPN++ N ++ E G LF I
Sbjct: 68 KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI 127
Query: 765 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDF 821
+HR +E + V G+ LH IVHRDLK NLL+ +K+ +K+ DF
Sbjct: 128 IHRMK--FNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 822 GLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 880
GLS + ++ + + GT ++APEVLR + +EKCDV+S GVIL+ L P+ G
Sbjct: 184 GLSAVFENQKKMKER--LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240
Query: 881 NPMQVVGAVGFQNRRLEIPKELDP----------LVARIIWECWQTDPSLRPSFAQLTVA 930
+++ V + + + L+ +++ Q D R S Q A
Sbjct: 241 TDQEILRKV----EKGKYTFDSPEWKNVSEGAKDLIKQML----QFDSQRRISAQQ---A 289
Query: 931 LK 932
L+
Sbjct: 290 LE 291
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 76/289 (26%), Positives = 139/289 (48%), Gaps = 28/289 (9%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPN 735
LG+ +G+G+ +G+V + G +VAVK L++ S + + +RE++ ++ RHP+
Sbjct: 20 LGDTLGVGT-FGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNC 790
++ ++ P ++ ++ E++ G LF I E RR I +D
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD------Y 131
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVL 849
H +VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 132 CHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVI 187
Query: 850 RNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
+ + D++S GVIL+ L LP+ + + + + P+ L+P V
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVIS 245
Query: 909 IIWECWQTDPSLRPSFAQLTV---ALKPLQRLVIPSHPDQPSSALPQEI 954
++ Q DP R + + + L + + P P S+ + E
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEA 294
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 60/286 (20%), Positives = 122/286 (42%), Gaps = 23/286 (8%)
Query: 680 LGERIGLGSSYGEVYHA-DWN-GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPN 735
+ +++G G VY A D +VA+K + L F+REV +L H N
Sbjct: 15 IVDKLGGGG-MSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 795
+V + ++ E++ +L + H + I + G+ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
IVHRD+K N+L+D N +K+ DFG+++ L + + GT ++ +PE + E +
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 855 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-------ELDPLVA 907
+E D+YS G++L+E+ + P+ G + + ++ + +P ++ ++
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVSIA----IKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 908 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 953
+I + D + R Q L ++ + ++ L +
Sbjct: 246 NVILRATEKDKANRYKTIQ--EMKDDLSSVLHENRANEDVYELDKM 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 17/195 (8%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
L IG GS +GEV A A KK K+E++IM+ L HPN++
Sbjct: 13 LENTIGRGS-WGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF--KQEIEIMKSLDHPNII 69
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
++ ++ E G LF R++H+ E ++ DV + H
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL-- 125
Query: 797 TIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+ HRDLK N L + +K+ DFGL+ K + ++ GTP +++P+VL
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEG- 182
Query: 853 PSNEKCDVYSFGVIL 867
+CD +S GV++
Sbjct: 183 LYGPECDEWSAGVMM 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 24/199 (12%)
Query: 680 LGERIGLGSSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMRRLR 732
+ E +G G+ +G V+ T K LD+ K E+ IM +L
Sbjct: 55 ILEELGSGA-FGVVHRCVEKATGRVFVAKFINTPYPLDKY-------TVKNEISIMNQLH 106
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 791
HP ++ A + +I EFL G LF RI + ++ E I G+ +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHM 165
Query: 792 HTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 848
H + IVH D+K N++ K +VK+ DFGL+ L + + K T T E+ APE+
Sbjct: 166 HEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEI 221
Query: 849 LRNEPSNEKCDVYSFGVIL 867
+ EP D+++ GV+
Sbjct: 222 VDREPVGFYTDMWAIGVLG 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRL 731
+ + +G G+ GEV A +VA+K + F+ + E + E++I+++L
Sbjct: 14 MSKTLGSGA-CGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNC 790
HP ++ + I+ E + G LF +++ + + + +
Sbjct: 73 NHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--FYQMLLAVQY 129
Query: 791 LHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 846
LH + I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++AP
Sbjct: 130 LHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAP 185
Query: 847 EVLRNEPS---NEKCDVYSFGVIL 867
EVL + + N D +S GVIL
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 47/251 (18%), Positives = 91/251 (36%), Gaps = 25/251 (9%)
Query: 694 YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753
+ + + + + S + + +++ M N V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 754 EFLPRGSLF-RILHRPHCQVDEKRRI-KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811
+ + +L + R + E + + +A + LH+ ++HRDLK N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT 198
Query: 812 KNWNVKVSDFGLSRLKHNTFLSSKSTA------------GTPEWMAPEVLRNEPSNEKCD 859
+ VKV DFGL GT +M+PE + + K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 860 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD---PLVARIIWECWQT 916
++S G+IL+EL M ++++ V R L+ P P ++ +
Sbjct: 259 IFSLGLILFELLYSFST--QMERVRIITDV----RNLKFPLLFTQKYPQEHMMVQDMLSP 312
Query: 917 DPSLRPSFAQL 927
P+ RP +
Sbjct: 313 SPTERPEATDI 323
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 66/301 (21%), Positives = 110/301 (36%), Gaps = 57/301 (18%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHP 734
L IG GS YG V A A+K K + + + K EV++M++L HP
Sbjct: 30 LKGAIGQGS-YGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
N+ + ++ E G L ++ + + + C
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 794 STPT------------------------------------IVHRDLKSPNLLV--DKNWN 815
+ I HRD+K N L +K++
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 816 VKVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWE 869
+K+ DFGLS+ + + + AGTP ++APEVL NE KCD +S GV+L
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 870 LATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV---AR-IIWECWQTDPSLRPSFA 925
L +P+ G+N + V N++L ++ AR ++ + R
Sbjct: 269 LLMGAVPFPGVNDADTISQV--LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326
Query: 926 Q 926
+
Sbjct: 327 R 327
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 679 VLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN 735
+ + +GLG G+V G + A+K D + ++EV + P+
Sbjct: 32 LSKQVLGLGV-NGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPH 83
Query: 736 VVLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNC 790
+V + L II E + G LF RI R E+ ++ D+ +
Sbjct: 84 IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 791 LHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
LH+ I HRD+K NLL +K+ +K++DFG ++ L ++ TP ++APE
Sbjct: 144 LHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAPE 199
Query: 848 VLRNEPSNEKCDVYSFGVIL 867
VL E ++ CD++S GVI+
Sbjct: 200 VLGPEKYDKSCDMWSLGVIM 219
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 43/302 (14%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLR 732
LG +G G +G V+ + +VA+K + + + EV ++ ++
Sbjct: 34 RLGPLLGKGG-FGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 733 ----HPNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRRIKMALDVAR 786
HP V+ + ++ E LP LF I + R V
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF--FGQVVA 150
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 845
+ H+ +VHRD+K N+L+D + K+ DFG L H+ GT +
Sbjct: 151 AIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVYSP 206
Query: 846 PEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------LEI 898
PE + V+S G++L+++ V G + F+ + L
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDM--------------VCGDIPFERDQEILEAELHF 252
Query: 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNS 958
P + P +I C PS RPS + + L P + P PS P ++ +
Sbjct: 253 PAHVSPDCCALIRRCLAPKPSSRPSLEE--ILLDPWMQTPAEDVPLNPSKGGPAPLAWSL 310
Query: 959 TP 960
P
Sbjct: 311 LP 312
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 45/198 (22%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 680 LGERIGLGSSYGEVYHADWNGT--EVAVK----KFLDQDFSGAALLEFKREVKIMRRLRH 733
+ E +G G +G V+ + K K DQ K+E+ I+ RH
Sbjct: 9 IAEDLGRGE-FGIVHRCVETSSKKTYMAKFVKVKGTDQV-------LVKKEISILNIARH 60
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLH 792
N++ + L +I EF+ +F RI +++E+ + V + LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH 119
Query: 793 TSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 849
+ I H D++ N++ ++ +K+ +FG +R LK + PE+ APEV
Sbjct: 120 SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVH 175
Query: 850 RNEPSNEKCDVYSFGVIL 867
+++ + D++S G ++
Sbjct: 176 QHDVVSTATDMWSLGTLV 193
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-33
Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRL 731
+ + +G G+ GEV A +VA++ + F+ + E + E++I+++L
Sbjct: 139 MSKTLGSGA-CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNC 790
HP ++ + I+ E + G LF +++ + E + +
Sbjct: 198 NHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQY 254
Query: 791 LHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 846
LH + I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++AP
Sbjct: 255 LHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAP 310
Query: 847 EVLRNEPS---NEKCDVYSFGVIL 867
EVL + + N D +S GVIL
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 8e-33
Identities = 43/322 (13%), Positives = 84/322 (26%), Gaps = 61/322 (18%)
Query: 677 DLVLGERIGLGSSYGEVYHA-DWN-GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 733
L L E + +G V+ D + A+K F + + S + L RL
Sbjct: 63 KLKLVEPLRVGD-RSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 734 PNVVLFMG--------AVTRPPNLSIITEFLPRGSLFRILHR----PHCQVD-------- 773
+ + + P + + + P VD
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 774 -----------EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822
+ + R L + +VH NL + + + + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 823 LSRLKHNTFLSSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIG 879
+ P AP + + G+ ++ + L LP+
Sbjct: 240 ALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 880 MNP-------MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
+ P + G + L V +I D R + A++
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE---AME 352
Query: 933 --PLQRLVIPSHPDQPSSALPQ 952
+L ++ SS+L
Sbjct: 353 TPEFLQL-----QNEISSSLST 369
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 66/264 (25%), Positives = 121/264 (45%), Gaps = 29/264 (10%)
Query: 679 VLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
+ ++G G+ +G+V+ + +G E +K +++D S + + + E+++++ L HPN+
Sbjct: 25 IFKRKLGSGA-FGDVHLVEERSSGLERVIK-TINKDRSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQV--DEKRRIKMALDVARGMNCLHT 793
+ N+ I+ E G L RI+ E ++ + + H+
Sbjct: 83 IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 794 STPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 849
+VH+DLK N+L + +K+ DFGL+ K + + AGT +MAPEV
Sbjct: 143 Q--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVF 198
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP----- 904
+ KCD++S GV+++ L T LP+ G + +V + E P
Sbjct: 199 K-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRPLTPQA 255
Query: 905 --LVARIIWECWQTDPSLRPSFAQ 926
L+ +++ DP RPS AQ
Sbjct: 256 VDLLKQML----TKDPERRPSAAQ 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRL 731
+ IG G V G E AVK + L + +RE I+R++
Sbjct: 98 PKDVIGRGV-SSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 732 R-HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 789
HP+++ + + + ++ + + +G LF + + + EK + + ++
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVS 214
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 848
LH + IVHRDLK N+L+D N +++SDFG S L+ L + GTP ++APE+
Sbjct: 215 FLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEI 270
Query: 849 LRNEPS------NEKCDVYSFGVIL 867
L+ ++ D+++ GVIL
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 677 DLVLGERIGLGSSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMR 729
+ E +G G +G+V+ + T ++A K D++ E K E+ +M
Sbjct: 90 TVSKTEILGGGR-FGQVHKCEETATGLKLAAKIIKTRGMKDKE-------EVKNEISVMN 141
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGM 788
+L H N++ A ++ ++ E++ G LF RI+ + + E I + G+
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGI 200
Query: 789 NCLHTSTPTIVHRDLKSPNLL-VDKNWN-VKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 845
+H I+H DLK N+L V+++ +K+ DFGL+R K L K GTPE++A
Sbjct: 201 RHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLA 256
Query: 846 PEVLRNEPSNEKCDVYSFGVIL 867
PEV+ + + D++S GVI
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 75/268 (27%), Positives = 119/268 (44%), Gaps = 41/268 (15%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPN 735
+ IG G+ +G VAVK ++++ A ++ +RE+ R LRHPN
Sbjct: 24 FVKDIGSGN-FGVARLMRDKLTKELVAVK-YIERG----AAIDENVQREIINHRSLRHPN 77
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNC 790
+V F + P +L+II E+ G L+ RI + DE R + + M
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ- 136
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPE 847
I HRDLK N L+D + +K+ DFG S+ ++ KST GTP ++APE
Sbjct: 137 -------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPE 187
Query: 848 VLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPM-------QVVGAVGFQN-RRLEI 898
VL + + + DV+S GV L+ + P+ Q + +V + + I
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247
Query: 899 PKELDPLVARIIWECWQTDPSLRPSFAQ 926
E L++RI DP+ R S +
Sbjct: 248 SPECCHLISRIF----VADPATRISIPE 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 28/266 (10%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ +G GS +GEV E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGS-FGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ + I+ E G LF I+ R E ++ V G+ +H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH-- 140
Query: 797 TIVHRDLKSPNLLV---DKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNE 852
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-G 197
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-----GAVGFQNRR-LEIPKELDPLV 906
+EKCDV+S GVIL+ L + P+ G N ++ G F + I + L+
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 907 ARIIWECWQTDPSLRPSFAQLTVALK 932
+++ PSLR + Q L+
Sbjct: 258 RKML----TFHPSLRITATQ---CLE 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 41/241 (17%), Positives = 85/241 (35%), Gaps = 39/241 (16%)
Query: 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFK 722
E ++ + + + +G G+ + +VY A N + +K A EF
Sbjct: 59 EFQLGSKLVYVHHLLGEGA-FAQVYEATQGDLNDAKNKQKFVLKVQ-----KPANPWEFY 112
Query: 723 REVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEK 775
++M RL+ + F A ++ E G+L ++ P + +
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 776 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----------DKNWNVKVSDFGLS 824
I A+ + + +H I+H D+K N ++ D + + + D G S
Sbjct: 173 LVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 825 R----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 880
T ++K T + E+L N+P N + D + ++ + +
Sbjct: 231 IDMKLFPKGTIFTAK--CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288
Query: 881 N 881
Sbjct: 289 E 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 81/299 (27%), Positives = 129/299 (43%), Gaps = 43/299 (14%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHAD--WNGTEVAV 705
+P V ST+ + +G GS +GEV G E AV
Sbjct: 12 TPGMFVQHSTAIFSDRYK--------------GQRVLGKGS-FGEVILCKDKITGQECAV 56
Query: 706 KKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-R 763
K + E REV+++++L HPN++ ++ E G LF
Sbjct: 57 KVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE 116
Query: 764 ILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSD 820
I+ R E ++ V G+ +H + IVHRDLK NLL+ K+ N+++ D
Sbjct: 117 IISRKR--FSEVDAARIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIID 172
Query: 821 FGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 879
FGLS + + + K GT ++APEVL +EKCDV+S GVIL+ L + P+ G
Sbjct: 173 FGLSTHFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNG 229
Query: 880 MNPMQVV-----GAVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
N ++ G F+ + ++ + L+ +++ PS+R S AL
Sbjct: 230 ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML----TYVPSMRISARD---ALD 281
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-32
Identities = 75/313 (23%), Positives = 125/313 (39%), Gaps = 61/313 (19%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGT--EVAV 705
+P V K+ + + ++G G+ YGEV E A+
Sbjct: 22 NPGMYVRKKEGKIGESYF--------------KVRKLGSGA-YGEVLLCKEKNGHSEKAI 66
Query: 706 K-----------KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754
K D E E+ +++ L HPN++ ++TE
Sbjct: 67 KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 755 FLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV--- 810
F G LF +I++R DE + + G+ LH IVHRD+K N+L+
Sbjct: 127 FYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENK 182
Query: 811 DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 869
+ N+K+ DFGLS + L + GT ++APEVL+ + NEKCDV+S GVI++
Sbjct: 183 NSLLNIKIVDFGLSSFFSKDYKLRDR--LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYI 239
Query: 870 LATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP----------LVARIIWECWQTDPS 919
L P+ G N ++ V + + + + L+ ++ D +
Sbjct: 240 LLCGYPPFGGQNDQDIIKKV----EKGKYYFDFNDWKNISDEAKELIKLML----TYDYN 291
Query: 920 LRPSFAQLTVALK 932
R + + AL
Sbjct: 292 KRCTAEE---ALN 301
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 79/309 (25%), Positives = 132/309 (42%), Gaps = 43/309 (13%)
Query: 680 LGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPN 735
LGE +G G EV+ A +VAVK L D + + L F+RE + L HP
Sbjct: 16 LGEILGFGG-MSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 736 VVLFMGAV--------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 787
+V AV P I+ E++ +L I+H + KR I++ D +
Sbjct: 74 IV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQA 128
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWM 844
+N H + I+HRD+K N+++ VKV DFG++R ++ S TA GT +++
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--------VGAVGFQNRRL 896
+PE R + + + DVYS G +L+E+ T + P+ G +P+ V ++
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE-- 244
Query: 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQ-----LTVALKPLQRLVIPSHPDQPSSALP 951
+ +LD +V + +P R A L D ++L
Sbjct: 245 GLSADLDAVVLK----ALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLL 300
Query: 952 QEISVNSTP 960
+ N +
Sbjct: 301 SSAAGNLSG 309
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 1e-31
Identities = 48/328 (14%), Positives = 96/328 (29%), Gaps = 77/328 (23%)
Query: 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR- 732
LV G +G A G V + A+ + K EV +R LR
Sbjct: 74 TLVRGTVLGQED-PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132
Query: 733 ------------------------HPNVVLFMGAVTRPPNLSI-ITEFLPRGSLFRILH- 766
++ LS + +L
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192
Query: 767 -----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821
H + R+++ L V R + LH +VH L+ ++++D+ V ++ F
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 822 GLSRLKHNTFLSSKSTAGTPEWMAPEVL-----------RNEPSNEKCDVYSFGVILWEL 870
+ ++ + + PE+ R D ++ G++++ +
Sbjct: 251 EHLV-RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 871 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930
LP + + F++ + IP+ + L+ + + R Q
Sbjct: 307 WCADLPITKDAALGGSEWI-FRSCK-NIPQPVRALLEGFL----RYPKEDRLLPLQ---- 356
Query: 931 LKPLQRLVIPSHP------DQPSSALPQ 952
P + S+ALP
Sbjct: 357 --------AMETPEYEQLRTELSAALPL 376
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 679 VLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN 735
V + +GLG G+V + A+K D + +REV++ R + P+
Sbjct: 65 VTSQVLGLGI-NGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPH 116
Query: 736 VVLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNC 790
+V + L I+ E L G LF RI R E+ ++ + +
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 791 LHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 846
LH+ I HRD+K NLL N +K++DFG ++ + L + TP ++AP
Sbjct: 177 LHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAP 232
Query: 847 EVLRNEPSNEKCDVYSFGVIL 867
EVL E ++ CD++S GVI+
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 66/280 (23%), Positives = 110/280 (39%), Gaps = 38/280 (13%)
Query: 599 GPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTS 658
P L + + + + E G R K T + + V+
Sbjct: 94 CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGT--EVAVK-----KFLDQ 711
V +D + E +G G+ +G V+ T A K D+
Sbjct: 154 HVLDHYD--------------IHEELGTGA-FGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 712 DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHC 770
+ ++E++ M LRHP +V A + +I EF+ G LF ++ H
Sbjct: 199 E-------TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HN 250
Query: 771 QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL-VDKNWN-VKVSDFGLSR-LK 827
++ E ++ V +G+ +H + VH DLK N++ K N +K+ DFGL+ L
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 867
+ K T GT E+ APEV +P D++S GV+
Sbjct: 309 PKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 17/196 (8%)
Query: 679 VLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPN 735
+ + +G GS + + AVK + + ++E+ ++ HPN
Sbjct: 14 LKDKPLGEGS-FSICRKCVHKKSNQAFAVKIISKRMEANT-----QKEITALKLCEGHPN 67
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
+V + ++ E L G LF RI + H E + + ++ +H
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDV 125
Query: 795 TPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
+VHRDLK NLL + N +K+ DFG +RLK K+ T + APE+L
Sbjct: 126 G--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 852 EPSNEKCDVYSFGVIL 867
+E CD++S GVIL
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 736
+ E IG+GS Y E AVK + + E++I+ R +HPN+
Sbjct: 26 VKEDIGVGS-YSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNI 78
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTST 795
+ + ++TE + G L +IL + E+ + + + + LH
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQG 136
Query: 796 PTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVL 849
+VHRDLK N+L ++++ DFG ++ N L + T ++APEVL
Sbjct: 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVL 192
Query: 850 RNEPSNEKCDVYSFGVIL 867
+ + CD++S GV+L
Sbjct: 193 ERQGYDAACDIWSLGVLL 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 39/292 (13%)
Query: 680 LGERIGLGSSYGEVYHA-----DWNGTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLR 732
L +G G G+VY A + VA+K + + S +RE + RL+
Sbjct: 38 LRRLVGRGG-MGDVYEAEDTVRER---IVALK-LMSETLSSDPVFRTRMQREARTAGRLQ 92
Query: 733 HPNVVLFMGAV----TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 788
P+VV + L + + L +L R + R + + + +
Sbjct: 93 EPHVV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSAL 147
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-GTPEWMAPE 847
+ H + HRD+K N+LV + + DFG++ + L+ GT +MAPE
Sbjct: 148 DAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------NRRLEIPKE 901
+ + D+Y+ +L+E T P+ G + + V+GA Q R IP
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVA 264
Query: 902 LDPLVARIIWECWQTDPSLR-PSFAQLTVALKPLQRLVIPSHPDQPSSALPQ 952
D ++AR +P R + L+ A + + D+ + L +
Sbjct: 265 FDAVIAR----GMAKNPEDRYVTCGDLSAA---AHAALATADQDRATDILRR 309
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 39/235 (16%)
Query: 652 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHAD--WNGTEVAVKKFL 709
S DS + + + ++ + + +G G+ + V E AVK
Sbjct: 2 STDSFSGRFEDVYQ-------------LQEDVLGEGA-HARVQTCINLITSQEYAVKIIE 47
Query: 710 DQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHR 767
Q + REV+++ + + H NV+ + ++ E + GS+ I R
Sbjct: 48 KQPGHIRS--RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR 105
Query: 768 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLS 824
H +E + DVA ++ LH I HRDLK N+L ++ VK+ DF L
Sbjct: 106 RH--FNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
Query: 825 R-LKHNTFLSSKST------AGTPEWMAPEVLRNEPS-----NEKCDVYSFGVIL 867
+K N S ST G+ E+MAPEV+ +++CD++S GVIL
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 60/284 (21%), Positives = 105/284 (36%), Gaps = 36/284 (12%)
Query: 680 LGERIGLGSSYGEVYHA-DW--NGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRH 733
+ I G G +Y A D NG V +K + D + E + + + H
Sbjct: 84 VKGCIAHGG-LGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM----AMAERQFLAEVVH 138
Query: 734 PNVVL-----FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 788
P++V P I+ E++ SL R + + I L++ +
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPAL 195
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 848
+ LH+ +V+ DLK N+++ + +K+ D G S GTP + APE+
Sbjct: 196 SYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPGFQAPEI 248
Query: 849 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
+R P+ D+Y+ G L L G + V + + L+ L+ R
Sbjct: 249 VRTGPT-VATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTYDSYGRLLRR 303
Query: 909 IIWECWQTDPSLRP-SFAQLTVALKPLQRLVIPSHPDQPSSALP 951
DP R + +++ L + R V+ P L
Sbjct: 304 ----AIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLS 343
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 55/265 (20%), Positives = 110/265 (41%), Gaps = 39/265 (14%)
Query: 676 EDLVLGERIGLGSSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFK------REVK 726
ED G+ +G GS + V E A+K +++ RE
Sbjct: 30 EDFKFGKILGEGS-FSTVVLARELA-TSREYAIKIL-----EKRHIIKENKVPYVTRERD 82
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMA 781
+M RL HP V L + G L + + + + R I A
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--G 839
L+ LH I+HRDLK N+L++++ +++++DFG +++ +++ + G
Sbjct: 143 LE------YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRL 896
T ++++PE+L + + + D+++ G I+++L P+ N + FQ
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEY 249
Query: 897 EIPKELDPLVARIIWECWQTDPSLR 921
+ P++ P ++ + D + R
Sbjct: 250 DFPEKFFPKARDLVEKLLVLDATKR 274
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 50/200 (25%), Positives = 79/200 (39%), Gaps = 43/200 (21%)
Query: 679 VLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN 735
V + +GLG G+V + A+K D + +REV++ R + P+
Sbjct: 21 VTSQVLGLGI-NGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPH 72
Query: 736 VVLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNC 790
+V + L I+ E L G LF RI R E+ ++ + +
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 791 LHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
LH+ I HRD+K NLL N +K++DFG A E
Sbjct: 133 LHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKE 169
Query: 848 VLRNEPSNEKCDVYSFGVIL 867
E ++ CD++S GVI+
Sbjct: 170 TTG-EKYDKSCDMWSLGVIM 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 51/242 (21%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 684 IGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPN 735
IG G+ +GEV + A+K + +L+ F+ E ++
Sbjct: 82 IGRGA-FGEVAVVKLKNADKVFAMKIL-----NKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDVARGMN 789
+ A NL ++ ++ G L +L + ++ E+ + +A+D
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------ 189
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEV 848
+H VHRD+K N+L+D N +++++DFG +L + + S GTP++++PE+
Sbjct: 190 SVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 849 LRNEPSNEK-----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
L+ + CD +S GV ++E+ + P+ + ++ G + R + P ++
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307
Query: 904 PL 905
+
Sbjct: 308 DV 309
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----I 778
E +I++ + P +V + NL ++ E++ G +F L R + R I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKST 837
+ + LH+ +++RDLK NLL+D+ ++V+DFG + R+K T+ +
Sbjct: 151 VLTFE------YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TL 198
Query: 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---R 894
GTPE +APE++ ++ N+ D ++ GV+++E+A P+ P+Q+ ++
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSG 253
Query: 895 RLEIPKELDPLVARIIWECWQTDPSLR 921
++ P + ++ Q D + R
Sbjct: 254 KVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 682 ERIGLGSSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPN 735
+IG GS YG V+ G VA+KKF +D AL RE++++++L+HPN
Sbjct: 9 GKIGEGS-YGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQLKHPN 63
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLH 792
+V + R L ++ E+ ++ L R V E K L + +N H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCH 119
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APE 847
+HRD+K N+L+ K+ +K+ DFG +RL L+ S E W +PE
Sbjct: 120 KHN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVATRWYRSPE 172
Query: 848 VLRNEPS-NEKCDVYSFGVILWELATLK 874
+L + DV++ G + EL +
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 48/239 (20%), Positives = 103/239 (43%), Gaps = 26/239 (10%)
Query: 684 IGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPN 735
IG G+ + EV T A+K + +L+ F+ E ++
Sbjct: 69 IGRGA-FSEVAVVKMKQTGQVYAMKIM-----NKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTS 794
+ A L ++ E+ G L +L + ++ + R +A ++ ++ +H
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRL 181
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEP 853
VHRD+K N+L+D+ +++++DFG +L+ + + S GTP++++PE+L+
Sbjct: 182 G--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 854 SNEK-------CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
CD ++ GV +E+ + P+ + + G + L +P + +
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPN 735
E+IG G+ YG V+ A VA+K+ LD D G AL RE+ +++ L+H N
Sbjct: 8 EKIGEGT-YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKN 62
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLH 792
+V + L+++ EF + L + + +D K + L +G+ H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCH 118
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APE 847
+ ++HRDLK NLL+++N +K+++FGL+R + E W P+
Sbjct: 119 SRN--VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVTLWYRPPD 171
Query: 848 VLRNEPS-NEKCDVYSFGVILWELATLKLP 876
VL + D++S G I ELA P
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 30/207 (14%)
Query: 682 ERIGLGSSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 736
E++G G+ YG VY A D G VA+K+ LD + G A+ RE+ +++ L HPN+
Sbjct: 27 EKVGEGT-YGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELHHPNI 81
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 793
V + + L+++ EF+ + L ++L + + K + L RG+ H
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQ 137
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 848
I+HRDLK NLL++ + +K++DFGL+R + T E W AP+V
Sbjct: 138 HR--ILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVTLWYRAPDV 190
Query: 849 LRNEPS-NEKCDVYSFGVILWELATLK 874
L + D++S G I E+ T K
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 682 ERIGLGSSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 736
E+IG G+ YG VY A + G A+KK L+++ G + RE+ I++ L+H N+
Sbjct: 8 EKIGEGT-YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI----REISILKELKHSNI 62
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 793
V + L ++ E L + L ++L ++ K + L G+ H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHD 118
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 848
++HRDLK NLL+++ +K++DFGL+R T E W AP+V
Sbjct: 119 RR--VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPDV 171
Query: 849 LRNEPS-NEKCDVYSFGVILWELATLK 874
L + D++S G I E+
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 684 IGLGSSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFM 740
IG G+ +GEV T A+K + + F E IM P VV
Sbjct: 77 IGRGA-FGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDVARGMNCLHTS 794
A L ++ E++P G L ++ V EK + +ALD +H+
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALD------AIHSM 187
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEP 853
+HRD+K N+L+DK+ ++K++DFG ++ + + GTP++++PEVL+++
Sbjct: 188 G--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 854 SNEK----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
+ CD +S GV L+E+ P+ + + + L P + D
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 71/317 (22%), Positives = 118/317 (37%), Gaps = 71/317 (22%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPN 735
+G GS YG V G VA+KKF D A+ RE+K++++LRH N
Sbjct: 31 GLVGEGS-YGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM----REIKLLKQLRHEN 85
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLH 792
+V + + ++ EF+ ++ L +D ++ + + G+ H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCH 141
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APE 847
+ I+HRD+K N+LV ++ VK+ DFG +R L++ E W APE
Sbjct: 142 SHN--IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVATRWYRAPE 194
Query: 848 VLRNEPS-NEKCDVYSFGVILWELATLK--LP----------------------WIGMNP 882
+L + + DV++ G ++ E+ + P N
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 883 MQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPS---------FAQL 927
V V + PK L +V + +C DP RP F
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313
Query: 928 TVALKPLQRLVIPSHPD 944
A + Q L + D
Sbjct: 314 GFAERFSQELQLKVQKD 330
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 9e-23
Identities = 51/207 (24%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 724 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----I 778
E ++ + HP ++ G + +I +++ G LF +L + + + +
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKST 837
+AL+ LH+ I++RDLK N+L+DKN ++K++DFG + + T+ +
Sbjct: 116 CLALE------YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TL 163
Query: 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---R 894
GTP+++APEV+ +P N+ D +SFG++++E+ P+ N M+ ++
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNA 218
Query: 895 RLEIPKELDPLVARIIWECWQTDPSLR 921
L P + V ++ D S R
Sbjct: 219 ELRFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
E ++++ RHP + + L + E+ G LF L R E R
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYG 254
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 841
++ ++ LH S +V+RDLK NL++DK+ ++K++DFGL + + K+ GTP
Sbjct: 255 AEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEI 898
E++APEVL + D + GV+++E+ +LP+ + ++ F+ +
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEIRF 368
Query: 899 PKELDPLVARIIWECWQTDPSLR 921
P+ L P ++ + DP R
Sbjct: 369 PRTLGPEAKSLLSGLLKKDPKQR 391
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-22
Identities = 44/207 (21%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
+E++IM+ L HP +V + ++ ++ + L G L L + +E ++ +
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGT 840
++ ++ L I+HRD+K N+L+D++ +V ++DF ++ L T +++ + GT
Sbjct: 123 -ELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GT 177
Query: 841 PEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNR 894
+MAPE+ + + D +S GV +EL + P+ + ++V F+
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETT 235
Query: 895 RLEIPKELDPLVARIIWECWQTDPSLR 921
+ P + ++ + + +P R
Sbjct: 236 VVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 30/207 (14%)
Query: 682 ERIGLGSSYGEVYHADWNGTE--VAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNV 736
+++G G+ Y VY T+ VA+K+ L+ + A+ REV +++ L+H N+
Sbjct: 8 DKLGEGT-YATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLKHANI 62
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 793
V + +L+++ E+L + L + L ++ K + L RG+ H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCHR 118
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 848
++HRDLK NLL+++ +K++DFGL+R K S + E W P++
Sbjct: 119 --QKVLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVTLWYRPPDI 171
Query: 849 LRNEPS-NEKCDVYSFGVILWELATLK 874
L + + D++ G I +E+AT +
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-21
Identities = 60/250 (24%), Positives = 101/250 (40%), Gaps = 22/250 (8%)
Query: 684 IGLGSSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNV 736
+G G +GEV T A KK + AL E K+ I+ ++ V
Sbjct: 192 LGKGG-FGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-KQ---ILEKVNSRFV 246
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTST 795
V A L ++ + G L ++ E R + A ++ G+ LH
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPS 854
IV+RDLK N+L+D + ++++SD GL+ H + GT +MAPEV++NE
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 855 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIW 911
D ++ G +L+E+ + P+ V + E + P +
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEVPEEYSERFSPQARSLCS 421
Query: 912 ECWQTDPSLR 921
+ DP+ R
Sbjct: 422 QLLCKDPAER 431
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNV 736
E++G G+ Y VY G VA+K+ LD + A+ RE+ +M+ L+H N+
Sbjct: 11 EKLGNGT-YATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENI 65
Query: 737 VLFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
V + L+++ EF+ R K L +G+
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLA 122
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM- 844
H + I+HRDLK NLL++K +K+ DFGL+R + E W
Sbjct: 123 FCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSEVVTLWYR 175
Query: 845 APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
AP+VL + + D++S G IL E+ T K
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 44/210 (20%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 682 ERIGLGSSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFK---------REVKIMRRL 731
I GS YG V D G VA+K+ + G + RE++++
Sbjct: 28 RFISSGS-YGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 732 RHPNVVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 785
HPN++ + ++TE + L +++H + + +
Sbjct: 87 HHPNILGLR-DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 845
G++ LH + +VHRDL N+L+ N ++ + DF L+R + + A
Sbjct: 145 LGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HRWYRA 201
Query: 846 PEVLRNEPS-NEKCDVYSFGVILWELATLK 874
PE++ + D++S G ++ E+ K
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK----FLDQDFSGA---ALLEFKREVKIMRRLR 732
+ +G G + VY A VA+KK + G AL RE+K+++ L
Sbjct: 16 DFLGEGQ-FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKLLQELS 70
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMN 789
HPN++ + A N+S++ +F+ L I+ + K + M L +G+
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---QGLE 126
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM- 844
LH I+HRDLK NLL+D+N +K++DFGL++ S + A T + W
Sbjct: 127 YLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GSPNRAYTHQVVTRWYR 179
Query: 845 APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
APE+L D+++ G IL EL
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 42/290 (14%), Positives = 84/290 (28%), Gaps = 55/290 (18%)
Query: 680 LGERIGLGSSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAA--LLEFKREVKIMRRLRHPN 735
L G + + A D +VA+ F+D L E + R+ P
Sbjct: 35 LLIFHGGVPP-LQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 795
V + V ++ E++ GSL + I+ +A + H +
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG 149
Query: 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 855
+ + V + +V ++ +N
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DAN 180
Query: 856 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------NRRLEIPKELDPLV 906
+ D+ G L+ L + P + + +IP ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240
Query: 907 ARIIWECWQTDPSLRPSFAQLTVALK----PLQRLVIPSHPDQPSSALPQ 952
AR Q D +R + L + + + V+ + P SA P+
Sbjct: 241 AR----SVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAPR 286
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPN 735
+IG G+ +GEV+ A G +VA+KK ++ + G AL RE+KI++ L+H N
Sbjct: 23 AKIGQGT-FGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL----REIKILQLLKHEN 77
Query: 736 VVLFMGAVT--------RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 787
VV + ++ ++ +F L +L + ++ + G
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----W 843
+ +H + I+HRD+K+ N+L+ ++ +K++DFGL+R + +S+ T W
Sbjct: 137 LYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARA-FSLAKNSQPNRYTNRVVTLW 193
Query: 844 M-APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
PE+L E D++ G I+ E+ T
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-21
Identities = 61/251 (24%), Positives = 103/251 (41%), Gaps = 21/251 (8%)
Query: 684 IGLGSSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNV 736
+G G +GEV+ T A KK + A++E K+ I+ ++ +
Sbjct: 193 LGRGG-FGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE-KK---ILAKVHSRFI 247
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---DEKRRIKMALDVARGMNCLHT 793
V A +L ++ + G + ++ E R I + G+ LH
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 853
I++RDLK N+L+D + NV++SD GL+ +K AGTP +MAPE+L E
Sbjct: 308 RN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 854 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARII 910
+ D ++ GV L+E+ + P+ + Q + + P + P
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKFSPASKDFC 424
Query: 911 WECWQTDPSLR 921
Q DP R
Sbjct: 425 EALLQKDPEKR 435
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
E ++++ RHP + A L + E+ G LF L R E+R
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYG 111
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSK 835
++ + LH+ +V+RD+K NL++DK+ ++K++DFGL + TF
Sbjct: 112 AEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---- 165
Query: 836 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--- 892
GTPE++APEVL + D + GV+++E+ +LP+ + ++ F+
Sbjct: 166 --CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELIL 218
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLR 921
+ P+ L P ++ + DP R
Sbjct: 219 MEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-21
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 45/216 (20%)
Query: 682 ERIGLGSSYGEVYHADWNGT-EVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 739
+ IG GS +G V+ A + EVA+KK D+ F RE++IMR ++HPNVV
Sbjct: 46 KVIGNGS-FGVVFQAKLVESDEVAIKKVLQDKRFKN-------RELQIMRIVKHPNVVDL 97
Query: 740 MGAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--------VA 785
+ L+++ E++P +++R K + M + +
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----AKLKQTMPMLLIKLYMYQLL 151
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPE-- 842
R + +H+ I HRD+K NLL+D +K+ DFG ++ +
Sbjct: 152 RSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGEPNVSYIC 203
Query: 843 --WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
+ APE++ + D++S G ++ EL +
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 682 ERIGLGSSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPN 735
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N
Sbjct: 31 KPIGSGA-QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKN 85
Query: 736 VVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVA 785
++ + T +L I+ E + +L +++ + +
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-------LLYQML 137
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 845
G+ LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + A
Sbjct: 138 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 194
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLK 874
PEV+ E D++S G I+ E+
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNV 736
+G G+ YG V A G VA+KK F F+ L RE+KI++ +H N+
Sbjct: 17 SLLGEGA-YGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENI 71
Query: 737 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVA 785
+ + RP + II E + L R++ H Q
Sbjct: 72 ITIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-------FIYQTL 122
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 844
R + LH S ++HRDLK NLL++ N ++KV DFGL+R+ + + G M
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 845 ---------APEVLRNEPS-NEKCDVYSFGVILWEL 870
APEV+ + DV+S G IL EL
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 682 ERIGLGSSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPN 735
++G G+ YGEVY A VA+K+ L+ + G A+ REV +++ L+H N
Sbjct: 40 TKLGEGT-YGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKELQHRN 94
Query: 736 VVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHT 793
++ + L +I E+ L + + + K + + G+N H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI---NGVNFCH- 149
Query: 794 STPTIVHRDLKSPNLLVDKNW-----NVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM 844
+ +HRDLK NLL+ + +K+ DFGL+R T E W
Sbjct: 150 -SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-----GIPIRQFTHEIITLWY 203
Query: 845 -APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
PE+L + D++S I E+
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 679 VLGERIGLGSSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734
G ++G G+ YG VY A + + A+K+ S +A RE+ ++R L+HP
Sbjct: 24 YEGCKVGRGT-YGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHP 78
Query: 735 NVVLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA------- 785
NV+ + + + ++ L+ I+ K+ +++ +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 786 -RGMNCLHTSTPTIVHRDLKSPNLLVDKNWN----VKVSDFGLSRLKHNTFLSSKSTAGT 840
G++ LH + ++HRDLK N+LV VK++D G +RL ++
Sbjct: 138 LDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP--LKPLADLD 193
Query: 841 PE----WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
P W APE+L + D+++ G I EL T +
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKM 780
K E I+ + HP +V A L +I +FL G LF L + E+ + +
Sbjct: 74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVKFYL 132
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 840
A ++A ++ LH+ I++RDLK N+L+D+ ++K++DFGLS+ + + S GT
Sbjct: 133 A-ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT 189
Query: 841 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLE 897
E+MAPEV+ + D +SFGV+++E+ T LP+ G + + +L
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----MTMILKAKLG 244
Query: 898 IPKELDPLVARIIWECWQTDPSLR 921
+P+ L P ++ ++ +P+ R
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-20
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
HP + NL + E+L G L + H D R A ++ G+ L
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFL 134
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVL 849
H+ IV+RDLK N+L+DK+ ++K++DFG+ K N +K+ GTP+++APE+L
Sbjct: 135 HSKG--IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEIL 190
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLV 906
+ N D +SFGV+L+E+ + P+ G + ++ F P+ L+
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEKEA 245
Query: 907 ARIIWECWQTDPSLR 921
++ + + +P R
Sbjct: 246 KDLLVKLFVREPEKR 260
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-20
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 48/221 (21%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLR---HPN 735
G G+ +G V G VA+KK D F RE++IM+ L HPN
Sbjct: 29 RMAGQGT-FGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPN 80
Query: 736 VV----LFMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD----- 783
+V F R L+++ E++P +L R + +R++
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-----RRQVAPPPILIKVF 134
Query: 784 ---VARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAG 839
+ R + CLH + + HRD+K N+LV++ + +K+ DFG ++ S S
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK------KLSPSEPN 188
Query: 840 TPEWM-----APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
APE++ D++S G I E+ +
Sbjct: 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-20
Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 43/218 (19%)
Query: 682 ERIGLGSSYGEVYHA-DWNGTE--VAVKKF-LDQDFSGA---ALLEFKREVKIMRRLR-- 732
IG G+ YG+V+ A D VA+K+ + G + REV ++R L
Sbjct: 17 AEIGEGA-YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRHLETF 71
Query: 733 -HPNVV-----LFMGAVTRPPNLSIITEFLPR--GSLFRILHRPHCQVDE-KRRIKMALD 783
HPNVV + R L+++ E + + + + P + K + L
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL- 130
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTP 841
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ T
Sbjct: 131 --RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TS 178
Query: 842 E----WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 874
W APEVL D++S G I E+ K
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 61/249 (24%), Positives = 105/249 (42%), Gaps = 20/249 (8%)
Query: 684 IGLGSSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNV 736
IG G +GEVY T A+K + AL E + + ++ P +
Sbjct: 197 IGRGG-FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFI 254
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
V A P LS I + + G L L + H E A ++ G+ +H
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF- 312
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-RNEPSN 855
+V+RDLK N+L+D++ +V++SD GL+ + ++ GT +MAPEVL + +
Sbjct: 313 -VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYD 369
Query: 856 EKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDPLVARIIWE 912
D +S G +L++L P+ ++ +E+P P + ++
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEG 427
Query: 913 CWQTDPSLR 921
Q D + R
Sbjct: 428 LLQRDVNRR 436
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKM 780
K E I+ ++HP +V + A L +I E+L G LF L R E +
Sbjct: 69 KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYL 127
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSS 834
A +++ + LH I++RDLK N++++ +VK++DFGL + +TF
Sbjct: 128 A-EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-- 182
Query: 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-- 892
GT E+MAPE+L N D +S G +++++ T P+ G N +
Sbjct: 183 ----GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----IDKI 233
Query: 893 -NRRLEIPKELDPLVARIIWECWQTDPSLR 921
+L +P L ++ + + + + R
Sbjct: 234 LKCKLNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPN 735
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N
Sbjct: 68 KPIGSGA-QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKN 122
Query: 736 VVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVA 785
++ + T L ++ E + +L +++ + +
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-------LLYQML 174
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 845
G+ LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + A
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 231
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLK 874
PEV+ E D++S G I+ E+ K
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 42/215 (19%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
+ IG GS +G VY A +G VA+KK D+ F RE++IMR+L H N+V
Sbjct: 60 KVIGNGS-FGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVR 111
Query: 739 FMGAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--------V 784
L+++ +++P +++R+ + + + + +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY-----SRAKQTLPVIYVKLYMYQL 165
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR-LKHNTFLSSK-STAGTP 841
R + +H+ I HRD+K NLL+D + +K+ DFG ++ L S +
Sbjct: 166 FRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---- 219
Query: 842 EWM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
+ APE++ DV+S G +L EL +
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 45/215 (20%)
Query: 682 ERIGLGSSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPN 735
+G G+ YG V A +G +VA+KK F + F+ A RE+ +++ ++H N
Sbjct: 30 THVGSGA-YGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHEN 84
Query: 736 VVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVA 785
V+ + T +L ++ F+ L +I+ Q + +
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-------LVYQML 136
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 844
+G+ +H++ +VHRDLK NL V+++ +K+ DFGL+R T +
Sbjct: 137 KGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 186
Query: 845 ----APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
APEV+ + N+ D++S G I+ E+ T K
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 37/216 (17%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK--REVKIMRRLR---H 733
IG+G+ YG VY A +G VA+K + G L REV ++RRL H
Sbjct: 15 AEIGVGA-YGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 734 PNVV-----LFMGAVTRPPNLSIITEFLPR--GSLFRILHRPHCQVDE-KRRIKMALDVA 785
PNVV R ++++ E + + + P + K ++ L
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL--- 130
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPE- 842
RG++ LH + IVHRDLK N+LV VK++DFGL+R+ TP
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVV 180
Query: 843 ---WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 874
W APEVL D++S G I E+ K
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 15/181 (8%)
Query: 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 805
L + +++ G LF L R C E R A ++A + LH+ IV+RDLK
Sbjct: 111 ADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLHSLN--IVYRDLKP 167
Query: 806 PNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSNEKCDVYSF 863
N+L+D ++ ++DFGL K N +S ++ GTPE++APEVL +P + D +
Sbjct: 168 ENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225
Query: 864 GVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVARIIWECWQTDPSL 920
G +L+E+ P+ N ++ + N + L++ + ++ Q D +
Sbjct: 226 GAVLYEMLYGLPPFYSRNTAEM-----YDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 280
Query: 921 R 921
R
Sbjct: 281 R 281
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 57/230 (24%), Positives = 89/230 (38%), Gaps = 57/230 (24%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPN 735
IG GS YG VY A VA+KK F D L RE+ I+ RL+
Sbjct: 32 HLIGRGS-YGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----REITILNRLKSDY 86
Query: 736 VVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALD 783
++ + P +L I+ E L ++ P H + + +
Sbjct: 87 IIRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-------ILYN 137
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR------------LKHNTF 831
+ G N +H S I+HRDLK N L++++ +VKV DFGL+R
Sbjct: 138 LLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 832 LSSKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 870
+ + APE++ + + + D++S G I EL
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 15/175 (8%)
Query: 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811
+ EF+ G L + + DE R A ++ + LH I++RDLK N+L+D
Sbjct: 102 VMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD 158
Query: 812 KNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 869
+ K++DFG+ K + GTP+++APE+L+ D ++ GV+L+E
Sbjct: 159 HEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216
Query: 870 LATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECWQTDPSLR 921
+ P+ N + F+ N + P L I+ +P++R
Sbjct: 217 MLCGHAPFEAENEDDL-----FEAILNDEVVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 38/212 (17%)
Query: 682 ERIGLGSSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPN 735
+ +G G+ YG V A G +VA+KK F + F+ A RE+++++ +RH N
Sbjct: 31 QPVGSGA-YGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHEN 85
Query: 736 VVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGM 788
V+ + T L ++ F+ L +++ + + RI+ + + +G+
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLVYQMLKGL 141
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM 844
+H + I+HRDLK NL V+++ +K+ DFGL+R + T W
Sbjct: 142 RYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVVTRWY 191
Query: 845 -APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
APEV+ N + D++S G I+ E+ T K
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 682 ERIGLGSSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPN 735
+G G+ YG V A G VAVKK F + RE+++++ ++H N
Sbjct: 35 SPVGSGA-YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHEN 89
Query: 736 VVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGM 788
V+ + T +L ++T + L I+ CQ ++ + + RG+
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLIYQILRGL 145
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW-MAPE 847
+H++ I+HRDLK NL V+++ +K+ DFGL+R + +T W APE
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT----RWYRAPE 199
Query: 848 VLRNEPS-NEKCDVYSFGVILWELATLK 874
++ N N+ D++S G I+ EL T +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 4e-18
Identities = 79/454 (17%), Positives = 165/454 (36%), Gaps = 34/454 (7%)
Query: 480 KTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKIN 539
T + ++ + V R ++ + + ++ K + K
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 540 REPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ--L 597
+ + + I D SR+ GS S + +
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 598 NGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSST 657
+G + P E E R+K + + + + S +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 658 SKVDQIFDDDVCECEIPWEDL-VLGERIGLGSSYGEVYHADWNGTE------VAVKKFLD 710
D++ D + L VLG+ S+G+V ++ GT+ + K +
Sbjct: 333 GNRDRMKLTD-------FNFLMVLGK-----GSFGKVMLSERKGTDELYAVKILKKDVVI 380
Query: 711 QDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC 770
QD + KR + + + P + L + E++ G L + +
Sbjct: 381 QDDDVECTMVEKRVLALPGK--PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG- 437
Query: 771 QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830
+ E + A ++A G+ L + I++RDLK N+++D ++K++DFG+ +
Sbjct: 438 RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495
Query: 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG 890
+++K+ GTP+++APE++ +P + D ++FGV+L+E+ + P+ G + ++
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----- 550
Query: 891 FQ---NRRLEIPKELDPLVARIIWECWQTDPSLR 921
FQ + PK + I P R
Sbjct: 551 FQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-18
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 42/214 (19%)
Query: 684 IGLGSSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 738
IG G+ YG V A + N VA+KK F Q + L RE+KI+ R RH N++
Sbjct: 35 IGEGA-YGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIG 89
Query: 739 FMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCL 791
+ R P + I+ + + L+++L Q I L + RG+ +
Sbjct: 90 IN-DIIRAPTIEQMKDVYIVQDLME-TDLYKLLK---TQHLSNDHICYFLYQILRGLKYI 144
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM------- 844
H++ ++HRDLK NLL++ ++K+ DFGL+R + ++
Sbjct: 145 HSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVATR 195
Query: 845 ---APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
APE++ N + D++S G IL E+ + +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 31/218 (14%)
Query: 673 IPWE---DLVLGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKI 727
+ W D L ++G G Y EV+ A N +V VK + KRE+KI
Sbjct: 30 VEWGNQDDYQLVRKLGRGK-YSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKI 83
Query: 728 MRRLR-HPNVVLFMGAVTRPP---NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKM 780
+ LR PN++ + + P +++ E + ++ + +
Sbjct: 84 LENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR----FYMYE 138
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAG 839
L + ++ H+ I+HRD+K N+++D ++ +++ D+GL+ H + A
Sbjct: 139 IL---KALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA- 192
Query: 840 TPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLP 876
+ + PE+L + + D++S G +L + K P
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 44/183 (24%), Positives = 85/183 (46%), Gaps = 22/183 (12%)
Query: 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811
+ E++ G L + R + E+ + +++ +N LH I++RDLK N+L+D
Sbjct: 88 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD 144
Query: 812 KNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGV 865
++K++D+G+ + +TF GTP ++APE+LR E D ++ GV
Sbjct: 145 SEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRGEDYGFSVDWWALGV 198
Query: 866 ILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDPLVARIIWECWQTDP 918
+++E+ + P+ + FQ +++ IP+ L A ++ DP
Sbjct: 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDP 258
Query: 919 SLR 921
R
Sbjct: 259 KER 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTSTPTIVHRDLK 804
L +I +++ G LF L + + E +I + ++ + LH I++RD+K
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVG-EIVLALEHLHKLG--IIYRDIK 186
Query: 805 SPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWMAPEVLRNEPS--NEKCD 859
N+L+D N +V ++DFGLS K ++ GT E+MAP+++R S ++ D
Sbjct: 187 LENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 244
Query: 860 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVARIIWECWQT 916
+S GV+++EL T P+ + + P+E+ L +I
Sbjct: 245 WWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQEMSALAKDLIQRLLMK 303
Query: 917 DPSLR 921
DP R
Sbjct: 304 DPKKR 308
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 62/235 (26%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPN 735
IG GS YG V A VA+KK F D L RE+ I+ RL H +
Sbjct: 59 HLIGTGS-YGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDH 113
Query: 736 VVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALD 783
VV + + P ++ ++ E ++ P H + + +
Sbjct: 114 VVKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-------LLYN 164
Query: 784 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------------L 826
+ G+ +H++ I+HRDLK N LV+++ +VKV DFGL+R
Sbjct: 165 LLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 827 KHNTFLSSKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 870
++ T + APE++ + + E DV+S G I EL
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 43/179 (24%), Positives = 84/179 (46%), Gaps = 23/179 (12%)
Query: 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811
+ E++ G L + + + E + A ++A G+ L + I++RDLK N+++D
Sbjct: 99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD 155
Query: 812 KNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGV 865
++K++DFG+ + TF GTP+++APE++ +P + D ++FGV
Sbjct: 156 SEGHIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAYQPYGKSVDWWAFGV 209
Query: 866 ILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECWQTDPSLR 921
+L+E+ + P+ G + ++ FQ + PK + I P R
Sbjct: 210 LLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 43/221 (19%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ +G G G V+ A + VA+KK D AL RE+KI+RRL H N+V
Sbjct: 17 KPLGCGG-NGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRLDHDNIV 71
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRI----------LHRP-HCQVDEKRRIKMAL-DVA 785
+ P + + L + L + ++ + +
Sbjct: 72 KVF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844
RG+ +H++ ++HRDLK NL ++ ++ +K+ DFGL+R +
Sbjct: 131 RGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR-------IMDPHYSHKGHL 181
Query: 845 ----------APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
+P +L + + + D+++ G I E+ T K
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 53/230 (23%), Positives = 97/230 (42%), Gaps = 53/230 (23%)
Query: 682 ERIGLGSSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLR-HP 734
+++G G+ YG V+ + G VAVKK F + + RE+ I+ L H
Sbjct: 15 KKLGKGA-YGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHE 69
Query: 735 NVVLFMGAVTRPPNLS---IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVAR 786
N+V + V R N ++ +++ L ++ H Q + + +
Sbjct: 70 NIVNLL-NVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQY-------VVYQLIK 120
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------LKHNTFLSSK 835
+ LH+ ++HRD+K N+L++ +VKV+DFGLSR + + +++
Sbjct: 121 VIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 836 STAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWELATLK 874
+ + APE+L + D++S G IL E+ K
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 44/183 (24%), Positives = 85/183 (46%), Gaps = 22/183 (12%)
Query: 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811
+ E++ G L + R + E+ + +++ +N LH I++RDLK N+L+D
Sbjct: 131 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD 187
Query: 812 KNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGV 865
++K++D+G+ + +TF GTP ++APE+LR E D ++ GV
Sbjct: 188 SEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 866 ILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDPLVARIIWECWQTDP 918
+++E+ + P+ + FQ +++ IP+ L A ++ DP
Sbjct: 242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDP 301
Query: 919 SLR 921
R
Sbjct: 302 KER 304
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 53/249 (21%), Positives = 92/249 (36%), Gaps = 78/249 (31%)
Query: 682 ERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVV- 737
+ +G GS +G V G A+KK L QD +K RE+ IM+ L H N++
Sbjct: 13 KTLGTGS-FGIVCEVFDIESGKRFALKKVL-QDPR------YKNRELDIMKVLDHVNIIK 64
Query: 738 -------------------------------LFMGAVTRPPN------LSIITEFLPRGS 760
+ + N L++I E++P +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DT 123
Query: 761 LFRILHRPHCQVDEKRRIKMALD--------VARGMNCLHTSTPTIVHRDLKSPNLLVD- 811
L ++L + + ++ + R + +H+ I HRD+K NLLV+
Sbjct: 124 LHKVLKSFI-----RSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNS 176
Query: 812 KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLRNEPS-NEKCDVYSFGV 865
K+ +K+ DFG ++ S + APE++ D++S G
Sbjct: 177 KDNTLKLCDFGSAK------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 866 ILWELATLK 874
+ EL K
Sbjct: 231 VFGELILGK 239
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 9e-12
Identities = 35/198 (17%), Positives = 55/198 (27%), Gaps = 49/198 (24%)
Query: 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKK------FLDQDFSGAALLEFKREVK 726
+P E L E+IG G +GEV+ + T VA+K L E E+
Sbjct: 17 LPTEKLQRCEKIGEGV-FGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 727 IMRRL---------RHPNVVLFMGA------------------------------VTRPP 747
I + L R + +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 807
L I+ EF G + + + I + + S HRDL N
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSI--LHQLTASLAVAEAS-LRFEHRDLHWGN 192
Query: 808 LLVDKNWNVKVSDFGLSR 825
+L+ K K+ +
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-10
Identities = 71/438 (16%), Positives = 124/438 (28%), Gaps = 160/438 (36%)
Query: 596 QLNGPPLVEDLSSNSKDENPKNV----E-DHEIGYHDRRKCTHDRFMGTNLKLRDLESPS 650
+ V++ + PK++ E DH I D T R T L
Sbjct: 23 SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT-LRLFWT---LLS--KQE 76
Query: 651 SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI--------GLGSSYGEVYHADWNGTE 702
V Q F ++V + L I + Y E +N +
Sbjct: 77 EMV--------QKFVEEVLRINYKF----LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 703 VAVKKFLDQDFSGAALLEFKREVKIMR------RLR-HPNVVLF-MG---------AVTR 745
V K + R ++ LR NV++ + V
Sbjct: 125 VFAKYNV------------SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 746 PPNLSIITEFLPRGSLFRI--LHRPHCQVDEKRRIKMA-----LDVARGMNCLHTSTPTI 798
+ + + F+I L+ +C E + +D H+S +
Sbjct: 173 --SYKVQCKM-D----FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225
Query: 799 VHRDLKS-----------PN-LLV-DKNWNVKVSD-FGL-------SRLKHNT-FLSSKS 836
+++ N LLV N K + F L +R K T FLS+ +
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285
Query: 837 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 896
T + + + E+ +L L ++ P
Sbjct: 286 T------------THISLDHHSMTLTPD----EVKSLLLKYLDCRPQ------------- 316
Query: 897 EIPKE---LDPLVARII----------WECWQT-----------------DPS-LRPSFA 925
++P+E +P II W+ W+ +P+ R F
Sbjct: 317 DLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD 376
Query: 926 QLTV----ALKPLQRLVI 939
+L+V A P L +
Sbjct: 377 RLSVFPPSAHIPTILLSL 394
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-07
Identities = 49/334 (14%), Positives = 93/334 (27%), Gaps = 63/334 (18%)
Query: 16 SNRTNETLASTTSCATDHNRTSSSSSNAAP-----PSPSASAATAASS--PAPVVS---- 64
+ T +R + + A P A PA V
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 65 --SGSRTDYMTSE--EEFQVQLAMA-----ISASSSN-PEDFSEKDQIRAATLLSLNNRR 114
SG + + ++VQ M ++ + N PE E Q + R
Sbjct: 159 LGSGKTW--VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 115 SDLG---RDKADVAAEVLSR--QYWEYN----VLD--YEERVVDGFYDIYG---LST--D 158
SD + + L R + Y VL + + F ++ L T
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF-NL-SCKILLTTRF 274
Query: 159 PSTQGKLPSLA--HLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILV 216
L + H+ + + T D L++ C DLP +
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTL-------TPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 217 QQLADLVNGHMGGPVKDANIMLARWMERSTE-LRRSLQTSVLPIGSINIGLSRHRALLFK 275
++L+ ++ ++D W + + L +++S + + R
Sbjct: 328 RRLS-II----AESIRDGLATWDNWKHVNCDKLTTIIESS---LNVLEPAEYRKMFDRLS 379
Query: 276 VLADSIRLP----CRLVKGSHYTGVEDDAVNIIK 305
V S +P + + V + K
Sbjct: 380 VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 3e-06
Identities = 91/653 (13%), Positives = 163/653 (24%), Gaps = 224/653 (34%)
Query: 296 VEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDS 355
V+D +I+ EE +D I+ +KD + L + +
Sbjct: 38 VQDMPKSILSKEE-----ID-----------HIIMSKDAVSGTL--RL--FWTLLSKQEE 77
Query: 356 GAVYSKPKPLHAEGSSQNSTVDGSLPLNGG--STSEKAESL-PSFPSPSYEPGAASSGIS 412
V+ L +N + K E PS + Y I
Sbjct: 78 MV---------------QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY--------IE 114
Query: 413 SR-VTPNQSDYLSS---------STIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQED 462
R N + + + +L + R NV+ G
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE-----------LRPAKNVLIDGV----- 158
Query: 463 SKSLFADLNPFQIKGAGKTSL------------------------HKNPTESKVEEFQS- 497
G+GKT + + N E+ +E Q
Sbjct: 159 -------------LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 498 -HRINPVSGRPPIPMMRKNQHPYNEVPRKKEY----SYMEGIL-------PKINREPNNN 545
++I+P ++ + Y +L K N +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 546 ---LSTSASTSSTSENFNPHSFKPS-NDANISSKDSESRSALSGSGPSLASSTSQLNGPP 601
L T+ T + S + +++ E +S L L+ P
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL----------KYLDCRP 315
Query: 602 LVEDLSSNSKDENP-------KNVEDHEIGYHDRRKCTHDRFMGTNL-KLRDLESPSSSV 653
+DL NP +++ D T D + N KL SS+
Sbjct: 316 --QDLPREVLTTNPRRLSIIAESIRDG--------LATWDNWKHVNCDKLT--TIIESSL 363
Query: 654 DSSTSKVDQ-------IFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVK 706
+ + +F IP +L + W +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSA---HIPTI--LL-----------SLI---WFDVIKSDV 404
Query: 707 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH 766
+ +L+E K+ + + SI E + LH
Sbjct: 405 MVVVNKLHKYSLVE-KQPKESTISI-P----------------SIYLELKVKLENEYALH 446
Query: 767 R-------PHCQVDEKRRIKMALD------VARGMNCLHTSTPTIVHRDLKSPNLLVDKN 813
R D I LD + H R + +D
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----HLKNIEHPERMTLFRMVFLDFR 501
Query: 814 W-NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK--CDVYSF 863
+ K+ + N S +T ++ P + N+P E+ + F
Sbjct: 502 FLEQKIRHDSTAW---NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 43/221 (19%), Positives = 93/221 (42%), Gaps = 45/221 (20%)
Query: 682 ERIGLGSSYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR- 732
++G G + V+ A D N T VA+K + + + E+K+++R+
Sbjct: 25 RKLGWGH-FSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA---------EDEIKLLQRVND 74
Query: 733 ----------HPNVVLFMGAVT-RPPNLS---IITEFLPRGSLFRILHRPHCQVDEKRRI 778
+++ + + PN ++ E L +L ++ + + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133
Query: 779 K-MALDVARGMNCLHTSTPTIVHRDLKSPNLLVD------KNWNVKVSDFGLSRLKHNTF 831
K ++ + G++ +H I+H D+K N+L++ +K++D G + +
Sbjct: 134 KQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872
+S T E+ +PEVL P D++S +++EL T
Sbjct: 193 TNSIQT---REYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 55/234 (23%), Positives = 89/234 (38%), Gaps = 61/234 (26%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---- 733
LG +IG GS +G++Y G EVA+K + + L E KI + ++
Sbjct: 13 LGRKIGSGS-FGDIYLGTDIAAGEEVAIKL--ECVKTKHPQL--HIESKIYKMMQGGVGI 67
Query: 734 PNV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM 780
P + V+ M G P+L LF R K +K
Sbjct: 68 PTIRWCGAEGDYNVMVMELLG-----PSLE---------DLFNFCSR-------KFSLKT 106
Query: 781 ALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL------- 826
L +A M +H+ +HRD+K N L+ V + DFGL++
Sbjct: 107 VLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
Query: 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 880
+H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 37/211 (17%)
Query: 682 ERIGLGSSYGEVYHADW--NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 733
IG GS +G+V A VA+K FL+Q A +E V+++ +
Sbjct: 60 SLIGKGS-FGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ-----AQIE----VRLLELMNK 109
Query: 734 P------NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVAR 786
+V +L ++ E L +L+ +L + + + A +
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN---TFLSSKSTAGTP 841
+ L T +I+H DLK N+L+ K +K+ DFG S ++ S+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF----- 223
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872
+ +PEVL P + D++S G IL E+ T
Sbjct: 224 -YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 47/224 (20%)
Query: 678 LVLGERIG--------LGS-SYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLE 720
V + + +G S+G+V A D VA+K +F Q A E
Sbjct: 89 QVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ-----AAEE 143
Query: 721 FKREVKIMRRLRH------PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 774
++I+ LR NV+ + T ++ + E L +L+ ++ + Q
Sbjct: 144 ----IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFS 198
Query: 775 KRRIK-MALDVARGMNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN-- 829
++ A + + ++ LH + I+H DLK N+L+ +KV DFG S +H
Sbjct: 199 LPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256
Query: 830 -TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872
T++ S+ + APEV+ D++S G IL EL T
Sbjct: 257 YTYIQSRF------YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 46/237 (19%), Positives = 86/237 (36%), Gaps = 63/237 (26%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---- 733
+G++IG G+ +GE+ + VA+K L E + ++L
Sbjct: 13 VGKKIGCGN-FGELRLGKNLYTNEYVAIK-LEPMKSRAPQL---HLEYRFYKQLGSGDGI 67
Query: 734 PNV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM 780
P V + + G P+L LF + R +K
Sbjct: 68 PQVYYFGPCGKYNAMVLELLG-----PSLE---------DLFDLCDR-------TFSLKT 106
Query: 781 ALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRL----- 826
L +A + +H+ +++RD+K N L+ + N + + DF L++
Sbjct: 107 VLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164
Query: 827 --KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 881
KH + KS GT +M+ + + + D+ + G + LPW G+
Sbjct: 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 63/237 (26%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---- 733
+G RIG GS +G ++ N +VA+K + S A L + E + + L
Sbjct: 14 VGRRIGEGS-FGVIFEGTNLLNNQQVAIKF--EPRRSDAPQL--RDEYRTYKLLAGCTGI 68
Query: 734 PNV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM 780
PNV VL + G P+L L + R K +K
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLG-----PSLE---------DLLDLCGR-------KFSVKT 107
Query: 781 ALDVARGM----NCLHTSTPTIVHRDLKSPNLLV----DKNWN-VKVSDFGLSRL----- 826
A+ M +H + +V+RD+K N L+ KN N + V DFG+ +
Sbjct: 108 VAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165
Query: 827 --KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 881
+H + K+ +GT +M+ + + D+ + G + LPW G+
Sbjct: 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 60/235 (25%), Positives = 90/235 (38%), Gaps = 61/235 (25%)
Query: 680 LGERIGLGSSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---- 733
LG +IG GS +GE+Y EVA+K + + L E KI R L+
Sbjct: 11 LGRKIGSGS-FGEIYLGTNIQTNEEVAIKL--ENVKTKHPQL--LYESKIYRILQGGTGI 65
Query: 734 PNV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM 780
PNV VL M G P+L LF R K +K
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLG-----PSLE---------DLFNFCSR-------KLSLKT 104
Query: 781 ALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL------- 826
L +A M +H+ + +HRD+K N L+ V + DFGL++
Sbjct: 105 VLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
Query: 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 881
+H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 47/236 (19%), Positives = 81/236 (34%), Gaps = 45/236 (19%)
Query: 680 LGERIGLGSSYGEVYHAD-WNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNV 736
+G IG G +G +Y AD + V + + S L E+K +R P
Sbjct: 39 VGLPIGQGG-FGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQ 95
Query: 737 VLFMGAVTRPPNLSIIT-----EFLPRGSLFRIL-----------HRPHCQVDEKRR--I 778
+ + L + G +R + +R
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN----AKRFSR 151
Query: 779 KMALDVARGM----NCLHTSTPTIVHRDLKSPNLLVD-KNWN-VKVSDFGLSRL------ 826
K L ++ + +H VH D+K+ NLL++ KN + V + D+GL+
Sbjct: 152 KTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 827 -KHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGM 880
K + GT E+ + + PS + D+ G + + T LPW
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 40/213 (18%), Positives = 74/213 (34%), Gaps = 67/213 (31%)
Query: 722 KREVKIMRRLR-----HPN---VVLFMGAVT-RPPN---LSIITEFLPRGSLFRILHRPH 769
E+++++ +R PN VV + N + ++ E L L + + + +
Sbjct: 81 LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN 139
Query: 770 CQVDEKRRIK-MALDVARGMNCLHTSTPTIVHRDLKSPNLLV------------------ 810
Q +K + V +G++ LHT I+H D+K N+L+
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 811 -------------------------------DKNWNVKVSDFGLSRLKHNTFLSSKSTAG 839
+ VK++D G + H F T
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT-- 256
Query: 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872
++ + EVL N D++S + +ELAT
Sbjct: 257 -RQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 47/237 (19%), Positives = 80/237 (33%), Gaps = 48/237 (20%)
Query: 679 VLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
VLG++IG G +G +Y A + A + ++ L E+K +R+ +
Sbjct: 40 VLGKKIGSGG-FGLIYLAFPTNKPEKDARH-VVKVEYQENGPLF--SELKFYQRVAKKDC 95
Query: 737 VLFMGAVTRPPNLSIIT-----EFLPRGSLFRILHRPHCQV------------DEKRR-- 777
+ + L I +G +R + V +
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM------VMERLGIDLQKISGQNGTFK 149
Query: 778 IKMALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWNVKV--SDFGLSRL----- 826
L + M +H + VH D+K+ NLL+ +V +D+GLS
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 827 --KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM 880
K K GT E+ + + + S + DV G + KLPW
Sbjct: 208 NHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-05
Identities = 53/236 (22%), Positives = 86/236 (36%), Gaps = 71/236 (30%)
Query: 682 ERIGLGSSYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR 732
+ +G G+ +G+V G VAVK ++ + A E ++++ L
Sbjct: 20 DTLGEGA-FGKVVECIDHKAGGRHVAVKIVKNVDRYCEA-----ARSE----IQVLEHLN 69
Query: 733 HP------NVVLFMGAVTRPPNLSIITEFLPRGSL--------FRILHRPHCQVDEKRRI 778
V + ++ I+ E L S F H +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIR------- 121
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------KNWNVKVS 819
KMA + + +N LH++ + H DLK N L V N ++KV
Sbjct: 122 KMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 820 DFG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872
DFG H+T +S++ APEV+ ++ CDV+S G IL E
Sbjct: 180 DFGSATYDDEHHSTLVSTRHYR------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 50/248 (20%), Positives = 91/248 (36%), Gaps = 77/248 (31%)
Query: 678 LVLGERIG--------LGS-SYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALL 719
+G+ + LG ++G+V ++VA+K K+ + A L
Sbjct: 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA-----ARL 65
Query: 720 EFKREVKIMRRLRHP------NVVLFMGAVTRPPNLSIITEFLP-------RGSLFRILH 766
E + ++++++ VL ++ I E L + + F+
Sbjct: 66 E----INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 121
Query: 767 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN-LLVD-------------- 811
PH + MA + + LH + + H DLK N L V+
Sbjct: 122 LPHVR-------HMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCE 172
Query: 812 ----KNWNVKVSDFG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG 864
KN +++V+DFG H T ++++ PEV+ + CDV+S G
Sbjct: 173 EKSVKNTSIRVADFGSATFDHEHHTTIVATRHY------RPPEVILELGWAQPCDVWSIG 226
Query: 865 VILWELAT 872
IL+E
Sbjct: 227 CILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 48/240 (20%), Positives = 89/240 (37%), Gaps = 75/240 (31%)
Query: 682 ERIGLGSSYGEVYHADW---NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR 732
++G G+ +G V N AVK K+ A +E I+++++
Sbjct: 41 RKMGDGT-FGRVLLC-QHIDNKKYYAVKVVRNIKKYTRS-----AKIE----ADILKKIQ 89
Query: 733 H-----PNVVLFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKM 780
+ N+V + G ++ +I E L + + H +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK-------LY 142
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------------KNWN 815
+++ + +N L + + H DLK N LL D K+
Sbjct: 143 CIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 816 VKVSDFG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 872
+K+ DFG H + ++++ + APEV+ N + D++SFG +L EL T
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 960 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.07 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 97.95 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 97.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.31 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 97.27 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.23 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.22 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.18 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.16 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.14 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.0 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.95 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.79 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 96.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.9 | |
| 2q3z_A | 687 | Transglutaminase 2; transglutaminase 2, tissue tra | 95.62 | |
| 1vjj_A | 692 | Protein-glutamine glutamyltransferase E; transglut | 95.56 | |
| 1g0d_A | 695 | Protein-glutamine gamma-glutamyltransferase; tissu | 95.3 | |
| 1ex0_A | 731 | Coagulation factor XIII A chain; transglutaminase, | 94.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.37 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.01 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=484.56 Aligned_cols=253 Identities=24% Similarity=0.435 Sum_probs=224.2
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
.+++|++++.||+| +||+||++++ +|+.||||++............+.+|+.+|++|+|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G-~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEG-SFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC-------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecC-CCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 46899999999999 7999999987 68999999998887777778889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 752 ITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
|||||+||+|.++|... ...+++.+++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999999754 345789999999999999999999999 999999999999999999999999999876544
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..+... ..+.++..+++++++||
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccCCHHHHHHH
Confidence 33344568999999999999999999999999999999999999999999998888887643 34567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||.+||.+||++.|++++
T Consensus 258 ~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=466.63 Aligned_cols=264 Identities=34% Similarity=0.574 Sum_probs=225.3
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
..|+|+.++|+++++||+| +||+||+|++.+ .||||+++...........|.+|+.+|++++|||||++++++.+ +.
T Consensus 29 ~~Wei~~~~l~l~~~iG~G-~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSG-SFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCCBCCTTSCCEEEECCCC-SSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cCcEEcHHHeEEeeEEeeC-CCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 3578899999999999999 799999998765 69999988776677777899999999999999999999998865 57
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|||||||++|+|.++|+.....+++.+++.|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 89999999999999999877678999999999999999999999998 9999999999999999999999999998764
Q ss_pred CC--cccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-ccc---CCC
Q 002146 829 NT--FLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRL---EIP 899 (960)
Q Consensus 829 ~~--~~~~~t~~GT~~Y~APEvl~g---~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~---~iP 899 (960)
.. .......+||+.|||||++.+ .+|+.++|||||||++|||++|+.||.+.+.......+.... ..+ .++
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 32 122345789999999999964 358999999999999999999999999877654444332222 222 356
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 900 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
..+++++++||.+||.+||.+||++.+|++.|+.++..
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 77899999999999999999999999999999988754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=472.74 Aligned_cols=249 Identities=21% Similarity=0.362 Sum_probs=224.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
.++|++++.||+| +||+||++++ +|+.||||++.+.... ......+.+|+++|++|+|||||+++++|++++.+||
T Consensus 31 ~~dy~i~~~lG~G-~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEG-SFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecc-cCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3679999999999 7999999986 6899999999764332 2235678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC-
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 830 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~- 830 (960)
|||||+||+|++++.+.+ .+++..+..|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.....
T Consensus 110 vmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999997654 7999999999999999999999999 999999999999999999999999999976432
Q ss_pred -cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 831 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 831 -~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..++...|. ...+.+|..+++++++|
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dl 264 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--KLEYDFPEKFFPKARDL 264 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTCCHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCcccCHHHHHH
Confidence 233456899999999999999999999999999999999999999999999998888885 34567889999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe 929 (960)
|.+||.+||.+||+++|++.
T Consensus 265 i~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHccCCHhHCcChHHHcC
Confidence 99999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=464.37 Aligned_cols=260 Identities=31% Similarity=0.544 Sum_probs=230.1
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
+|..++|.+.+.||+| +||+||+|++ +++.||||+++.. .....++|.+|+++|++|+|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G-~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEG-AFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC---CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeC-CCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 4667889999999999 7999999986 3678999998653 4555678999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCC------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPH------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 812 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~ 812 (960)
+++.+|||||||++|+|.++|++.+ ..+++.+++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGE 163 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECC
Confidence 9999999999999999999997532 36899999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHh
Q 002146 813 NWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 889 (960)
Q Consensus 813 ~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I 889 (960)
++++||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999987543322 2234569999999999999999999999999999999998 89999999999888887
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 890 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 890 ~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
. ...++.+|..+++++++||.+||+.||.+||++.+|++.|+++.+.
T Consensus 244 ~-~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 T-QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp H-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 6 3456778899999999999999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=464.75 Aligned_cols=261 Identities=33% Similarity=0.532 Sum_probs=225.3
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 743 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f 743 (960)
.++..++|.+.++||+| +||+||+|++ +++.||||+++.. .....++|.+|+++|++|+|||||+++++|
T Consensus 36 ~~i~~~d~~l~~~LG~G-~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEG-AFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEEC-SSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccC-CCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34566789999999999 7999999986 3678999998653 355567899999999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHhhCCC--------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEE
Q 002146 744 TRPPNLSIITEFLPRGSLFRILHRPH--------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 809 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL~dlL~k~~--------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNIL 809 (960)
.+...+|||||||++|+|.+++++.. ..+++.+++.|+.||+.||+|||+++ ||||||||+|||
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NIL 190 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCL 190 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEE
Confidence 99999999999999999999997532 35889999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 002146 810 VDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVV 886 (960)
Q Consensus 810 Ld~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~ 886 (960)
|+.++++||+|||+++...... ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++.
T Consensus 191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp EETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999998764332 22345679999999999999999999999999999999999 89999999998888
Q ss_pred HHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 887 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 887 ~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
..+. ...++.+|..+++++++||.+||++||.+||++.+|+++|+.+.+.
T Consensus 271 ~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 7775 3457788999999999999999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=471.17 Aligned_cols=248 Identities=29% Similarity=0.414 Sum_probs=221.8
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
+.|+++++||+| +||+||+|++ +|+.||||++....... ...+.+|+.+|++++|||||+++++|++++.+||||
T Consensus 74 ~~y~~~~~iG~G-~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEG-STGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecC-cCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 569999999999 7999999987 68999999997654332 345789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|||+||+|.+++.+. .+++.++..|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+........
T Consensus 151 Ey~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999999763 5999999999999999999999999 999999999999999999999999999987655455
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cccCCCCCCcHHHHHHHHH
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~~iP~~lS~eLkdLI~k 912 (960)
..+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++..+.... .....+..+++++++||.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 667899999999999999999999999999999999999999999999888887775321 1223345789999999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
||.+||.+||++.|++++
T Consensus 307 ~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HcCCChhHCcCHHHHhcC
Confidence 999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=461.95 Aligned_cols=259 Identities=30% Similarity=0.515 Sum_probs=228.8
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
+++..+++++++||+| +||+||+|++ +++.||||+++... .....++|.+|+.+|++++|||||+++|++.
T Consensus 22 ei~~~~~~~~~~lG~G-~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGED-RFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEEC-SSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccC-CCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 4677889999999999 7999999986 45789999986543 3344568999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEE
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 809 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNIL 809 (960)
++..++||||||++|+|.++|.... ..+++..++.|+.||+.||+|||+++ ||||||||+|||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NIL 177 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVL 177 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceE
Confidence 9999999999999999999996532 35889999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 002146 810 VDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVV 886 (960)
Q Consensus 810 Ld~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~ 886 (960)
|++++++||+|||+++...... ......+||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..++.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998764322 22345689999999999999999999999999999999998 89999999999888
Q ss_pred HHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 887 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 887 ~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
..+. ...+++.|..+++++.+||.+||+.||.+||++.+|+++|+.+.
T Consensus 258 ~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 EMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 8876 44566788999999999999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-54 Score=469.34 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=217.4
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
+..++|++++.||+| +||+||++++ +++.||||++.+..........+.+|+.+|++++|||||+++++|++++
T Consensus 21 ~~p~~Y~i~~~lG~G-~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQG-SFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECG-GGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecC-CCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 445789999999999 7999999976 4678999999765443333446789999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|||||||+||+|.+++.+.+ .+++.++..|+.||+.||+|||++| ||||||||+|||++.+|++||+|||+|+..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999999998654 6999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
........+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+. ...+.+|..++++++
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~ 254 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQ 254 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCcCCHHHH
Confidence 554445567899999999999999999999999999999999999999999999998888874 346678899999999
Q ss_pred HHHHHhhhhCCCCCCC-----HHHHHHH
Q 002146 908 RIIWECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPS-----a~eILe~ 930 (960)
+||.+||.+||.+||+ ++||+++
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 9999999999999998 4677653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=462.97 Aligned_cols=255 Identities=27% Similarity=0.356 Sum_probs=222.8
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
...++|++.++||+| +||+||++++ +|+.||||+++..... .+|+.+|++|+|||||+++++|++++.+|
T Consensus 55 ~~~~~~~~~~~lG~G-~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRG-SFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccC-CCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 345679999999999 7999999987 5899999999865432 37999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-cEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-~VKL~DFGLAr~~~~ 829 (960)
||||||+||+|.++|.+.+ .+++.+++.|+.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+|+....
T Consensus 127 ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999999997654 6999999999999999999999999 99999999999999887 699999999987643
Q ss_pred Cc-----ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-cCCCCCCc
Q 002146 830 TF-----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LEIPKELD 903 (960)
Q Consensus 830 ~~-----~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~-~~iP~~lS 903 (960)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...+...... ..+|..++
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence 21 1233468999999999999999999999999999999999999999998877777776543322 24688899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
+++++||.+||.+||.+||++.||+++|..+....
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999998886543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=451.72 Aligned_cols=247 Identities=27% Similarity=0.447 Sum_probs=207.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.+|++++.||+| +||+||++++ +|+.||||++.+..... .....+.+|+.+|++++|||||+++++|++++.+|||
T Consensus 13 g~Y~i~~~lG~G-~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEG-SFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC----CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecC-cCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 689999999999 7999999986 68999999998765433 3356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||| +|+|.+++.+.+ .+++.++..++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+..... .
T Consensus 92 mEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~ 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-N 166 (275)
T ss_dssp EECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCC-C
Confidence 9999 679999987654 7999999999999999999999999 999999999999999999999999999876443 2
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
...+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+..++...+. ...+.+|..+++++++||.
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Confidence 3456789999999999999886 589999999999999999999999998888887774 3466788999999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||.+|||+.|++++
T Consensus 245 ~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHC
T ss_pred HHccCChhHCcCHHHHHcC
Confidence 9999999999999999984
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=453.27 Aligned_cols=249 Identities=31% Similarity=0.464 Sum_probs=216.3
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc----CCceE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLS 750 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~----~~~l~ 750 (960)
.|++.++||+| +||+||+|.+ +++.||||++............|.+|+.+|++|+|||||+++++|++ ...+|
T Consensus 27 ~~~~~~~iG~G-~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 27 FLKFDIEIGRG-SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred eEEeeeEEecC-cCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 35788999999 7999999987 58899999998877777777889999999999999999999999865 35689
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLAr~~~~ 829 (960)
||||||+||+|.+++.+.+ .+++..+..|+.||+.||+|||+++++||||||||+||||+ .+|.+||+|||+|+....
T Consensus 106 lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999997643 78999999999999999999999887899999999999998 489999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhccccccCCCCCCcHHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
. ...+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+... ..+...+.....+..++..+++++++
T Consensus 185 ~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 185 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 2 3456789999999999876 599999999999999999999999987554 44555554333444566778899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||.+||.+||++.|++++
T Consensus 262 li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=474.16 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=223.1
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.+.|+++++||+| +||+||+|++ +|+.||||++....... ...+.+|+.+|+.|+|||||+++++|++.+.+|||
T Consensus 150 ~~~y~~~~~iG~G-~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEG-STGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccC-cCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 3579999999999 7999999987 68999999997654332 34678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
||||+||+|.+++... .+++.++..|+.||+.||+|||++| ||||||||+||||+.+|+|||+|||+|+.......
T Consensus 227 mEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999999999753 5999999999999999999999999 99999999999999999999999999998765545
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~~iP~~lS~eLkdLI~ 911 (960)
...+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++..+.... .....+..+++++++||.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 5667899999999999999999999999999999999999999999999888887775322 123345678999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||.+||++.|++++
T Consensus 383 ~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 383 RLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHSCSSTTTSCCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHhcC
Confidence 9999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=462.33 Aligned_cols=267 Identities=31% Similarity=0.503 Sum_probs=231.5
Q ss_pred CccccCcCCCCeEEEEEeeccCCeeEEEEEEECC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC-Cceee
Q 002146 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVL 738 (960)
Q Consensus 667 ~~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g-------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H-PNIVk 738 (960)
+..+|+|+.++|++++.||+| +||+||+|++.+ +.||||++.... .......|.+|+.+|++++| ||||+
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G-~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRG-AFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEEC-SSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccEecHHHeEEeeEEecC-CCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 445688999999999999999 799999998743 579999986543 44556789999999999965 89999
Q ss_pred EecccccC-CceEEEEeecCCCCHHHHhhCC---------------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEec
Q 002146 739 FMGAVTRP-PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 802 (960)
Q Consensus 739 L~g~f~~~-~~l~LVmEY~~gGsL~dlL~k~---------------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRD 802 (960)
++++|.+. ..++||||||++|+|.++|++. ...+++..++.|+.||+.||+|||+++ |||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRD 210 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD 210 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCc
Confidence 99998664 5799999999999999999743 234889999999999999999999999 99999
Q ss_pred cCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 002146 803 LKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIG 879 (960)
Q Consensus 803 LKPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~ 879 (960)
|||+||||++++++||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||+| |..||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998764332 22345679999999999999999999999999999999998 9999999
Q ss_pred CChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 880 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 880 ~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+..+.+..+.....++.+|..+++++++||.+||+.||.+||++.+|+++|+++.+.
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 8765555444445667888999999999999999999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=430.88 Aligned_cols=256 Identities=33% Similarity=0.520 Sum_probs=204.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC----ceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~----~l~L 751 (960)
++|.+.++||+| +||+||+|+++|+.||||++.... .....++.|+.++.+++|||||++++++.+++ .+||
T Consensus 3 r~i~L~~~iG~G-~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKG-RFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEEC-SSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeC-CCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 468999999999 799999999999999999986432 11223345666677889999999999987654 5899
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC------CCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~------g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
|||||++|+|.+++++. .+++..+++|+.|++.||+|||++ .++||||||||+||||+.++++||+|||+++
T Consensus 79 V~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999999864 588999999999999999999986 2249999999999999999999999999998
Q ss_pred cccCCcc----cCCCCCCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCC----------C-----
Q 002146 826 LKHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIG----------M----- 880 (960)
Q Consensus 826 ~~~~~~~----~~~t~~GT~~Y~APEvl~g~------~ys~ksDIWSLGvLLyELLTG~~PF~~----------~----- 880 (960)
....... .....+||+.|||||++.+. .|+.++|||||||++|||++|.+||.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7643321 22346899999999999765 367899999999999999999766532 2
Q ss_pred ChhHHHHHhhccccccCCCCCC-----cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 881 NPMQVVGAVGFQNRRLEIPKEL-----DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~l-----S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
...++...+.....++.+|... ...+.+||.+||..||.+|||+.+|++.|+++.+.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1123333343344556666532 35789999999999999999999999999998653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=442.35 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=213.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc------cCC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT------RPP 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~------~~~ 747 (960)
++|++++.||+| +||+||+|++ +|+.||||++............+.+|+.+|+.|+|||||++++++. +.+
T Consensus 54 ~~Y~~~~~lG~G-~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNG-AYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecc-cCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999 7999999987 6999999999876666666778899999999999999999999865 346
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|||||||+ |+|.+++.+.+ .+++..+..|++||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7999999995 68999997654 7999999999999999999999999 999999999999999999999999999875
Q ss_pred cCC----cccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC-----
Q 002146 828 HNT----FLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE----- 897 (960)
Q Consensus 828 ~~~----~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~----- 897 (960)
... .....+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|......+.
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 332 22345679999999999998864 69999999999999999999999999888777666532111110
Q ss_pred ------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 898 ------------------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 898 ------------------------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+...+++++++||.+||.+||.+|||+.|+|++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 113468899999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=431.52 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=193.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC------
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~------ 747 (960)
++|++++.||+| +||+||++++ +|+.||||++.... .+.....+.+|+.+|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G-~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRG-GFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEEC-C--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecC-CCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 469999999999 7999999987 68999999987654 3445568899999999999999999999987544
Q ss_pred ------ceEEEEeecCCCCHHHHhhCCCC--CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 748 ------NLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 748 ------~l~LVmEY~~gGsL~dlL~k~~~--~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
.+|||||||+||+|.+++..... ..++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999987542 2345667889999999999999999 9999999999999999999999
Q ss_pred ecCccccccCCcc------------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHH
Q 002146 820 DFGLSRLKHNTFL------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVV 886 (960)
Q Consensus 820 DFGLAr~~~~~~~------------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~ 886 (960)
|||+|+....... ...+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+... ....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999987643211 1234689999999999999999999999999999999996 7865322 1222
Q ss_pred HHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 887 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 887 ~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+. ....+..+...++.+++||.+||.+||.+||++.|++++
T Consensus 238 ~~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2222 111111223455778999999999999999999999873
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=413.82 Aligned_cols=272 Identities=64% Similarity=1.095 Sum_probs=232.8
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
...+++.+.+|++.+.||.| .||+||+++++|+.||||++............+.+|+.+|++++||||+++++++.+..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G-~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAG-SFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEEC-SSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecC-CCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34567888999999999999 69999999999999999999877777777788999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCC--CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~--~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
.+++||||+++++|.+++.+... .+++..++.++.||+.||+|||++|++|+||||||+||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999987542 3899999999999999999999987779999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........+|..++++
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 76544444456789999999999999999999999999999999999999999999888888776667778889999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCC
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p 940 (960)
+.+||.+||..||.+||++.+|++.|+.+.+...|
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999999776443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=449.66 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=222.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++++.||+| +||+||++++ +|+.||||++.... ......+.+|+.+|+.|+|||||+++++|++...+|||
T Consensus 156 l~~Y~i~~~lG~G-~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTG-AFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeec-cCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999 7999999987 68999999987653 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC--CCcEEEEecCccccccCC
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~--~g~VKL~DFGLAr~~~~~ 830 (960)
||||+||+|+++|.+....+++.++..|+.||+.||+|||+++ |+||||||+||||+. .+++||+|||+++.+...
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999876668999999999999999999999999 999999999999985 489999999999987543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--CCCCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--~iP~~lS~eLkd 908 (960)
......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..+....... ..+..+++++++
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 23345789999999999999999999999999999999999999999999998888875443222 223568999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||.+||.+||++.|+++|
T Consensus 390 li~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=454.09 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=214.7
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~----~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
..+..++|+++++||+| +||+||++++ +|+.||||++.+..+. .......+.++.+++.++|||||+++++|+
T Consensus 184 ~~~slddf~i~k~LG~G-~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRG-GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CCCCGGGEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCCchHHeEEEEEEecc-cCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 45677899999999999 7999999987 6899999999754321 122223334466667779999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+.+.+|||||||+||+|+++|.+.+ .+++..+..|+.||+.||+|||++| ||||||||+||||+.+|+|||+|||+|
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999999999998754 6999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHhhccccccCCCC
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~-g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~---~~ei~~~I~~~~~~~~iP~ 900 (960)
+..... ...+.+||+.|||||++. +..|+.++|||||||++|||++|.+||.+.+ ..++...+ ....+.+|.
T Consensus 340 ~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~ 415 (689)
T 3v5w_A 340 CDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPD 415 (689)
T ss_dssp EECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCT
T ss_pred eecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCc
Confidence 876543 345689999999999996 4679999999999999999999999998743 23344444 344667889
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPS-----a~eILe~ 930 (960)
.+++++++||.+||.+||.+|++ +++|++|
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 99999999999999999999998 6888764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=421.04 Aligned_cols=244 Identities=22% Similarity=0.342 Sum_probs=199.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l 749 (960)
+.|+++++||+| +||+||+|++ +++.||||++.... ...++.+|+++|+.+ +|||||+++++|++.+.+
T Consensus 21 ~~Y~i~~~lG~G-~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEG-TFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEEC-SSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecc-cCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 579999999999 7999999975 36789999886543 234678999999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC-CcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-g~VKL~DFGLAr~~~ 828 (960)
|||||||+||+|.+++. .+++.++..++.||+.||+|||++| ||||||||+||||+.+ +++||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999994 4899999999999999999999999 9999999999999876 899999999998643
Q ss_pred CCc----------------------------ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Q 002146 829 NTF----------------------------LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG 879 (960)
Q Consensus 829 ~~~----------------------------~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~ 879 (960)
... ....+.+||+.|+|||++.+.. |+.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 221 1123457999999999998864 89999999999999999999999965
Q ss_pred CC-hhHHHHHhhcc----------------------------------------------------ccccCCCCCCcHHH
Q 002146 880 MN-PMQVVGAVGFQ----------------------------------------------------NRRLEIPKELDPLV 906 (960)
Q Consensus 880 ~~-~~ei~~~I~~~----------------------------------------------------~~~~~iP~~lS~eL 906 (960)
.. ..+.+..|... .........+++++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 43 22222211100 00011224578999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++||.+||..||.+|+|++|+++|
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=400.16 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=226.3
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
...+|++++.||+| .||.||++++ +|+.||||++............+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 13 ~~~~y~~~~~lG~G-~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKG-NFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeC-CCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 45789999999999 7999999986 78999999998877777777889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++++|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp EECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999999987643 6899999999999999999999999 999999999999999999999999999876443
Q ss_pred ccCCCCCCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys-~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..++...+. .....+|..+++++.+||
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIPFYMSTDCENLL 245 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHH
Confidence 234567899999999999998875 89999999999999999999999999888887774 335667888999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||..||.+||++.+++++
T Consensus 246 ~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTC
T ss_pred HHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999885
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=379.61 Aligned_cols=260 Identities=31% Similarity=0.604 Sum_probs=233.5
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC--Cc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 748 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~--~~ 748 (960)
..+..++|++.+.||.| .||.||+++++++.||||++............+.+|+.+|++++||||+++++++.+. ..
T Consensus 5 ~~i~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNEN-HSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCCGGGCEEEEEEEEE-TTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCCCHHHhHHHHHhcCC-CcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 45677899999999999 7999999999999999999988776777777899999999999999999999999887 78
Q ss_pred eEEEEeecCCCCHHHHhhCCCC-CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~-~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
+++||||+++++|.+++.+... .+++..++.++.||+.||.|||+++.+|+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999999987543 589999999999999999999998777999999999999999999999999987643
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~---ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
. .....||+.|+|||++.+..++. ++|||||||++|+|++|..||.+.+..+....+......+.+|..+++
T Consensus 164 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 164 Q-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp S-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred c-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 2 23457899999999998876544 899999999999999999999999888887777666677788899999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
++.+||.+||..||.+||++.++++.|+++.+
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999854
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=403.09 Aligned_cols=252 Identities=23% Similarity=0.409 Sum_probs=224.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+..++|++++.||+| .||+||+++. +|+.||||++.+... .......+.+|+.+|+.++||||++++++|++.+.+
T Consensus 2 ~~~~~y~~~~~lG~G-~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKG-TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEecC-CCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 456789999999999 7999999987 688999999875422 122345788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+||||++||+|..++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999999997643 6899999999999999999999999 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++++++|
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSL 235 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHH
Confidence 43445667899999999999999999999999999999999999999999988888777743 3566788999999999
Q ss_pred HHHhhhhCCCCCC-----CHHHHHHH
Q 002146 910 IWECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
|.+||.+||.+|| ++.+|+++
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 9999999999999 89999876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=399.48 Aligned_cols=263 Identities=31% Similarity=0.542 Sum_probs=229.6
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE---------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEe
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 740 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~---------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~ 740 (960)
+++..++|++++.||+| .||.||++++ ++..||||++... ........+.+|+.+|+++ +|||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G-~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEG-CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCC-SSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeC-CCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 45667899999999999 7999999985 2346999998654 3445567899999999999 899999999
Q ss_pred cccccCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCC
Q 002146 741 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 805 (960)
Q Consensus 741 g~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKP 805 (960)
+++.+.+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++| |+||||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 99999999999999999999999997543 24788999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 002146 806 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 882 (960)
Q Consensus 806 eNILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~ 882 (960)
+||||+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999986643322 2233457889999999999999999999999999999999 9999999888
Q ss_pred hHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 883 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 883 ~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
.++...+. ...+...|..++.++.+||.+||..||.+||++.+|++.|+++....
T Consensus 312 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 87776664 34466778889999999999999999999999999999999997653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=377.72 Aligned_cols=261 Identities=31% Similarity=0.530 Sum_probs=231.7
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
.+.+..++|++++.||+| .||.||++++ +++.||||++....... ..+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~i~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSG-QFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp -CBCCGGGEEEEEEEEEC-SSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cEEeChhhceeeheecCC-CccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 456778899999999999 7999999987 77889999987655443 468899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccc
Confidence 99999999999999999877767999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 829 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 829 ~~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. .......|..+++.+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHV 236 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHHH
Confidence 322 22334567889999999999999999999999999999999 999999998888877765 334556677889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+||.+||..||.+||++.+++++|+++.+.
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=391.05 Aligned_cols=263 Identities=32% Similarity=0.491 Sum_probs=229.3
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
.++...+|++.+.||+| .||.||++++ .+..||||++... ........+.+|+.+|++++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G-~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSG-DSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEET-TTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeC-CCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 35667889999999999 6999999987 3445999998654 345556789999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
...+++||||+++++|.+++......+++..++.|+.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999999877668999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 826 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 826 ~~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 278 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCC
Confidence 7643321 1223346788999999999999999999999999999999 999999999888877765 3345667788
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
+++.+.+||.+||..||.+||++.+|++.|+.+.+..
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 9999999999999999999999999999999998763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=387.70 Aligned_cols=267 Identities=33% Similarity=0.499 Sum_probs=225.0
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
+..++|+++++||+| .||+||++.+ +++.||+|++... .......+.+|+.+|++++||||+++++++.+...++
T Consensus 7 ~~~~~~~~~~~lG~G-~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKG-CFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECC-SSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCC-CCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 456789999999999 6999999987 5889999987543 4556678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999999999999876668999999999999999999999999 999999999999999999999999999875432
Q ss_pred ccc--------------CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhh-ccccc
Q 002146 831 FLS--------------SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRR 895 (960)
Q Consensus 831 ~~~--------------~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~-~~~~~ 895 (960)
... ....+||+.|+|||++.+..++.++||||||+++|+|++|..||............. .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 211 114679999999999999999999999999999999999999997644322111100 01112
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCCCCCC
Q 002146 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 944 (960)
Q Consensus 896 ~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p~~P~ 944 (960)
...+..+++.+.+||.+||..||.+||++.+|++.|+.+........|.
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~~ 290 (310)
T 3s95_A 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290 (310)
T ss_dssp HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCCC
T ss_pred ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcccC
Confidence 3356778899999999999999999999999999999998876544443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=404.39 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=216.6
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEecccccCC
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 747 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~ 747 (960)
.+..++|+++++||+| +||+||++++ +++.||||++.+... .......+.+|+.+|+.+ +||||++++++|++.+
T Consensus 19 ~~~~~~y~~~~~lG~G-~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKG-SFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp ----CCEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCchhheEEEEEEeeC-CCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 4567899999999999 7999999987 588999999876432 122345678999999998 7999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+||||++||+|..++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999997643 6999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
..........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++...+. .....+|..++++++
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~ 252 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLHEDAT 252 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHH
Confidence 444445566789999999999999999999999999999999999999999999988888874 345677888999999
Q ss_pred HHHHHhhhhCCCCCCCH------HHHHH
Q 002146 908 RIIWECWQTDPSLRPSF------AQLTV 929 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa------~eILe 929 (960)
+||.+||.+||.+||++ .+|++
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 99999999999999998 77776
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=374.25 Aligned_cols=258 Identities=38% Similarity=0.671 Sum_probs=216.5
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~--~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
++..++|++.+.||+| .||.||++.+.++.||||++...... ......+.+|+.+++.++||||+++++++.+...+
T Consensus 3 ~~~~~~~~~~~~lg~G-~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIG-GFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp BCCTTSEEEEEEEEEE-TTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred ccchhheeeeeeeccC-CCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 5677899999999999 69999999999999999998654322 23356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCC-CEEEeccCCCcEEEcC--------CCcEEEEe
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSD 820 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~-~IIHRDLKPeNILLd~--------~g~VKL~D 820 (960)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||+++. +|+||||||+|||++. ++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999965 368999999999999999999999874 3889999999999986 77899999
Q ss_pred cCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 821 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 821 FGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+........++.
T Consensus 160 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 160 FGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp CCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred CCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence 99998654332 2345799999999999999999999999999999999999999999888877777766666677888
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.+++.+.+||.+||..||.+||++.+++++|+++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=391.94 Aligned_cols=268 Identities=31% Similarity=0.495 Sum_probs=229.6
Q ss_pred CccccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceee
Q 002146 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 738 (960)
Q Consensus 667 ~~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVk 738 (960)
....+++..++|++++.||.| .||.||++++ +++.||||++... ........+.+|+.+|+++ +|||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRG-AFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEEC-SSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccccccceeeceeecCC-CCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 445678888999999999999 7999999974 3478999998754 3444566789999999999 8999999
Q ss_pred EecccccCCc-eEEEEeecCCCCHHHHhhCCCC-----------------------------------------------
Q 002146 739 FMGAVTRPPN-LSIITEFLPRGSLFRILHRPHC----------------------------------------------- 770 (960)
Q Consensus 739 L~g~f~~~~~-l~LVmEY~~gGsL~dlL~k~~~----------------------------------------------- 770 (960)
+++++.+.+. +++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887654 9999999999999999976432
Q ss_pred ------------------CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002146 771 ------------------QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 831 (960)
Q Consensus 771 ------------------~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~- 831 (960)
.+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1889999999999999999999999 9999999999999999999999999998653321
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 832 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 832 -~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+..............|..+++++.+|
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 22334568899999999999999999999999999999998 9999998776555555444555677788899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 910 IWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
|.+||..||.+||++.+|+++|+.+....
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999987653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=374.26 Aligned_cols=259 Identities=33% Similarity=0.584 Sum_probs=227.9
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+++..++|++++.||.| .||.||++++. +..||||++....... ..+.+|+.++++++||||+++++++.+...+
T Consensus 3 ~~l~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 3 MELKREEITLLKELGSG-QFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TBCCGGGEEEEEEEEEE-TTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred eEechhheeeeeeeccC-CCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 45677899999999999 79999999875 5579999987655443 4688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999999999876657999999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 830 TF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 830 ~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......|..+++.+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 235 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIY 235 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHH
Confidence 32 22234456788999999999999999999999999999999 999999988887776664 3345556777899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
+||.+||..||.+||++.+++++|+.+.+
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 99999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=384.90 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=219.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|+++++||+| .||+||++.+ +++.||||++....... ...+.+|+.+++.++||||++++++|...+.+++|
T Consensus 19 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQG-ASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEE-TTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccC-CCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4679999999999 7999999975 78899999987654332 34678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999764 5899999999999999999999999 99999999999999999999999999987765544
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-ccccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~-~~~~~iP~~lS~eLkdLI~ 911 (960)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ......+..++..+++||.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 455678999999999999999999999999999999999999999998877665554322 2234456788999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||..||.+||++.+++++
T Consensus 252 ~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTC
T ss_pred HHccCChhHCcCHHHHhhC
Confidence 9999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=375.34 Aligned_cols=262 Identities=31% Similarity=0.501 Sum_probs=228.1
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+++..++|++++.||.| .||.||++++. +..||||++....... ..+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTG-QFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CTTBCCGGGEEEEEECC----CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCccCCHHHHHhHhhcCCC-CCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 3467788899999999999 79999999884 5579999987655443 46889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccccc
Confidence 999999999999999999875567999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 828 HNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 828 ~~~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. .......|..+++.
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEK 249 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHH
Confidence 4322 12233457889999999999999999999999999999998 999999998887777765 33455667788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+.+||.+||..+|.+||++.+++++|+.+.+.
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999999999999999998653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=386.17 Aligned_cols=263 Identities=29% Similarity=0.480 Sum_probs=228.7
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEECC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 742 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g-------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~ 742 (960)
.+++..++|++++.||.| .||.||++++.+ +.||||++.... .......+.+|+.+|++++||||++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEG-AFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HTBCCGGGCEEEEEEEEC-SSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeEecHHHCeeeeeeeec-CCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 456677899999999999 799999998753 789999987543 44556789999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHHHHhhCCC-----------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEE
Q 002146 743 VTRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIV 799 (960)
Q Consensus 743 f~~~~~l~LVmEY~~gGsL~dlL~k~~-----------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~II 799 (960)
+.+...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iv 196 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 196 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 999999999999999999999997532 46899999999999999999999999 99
Q ss_pred EeccCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 002146 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLP 876 (960)
Q Consensus 800 HRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~P 876 (960)
||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999999999999999999998654322 12234567899999999999999999999999999999999 9999
Q ss_pred CCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 877 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 877 F~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
|.+....++...+. ......+|..++.++.+||.+||..||.+||++.+|++.|+++...
T Consensus 277 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 277 YYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 99998888777664 3345567888999999999999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=377.54 Aligned_cols=263 Identities=31% Similarity=0.538 Sum_probs=229.7
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEec
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 741 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g 741 (960)
..+++..++|++++.||.| .||.||++.+ +++.||||++... ........+.+|+.+|++++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEG-EFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEEC-SSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeeccc-CCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 4567778999999999999 7999999975 3478999998754 34556678899999999999999999999
Q ss_pred ccccCCceEEEEeecCCCCHHHHhhCCC-----------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCE
Q 002146 742 AVTRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTI 798 (960)
Q Consensus 742 ~f~~~~~l~LVmEY~~gGsL~dlL~k~~-----------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~I 798 (960)
++.+...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i 171 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--L 171 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--C
Confidence 9999999999999999999999997543 24889999999999999999999999 9
Q ss_pred EEeccCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 002146 799 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKL 875 (960)
Q Consensus 799 IHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~ 875 (960)
+||||||+||||+.++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998654322 12233457889999999999999999999999999999999 999
Q ss_pred CCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 876 PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 876 PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
||.+....++...+. .......+..+++++.+||.+||..||.+||++.+|+++|+++..
T Consensus 252 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 252 PYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999988877776664 334566778899999999999999999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=398.72 Aligned_cols=263 Identities=31% Similarity=0.544 Sum_probs=231.0
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
.+++..++|++++.||.| .||.||++++ +++.||||++... ........+.+|+.+|++++|||||++++++....
T Consensus 108 ~~~~~~~~~~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRG-NFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccC-CCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 467778899999999999 7999999998 5889999998643 34445567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+++||||+++|+|.+++...+..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999999999876667899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccC--CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 828 HNTFLSS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 828 ~~~~~~~--~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..+++
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 342 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPD 342 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 4332211 12235678999999999999999999999999999998 999999998877766664 3446677888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
++.+||.+||..||.+||++.+|++.|+.+.+.
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 999999999999999999999999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=391.81 Aligned_cols=252 Identities=22% Similarity=0.363 Sum_probs=218.4
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~ 748 (960)
+..++|++++.||+| .||.||++++ +++.||||++.+.... ......+.+|+.+|+++ +|||||+++++|++...
T Consensus 6 ~~~~~y~~~~~lG~G-~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRG-SYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCGGGEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CchhheEEEEEEEec-CCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 456789999999999 7999999987 5889999999876543 44566788999999998 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999999997643 6899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHHhhccccccCCC
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---------NPMQVVGAVGFQNRRLEIP 899 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~---------~~~ei~~~I~~~~~~~~iP 899 (960)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||... ....+...+ ......+|
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCC
Confidence 4334455678999999999999999999999999999999999999999762 222333344 23456788
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCH------HHHHHH
Q 002146 900 KELDPLVARIIWECWQTDPSLRPSF------AQLTVA 930 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRPSa------~eILe~ 930 (960)
..++.++++||.+||.+||.+||++ .+++++
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 8999999999999999999999995 566654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=398.67 Aligned_cols=254 Identities=20% Similarity=0.337 Sum_probs=221.2
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
..+..++|++++.||+| .||+||++++ +++.||||++.+... .......+.+|+.+|..+ +||||++++++|++.
T Consensus 15 ~~~~~~~y~~~~~lG~G-~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKG-SFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp ----CTTEEEEEEEEEE-TTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CCCchHHcEEEEEEeeC-CCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 45667899999999999 7999999987 467899999876432 112345678899999988 899999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++.
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999999997643 6899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
...........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~ 248 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEA 248 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHH
Confidence 54433445667899999999999999999999999999999999999999999998888887743 4567888999999
Q ss_pred HHHHHHhhhhCCCCCCC-----HHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPS-----a~eILe~ 930 (960)
++||.+||.+||.+||+ +.+|+++
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999995 5777764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=387.73 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=211.8
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~--~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
.+..++|++++.||+| .||.||++++ +++.||||++...... ......+.+|+.+|+.++||||+++++++.
T Consensus 13 ~~~~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 13 KIRPECFELLRVLGKG-GYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp CCCGGGEEEEEEEEEE-TTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCHHHeEEEEEEEeC-CCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4556889999999999 6999999986 6889999998765432 223456789999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
..+.+|+||||+++++|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999999997643 6889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
+............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..++.
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~ 246 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--KCKLNLPPYLTQ 246 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTCCCCCTTSCH
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCH
Confidence 865443333456789999999999999999999999999999999999999999988887777764 335667888999
Q ss_pred HHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
++++||.+||..||.+|| ++.+++++
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 999999999999999999 78888764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=388.87 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=221.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+..++|++++.||+| .||+||+++. +|+.||||++.+.... ......+.+|+.+|+.++||||+++++++++...+
T Consensus 3 ~~~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 3 YSLQDFQILRTLGTG-SFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CCGGGEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred CChHHcEEEEEEeeC-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 345789999999999 7999999987 6899999998754221 12345678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+||||++||+|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999999997644 6899999999999999999999999 99999999999999999999999999987543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.. ....+|..+++++++|
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~l 233 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDL 233 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHH
Confidence 2 3457899999999999999999999999999999999999999999988888777743 3566788899999999
Q ss_pred HHHhhhhCCCCCC-----CHHHHHHH
Q 002146 910 IWECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
|.+||..||.+|| ++++|+++
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 9999999999999 88888864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=390.68 Aligned_cols=265 Identities=32% Similarity=0.538 Sum_probs=233.0
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceee
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 738 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVk 738 (960)
..+++..++|+++++||+| .||+||++++. +..||||++... ........+.+|+++++++ +|||||+
T Consensus 62 ~~~~i~~~~y~i~~~LG~G-~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEG-AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEEC-SSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecC-CCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 4567788899999999999 79999999852 257999998654 3455667899999999999 9999999
Q ss_pred EecccccCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 739 L~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
+++++.+.+.+++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dl 217 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDL 217 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCC
Confidence 9999999999999999999999999997543 35899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 218 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998764332 22334457889999999999999999999999999999999 99999999
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
...++...+. .......+..+++++.+||.+||..||.+||++.+|+++|+++....
T Consensus 298 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 298 PVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp CHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 8888777665 44466678889999999999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.54 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=212.0
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh------------------------HHHHHHHHHHH
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG------------------------AALLEFKREVK 726 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~------------------------~~~~~~~~Ei~ 726 (960)
+..++|++.+.||+| .||.||+++. +++.||||++....... .....+.+|+.
T Consensus 10 ~~~~~y~~~~~lG~G-~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKG-SYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp CEETTEEEEEEEEC---CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred eeecceEEEeEEeec-CCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 345789999999999 7999999976 68899999987654221 12346889999
Q ss_pred HHHHcCCCceeeEeccccc--CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccC
Q 002146 727 IMRRLRHPNVVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 804 (960)
Q Consensus 727 ILk~L~HPNIVkL~g~f~~--~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLK 804 (960)
+|++++||||+++++++.+ ...+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+|||||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlk 164 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIK 164 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCC
Confidence 9999999999999999886 5679999999999999987654 36899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002146 805 SPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMN 881 (960)
Q Consensus 805 PeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~---ys~ksDIWSLGvLLyELLTG~~PF~~~~ 881 (960)
|+||||+.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999987654433344568999999999998766 3789999999999999999999999988
Q ss_pred hhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 882 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 882 ~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+...+............+++++++||.+||..||.+||++.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 7777666644333333345789999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=398.75 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=220.6
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEecccccCC
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 747 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~ 747 (960)
.+..++|++++.||+| .||+||++++ +|+.||||++.+... .......+..|+.+|+.+ +||||++++++|++..
T Consensus 13 ~~~~~~y~~~~~lG~G-~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKG-SFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ---CTTEEEEEEEEEC-SSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCChHHeEEEEEEeeC-CCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 4567899999999999 7999999987 588999999875421 112345678899999987 9999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++..
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999997643 6899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ..+.+|..++++++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~ 246 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAK 246 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHH
Confidence 4333445667899999999999999999999999999999999999999999998888887743 35667888999999
Q ss_pred HHHHHhhhhCCCCCCCHH-HHHH
Q 002146 908 RIIWECWQTDPSLRPSFA-QLTV 929 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~-eILe 929 (960)
+||.+||..||.+||++. +|++
T Consensus 247 ~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHhcCCHhHcCCChHHHHc
Confidence 999999999999999997 6653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=381.38 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=211.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
...++|+++++||+| .||+||++++ +++.||||++............+.+|+.+|++++||||+++++++.+...+++
T Consensus 18 ~l~~~y~~~~~lG~G-~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEG-TYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEEC-SSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCC-CCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 345789999999999 7999999987 68899999987654444455678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999975 888888877667999999999999999999999999 9999999999999999999999999998765444
Q ss_pred ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--------------
Q 002146 832 LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-------------- 896 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~-------------- 896 (960)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+......+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 44455679999999999987 568999999999999999999999998877665544432110000
Q ss_pred --------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 --------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 --------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+...+++++++||.+||..||.+||++.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0123467899999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=368.95 Aligned_cols=261 Identities=31% Similarity=0.533 Sum_probs=230.0
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
++.+..++|++++.||.| .||.||++.+ +++.||||++....... ..+.+|+.++++++||||+++++++.+.+.
T Consensus 2 ~~~i~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSG-QFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp -CBCCGGGEEEEEEEEEE-TTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ceEEchhheeeeeEecCC-CceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 356777899999999999 7999999987 67789999987655433 468899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccc
Confidence 99999999999999999876667899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 829 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 829 ~~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.. ......|..++..+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l 234 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 234 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCCCCccCcHHH
Confidence 321 12234567889999999999999999999999999999999 8999999888877776653 33455677889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+||.+||..||.+||++.+++++|+++.+.
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=383.83 Aligned_cols=265 Identities=29% Similarity=0.417 Sum_probs=225.1
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEe
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 740 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~ 740 (960)
.++++..++|++++.||.| .||.||++++ ++..||||++.... .......+.+|+.+|+++ +||||++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSG-AFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GGGBCCGGGEEEEEEEEEC-SSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccCHHHceeeeeecCC-CCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 4577888999999999999 7999999986 35579999987542 233446789999999999 899999999
Q ss_pred cccccCCceEEEEeecCCCCHHHHhhCCCC----------------------CCcHHHHHHHHHHHHHHHHHHhhCCCCE
Q 002146 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHC----------------------QVDEKRRIKMALDVARGMNCLHTSTPTI 798 (960)
Q Consensus 741 g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~----------------------~lse~~~~~Ia~QIa~AL~YLHs~g~~I 798 (960)
+++...+.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 193 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--C 193 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 999999999999999999999999986542 3788999999999999999999999 9
Q ss_pred EEeccCCCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 002146 799 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKL 875 (960)
Q Consensus 799 IHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~ 875 (960)
+||||||+||||+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999986543221 1233457889999999999999999999999999999998 999
Q ss_pred CCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 876 PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 876 PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
||.+.........+.........+..+++++.+||.+||..||.+||++.+|+++|+.+...
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 99987765555554445556667888999999999999999999999999999999998553
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=391.73 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=218.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~----~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+.|++++.||.| .||.||++++ +|+.||||++....... .....+.+|+.+|++++||||++++++|.+...+
T Consensus 12 ~~y~~~~~LG~G-~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 12 DFYDIGEELGSG-QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GTEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hceEEeeEEeeC-cCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 579999999999 7999999987 58899999998654332 1345788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC----cEEEEecCccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSR 825 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g----~VKL~DFGLAr 825 (960)
++||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999997644 7999999999999999999999999 99999999999998776 79999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--CCCCCCc
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 903 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--~iP~~lS 903 (960)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... .++..++
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 168 EIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp ECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred EcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 76543 23445789999999999999999999999999999999999999999998888887775332211 1235688
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
+++++||.+||..||.+||++.++++
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=383.49 Aligned_cols=268 Identities=28% Similarity=0.494 Sum_probs=214.2
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEEC--C---cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccc
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 743 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~--g---~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f 743 (960)
....+..++|++++.||+| .||.||++++. + ..||||++............+.+|+.++++++||||+++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKG-EFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp CTTBCC---CEEEEEEEEE-TTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhcccChhHeEEeceeccc-CCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 4456777899999999999 79999999763 2 2799999877655556677899999999999999999999999
Q ss_pred ccCCce------EEEEeecCCCCHHHHhhCC-----CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC
Q 002146 744 TRPPNL------SIITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 812 (960)
Q Consensus 744 ~~~~~l------~LVmEY~~gGsL~dlL~k~-----~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~ 812 (960)
...... ++||||+.+++|.+++... ...+++..++.|+.||+.||.|||++| |+||||||+||||+.
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAE 172 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECT
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcC
Confidence 877665 9999999999999998532 125899999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHh
Q 002146 813 NWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 889 (960)
Q Consensus 813 ~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I 889 (960)
++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 99999999999987543321 1223456789999999999999999999999999999999 99999998888777766
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCC
Q 002146 890 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940 (960)
Q Consensus 890 ~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p 940 (960)
. .......+..+++++++||.+||..||.+||++.++++.|+++....+-
T Consensus 253 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 253 I-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp H-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred h-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 4 3345667788999999999999999999999999999999999887654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=400.39 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=216.8
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHc-CCCceeeEecccccCC
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 747 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~ 747 (960)
.+..++|+++++||+| +||+||++++ +++.||||++.+..... .....+.+|+.+|+++ +|||||+++++|++..
T Consensus 48 ~~~~~~y~~~~~LG~G-~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRG-SYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp -CCGGGEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCChhHcEEEEEEeeC-CCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 4567899999999999 7999999987 57889999998754432 3344678999999887 8999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+||||++||+|..++.+.+ .+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++..
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999999997643 6999999999999999999999999 999999999999999999999999999864
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------hhHHHHHhhccccccCC
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------PMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~---------~~ei~~~I~~~~~~~~i 898 (960)
..........+||+.|+|||++.+..|+.++|||||||++|||++|..||.... ...+...+ ......+
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~ 281 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRI 281 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCC
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCC
Confidence 444445567899999999999999999999999999999999999999997532 12233333 3446778
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHHH
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSF------AQLTVA 930 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa------~eILe~ 930 (960)
|..+++++++||.+||++||.+||++ .+|+++
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 89999999999999999999999985 566553
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=391.06 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=220.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++++.||+| .||.||++.+ +++.||||++............+.+|+.+|++++|||||++++++.+...+|+||
T Consensus 29 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecC-CCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999 7999999987 5889999999887777777778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC---CcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~---g~VKL~DFGLAr~~~~~ 830 (960)
||+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||+++.....
T Consensus 108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999987654 6899999999999999999999999 9999999999999864 45999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC--CCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP--~~lS~eLkd 908 (960)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.........+ ..+++++++
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred -cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 22345689999999999999999999999999999999999999999998888877765433222222 457899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+||++.+++++
T Consensus 264 li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999998765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=373.62 Aligned_cols=263 Identities=30% Similarity=0.502 Sum_probs=217.3
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccc
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 743 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f 743 (960)
..+++..++|++++.||+| .||.||++.+. +..||||++... ........+.+|+.++++++||||+++++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEG-QFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp -CCBCCGGGEEEEEEEEEC-SSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEehHHeEEEeEeeec-CCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 3456777899999999999 79999999762 456999987653 2345566889999999999999999999998
Q ss_pred ccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 744 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
. .+..++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccc
Confidence 5 46789999999999999999876667999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 824 SRLKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 824 Ar~~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.. .....++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 241 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPN 241 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-CCCCCCCCC
Confidence 987643321 2233456789999999999999999999999999999996 9999999888877776653 345667888
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+++.+.+||.+||..||.+||++.+|++.|+++.+.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=380.27 Aligned_cols=267 Identities=30% Similarity=0.531 Sum_probs=230.9
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE---------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceee
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 738 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~---------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVk 738 (960)
..+++..++|++++.||+| .||.||++++ ++..||||++... ........+.+|+.+|+++ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEG-AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEEC-SSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeec-CceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 4567788999999999999 7999999985 3567999998654 3455567889999999999 8999999
Q ss_pred EecccccCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 739 L~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
+++++.+.+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dl 183 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDL 183 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCC
Confidence 9999999999999999999999999997643 24889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+||||+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999999987644321 2233457889999999999999999999999999999999 99999998
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCC
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p 940 (960)
...++...+. ......++..++.++++||.+||..||.+||++.+|++.|+++......
T Consensus 264 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 264 PVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp CHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 8877776654 3345667788999999999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=386.61 Aligned_cols=264 Identities=30% Similarity=0.383 Sum_probs=217.3
Q ss_pred CCccccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 666 DDVCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 666 ~~~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+...++.+..++|+++++||+| .||+||++++.++.||||++... ......+.+|+.+|++++|||||++++++..
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARG-RFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECS-TTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cCccccccchhhchhhheeccc-CceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 3455667788999999999999 69999999999999999998643 2333456679999999999999999999887
Q ss_pred CCc----eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC----------CCCEEEeccCCCcEEEc
Q 002146 746 PPN----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS----------TPTIVHRDLKSPNLLVD 811 (960)
Q Consensus 746 ~~~----l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~----------g~~IIHRDLKPeNILLd 811 (960)
... +++||||+++|+|.+++... .+++..++.++.||+.||.|||+. + |+||||||+||||+
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK 165 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC
Confidence 543 79999999999999999764 489999999999999999999998 7 99999999999999
Q ss_pred CCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCh--
Q 002146 812 KNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNE-----PSNEKCDVYSFGVILWELATLKLPWIGMNP-- 882 (960)
Q Consensus 812 ~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~-----~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-- 882 (960)
.++.+||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+...
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 999999999999987643322 23346799999999999874 456788999999999999999999976432
Q ss_pred --------------hHHHHHhhccccccCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 883 --------------MQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 883 --------------~ei~~~I~~~~~~~~iP~~-----lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
..+...+.....++.++.. .+.++.+||.+||..||.+||++.+|++.|+++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 2222223222333333322 345699999999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=374.65 Aligned_cols=265 Identities=29% Similarity=0.435 Sum_probs=228.6
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEe
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 740 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~ 740 (960)
..+++..++|++++.||.| .||.||++++ +++.||||++.... .......+.+|+.+|+++ +||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAG-AFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GGGBCCGGGEEEEEEEEEC-SSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccChhhhhHHHhhCcc-CCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 4467788899999999999 7999999985 45789999987543 334557889999999999 999999999
Q ss_pred cccccCCceEEEEeecCCCCHHHHhhCCCC-----------------CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHC-----------------QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 741 g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~-----------------~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
+++...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |+||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl 171 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDL 171 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCC
Confidence 999999999999999999999999976432 4899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+||||+.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999999987644321 1233457889999999999999999999999999999998 99999887
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
..................+..++..+.+||.+||..||.+||++.++++.|+++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 765544444334445556778999999999999999999999999999999998765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=374.00 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=211.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|+++++||.| .||+||++++ +++.||||++............+.+|+.+|++++||||+++++++.+...+++||
T Consensus 2 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEG-TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEEC-SSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCC-CCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999 7999999987 6889999999876665556678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||+++ +|.+++......+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++........
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 99976 666666554557999999999999999999999999 999999999999999999999999999877554444
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCC-CCCChhHHHHHhhcccc-----------------
Q 002146 834 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAVGFQNR----------------- 894 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF-~~~~~~ei~~~I~~~~~----------------- 894 (960)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+..+....+.....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 55668999999999998776 799999999999999999887775 45454444433321000
Q ss_pred ----------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 ----------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ----------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.......++.++++||.+||+.||.+||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 011223578999999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=371.02 Aligned_cols=256 Identities=32% Similarity=0.594 Sum_probs=219.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHH-----HHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAA-----LLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~-----~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+..++|++.+.||.| .||+||++++ +++.||||++......... ...+.+|+.++++++||||+++++++.+
T Consensus 16 ~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKG-GFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCC-SSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhccceehhccccC-CceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 456789999999999 6999999987 6889999998764433221 1578999999999999999999999977
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc-----EEEEe
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSD 820 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~-----VKL~D 820 (960)
.. ++||||+++++|.+++.+....+++..++.++.||+.||+|||++|.+|+||||||+||||+.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 65 699999999999999987777899999999999999999999998767999999999999988776 99999
Q ss_pred cCccccccCCcccCCCCCCCCCccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHH--HHHhhcccccc
Q 002146 821 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--VGAVGFQNRRL 896 (960)
Q Consensus 821 FGLAr~~~~~~~~~~t~~GT~~Y~APEvl~--g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei--~~~I~~~~~~~ 896 (960)
||+++..... .....||+.|+|||++. +..++.++|||||||++|+|++|..||........ ...+.......
T Consensus 173 fg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 173 FGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 9999854332 33467999999999994 45578999999999999999999999987654433 34444445566
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 897 ~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.++..+++++++||.+||..||.+||++.++++.|+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 77889999999999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=392.19 Aligned_cols=261 Identities=28% Similarity=0.463 Sum_probs=226.2
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
++..++|+++++||+| .||+||++++ +++.||||++... ........+.+|+.+|++++|||||++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G-~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHG-AFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCC-SSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeC-CCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4567889999999999 7999999985 3567999998643 34455567889999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCC------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC---c
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---N 815 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g---~ 815 (960)
+....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+| .
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999997532 35889999999999999999999999 99999999999999555 5
Q ss_pred EEEEecCccccccCC--cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcc
Q 002146 816 VKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 892 (960)
Q Consensus 816 VKL~DFGLAr~~~~~--~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~ 892 (960)
+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. .
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 999999999864322 122334568999999999999999999999999999999998 999999998888877765 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 893 ~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
......+..++..+.+||.+||..||.+||++.+|+++|+.+...
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 345667788999999999999999999999999999999999654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=376.95 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=209.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
++|++++.||.| .||+||++++ +++.||||++............+.+|+.+|++++||||+++++++...+.+++|||
T Consensus 2 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEG-TYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEE-TTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccC-CCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 689999999999 7999999987 58899999987654333334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+++ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9975 999999876667999999999999999999999999 9999999999999999999999999998765433334
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc------------------
Q 002146 835 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------ 895 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~------------------ 895 (960)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 456789999999999764 5899999999999999999999999988766555443211000
Q ss_pred ---------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ---------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ---------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+...+++++++||.+||..||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01224578999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=400.30 Aligned_cols=258 Identities=32% Similarity=0.574 Sum_probs=227.2
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP- 747 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~- 747 (960)
..+++..++|++++.||+| .||.||+++++++.||||+++... ....+.+|+.+|++++|||||++++++.+..
T Consensus 186 ~~~~i~~~~~~~~~~lG~G-~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKG-EFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp TTCBCCGGGEEEEEEEEEC-SSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccccChHHeEEEeeecCc-CCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 3467888999999999999 799999999999999999987543 2347889999999999999999999976655
Q ss_pred ceEEEEeecCCCCHHHHhhCCCC-CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~-~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+++||||+++|+|.+++.+.+. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 79999999999999999986543 4789999999999999999999999 99999999999999999999999999985
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
.... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ...+...|..+++.
T Consensus 339 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 414 (450)
T 1k9a_A 339 ASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPA 414 (450)
T ss_dssp CC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHH
T ss_pred cccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHH
Confidence 4332 223467889999999999999999999999999999998 999999988877777664 34567788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+.+||.+||..||.+||++.+|++.|+.+...
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999999998765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=401.88 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=222.1
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++++.||+| .||+||++.+ +|+.||+|++............+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 11 ~~Y~i~~~LG~G-~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKG-AFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC---CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccC-CCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 579999999999 7999999976 7899999999877666666778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc---CCCcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd---~~g~VKL~DFGLAr~~~~~ 830 (960)
||+.||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++.....
T Consensus 90 E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999987654 6999999999999999999999999 99999999999998 5688999999999876554
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC--CCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i--P~~lS~eLkd 908 (960)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+......... ...+++++++
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 44445678999999999999999999999999999999999999999999988888777544333222 2468999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+||++.+++++
T Consensus 247 li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 247 LINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHcCCChhHCCCHHHHhcC
Confidence 9999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=375.40 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=217.0
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
++..++|++++.||+| .||+||++++ +++.||||++... .......+.+|+.+|++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G-~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKG-NFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEEC-SSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeecc-CCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4556789999999999 7999999984 6789999998643 34556788999999999999999999998754
Q ss_pred --CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 746 --PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 746 --~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
...+++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCcc
Confidence 35689999999999999999876667999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----------------H
Q 002146 824 SRLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----------------Q 884 (960)
Q Consensus 824 Ar~~~~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~----------------e 884 (960)
++...... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 98764321 1122345777899999999999999999999999999999999998653221 1
Q ss_pred HHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 885 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 885 i~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
....+ ....+...|..+++++.+||.+||..||.+||++.+|++.|+.+.+.+
T Consensus 241 ~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHH-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11112 233456678889999999999999999999999999999999997653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=391.85 Aligned_cols=249 Identities=22% Similarity=0.374 Sum_probs=221.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
...++|++++.||+| .||.||++++ +|+.||||++...... ......+.+|+.+|+.++||||+++++++.+...+
T Consensus 38 ~~~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTG-SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCGGGEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCHHHCEEEEEeecC-cCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 455789999999999 7999999987 6889999998754321 12345788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999999997644 6899999999999999999999999 99999999999999999999999999987643
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.. ....+|..+++++++|
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDL 268 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHH
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHH
Confidence 3 3456899999999999999999999999999999999999999999998888877753 3567788999999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHHH
Q 002146 910 IWECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPS-----a~eILe~ 930 (960)
|.+||..||.+||+ +.+|+++
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhC
Confidence 99999999999998 8888764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=396.79 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=212.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHH-HHHcCCCceeeEecccccCCc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~I-Lk~L~HPNIVkL~g~f~~~~~ 748 (960)
+..++|++++.||+| .||+||++++ +++.||||++.+.... ......+.+|..+ ++.++|||||+++++|++.+.
T Consensus 35 ~~~~~y~~~~~lG~G-~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKG-SFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp CCGGGEEEEEEEECC-TTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeC-CCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 455789999999999 7999999987 5788999999876543 2334456777777 466899999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999999997643 6889999999999999999999999 9999999999999999999999999998754
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++...+. .....++..++.++++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ 268 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARH 268 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH--HSCCCCCSSSCHHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcccCCCCCCCHHHHH
Confidence 44445567889999999999999999999999999999999999999999999888887774 3356678889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLT 928 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eIL 928 (960)
||.+||.+||.+||++.+.+
T Consensus 269 li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTH
T ss_pred HHHHHcccCHHhCCCCCCCH
Confidence 99999999999999975433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=372.69 Aligned_cols=263 Identities=36% Similarity=0.630 Sum_probs=212.4
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
...++...+|+++++||+| .||.||++++.+ .||||++............+.+|+.+|++++||||+++++++ ....
T Consensus 17 ~~~ei~~~~y~~~~~lG~G-~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSG-SFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp -CCBCCTTSCEEEEEEEEC-SSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCCccCccceeeeeEecCC-CCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 3467888999999999999 699999998655 599999987766677778899999999999999999999965 5567
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccc
Confidence 89999999999999999877778999999999999999999999999 9999999999999999999999999997653
Q ss_pred CC--cccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHh-hccccc---cCCC
Q 002146 829 NT--FLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRR---LEIP 899 (960)
Q Consensus 829 ~~--~~~~~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I-~~~~~~---~~iP 899 (960)
.. ........||+.|+|||++. +..++.++||||||+++|+|++|..||.+....+..... ...... ..++
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 21 12233457999999999997 667889999999999999999999999886654433332 221112 2234
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 900 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
..+++.+++||.+||..+|.+||++.+|++.|+++.+
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 5788999999999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=382.58 Aligned_cols=249 Identities=18% Similarity=0.304 Sum_probs=218.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++++.||+| .||.||++.+ +++.||+|.+... ......+.+|+.+|+.++||||+++++++.+.+.+++|
T Consensus 4 ~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRG-EFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecC-CCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4689999999999 7999999987 5889999988643 23445688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC--CCcEEEEecCccccccCC
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~--~g~VKL~DFGLAr~~~~~ 830 (960)
|||++|++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999999876667999999999999999999999999 999999999999987 789999999999876443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC--CCCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~--iP~~lS~eLkd 908 (960)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+........ .+..++.++++
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred -CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 223345799999999999999899999999999999999999999999988887777643322211 12468999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+||++.+++++
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999999984
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=366.08 Aligned_cols=261 Identities=32% Similarity=0.562 Sum_probs=226.5
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
++++..++|++++.||.| .||.||++++. +..||||++...... ...+.+|+++|++++||||+++++++.. +.
T Consensus 7 ~~~v~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAG-QFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp TTBCCGGGEEEEEEEEEE-TTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hcccCHHhhhheeeecCC-CCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 467788999999999999 79999999874 568999998765433 3578899999999999999999999874 56
Q ss_pred eEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 899999999999999997632 25899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 828 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 828 ~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
..... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. .......+..++.+
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHH
Confidence 54322 2234457889999999999899999999999999999999 999999988887776664 33355667789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
+.+||.+||..||.+||++.+|++.|+.+....
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999997664
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=381.24 Aligned_cols=259 Identities=25% Similarity=0.458 Sum_probs=219.5
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcE----EEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~----VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+..++|+++++||.| .||+||++++ +++. ||+|.+..... ......+.+|+.++++++||||+++++++. .
T Consensus 10 ~~~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSG-VFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECC-SSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeec-CCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 456789999999999 6999999986 4444 77787654321 222335678999999999999999999886 4
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
...++||||+.+|+|.+++......+++..++.|+.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccc
Confidence 6789999999999999999876668999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 827 KHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 827 ~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
..... .......|+..|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......|..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 243 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICT 243 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCc
Confidence 64332 12234568889999999999999999999999999999999 999999988777766664 344666778889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.++.+||.+||..||.+||++.+++++|+++.+.
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=392.16 Aligned_cols=262 Identities=29% Similarity=0.523 Sum_probs=218.1
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
++...+|++.+.||+| .||.||++++ ++..||||++... ........+.+|+.+|++++||||+++++++.+.
T Consensus 41 ~~~~~~~~~~~~lG~G-~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAG-EFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEEC-SSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeC-CCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 4566789999999999 6999999975 3667999998654 3455567899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+++||||+++++|.+++.+....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999999887768999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCC
Q 002146 827 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 827 ~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~l 902 (960)
...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ...+...+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~ 275 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDC 275 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTC
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccc
Confidence 643321 1122345778999999999999999999999999999998 999999998887777664 33355567789
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
+..+.+||.+||..||.+||++.+|++.|+++.+..
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 999999999999999999999999999999997653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=366.79 Aligned_cols=260 Identities=17% Similarity=0.241 Sum_probs=219.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l 749 (960)
+..++|++++.||.| .||.||++.+ +++.||||++...... ..+.+|+.+++.+ +|+||+++++++......
T Consensus 7 ~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEG-SFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEEC-SSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeec-CCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 345789999999999 7999999985 7899999998654322 2567899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc-----EEEEecCcc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLS 824 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~-----VKL~DFGLA 824 (960)
++||||+ +++|.+++......+++..++.++.||+.||+|||++| |+||||||+||||+.++. +||+|||++
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999999 99999999876667999999999999999999999999 999999999999987776 999999999
Q ss_pred ccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHhhcccc
Q 002146 825 RLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNR 894 (960)
Q Consensus 825 r~~~~~~~-------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~---~~ei~~~I~~~~~ 894 (960)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87643321 2345679999999999999999999999999999999999999998854 3333333321111
Q ss_pred ---ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCC
Q 002146 895 ---RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940 (960)
Q Consensus 895 ---~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p 940 (960)
...+...+++++++||.+||..||.+||++.+|++.|+++.+..-.
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 1123357899999999999999999999999999999999876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=366.93 Aligned_cols=261 Identities=25% Similarity=0.446 Sum_probs=227.5
Q ss_pred cCcCCCCeEEEE-EeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 671 CEIPWEDLVLGE-RIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 671 ~ei~~~dy~i~k-~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+.+..++|.+.+ .||+| .||.||++.+ ++..||||++... ........+.+|+.+|++++||||+++++++ .
T Consensus 4 ~~~~~~~~~i~~~~lg~G-~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCG-NFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECC-TTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccccHHHhhhhhcccccc-CceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 456667888877 99999 7999999975 5778999998764 3445567899999999999999999999999 4
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
.+.+++||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECccccee
Confidence 56799999999999999999876667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 826 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 826 ~~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. ...+..+|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~ 237 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 237 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTT
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCC
Confidence 7643211 1233457889999999999899999999999999999998 999999988877776664 3445677889
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+++++.+||.+||..||.+||++.+++++|+.+...
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999999654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=388.50 Aligned_cols=261 Identities=21% Similarity=0.292 Sum_probs=216.7
Q ss_pred CcCCCCeEEEEEeecc--CCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 672 EIPWEDLVLGERIGLG--SSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 672 ei~~~dy~i~k~LG~G--GsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
.....+|+++++||+| + ||+||++++ +++.||||++............+.+|+.+|+.++|||||+++++|.+.+
T Consensus 21 ~~~~~~y~~~~~lG~G~~~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFED-LMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTT-TEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEEecccCCcCC-ceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 3445789999999999 6 999999987 5899999999887767777778899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+|+||||+++++|.+++... ...+++..++.|+.||+.||+|||++| |+||||||+||||+.++.+||+|||++..
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999999998754 246899999999999999999999999 99999999999999999999999999865
Q ss_pred ccCCc-------ccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc---
Q 002146 827 KHNTF-------LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--- 894 (960)
Q Consensus 827 ~~~~~-------~~~~t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~--- 894 (960)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 42211 11233478999999999988 6789999999999999999999999988766554433221100
Q ss_pred -----------------------------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--H
Q 002146 895 -----------------------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--L 931 (960)
Q Consensus 895 -----------------------------------------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--L 931 (960)
...++..+++++++||.+||..||.+||++.+++++ +
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 012345678999999999999999999999999976 5
Q ss_pred HHhH
Q 002146 932 KPLQ 935 (960)
Q Consensus 932 e~i~ 935 (960)
+.+.
T Consensus 338 ~~~~ 341 (389)
T 3gni_B 338 KQIK 341 (389)
T ss_dssp GGC-
T ss_pred HHHh
Confidence 5443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=378.41 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=217.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~----~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+.|++++.||.| .||.||++.+ +|+.||||++....... .....+.+|+.+|++++||||+++++++.+...+
T Consensus 11 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSG-QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEEEEEEECC-SSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceEeceEEeeC-CCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 569999999999 7999999987 58899999987654321 1356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC----cEEEEecCccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSR 825 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g----~VKL~DFGLAr 825 (960)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999999999764 37999999999999999999999999 99999999999999887 89999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--CCCCCCc
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 903 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--~iP~~lS 903 (960)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+..++
T Consensus 167 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 167 KIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp ECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 76433 22345679999999999999999999999999999999999999999988877776664322111 1225688
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+++||.+||..||.+||++.+++++
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=364.85 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=221.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++.+.||.| .||.||++.+ +++.||+|++............+.+|+.++++++||||+++++++......++|
T Consensus 5 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCc-CCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4679999999999 7999999986 588999999987777777778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc---EEEEecCccccccC
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHN 829 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~---VKL~DFGLAr~~~~ 829 (960)
|||+.+++|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999999887643 6899999999999999999999999 999999999999986655 99999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC--CCCCcHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVA 907 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i--P~~lS~eLk 907 (960)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+......... ...++++++
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 161 S-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp S-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred C-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 3 2334567999999999999999999999999999999999999999999888877776543332222 246899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||..||.+||++.+++++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999984
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=402.96 Aligned_cols=252 Identities=23% Similarity=0.409 Sum_probs=213.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+..++|+++++||+| .||.||+++. +|+.||||++..... .......+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 145 ~~~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKG-TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCGGGEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CChHHcEEeEEEeeC-cCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 455789999999999 7999999986 688999999875432 233345678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++||||+++++|.+++.+.. .+++..++.++.||+.||+|||+ +| ||||||||+||||+.++++||+|||+++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999997643 68999999999999999999998 88 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++++++
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKS 378 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHH
Confidence 444445567899999999999999999999999999999999999999999998888877743 356678889999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHHH
Q 002146 909 IIWECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
||.+||.+||.+|| ++.+++++
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 99999999999999 99999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=372.42 Aligned_cols=267 Identities=28% Similarity=0.476 Sum_probs=220.6
Q ss_pred CccccCcCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEec
Q 002146 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 741 (960)
Q Consensus 667 ~~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g 741 (960)
....+.+..++|.+++.||.| .||.||++++ .+..||||++............+.+|+.++++++||||+++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEG-EFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC--CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hHHhcccCHHHeeeccceeec-CCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 345566777899999999999 6999999975 2347999998877666667778999999999999999999999
Q ss_pred ccccCC-----ceEEEEeecCCCCHHHHhhC-----CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc
Q 002146 742 AVTRPP-----NLSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811 (960)
Q Consensus 742 ~f~~~~-----~l~LVmEY~~gGsL~dlL~k-----~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd 811 (960)
++.+.. ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+||||+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~ 181 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR 181 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc
Confidence 987755 35999999999999999842 2346899999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 002146 812 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 888 (960)
Q Consensus 812 ~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~ 888 (960)
.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 99999999999998654322 11233457889999999999999999999999999999999 9999999888777766
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 889 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 889 I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+. .......+..+++.+.+||.+||..||.+||++.+|+++|+++...
T Consensus 262 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 LL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 64 3345667788999999999999999999999999999999999765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=372.23 Aligned_cols=260 Identities=22% Similarity=0.357 Sum_probs=218.7
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
..++|++++.||+| .||.||++++ +++.||||++..... .......+.+|+.++++++||||+++++++.+.+.+|
T Consensus 9 ~~~~y~i~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 9 INERYKIVDKLGGG-GMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp EETTEEEEEEEEEE-TTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred hhccEEEEEEEccC-CCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34689999999999 6999999986 688999999865443 3455678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+++++|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999997644 6899999999999999999999999 999999999999999999999999999876433
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc---cCCCCCCcHHH
Q 002146 831 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---LEIPKELDPLV 906 (960)
Q Consensus 831 ~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~---~~iP~~lS~eL 906 (960)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.............. ..++..+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 2 2233467999999999999999999999999999999999999999998876655443322111 22456789999
Q ss_pred HHHHHHhhhhCCCCCC-CHHHHHHHHHHhHHh
Q 002146 907 ARIIWECWQTDPSLRP-SFAQLTVALKPLQRL 937 (960)
Q Consensus 907 kdLI~kcL~kDP~kRP-Sa~eILe~Le~i~~~ 937 (960)
.++|.+||.+||.+|| ++.++++.|+.+...
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 9999999999999998 899999999987543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=373.07 Aligned_cols=267 Identities=30% Similarity=0.497 Sum_probs=227.0
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeE
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 739 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL 739 (960)
...+++..++|++++.||.| .||+||++++ +++.||||++.... .......+.+|+.+|+++ +||||+++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRG-AFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEEC-SSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceecchhheeeeeEEcCC-CceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34567778899999999999 6999999974 35789999987543 444556789999999999 79999999
Q ss_pred ecccccCC-ceEEEEeecCCCCHHHHhhCCCCC---------------CcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 740 MGAVTRPP-NLSIITEFLPRGSLFRILHRPHCQ---------------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 740 ~g~f~~~~-~l~LVmEY~~gGsL~dlL~k~~~~---------------lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
++++...+ .+++||||+++++|.+++...... +++..++.++.||+.||.|||++| |+||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~di 174 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 174 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccC
Confidence 99987655 499999999999999999875432 889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999998654321 12234457889999999999999999999999999999998 99999887
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
..................+..+++.+.+||.+||..||.+||++.+|+++|+.+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 6554443333344556677889999999999999999999999999999999997654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=370.23 Aligned_cols=260 Identities=30% Similarity=0.477 Sum_probs=216.8
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
.+....|++++.||.| .||.||++++ +++.||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~~~~~~~~~~~lg~G-~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEG-HFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEEC-SSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCC-CceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3445679999999999 7999999984 68899999987543 22345678899999999999999999999987
Q ss_pred C--CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 746 P--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 746 ~--~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
. ..+++||||+++++|.+++.+....+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccc
Confidence 6 6789999999999999999766667999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------------ChhHHH
Q 002146 824 SRLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--------------NPMQVV 886 (960)
Q Consensus 824 Ar~~~~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~--------------~~~ei~ 886 (960)
++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||... ......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 98765432 2233456888999999999999999999999999999999999876432 111111
Q ss_pred HHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 887 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 887 ~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
............+..+++++.+||.+||..||.+||++.++++.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222234456677889999999999999999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=403.13 Aligned_cols=258 Identities=20% Similarity=0.332 Sum_probs=222.5
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
...+..++|+++++||+| .||+||++++ +++.||||++.+.... ......+.+|+.+|..++||||++++++|++.
T Consensus 68 ~~~~~~~~y~~~~~LG~G-~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRG-AFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHSCCGGGEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred cccCChhheEEEEEEEeC-CCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 345667899999999999 7999999987 5788999998753211 11122478999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+||||||++||+|.+++.+....+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+++.
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 9999999999999999999886668999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCc-ccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 827 KHNTF-LSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 827 ~~~~~-~~~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
..... ......+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+....+........+|.
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 54332 2234568999999999997 56689999999999999999999999999998888887764444455554
Q ss_pred ---CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 002146 901 ---ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 930 (960)
Q Consensus 901 ---~lS~eLkdLI~kcL~kDP~k--RPSa~eILe~ 930 (960)
.+++++++||++||..+|++ |+++++++++
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 48999999999999888888 9999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=363.39 Aligned_cols=261 Identities=31% Similarity=0.557 Sum_probs=222.5
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCc---EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce-E
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGT---EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL-S 750 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~---~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l-~ 750 (960)
.|.+.++||+| .||+||++++ ++. .||||.+... ........+.+|+.++++++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKG-HFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEE-TTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccC-CCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46778999999 6999999986 222 6999988643 3345567889999999999999999999999876665 9
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+.+++|.+++......+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999999887778999999999999999999999999 999999999999999999999999999865432
Q ss_pred c----ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 831 F----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 831 ~----~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
. .......+++.|+|||++.+..++.++|||||||++|+|++ +.+||...+..+....+. .......+..++..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 256 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDS 256 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHH
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHH
Confidence 1 22334568899999999999999999999999999999999 556666666666665554 34456667889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCCCC
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 942 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p~~ 942 (960)
+.+||.+||..||.+||++.++++.|+++.+.+....
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999988765544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=400.85 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=221.5
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
...+..++|+++++||+| +||+||++++ +++.||||++.+.... ......+.+|+.+|+.++|||||+++++|++.
T Consensus 63 ~~~~~~~~y~~~~~LG~G-~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRG-AFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHSCCGGGEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCccccEEEEEEEcC-CCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345677899999999999 7999999987 5889999998653211 11122477899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+||||||++||+|.+++.+. .+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 9999999999999999999764 5899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC--
Q 002146 827 KHNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-- 899 (960)
Q Consensus 827 ~~~~~-~~~~t~~GT~~Y~APEvl~g~~----ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP-- 899 (960)
..... ......+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+.+.......+........+|
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 64432 2345678999999999998776 7899999999999999999999999999888888876444344555
Q ss_pred CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 002146 900 KELDPLVARIIWECWQTDPSL--RPSFAQLTVA 930 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~k--RPSa~eILe~ 930 (960)
..+++++++||.+||..+|.+ |+++++|+++
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 368999999999999999988 9999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=397.72 Aligned_cols=261 Identities=30% Similarity=0.550 Sum_probs=228.3
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+++..++|++.+.||+| .||+||++++ ++..||||++..... ....+.+|+.+|++++|||||++++++. ..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G-~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAG-QFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TCSBCCGGGEEEEEEEECC-SSEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred cceeechHHeEEEEEcccC-CceEEEEEEECCccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 4567888999999999999 7999999988 477899999876543 2457899999999999999999999987 56
Q ss_pred ceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 7999999999999999997643 25788899999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 827 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 827 ~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...+...|..+++
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 412 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPE 412 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCH
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 643221 1233456789999999999999999999999999999999 999999998888877765 3445667888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
++.+||.+||..||.+||++.+|++.|+.+...
T Consensus 413 ~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999998654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.87 Aligned_cols=261 Identities=35% Similarity=0.599 Sum_probs=229.1
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
..+++..++|++.+.||.| .||.||++.+ ++..||||++.... .....+.+|+.++++++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGG-QYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGG-TTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCC-CceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4567788999999999999 6999999987 48889999986543 2356788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
..+++||||+++++|.+++.+. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999999753 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 826 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 826 ~~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++...+. .......+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCC
Confidence 7653321 2233456889999999999999999999999999999999 999999988877776664 344566778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
+.+.+||.+||..||.+||++.++++.|+.+..
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999999998854
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=386.26 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=210.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~---~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
+.|++++.||+| .||+||++.+ +++.||||++..... .......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 24 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKG-PFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeC-CCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 569999999999 7999999986 689999999864321 1113457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc---EEEEecCcc
Q 002146 751 IITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLS 824 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~---~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~---VKL~DFGLA 824 (960)
+||||+++++|.+++.+. +..+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||++
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998877542 335899999999999999999999999 999999999999986554 999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--CCCCCC
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKEL 902 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--~iP~~l 902 (960)
+............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .++...+....... ..+..+
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence 877654444456789999999999999999999999999999999999999998854 34444443221111 112468
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
+.++++||.+||..||.+||++.++++
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 899999999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=400.03 Aligned_cols=257 Identities=19% Similarity=0.319 Sum_probs=220.3
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+..+..++|+++++||+| .||+||++++ +|+.||||++.+.... ......+.+|+.+|..++||||++++++|++.
T Consensus 55 ~~~~~~~~f~~~~~lG~G-~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRG-AFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHSCCGGGEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hccCChhhEEEEEEEeeC-CCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 345677899999999999 7999999987 6899999998753221 12233578999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+.+||||||++||+|.+++.+.+..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhhee
Confidence 9999999999999999999875557999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC
Q 002146 827 KHNTFL-SSKSTAGTPEWMAPEVLR-------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 827 ~~~~~~-~~~t~~GT~~Y~APEvl~-------g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i 898 (960)
...... .....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+....+........+
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 644322 234568999999999997 456899999999999999999999999999988887777543333334
Q ss_pred C---CCCcHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q 002146 899 P---KELDPLVARIIWECWQTDPSLR---PSFAQLTVA 930 (960)
Q Consensus 899 P---~~lS~eLkdLI~kcL~kDP~kR---PSa~eILe~ 930 (960)
| ..+++++++||.+||. +|.+| |++++|+++
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 4 5799999999999999 99998 589998765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.71 Aligned_cols=258 Identities=33% Similarity=0.577 Sum_probs=218.4
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc-CCc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPN 748 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-~~~ 748 (960)
.+.+..++|++++.||.| .||.||+++++|+.||||++.... ....+.+|+.++++++||||+++++++.+ ...
T Consensus 15 ~~~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKG-EFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp CCBCCGGGEEEEEEEEEC-SSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cccCChhhceEEeEEecC-CCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 456778899999999999 699999999999999999986543 34578899999999999999999998654 457
Q ss_pred eEEEEeecCCCCHHHHhhCCCC-CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~-~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
+++||||+++++|.+++.+... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 9999999999999999975432 3788999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 906 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eL 906 (960)
... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ......++..+++.+
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 168 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHH
T ss_pred ccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHH
Confidence 432 223467899999999999999999999999999999998 999999988777776664 334566778899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
.+||.+||..||.+||++.++++.|+.+....
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999997653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=379.15 Aligned_cols=258 Identities=28% Similarity=0.509 Sum_probs=216.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcE----EEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~----VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+..++|+++++||+| .||.||++++ +++. ||+|.+.... .......+.+|+.+|++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSG-AFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEEC-SSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeC-CCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 456789999999999 7999999987 4554 5777665432 233456788999999999999999999999875
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..++|+||+.+|+|.+++......+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 488999999999999999876667999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 827 KHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 827 ~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
..... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......+..++
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICT 245 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCC
Confidence 64322 12233456889999999999999999999999999999999 999999988877776664 344566778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.++.+||.+||..||.+||++.+|++.|+++.+
T Consensus 246 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 246 IDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999999999964
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=374.65 Aligned_cols=254 Identities=18% Similarity=0.250 Sum_probs=214.3
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~L 751 (960)
.++|++++.||.| .||+||+++. +++.||||++...... ..+.+|+.+++++ +||||+++++++......++
T Consensus 8 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCG-NFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC--CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeecc-CCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 4689999999999 7999999985 7899999998754332 2578999999999 99999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc-----EEEEecCcccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRL 826 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~-----VKL~DFGLAr~ 826 (960)
||||+ +++|.+++......+++..++.|+.||+.||+|||++| |+||||||+||||+.++. +||+|||+++.
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99999 99999999876568999999999999999999999999 999999999999998887 99999999987
Q ss_pred ccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHhhcccccc
Q 002146 827 KHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRL 896 (960)
Q Consensus 827 ~~~~~~-------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---ei~~~I~~~~~~~ 896 (960)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 543221 124568999999999999999999999999999999999999999985443 3333332111111
Q ss_pred C---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 897 E---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 897 ~---iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
. +...++ ++++||.+||..||.+||++.+|++.|+.+.+.
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 1 122355 999999999999999999999999999998664
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=367.06 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=223.0
Q ss_pred ccCcCCCCeEEEE-EeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 670 ECEIPWEDLVLGE-RIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 670 ~~ei~~~dy~i~k-~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
+..+..++|++.+ .||.| .||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G-~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSG-NFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEEC-SSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccc-cCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 3456667899998 99999 6999999954 467899999876654455567899999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
..+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 5678899999999999999998643 6899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 825 RLKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 825 r~~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
+....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++...+. ...+..++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 243 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPA 243 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 87643321 1222346789999999999889999999999999999999 999999998887776665 344566788
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+++.+.+||.+||..||.+||++.++++.|+++...
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 8999999999999999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.31 Aligned_cols=262 Identities=31% Similarity=0.530 Sum_probs=226.3
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 742 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~ 742 (960)
.+++..++|++.+.||.| .||.||++.+. ++.||||++.... .......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQG-SFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEEC-SSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccC-CceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 456777899999999999 79999999753 5789999987543 34455678999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHHHHhhCCC---------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC
Q 002146 743 VTRPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 813 (960)
Q Consensus 743 f~~~~~l~LVmEY~~gGsL~dlL~k~~---------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~ 813 (960)
+.+....++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence 999999999999999999999986421 35688999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhh
Q 002146 814 WNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 890 (960)
Q Consensus 814 g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~ 890 (960)
+.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 999999999998654322 11233457889999999999999999999999999999999 899999988887776664
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 891 ~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.......+..++..+++||.+||..||.+||++.+++++|+++..
T Consensus 255 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 333456678899999999999999999999999999999988733
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=374.80 Aligned_cols=262 Identities=29% Similarity=0.511 Sum_probs=222.9
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEEC------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
.++...+|++.+.||+| .||.||++.+. +..||||++... ........+.+|+.++++++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAG-EFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEEC-SSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecC-CCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 45677899999999999 79999999763 235999998654 34455667899999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+...+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999999999999876667999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 825 RLKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 825 r~~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
+....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. ...+...+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~ 273 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPM 273 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCT
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCcc
Confidence 87643211 1222346789999999999999999999999999999999 999999988887777664 333556677
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.++..+.+||.+||..||.+||++.+|++.|+++.+.
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 8999999999999999999999999999999998664
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=391.40 Aligned_cols=252 Identities=21% Similarity=0.342 Sum_probs=216.5
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+..++|++++.||+| +||.||++++ +++.||||++...... ......+.+|+.+|+.++|||||+++++|.+..
T Consensus 10 ~~v~~~~y~i~~~LG~G-~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKG-SFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCGGGEEEEEEEECC-TTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeC-CCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45677899999999999 7999999987 5788999998754321 223457889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+||||+.||+|.+++.+.. .+++..++.|+.||+.||.|||++| |+||||||+||||+.+|++||+|||+++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999998754 6999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHhhccccccCCCCC
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g---~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~---~ei~~~I~~~~~~~~iP~~ 901 (960)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||..... .++...+ ......+|..
T Consensus 166 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~ 242 (384)
T 4fr4_A 166 PRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSA 242 (384)
T ss_dssp CTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTT
T ss_pred cCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCc
Confidence 433 33456789999999999974 4589999999999999999999999985433 3333333 3345677888
Q ss_pred CcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 002146 902 LDPLVARIIWECWQTDPSLRPS-FAQLTV 929 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPS-a~eILe 929 (960)
++.++++||.+||..||.+||+ +.+|++
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 9999999999999999999998 777664
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.24 Aligned_cols=251 Identities=33% Similarity=0.584 Sum_probs=205.9
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHH--cCCCceeeEeccccc----CC
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTR----PP 747 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~--L~HPNIVkL~g~f~~----~~ 747 (960)
..++|++++.||+| .||+||+++++++.||||++... ....+.+|.+++.. ++||||+++++++.. ..
T Consensus 6 ~~~~y~~~~~lg~G-~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKG-RYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEEC-SSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccC-CCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 34689999999999 69999999999999999998643 23455677777777 799999999998543 35
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHh--------hCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLH--------s~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
.+++||||+++|+|.++++.. .+++..++.++.||+.||+||| +++ |+||||||+||||+.++.+||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEEC
T ss_pred eeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEe
Confidence 689999999999999999653 5899999999999999999999 777 9999999999999999999999
Q ss_pred ecCccccccCCcc----cCCCCCCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Q 002146 820 DFGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATL----------KLPWIG 879 (960)
Q Consensus 820 DFGLAr~~~~~~~----~~~t~~GT~~Y~APEvl~g~------~ys~ksDIWSLGvLLyELLTG----------~~PF~~ 879 (960)
|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999976543221 12345799999999999887 445799999999999999999 889976
Q ss_pred CCh-----hHHHHHhhccccccCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 880 MNP-----MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 880 ~~~-----~ei~~~I~~~~~~~~iP~-----~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
... ..+...+.....++.+|. .++.++.+||.+||..||.+||++.+|++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 432 222222322333444443 3567899999999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=364.67 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=222.6
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+.+..++|++.+.||+| .||.||++.+. +..||||.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEG-FFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEEC-SSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEec-CCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 45667899999999999 79999999763 2359999887543 44556789999999999999999999999875
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
...++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCc
Confidence 4578999999999999999876667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 826 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 826 ~~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..++
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCC
Confidence 7643321 2234457889999999999999999999999999999998 999999887777666554 334556677899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+.+.+||.+||..||.+||++.+++++|+.+...
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999998653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=374.21 Aligned_cols=263 Identities=28% Similarity=0.464 Sum_probs=226.1
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC--C-----cEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEec
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN--G-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 741 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~--g-----~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g 741 (960)
.+++..++|++++.||.| .||.||++.+. + ..||||.+.... .......+.+|+.+|+++ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAG-AFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEEC-SSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccC-CCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 467888999999999999 69999999873 2 479999986543 344567789999999999 8999999999
Q ss_pred ccccCCceEEEEeecCCCCHHHHhhCC-------------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcE
Q 002146 742 AVTRPPNLSIITEFLPRGSLFRILHRP-------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 808 (960)
Q Consensus 742 ~f~~~~~l~LVmEY~~gGsL~dlL~k~-------------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNI 808 (960)
++.+.+.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NI 195 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNV 195 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGC
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceE
Confidence 999999999999999999999998642 235789999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 002146 809 LVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQV 885 (960)
Q Consensus 809 LLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei 885 (960)
||+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999999986543221 1233457889999999999999999999999999999998 9999998776555
Q ss_pred HHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 886 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 886 ~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
...+.........|..++..+.+||.+||..||.+||++.+|++.|+.+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 555444445566677889999999999999999999999999999998854
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=364.98 Aligned_cols=260 Identities=30% Similarity=0.482 Sum_probs=220.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc-cccCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA-VTRPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~-f~~~~~l 749 (960)
..|++.++||+| .||.||++.+. ...||||.+... ........+.+|+.++++++||||++++++ +......
T Consensus 25 ~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRG-HFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEE-TTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeec-CCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 469999999999 79999999752 225899987653 344556788999999999999999999998 4566788
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++||||+++++|.+++.+....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999999877667899999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc----ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 830 TF----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 830 ~~----~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
.. .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+. .......|..++.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCH
Confidence 21 12234457889999999999999999999999999999999 677887777666665554 3345556778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCC
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p 940 (960)
.+.+||.+||..||.+||++.++++.|+++...+..
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=377.18 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=216.3
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcE----EEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~----VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+..++|+++++||+| .||+||++++ +++. ||+|.+.... .......+.+|+.+|++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSG-AFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEE-TTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeC-CCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 445789999999999 6999999986 4443 5777765432 233456789999999999999999999999875
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..++|+||+.+|+|.+++.+....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 478999999999999999876678999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCc
Q 002146 827 KHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 827 ~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. .......+..++
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICT 245 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCC
Confidence 643322 2233456889999999999999999999999999999999 999999988877766654 344566778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.++.+||.+||..||.+||++.+++++|+.+.+
T Consensus 246 ~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 246 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999999999999999999999999999999865
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=368.91 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=208.3
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++++.||.| .||+||++++ +|+.||||++............+.+|+.++++++||||+++++++.....+++|
T Consensus 2 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEG-SYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeec-CCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 3689999999999 6999999987 588999999877665566667788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 9999999999988754 36899999999999999999999999 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-------------------
Q 002146 833 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------------- 892 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~------------------- 892 (960)
.....+||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 4455679999999999987 56899999999999999999999999998766554433211
Q ss_pred ccccCC----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 NRRLEI----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 ~~~~~i----------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...... ...++..+.+||.+||..||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 13578889999999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=368.11 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=194.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
.++|++++.||+| .||.||+++. +|+.||||++...... ......+.+|+.++++++||||+++++++.+.+.+++
T Consensus 10 ~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKG-SFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCC-CceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4679999999999 7999999986 7899999998653221 1224578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999999999877667999999999999999999999999 9999999999999999999999999998765433
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....+|..++.++++||.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 244 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDLIH 244 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHHHH
Confidence 33345679999999999999999999999999999999999999998876655554442 2344567789999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||..||.+||++.+++++
T Consensus 245 ~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 245 QLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHSCSSGGGSCCHHHHTTS
T ss_pred HHcccCHhhCCCHHHHhcC
Confidence 9999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=377.52 Aligned_cols=251 Identities=27% Similarity=0.341 Sum_probs=209.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++++.||+| .||+||++.+ +++.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~i~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEG-AYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecC-CCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3689999999999 7999999986 6889999998654332 2235678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC--
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 830 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~-- 830 (960)
|||+++++|.+++.... .+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999999997643 6999999999999999999999999 999999999999999999999999999865322
Q ss_pred cccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHH-HHHhhccccccCCCCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQV-VGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei-~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+...... ................++..+.+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence 122345689999999999988775 7899999999999999999999987655322 22222122222233568999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+||++.|++++
T Consensus 241 li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhhCcCHHHHhhC
Confidence 9999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.77 Aligned_cols=253 Identities=31% Similarity=0.613 Sum_probs=211.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+..++|++.+.||+| .||.||++++.++.||||++... .....+.+|+.+|++++||||+++++++.+ ..++|
T Consensus 5 i~~~~~~~~~~lg~G-~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 5 IDYKEIEVEEVVGRG-AFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp CCGGGEEEEEEEECC-SSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred CCHhHeeeeeEeecC-CCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 556789999999999 69999999999999999998543 234678899999999999999999999874 58999
Q ss_pred EeecCCCCHHHHhhCCCC--CCcHHHHHHHHHHHHHHHHHHhh---CCCCEEEeccCCCcEEEcCCCc-EEEEecCcccc
Q 002146 753 TEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHT---STPTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRL 826 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~--~lse~~~~~Ia~QIa~AL~YLHs---~g~~IIHRDLKPeNILLd~~g~-VKL~DFGLAr~ 826 (960)
|||+++++|.+++..... .+++..++.++.||+.||.|||+ +| |+||||||+||||+.++. +||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 999999999999986543 46888999999999999999999 66 999999999999998886 79999999976
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--HHHHHhhccccccCCCCCCcH
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~--ei~~~I~~~~~~~~iP~~lS~ 904 (960)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .+...+. ....+.++..++.
T Consensus 156 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 231 (307)
T 2eva_A 156 IQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLPK 231 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCCCCCBTTCCH
T ss_pred cccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCCCCcccccCH
Confidence 5432 22356999999999999999999999999999999999999999865432 2222222 3345566778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
.+.+||.+||..||.+||++.++++.|+.+.+..
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999997653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.99 Aligned_cols=251 Identities=25% Similarity=0.466 Sum_probs=217.3
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
.+..++|++++.||.| .||.||++++ +++.||||++....... .....+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKG-KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCGGGEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred eeecccEEEeeEEecC-CCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 3456889999999999 7999999987 56789999986543221 124568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
.++||||+++++|.+++.+.. .+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999999987643 6899999999999999999999998 9999999999999999999999999986543
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+. .....+|..++..+++
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 236 (279)
T 3fdn_A 161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARD 236 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHH
T ss_pred cc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHH
Confidence 32 2334679999999999999999999999999999999999999999988887777663 3355678889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+||++.+++++
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHhccChhhCCCHHHHhhC
Confidence 9999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.57 Aligned_cols=262 Identities=24% Similarity=0.449 Sum_probs=210.6
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
...+|++.+.||.| .||.||++.. +|+.||||++..... .......+.+|+.++++++||||+++++++...+.++
T Consensus 30 ~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRG-QFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC---CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCC-CCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 45689999999999 7999999986 689999999876443 3455678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 751 IITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999864 3446899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHhhccccccCCCCCCcHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~--~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
...........|++.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+.........+..++.+
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 544333445679999999999999999999999999999999999999997653 334444443222222234678999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
+++||.+||..||.+||++.+|++.|+++....
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=367.61 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=219.1
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccc--ccCCceE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNLS 750 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f--~~~~~l~ 750 (960)
.++|++++.||.| .||.||++++ +++.||||++............+.+|+.++++++||||+++++++ .....++
T Consensus 5 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTG-SYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEEC-SSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCC-CCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4689999999999 7999999987 688999999987776777778899999999999999999999987 4467899
Q ss_pred EEEeecCCCCHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHhhCC---CCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 751 IITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~---~~~lse~~~~~Ia~QIa~AL~YLHs~g---~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999998742 234899999999999999999999976 23999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
+.............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..++...+.. .....++..++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 242 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSD 242 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTTSCH
T ss_pred eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcccCH
Confidence 8764332222335689999999999999999999999999999999999999999888777766643 334567788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
++++||.+||..||.+||++.+|++++.
T Consensus 243 ~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 243 ELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 9999999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=385.69 Aligned_cols=248 Identities=27% Similarity=0.461 Sum_probs=215.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
..+|++++.||+| .||.||++.+ +++.||||++....... .....+.+|+.+|+.++||||+++++++.+...+++
T Consensus 8 i~~Y~i~~~lG~G-~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEG-SFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecC-CCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4689999999999 7999999987 78899999986532211 123468899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+ +|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp EECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 99999 689999886543 6899999999999999999999999 999999999999999999999999999876443
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.....+...+ ......+|..+++++++||
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHH
Confidence 23455789999999999998886 78999999999999999999999887666555444 3335567888999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||..||.+||++.+++++
T Consensus 240 ~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHHhC
Confidence 99999999999999999885
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=398.79 Aligned_cols=261 Identities=35% Similarity=0.599 Sum_probs=229.7
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
...+++...+|++.++||.| .||.||++.+. +..||||++...... ...+.+|+.+|++++|||||++++++.+
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G-~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGG-QYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGG-TTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccccCHHHceeeeEecCC-CCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34577888899999999999 79999999884 789999998765432 4578999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
...++|||||+++|+|.+++.+. ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccc
Confidence 99999999999999999999753 346899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCC
Q 002146 825 RLKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 825 r~~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~l 902 (960)
+....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...+...|..+
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 444 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGC 444 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTC
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 87643322 2233456789999999999999999999999999999999 999999988887776664 34466778889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
++.+.+||.+||..||.+||++.+|++.|+.+.
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=372.66 Aligned_cols=259 Identities=32% Similarity=0.599 Sum_probs=221.4
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEE--EEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEV--AVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 747 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~V--AVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~ 747 (960)
+.+++|++.+.||.| .||.||++++ ++..+ |||.+.... .......+.+|+.+|+++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEG-NFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECG-GGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecC-CCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 566899999999999 7999999975 56644 999886432 233445788999999999 9999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC
Q 002146 748 NLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 812 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~ 812 (960)
.+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcC
Confidence 9999999999999999997653 36899999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhc
Q 002146 813 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 891 (960)
Q Consensus 813 ~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~ 891 (960)
++.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+.
T Consensus 178 ~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~- 255 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 255 (327)
T ss_dssp GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-
Confidence 999999999999754322 22233457889999999999999999999999999999998 999999998888777664
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 892 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 892 ~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.......+..+++++++||.+||..||.+||++.+++++|+++...
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 3345566788999999999999999999999999999999999765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=369.27 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=215.2
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEEC--C-------cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWN--G-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 742 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~--g-------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~ 742 (960)
++..++|++.+.||+| .||+||++.+. + ..||+|++.... ......+.+|+.+|++++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQG-TFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEE-TTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccC-CCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4556789999999999 79999999763 3 569999986542 3345678999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc-------
Q 002146 743 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN------- 815 (960)
Q Consensus 743 f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~------- 815 (960)
+.+.+..++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccc
Confidence 99999999999999999999999876666999999999999999999999999 999999999999998877
Q ss_pred -EEEEecCccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHhhcc
Q 002146 816 -VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892 (960)
Q Consensus 816 -VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG-~~PF~~~~~~ei~~~I~~~ 892 (960)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||............
T Consensus 159 ~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~--- 231 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY--- 231 (289)
T ss_dssp EEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---
T ss_pred eeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---
Confidence 999999999755332 22457889999999988 6789999999999999999995 5566555554443332
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 893 ~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.....++...+.++++||.+||..||.+||++.+++++|+.+..
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 23556677788899999999999999999999999999999854
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=375.79 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=197.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++++.||+| .||.||++.+ +|+.||||++..... ......+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus 4 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNG-TYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCC-CCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 3679999999999 7999999976 588999999875432 22334678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCC-----CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 753 TEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~-----~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
|||++ ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99997 5999988642 235889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc------------
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------ 894 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~------------ 894 (960)
..........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 5443344456799999999999874 689999999999999999999999999887665544421100
Q ss_pred --------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 --------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 --------------------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....+..++.++++||.+||..||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 011223578899999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.93 Aligned_cols=247 Identities=28% Similarity=0.389 Sum_probs=215.9
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.|...++||+| .||.||+++. +|+.||||++...... ....+.+|+.+|++++||||+++++++...+.+++|||
T Consensus 46 ~~~~~~~lg~G-~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEG-STGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccC-CCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 47888999999 7999999986 6899999998755432 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+++++|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.........
T Consensus 123 ~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 123 FLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp CCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred cCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence 99999999998753 5899999999999999999999999 9999999999999999999999999998765543344
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-ccCCCCCCcHHHHHHHHHh
Q 002146 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-~~~iP~~lS~eLkdLI~kc 913 (960)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ....+..+++.+++||.+|
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 567899999999999999999999999999999999999999999888777666542221 1122346789999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~ 930 (960)
|..||.+||++.+++++
T Consensus 279 l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 279 LVRDPQERATAQELLDH 295 (321)
T ss_dssp SCSSTTTSCCHHHHHTS
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=365.92 Aligned_cols=261 Identities=34% Similarity=0.544 Sum_probs=217.0
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE---CCc--EEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW---NGT--EVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~---~g~--~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
.+..++|++++.||.| .||+||++++ +++ .||||++...... ......+.+|+.++++++||||+++++++..
T Consensus 14 ~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDG-SFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC-----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCC-CceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 4456789999999999 7999999986 223 5899988765432 3456788999999999999999999999987
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
.. .++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccc
Confidence 65 89999999999999999875557899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 826 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 826 ~~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
....... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.........+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence 7643321 1233457889999999999999999999999999999999 99999999988888877666666667788
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
++.++++||.+||..||.+||++.++++.|++++.
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 99999999999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=373.82 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=218.6
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc--
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-- 744 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~-- 744 (960)
+..++|++++.||.| .||.||++++ +++.||||++... .......+.+|+.+|++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKG-NFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEE-TTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCC-CCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 445789999999999 7999999984 5788999998754 3445567899999999999999999999876
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+...+++||||+++++|.+++......+++..++.|+.||+.||+|||+.| |+||||||+||||+.++.+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccc
Confidence 456699999999999999999875557999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------------HHHH
Q 002146 825 RLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--------------QVVG 887 (960)
Q Consensus 825 r~~~~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~--------------ei~~ 887 (960)
+...... .......||..|+|||++.+..++.++|||||||++|+|++|..||...... ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 8764322 1233456888999999999999999999999999999999999999654322 1111
Q ss_pred HhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 888 ~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
...........+..+++.+++||.+||..||.+||++.+|+++|+.+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 122234455667889999999999999999999999999999999986653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=363.27 Aligned_cols=252 Identities=24% Similarity=0.436 Sum_probs=220.2
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+..++|++++.||.| .||.||++++ +++.||||++....... .....+.+|+.++++++||||+++++++.+.+
T Consensus 9 ~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKG-KFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp -CCCGGGEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cchhhhhceeeheecCC-CCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 34566889999999999 7999999987 57789999986542211 12356889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+++||||+++++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999999997643 6899999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
... ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....+|..++.+++
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 240 (284)
T 2vgo_A 165 PSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSK 240 (284)
T ss_dssp SSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHH
T ss_pred ccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHH
Confidence 432 2345679999999999999999999999999999999999999999988777766653 335567888999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||..||.+||++.+++++
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHHhhcCHhhCCCHHHHhhC
Confidence 99999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.67 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=222.7
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
...+|++++.||+| .||.||++++ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.++
T Consensus 13 ~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKG-GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTEEEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeec-CCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34679999999999 6999999987 478899999876543 3445667899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999999987543 6899999999999999999999999 999999999999999999999999999876544
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
........||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....+|..+++.+.+||
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 246 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLI 246 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHH
Confidence 344455679999999999999999999999999999999999999999988777766653 335567888999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||..||.+||++.+++++
T Consensus 247 ~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 247 QKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHTCSSGGGSCCGGGGGGS
T ss_pred HHHcccChhhCcCHHHHhhC
Confidence 99999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=392.20 Aligned_cols=261 Identities=33% Similarity=0.565 Sum_probs=222.8
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEECC-cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g-~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+++..++|++.++||+| .||.||++.+.+ ..||||++...... ...+.+|+.+|++++||||+++++++.+ .
T Consensus 177 ~~~~i~~~~~~~~~~lG~G-~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQG-CFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TCSBCCGGGEEEEEEEEEC-SSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccccChhHceeeeeecCC-CCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 3467888999999999999 799999999854 67999998765433 3478899999999999999999999876 6
Q ss_pred ceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 789999999999999999742 235889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 827 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 827 ~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ...+...|..+++
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 408 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 408 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCH
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 643321 1233457789999999999999999999999999999999 999999998888877765 3446667888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+.+||.+||..||.+||++.+|++.|+.+...
T Consensus 409 ~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 999999999999999999999999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=415.07 Aligned_cols=255 Identities=20% Similarity=0.346 Sum_probs=222.7
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHc-CCCceeeEeccccc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR 745 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~ 745 (960)
...+..++|+++++||+| +||+||++++ +++.||||++.+... .......+..|..+|..+ +||||++++++|++
T Consensus 335 ~~~~~~~~f~~~~~LG~G-~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKG-SFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413 (674)
T ss_dssp -----CTTEEEEEESSBT-TTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred cccccccceEEEEEEccC-CCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence 345667899999999999 7999999987 577899999875422 122345678899999988 79999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
.+.+||||||++||+|.+++.+.+ .+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999999998654 6899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++...|. .....+|..++++
T Consensus 491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~ 568 (674)
T 3pfq_A 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKE 568 (674)
T ss_dssp ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHH
T ss_pred ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHH
Confidence 65444445567889999999999999999999999999999999999999999999998888885 3467788999999
Q ss_pred HHHHHHHhhhhCCCCCCCH-----HHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSF-----AQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa-----~eILe~ 930 (960)
+++||.+||.+||.+|+++ ++|+++
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 9999999999999999997 777653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=382.29 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=203.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCC--ce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP--NL 749 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~--~l 749 (960)
.++|++++.||.| +||.||++.+ +|+.||||++............+.+|+.+|+.+. ||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKG-AYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC--------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeC-CCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3689999999999 7999999976 6899999998766556666778889999999996 999999999987544 69
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+||||++ ++|..++... .+++..+..++.||+.||+|||+.| |+||||||+||||+.++.+||+|||+++....
T Consensus 87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999997 5899998763 5899999999999999999999999 99999999999999999999999999986532
Q ss_pred C---------------------cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 002146 830 T---------------------FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 887 (960)
Q Consensus 830 ~---------------------~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~ 887 (960)
. .......+||++|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 111234579999999999987 678999999999999999999999999988766655
Q ss_pred Hhhcccccc---------------------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCC
Q 002146 888 AVGFQNRRL---------------------------------------------EIPKELDPLVARIIWECWQTDPSLRP 922 (960)
Q Consensus 888 ~I~~~~~~~---------------------------------------------~iP~~lS~eLkdLI~kcL~kDP~kRP 922 (960)
.+......+ ..+..+++++++||.+||..||.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 542110000 01226788999999999999999999
Q ss_pred CHHHHHHH--HHHh
Q 002146 923 SFAQLTVA--LKPL 934 (960)
Q Consensus 923 Sa~eILe~--Le~i 934 (960)
++.+++++ |+.+
T Consensus 322 t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 322 SANDALKHPFVSIF 335 (388)
T ss_dssp CHHHHTTSTTTTTT
T ss_pred CHHHHhCCHHHHHh
Confidence 99999987 5444
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=371.52 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=209.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCc---
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN--- 748 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~--- 748 (960)
.++|++++.||.| .||.||++++ +++.||||++...... ......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFG-GMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccC-CCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4679999999999 7999999985 7889999999765433 3455678999999999999999999999876554
Q ss_pred -eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 749 -LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 -l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.|+||||+++++|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 499999999999999997643 6899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--CCCCCC
Q 002146 828 HNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKEL 902 (960)
Q Consensus 828 ~~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--~iP~~l 902 (960)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......+ ..+..+
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 4321 12234569999999999999999999999999999999999999999988776655543222111 123568
Q ss_pred cHHHHHHHHHhhhhCCCCCCCH-HHHHHHHHHhHHh
Q 002146 903 DPLVARIIWECWQTDPSLRPSF-AQLTVALKPLQRL 937 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa-~eILe~Le~i~~~ 937 (960)
+.++.+||.+||..||.+||+. +++.+.+.++...
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 9999999999999999999965 4555666665544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=369.79 Aligned_cols=264 Identities=28% Similarity=0.421 Sum_probs=219.5
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-- 745 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-- 745 (960)
....|+++++||.| .||+||++.+ +++.||||++... ........+.+|+.+|++++||||+++++++.+
T Consensus 29 ~~r~~~~~~~lG~G-~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEG-HFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CGGGEEEEEEEEEC-SSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cHHHHhhhheecCC-CCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 33456999999999 7999999865 6788999998754 344556788999999999999999999999987
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
...+++||||+++++|.+++.+. .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccc
Confidence 46789999999999999999764 3899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH--------------HHHH
Q 002146 826 LKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--------------VVGA 888 (960)
Q Consensus 826 ~~~~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e--------------i~~~ 888 (960)
...... .......||..|+|||++.+..++.++|||||||++|+|++|..||....... ....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 764432 12334568889999999999999999999999999999999999997642210 0111
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCCCCC
Q 002146 889 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 943 (960)
Q Consensus 889 I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p~~P 943 (960)
..........+..++.++.+||.+||..||.+||++.++++.|+.+.+.+....|
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 1123345567788999999999999999999999999999999999887654433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.47 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=217.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~----~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
++|++++.||.| .||.||++++ +|+.||||++....... .....+.+|+.+|++++||||+++++++.+...+
T Consensus 12 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 12 DFYDIGEELGSG-QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccEEEeeEeeec-CCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 569999999999 7999999987 58899999987654322 1356789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC----cEEEEecCccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSR 825 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g----~VKL~DFGLAr 825 (960)
++||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999997643 6899999999999999999999999 99999999999999887 79999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc--cCCCCCCc
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELD 903 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~--~~iP~~lS 903 (960)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...... ..++..++
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 168 EIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp ECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred ecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 76543 2234567999999999999999999999999999999999999999998887777666432211 11225688
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+++||.+||..||.+||++.+++++
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=379.04 Aligned_cols=250 Identities=27% Similarity=0.372 Sum_probs=200.7
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
...++|++++.||+| .||+||+++. +++.||||++....... ..+.+|+.+++.++||||+++++++.+...++
T Consensus 17 ~~~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSG-NFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSS-TTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccC-CCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 345789999999999 7999999987 68899999987654332 35789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc--EEEEecCcccccc
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRLKH 828 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~--VKL~DFGLAr~~~ 828 (960)
+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||||+.++. +||+|||+++...
T Consensus 93 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999999987643 6999999999999999999999999 999999999999987665 9999999997543
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHhhccccccCCCCCCc
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEK-CDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~k-sDIWSLGvLLyELLTG~~PF~~~~~----~ei~~~I~~~~~~~~iP~~lS 903 (960)
.. ......+||+.|+|||++.+..+..+ +|||||||++|+|++|..||.+... ......+............++
T Consensus 170 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 170 LH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred cc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 22 22345679999999999998888655 8999999999999999999987544 333333322222222233689
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++++||.+||..||.+||++.+++++
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 999999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=371.89 Aligned_cols=260 Identities=29% Similarity=0.420 Sum_probs=204.7
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHH--HHHcCCCceeeEecc-----c
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGA-----V 743 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~I--Lk~L~HPNIVkL~g~-----f 743 (960)
..+..++|++++.||+| .||.||+++++++.||||++.... ...+..|.++ +..++||||+++++. +
T Consensus 8 ~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRG-RYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp -CCCTTSEEEEEEEEEC-SSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CCcChHHhheeeecccC-CCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 45677899999999999 799999999999999999986432 2233344444 445799999999874 3
Q ss_pred ccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC---------CCCEEEeccCCCcEEEcCCC
Q 002146 744 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS---------TPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~---------g~~IIHRDLKPeNILLd~~g 814 (960)
.....+++||||+++|+|.+++.... .++..++.++.||+.||.|||+. + |+||||||+||||+.++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTS
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCC
Confidence 34446889999999999999997644 58888999999999999999998 8 99999999999999999
Q ss_pred cEEEEecCccccccCCc--------ccCCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002146 815 NVKVSDFGLSRLKHNTF--------LSSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATLKLPWIG 879 (960)
Q Consensus 815 ~VKL~DFGLAr~~~~~~--------~~~~t~~GT~~Y~APEvl~g-------~~ys~ksDIWSLGvLLyELLTG~~PF~~ 879 (960)
.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999998654321 12234579999999999987 3566789999999999999999777654
Q ss_pred CCh------------------hHHHHHhhccccccCCCCC------CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 880 MNP------------------MQVVGAVGFQNRRLEIPKE------LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 880 ~~~------------------~ei~~~I~~~~~~~~iP~~------lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
... ......+.....++.+|.. +++++++||.+||..||.+||++.++++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 221 1111122223334445443 4458999999999999999999999999999998
Q ss_pred HhhCC
Q 002146 936 RLVIP 940 (960)
Q Consensus 936 ~~~~p 940 (960)
.....
T Consensus 318 ~~~~~ 322 (336)
T 3g2f_A 318 MIWER 322 (336)
T ss_dssp HCCCC
T ss_pred HHHHh
Confidence 66433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=368.62 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=209.8
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC--ceE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLS 750 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~--~l~ 750 (960)
.++|+++++||+| .||+||++++ +++.||||++...... .....+.+|+.+|++++||||+++++++.... .++
T Consensus 8 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQG-ATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCC-CCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 4679999999999 7999999987 4889999998754322 22456789999999999999999999987655 789
Q ss_pred EEEeecCCCCHHHHhhCCCC--CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE----cCCCcEEEEecCcc
Q 002146 751 IITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLS 824 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~--~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL----d~~g~VKL~DFGLA 824 (960)
+||||+++++|.+++..... .+++..++.++.||+.||.|||+.| |+||||||+|||| +.++.+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999999986432 3899999999999999999999999 9999999999999 78889999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHhhcc
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQ 892 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~--------g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~----~ei~~~I~~~ 892 (960)
+..... .......||+.|+|||++. +..++.++|||||||++|||++|..||..... .++...+...
T Consensus 164 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 876543 2334567999999999986 57789999999999999999999999975432 2222222111
Q ss_pred cc-----------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 893 NR-----------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 893 ~~-----------------------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.. ...++..++..+.+||.+||..||.+||+++|++++...-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 10 0122334567899999999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=373.63 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=212.3
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC--CceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H--PNIVkL~g~f~~~~~ 748 (960)
.+..+.|++++.||+| .||.||++.. +++.||||++............+.+|+.+|++++| |||+++++++.....
T Consensus 5 ~~~~~~y~i~~~lG~G-~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSG-GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCC-SSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecC-CCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4556789999999999 7999999976 67889999998777677777889999999999976 999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++|||| .+++|.+++.+.. .+++..++.|+.||+.||+|||+++ |+||||||+||||+ ++.+||+|||+++...
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9999995 5789999998754 6899999999999999999999999 99999999999997 6789999999998764
Q ss_pred CCcc--cCCCCCCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhcccc
Q 002146 829 NTFL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNR 894 (960)
Q Consensus 829 ~~~~--~~~t~~GT~~Y~APEvl~g-----------~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~~~~ 894 (960)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 3321 2335679999999999975 6789999999999999999999999987533 233334433445
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+|...+.++.+||.+||..||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 566788889999999999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=369.88 Aligned_cols=261 Identities=28% Similarity=0.458 Sum_probs=221.6
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
++..++|++++.||.| .||.||++++ +++.||||++... ........+.+|+.++++++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHG-AFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC---CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCC-CCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4566889999999999 6999999973 4668999998643 34455668899999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCC------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWN 815 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~ 815 (960)
+....++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+. +..
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcce
Confidence 9999999999999999999997643 34888999999999999999999999 999999999999984 446
Q ss_pred EEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcc
Q 002146 816 VKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 892 (960)
Q Consensus 816 VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~ 892 (960)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-c
Confidence 9999999997653321 12233467899999999999999999999999999999998 999999988877776664 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 893 ~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
......+..++..+.+||.+||..||.+||++.+|+++|+.+...
T Consensus 261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 345667788999999999999999999999999999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=372.52 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=222.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
..+|.+++.||+| .||.||++++ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 40 ~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKG-GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEeeC-CCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4679999999999 6999999987 578899999876543 34556678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 119 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999999987643 6899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....+|..+++.+++||.
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 273 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQ 273 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHHHH
Confidence 44455679999999999999999999999999999999999999999988777666553 3345678889999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||..||.+||++.+++++
T Consensus 274 ~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 274 KMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHTCSSGGGSCCGGGGGGS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=373.32 Aligned_cols=262 Identities=28% Similarity=0.428 Sum_probs=217.1
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
.+...++|++.+.||+| .||.||++++ +++.||||++..... .....+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 34 ~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHG-VFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCSCCCCSCBC-SSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHhccCccceeecC-CCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33455789999999999 7999999987 588999998765432 3456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCC---CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 750 SIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~---~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999997543 25889999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhh------c-------
Q 002146 827 KHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------F------- 891 (960)
Q Consensus 827 ~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~------~------- 891 (960)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+.+...... .
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 53221 12234568999999999999999999999999999999999999998754432211100 0
Q ss_pred --cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 892 --QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 892 --~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
......++..++..+.+|+.+||..||.+||++.+++++|+.+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 0001122334567899999999999999999999999999998765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=383.36 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=218.1
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++++.||.| .||.||++.. +++.||+|++.... ......+.+|+.+|+.++|||||++++++.+...+++|
T Consensus 50 ~~~y~i~~~LG~G-~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSG-AFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecC-CCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3679999999999 7999999987 68899999987543 33445788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC--CCcEEEEecCccccccCC
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~--~g~VKL~DFGLAr~~~~~ 830 (960)
|||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+. .+.+||+|||+++.....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999999876667999999999999999999999999 999999999999974 578999999999876443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc--ccCCCCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~--~~~iP~~lS~eLkd 908 (960)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ....+..+++++++
T Consensus 205 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 205 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred c-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 2 22345799999999999999999999999999999999999999999888777766643322 22234568999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+||++.+++++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCChhHCcCHHHHhhC
Confidence 9999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=396.45 Aligned_cols=252 Identities=26% Similarity=0.512 Sum_probs=222.3
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
.+...+|.+++.||.| .||.||++++ +|+.||||++....... .....+.+|+.+|+.++||||+++++++.+...
T Consensus 12 ~~~~~~Y~l~~~LG~G-~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 12 RVKIGHYILGDTLGVG-TFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp CCEETTEEEEEEEECC-SSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CceecCEEEEEEEeeC-CCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3456789999999999 7999999987 68999999987543211 234578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+||||+++++|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999999997644 6999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+. ......|..++++++
T Consensus 168 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~ 244 (476)
T 2y94_A 168 DG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPSVI 244 (476)
T ss_dssp TT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHHHH
T ss_pred cc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHHHH
Confidence 43 23345689999999999998876 789999999999999999999999988887777764 334567788999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||..||.+||++.+|+++
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHcCCCchhCcCHHHHHhC
Confidence 99999999999999999999984
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=368.71 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=200.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC------
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~------ 747 (960)
++|++++.||+| .||.||++++ +|+.||||++.... .......+.+|+.+|++++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G-~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRG-GFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC--CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCC-CCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 579999999999 7999999987 68999999987654 3334567899999999999999999999875543
Q ss_pred ---------------------------------------------------ceEEEEeecCCCCHHHHhhCCCC--CCcH
Q 002146 748 ---------------------------------------------------NLSIITEFLPRGSLFRILHRPHC--QVDE 774 (960)
Q Consensus 748 ---------------------------------------------------~l~LVmEY~~gGsL~dlL~k~~~--~lse 774 (960)
.+++||||+++++|.+++.+... ...+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999987543 3445
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc------------ccCCCCCCCCC
Q 002146 775 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF------------LSSKSTAGTPE 842 (960)
Q Consensus 775 ~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~------------~~~~t~~GT~~ 842 (960)
..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...... ......+||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 568899999999999999999 9999999999999999999999999998765431 12334579999
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 002146 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRP 922 (960)
Q Consensus 843 Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRP 922 (960)
|+|||++.+..++.++|||||||++|+|++|..|+... ......+. ....+..+...++++++||.+||..||.+||
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 99999999999999999999999999999987765321 12222221 1111112234567899999999999999999
Q ss_pred CHHHHHHH
Q 002146 923 SFAQLTVA 930 (960)
Q Consensus 923 Sa~eILe~ 930 (960)
++.+++++
T Consensus 319 s~~~~l~~ 326 (332)
T 3qd2_B 319 EATDIIEN 326 (332)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhhc
Confidence 99999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=377.81 Aligned_cols=245 Identities=23% Similarity=0.382 Sum_probs=209.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++++.||.| .||+||++.+ +++.||||++...... ..+|+++|.++ +||||+++++++.+...+|+|
T Consensus 22 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVG-SYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeC-CCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 579999999999 7999999987 5889999998765432 34688888888 799999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC----CcEEEEecCcccccc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRLKH 828 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~----g~VKL~DFGLAr~~~ 828 (960)
|||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||+... +.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999997754 6899999999999999999999999 9999999999998532 359999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CChhHHHHHhhcccccc--CCCCCCc
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG---MNPMQVVGAVGFQNRRL--EIPKELD 903 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~---~~~~ei~~~I~~~~~~~--~iP~~lS 903 (960)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+ ....++...+....... ..+..++
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 544444567899999999999988899999999999999999999999986 34555666554332221 2345789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++++||.+||..||.+||++.+++++
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=368.71 Aligned_cols=246 Identities=24% Similarity=0.262 Sum_probs=206.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|+++++||+| .||+||++++ +|+.||||++............+..|+..+.++ +||||++++++|.+...+++|
T Consensus 57 ~~y~~~~~LG~G-~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHG-SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEE-TTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccC-CCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 579999999999 6999999987 589999999876655555555666777777666 999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+ +++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..... .
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-G 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccC-C
Confidence 9999 67999988776667999999999999999999999999 999999999999999999999999999876443 2
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~k 912 (960)
......||+.|+|||++.+ .++.++|||||||++|||++|..||.+.... ..+........++..+++++++||.+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~ 287 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVM 287 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSCHHHHHHHHH
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCCHHHHHHHHH
Confidence 3345679999999999987 6899999999999999999997777654322 22222222334556789999999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 002146 913 CWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 913 cL~kDP~kRPSa~eILe~ 930 (960)
||..||.+||++.+++++
T Consensus 288 ~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 288 MLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HSCSSTTTSCCHHHHHTS
T ss_pred HcCCChhhCcCHHHHHhC
Confidence 999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.44 Aligned_cols=253 Identities=30% Similarity=0.443 Sum_probs=215.4
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc----C
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----P 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~----~ 746 (960)
.....|++.+.||+| .||.||++.+ ++..||+|++............+.+|+.+|++++||||+++++++.. .
T Consensus 23 ~~~~~~~~~~~lg~G-~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRG-SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred cCceeEEeeeeccCC-CCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344569999999999 7999999987 57789999998877777777889999999999999999999998765 4
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLAr 825 (960)
..+++||||+++++|.+++.+. ..+++..++.|+.||+.||.|||+.+.+|+||||||+||||+ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 5689999999999999999764 368999999999999999999999876799999999999998 78999999999997
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhccccccCCCCCCcH
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ......+........++...++
T Consensus 181 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 65433 2334579999999998875 489999999999999999999999988544 4444444333334445667789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++++||.+||..||.+||++.+++++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 99999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=371.10 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=209.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCC---CChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~---~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
++|++++.||.| .||.||++.+ +++.||||++.... ........+.+|+.+|++++||||+++++++.+...++
T Consensus 26 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQG-SYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeec-CCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 579999999999 7999999987 67889999987542 23344568899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCC---------------------------------------CCCCcHHHHHHHHHHHHHHHHHH
Q 002146 751 IITEFLPRGSLFRILHRP---------------------------------------HCQVDEKRRIKMALDVARGMNCL 791 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~---------------------------------------~~~lse~~~~~Ia~QIa~AL~YL 791 (960)
+||||+++|+|.+++... ...+++..++.|+.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998520 11346788889999999999999
Q ss_pred hhCCCCEEEeccCCCcEEEcCCC--cEEEEecCccccccCCc----ccCCCCCCCCCccCcccccC--CCCCchhhHHHH
Q 002146 792 HTSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTF----LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSF 863 (960)
Q Consensus 792 Hs~g~~IIHRDLKPeNILLd~~g--~VKL~DFGLAr~~~~~~----~~~~t~~GT~~Y~APEvl~g--~~ys~ksDIWSL 863 (960)
|+.+ |+||||||+||||+.++ .+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||
T Consensus 185 H~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 185 HNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9999 99999999999998776 89999999998653221 12345679999999999976 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 864 GVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 864 GvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP--~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
||++|+|++|..||.+.+..+....+.........+ ..+++++++||.+||..||.+||++.+++++
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999988887777665433333322 2478999999999999999999999999884
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=375.06 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=201.1
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
..++|+++++||+| .||+||++.+ +++.||||++............+.+|+.+|++++||||+++++++.+...+++
T Consensus 32 ~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEG-TYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEEC-SSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEec-CCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34689999999999 7999999976 68899999987665545455677899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE-----cCCCcEEEEecCcccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSRL 826 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL-----d~~g~VKL~DFGLAr~ 826 (960)
||||++ ++|.+++.+.. .+++..++.|+.||+.||.|||++| |+||||||+|||| +..+.+||+|||+++.
T Consensus 111 v~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999997 49999987654 6899999999999999999999999 9999999999999 4556699999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc---------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--------- 896 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--------- 896 (960)
...........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+......+
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 654434445567899999999998754 8999999999999999999999999988766655543211000
Q ss_pred -------C------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 -------E------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 -------~------------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. ++..+++++++||.+||..||.+||++.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 011267899999999999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.12 Aligned_cols=249 Identities=27% Similarity=0.483 Sum_probs=221.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
+.|++++.||.| .||.||++.. +++.||||++...... .....+.+|+.+++.++||||+++++++.+...+++||
T Consensus 22 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKG-SFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEEC-SSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhccc-CCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 569999999999 6999999976 6889999998765432 34567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||+++++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++.........
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999975 35899999999999999999999999 999999999999999999999999999876554444
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHh
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 913 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kc 913 (960)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. ......++..++..+++||.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999988877766654 2345566778999999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 002146 914 WQTDPSLRPSFAQLTVAL 931 (960)
Q Consensus 914 L~kDP~kRPSa~eILe~L 931 (960)
|..||.+||++.+++++.
T Consensus 255 l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCSSGGGSCCHHHHTTCH
T ss_pred cCCChhhCcCHHHHhhCh
Confidence 999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=361.07 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=197.6
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
+++..++|++++.||.| .||+||++++ +|+.||||++............+..+..+++.++||||+++++++.+.+.
T Consensus 2 ~~i~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 2 MEVKADDLEPIMELGRG-AYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCCGGGEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred CcccHHhhhhHHhcCCC-CCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 35667899999999999 7999999987 78999999987654444444445555566777899999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 749 LSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
.++||||+++ +|.+++.. ....+++..++.++.||+.||.|||++ | |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCc
Confidence 9999999974 88777653 345799999999999999999999997 8 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHhhccccccCCC
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIP 899 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl----~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~-~~ei~~~I~~~~~~~~iP 899 (960)
+..... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.... .................+
T Consensus 158 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 158 GYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred cccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 876443 223345799999999996 56678999999999999999999999998643 333333332222223334
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 900 KELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
..+++++++||.+||..||.+||++.++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 578999999999999999999999999988
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=375.27 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=197.6
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
...+.|++.+.||+| .||.||++++ +++.||||++.... ....+.+|+.+|++++||||+++++++.+...++
T Consensus 50 ~~~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRG-ATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeC-CCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 345679999999999 7999999987 57789999987543 2346789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecCccccc
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLK 827 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFGLAr~~ 827 (960)
+||||+++++|.+++...+ .+++..++.++.||+.||.|||+.| |+||||||+||||+. ++.+||+|||+++..
T Consensus 125 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999999997654 6899999999999999999999999 999999999999975 889999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHhhcccccc--CCCCCCcH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRL--EIPKELDP 904 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e-i~~~I~~~~~~~--~iP~~lS~ 904 (960)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ ....+....... .....++.
T Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 202 EHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred Ccc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 433 22345679999999999999999999999999999999999999998766554 444443222111 22356899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++++||.+||..||.+||++.+++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.88 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=213.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.+.||+| .||.||++.+ ++..||+|++....... ...+.+|+.+|++++||||+++++++.+...+++||
T Consensus 9 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRG-SWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeec-CCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 469999999999 7999999987 46689999987654332 457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE---cCCCcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL---d~~g~VKL~DFGLAr~~~~~ 830 (960)
||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred eccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999999887643 6899999999999999999999999 9999999999999 78899999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCC----CCcHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK----ELDPLV 906 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~----~lS~eL 906 (960)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+... ...++. .+++.+
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQA 238 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHH
T ss_pred -cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHH
Confidence 233456799999999998765 899999999999999999999999998888777766432 333332 688999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++||.+||..||.+||++.+++++
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=378.00 Aligned_cols=262 Identities=18% Similarity=0.187 Sum_probs=209.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHH---------HHHHHHHHHHHHHcCCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAA---------LLEFKREVKIMRRLRHPNV 736 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~---------~~~~~~Ei~ILk~L~HPNI 736 (960)
+..++|++++.||+| .||.||++.+. ++.||||++......... ...+..|+..++.++||||
T Consensus 32 ~~~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQG-GFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC--CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred cCCCeEEEEEEEecC-CCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 456789999999999 69999999873 478999998754311100 0123455666777789999
Q ss_pred eeEecccccC----CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-
Q 002146 737 VLFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD- 811 (960)
Q Consensus 737 VkL~g~f~~~----~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd- 811 (960)
+++++++... ..++|||||+ +++|.+++......+++..++.|+.||+.||+|||+++ |+||||||+||||+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 9999998765 4589999999 99999999876668999999999999999999999999 99999999999999
Q ss_pred -CCCcEEEEecCccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Q 002146 812 -KNWNVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 883 (960)
Q Consensus 812 -~~g~VKL~DFGLAr~~~~~~~-------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ 883 (960)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999987543211 123456999999999999999999999999999999999999999864322
Q ss_pred HHHHHhhccccccC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 884 QVVGAVGFQNRRLE---------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 884 ei~~~I~~~~~~~~---------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
.............. .+..++.++.+||..||..+|.+||++.+|++.|+.+.+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 22111110000111 12567899999999999999999999999999999997653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=401.70 Aligned_cols=268 Identities=24% Similarity=0.430 Sum_probs=227.0
Q ss_pred cCcCCCCeEEEE-EeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 671 CEIPWEDLVLGE-RIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 671 ~ei~~~dy~i~k-~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+.+..+++.+.+ .||+| .||.||++.+ ++..||||+++... .......+.+|+++|++++|||||++++++..
T Consensus 330 ~~~~~~~~~~~~~~LG~G-~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCG-NFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEEC-SSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred eeccccceeEcCcEEecC-CCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 345566777776 89999 7999999976 35579999987543 23345688999999999999999999999976
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
+.++|||||+.+|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 5699999999999999999876667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 826 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 826 ~~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...+..+|..
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~ 563 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTT
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCc
Confidence 7643211 1122345689999999999999999999999999999998 999999998888877775 3456778889
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCCCCCC
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 944 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p~~P~ 944 (960)
+++++.+||.+||..+|.+||++.+|++.|+.+........+.
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~ 606 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCC
Confidence 9999999999999999999999999999999997776554443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.95 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=209.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LV 752 (960)
++|++++.||+| .||+||++.+ +++.||||++............+.+|+.++..+ +||||+++++++.+.+.+++|
T Consensus 11 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSG-EFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCC-CceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 579999999999 7999999987 689999999987655555667888999999999 999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCC---CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC----------------
Q 002146 753 TEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---------------- 813 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~---~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~---------------- 813 (960)
|||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999997531 35899999999999999999999999 9999999999999844
Q ss_pred ---CcEEEEecCccccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 002146 814 ---WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 889 (960)
Q Consensus 814 ---g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I 889 (960)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++...... ..+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHH
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHH
Confidence 47999999999876433 235699999999999876 5678999999999999999999887654332 222
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 890 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 890 ~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. ......+|..+++++++||.+||..||.+||++.+++++
T Consensus 241 ~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 241 R-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 2 334556788899999999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.93 Aligned_cols=266 Identities=32% Similarity=0.552 Sum_probs=221.8
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
...+++..++|++++.||.| .||.||++++.+ .||||++............+.+|+.++++++||||+++++++.+..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G-~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKG-RFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCS-SSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccC-CceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 45678889999999999999 799999998866 5999998765443333446778999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999887667999999999999999999999999 99999999999998 679999999998764
Q ss_pred cCC-----cccCCCCCCCCCccCcccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 002146 828 HNT-----FLSSKSTAGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 893 (960)
Q Consensus 828 ~~~-----~~~~~t~~GT~~Y~APEvl~g---------~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~ 893 (960)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 311 112233468999999999875 457899999999999999999999999988887777665443
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 894 ~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
.....+..++.++.+||.+||..||.+||++.++++.|+.+.+..
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 333334568899999999999999999999999999999987653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.43 Aligned_cols=254 Identities=32% Similarity=0.570 Sum_probs=207.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc--CCCceeeEecccccC----Cc
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL--RHPNVVLFMGAVTRP----PN 748 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L--~HPNIVkL~g~f~~~----~~ 748 (960)
.++|++++.||.| .||.||+++++++.||||++.... ...+.+|.+++..+ +||||+++++++... ..
T Consensus 36 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 36 AKQIQMVKQIGKG-RYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHCEEEEEEEEE-TTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccceEEEeEeecC-CCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3679999999999 799999999999999999986432 23445566666554 899999999998877 68
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC--------CCCEEEeccCCCcEEEcCCCcEEEEe
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS--------TPTIVHRDLKSPNLLVDKNWNVKVSD 820 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~--------g~~IIHRDLKPeNILLd~~g~VKL~D 820 (960)
+++||||+++|+|.+++... .+++..++.++.|++.||.|||++ + |+||||||+||||+.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEEEe
Confidence 99999999999999999764 589999999999999999999998 7 99999999999999999999999
Q ss_pred cCccccccCCccc----CCCCCCCCCccCcccccCCCCCch------hhHHHHHHHHHHHHhC----------CCCCCCC
Q 002146 821 FGLSRLKHNTFLS----SKSTAGTPEWMAPEVLRNEPSNEK------CDVYSFGVILWELATL----------KLPWIGM 880 (960)
Q Consensus 821 FGLAr~~~~~~~~----~~t~~GT~~Y~APEvl~g~~ys~k------sDIWSLGvLLyELLTG----------~~PF~~~ 880 (960)
||+++........ ....+||+.|+|||++.+..+... +|||||||++|||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 9999765433211 235679999999999988776654 9999999999999999 7777654
Q ss_pred Ch-----hHHHHHhhccccccCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 881 NP-----MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 881 ~~-----~ei~~~I~~~~~~~~iP~-----~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
.. ......+.....++.+|. .+++++.+||.+||..||.+||++.+|+++|+++.+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 22 223333333333444443 46678999999999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=355.66 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=212.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEec-ccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG-AVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g-~f~~~~~l~L 751 (960)
.++|++++.||+| .||.||++++ +++.||||++....... .+.+|+.+++.++|++++..+. ++......++
T Consensus 8 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSG-SFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEE-TTEEEEEEEETTTTEEEEEEEEESCSSCC----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccC-CCeEEEEEEEcCCCcEEEEEEecCCcchh----HHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 3679999999999 7999999985 78999999987654332 5789999999998877665554 4466778899
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE---cCCCcEEEEecCcccccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL---d~~g~VKL~DFGLAr~~~ 828 (960)
||||+ +++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||| +.++.+||+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999 89999999865567999999999999999999999999 9999999999999 488999999999998764
Q ss_pred CCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHhhccc---cc
Q 002146 829 NTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQN---RR 895 (960)
Q Consensus 829 ~~~~-------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---ei~~~I~~~~---~~ 895 (960)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +....+.... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 4321 124567999999999999999999999999999999999999999875432 2222221111 11
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhC
Q 002146 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 939 (960)
Q Consensus 896 ~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~ 939 (960)
..++..+++++.+||.+||..||.+||++.+|++.|+++.....
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 12336789999999999999999999999999999999977643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=374.87 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=215.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+.|++++.||+| .||+||+++. +++.||||++...... ......+.+|+.+|++++|||||++++++.+....++|
T Consensus 54 ~~y~~~~~lG~G-~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHG-SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccC-CCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 459999999999 7999999985 7889999998765443 34456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+. |+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 99997 5888888655557999999999999999999999999 99999999999999999999999999976543
Q ss_pred cCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
....+||+.|+|||++. +..++.++|||||||++|||++|..||.+.+.......+.....+...+..++..+++|
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 23467999999999985 56789999999999999999999999999887776666554443444456789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
|.+||..||.+||++.+++++
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHcccChhhCcCHHHHhhC
Confidence 999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=379.37 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=209.1
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|...+.||+| .||.||+++. +|+.||||++.... ......+.+|+.+|++++|||||++++++.+.+.++|||||
T Consensus 91 ~~~~~~lG~G-~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGG-RFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEEECC------CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eecceEEecC-cCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 3447889999 7999999986 68899999987653 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE--cCCCcEEEEecCccccccCCccc
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL--d~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++...... .
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~ 244 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-K 244 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-B
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-c
Confidence 9999999998766567999999999999999999999999 9999999999999 577899999999998765432 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC--CCCCCcHHHHHHHH
Q 002146 834 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARIIW 911 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~--iP~~lS~eLkdLI~ 911 (960)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ ....+++++++||.
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 3446799999999999999999999999999999999999999999988877766643322211 12468999999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe 929 (960)
+||..||.+||++.++++
T Consensus 325 ~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCSSGGGSCCHHHHHH
T ss_pred HHcCCChhhCCCHHHHhc
Confidence 999999999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=391.98 Aligned_cols=249 Identities=30% Similarity=0.479 Sum_probs=215.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|+++++||+| .||+||++++ +++.||||++............+.+|+.+|++++|||||++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKG-SFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECC-SSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeec-CCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 579999999999 7999999987 5889999998754333333567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc---CCCcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd---~~g~VKL~DFGLAr~~~~~ 830 (960)
||+.+++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999886643 6899999999999999999999999 99999999999995 5568999999999876443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC--CCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP--~~lS~eLkd 908 (960)
......+||+.|+|||++.+. |+.++|||||||++|+|++|.+||.+.+..++...+.........| ..+++++++
T Consensus 178 -~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 178 -TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp -----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred -CccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence 233456799999999999874 9999999999999999999999999999888887775444333333 468999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+||++.+++++
T Consensus 256 li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=375.44 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=203.8
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+++|++++.||.| .||+||++++ +++.||||++...... .....+.+|+.+|++++||||+++++++.....+++|
T Consensus 1 l~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEG-TYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCC-CCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 3689999999999 7999999987 5889999998654321 1112345799999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||++ ++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 99997 5999998877667999999999999999999999999 99999999999999999999999999987654434
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc---------------
Q 002146 833 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--------------- 896 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--------------- 896 (960)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 4445678999999999987 568999999999999999999999999988776655543211100
Q ss_pred -------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 -------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 -------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+..+++++++||.+||..||.+||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0123568899999999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.79 Aligned_cols=252 Identities=27% Similarity=0.355 Sum_probs=206.5
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHHc---CCCceeeEeccccc
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRL---RHPNVVLFMGAVTR 745 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~---~~~~~~~~~Ei~ILk~L---~HPNIVkL~g~f~~ 745 (960)
..++|+++++||.| .||+||++++ +++.||||++...... ......+.+|+.+++++ +||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 7 ATSRYEPVAEIGVG-AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ---CCEEEEEECCS-SSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred cccceEEEEEEecC-CCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 35689999999999 7999999985 7889999998753321 11123556777777766 49999999999877
Q ss_pred CC-----ceEEEEeecCCCCHHHHhhCCCC-CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 746 PP-----NLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 746 ~~-----~l~LVmEY~~gGsL~dlL~k~~~-~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
.. .+++||||+. ++|.+++..... .+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 65 4899999996 599999887543 4899999999999999999999999 9999999999999999999999
Q ss_pred ecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc---
Q 002146 820 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--- 896 (960)
Q Consensus 820 DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--- 896 (960)
|||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 163 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999876433 23345679999999999999999999999999999999999999999988776665543211000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 ----------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 ----------------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+...+++.+++||.+||..||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0123578899999999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=385.59 Aligned_cols=250 Identities=25% Similarity=0.295 Sum_probs=191.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc-----cCCc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-----RPPN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~-----~~~~ 748 (960)
++|+++++||+| +||+||++.+ +++.||||++............+.+|+.+|+.++|||||++++++. ....
T Consensus 53 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTG-SYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC--------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeec-CCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 679999999999 7999999975 6889999999776556666778999999999999999999999984 3467
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+||||+ +++|.+++.... .+++..++.|+.||+.||+|||+.| ||||||||+||||+.++++||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99999998 579999997653 6999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCc---------------------------ccCCCCCCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHh--------
Q 002146 829 NTF---------------------------LSSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELAT-------- 872 (960)
Q Consensus 829 ~~~---------------------------~~~~t~~GT~~Y~APEvl-~g~~ys~ksDIWSLGvLLyELLT-------- 872 (960)
... ......+||++|+|||++ .+..|+.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221 112345789999999986 55669999999999999999998
Q ss_pred ---CCCCCCCCChh--------------------HHHHHhhc------------------------c--c---cccCCCC
Q 002146 873 ---LKLPWIGMNPM--------------------QVVGAVGF------------------------Q--N---RRLEIPK 900 (960)
Q Consensus 873 ---G~~PF~~~~~~--------------------ei~~~I~~------------------------~--~---~~~~iP~ 900 (960)
|.++|.+.... +.+..+.. . . .......
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 67777664310 00000000 0 0 0001123
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+++++.+||.+||..||.+||+++|++++
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 468999999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=379.26 Aligned_cols=261 Identities=30% Similarity=0.500 Sum_probs=214.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--C-C--cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc-cCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--N-G--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~-g--~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~-~~~~l 749 (960)
..|++.++||+| .||+||++++ + + ..||||.+... ........+.+|+.+|++++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G-~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRG-HFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECC-SSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeC-CCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 358889999999 7999999976 2 2 35899987643 23445678999999999999999999999854 55688
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++||||+++|+|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999999887777899999999999999999999999 99999999999999999999999999986533
Q ss_pred Ccc----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 830 TFL----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 830 ~~~----~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
... ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+. ...+...|..++.
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~ 323 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 323 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCH
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 211 1233457889999999999999999999999999999999 788898877766665554 3445566788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCCC
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 941 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p~ 941 (960)
.+.+||.+||..||.+||++.+|++.|+.+...+...
T Consensus 324 ~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 324 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 9999999999999999999999999999998775543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=371.09 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=210.1
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc------
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------ 745 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~------ 745 (960)
...+|+++++||+| .||.||++++ +|+.||||++............+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQG-TFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSC-STTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecC-CCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 35789999999999 7999999987 68899999987665444444577899999999999999999999876
Q ss_pred --CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 746 --PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 746 --~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
.+.+++||||+++ +|.+.+......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4468999999975 888888776667999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCC----cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--
Q 002146 824 SRLKHNT----FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-- 896 (960)
Q Consensus 824 Ar~~~~~----~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~-- 896 (960)
++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9865421 122344678999999999987 458999999999999999999999999988766655543211111
Q ss_pred CCCCC----------------------------CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 EIPKE----------------------------LDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 ~iP~~----------------------------lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..... .++.+++||.+||..||.+||++.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11011 26789999999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=399.24 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=218.5
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
.+..++|+++++||+| +||.||++++ +|+.||||++.+..... .....+.+|+.+|++++||||++++++|++...
T Consensus 181 ~~~~~~f~~~~~LG~G-~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRG-GFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCCGGGEEEEEEEEEC-SSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhheEEEEEEeeC-CCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 3556789999999999 7999999987 68999999987543221 224568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCC---CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 749 LSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~---~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
+|+||||++||+|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceee
Confidence 999999999999999987542 36899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHhhccccccCCCCC
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~----~~ei~~~I~~~~~~~~iP~~ 901 (960)
............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+ ..++...+. .....+|..
T Consensus 338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~ 415 (543)
T 3c4z_A 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDK 415 (543)
T ss_dssp ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTT
T ss_pred eccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCcc
Confidence 76554333455689999999999999999999999999999999999999998753 344544442 335667888
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 002146 902 LDPLVARIIWECWQTDPSLRPSF-----AQLTV 929 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa-----~eILe 929 (960)
+++++++||.+||.+||.+||++ .+|++
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 99999999999999999999965 66665
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=378.43 Aligned_cols=252 Identities=20% Similarity=0.312 Sum_probs=212.4
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC--CCceeeEecccccCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~--HPNIVkL~g~f~~~~~l 749 (960)
+...+|++++.||+| .||+||++.. +++.||||++............+.+|+.+|++++ |||||++++++.....+
T Consensus 53 ~~~~~y~~~~~LG~G-~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 53 VKGRIYSILKQIGSG-GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp ETTEEEEEEEEEECC-SSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEccC-CCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 345679999999999 7999999976 5888999999877666777788999999999996 59999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
||||| +.+++|.+++.+.. .+++..++.|+.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99999 55889999998654 6888899999999999999999999 99999999999995 58999999999987643
Q ss_pred Cc--ccCCCCCCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhccccc
Q 002146 830 TF--LSSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRR 895 (960)
Q Consensus 830 ~~--~~~~t~~GT~~Y~APEvl~g-----------~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~~~~~ 895 (960)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 22 12345679999999999976 4689999999999999999999999987543 3344444434445
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+|...+.++++||.+||..||.+||++.+++++
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 56777788999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=390.85 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=203.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------ 746 (960)
.++|++++.||+| .||+||++.+ +++.||||++...........++.+|+.+|+.++|||||+++++|...
T Consensus 61 ~~~y~~~~~lG~G-~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSG-AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEEC-SSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecC-CCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4789999999999 7999999976 688999999987655666677899999999999999999999998655
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+||||||+++ +|.+++.. .+++..++.++.||+.||+|||+.| |+||||||+||||+.++.+||+|||+++.
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 357999999975 57777654 4889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-----------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 895 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~----------- 895 (960)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 214 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 214 AGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred cCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 6543 2344578999999999999999999999999999999999999999998866555444211000
Q ss_pred ---------cC---------CCCC-----------CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ---------LE---------IPKE-----------LDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ---------~~---------iP~~-----------lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+. +|.. .++++++||.+||..||.+|||++|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 1111 15679999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=362.78 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=198.4
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEeccc---
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAV--- 743 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f--- 743 (960)
.+++...+|+++++||.| .||.||++++ +++.||||++... .......+.+|+.+++++. ||||+++++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEG-GFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECC-SSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccC-CceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 345566789999999999 7999999997 7889999988654 3445567899999999995 99999999988
Q ss_pred -----ccCCceEEEEeecCCCCHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcE
Q 002146 744 -----TRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 816 (960)
Q Consensus 744 -----~~~~~l~LVmEY~~gGsL~dlL~k--~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~V 816 (960)
.....+++||||+. |+|.+++.. ....+++..++.|+.||+.||.|||+++++|+||||||+||||+.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 44455899999995 689888764 3346999999999999999999999987779999999999999999999
Q ss_pred EEEecCccccccCCcc------------cCCCCCCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002146 817 KVSDFGLSRLKHNTFL------------SSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMN 881 (960)
Q Consensus 817 KL~DFGLAr~~~~~~~------------~~~t~~GT~~Y~APEvl---~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~ 881 (960)
||+|||+++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 9999999987543211 11145689999999998 56778999999999999999999999998765
Q ss_pred hhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 882 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 882 ~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
...+... ......+..++..+.+||.+||..||.+||++.+++++|+.+....
T Consensus 258 ~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 258 KLRIVNG----KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhhcC----cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 5444332 2233344567788999999999999999999999999999997653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=390.28 Aligned_cols=253 Identities=30% Similarity=0.400 Sum_probs=213.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
+.|+++++||+| .||+||++++ ++..||||++............+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSG-AYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC----EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecC-CCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 469999999999 7999999987 6889999999876544444567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFGLAr~~~~~ 830 (960)
|||.+|+|.+++.+.. .+++..++.|+.||+.||.|||++| |+||||||+||||+. ++.+||+|||+++.....
T Consensus 116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999886543 6899999999999999999999999 999999999999976 455999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC--CCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i--P~~lS~eLkd 908 (960)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+......... ...+++.+++
T Consensus 193 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred -ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 23445689999999999874 5899999999999999999999999999988888777544333322 2468999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH--HHHh
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA--LKPL 934 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~--Le~i 934 (960)
||.+||..||.+||++.+++++ |+.+
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHCCCChhhCccHHHHhcCcccccC
Confidence 9999999999999999999975 5444
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=357.65 Aligned_cols=252 Identities=27% Similarity=0.495 Sum_probs=211.6
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
.+..++|++++.||.| .||.||++++ +|+.||||++...... ......+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~~y~i~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVG-TFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp CCEETTEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cceeccEEEEeeecCC-CCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 4456789999999999 7999999987 5899999998654221 1234578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+++||||+++++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999999997643 6899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+. .....+|..++..+.
T Consensus 163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~ 239 (276)
T 2h6d_A 163 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVA 239 (276)
T ss_dssp C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHH
T ss_pred CCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHH
Confidence 432 2334578999999999998876 689999999999999999999999988777776663 334556788999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||+.||.+||++.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhhCCCHHHHHhC
Confidence 99999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=363.46 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=209.6
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEeccccc-
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR- 745 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~- 745 (960)
.......+|++++.||.| .||.||++++ +++.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNG-TYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccC-CCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 344456789999999999 6999999988 7899999998754332 34678999999999 89999999999876
Q ss_pred -----CCceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 746 -----PPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 746 -----~~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEEC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEe
Confidence 467999999999999999997542 46899999999999999999999999 9999999999999999999999
Q ss_pred ecCccccccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc
Q 002146 820 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 894 (960)
Q Consensus 820 DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~ 894 (960)
|||++..............||+.|+|||++. +..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 9999987654333344567999999999997 56689999999999999999999999999887766655543333
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....+..++..+++||.+||..||.+||++.+++++
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 333456789999999999999999999999999884
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=360.78 Aligned_cols=251 Identities=28% Similarity=0.452 Sum_probs=212.5
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
...++|++++.||.| .||.||++.+ +|+.||||++..... ...+.+|+.++++++||||+++++++.....++
T Consensus 26 ~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEG-SYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC-----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccC-CCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 445789999999999 7999999987 488999999876532 346789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999999754557999999999999999999999999 999999999999999999999999999876554
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cccCCCCCCcHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARI 909 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~~iP~~lS~eLkdL 909 (960)
........||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.... .....+..++..+.+|
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 444455679999999999999999999999999999999999999999887766554443221 1223355688999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
|.+||..||.+||++.+++++
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999873
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=355.09 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=216.1
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~----~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
++|++++.||.| .||.||++++ +++.||||++....... .....+.+|+.+|++++||||+++++++.+...+
T Consensus 5 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSG-QFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhccc-CceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 469999999999 7999999987 58899999987654332 1356789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC----cEEEEecCccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSR 825 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g----~VKL~DFGLAr 825 (960)
++||||+++++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999997533 6899999999999999999999999 99999999999998877 89999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--CCCCCCc
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 903 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--~iP~~lS 903 (960)
...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+....... ..+..++
T Consensus 161 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 161 KIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp ECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 764332 2334579999999999999999999999999999999999999999988877766654322111 1235678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTV--ALKPLQR 936 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe--~Le~i~~ 936 (960)
..+++||.+||..||.+||++.++++ .++.+..
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 99999999999999999999999998 4565543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=397.09 Aligned_cols=261 Identities=33% Similarity=0.565 Sum_probs=227.9
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEECC-cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g-~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..+++..++|++.++||+| .||.||++++.+ ..||||++...... ...+.+|+.+|++++|||||++++++.+ .
T Consensus 260 ~~~~i~~~~~~~~~~lG~G-~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQG-CFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TCSBCCGGGEEEEEEEEEC-SSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cceecchhhhhhheecccC-CCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 4577888999999999999 799999999854 67999998765433 3478899999999999999999999876 6
Q ss_pred ceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+||||||+.+|+|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 799999999999999999742 235889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 827 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 827 ~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ...+...+..++.
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 491 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 643221 1233457889999999999999999999999999999999 999999998888877765 3445667888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+.+||.+||..||.+||++.+|++.|+.+...
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999999999999999999987544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=354.84 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=209.1
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc-cccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA-VTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~-f~~~~~l~LV 752 (960)
++|++++.||.| .||.||++++ +++.||||++...... ..+.+|+.+++.++|++++..+.. +......++|
T Consensus 9 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSG-SFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEEC-SSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCC-CCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 679999999999 7999999985 7889999987654332 257789999999988776665554 5677788999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE---cCCCcEEEEecCccccccC
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL---d~~g~VKL~DFGLAr~~~~ 829 (960)
|||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999 99999999865667999999999999999999999999 9999999999999 7889999999999987643
Q ss_pred Ccc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHhhccccc---c
Q 002146 830 TFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRR---L 896 (960)
Q Consensus 830 ~~~-------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---ei~~~I~~~~~~---~ 896 (960)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +....+...... .
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 321 223567999999999999999999999999999999999999999875432 222222111111 1
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhC
Q 002146 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 939 (960)
Q Consensus 897 ~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~ 939 (960)
.+...+++++.+||.+||..||.+||++.+|++.|+++....-
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 1236678999999999999999999999999999999977643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=370.54 Aligned_cols=252 Identities=24% Similarity=0.251 Sum_probs=207.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~---~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
.++|++++.||.| .||.||++++ +|+.||||++....... .....+.+|+.+++.++||||+++++++.+...+
T Consensus 9 ~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEG-QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEE-TTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeec-CCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4679999999999 7999999986 58899999987543221 1224678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
++||||+++ +|.+++......+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999976 899998877667999999999999999999999999 99999999999999999999999999987655
Q ss_pred CcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc------------
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------------ 896 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~------------ 896 (960)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+......+
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 44444567899999999999764 48999999999999999999999999988766655543211000
Q ss_pred ---------C-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 897 ---------E-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 897 ---------~-----iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. +...++.++++||.+||..||.+||++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 014567899999999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.98 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=210.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
...++|++++.||.| .||.||++++ +|+.||||++............+.+|+.++++++||||+++++++.+...++
T Consensus 22 ~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEG-SYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGG-TTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeec-CCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 345789999999999 6999999987 4889999999877666666677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++.....
T Consensus 101 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999999998876544 6899999999999999999999999 999999999999999999999999999876544
Q ss_pred cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc---------------
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------------- 894 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~--------------- 894 (960)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 3444556799999999999876 689999999999999999999999998876655443321100
Q ss_pred -----ccC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 -----RLE---------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 -----~~~---------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+. ....+++.+.+||.+||..||.+||++.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 113578999999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=374.04 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=206.3
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----- 747 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~----- 747 (960)
.++|++++.||+| .||.||++.+ +|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G-~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSG-AYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC-------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeec-CCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3679999999999 7999999986 6899999998766555666678899999999999999999999987663
Q ss_pred -ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 -NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 -~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+|+||||+ +++|.+++... .+++..+..++.||+.||+|||+.| |+||||||+||||+.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 88999999763 5899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-----------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------- 894 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~----------- 894 (960)
.... ....+||++|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 178 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 178 ADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 5432 345679999999999987 6799999999999999999999999998876655444321100
Q ss_pred ------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 ------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ------------------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...+...+++++.+||.+||..||.+||++.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 012234678999999999999999999999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=368.77 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=211.4
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-----CCceeeEe
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----HPNVVLFM 740 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-----HPNIVkL~ 740 (960)
.....+..++|+++++||.| .||+||++++ +++.||||++... ......+..|+.+++.+. |||||+++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDG-TFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCTTCEETTTEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eecceEecCEEEEEEEEccc-CCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 33445556889999999999 7999999987 7889999998632 344556788999999996 99999999
Q ss_pred cccccCCceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-------
Q 002146 741 GAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK------- 812 (960)
Q Consensus 741 g~f~~~~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~------- 812 (960)
+++...+.+++||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+||||+.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccc
Confidence 9999999999999999 899999987643 35899999999999999999999999 999999999999975
Q ss_pred ------------------CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC
Q 002146 813 ------------------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 874 (960)
Q Consensus 813 ------------------~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~ 874 (960)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 789999999999865432 33567999999999999999999999999999999999999
Q ss_pred CCCCCCChhHHHHHhhccccc------------------------cCCCC--------------------CCcHHHHHHH
Q 002146 875 LPWIGMNPMQVVGAVGFQNRR------------------------LEIPK--------------------ELDPLVARII 910 (960)
Q Consensus 875 ~PF~~~~~~ei~~~I~~~~~~------------------------~~iP~--------------------~lS~eLkdLI 910 (960)
.||.+.+..+....+...... ..+|. ..++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 999988776655443221100 00111 1236788999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||+.||.+||++.+++++
T Consensus 337 ~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhcCChhhCCCHHHHhcC
Confidence 99999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=373.26 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=212.7
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
....++..++|++.+.||+| .||.||++++ +++.||||++....... ....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRG-GFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp THHHHTTTTSSCSTTEEECC-SSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHHhhccccceeEecC-CCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 34456677899999999999 7999999986 68899999987543221 223688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCC---CCCcHHHHHHHHHHHHHHHHHHhhC---CCCEEEeccCCCcEEEcCCCcEEEEe
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSD 820 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~---~~lse~~~~~Ia~QIa~AL~YLHs~---g~~IIHRDLKPeNILLd~~g~VKL~D 820 (960)
...++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||++ | |+||||||+||||+.++.+||+|
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999998643 2489999999999999999999998 8 99999999999999999999999
Q ss_pred cCccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----Chh---HHHHHhhc
Q 002146 821 FGLSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPM---QVVGAVGF 891 (960)
Q Consensus 821 FGLAr~~~~~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~-----~~~---ei~~~I~~ 891 (960)
||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ... +.......
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998764322 2233456999999999999999999999999999999999999999521 111 11111100
Q ss_pred ---------cccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 892 ---------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 892 ---------~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
......++...+..+.+|+.+||..||.+||++.+|+++|+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 0011122333457899999999999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=359.62 Aligned_cols=249 Identities=25% Similarity=0.441 Sum_probs=208.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++.++||+| .||.||+++. ++..||||++..... ......+.+|+++|++++||||+++++++.+...+++||
T Consensus 22 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSG-AFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccC-CCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 569999999999 7999999986 588999999876542 223567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE---cCCCcEEEEecCccccc
Q 002146 754 EFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 754 EY~~gGsL~dlL~k~---~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL---d~~g~VKL~DFGLAr~~ 827 (960)
||+++++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+|||| +.++.+||+|||+++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999988532 346899999999999999999999999 9999999999999 45688999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC-CCCCcHHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-PKELDPLV 906 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i-P~~lS~eL 906 (960)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......... ...+++++
T Consensus 178 ~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 178 KSD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred CCc-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 443 22345679999999999864 5889999999999999999999999998887777666433322222 23478999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||.+||..||.+||++.+++++
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=379.91 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=197.6
Q ss_pred CCCeEEE-EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEeccccc----C
Q 002146 675 WEDLVLG-ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----P 746 (960)
Q Consensus 675 ~~dy~i~-k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~----~ 746 (960)
.++|.+. ++||.| .||+||++.+ +++.||||++... ..+.+|+.++.++ +||||++++++|.. .
T Consensus 60 ~~~y~~~~~~LG~G-~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLG-INGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeec-cCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 3567776 789999 7999999987 5889999998632 2567888887554 89999999998865 5
Q ss_pred CceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecC
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFG 822 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFG 822 (960)
..+||||||++||+|.+++.... ..+++..++.|+.||+.||.|||++| |+||||||+||||+. ++.+||+|||
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecc
Confidence 67999999999999999998754 36999999999999999999999999 999999999999997 7899999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH----HHHHhhccccccC-
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVGFQNRRLE- 897 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e----i~~~I~~~~~~~~- 897 (960)
+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+..... +...+........
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 210 FAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 99865433 22345789999999999999999999999999999999999999998765432 2233322222221
Q ss_pred -CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 898 -IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 898 -iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....++.++++||.+||..||.+||++.+|+++
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 125689999999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=390.18 Aligned_cols=250 Identities=30% Similarity=0.438 Sum_probs=218.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
.++|++.++||+| .||.||+++. +++.||||++...... ......+.+|+.+|++++|||||++++++.+...+|+
T Consensus 25 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKG-SFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecC-CCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3579999999999 7999999987 6889999999765443 2345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE---cCCCcEEEEecCcccccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL---d~~g~VKL~DFGLAr~~~ 828 (960)
||||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999987654 6999999999999999999999999 9999999999999 567899999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC--CCCcHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLV 906 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP--~~lS~eL 906 (960)
.. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..++...+.........| ..+++++
T Consensus 181 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 181 AS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred cc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 43 22334579999999999987 58999999999999999999999999999888888776544333333 4689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++||.+||..||.+||++.+++++
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHCCCChhHCcCHHHHhhC
Confidence 999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=387.88 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=213.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-----------HHHHHHHHHHHHHHHcCCCceeeEec
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-----------AALLEFKREVKIMRRLRHPNVVLFMG 741 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-----------~~~~~~~~Ei~ILk~L~HPNIVkL~g 741 (960)
.++|+++++||+| +||+||++++ +++.||||++....... .....+.+|+.+|++++|||||++++
T Consensus 35 ~~~Y~~~~~lG~G-~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 35 GESYFKVRKLGSG-AYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGTEEEEEEEEC---CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccceEEEeEeccc-CCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4679999999999 7999999987 57899999987654322 23457889999999999999999999
Q ss_pred ccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC---cEEE
Q 002146 742 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKV 818 (960)
Q Consensus 742 ~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g---~VKL 818 (960)
++.+...+|+|||||++|+|.+++.+.. .+++..++.|+.||+.||.|||++| |+||||||+||||+.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999887643 6999999999999999999999999 99999999999998776 6999
Q ss_pred EecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC
Q 002146 819 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 819 ~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i 898 (960)
+|||+++..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+.........
T Consensus 191 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 191 VDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred EECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 999999876543 23445679999999999875 5899999999999999999999999999988888877543322221
Q ss_pred --CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 899 --PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 899 --P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+..+++++++||.+||..||.+||++.+++++
T Consensus 269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 25689999999999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=358.96 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=210.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHHcCCCceeeEeccc--ccCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~--~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f--~~~~~l 749 (960)
.+|++++.||.| .||.||++.+ +++.||||++...... ......+.+|+.++++++||||+++++++ .+...+
T Consensus 5 ~~y~i~~~lg~G-~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEG-SYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEEC-SSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecC-CCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 679999999999 6999999987 6789999998754321 12346789999999999999999999998 455689
Q ss_pred EEEEeecCCCCHHHHhhC-CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k-~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
++||||+.++ |.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999999876 6666653 3446899999999999999999999999 9999999999999999999999999998754
Q ss_pred CC--cccCCCCCCCCCccCcccccCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 829 NT--FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 829 ~~--~~~~~t~~GT~~Y~APEvl~g~~y--s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
.. ........||+.|+|||++.+... +.++||||||+++|+|++|..||.+.+..+....+. .....++..+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~~~~~~~~~ 238 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCGP 238 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCCSSSCH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--cCCCCCCCccCH
Confidence 22 122335579999999999987543 789999999999999999999999988887777664 335567888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+.+||.+||..||.+||++.+++++
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.03 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=210.5
Q ss_pred eEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCC--CChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEee
Q 002146 678 LVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 755 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~--~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmEY 755 (960)
|..+++||.| .||.||+++++++.||||++.... ........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~~~~~lg~G-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 33 SVGGNKMGEG-GFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TTTCCEEEEC-SSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cccCCccccC-CCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 4456889999 799999999999999999987542 2234466789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc--
Q 002146 756 LPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 831 (960)
Q Consensus 756 ~~gGsL~dlL~k~--~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~-- 831 (960)
+++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 9999999998743 235899999999999999999999999 9999999999999999999999999998654321
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHh----hc---------cccccCC
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV----GF---------QNRRLEI 898 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I----~~---------~~~~~~i 898 (960)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+ .. .......
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred ccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 123345799999999998764 789999999999999999999999876543222111 10 0111122
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
+..++..+.+||.+||..||.+||++.+|++.|+++..
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 34456789999999999999999999999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=369.69 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=213.8
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
.++..++|++++.||.| .||.||++++ +++.||+|++... ........+.+|+.+|++++||||+++++++...+.
T Consensus 28 ~~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAG-NGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCC-CCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 35666889999999999 7999999987 4889999998765 345556788999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
+++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+. | |+||||||+||||+.++.+||+|||+++..
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999999997643 689999999999999999999985 8 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhh-----------------
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----------------- 890 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~----------------- 890 (960)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+.
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 183 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 332 2334679999999999999999999999999999999999999998876554322210
Q ss_pred ------------------------ccccccCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 891 ------------------------FQNRRLEI-PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 891 ------------------------~~~~~~~i-P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.......+ +..++.++++||.+||..||.+||++.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 01111222 23478899999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=376.98 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=201.4
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC-----C
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----P 747 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~-----~ 747 (960)
.++|++++.||+| +||.||++.+ +++.||||++............+.+|+.+|++++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G-~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRG-SYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEE-TTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeec-CCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4689999999999 7999999986 678999999987655566677899999999999999999999998776 5
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.| |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 7999999996 5999999764 36999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc----------------------cCCCCCCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHhC-----------
Q 002146 828 HNTFL----------------------SSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATL----------- 873 (960)
Q Consensus 828 ~~~~~----------------------~~~t~~GT~~Y~APEvl-~g~~ys~ksDIWSLGvLLyELLTG----------- 873 (960)
..... .....+||++|+|||++ .+..|+.++|||||||++|||++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 43211 12456899999999986 556699999999999999999984
Q ss_pred CCCCCCCCh-----------------hH------------------------HHHHhhccccccCC-----CCCCcHHHH
Q 002146 874 KLPWIGMNP-----------------MQ------------------------VVGAVGFQNRRLEI-----PKELDPLVA 907 (960)
Q Consensus 874 ~~PF~~~~~-----------------~e------------------------i~~~I~~~~~~~~i-----P~~lS~eLk 907 (960)
.++|.+.+. .. ....+......... ...++++++
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 444444321 00 00111000001111 135789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||..||.+||+++|++++
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=373.39 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=204.5
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCChH---------HHHHHHHHHHHHHHcCCCceee
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGA---------ALLEFKREVKIMRRLRHPNVVL 738 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~~~---------~~~~~~~Ei~ILk~L~HPNIVk 738 (960)
+..++|++++.||+| .||.||++.+ .+..||||++........ ....+.+|+.+++.++||||++
T Consensus 34 ~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSG-GFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC-------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred ccCceEEEEeeEeec-CCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 445789999999999 7999999987 567899999876532111 1123667889999999999999
Q ss_pred Eeccccc----CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC
Q 002146 739 FMGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 739 L~g~f~~----~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g 814 (960)
+++++.. ...+|+||||+ +++|.+++...+ .+++..++.|+.||+.||+|||+++ |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCC
Confidence 9999877 77899999999 999999997655 7999999999999999999999999 99999999999999877
Q ss_pred --cEEEEecCccccccCCc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--Chh
Q 002146 815 --NVKVSDFGLSRLKHNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--NPM 883 (960)
Q Consensus 815 --~VKL~DFGLAr~~~~~~-------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~--~~~ 883 (960)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999998753221 1124457999999999999999999999999999999999999999653 222
Q ss_pred HHHHHhhccccccCCCC---------CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 884 QVVGAVGFQNRRLEIPK---------ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 884 ei~~~I~~~~~~~~iP~---------~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
...... ......+|. .++.++++||.+||..||.+||++.+|++.|+.+.
T Consensus 269 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 269 AVQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 221111 111222222 68899999999999999999999999999998864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=351.37 Aligned_cols=250 Identities=28% Similarity=0.348 Sum_probs=210.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++++.||.| .||.||++.+ +++.||||++...... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 7 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEG-AYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEEC-SSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecC-CCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 579999999999 7999999987 5889999998755432 33467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc--
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 831 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~-- 831 (960)
||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999999764 36899999999999999999999999 9999999999999999999999999998653221
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHhhccccccCCCCCCcHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~e-i~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... ....+.........+..++..+++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 22345679999999999988775 789999999999999999999998765432 2222221222222335689999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
|.+||..||.+||++.+++++
T Consensus 242 i~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHCCCCchhCCCHHHHhcC
Confidence 999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=373.38 Aligned_cols=242 Identities=22% Similarity=0.353 Sum_probs=210.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChH------HHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~------~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
++|++++.||.| .||.||++.+ +++.||||++........ ....+.+|+.+|++++||||++++++|.+..
T Consensus 24 ~~y~~~~~lG~G-~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 24 QKYSTMSPLGSG-AFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHEEEEEECSSS-SSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceEEEeEEEec-CCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 579999999999 7999999975 788999999987543221 2335678999999999999999999999999
Q ss_pred ceEEEEeecCCC-CHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gG-sL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+++||||+.+| +|.+++.+.. .+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999766 9999998754 6999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .......|..++++
T Consensus 180 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 180 LERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKE 250 (335)
T ss_dssp CCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTCCCCSSCCCHH
T ss_pred CCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------HhhccCCCcccCHH
Confidence 6543 22344679999999999998887 88999999999999999999999763221 22234556778999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++||.+||..||.+||++.+++++
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=363.83 Aligned_cols=260 Identities=20% Similarity=0.263 Sum_probs=211.0
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
..++|++++.||.| .||.||++++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.++
T Consensus 32 ~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRG-GMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEEC-SSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCC-CCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 35789999999999 7999999986 688999999876533 2344567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||+++++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999997643 6899999999999999999999999 999999999999999999999999999765433
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-ccCCCCCCcHHHHH
Q 002146 831 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVAR 908 (960)
Q Consensus 831 ~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-~~~iP~~lS~eLkd 908 (960)
. .......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+...+...+..... ...++..++.++.+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence 2 122345799999999999999999999999999999999999999998776654444432211 22356678999999
Q ss_pred HHHHhhhhCCCCCC-CHHHHHHHHHHhHHh
Q 002146 909 IIWECWQTDPSLRP-SFAQLTVALKPLQRL 937 (960)
Q Consensus 909 LI~kcL~kDP~kRP-Sa~eILe~Le~i~~~ 937 (960)
||.+||..||.+|| +++++++.|+++...
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 99999999999999 999999999987544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=365.37 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=213.4
Q ss_pred CCeEEE-EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEE
Q 002146 676 EDLVLG-ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 676 ~dy~i~-k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~L 751 (960)
+.|.+. +.||+| .||.||++.. +++.||||++............+.+|+.+++.+ .||||+++++++.+...+++
T Consensus 28 ~~y~~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRG-KFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCC-CCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 457776 899999 7999999987 589999999987655555566889999999999 56999999999999999999
Q ss_pred EEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecCccccc
Q 002146 752 ITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLK 827 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFGLAr~~ 827 (960)
||||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+||||+. ++.+||+|||+++..
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 99999999999998653 347899999999999999999999999 999999999999997 789999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc--ccCCCCCCcHH
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPL 905 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~--~~~iP~~lS~e 905 (960)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ....+..+++.
T Consensus 185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 185 GHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263 (327)
T ss_dssp ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence 443 223456799999999999999999999999999999999999999999888777666543222 22334578999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++||.+||..||.+||++++++++
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 264 ATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhCC
Confidence 9999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=369.57 Aligned_cols=243 Identities=23% Similarity=0.388 Sum_probs=186.7
Q ss_pred CeEEE---EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceE
Q 002146 677 DLVLG---ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 677 dy~i~---k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~ 750 (960)
+|++. +.||+| .||+||++.+ +++.||||++... ....+.+|+.+|+.+. ||||+++++++.+....|
T Consensus 9 ~y~~~~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEG-SFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEE-TTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccC-CCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 45554 789999 6999999987 5889999998643 2346789999999996 999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC---cEEEEecCccccc
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLK 827 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g---~VKL~DFGLAr~~ 827 (960)
+||||+++++|.+++.+.. .+++..++.|+.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999998653 7999999999999999999999999 99999999999998765 8999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------hHHHHHhhccccccCCC-
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVGFQNRRLEIP- 899 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-------~ei~~~I~~~~~~~~iP- 899 (960)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. .++...+... ...++
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--~~~~~~ 237 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--DFSFEG 237 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--CCCCCS
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--CCCCCc
Confidence 5544444567899999999999999999999999999999999999999987543 3444444322 22232
Q ss_pred ---CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 900 ---KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 900 ---~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+++++++||.+||..||.+||++.+++++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 3578999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=360.86 Aligned_cols=252 Identities=30% Similarity=0.478 Sum_probs=210.9
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
..+.|++++.||.| .||.||++++ +++.||+|++.... ......+.+|+.+++.++||||+++++++.....+++
T Consensus 17 ~~~~y~i~~~lg~G-~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDG-AFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECS-TTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccC-CCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 34679999999999 6999999987 48899999986543 2235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999999998765567999999999999999999999999 9999999999999999999999999986543222
Q ss_pred ccCCCCCCCCCccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-cCCCCCCcHH
Q 002146 832 LSSKSTAGTPEWMAPEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LEIPKELDPL 905 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl-----~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~-~~iP~~lS~e 905 (960)
.......||+.|+|||++ .+..++.++||||||+++|+|++|..||...+.......+...... ...+..++..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence 223446799999999998 4677899999999999999999999999998877766655433222 2235678999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.+||.+||..||.+||++.+++++
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHcccChhhCCCHHHHhcC
Confidence 9999999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=358.93 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=212.8
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|.+++.||.| .||.||+++. +|+.||||++..... .....+.+|+.+|++++||||+++++++.+...+++||
T Consensus 9 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSG-AFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCC-CCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 579999999999 7999999987 689999999875432 22346889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE---cCCCcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL---d~~g~VKL~DFGLAr~~~~~ 830 (960)
||+++++|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999999986543 6899999999999999999999999 9999999999999 78899999999999765332
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc--cCCCCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~--~~iP~~lS~eLkd 908 (960)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...... ..++..+++++++
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 122346899999999999999999999999999999999999999998887777666433222 2334678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+||++.+++++
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=399.05 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=218.6
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
.+..++|+++++||+| .||.||++++ +|+.||||++.+.... ......+.+|+.+|+.++|||||+++++|++.+.
T Consensus 180 ~~~~~~f~~~~~LG~G-~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKG-GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CccccceEEEEEEeeC-CCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 3566889999999999 7999999987 6899999998754321 1223467899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
+|+||||++||+|.+++...+ ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999999997654 35899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHhhccccccCCCCCCc
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~----~~ei~~~I~~~~~~~~iP~~lS 903 (960)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.. ..++...+ ......+|..++
T Consensus 337 ~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s 413 (576)
T 2acx_A 337 PEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFS 413 (576)
T ss_dssp CTT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSC
T ss_pred ccC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCC
Confidence 433 22345689999999999999999999999999999999999999998764 23344444 233566788899
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
+++++||.+||.+||.+|| ++.+|+++
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 9999999999999999999 78888875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=362.18 Aligned_cols=253 Identities=35% Similarity=0.583 Sum_probs=212.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHH--cCCCceeeEecccccCC----c
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----N 748 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~--L~HPNIVkL~g~f~~~~----~ 748 (960)
.++|++.+.||.| .||.||+++++++.||||++... ....+.+|+++++. ++||||+++++++.... .
T Consensus 41 ~~~y~~~~~lg~G-~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 41 ARTIVLQESIGKG-RFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHCEEEEEEEEE-TTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccEEEEeeecCC-CCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3579999999999 79999999999999999998543 23467789999988 69999999999998876 7
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHh--------hCCCCEEEeccCCCcEEEcCCCcEEEEe
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVSD 820 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLH--------s~g~~IIHRDLKPeNILLd~~g~VKL~D 820 (960)
+++||||+++|+|.+++.+. .+++..++.++.||+.||.||| +.+ |+||||||+||||+.++.+||+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEECC
T ss_pred eEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEEE
Confidence 99999999999999999764 5899999999999999999999 777 99999999999999999999999
Q ss_pred cCccccccCCcc----cCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCC
Q 002146 821 FGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATL----------KLPWIGM 880 (960)
Q Consensus 821 FGLAr~~~~~~~----~~~t~~GT~~Y~APEvl~g~~------ys~ksDIWSLGvLLyELLTG----------~~PF~~~ 880 (960)
||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 999987644321 234567999999999998763 33789999999999999999 8899775
Q ss_pred C-----hhHHHHHhhccccccCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 881 N-----PMQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 881 ~-----~~ei~~~I~~~~~~~~iP~-----~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
. ...+...+.....++.++. .++..+.+||.+||..||.+||++.+|+++|+++.+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 3 2333333433334444543 3446899999999999999999999999999999765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=362.84 Aligned_cols=261 Identities=30% Similarity=0.507 Sum_probs=219.1
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
.+..++|++++.||.| .||.||++++ +++.||||++... .......+.+|+.+|++++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKG-NFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECC-SSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccC-CCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 4556789999999999 7999999984 5889999998754 34456688999999999999999999998866
Q ss_pred CC--ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 746 PP--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 746 ~~--~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
.. .+++||||+++++|.+++.+....+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcc
Confidence 54 789999999999999999876667999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----------------H
Q 002146 824 SRLKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----------------Q 884 (960)
Q Consensus 824 Ar~~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~----------------e 884 (960)
++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 987643321 122345778899999999999999999999999999999999998643110 1
Q ss_pred HHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 885 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 885 i~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
+...+ ....+...+..++.++.+||.+||..||.+||++.+|++.|+.+.+.+
T Consensus 272 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 272 LIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHh-hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111 123345667889999999999999999999999999999999997653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=362.79 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=210.9
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc----
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT---- 744 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~---- 744 (960)
+.+..++|++++.||+| .||.||+++. +++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 24 ~~i~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEG-GFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEETTEEEEEEEEEEC---CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EEECCeEEEEEEEecCC-CCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 34566789999999999 7999999985 7899999988653 3445667899999999999999999999986
Q ss_pred cCCceEEEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEec
Q 002146 745 RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DF 821 (960)
....+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEec
Confidence 34578999999999999999875 3457999999999999999999999999 999999999999999999999999
Q ss_pred CccccccCCccc---------CCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHH
Q 002146 822 GLSRLKHNTFLS---------SKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVG 887 (960)
Q Consensus 822 GLAr~~~~~~~~---------~~t~~GT~~Y~APEvl~g~~---ys~ksDIWSLGvLLyELLTG~~PF~~~~~--~ei~~ 887 (960)
|++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .....
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 998764321100 11235799999999998665 68999999999999999999999964211 11111
Q ss_pred HhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 888 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 888 ~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
.+. .......+..++.++.+||.+||..||.+||++.+++++|+.++
T Consensus 259 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 AVQ-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHH-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred Hhh-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 121 22233445678999999999999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.30 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=214.8
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC---C----hHHHHHHHHHHHHHHHcC-CCceeeEecccc
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF---S----GAALLEFKREVKIMRRLR-HPNVVLFMGAVT 744 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~---~----~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~ 744 (960)
.++|++.+.||.| .||.||++.+ +++.||||++..... . ......+.+|+.+|+++. ||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 16 YENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp TTTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhccceeeeecCC-CceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4789999999999 7999999987 678999999876531 1 123456789999999995 999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
....+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccch
Confidence 999999999999999999999764 36899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~------g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i 898 (960)
...... .......|++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.........
T Consensus 172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 172 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 876443 2334567999999999985 456889999999999999999999999998877776666433322222
Q ss_pred C--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 899 P--KELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 899 P--~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
+ ..++..+++||.+||..||.+||++.++++
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 2 468899999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=356.46 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=210.2
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
+.+..++|.....||+| .||.||++.+ +++.||||++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~~~~~~lg~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKG-TYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp EEECBCTTSSBCEEEEC-SSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccCCCCcEEEeec-CcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 34445556666789999 7999999987 67899999987653 2334578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-CCcEEEEecCccc
Q 002146 749 LSIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSR 825 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~--~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr 825 (960)
+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||+++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccccc
Confidence 999999999999999997643 24678889999999999999999999 999999999999987 8999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHhhccccccCCCCCC
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~--ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e-i~~~I~~~~~~~~iP~~l 902 (960)
.............||+.|+|||++.+.. ++.++||||||+++|+|++|..||....... ...........+.++..+
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (295)
T 2clq_A 172 RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM 251 (295)
T ss_dssp ESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTS
T ss_pred ccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccC
Confidence 7654333344567999999999997754 8899999999999999999999997654332 222222234456678889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.++++||.+||..||.+||++.+++++
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=398.68 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=221.6
Q ss_pred CcCCCCeEEE-EEeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 672 EIPWEDLVLG-ERIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 672 ei~~~dy~i~-k~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
.+....+.+. +.||.| .||+||++.+ .++.||||+++...........+.+|+.+|++++|||||++++++..
T Consensus 364 ~~~~~~~~l~~~~LG~G-~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 364 YLDRKLLTLEDKELGSG-NFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA- 441 (635)
T ss_dssp BCCGGGEEEEEEEEEEC-SSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred cccchhccccCCEeccC-CCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3444455554 589999 7999999965 45789999987765555556789999999999999999999999865
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+.++|||||+++|+|.+++.... .+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred CCEEEEEEccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 56899999999999999997643 6899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCC
Q 002146 827 KHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 827 ~~~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~l 902 (960)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...+..+|..+
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 597 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGC 597 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 64322 11223346789999999999999999999999999999998 999999999888877775 34466778899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
++++.+||.+||..||.+||++.+|++.|+.+...+
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999986543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=352.05 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=210.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--------
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-------- 745 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-------- 745 (960)
.+|++++.||.| .||.||++++ +++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSG-GFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECS-SSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccC-CceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 569999999999 7999999987 58999999987543 246789999999999999999998754
Q ss_pred --------CCceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcE
Q 002146 746 --------PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 816 (960)
Q Consensus 746 --------~~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~V 816 (960)
...+++||||+++++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCE
Confidence 45589999999999999999753 346899999999999999999999999 9999999999999999999
Q ss_pred EEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc
Q 002146 817 KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 896 (960)
Q Consensus 817 KL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~ 896 (960)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+. ..
T Consensus 162 kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~----~~ 234 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR----DG 234 (284)
T ss_dssp EECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH----TT
T ss_pred EECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh----cc
Confidence 999999998765432 234467999999999999999999999999999999999999988542 22222221 23
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 897 ~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.++..++..+++||.+||..||.+||++.+++++|+.+.+.
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 45677899999999999999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.59 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=200.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----- 747 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~----- 747 (960)
.++|++++.||.| .||.||++.. +++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSG-AQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEec-CCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4689999999999 7999999976 6889999999876555666778899999999999999999999987665
Q ss_pred -ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 -NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 -~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+|+||||+++ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 68999999975 78888864 4889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-----------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 895 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~----------- 895 (960)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 177 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 6433 2234467999999999999999999999999999999999999999998876655544321100
Q ss_pred ---------cC--------------CCC------CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ---------LE--------------IPK------ELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ---------~~--------------iP~------~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+. +|. ..+.++++||.+||..||.+||++.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 011 125689999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=367.06 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=215.3
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChH---------------HHHHHHHHHHHHHHcCCCcee
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGA---------------ALLEFKREVKIMRRLRHPNVV 737 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~---------------~~~~~~~Ei~ILk~L~HPNIV 737 (960)
+..++|++++.||.| .||.||+++++++.||||++........ ....+.+|+.++++++||||+
T Consensus 28 ~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 28 KYINDYRIIRTLNQG-KFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EEETTEEEEEEEECC-SSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCceEEEEEEcCC-CCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 445789999999999 7999999999999999999875422211 126789999999999999999
Q ss_pred eEecccccCCceEEEEeecCCCCHHHH------hhCC-CCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEE
Q 002146 738 LFMGAVTRPPNLSIITEFLPRGSLFRI------LHRP-HCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLL 809 (960)
Q Consensus 738 kL~g~f~~~~~l~LVmEY~~gGsL~dl------L~k~-~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNIL 809 (960)
++++++.+.+.+++||||+++++|.++ +.+. ...+++..++.++.||+.||.|||+ +| |+||||||+|||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence 999999999999999999999999998 6542 4578999999999999999999999 88 999999999999
Q ss_pred EcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCh-hHHH
Q 002146 810 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNE-KCDVYSFGVILWELATLKLPWIGMNP-MQVV 886 (960)
Q Consensus 810 Ld~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~-ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~ 886 (960)
|+.++.+||+|||++...... ......||..|+|||++.+. .++. ++|||||||++|+|++|..||..... .+..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999876443 23456799999999999988 5666 99999999999999999999998776 5666
Q ss_pred HHhhccccccCCC-------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 887 GAVGFQNRRLEIP-------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 887 ~~I~~~~~~~~iP-------------------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+.. ....+| ..++.++++||.+||..||.+||++.+++++
T Consensus 263 ~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTS--CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhc--cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 55532 233344 5688999999999999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=359.53 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=201.7
Q ss_pred CCeEEE-EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEE
Q 002146 676 EDLVLG-ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 676 ~dy~i~-k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~L 751 (960)
+.|++. +.||+| .||+||++++ +++.||||++..... .....+.+|+.+|+++ +||||+++++++.+.+.+++
T Consensus 12 ~~y~i~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEG-AHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCC-SSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCC-ceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 468884 789999 7999999975 689999999876532 2345788999999995 79999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc---EEEEecCcccccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKH 828 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~---VKL~DFGLAr~~~ 828 (960)
||||+++++|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+++...
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999997643 6899999999999999999999999 999999999999998766 9999999997653
Q ss_pred CCc-------ccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------------
Q 002146 829 NTF-------LSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNP-------------- 882 (960)
Q Consensus 829 ~~~-------~~~~t~~GT~~Y~APEvl~g-----~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-------------- 882 (960)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 11224569999999999976 4578999999999999999999999987642
Q ss_pred -hHHHHHhhccccccCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 883 -MQVVGAVGFQNRRLEIP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 883 -~ei~~~I~~~~~~~~iP----~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+...+. .....+| ..+++++++||.+||..||.+||++.+++++
T Consensus 246 ~~~~~~~i~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQ--EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHh--ccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22333332 2233344 3578999999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=371.54 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=211.3
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHHc-CCCceeeEecccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVT 744 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~--~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~ 744 (960)
+..++|++++.||+| .||.||++++ +++.||||++...... ......+.+|+.+|+.+ +||||+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 51 VGIENFELLKVLGTG-AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCGGGEEEEEEEEET-TTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccccceEEEEEeccC-CCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 445789999999999 6999999987 6889999998653221 11223567899999999 7999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
....+++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999999997643 6899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCC-cccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHhhccccccC
Q 002146 825 RLKHNT-FLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLE 897 (960)
Q Consensus 825 r~~~~~-~~~~~t~~GT~~Y~APEvl~g~--~ys~ksDIWSLGvLLyELLTG~~PF~~~~~----~ei~~~I~~~~~~~~ 897 (960)
+..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ..+...+ ....+.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~ 284 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPP 284 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCC
Confidence 865332 1223346799999999999863 478999999999999999999999975432 2333333 233566
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHH
Q 002146 898 IPKELDPLVARIIWECWQTDPSLRP-----SFAQLTVAL 931 (960)
Q Consensus 898 iP~~lS~eLkdLI~kcL~kDP~kRP-----Sa~eILe~L 931 (960)
+|..++..+++||.+||..||.+|| ++.+++++.
T Consensus 285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 7888999999999999999999999 999998864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=363.71 Aligned_cols=257 Identities=16% Similarity=0.178 Sum_probs=213.1
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEE-------ECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC---CCceee
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVL 738 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak-------~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~---HPNIVk 738 (960)
..+++..++|.+.++||+| .||+||++. ..++.||||++.... ..++.+|+.+++.++ |+||++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEG-AFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp CEEECSSSEEEEEEEEEEC-SSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred eeEEECCEEEEEEEEeecc-CCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 3455677889999999999 699999993 368899999986532 346778888888886 999999
Q ss_pred EecccccCCceEEEEeecCCCCHHHHhhC----CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC--
Q 002146 739 FMGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-- 812 (960)
Q Consensus 739 L~g~f~~~~~l~LVmEY~~gGsL~dlL~k----~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-- 812 (960)
+++++...+..||||||+++|+|.+++.. ....+++..++.|+.||+.||+|||++| ||||||||+||||+.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGG
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccc
Confidence 99999999999999999999999999974 3446999999999999999999999999 999999999999998
Q ss_pred ---------CCcEEEEecCcccccc--CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002146 813 ---------NWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 881 (960)
Q Consensus 813 ---------~g~VKL~DFGLAr~~~--~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~ 881 (960)
++.+||+|||+++... .........+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 8999999999997643 12223455789999999999999999999999999999999999999996543
Q ss_pred hhHHHHHhhccccccCCC-CCCcHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHhHHhhCC
Q 002146 882 PMQVVGAVGFQNRRLEIP-KELDPLVARIIWECWQTDPSLR-PSFAQLTVALKPLQRLVIP 940 (960)
Q Consensus 882 ~~ei~~~I~~~~~~~~iP-~~lS~eLkdLI~kcL~kDP~kR-PSa~eILe~Le~i~~~~~p 940 (960)
..... + ...+. ...++.+.+++..||+.+|.+| |++.++.+.|+.+.....+
T Consensus 290 ~~~~~--~-----~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 290 GGECK--P-----EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp TTEEE--E-----CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred CCcee--e-----chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 32111 0 01111 1246789999999999999999 6789999999998766443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=365.31 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=213.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC--Ch----HHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF--SG----AALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~--~~----~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
++|++.+.||.| .||.||++.+ +|+.||||++..... .. .....+.+|+.+++++ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G-~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 94 QKYDPKDVIGRG-VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhcccceEEecC-CCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 569999999999 7999999987 589999999876432 21 2245678999999999 899999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
...++||||++|++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+||||+.+|.+||+|||++..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 9999999999999999999754 36899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC--
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-- 898 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g------~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i-- 898 (960)
.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.........
T Consensus 250 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 250 LEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred cCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 6543 23345689999999999864 35889999999999999999999999998877776666433222221
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+..++..+.+||.+||..||.+||++.+++++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 24678899999999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=367.92 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=205.2
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc----
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR---- 745 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~---- 745 (960)
+...++|++++.||.| +||+||++.+ +|+.||||++..... ...+|+.+|+.++|||||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G-~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTG-SFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC--CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEec-cCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 3455789999999999 7999999986 789999999875432 12379999999999999999999843
Q ss_pred ----------------------------------CCceEEEEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHH
Q 002146 746 ----------------------------------PPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGM 788 (960)
Q Consensus 746 ----------------------------------~~~l~LVmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL 788 (960)
...+++||||++ ++|.+++.. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 344889999997 477776642 345799999999999999999
Q ss_pred HHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHH
Q 002146 789 NCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVI 866 (960)
Q Consensus 789 ~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvL 866 (960)
.|||++| |+||||||+||||+ .++.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||+
T Consensus 155 ~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 155 GFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999999 99999999999998 6899999999999876443 2344567899999999998755 8999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHhhccc---------------------------cccCCCCCCcHHHHHHHHHhhhhCCC
Q 002146 867 LWELATLKLPWIGMNPMQVVGAVGFQN---------------------------RRLEIPKELDPLVARIIWECWQTDPS 919 (960)
Q Consensus 867 LyELLTG~~PF~~~~~~ei~~~I~~~~---------------------------~~~~iP~~lS~eLkdLI~kcL~kDP~ 919 (960)
+|+|++|+.||.+.+..+....+.... ....++..+++++++||.+||..||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999987766555442110 01114566889999999999999999
Q ss_pred CCCCHHHHHHH--HHHh
Q 002146 920 LRPSFAQLTVA--LKPL 934 (960)
Q Consensus 920 kRPSa~eILe~--Le~i 934 (960)
+||++.|++++ ++.+
T Consensus 312 ~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GSCCHHHHHTSGGGHHH
T ss_pred hCCCHHHHhcCHHHHHH
Confidence 99999999863 4444
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.97 Aligned_cols=250 Identities=28% Similarity=0.388 Sum_probs=207.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc---CCCceeeEecccc-----
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT----- 744 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~---~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L---~HPNIVkL~g~f~----- 744 (960)
++|++++.||.| .||.||++++ +++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 11 QQYECVAEIGEG-AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GTEEEEEEEEEE-TTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hceeeeeeeccc-ccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 679999999999 7999999986 478899999875443322223456777777766 8999999999987
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 823 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGL 823 (960)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5677999999997 59999987543 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc----------
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------- 893 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~---------- 893 (960)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 167 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 167 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 9876433 23345679999999999999999999999999999999999999999987766554442110
Q ss_pred ---------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ---------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ---------------~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....++..++..+++||.+||..||.+||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112345688999999999999999999999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=357.30 Aligned_cols=257 Identities=29% Similarity=0.442 Sum_probs=195.5
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
.+.+..++|++++.||.| .||.||++.+ +++.||||++..... ......+.+|+.++++++||||+++++++...+
T Consensus 9 p~~i~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSG-ATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ----CCCCCEEEEECC----CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccchhhhhhhheeccc-cceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 356677899999999999 7999999975 788999998865432 233457889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhC-------CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEe
Q 002146 748 NLSIITEFLPRGSLFRILHR-------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 820 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k-------~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~D 820 (960)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEe
Confidence 99999999999999999863 2346899999999999999999999999 99999999999999999999999
Q ss_pred cCccccccCCc-----ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc
Q 002146 821 FGLSRLKHNTF-----LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 894 (960)
Q Consensus 821 FGLAr~~~~~~-----~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~ 894 (960)
||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+..........
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99987653221 11234579999999999976 5689999999999999999999999998776655443321111
Q ss_pred --------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 --------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 --------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.......++.++++||.+||..||.+||++.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112335678999999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=364.67 Aligned_cols=255 Identities=16% Similarity=0.176 Sum_probs=209.0
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEEC----------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceee-----
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWN----------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL----- 738 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~----------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVk----- 738 (960)
..++|++++.||.| .||.||++++. ++.||||++... ..+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G-~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 40 SGRQWKLKSFQTRD-NQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TSCEEEEEEEEEEE-TTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cCCeEEEEEEecCC-CCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence 35789999999999 79999999863 678999998754 25779999999999999998
Q ss_pred ----------Eeccccc-CCceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCC
Q 002146 739 ----------FMGAVTR-PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 806 (960)
Q Consensus 739 ----------L~g~f~~-~~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPe 806 (960)
+++++.. ...+++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++| |+||||||+
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~ 188 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAE 188 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHH
Confidence 4445444 67899999999 99999999864 347999999999999999999999999 999999999
Q ss_pred cEEEcCCC--cEEEEecCccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002146 807 NLLVDKNW--NVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 877 (960)
Q Consensus 807 NILLd~~g--~VKL~DFGLAr~~~~~~~-------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF 877 (960)
||||+.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 999999999987543211 123457999999999999999999999999999999999999999
Q ss_pred CCCC--hhHHHHHhh-ccccccCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhC
Q 002146 878 IGMN--PMQVVGAVG-FQNRRLEIP------KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 939 (960)
Q Consensus 878 ~~~~--~~ei~~~I~-~~~~~~~iP------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~ 939 (960)
.+.. ...+..... .......++ ..++.++++||.+||..||.+||++.+|++.|+.+.+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 8764 222222211 011112221 2468999999999999999999999999999999987653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=376.98 Aligned_cols=249 Identities=16% Similarity=0.150 Sum_probs=198.8
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHH---HHHHcCCCceeeEe------
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK---IMRRLRHPNVVLFM------ 740 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~---ILk~L~HPNIVkL~------ 740 (960)
...++|++++.||.| .||+||++++ +|+.||||++..... .......+.+|+. +|++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G-~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 70 ERPRTLVRGTVLGQE-DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CCCEEEEEEEEEEEE-TTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCceEEEcceeecC-CCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 345789999999999 7999999985 689999999975432 3345667889994 55555899999998
Q ss_pred -cccccCC-----------------ceEEEEeecCCCCHHHHhhCCCC------CCcHHHHHHHHHHHHHHHHHHhhCCC
Q 002146 741 -GAVTRPP-----------------NLSIITEFLPRGSLFRILHRPHC------QVDEKRRIKMALDVARGMNCLHTSTP 796 (960)
Q Consensus 741 -g~f~~~~-----------------~l~LVmEY~~gGsL~dlL~k~~~------~lse~~~~~Ia~QIa~AL~YLHs~g~ 796 (960)
+++...+ ..||||||+ +|+|.+++.+.+. .+++..++.|+.||+.||+|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4444443 388999999 6799999975321 2334888889999999999999999
Q ss_pred CEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCC-----------CCCchhhHHHHHH
Q 002146 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-----------PSNEKCDVYSFGV 865 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~-----------~ys~ksDIWSLGv 865 (960)
|+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999986433 2335678 999999999988 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhH
Q 002146 866 ILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPLQ 935 (960)
Q Consensus 866 LLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe--~Le~i~ 935 (960)
++|||++|..||.+.+.......+ ...+..+++++++||.+||..||.+||++.++++ .++.+.
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999999999887655443333 2233578899999999999999999999999986 455443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=356.50 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=200.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~------~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
++|++++.||.| .||.||++.+ +++.||||++...... ......+.+|+.+|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSG-ACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecC-CCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 579999999999 7999999987 5789999998754321 122345789999999999999999999987654
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc---EEEEecCcc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLS 824 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~---VKL~DFGLA 824 (960)
+|+||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 899999999999999987643 7899999999999999999999999 999999999999987654 999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHhhcccc--ccCC
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNR--RLEI 898 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-ei~~~I~~~~~--~~~i 898 (960)
+...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...... .+...+..... .+..
T Consensus 165 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 165 KILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp EECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred eeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 8764331 122356899999999974 566899999999999999999999999875443 22222221111 1112
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 899 P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
+..++..+++||.+||..||.+||++.++++
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 3567899999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.01 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=214.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++++.||.| .||.||+++. +++.||||++............+.+|+.++++++||||+++++++.+...+++||
T Consensus 22 ~~y~i~~~lg~G-~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKG-SFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCC-CCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 579999999999 6999999987 6889999998765544445667899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC---CcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~---g~VKL~DFGLAr~~~~~ 830 (960)
||+++++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999999886543 6899999999999999999999999 9999999999999754 47999999999865433
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC--CCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP--~~lS~eLkd 908 (960)
. ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..++...+.........+ ..++.++++
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 178 T-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp S-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred C-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 2 22334588999999998775 8999999999999999999999999988887777665433333332 468899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+||++.+++++
T Consensus 256 li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHcccChhhCcCHHHHhcC
Confidence 9999999999999999999984
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=374.94 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=211.4
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC--ceE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLS 750 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~--~l~ 750 (960)
.++|+++++||+| .||+||++++ +|+.||||++...... .....+.+|+++|++++||||+++++++.... .++
T Consensus 8 ~~~y~i~~~LG~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQG-ATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcC-CCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 4679999999999 6999999987 4889999998754322 22456789999999999999999999987655 789
Q ss_pred EEEeecCCCCHHHHhhCCCC--CCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE----cCCCcEEEEecCcc
Q 002146 751 IITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLS 824 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~--~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL----d~~g~VKL~DFGLA 824 (960)
+||||+++++|.+++.+... .+++..++.++.||+.||+|||++| |+||||||+|||| +.++.+||+|||++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999999976432 3899999999999999999999999 9999999999999 78888999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHhhcc
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRN--------EPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQ 892 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g--------~~ys~ksDIWSLGvLLyELLTG~~PF~~~~----~~ei~~~I~~~ 892 (960)
+..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ..++...+...
T Consensus 164 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 876543 23345679999999999875 567889999999999999999999997532 22333332211
Q ss_pred cc-----------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 893 NR-----------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 893 ~~-----------------------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.. ...++..++..+.+||.+||..||.+||++.++++.++.+...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 10 0012234567899999999999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=374.57 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=197.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~------~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
.++|.+.+.||+| .||+||++.+ +++.||||++...... ......+.+|+.+|++++|||||++++++..
T Consensus 134 ~~~y~~~~~LG~G-~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSG-ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEEC-SSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeC-CCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3679999999999 7999999986 6789999998764322 1122357899999999999999999999865
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC---cEEEEecCc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGL 823 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g---~VKL~DFGL 823 (960)
..+|+||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 45899999999999999987654 6899999999999999999999999 99999999999997544 599999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHhhcccc--ccC
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNR--RLE 897 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g---~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e-i~~~I~~~~~--~~~ 897 (960)
++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... +...+..... .+.
T Consensus 289 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 289 SKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp TTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred ceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 9876543 23345789999999999864 568899999999999999999999998754432 2222321111 111
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 898 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 898 iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.+..+++.+++||.+||..||.+||++.+++++
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 224688999999999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=371.27 Aligned_cols=248 Identities=14% Similarity=0.071 Sum_probs=189.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHc--CCCceeeEeccc------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL--RHPNVVLFMGAV------ 743 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L--~HPNIVkL~g~f------ 743 (960)
..+|++++.||.| .||+||++++ +++.||||++...... ......+.+|+.+++.| +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVG-DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCC-CCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3569999999999 7999999986 6889999999876653 34456677886655555 699988865333
Q ss_pred -ccC-----------------CceEEEEeecCCCCHHHHhhCCCCCCcHHHH------HHHHHHHHHHHHHHhhCCCCEE
Q 002146 744 -TRP-----------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRR------IKMALDVARGMNCLHTSTPTIV 799 (960)
Q Consensus 744 -~~~-----------------~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~------~~Ia~QIa~AL~YLHs~g~~II 799 (960)
... ..+||||||++ ++|.+++...+..+.+..+ +.++.||+.||+|||++| ||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--iv 216 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LV 216 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Cc
Confidence 222 34899999998 8999999865445566666 778899999999999999 99
Q ss_pred EeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 002146 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPW 877 (960)
Q Consensus 800 HRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF 877 (960)
||||||+||||+.+|.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998764322 13456799999999988 67999999999999999999999999
Q ss_pred CCCChhHHH--HH---hhccccccCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 878 IGMNPMQVV--GA---VGFQNRRLEI--PKELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 878 ~~~~~~ei~--~~---I~~~~~~~~i--P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
.+....... .. .........+ +..+++.+++||.+||..||.+||++.++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 887443211 00 0011112222 3578999999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=370.09 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=192.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC------C
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~------~ 747 (960)
++|++++.||.| .||.||++.+ +|+.||||++............+.+|+.+|+.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G-~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSG-AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC-----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeec-CCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 689999999999 7999999976 688999999876555556667889999999999999999999998654 5
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999999 7899999875 36999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-----------
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 895 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~----------- 895 (960)
... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 432 334679999999999987 67899999999999999999999999998776554443211000
Q ss_pred ----------cC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ----------LE--------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ----------~~--------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. +...+++.+++||.+||..||.+||++.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 113467899999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.00 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=197.0
Q ss_pred ccccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 668 VCECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 668 ~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
...+.+..++|++++.||.| .||.||++++ +|+.||||++............+..+..+++.++||||+++++++.+
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSG-TCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp SSEEECCGGGEEEEEEC-------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred chhhhhhhccccccceeeec-CCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 34566778899999999999 7999999987 58999999998765444444445555667788899999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
.+.+++||||+ ++.+..++......+++..++.++.||+.||.|||+. | |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999999 6677776655455789999999999999999999985 8 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHhhccccccCC
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~-~~ei~~~I~~~~~~~~i 898 (960)
...... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.... ..+....+. ......+
T Consensus 173 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~ 250 (318)
T 2dyl_A 173 GRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLL 250 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCC
T ss_pred hhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCC
Confidence 765433 2233457999999999994 5568899999999999999999999998743 334444432 2223333
Q ss_pred C--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 899 P--KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 899 P--~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+ ..+++++.+||.+||..||.+||++.+|+++
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3 4588999999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=361.57 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=207.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC-----Cc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~-----~~ 748 (960)
.+|++++.||+| .||.||++.+ +++.||||++.... .......+.+|+.+|++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEG-AYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecC-CCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 579999999999 6999999986 68889999987532 344556789999999999999999999998655 46
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+|+||||+. ++|.+++... .+++..++.|+.||+.||+|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999996 5999998764 5899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCcc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc---------
Q 002146 829 NTFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--------- 895 (960)
Q Consensus 829 ~~~~---~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~--------- 895 (960)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 3321 1234589999999998765 45899999999999999999999999988776655544211000
Q ss_pred --------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 --------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 --------------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+...+++++++||.+||..||.+||++.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01124578999999999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=363.86 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=207.1
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce----
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL---- 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l---- 749 (960)
++|.+.+.||.| .||.||++.+ +|+.||||++............+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSG-AYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecC-CCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 689999999999 7999999976 689999999987666666677889999999999999999999999877765
Q ss_pred --EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 750 --SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 750 --~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
++||||+. ++|.+++.. .+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999996 689888854 4899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc-----------
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 895 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~----------- 895 (960)
... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 195 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred ccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 432 335678999999999987 67899999999999999999999999998766655444211000
Q ss_pred ------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ------------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..++..+++.+++||.+||..||.+||++.+++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 01124578999999999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=354.52 Aligned_cols=243 Identities=20% Similarity=0.313 Sum_probs=201.4
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEeccccc--CCce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNL 749 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~--~~~l 749 (960)
.++|+++++||.| .||+||++.+ +++.||||++.... ...+.+|+.+|++++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRG-KYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEeccc-CCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 3679999999999 7999999976 78899999986432 346889999999996 9999999999987 6679
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-cEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-~VKL~DFGLAr~~~ 828 (960)
++||||+.+++|.+++.. +++..++.++.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++...
T Consensus 109 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999999999853 889999999999999999999999 99999999999999776 89999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHhhc-------------cc
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGF-------------QN 893 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~-~~ei~~~I~~-------------~~ 893 (960)
.. .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+.. ..
T Consensus 183 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 183 PG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 43 23345679999999999987 668999999999999999999999995532 2111111100 00
Q ss_pred ----------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ----------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ----------------------~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.....+..+++++++||.+||..||.+||++++++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011122378999999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=364.04 Aligned_cols=246 Identities=19% Similarity=0.221 Sum_probs=200.0
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC--------CCceeeEecccc
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--------HPNVVLFMGAVT 744 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~--------HPNIVkL~g~f~ 744 (960)
..+|+++++||+| .||+||++++ +++.||||++... ......+.+|+.+|+.++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWG-HFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeec-CCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 4689999999999 7999999976 6889999998643 344567889999999995 788999999987
Q ss_pred ----cCCceEEEEeecCCCCHHHHh-hCCCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCC----
Q 002146 745 ----RPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW---- 814 (960)
Q Consensus 745 ----~~~~l~LVmEY~~gGsL~dlL-~k~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g---- 814 (960)
....+++||||+ +++|.+++ ......+++..++.|+.||+.||.|||++ | |+||||||+||||+.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhh
Confidence 566899999999 45555555 44445799999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------cEEEEecCccccccCCcccCCCCCCCCCccCcccc
Q 002146 815 ---------------------------------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849 (960)
Q Consensus 815 ---------------------------------------------~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl 849 (960)
.+||+|||+++..... ....+||+.|+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence 7999999999876433 3346799999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh------HHHHHhhc-cc-----------------------------
Q 002146 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM------QVVGAVGF-QN----------------------------- 893 (960)
Q Consensus 850 ~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~------ei~~~I~~-~~----------------------------- 893 (960)
.+..++.++|||||||++|+|++|..||.+.+.. .....+.. ..
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999865421 11111100 00
Q ss_pred ----------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ----------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ----------~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....++...+..+++||.+||..||.+||++.+++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011233446779999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=351.68 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=211.1
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC--CCceeeEecccccCC
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPP 747 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~--HPNIVkL~g~f~~~~ 747 (960)
..+..++|++++.||.| .||.||++.+ +++.||||++............+.+|+.+|++++ ||||+++++++....
T Consensus 23 ~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSG-GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEETTEEEEEEEEEECC-SSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeccceEEEEEEecCC-CCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 45566789999999999 7999999976 5888999999877666777788999999999996 599999999999999
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+++||| +.+++|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||+++ +.+||+|||+++..
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999999 55789999997654 6889999999999999999999999 999999999999965 89999999999875
Q ss_pred cCCcc--cCCCCCCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhccc
Q 002146 828 HNTFL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQN 893 (960)
Q Consensus 828 ~~~~~--~~~t~~GT~~Y~APEvl~g-----------~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~~~ 893 (960)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 43221 1234579999999999976 4688999999999999999999999987543 23333333344
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....++...+.++++||.+||..||.+||++.+++++
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 4556777889999999999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=371.29 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=198.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc------CC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PP 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~------~~ 747 (960)
.+|++++.||+| .||.||++++ +|+.||||++..... .+.+|+++|+.++|||||+++++|.. ..
T Consensus 54 ~~y~~~~~lG~G-~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNG-SFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeC-CCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 469999999999 7999999987 589999999865421 23479999999999999999998743 22
Q ss_pred ceEEEEeecCCCCHHHHhh---CCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC-CcEEEEecCc
Q 002146 748 NLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGL 823 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~---k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-g~VKL~DFGL 823 (960)
.+++||||+++ +|.+++. +....+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence 37799999975 6666554 23457899999999999999999999999 9999999999999954 6789999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc---------
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------- 893 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~--------- 893 (960)
++..... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 204 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 204 AKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9876433 223456799999999999775 68999999999999999999999999987655444332110
Q ss_pred ------cccC------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ------RRLE------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ------~~~~------------iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.... ++..+++++++||.+||..||.+||++.+++++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0111 234578999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.96 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=203.0
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCC---------hHHHHHHHHHHHHHHHcCCCceeeEec
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFS---------GAALLEFKREVKIMRRLRHPNVVLFMG 741 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~---------~~~~~~~~~Ei~ILk~L~HPNIVkL~g 741 (960)
....++|++++.||.| .||.||++.. +|+.||||++...... ......+.+|+.+|++++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSG-SYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEE-TTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccC-CCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3445789999999999 7999999975 6889999988653322 223467899999999999999999999
Q ss_pred ccc-----cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcE
Q 002146 742 AVT-----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 816 (960)
Q Consensus 742 ~f~-----~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~V 816 (960)
++. ....+|+||||+. |+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCE
Confidence 983 3446899999997 6888888876668999999999999999999999999 9999999999999999999
Q ss_pred EEEecCccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc
Q 002146 817 KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 895 (960)
Q Consensus 817 KL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~ 895 (960)
||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 174 kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 174 TICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp EECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999999865433 23344679999999999987 67899999999999999999999999998766555444211000
Q ss_pred ------------------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ------------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ------------------------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..++..+++.+.+||.+||..||.+||++.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 01224568899999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.08 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=205.8
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc-----
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----- 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~----- 748 (960)
++|.+.+.||.| .||.||++.+ +|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSG-AYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecC-CCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 679999999999 7999999986 68999999997765556667788999999999999999999999987654
Q ss_pred -eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 749 -LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 749 -l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 588888754 4899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-------------
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 893 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~------------- 893 (960)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 177 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 177 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 432 234678999999999987 678999999999999999999999999887655444332100
Q ss_pred ----------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 ----------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ----------------~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....++..+++++++||.+||..||.+||++.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112234678999999999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.39 Aligned_cols=249 Identities=26% Similarity=0.342 Sum_probs=205.0
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC-----C
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----P 747 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~-----~ 747 (960)
.++|++++.||.| .||.||++.+ +|+.||||++.... .......+.+|+.+|++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEG-AYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCC-CCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4689999999999 7999999987 48899999986432 344556788999999999999999999987654 6
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+++||||+. ++|.+++... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7999999996 5899998763 5899999999999999999999999 999999999999999999999999999875
Q ss_pred cCCcc----------cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc--
Q 002146 828 HNTFL----------SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-- 894 (960)
Q Consensus 828 ~~~~~----------~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-- 894 (960)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43211 1223578999999998765 6789999999999999999999999998876544333211000
Q ss_pred --------------------cc--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 --------------------RL--------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 --------------------~~--------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. ..+..+++++++||.+||..||.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 1124678999999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=351.03 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=206.8
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC------ceeeEeccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP------NVVLFMGAV 743 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~---~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP------NIVkL~g~f 743 (960)
+..++|++++.||.| .||+||++.+ +++.||||++... ......+.+|+.+++.++|+ +|+++++++
T Consensus 11 ~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEG-AFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEE-TTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecC-CCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 345789999999999 7999999975 5789999998643 34456788999999998765 499999999
Q ss_pred ccCCceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC----------
Q 002146 744 TRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---------- 812 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---------- 812 (960)
...+.+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+||||+.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999999 889999987644 36889999999999999999999999 999999999999987
Q ss_pred ---------CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Q 002146 813 ---------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 883 (960)
Q Consensus 813 ---------~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ 883 (960)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999865432 33567999999999999999999999999999999999999999988766
Q ss_pred HHHHHhhcccc------------------------------------------ccCCCCCCcHHHHHHHHHhhhhCCCCC
Q 002146 884 QVVGAVGFQNR------------------------------------------RLEIPKELDPLVARIIWECWQTDPSLR 921 (960)
Q Consensus 884 ei~~~I~~~~~------------------------------------------~~~iP~~lS~eLkdLI~kcL~kDP~kR 921 (960)
+....+..... ....+...++++.+||.+||..||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 54433211100 001122346789999999999999999
Q ss_pred CCHHHHHHH
Q 002146 922 PSFAQLTVA 930 (960)
Q Consensus 922 PSa~eILe~ 930 (960)
|++.+++++
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999865
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=378.33 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=212.8
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC-CceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H-PNIVkL~g~f~~~~~l~L 751 (960)
.++|+++++||.| .||.||++++ +++.||||++....... .+.+|+++++.|+| ++|+.+..++...+..+|
T Consensus 6 ~~~y~i~~~LG~G-~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSG-SFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEEC-SSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeC-CCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 4689999999999 7999999986 58999999877554332 46789999999976 666677777788888999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE---cCCCcEEEEecCcccccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL---d~~g~VKL~DFGLAr~~~ 828 (960)
||||+ +++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+|||| +.++.+||+|||+++...
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99999 99999999866667999999999999999999999999 9999999999999 588999999999998764
Q ss_pred CCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHhhcc---ccc
Q 002146 829 NTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQ---NRR 895 (960)
Q Consensus 829 ~~~~-------~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---ei~~~I~~~---~~~ 895 (960)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 3321 223567999999999999999999999999999999999999999886542 222222111 111
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 896 ~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
..++..++.++.+||.+||..+|.+||++.+|++.|+.+..
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 12336788999999999999999999999999999999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=389.52 Aligned_cols=261 Identities=30% Similarity=0.519 Sum_probs=223.9
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
.+++..++|++++.||+| .||.||++.+. +..||||.+... ........+.+|+.+|++++|||||++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G-~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEG-QFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECC-SSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccEEEeeEEeeC-CCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 345666889999999999 79999999862 456999987643 34455678899999999999999999999985
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+ +.+++||||+++|+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCC
Confidence 4 6789999999999999999876667899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCC
Q 002146 825 RLKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 825 r~~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~l 902 (960)
+....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+..+|..+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~ 617 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 617 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCccc
Confidence 87643321 2223457789999999999999999999999999999997 999999998888877765 33456678899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
++.+.+||.+||..||.+||++.+|++.|+.+.+
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.60 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=200.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccc---------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV--------- 743 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f--------- 743 (960)
..+|++++.||.| .||.||++.+ +++.||||++... .......+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCG-GNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC------CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccC-CCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 3679999999999 6999999987 4889999998754 345567889999999999999999999876
Q ss_pred -----ccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEE
Q 002146 744 -----TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVK 817 (960)
Q Consensus 744 -----~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VK 817 (960)
.+...+++||||+. ++|.+++.+ ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEE
Confidence 34467899999997 599999975 35889999999999999999999999 99999999999997 567999
Q ss_pred EEecCccccccCCc---ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 002146 818 VSDFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 893 (960)
Q Consensus 818 L~DFGLAr~~~~~~---~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~ 893 (960)
|+|||+++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998754321 11233457999999999876 678999999999999999999999999987765554432110
Q ss_pred c----------------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 R----------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 ~----------------------------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. ...++..++.++++||.+||..||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 001234678999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=347.05 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=198.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--------
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-------- 745 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-------- 745 (960)
++|++++.||.| .||.||+++. +++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQG-AFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccC-CcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 469999999999 7999999986 6899999998643 3455678999999999999999999998754
Q ss_pred -----CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEe
Q 002146 746 -----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 820 (960)
Q Consensus 746 -----~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~D 820 (960)
...+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEee
Confidence 45689999999999999999876667888999999999999999999999 99999999999999999999999
Q ss_pred cCccccccCC--------------cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-ChhH
Q 002146 821 FGLSRLKHNT--------------FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGM-NPMQ 884 (960)
Q Consensus 821 FGLAr~~~~~--------------~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~-~~~e 884 (960)
||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||... ...+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9999865421 1122345689999999999875 68999999999999999998 55432 2233
Q ss_pred HHHHhhcc--ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 885 VVGAVGFQ--NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 885 i~~~I~~~--~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....+... ..+..++...+..+++||.+||..||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 33333221 12233455677889999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=354.35 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=188.0
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHH-HHHHcCCCceeeEeccccc
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVK-IMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~-ILk~L~HPNIVkL~g~f~~ 745 (960)
..+.+..++|++++.||.| .||.||++.+ +|+.||||++.... .......+..|+. +++.++||||+++++++.+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRG-AYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEEC-SSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccC-CCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4567788999999999999 7999999987 48999999987653 3334445666666 6666799999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhC----CCCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEcCCCcEEEEe
Q 002146 746 PPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSD 820 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k----~~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd~~g~VKL~D 820 (960)
.+..++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. | |+||||||+||||+.++.+||+|
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEcc
Confidence 9999999999975 88777652 244789999999999999999999998 8 99999999999999999999999
Q ss_pred cCccccccCCcccCCCCCCCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHhhccccc
Q 002146 821 FGLSRLKHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRR 895 (960)
Q Consensus 821 FGLAr~~~~~~~~~~t~~GT~~Y~APEvl----~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~-ei~~~I~~~~~~ 895 (960)
||+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.... +....+. ....
T Consensus 170 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~ 247 (327)
T 3aln_A 170 FGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-KGDP 247 (327)
T ss_dssp CSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-CSCC
T ss_pred CCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-cCCC
Confidence 99998764432 22334799999999999 5667899999999999999999999999875432 2222221 2222
Q ss_pred cCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 LEIP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~~iP----~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+.++ ..+++.+++||.+||..||.+||++.+|+++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 2222 4688999999999999999999999999773
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=365.11 Aligned_cols=246 Identities=23% Similarity=0.267 Sum_probs=199.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 747 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~------ 747 (960)
..+|+++++||.| +||+||++++ .+..||+|++...... ..+|+.+|+.++|||||+++++|....
T Consensus 39 ~~~Y~~~~~lG~G-~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNG-SFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEE-TTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeC-CCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3569999999999 7999999987 5566999988654321 237999999999999999999985433
Q ss_pred ceEEEEeecCCCCHHHHhh--CCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecCcc
Q 002146 748 NLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLS 824 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~--k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLA 824 (960)
.+++||||++++.+..+.. +....+++..++.++.||+.||+|||++| |+||||||+||||+ .++.+||+|||++
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 3889999998754433321 23447899999999999999999999999 99999999999999 7999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc---------
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------- 894 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~--------- 894 (960)
+..... .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 190 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876433 233456789999999999775 489999999999999999999999999876655444321100
Q ss_pred ------c------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 ------R------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ------~------------~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. ..++..+++++++||.+||..||.+||++.+++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 01234578999999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=366.17 Aligned_cols=246 Identities=24% Similarity=0.268 Sum_probs=206.4
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc------CCCceeeEecccccC
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL------RHPNVVLFMGAVTRP 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L------~HPNIVkL~g~f~~~ 746 (960)
..+|+++++||+| .||+||++.+ +++.||||++... ......+.+|+.+++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G-~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKG-SFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEES-SSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccC-ccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3579999999999 7999999976 5789999998643 33445678899998887 577999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc--EEEEecCc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGL 823 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~--VKL~DFGL 823 (960)
..+++||||+. ++|.+++.... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++. +||+|||+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999999995 68999887543 35899999999999999999999999 999999999999999887 99999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc-------
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------- 896 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~------- 896 (960)
++..... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+......+
T Consensus 249 a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 249 SCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp CEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 9765432 335689999999999999999999999999999999999999999987765544332100000
Q ss_pred --------------------------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 002146 897 --------------------------------------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQ 926 (960)
Q Consensus 897 --------------------------------------------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~e 926 (960)
.++...++++++||.+||..||.+|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 011234788999999999999999999999
Q ss_pred HHHH
Q 002146 927 LTVA 930 (960)
Q Consensus 927 ILe~ 930 (960)
++++
T Consensus 406 ~L~H 409 (429)
T 3kvw_A 406 ALRH 409 (429)
T ss_dssp HHTS
T ss_pred HhCC
Confidence 9974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.00 Aligned_cols=250 Identities=19% Similarity=0.241 Sum_probs=192.5
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc--
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-- 748 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~-- 748 (960)
...++|++++.||.| .||.||++++ +|+.||||++....... ..+.+|++.+..++||||++++++|.....
T Consensus 20 ~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQG-TFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC-----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecC-CCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345789999999999 7999999987 58899999886543222 245677888899999999999999865433
Q ss_pred -----eEEEEeecCCCCHHHHhh---CCCCCCcHHHHHHHHHHHHHHHHHHh--hCCCCEEEeccCCCcEEEcC-CCcEE
Q 002146 749 -----LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH--TSTPTIVHRDLKSPNLLVDK-NWNVK 817 (960)
Q Consensus 749 -----l~LVmEY~~gGsL~dlL~---k~~~~lse~~~~~Ia~QIa~AL~YLH--s~g~~IIHRDLKPeNILLd~-~g~VK 817 (960)
+++||||+++ +|.+.+. .....+++..++.++.||+.||.||| ++| |+||||||+||||+. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEE
Confidence 8899999976 5544332 23457889999999999999999999 777 999999999999996 89999
Q ss_pred EEecCccccccCCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc--
Q 002146 818 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-- 894 (960)
Q Consensus 818 L~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-- 894 (960)
|+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 173 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 173 LCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp ECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999999876543 2334567899999999997655 89999999999999999999999999887666555432100
Q ss_pred ----------------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 ----------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ----------------------------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....+...++++++||.+||..||.+||++.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011223367899999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.76 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=201.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CC-cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc------eeeEeccccc
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN------VVLFMGAVTR 745 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g-~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN------IVkL~g~f~~ 745 (960)
.++|++++.||.| .||+||++.+ ++ +.||||++... ......+.+|+.+++.++|++ |+.+++++..
T Consensus 18 ~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEG-TFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEE-TTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeecc-CCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 4789999999999 7999999986 34 68999998643 344567889999999997665 9999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE--------------
Q 002146 746 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-------------- 810 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL-------------- 810 (960)
...+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccccc
Confidence 99999999999 55666666543 346899999999999999999999999 9999999999999
Q ss_pred -----cCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 002146 811 -----DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 885 (960)
Q Consensus 811 -----d~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei 885 (960)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999865432 3456799999999999999999999999999999999999999998776554
Q ss_pred HHHhhcccccc------------------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 002146 886 VGAVGFQNRRL------------------------------------------EIPKELDPLVARIIWECWQTDPSLRPS 923 (960)
Q Consensus 886 ~~~I~~~~~~~------------------------------------------~iP~~lS~eLkdLI~kcL~kDP~kRPS 923 (960)
...+....... ......+.++.+||.+||..||.+||+
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 43322110000 001123568999999999999999999
Q ss_pred HHHHHHH
Q 002146 924 FAQLTVA 930 (960)
Q Consensus 924 a~eILe~ 930 (960)
+.+++++
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=351.07 Aligned_cols=244 Identities=23% Similarity=0.416 Sum_probs=200.2
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHHc----CCCceeeEecc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRL----RHPNVVLFMGA 742 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~----~~~~~~~~Ei~ILk~L----~HPNIVkL~g~ 742 (960)
.-.++|++++.||.| .||.||++++ +++.||||++....... .....+.+|+.+++++ +||||++++++
T Consensus 28 ~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKG-GFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp -----CEEEEEEEEE-TTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhceEEeeEEEcC-CCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345679999999999 6999999986 68899999987654332 1223456799999999 89999999999
Q ss_pred cccCCceEEEEee-cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEe
Q 002146 743 VTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSD 820 (960)
Q Consensus 743 f~~~~~l~LVmEY-~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~D 820 (960)
+...+..++|||| +.+++|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 78999999997643 6899999999999999999999999 99999999999999 899999999
Q ss_pred cCccccccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC
Q 002146 821 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 899 (960)
Q Consensus 821 FGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP 899 (960)
||+++..... ......||..|+|||++.+..+ +.++|||||||++|+|++|..||.... ++ ......++
T Consensus 184 fg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~------~~~~~~~~ 253 (312)
T 2iwi_A 184 FGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EI------LEAELHFP 253 (312)
T ss_dssp CSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH------HHTCCCCC
T ss_pred cchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HH------hhhccCCc
Confidence 9999876543 2345679999999999987776 458999999999999999999997632 11 12245577
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 900 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..++..+++||.+||..||.+||++.+++++
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=361.89 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=183.3
Q ss_pred CeEE-EEEeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccc--ccCCce
Q 002146 677 DLVL-GERIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNL 749 (960)
Q Consensus 677 dy~i-~k~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f--~~~~~l 749 (960)
.|++ +++||+| .||+||++++ +++.||||++....... .+.+|+.+|++++|||||+++++| .....+
T Consensus 21 ~y~~~g~~lG~G-~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRG-TYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HEECSSCCCC------EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhcCcEeeec-CCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3665 5689999 7999999986 37789999987654433 577999999999999999999999 457789
Q ss_pred EEEEeecCCCCHHHHhhC--------CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEE----cCCCcEE
Q 002146 750 SIITEFLPRGSLFRILHR--------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVK 817 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k--------~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILL----d~~g~VK 817 (960)
++||||+. ++|.+++.. ....+++..++.|+.||+.||.|||++| |+||||||+|||| +.++.+|
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999996 588887752 1124899999999999999999999999 9999999999999 6789999
Q ss_pred EEecCccccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChh---------H
Q 002146 818 VSDFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------Q 884 (960)
Q Consensus 818 L~DFGLAr~~~~~~---~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---------e 884 (960)
|+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998764321 223456799999999999885 4899999999999999999999999765431 1
Q ss_pred HHHHhhcc-cccc-----------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 002146 885 VVGAVGFQ-NRRL-----------------------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLT 928 (960)
Q Consensus 885 i~~~I~~~-~~~~-----------------------------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eIL 928 (960)
.+..+... .... ......++.+.+||.+||..||.+|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11111100 0000 00112267899999999999999999999999
Q ss_pred HH
Q 002146 929 VA 930 (960)
Q Consensus 929 e~ 930 (960)
++
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 85
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.45 Aligned_cols=244 Identities=21% Similarity=0.373 Sum_probs=207.6
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHHcC--CCceeeEecccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLR--HPNVVLFMGAVT 744 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~----~~~~~~~~Ei~ILk~L~--HPNIVkL~g~f~ 744 (960)
...++|++++.||.| .||.||++.+ +++.||||++....... .....+.+|+.++++++ |+||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 40 PLESQYQVGPLLGSG-GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp CCTTTEEEEEECSSS-SSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CccCceEEEEEEeeC-CCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 445789999999999 7999999986 78899999987654322 11235678999999996 599999999999
Q ss_pred cCCceEEEEeecCC-CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecC
Q 002146 745 RPPNLSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFG 822 (960)
Q Consensus 745 ~~~~l~LVmEY~~g-GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFG 822 (960)
..+.+++||||+.+ ++|.+++...+ .+++..++.++.||+.||.|||+.| |+||||||+||||+ .++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999976 89999987643 6899999999999999999999999 99999999999999 78999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .. .....++..
T Consensus 196 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~------~~~~~~~~~ 265 (320)
T 3a99_A 196 SGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--II------RGQVFFRQR 265 (320)
T ss_dssp TCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH------HCCCCCSSC
T ss_pred cccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hh------ccccccccc
Confidence 99876543 2334679999999999987776 6889999999999999999999976421 11 123456678
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++++++||.+||..||.+||++.+|+++
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999999884
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.21 Aligned_cols=249 Identities=23% Similarity=0.247 Sum_probs=203.9
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CC-----ceeeEeccccc
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HP-----NVVLFMGAVTR 745 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HP-----NIVkL~g~f~~ 745 (960)
-.++|++++.||+| .||+||++.+ +++.||||++... ......+.+|+.+++.++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G-~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKG-SFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEE-TTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeec-CCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 35789999999999 7999999986 5888999998643 344567788999999884 55 49999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc--CCCcEEEEecC
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFG 822 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd--~~g~VKL~DFG 822 (960)
.+.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||.+..+||||||||+||||+ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999996 59999987643 468999999999999999999996433499999999999995 57889999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc------
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------ 896 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~------ 896 (960)
+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876432 335689999999999999999999999999999999999999999988766555443210000
Q ss_pred ----------CCCC----------------------------------------------CCcHHHHHHHHHhhhhCCCC
Q 002146 897 ----------EIPK----------------------------------------------ELDPLVARIIWECWQTDPSL 920 (960)
Q Consensus 897 ----------~iP~----------------------------------------------~lS~eLkdLI~kcL~kDP~k 920 (960)
.+|. ...+++++||.+||..||.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 0000 00147899999999999999
Q ss_pred CCCHHHHHHH
Q 002146 921 RPSFAQLTVA 930 (960)
Q Consensus 921 RPSa~eILe~ 930 (960)
|||+.|++++
T Consensus 364 Rpta~e~L~h 373 (382)
T 2vx3_A 364 RIQPYYALQH 373 (382)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=351.15 Aligned_cols=248 Identities=19% Similarity=0.289 Sum_probs=200.8
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-----------CCceeeE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLF 739 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-----------HPNIVkL 739 (960)
+...+|++++.||.| .||+||++++ +++.||||++... ......+.+|+.++++++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWG-HFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeec-CCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 445789999999999 7999999986 7889999998643 334557789999999886 8999999
Q ss_pred ecccccCC----ceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhC-CCCEEEeccCCCcEEEc--
Q 002146 740 MGAVTRPP----NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVD-- 811 (960)
Q Consensus 740 ~g~f~~~~----~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~-g~~IIHRDLKPeNILLd-- 811 (960)
++++.... .+++||||+ +++|.+++.+. ...+++..++.++.||+.||.|||++ | |+||||||+||||+
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 168 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence 99987654 789999999 88999998753 34589999999999999999999998 8 99999999999994
Q ss_pred ----CCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----
Q 002146 812 ----KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---- 883 (960)
Q Consensus 812 ----~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---- 883 (960)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4458999999999876432 23457999999999999999999999999999999999999999865421
Q ss_pred --HHHHHhhc----------------------------------------cccccCCCCCCcHHHHHHHHHhhhhCCCCC
Q 002146 884 --QVVGAVGF----------------------------------------QNRRLEIPKELDPLVARIIWECWQTDPSLR 921 (960)
Q Consensus 884 --ei~~~I~~----------------------------------------~~~~~~iP~~lS~eLkdLI~kcL~kDP~kR 921 (960)
.....+.. ......++..++.++++||.+||..||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111100 001123445567889999999999999999
Q ss_pred CCHHHHHHH
Q 002146 922 PSFAQLTVA 930 (960)
Q Consensus 922 PSa~eILe~ 930 (960)
|++.+++++
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999884
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.91 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=175.2
Q ss_pred CCCeEEE-EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc----CC
Q 002146 675 WEDLVLG-ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PP 747 (960)
Q Consensus 675 ~~dy~i~-k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~----~~ 747 (960)
.++|.+. ++||.| .||+||++.+ +++.||||++... ... .......++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLG-VNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeC-CCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 4678885 469999 6999999987 5899999998643 111 1222334566799999999999876 45
Q ss_pred ceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecCc
Q 002146 748 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGL 823 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFGL 823 (960)
.+++||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 5899999999999999998754 36999999999999999999999999 999999999999986 45599999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHH----Hhhcccc--ccC
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG----AVGFQNR--RLE 897 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~----~I~~~~~--~~~ 897 (960)
++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ .+..... ...
T Consensus 178 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 178 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred ceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 9865432 2335678999999999999889999999999999999999999998766544321 1111111 112
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 898 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 898 iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....+++++++||.+||..||.+||++.+++++
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 225689999999999999999999999999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=360.99 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=196.7
Q ss_pred cCcCCCCeEEEEEeeccCCeeEE-EEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCc
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEV-YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~V-y~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~ 748 (960)
+.+...+|.+.++||.| +||+| +++.++++.||||++...... .+.+|+.+|+.+ +|||||++++++.+...
T Consensus 19 ~~i~~~~y~~~~~LG~G-~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHG-AEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp EEETTEEEEEEEEEEEC-GGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred EEEccEEEecCCeeecC-cCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 44555679999999999 79985 555678999999998654322 346899999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-----CCcEEEEecCc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGL 823 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-----~g~VKL~DFGL 823 (960)
+|||||||. |+|.+++......+.+..++.++.||+.||.|||++| |+||||||+||||+. ...+||+|||+
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999999996 5999999876656666677889999999999999999 999999999999953 33588999999
Q ss_pred cccccCCc---ccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcccccc
Q 002146 824 SRLKHNTF---LSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 896 (960)
Q Consensus 824 Ar~~~~~~---~~~~t~~GT~~Y~APEvl~---g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~ 896 (960)
++...... ......+||+.|+|||++. +..++.++|||||||++|||++ |..||...........+.......
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 98764321 2234567999999999998 4567889999999999999999 999997665544433332111111
Q ss_pred -CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 897 -EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 897 -~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
..+...+..+++||.+||..||.+||++.++++
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 112345677999999999999999999999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.50 Aligned_cols=231 Identities=15% Similarity=0.106 Sum_probs=192.4
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEEC--CcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~--g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
...+|++.+.||.| .||.||++++. ++.||||++...... ......+.+|+.++++++||||+++++++.+.+.+|
T Consensus 29 ~~~~y~i~~~lg~G-~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 29 ANGRYRLLIFHGGV-PPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTTTEEEEEEEEBS-TTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ecCcEEEEEEEccc-CCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34679999999999 69999999874 899999999866443 455678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+||||++|++|.+++.+. ....++..|+.||+.||+|||++| |+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999999642 455677889999999999999999 9999999999999999999998543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHh-hcccccc----CCCCCCcHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRL----EIPKELDPL 905 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I-~~~~~~~----~iP~~lS~e 905 (960)
|++ +++.++|||||||++|+|++|..||.+.+........ ....... .++..++++
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 333 3789999999999999999999999987654322110 0011111 233578999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
+++||.+||.+||.+| ++.++++.|+++....
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 9999999999999999 9999999999986543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=350.75 Aligned_cols=243 Identities=26% Similarity=0.363 Sum_probs=187.5
Q ss_pred CCeEEEEEeeccCCeeEEEEE-EECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~a-k~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVm 753 (960)
+.|.+.+.||.| +||+||.+ ..+|+.||||++.... ...+.+|+.+|+++ +|||||++++++.+...+|+||
T Consensus 15 ~~~~~~~~LG~G-~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYG-SSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEEC-STTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeC-CCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 346678999999 79999655 4589999999986532 34567899999987 8999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCC------CcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC-------------C
Q 002146 754 EFLPRGSLFRILHRPHCQ------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-------------W 814 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~------lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-------------g 814 (960)
|||. |+|.+++...... ..+..++.++.||+.||+|||++| |+||||||+||||+.+ +
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCce
Confidence 9996 6999999865421 123345679999999999999999 9999999999999754 4
Q ss_pred cEEEEecCccccccCCcc----cCCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 002146 815 NVKVSDFGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 882 (960)
Q Consensus 815 ~VKL~DFGLAr~~~~~~~----~~~t~~GT~~Y~APEvl~g-------~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~ 882 (960)
.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+...
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 899999999987654321 1234579999999999976 668999999999999999999 9999977644
Q ss_pred hHHHHHhhcccccc-CC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 002146 883 MQVVGAVGFQNRRL-EI----PKELDPLVARIIWECWQTDPSLRPSFAQLTV 929 (960)
Q Consensus 883 ~ei~~~I~~~~~~~-~i----P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe 929 (960)
.... +....... .. +..+++++++||.+||..||.+||++.++++
T Consensus 246 ~~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 3321 11111111 11 2245688999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=346.14 Aligned_cols=244 Identities=17% Similarity=0.128 Sum_probs=190.3
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcCC-Cceee----------
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVL---------- 738 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~H-PNIVk---------- 738 (960)
.....|.++++||+| .||+||++++ +|+.||||++..... .......+.+|+.+++.++| +|+..
T Consensus 75 ~~~~~~~~~~~LG~G-~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQE-DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SCCEEEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCceeEEEecccccC-CCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 345668999999999 6999999997 499999999874332 22335678999999999977 32211
Q ss_pred -----------Eeccccc-----CCceEEEEeecCCCCHHHHhh------CCCCCCcHHHHHHHHHHHHHHHHHHhhCCC
Q 002146 739 -----------FMGAVTR-----PPNLSIITEFLPRGSLFRILH------RPHCQVDEKRRIKMALDVARGMNCLHTSTP 796 (960)
Q Consensus 739 -----------L~g~f~~-----~~~l~LVmEY~~gGsL~dlL~------k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~ 796 (960)
++.++.. ...++++|+++ +++|.+++. .....+++..++.|+.||+.||+|||++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 1111111 23467777766 679999984 33446888899999999999999999999
Q ss_pred CEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccc----------cCCCCCchhhHHHHHHH
Q 002146 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL----------RNEPSNEKCDVYSFGVI 866 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl----------~g~~ys~ksDIWSLGvL 866 (960)
||||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999999875443 345678 999999999 55668899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 867 LWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 867 LyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+|||++|+.||.+.+..+....+. .....+++++++||.+||..||.+||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999998876655444331 1224678999999999999999999997777543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.68 Aligned_cols=223 Identities=25% Similarity=0.403 Sum_probs=182.1
Q ss_pred CCeEEE-EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHH-HHcCCCceeeEeccccc----CC
Q 002146 676 EDLVLG-ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIM-RRLRHPNVVLFMGAVTR----PP 747 (960)
Q Consensus 676 ~dy~i~-k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~IL-k~L~HPNIVkL~g~f~~----~~ 747 (960)
++|.+. +.||.| .||.||++.. +++.||||++... ..+.+|+.++ +.++||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLG-INGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccC-CCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 567776 889999 7999999987 6889999998642 2567888888 55599999999999876 67
Q ss_pred ceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecCc
Q 002146 748 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGL 823 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFGL 823 (960)
.+++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+||||+. ++.+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 7999999999999999997643 36999999999999999999999999 999999999999997 78999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--cccccCCC--
Q 002146 824 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIP-- 899 (960)
Q Consensus 824 Ar~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~--~~~~~~iP-- 899 (960)
+.... +..++.++|||||||++|+|++|..||.+.........+.. ......++
T Consensus 167 a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 167 AKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp CEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred ccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence 86432 23467899999999999999999999988665443322211 11122233
Q ss_pred --CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 900 --KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 900 --~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+++++++||.+||..||.+||++.+++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 4688999999999999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.94 Aligned_cols=240 Identities=19% Similarity=0.173 Sum_probs=190.1
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHHcC--------------
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDF------SGAALLEFKREVKIMRRLR-------------- 732 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~------~~~~~~~~~~Ei~ILk~L~-------------- 732 (960)
+..++|++++.||+| .||+||+++++|+.||||++..... .......+.+|+.+|+.++
T Consensus 17 ~~~~~y~~~~~lG~G-~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEG-VFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEE-TTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeeccc-CceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 345679999999999 7999999999999999999986542 2233467889999999986
Q ss_pred ------------CCceeeEeccccc-------------CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHH
Q 002146 733 ------------HPNVVLFMGAVTR-------------PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 787 (960)
Q Consensus 733 ------------HPNIVkL~g~f~~-------------~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~A 787 (960)
||||++++++|.+ ...+||||||+++|++.+.+.+ ..+++..++.|+.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 5666666666664 7889999999999977776644 358999999999999999
Q ss_pred HHHHh-hCCCCEEEeccCCCcEEEcCCC--------------------cEEEEecCccccccCCcccCCCCCCCCCccCc
Q 002146 788 MNCLH-TSTPTIVHRDLKSPNLLVDKNW--------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 846 (960)
Q Consensus 788 L~YLH-s~g~~IIHRDLKPeNILLd~~g--------------------~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~AP 846 (960)
|+||| ++| ||||||||+||||+.++ .+||+|||+++..... ..+||+.|+||
T Consensus 174 L~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 99999 899 99999999999999887 9999999999876432 34799999999
Q ss_pred ccccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCh-hHHHHHhhcc-cccc----CCCCCCcHHHHHHHHHhhhhCCC
Q 002146 847 EVLRNEPSNEKCDVYSFGVI-LWELATLKLPWIGMNP-MQVVGAVGFQ-NRRL----EIPKELDPLVARIIWECWQTDPS 919 (960)
Q Consensus 847 Evl~g~~ys~ksDIWSLGvL-LyELLTG~~PF~~~~~-~ei~~~I~~~-~~~~----~iP~~lS~eLkdLI~kcL~kDP~ 919 (960)
|++.+.. +.++||||||++ .++++.|..||.+... ......+... .... .++..+++++++||.+||.+|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 9999877 899999998777 7778889999965321 1111121100 1111 112357889999999999977
Q ss_pred CCCCHHHHH
Q 002146 920 LRPSFAQLT 928 (960)
Q Consensus 920 kRPSa~eIL 928 (960)
++.|++
T Consensus 324 ---sa~e~l 329 (336)
T 2vuw_A 324 ---SATDLL 329 (336)
T ss_dssp ---SHHHHH
T ss_pred ---CHHHHH
Confidence 899888
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=363.37 Aligned_cols=243 Identities=22% Similarity=0.271 Sum_probs=199.4
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc-
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN- 748 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~---~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~- 748 (960)
+..++|+++++||.| .||.||++.+ +++.||||++.... .......+.+|+.+|++++|||||+++++|...+.
T Consensus 77 ~~~~~y~i~~~lg~G-~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHG-GLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEE-TTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeC-CCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 344789999999999 6999999986 47899999886532 34455678899999999999999999999987766
Q ss_pred ----eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 749 ----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 749 ----l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+||||||++|++|.+++.. .+++..++.|+.||+.||.|||++| ||||||||+||||+.+ .+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999998765 6899999999999999999999999 9999999999999875 8999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC-CCCCc
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-PKELD 903 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i-P~~lS 903 (960)
+..... ...+||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+.....+ .... ....+
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------~~~~~~~~~~ 294 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------PEDDPVLKTY 294 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------CTTCHHHHHC
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------cccccccccC
Confidence 876433 3467999999999998764 8999999999999999999998875321100 0000 11245
Q ss_pred HHHHHHHHHhhhhCCCCCCC-HHHHHHHHHHhHHh
Q 002146 904 PLVARIIWECWQTDPSLRPS-FAQLTVALKPLQRL 937 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPS-a~eILe~Le~i~~~ 937 (960)
+.+.+||.+||.+||.+||+ ++++.+.|..+.+.
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 78999999999999999994 77777777776543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=361.42 Aligned_cols=257 Identities=23% Similarity=0.289 Sum_probs=204.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc------C
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------P 746 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~------~ 746 (960)
..+|+++++||.| .||.||++.+ +|+.||||++... ........+.+|+.+|++++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G-~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTG-GFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBC-SSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeC-CCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3679999999999 6999999976 6889999988654 345566788999999999999999999998765 6
Q ss_pred CceEEEEeecCCCCHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCc---EEEEec
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDF 821 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~--~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~---VKL~DF 821 (960)
+..++||||+++++|.+++.... ..+++..++.|+.||+.||+|||+.| |+||||||+||||+.++. +||+||
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccc
Confidence 77899999999999999998643 25889999999999999999999999 999999999999997665 999999
Q ss_pred CccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHH---------Hhh-c
Q 002146 822 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG---------AVG-F 891 (960)
Q Consensus 822 GLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~---------~I~-~ 891 (960)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ .+. .
T Consensus 169 G~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 169 GYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 999876543 23345689999999999999999999999999999999999999997643221100 000 0
Q ss_pred --ccc----------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH-----HHHHHHHhHH
Q 002146 892 --QNR----------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQ-----LTVALKPLQR 936 (960)
Q Consensus 892 --~~~----------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~e-----ILe~Le~i~~ 936 (960)
... ...++..+++.+.+||.+||..||.+||++.+ +++.++.+..
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 11123346789999999999999999999988 5666666644
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=306.61 Aligned_cols=184 Identities=15% Similarity=0.104 Sum_probs=132.2
Q ss_pred eeccCCeeEEEEEE--ECCcEEEEEEeecCCC----C----hHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEE
Q 002146 684 IGLGSSYGEVYHAD--WNGTEVAVKKFLDQDF----S----GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 684 LG~GGsFG~Vy~ak--~~g~~VAVK~i~~~~~----~----~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LV 752 (960)
++.| .+|.+..++ +.|+.||||++.+... . +....+|.+|+++|+++ .|+||++++++++++..+|||
T Consensus 242 ~~~~-~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 242 PYAG-AGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp -C---------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred cccC-CcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4455 455555543 3799999999976532 1 23345799999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||++|++|.++|.+.+ .+++. .|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.......
T Consensus 321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999998754 56654 47889999999999999 99999999999999999999999999987765544
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 875 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~ 875 (960)
...+.+||+.|||||++.+. +..++|+|++|+++++|.++..
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 45567899999999999875 5678999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=272.20 Aligned_cols=186 Identities=15% Similarity=0.220 Sum_probs=147.8
Q ss_pred EEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChH------HHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 679 VLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 679 ~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~------~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
...++||+| .||.||++++.++.+++|++........ ...++.+|+++|++++||||+++..++...+..|||
T Consensus 339 ~~~~~LG~G-~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKG-AEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ----------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeC-CCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 346789999 7999999999999999998765443322 234589999999999999999655555567778999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++++|.+++.+ ++.|+.||+.||.|||+++ |+||||||+||||+. ++||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999875 5578999999999999999 999999999999998 999999999997654311
Q ss_pred -------cCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002146 833 -------SSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWI 878 (960)
Q Consensus 833 -------~~~t~~GT~~Y~APEvl~g--~~ys~ksDIWSLGvLLyELLTG~~PF~ 878 (960)
.....+||+.|||||++.+ ..|+...|+|+..+-..+.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1235679999999999987 568888999999988888887776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=217.00 Aligned_cols=146 Identities=19% Similarity=0.170 Sum_probs=116.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCCh----------------HHHHHHHHHHHHHHHcCCCceeeE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSG----------------AALLEFKREVKIMRRLRHPNVVLF 739 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~----------------~~~~~~~~Ei~ILk~L~HPNIVkL 739 (960)
.|.+++.||.| .||.||++.+ +|+.||||+++...... .....+.+|+.+|++++ | +++
T Consensus 91 ~~~~~~~iG~G-~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEG-KESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEEC-SSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccC-CCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 45667999999 7999999988 58899999986432111 13457899999999998 4 666
Q ss_pred ecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEE
Q 002146 740 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 819 (960)
Q Consensus 740 ~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~ 819 (960)
.+++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||++| |+||||||+||||+ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEE
Confidence 665543 56799999999999998 422 123468999999999999999 99999999999999 9999999
Q ss_pred ecCccccccCCcccCCCCCCCCCccCcccccC
Q 002146 820 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851 (960)
Q Consensus 820 DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g 851 (960)
|||+++. +..|+|||.+..
T Consensus 235 DFG~a~~-------------~~~~~a~e~l~r 253 (282)
T 1zar_A 235 DFPQSVE-------------VGEEGWREILER 253 (282)
T ss_dssp CCTTCEE-------------TTSTTHHHHHHH
T ss_pred ECCCCeE-------------CCCCCHHHHHHH
Confidence 9999863 335788998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=185.20 Aligned_cols=137 Identities=20% Similarity=0.243 Sum_probs=107.1
Q ss_pred eEEEEEeeccCCeeEEEEEEE--CCcE--EEEEEeecCCCC----------------------hHHHHHHHHHHHHHHHc
Q 002146 678 LVLGERIGLGSSYGEVYHADW--NGTE--VAVKKFLDQDFS----------------------GAALLEFKREVKIMRRL 731 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~--~g~~--VAVK~i~~~~~~----------------------~~~~~~~~~Ei~ILk~L 731 (960)
|.+.+.||.| .||.||++.+ +|+. ||||+++..... ......+.+|+.+|+++
T Consensus 49 ~~i~~~ig~G-~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 49 TAMGGVISTG-KEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEC-SSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeec-ceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 7899999999 7999999987 8999 999987543211 01123678999999999
Q ss_pred CCCce--eeEecccccCCceEEEEeecCC-C----CHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHh-hCCCCEEEecc
Q 002146 732 RHPNV--VLFMGAVTRPPNLSIITEFLPR-G----SLFRILHRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDL 803 (960)
Q Consensus 732 ~HPNI--VkL~g~f~~~~~l~LVmEY~~g-G----sL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLH-s~g~~IIHRDL 803 (960)
.|++| +.+++. ...+|||||+.+ | .|.++... .++.....++.||+.+|.||| .+| ||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence 87754 334432 357899999942 3 67776532 335567789999999999999 898 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccc
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
||+||||+. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=5.8e-16 Score=175.42 Aligned_cols=136 Identities=15% Similarity=0.166 Sum_probs=97.7
Q ss_pred eEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCC------------hHHH--------HHHHHHHHHHHHcCCCce
Q 002146 678 LVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFS------------GAAL--------LEFKREVKIMRRLRHPNV 736 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~------------~~~~--------~~~~~Ei~ILk~L~HPNI 736 (960)
|.++++||.| .||.||+|.. +|+.||||+++..... .... ....+|...|.++.+.+|
T Consensus 97 Y~I~~~IG~G-k~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVG-KESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEEC-SSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeC-CceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 8999999999 6999999975 7899999987532110 0001 112356666666644333
Q ss_pred e--eEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC
Q 002146 737 V--LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 814 (960)
Q Consensus 737 V--kL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g 814 (960)
. ..++. ...+|||||++|+.|.++... . ....++.||+.+|.|||++| ||||||||.||||+++|
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-----~--~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-----P--DPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC-----S--CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc-----H--HHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCC
Confidence 2 22221 234699999999988765432 1 23457789999999999999 99999999999998776
Q ss_pred ----------cEEEEecCccccc
Q 002146 815 ----------NVKVSDFGLSRLK 827 (960)
Q Consensus 815 ----------~VKL~DFGLAr~~ 827 (960)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=5.9e-12 Score=131.94 Aligned_cols=141 Identities=16% Similarity=0.033 Sum_probs=110.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEEEEe
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
..|++...++.| +++.||++...++.+++|+........ ...+.+|+.+|+.+ .+..+.++++++...+..|+|||
T Consensus 14 ~~~~~~~~~~g~-s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGM-SPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCC-SSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccceeEeeccCC-CCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 457888888877 689999998888999999876421111 12578999999999 46778889999888889999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST--------------------------------------- 795 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g--------------------------------------- 795 (960)
|++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999999876421 1223467789999999999810
Q ss_pred ------------------CCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 796 ------------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 796 ------------------~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 239999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.4e-10 Score=119.75 Aligned_cols=135 Identities=19% Similarity=0.174 Sum_probs=98.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc--eeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN--IVkL~g~f~~~~~l~LV 752 (960)
..+.+.. ++.||..+.||++.. +|+.|++|+..... ...+.+|+.+|+.+.+.+ +.++++++...+..++|
T Consensus 20 ~~~~~~~-~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQ-QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTCEEEE-CSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCCceEe-cccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 3455544 443437899999976 46789999865431 135678999999985434 56688888888889999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------------------------------------- 795 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g------------------------------------- 795 (960)
|||++|..|. ... .. ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9999998884 221 11 1246678888888888743
Q ss_pred -------------------CCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 796 -------------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 796 -------------------~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
..++|+|++|.|||++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.7e-10 Score=125.37 Aligned_cols=142 Identities=19% Similarity=0.206 Sum_probs=106.6
Q ss_pred EEEEeeccCCeeEEEEEEECCcEEEEEEee--cCCCChHHHHHHHHHHHHHHHcC--CCceeeEecccccC---CceEEE
Q 002146 680 LGERIGLGSSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRP---PNLSII 752 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~--~~~~~~~~~~~~~~Ei~ILk~L~--HPNIVkL~g~f~~~---~~l~LV 752 (960)
.++.|+.| .++.||+++..+..+++|+.. .... ......+.+|+.+|+.|. +..+++++.++.+. +..|+|
T Consensus 42 ~~~~l~~G-~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGG-QSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC--CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCc-ccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 45678888 799999999888899999765 2211 112346788999999996 34578888887766 458999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-------------------------------------- 794 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~-------------------------------------- 794 (960)
|||++|..+.+... ..+++.....++.+++..|..||..
T Consensus 120 me~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999987754221 2367778888999999999999973
Q ss_pred ------------------CCCEEEeccCCCcEEEcCCCc--EEEEecCcccc
Q 002146 795 ------------------TPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRL 826 (960)
Q Consensus 795 ------------------g~~IIHRDLKPeNILLd~~g~--VKL~DFGLAr~ 826 (960)
...+||||+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999997653 69999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=2.9e-09 Score=114.71 Aligned_cols=185 Identities=18% Similarity=0.170 Sum_probs=121.2
Q ss_pred EEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCc--eeeEecccccCC---ceEEEEee
Q 002146 682 ERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN--VVLFMGAVTRPP---NLSIITEF 755 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPN--IVkL~g~f~~~~---~l~LVmEY 755 (960)
+.++.| ....||++. ..+++|+... ......+.+|..+|+.+ .+.. +.+++....... ..|+||||
T Consensus 26 ~~~~~G-~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEG-NDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEEC-SSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCC-CcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 448888 688898874 6788997532 23456788999999988 3332 345555443333 35789999
Q ss_pred cCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 002146 756 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST---------------------------------------- 795 (960)
Q Consensus 756 ~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g---------------------------------------- 795 (960)
++|..|...... .++..+...++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999888753321 3667777788888888888888621
Q ss_pred ----------------CCEEEeccCCCcEEEcC--CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccC----CC
Q 002146 796 ----------------PTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN----EP 853 (960)
Q Consensus 796 ----------------~~IIHRDLKPeNILLd~--~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g----~~ 853 (960)
+.++|+|++|.|||++. .+.+.|+||+.+..-.....-.. ......-..|+.... ..
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~-~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS-LMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT-TCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH-HHhhccccCHHHHHHHHHHcC
Confidence 24899999999999998 55689999999875322110000 000000023332111 00
Q ss_pred -C---------CchhhHHHHHHHHHHHHhCCCCCC
Q 002146 854 -S---------NEKCDVYSFGVILWELATLKLPWI 878 (960)
Q Consensus 854 -y---------s~ksDIWSLGvLLyELLTG~~PF~ 878 (960)
. ....++|+++.++|.+.+|..+|.
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 123689999999999999988764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.8e-06 Score=93.56 Aligned_cols=135 Identities=18% Similarity=0.145 Sum_probs=92.9
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC---ceeeEecccc-cCCceEEEEeec
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVT-RPPNLSIITEFL 756 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP---NIVkL~g~f~-~~~~l~LVmEY~ 756 (960)
++.++.| ....||+. |..+++|+-. .......+.+|..+|+.|.+. .|.+.+.+.. ..+..++||||+
T Consensus 24 v~~l~~G-~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEG-FRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEEC-SSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCC-cceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 3457777 67889988 6788899742 233456788999999999642 2455565553 445678999999
Q ss_pred CCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------
Q 002146 757 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST----------------------------------------- 795 (960)
Q Consensus 757 ~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g----------------------------------------- 795 (960)
+|..|....-. .++......++.++...|..||+..
T Consensus 96 ~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 96 QGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99888763211 2344444555555555555555422
Q ss_pred -----------------CCEEEeccCCCcEEEcC---CCc-EEEEecCcccc
Q 002146 796 -----------------PTIVHRDLKSPNLLVDK---NWN-VKVSDFGLSRL 826 (960)
Q Consensus 796 -----------------~~IIHRDLKPeNILLd~---~g~-VKL~DFGLAr~ 826 (960)
+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 24799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.7e-06 Score=89.15 Aligned_cols=132 Identities=17% Similarity=0.195 Sum_probs=94.0
Q ss_pred eeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEEEEeecCCCC
Q 002146 684 IGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 684 LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~LVmEY~~gGs 760 (960)
+..|.+-..||+... .+..+++|+-.. .....+.+|..+|+.|. +=-|.+++.++.+.+..++|||+++|..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 444533457888764 466799997542 23456788999999883 3236678888888889999999999988
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCC--------------------------------------------
Q 002146 761 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP-------------------------------------------- 796 (960)
Q Consensus 761 L~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~-------------------------------------------- 796 (960)
+.+..... ......++.+++..|.-||....
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 87765321 12223455666677777775311
Q ss_pred ------------CEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 797 ------------TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 797 ------------~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
.++|+|+++.|||++.++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 28999999999999987777899999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=2.4e-06 Score=93.57 Aligned_cols=84 Identities=6% Similarity=-0.031 Sum_probs=55.1
Q ss_pred eEEEEEe-eccCCeeEEEEEEEC--------CcEEEEEEeecCCC-ChHHHHHHHHHHHHHHHcC-C--CceeeEecccc
Q 002146 678 LVLGERI-GLGSSYGEVYHADWN--------GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-H--PNVVLFMGAVT 744 (960)
Q Consensus 678 y~i~k~L-G~GGsFG~Vy~ak~~--------g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk~L~-H--PNIVkL~g~f~ 744 (960)
....+.| +.| ....+|+.... ++.+++|+...... .......+.+|..+|+.|. + -.+.+++.+..
T Consensus 22 v~~~~~l~~~G-~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 22 VTVESGVDSTG-MSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEEEECTTS-SEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred eEEEEECCCCC-ccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 3445778 667 78999998765 77899997543220 0000124678888888873 3 24667777665
Q ss_pred cC---CceEEEEeecCCCCHH
Q 002146 745 RP---PNLSIITEFLPRGSLF 762 (960)
Q Consensus 745 ~~---~~l~LVmEY~~gGsL~ 762 (960)
+. +..++||||++|..+.
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCCC
T ss_pred CCCccCCceEEEEecCCCChh
Confidence 54 3578999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=9.7e-06 Score=87.11 Aligned_cols=138 Identities=14% Similarity=0.064 Sum_probs=79.5
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC--CceeeEecc------cccCCceEEE
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGA------VTRPPNLSII 752 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H--PNIVkL~g~------f~~~~~l~LV 752 (960)
++.|+.| ..+.||++...+..+++|+.... . ..+..|..+++.|.. -.+.+++.. ....+..+++
T Consensus 37 ~~~l~gG-~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGN-QMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC-----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeecccc-ccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 4557656 78999999887777999987642 2 233455566655521 123344431 1345678999
Q ss_pred EeecCCCCHH-----------HH---hh---CCC--C-C-------CcHHH-----------------------------
Q 002146 753 TEFLPRGSLF-----------RI---LH---RPH--C-Q-------VDEKR----------------------------- 776 (960)
Q Consensus 753 mEY~~gGsL~-----------dl---L~---k~~--~-~-------lse~~----------------------------- 776 (960)
|||++|..+. .. ++ ... . . ..+..
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 11 11 100 0 0 01100
Q ss_pred --HHHHHHHHHHHHHHHhh-----------CCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 777 --RIKMALDVARGMNCLHT-----------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 777 --~~~Ia~QIa~AL~YLHs-----------~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
+..+..++..++.+|+. ....+||+|+++.|||++.++.+.|+||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 01111223345666652 22359999999999999888899999999774
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=97.95 E-value=8.7e-06 Score=88.98 Aligned_cols=102 Identities=15% Similarity=0.119 Sum_probs=69.3
Q ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHHhCCceeEeeecccccchhhHHHHH
Q 002146 196 LVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFK 275 (960)
Q Consensus 196 L~~~a~~l~~~l~~~~~~~~~~~lA~~V~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~pig~l~~g~~~~~a~lfk 275 (960)
|.+.|..+..+.. +..+.++.|...|.+.+. ........... ...-| .-+.|+|+++|.||-
T Consensus 128 i~~~A~~~~~~~~--~~~~~~~ai~~~v~~~~~-Y~~~~~~~~~~---a~~~l------------~~~~G~C~d~A~l~v 189 (293)
T 3isr_A 128 LQKLAYKEFGKIE--NVYSKVLAITDWIYNNVE-YISGSTNSQTS---AFDTI------------TERAGVCRDFAHLGI 189 (293)
T ss_dssp SHHHHHHHHTTCC--SHHHHHHHHHHHHHHHSE-ECTTSCCTTCC---HHHHH------------HHCEECHHHHHHHHH
T ss_pred HHHHHHHHhccCC--CHHHHHHHHHHHHHhhcE-EeccCCCCCCC---HHHhh------------cCCcEehHHHHHHHH
Confidence 5666777765543 336778999999988654 21111100001 11122 236899999999999
Q ss_pred HHhhhcCCceEEeeccccc--CCCCCeeEEEEecCcceeeeec
Q 002146 276 VLADSIRLPCRLVKGSHYT--GVEDDAVNIIKLEEEREFLVDL 316 (960)
Q Consensus 276 ~l~d~~~~~~~lv~G~~y~--~~~~~a~~~v~~~~~~~y~vDl 316 (960)
.||..+|||||+|.|.... ..+.|||++|.+.+ .|+.||-
T Consensus 190 al~Ra~GIPAR~VsGy~~~~~~~~~HAW~Evyl~g-gWv~~Dp 231 (293)
T 3isr_A 190 ALCRALSIPARYFTGYAFKLNPPDFHACFEAYIGG-NWIIFDA 231 (293)
T ss_dssp HHHHHTTCCEEEEEEEETTCSSCCEEEEEEEEETT-EEEEECT
T ss_pred HHHHHCCCCEEEEEEECCCCCCCCeEEEEEEEECC-cEEEEEC
Confidence 9999999999999993322 12349999999954 8999995
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=2.6e-05 Score=86.97 Aligned_cols=77 Identities=17% Similarity=0.113 Sum_probs=49.1
Q ss_pred EEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC--Ch---HHHHHHHHHHHHHHHcC-C-C-ceeeEecccccCCce
Q 002146 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF--SG---AALLEFKREVKIMRRLR-H-P-NVVLFMGAVTRPPNL 749 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~--~~---~~~~~~~~Ei~ILk~L~-H-P-NIVkL~g~f~~~~~l 749 (960)
..+.||.| ..+.||++.. .++.|+||....... .. ....++..|.++|+.+. + + .+.+++.+ +....
T Consensus 34 ~~~~lg~G-~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 34 TCQEIGDG-NLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEEECCSS-SSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EEEECCCC-ceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 35679988 7999999953 568899997643211 00 11235678899998873 2 3 34456544 34456
Q ss_pred EEEEeecCCC
Q 002146 750 SIITEFLPRG 759 (960)
Q Consensus 750 ~LVmEY~~gG 759 (960)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00014 Score=79.89 Aligned_cols=76 Identities=20% Similarity=0.126 Sum_probs=60.4
Q ss_pred EEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC---CCceeeEecccccCCceEEEEeec
Q 002146 680 LGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFL 756 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~---HPNIVkL~g~f~~~~~l~LVmEY~ 756 (960)
-.+.|+.| ....+|+...++..+++|+.... ....+..|...|+.|. ...+++++.+....+..++||||+
T Consensus 40 ~~~~l~gG-~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSG-EMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCS-SSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCc-cceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 45678888 79999999888889999986532 2456788999998883 356778888887778899999999
Q ss_pred CCCCH
Q 002146 757 PRGSL 761 (960)
Q Consensus 757 ~gGsL 761 (960)
+|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00019 Score=80.86 Aligned_cols=75 Identities=17% Similarity=0.172 Sum_probs=45.5
Q ss_pred CEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCC--CCCccCcccccCCC---CCchhhHHHHHHHHHHHH
Q 002146 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TPEWMAPEVLRNEP---SNEKCDVYSFGVILWELA 871 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~~G--T~~Y~APEvl~g~~---ys~ksDIWSLGvLLyELL 871 (960)
.++|+|+++.|||++.++ ++|+||+.+..-.....-. ...+ ...|++|+...... .....++..+...+|+.+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 499999999999998876 9999999887532111000 0000 12456665543211 122345557777777777
Q ss_pred hC
Q 002146 872 TL 873 (960)
Q Consensus 872 TG 873 (960)
.+
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=6.2e-05 Score=82.08 Aligned_cols=51 Identities=18% Similarity=0.182 Sum_probs=46.5
Q ss_pred cccccchhhHHHHHHHhhhcCCceEEeecccccCCCCCeeEEEEecC-cceeeeecc
Q 002146 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVDLM 317 (960)
Q Consensus 262 l~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~y~~~~~~a~~~v~~~~-~~~y~vDlm 317 (960)
-+.|+|+++|.||-.||-.+|||||+|-| | +.|||+.|-+.. .+|+-||--
T Consensus 138 ~r~G~C~d~A~lf~al~Ra~GIpAR~V~G--y---~~HaW~Evy~~g~~gWv~~Dpt 189 (295)
T 2f4m_A 138 TRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPSQQRWLHCDAC 189 (295)
T ss_dssp HCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETTTTEEEEEETT
T ss_pred cCCEeeHHHHHHHHHHHHHCCCCEEEEcC--C---CCEEEEEEEECCCCeEEEEeCC
Confidence 37899999999999999999999999999 5 689999999976 689999965
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00057 Score=74.13 Aligned_cols=31 Identities=39% Similarity=0.461 Sum_probs=27.2
Q ss_pred CEEEeccCCCcEEEcCC----CcEEEEecCccccc
Q 002146 797 TIVHRDLKSPNLLVDKN----WNVKVSDFGLSRLK 827 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~----g~VKL~DFGLAr~~ 827 (960)
.++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 59999999999999874 68999999988753
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00061 Score=79.61 Aligned_cols=104 Identities=13% Similarity=0.109 Sum_probs=66.6
Q ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHHhCCceeEeeecccccchhhHHHHH
Q 002146 196 LVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFK 275 (960)
Q Consensus 196 L~~~a~~l~~~l~~~~~~~~~~~lA~~V~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~pig~l~~g~~~~~a~lfk 275 (960)
+++.|..|..+.. +..+.++.|-.+|.+.+.=.....+.....-.....-|+.. .|.|...|+||.
T Consensus 230 i~~~a~~l~~~~~--~~~ek~~~iy~~V~~~i~y~~~~~~~~g~~~~~a~~vl~~~------------~G~C~d~a~Ll~ 295 (506)
T 3kd4_A 230 SKTFAQFLTDKSG--NEQEKVNIIRDHILNNLSTCPIPMAMTGYTVRDIDTVLRSA------------YGTPLEIAQLLN 295 (506)
T ss_dssp HHHHHHHHHSSCS--SHHHHHHHHHHHHHHHCEECCCCGGGGTTCCCCHHHHHHHT------------EECHHHHHHHHH
T ss_pred HHHHHHHHHhcCC--CHHHHHHHHHHHHHhccEecceecccCCCCCCCHHHHHHhC------------CcchHHHHHHHH
Confidence 4445555555543 33566677777777666311000000000000122333333 699999999999
Q ss_pred HHhhhcCCceEEeecccccCCC----------CCeeEEEEecCcceeeeec
Q 002146 276 VLADSIRLPCRLVKGSHYTGVE----------DDAVNIIKLEEEREFLVDL 316 (960)
Q Consensus 276 ~l~d~~~~~~~lv~G~~y~~~~----------~~a~~~v~~~~~~~y~vDl 316 (960)
.||..+||||++|-+ |++.. +|+|+.|++ ||+||++|-
T Consensus 296 AllRa~GIpA~~v~~--~t~~~~~~~~~lp~~nh~i~~v~~-~g~~y~lDa 343 (506)
T 3kd4_A 296 VMLNAAGIPSEVLAV--YPGHLDTDACGLAAIQTLAVKATV-DGKDQYLSA 343 (506)
T ss_dssp HHHHHTTCCEEEEEE--EETTSCGGGCCSTTCCEEEEEEEE-TTEEEEESS
T ss_pred HHHHHCCCCcEEEEE--EcCCCCCccCCCCCCCEEEEEEEE-CCEEEEEec
Confidence 999999999999998 54322 599999998 899999997
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0016 Score=69.98 Aligned_cols=145 Identities=12% Similarity=0.076 Sum_probs=80.7
Q ss_pred CeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc--eeeEecc------cccCCc
Q 002146 677 DLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGA------VTRPPN 748 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN--IVkL~g~------f~~~~~ 748 (960)
...-.+.|+.| ....+|+....+..+++|+..... ....+..|+.+++.|...+ +.+++.. ....+.
T Consensus 23 ~~~~~~~i~~G-~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 23 SLTSYKGIAEG-VENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp CEEEEEEECC----EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred cceEeeccCCC-cccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34456678877 678999998776689999876521 1124556777777773212 3333322 122356
Q ss_pred eEEEEeecCCCCHHH-----------H---hhC---C-C-CC---Cc---HHHHH--------H----HHHHHHHHHHHH
Q 002146 749 LSIITEFLPRGSLFR-----------I---LHR---P-H-CQ---VD---EKRRI--------K----MALDVARGMNCL 791 (960)
Q Consensus 749 l~LVmEY~~gGsL~d-----------l---L~k---~-~-~~---ls---e~~~~--------~----Ia~QIa~AL~YL 791 (960)
.+++|+|++|..+.. . ++. . . .. .. +...+ . +...+...+.+|
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 789999998865311 0 111 0 0 00 00 11100 0 001133444555
Q ss_pred hhC-----CCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 792 HTS-----TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 792 Hs~-----g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+.. ...+||+|+++.|||++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 421 12499999999999999876668999997753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0022 Score=68.27 Aligned_cols=80 Identities=16% Similarity=0.107 Sum_probs=55.2
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-C-C-ceeeEecccccCCceE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-P-NVVLFMGAVTRPPNLS 750 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-H-P-NIVkL~g~f~~~~~l~ 750 (960)
..++.-++.+|.| ..+.||+.+. +|+.|++|+........ ...+..|...|+.|. . + -+++++++. .-+
T Consensus 14 G~~v~~v~~~g~G-~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 14 GREVAAVAERGHS-HRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp CCCEEEEEEEEEE-TTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred CCCeEEEEecCCC-CCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 3456677889989 7999999987 68999999754332211 224678999999883 2 1 345555542 347
Q ss_pred EEEeecCCCCH
Q 002146 751 IITEFLPRGSL 761 (960)
Q Consensus 751 LVmEY~~gGsL 761 (960)
+||||+.++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0018 Score=68.12 Aligned_cols=140 Identities=18% Similarity=0.167 Sum_probs=96.7
Q ss_pred CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHH-hhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002146 759 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837 (960)
Q Consensus 759 GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YL-Hs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~~t~ 837 (960)
-+|.++|...+..++|.++|.+++|.+.+|.-+ +... -..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------
Confidence 479999998888999999999999999998766 2212 12333457899999999998763 1110
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhh-
Q 002146 838 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT- 916 (960)
Q Consensus 838 ~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~k- 916 (960)
.....+.+||... ...+.+.=|||||+++|..+--..| ..-+..+++.+.+||..|..-
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhcc
Confidence 1223566888764 3456888999999999999863332 222345899999999999865
Q ss_pred ------------------------CCCCCCCHHHHHHHHHH
Q 002146 917 ------------------------DPSLRPSFAQLTVALKP 933 (960)
Q Consensus 917 ------------------------DP~kRPSa~eILe~Le~ 933 (960)
.+..|+++++|++.=+.
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 24688999999876544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00094 Score=76.12 Aligned_cols=73 Identities=15% Similarity=0.211 Sum_probs=48.6
Q ss_pred EEEEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCce
Q 002146 680 LGERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l 749 (960)
-++.|+.| ....||++... +..|++|+..... . ...+.+|..+++.|. +.-..++++.+..
T Consensus 77 ~v~~l~gG-~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGG-MSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCC-TTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCC-cccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 34567767 67999999864 4789999874321 1 124457889998883 3334667776543
Q ss_pred EEEEeecCCCCH
Q 002146 750 SIITEFLPRGSL 761 (960)
Q Consensus 750 ~LVmEY~~gGsL 761 (960)
.+|+||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00081 Score=72.07 Aligned_cols=135 Identities=14% Similarity=0.085 Sum_probs=73.8
Q ss_pred EEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEEEEeec-CC
Q 002146 681 GERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFL-PR 758 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~LVmEY~-~g 758 (960)
++.|+.| ....+|++ ..+++|+..... . ......+|..+++.+. +.-..++++++ .+.-++|+||+ +|
T Consensus 23 i~~l~gG-~tN~~~~~----~~~vlR~~~~~~--~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGG-LTNLVFRA----GDLCLRIPGKGT--E-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESC-SSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCc-ccccccee----eeEEEECCCCCc--c-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 5678878 78999998 678889765421 1 1112346777777773 22224555543 33456899999 66
Q ss_pred CCHHH--------H----------hhCCCCCC----c-HHHHHHHH-----------------HHHHHHH-HHHh--hCC
Q 002146 759 GSLFR--------I----------LHRPHCQV----D-EKRRIKMA-----------------LDVARGM-NCLH--TST 795 (960)
Q Consensus 759 GsL~d--------l----------L~k~~~~l----s-e~~~~~Ia-----------------~QIa~AL-~YLH--s~g 795 (960)
..|.. + ++.....+ . ...+..+. .+.+..+ ..|. ...
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 54421 0 11111101 0 01111111 1111111 1111 122
Q ss_pred CCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 796 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 796 ~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..++|+|+.+.||| ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 34899999999999 5667789999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0022 Score=74.03 Aligned_cols=73 Identities=18% Similarity=0.106 Sum_probs=47.1
Q ss_pred EEEeeccCCeeEEEEEEECC--cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc-eeeEecccccCCceEEEEeecC
Q 002146 681 GERIGLGSSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIITEFLP 757 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g--~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN-IVkL~g~f~~~~~l~LVmEY~~ 757 (960)
++.|+.| ....+|++...+ ..|++|+..... .. .....+|..+|+.|...+ ..++++.+.. .+||||++
T Consensus 113 i~~lsgG-~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGG-ITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD 184 (458)
T ss_dssp EEEECC---CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred EEEcCCC-eEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence 4567767 789999998866 789999864321 10 111258899999985433 3567777632 35999998
Q ss_pred CCCH
Q 002146 758 RGSL 761 (960)
Q Consensus 758 gGsL 761 (960)
|..|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0011 Score=73.21 Aligned_cols=73 Identities=14% Similarity=0.154 Sum_probs=43.6
Q ss_pred EEEeeccCCeeEEEEEEECC----------cEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCce
Q 002146 681 GERIGLGSSYGEVYHADWNG----------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~g----------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l 749 (960)
.+.|+.| ....+|++...+ ..|++|+..... ........|..+++.|. +.-+.++++.+. -
T Consensus 38 ~~~l~~G-~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 38 VKQILSG-LTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEC-----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEeCCc-ccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 4567767 678999998754 688889764321 11112357888888873 322446665442 3
Q ss_pred EEEEeecCCCCH
Q 002146 750 SIITEFLPRGSL 761 (960)
Q Consensus 750 ~LVmEY~~gGsL 761 (960)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0011 Score=74.63 Aligned_cols=137 Identities=13% Similarity=0.151 Sum_probs=80.3
Q ss_pred EEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccCCceEE
Q 002146 682 ERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~~~l~L 751 (960)
+.|..| ....+|++... ++.|++|+.-.. . .....+.+|..+++.| .+.-..++++.+.+ .+
T Consensus 56 ~~lsGG-~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGG-LSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC------CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCc-ccccEEEEEeCCCccccCCCCCeEEEEECCCc-c--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 446556 67889998763 478999975321 1 1234556899999888 34334667776654 29
Q ss_pred EEeecCCCCHHH--------------H---hhCCC----CCC--cHHHHHHHHHHHHH-------------------HHH
Q 002146 752 ITEFLPRGSLFR--------------I---LHRPH----CQV--DEKRRIKMALDVAR-------------------GMN 789 (960)
Q Consensus 752 VmEY~~gGsL~d--------------l---L~k~~----~~l--se~~~~~Ia~QIa~-------------------AL~ 789 (960)
||||++|..|.. . |+... ... -+.++.++..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998765421 1 12211 111 12344444433321 122
Q ss_pred H----HhhC--CCCEEEeccCCCcEEEcCC----CcEEEEecCcccc
Q 002146 790 C----LHTS--TPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRL 826 (960)
Q Consensus 790 Y----LHs~--g~~IIHRDLKPeNILLd~~----g~VKL~DFGLAr~ 826 (960)
. |... ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 3221 2259999999999999876 7899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0047 Score=67.85 Aligned_cols=31 Identities=23% Similarity=0.408 Sum_probs=27.7
Q ss_pred CEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 797 ~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.++|+|+.+.|||++.++.+.|+||+.+..-
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5999999999999998888999999887653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0055 Score=65.87 Aligned_cols=138 Identities=12% Similarity=0.093 Sum_probs=77.6
Q ss_pred EEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCC--ceeeEecc-----cccCCceEEEE
Q 002146 682 ERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGA-----VTRPPNLSIIT 753 (960)
Q Consensus 682 k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HP--NIVkL~g~-----f~~~~~l~LVm 753 (960)
+.|+ | ....||++.. +|+.+++|......... ..+..|..+++.|... .+++++.. ....+..+++|
T Consensus 32 ~~l~-g-~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-S-YENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-C-SSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-C-cccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 3456 6 5688998876 46689999876432222 3556788888877321 24444443 11244567899
Q ss_pred eecCCCCHH-----H------H---hh----CC----CCCCcHHHH----------------------HHHHHHHHHHHH
Q 002146 754 EFLPRGSLF-----R------I---LH----RP----HCQVDEKRR----------------------IKMALDVARGMN 789 (960)
Q Consensus 754 EY~~gGsL~-----d------l---L~----k~----~~~lse~~~----------------------~~Ia~QIa~AL~ 789 (960)
+|++|..+. . . ++ .. ....+.... ...+.+++..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999875431 1 1 11 00 001111100 111122222222
Q ss_pred HHhh--CCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 790 CLHT--STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 790 YLHs--~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
-+-. ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2211 223489999999999999 4 899999998754
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0037 Score=69.01 Aligned_cols=58 Identities=21% Similarity=0.087 Sum_probs=49.0
Q ss_pred ccccchhhHHHHHHHhhhcCCceEEeecccccCCCCCeeEEEEecC-cceeeeecccCCCccCCcc
Q 002146 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVDLMAAPGTLIPAD 327 (960)
Q Consensus 263 ~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~y~~~~~~a~~~v~~~~-~~~y~vDlm~~pg~l~~~~ 327 (960)
+.|.|.|.|.||-.||-.+|||||+|-| ..+|+|+.|.... ++|.=||-.. |.+-.|.
T Consensus 180 r~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~~rWv~vDp~~--~~id~P~ 238 (335)
T 1x3z_A 180 RKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFLNRWVHVDSCE--QSFDQPY 238 (335)
T ss_dssp CEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTTTEEEEEETTT--TEESCTH
T ss_pred CCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCCCCEEEECCCC--CccCCCc
Confidence 4899999999999999999999999987 3589999999976 5799999664 5554443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0081 Score=68.69 Aligned_cols=73 Identities=14% Similarity=0.147 Sum_probs=46.9
Q ss_pred EEEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceE
Q 002146 681 GERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~ 750 (960)
++.|..| ....+|++... +..|++|+..... .......+|..+++.|. +.-..++++.+. -+
T Consensus 75 v~~lsGG-~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 75 VKQIFSG-LTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEECCC-SSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEcCCC-cccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 4456556 78899999875 6889999864321 11112357888888873 333455665443 37
Q ss_pred EEEeecCCCCH
Q 002146 751 IITEFLPRGSL 761 (960)
Q Consensus 751 LVmEY~~gGsL 761 (960)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998653
|
| >2q3z_A Transglutaminase 2; transglutaminase 2, tissue transglutaminase, TG2, transferas; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1kv3_A 3ly6_A* | Back alignment and structure |
|---|
Probab=95.62 E-value=0.0062 Score=73.12 Aligned_cols=54 Identities=15% Similarity=0.082 Sum_probs=43.8
Q ss_pred cccccchhhHHHHHHHhhhcCCceEEeeccc--------------cc--C------C----CCCeeEEEEec------C-
Q 002146 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSH--------------YT--G------V----EDDAVNIIKLE------E- 308 (960)
Q Consensus 262 l~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~--------------y~--~------~----~~~a~~~v~~~------~- 308 (960)
.+.|+|+++|-+|-++|-.+|||||+|.|.. |. | . +-|||++|-+. .
T Consensus 272 ~k~G~C~dfA~~~~~llRalGIPAR~VsGy~~~~~~~~~l~~d~~~~~~g~~~~~~~d~~~~~HAW~Ev~~~rpDLp~g~ 351 (687)
T 2q3z_A 272 VKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPGY 351 (687)
T ss_dssp EEEECHHHHHHHHHHHHHHHTCCEEEEEEEEEECC--CCHHHHHHHC---------CCCCBSEEEEEEEEECCTTSSTTC
T ss_pred cceeehHHHHHHHHHHHHhCCCCcEEEeecccccccccccccccccCCCCceeeecCCcccceeEEEEEEcccCCCCCCC
Confidence 7899999999999999999999999999942 11 1 1 24999999996 3
Q ss_pred cceeeee
Q 002146 309 EREFLVD 315 (960)
Q Consensus 309 ~~~y~vD 315 (960)
+.|..||
T Consensus 352 ~GW~~~D 358 (687)
T 2q3z_A 352 EGWQALD 358 (687)
T ss_dssp CEEEEEC
T ss_pred CCEEEEC
Confidence 4587777
|
| >1vjj_A Protein-glutamine glutamyltransferase E; transglutaminase 3, X-RAY crystallography, metalloenzyme, calcium ION; HET: GDP; 1.90A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1sgx_A* 1l9m_A 1l9n_A* 1nud_A 1nuf_A 1nug_A 1rle_A* | Back alignment and structure |
|---|
Probab=95.56 E-value=0.0056 Score=73.42 Aligned_cols=74 Identities=15% Similarity=0.122 Sum_probs=51.5
Q ss_pred HhHHHHHHHHHHHhCCceeEeeecccccchhhHHHHHHHhhhcCCceEEeecc--------------cccC-------C-
Q 002146 239 ARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGS--------------HYTG-------V- 296 (960)
Q Consensus 239 ~~~~~~~~~l~~~~~s~v~pig~l~~g~~~~~a~lfk~l~d~~~~~~~lv~G~--------------~y~~-------~- 296 (960)
..|.-....|++-+.+.+.| ++.|+|+|+|-+|-+|+-.+|||||+|.|. ||.. .
T Consensus 247 ~~~~gs~~il~~~~~~~~~P---V~~G~C~~fA~~~~~~lR~lGIPaR~Vtgy~s~~d~~~nL~~d~~~~~~g~~~~~~~ 323 (692)
T 1vjj_A 247 RSWNGSVEILKNWKKSGLSP---VRYGQCWVFAGTLNTALRSLGIPSRVITNFNSAHDTDRNLSVDVYYDPMGNPLDKGS 323 (692)
T ss_dssp GGCCBSHHHHHHHHHTTSCC---EEEECHHHHHHHHHHHHHHHTCCEEEEEEEEEEECSSSSSEEEEEECTTSCBCCCCS
T ss_pred cccCChHHHHHHHHHcCCCc---ccceeeHHHHHHHHHHHHhCCCCeeEEcccccccCCCCCcccceeeccCCccccccc
Confidence 34433333333333334444 578999999999999999999999999994 1221 1
Q ss_pred ----CCCeeEEEEecC-------cceeeee
Q 002146 297 ----EDDAVNIIKLEE-------EREFLVD 315 (960)
Q Consensus 297 ----~~~a~~~v~~~~-------~~~y~vD 315 (960)
+=|||+.+-+.. +.|+.||
T Consensus 324 dsIW~~HaW~E~w~~rpDLp~~~~gW~~~D 353 (692)
T 1vjj_A 324 DSVWNFHVWNEGWFVRSDLGPSYGGWQVLD 353 (692)
T ss_dssp CEEEEEEEEEEEEECCTTTCGGGCEEEEEC
T ss_pred ccccceeEEEEEeccccCCCCCCCCEEEEC
Confidence 139999999853 5688888
|
| >1g0d_A Protein-glutamine gamma-glutamyltransferase; tissue transglutaminase,acyltransferase; 2.50A {Pagrus major} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 | Back alignment and structure |
|---|
Probab=95.30 E-value=0.011 Score=70.89 Aligned_cols=100 Identities=13% Similarity=0.129 Sum_probs=62.4
Q ss_pred HHHHHHHHHHHHhhc-CCCCC-------ChhHHHHhHHHHHHHHHHHhCCceeEeeecccccchhhHHHHHHHhhhcCCc
Q 002146 213 GILVQQLADLVNGHM-GGPVK-------DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLP 284 (960)
Q Consensus 213 ~~~~~~lA~~V~~~m-gg~~~-------~~~~~~~~~~~~~~~l~~~~~s~v~pig~l~~g~~~~~a~lfk~l~d~~~~~ 284 (960)
..++..|+..|...- .|.+. ..+..-..|.-....|++-+.+.+.| +|.|.|+|+|-+|-+++-.+|||
T Consensus 213 v~v~r~lsa~vn~~dD~gvl~g~W~~~y~~g~~P~~w~gs~~il~~~~~~~~~P---V~~G~C~~fA~v~~t~lR~lGIP 289 (695)
T 1g0d_A 213 VYVGRTITAMVNSNGDRGVLTGRWEEPYTDGVAPYRWTGSVPILQQWSKAGVRP---VKYGQCWVFAAVACTVLRCLGIP 289 (695)
T ss_dssp HHHHHHHHHHHTTCTTTCSEEECCSSCCTTSCCGGGCSBSHHHHHHHHHTTSCC---EEEECHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHhhccCcCceeecccccccCCCcCCcccCChHHHHHHHHHcCCCc---ccceeeHHHHHHHHHHHHhCCCC
Confidence 456677888775542 11111 11112233443333443333333333 58899999999999999999999
Q ss_pred eEEeeccccc-----------------------CC-----CCCeeEEEEecC-------cceeeee
Q 002146 285 CRLVKGSHYT-----------------------GV-----EDDAVNIIKLEE-------EREFLVD 315 (960)
Q Consensus 285 ~~lv~G~~y~-----------------------~~-----~~~a~~~v~~~~-------~~~y~vD 315 (960)
||+|.|..+. .. +-|+|+.+-+.. +.|..||
T Consensus 290 aR~Vtgy~sa~d~~~nL~id~~~~~~g~~~~~~~~~dsiw~~HaW~E~w~~rpDLp~~~~gWq~~D 355 (695)
T 1g0d_A 290 TRPITNFASAHDVDGNLSVDFLLNERLESLDSRQRSDSSWNFHCWVESWMSREDLPEGNDGWQVLD 355 (695)
T ss_dssp EEEEEEEEETTTTTTCSEEEEEECTTSCBSCTTCCBCSSEEEEEEEEEEECCTTSCTTCCEEEEEE
T ss_pred eeEEccccccCCCCCccceeeeecccCceecccccCCcceeeEEEEEeecccCCCCCCCCCeEEEc
Confidence 9999994211 01 128999999853 4588888
|
| >1ex0_A Coagulation factor XIII A chain; transglutaminase, blood coagulation, mutant, W279F, oxyanion, transferase; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1evu_A 1fie_A 1f13_A 1ggt_A 1ggu_A 1ggy_A 1qrk_A | Back alignment and structure |
|---|
Probab=94.70 E-value=0.02 Score=69.05 Aligned_cols=33 Identities=21% Similarity=0.402 Sum_probs=30.0
Q ss_pred ecccccchhhHHHHHHHhhhcCCceEEeecccccC
Q 002146 261 SINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTG 295 (960)
Q Consensus 261 ~l~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~y~~ 295 (960)
.++.|.|.|+|-+|-++.-.+|||||+|.| |.+
T Consensus 308 PV~~G~C~~fA~v~~~~lR~lGIPaRvVtg--y~s 340 (731)
T 1ex0_A 308 PVRYGQCWVFAGVFNTFLRCLGIPARIVTN--YFS 340 (731)
T ss_dssp CEEEECHHHHHHHHHHHHHHHTCCEEEEEE--EEE
T ss_pred ccceeeehhHHHHHHHHHHhCCCCeeEEcc--ccc
Confidence 368899999999999999999999999999 544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.37 E-value=0.19 Score=56.39 Aligned_cols=29 Identities=24% Similarity=0.425 Sum_probs=25.3
Q ss_pred EEEeccCCCcEEE------cCCCcEEEEecCcccc
Q 002146 798 IVHRDLKSPNLLV------DKNWNVKVSDFGLSRL 826 (960)
Q Consensus 798 IIHRDLKPeNILL------d~~g~VKL~DFGLAr~ 826 (960)
++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.01 E-value=3.3 Score=43.24 Aligned_cols=116 Identities=11% Similarity=0.086 Sum_probs=77.7
Q ss_pred CCCceeeEecccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc
Q 002146 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811 (960)
Q Consensus 732 ~HPNIVkL~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd 811 (960)
.||+++.. .+-.+.+.+.+.++.-..+.=+.-+. .++...+++++.+|+....+++. -+|-=|+|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEEc
Confidence 68888866 45555566655555443222222233 47788999999999988866654 37888999999999
Q ss_pred CCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002146 812 KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 878 (960)
Q Consensus 812 ~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~ 878 (960)
.++.+++.--|+-..+ +|. .++...=+-.+=|++..++.+...|.
T Consensus 114 ~~~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RDGLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TTSCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999866643221 221 12333444567789999999888774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 960 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-80 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-74 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-71 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-70 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-70 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-69 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-69 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-68 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-68 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-67 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-67 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-65 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-62 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-60 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-60 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-57 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-54 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-53 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (666), Expect = 1e-80
Identities = 93/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
EIP + +G+RIG GS +G VY W+G VAVK + L FK EV ++R+
Sbjct: 4 EIPDGQITVGQRIGSGS-FGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
RH N++LFMG T P L+I+T++ SL+ LH + + + I +A A+GM+ L
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVL 849
H +I+HRDLKS N+ + ++ VK+ DFGL+ +K S + +G+ WMAPEV+
Sbjct: 121 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 850 RNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----EIPKEL 902
R + P + + DVY+FG++L+EL T +LP+ +N + + + ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
+ R++ EC + RP F Q+ +++ L R
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 2e-74
Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 14/268 (5%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
+ ++L L + IG G +G+V D+ G +VAVK + A F E +M +L
Sbjct: 3 ALNMKELKLLQTIGKGE-FGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQL 57
Query: 732 RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMN 789
RH N+V +G + L I+TE++ +GSL L R + +K +LDV M
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
L VHRDL + N+LV ++ KVSDFGL++ +T + +W APE L
Sbjct: 118 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEAL 172
Query: 850 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908
R + + K DV+SFG++LWE+ + ++P+ + VV V + +++ P P V
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231
Query: 909 IIWECWQTDPSLRPSFAQLTVALKPLQR 936
++ CW D ++RPSF QL L+ ++
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 7e-71
Identities = 80/258 (31%), Positives = 122/258 (47%), Gaps = 10/258 (3%)
Query: 673 IPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
I +DL + +G G +G V + W +VA+K + S EF E K+M L
Sbjct: 1 IDPKDLTFLKELGTGQ-FGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 56
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
H +V G T+ + IITE++ G L L + ++ ++M DV M L
Sbjct: 57 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLR 850
+ +HRDL + N LV+ VKVSDFGLSR + + + SS + W PEVL
Sbjct: 117 E--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 851 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V I
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTI 233
Query: 910 IWECWQTDPSLRPSFAQL 927
++ CW RP+F L
Sbjct: 234 MYSCWHEKADERPTFKIL 251
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 2e-70
Identities = 81/266 (30%), Positives = 130/266 (48%), Gaps = 10/266 (3%)
Query: 673 IPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
I +L + IG G +G V+ W N +VA+K + S +F E ++M +L
Sbjct: 2 IDPSELTFVQEIGSGQ-FGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKL 57
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
HP +V G + ++ EF+ G L L + + M LDV GM L
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLR 850
++HRDL + N LV +N +KVSDFG++R + + + SS T +W +PEV
Sbjct: 118 EE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 851 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +I
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQI 234
Query: 910 IWECWQTDPSLRPSFAQLTVALKPLQ 935
+ CW+ P RP+F++L L +
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 234 bits (597), Expect = 2e-70
Identities = 87/288 (30%), Positives = 135/288 (46%), Gaps = 21/288 (7%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVK 726
EI + + + IG G +GEV VA+K L ++ +F E
Sbjct: 22 EIDISCVKIEQVIGAGE-FGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEAS 79
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
IM + HPNV+ G VT+ + IITEF+ GSL L + Q + + M +A
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTP 841
GM L VHRDL + N+LV+ N KVSDFGLSR T+ S+
Sbjct: 140 GMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 900
W APE ++ DV+S+G+++WE+ + + P+ M V+ A+ Q+ RL P
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPM 256
Query: 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 948
+ + +++ +CWQ D + RP F Q+ L + R +P+ +
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR-----NPNSLKA 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 2e-70
Identities = 70/262 (26%), Positives = 121/262 (46%), Gaps = 12/262 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
ED + IG GS YG +G + K+ + A EV ++R L+H
Sbjct: 4 EDYEVLYTIGTGS-YGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 734 PNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGM 788
PN+V + + N L I+ E+ G L ++ + +DE+ +++ + +
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 789 NCLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 845
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905
PE + NEK D++S G +L+EL L P+ + ++ G + + + IP
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDE 241
Query: 906 VARIIWECWQTDPSLRPSFAQL 927
+ II RPS ++
Sbjct: 242 LNEIITRMLNLKDYHRPSVEEI 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 7e-70
Identities = 84/276 (30%), Positives = 142/276 (51%), Gaps = 15/276 (5%)
Query: 663 IFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEF 721
++D+ E+P E L L ER+G G +GEV+ +N T+VAVK S F
Sbjct: 3 WWEDEW---EVPRETLKLVERLGAGQ-FGEVWMGYYNGHTKVAVKSLKQGSMSPD---AF 55
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKM 780
E +M++L+H +V VT+ P + IITE++ GSL L P ++ + + M
Sbjct: 56 LAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 781 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG 839
A +A GM + +HRDL++ N+LV + K++DFGL+R ++ N + + +
Sbjct: 115 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172
Query: 840 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 898
+W APE + K DV+SFG++L E+ T ++P+ GM +V+ + + R+
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVR 231
Query: 899 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
P + +++ CW+ P RP+F L L+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 1e-69
Identities = 87/275 (31%), Positives = 129/275 (46%), Gaps = 14/275 (5%)
Query: 671 CEIPWEDLVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLE-FKRE 724
C I +DL L E++G GS +G V +W+ VAVK S ++ F RE
Sbjct: 3 CLIGEKDLRLLEKLGDGS-FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
V M L H N++ G V PP + ++TE P GSL L + + A+ V
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTP 841
A GM L + +HRDL + NLL+ VK+ DFGL R + ++ +
Sbjct: 121 AEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 900
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P+
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238
Query: 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935
+ + ++ +CW P RP+F L L Q
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 5e-69
Identities = 91/283 (32%), Positives = 142/283 (50%), Gaps = 14/283 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRR 730
EIP E L L ++G G +GEV+ WNGT VA+K S F +E ++M++
Sbjct: 13 EIPRESLRLEVKLGQGC-FGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 68
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMN 789
LRH +V V+ P + I+TE++ +GSL L + + + MA +A GM
Sbjct: 69 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEV 848
+ VHRDL++ N+LV +N KV+DFGL+RL + N + + + +W APE
Sbjct: 128 YVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 849 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 244
Query: 908 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 950
++ +CW+ +P RP+F L L+ QP L
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 2e-68
Identities = 69/272 (25%), Positives = 127/272 (46%), Gaps = 15/272 (5%)
Query: 670 ECEIPWEDLVLGER-IGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKRE 724
+ + ++L++ + +G G+ +G V + +VA+K L Q A E RE
Sbjct: 2 KLFLKRDNLLIADIELGCGN-FGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMRE 59
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
+IM +L +P +V +G V + L ++ E G L + L ++ ++ V
Sbjct: 60 AQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTP 841
+ GM L VHRDL + N+L+ K+SDFGLS+ + + + +
Sbjct: 119 SMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 842 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 900
+W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPP 235
Query: 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
E P + ++ +CW RP F + ++
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 4e-68
Identities = 81/270 (30%), Positives = 126/270 (46%), Gaps = 13/270 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVK 726
EI E + LG IG G +G+V+ + E VA+K S + +F +E
Sbjct: 3 EIQRERIELGRCIGEGQ-FGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEAL 60
Query: 727 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 786
MR+ HP++V +G +T + II E G L L +D I A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 787 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 845
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ +T+ + +WMA
Sbjct: 120 ALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904
PE + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPP 236
Query: 905 LVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ ++ +CW DPS RP F +L L +
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 4e-68
Identities = 79/256 (30%), Positives = 121/256 (47%), Gaps = 13/256 (5%)
Query: 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
IG GS + VY EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 13 FDIEIGRGS-FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 738 LFMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
F + V + ++TE + G+L L R + K + +G+ LHT
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 794 STPTIVHRDLKSPN-LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
TP I+HRDLK N + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEK 188
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
E DVY+FG+ + E+AT + P+ N Q+ V + K P V II
Sbjct: 189 YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247
Query: 912 ECWQTDPSLRPSFAQL 927
C + + R S L
Sbjct: 248 GCIRQNKDERYSIKDL 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 1e-67
Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 15/270 (5%)
Query: 673 IPWEDLVLGER-IGLGSSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKI 727
+ + L L ++ +G G+ +G V + VAVK ++ A E E +
Sbjct: 3 LDRKLLTLEDKELGSGN-FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 728 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 787
M++L +P +V +G + + ++ E G L + L + + V +K I++ V+ G
Sbjct: 62 MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMG 119
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWM 844
M L S VHRDL + N+L+ K+SDFGLS+ N + + +W
Sbjct: 120 MKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 903
APE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCP 236
Query: 904 PLVARIIWECWQTDPSLRPSFAQLTVALKP 933
+ ++ CW D RP FA + + L+
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 224 bits (573), Expect = 2e-67
Identities = 89/269 (33%), Positives = 137/269 (50%), Gaps = 10/269 (3%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
E+ D+ + ++G G YGEVY W VAVK + EF +E +M+
Sbjct: 13 EMERTDITMKHKLGGGQ-YGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMK 68
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGM 788
++HPN+V +G TR P IITEF+ G+L L +V + MA ++ M
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 847
L +HRDL + N LV +N VKV+DFGLSR + +T+ + +W APE
Sbjct: 129 EYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
L + K DV++FGV+LWE+AT + + V + ++ R+E P+ V
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 908 RIIWECWQTDPSLRPSFAQLTVALKPLQR 936
++ CWQ +PS RPSFA++ A + + +
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 9e-67
Identities = 83/286 (29%), Positives = 137/286 (47%), Gaps = 27/286 (9%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGT----EVAVKKFLDQDFSGAALLEFKREVKI 727
+ W D+ + IG G+ +G+V A + A+K+ + + S +F E+++
Sbjct: 6 VLDWNDIKFQDVIGEGN-FGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEV 63
Query: 728 MRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ--------------- 771
+ +L HPN++ +GA L + E+ P G+L L +
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 772 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831
+ ++ + A DVARGM+ L +HRDL + N+LV +N+ K++DFGLSR +
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVY 180
Query: 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVG 890
+ WMA E L DV+S+GV+LWE+ +L P+ GM ++ +
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
Query: 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936
Q RLE P D V ++ +CW+ P RPSFAQ+ V+L +
Sbjct: 241 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-66
Identities = 81/294 (27%), Positives = 128/294 (43%), Gaps = 37/294 (12%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGT-------EVAVKKFLDQDFSGAALLEFKRE 724
E P E+L G+ +G G+ +G+V +A G +VAVK L + + E
Sbjct: 33 EFPRENLEFGKVLGSGA-FGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSE 90
Query: 725 VKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------------ 771
+K+M +L H N+V +GA T + +I E+ G L L +
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 772 ----------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821
+ + + A VA+GM L + VHRDL + N+LV VK+ DF
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 822 GLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWI 878
GL+R + ++ + +WMAPE L K DV+S+G++LWE+ +L P+
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 879 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
G+ + +++ P + I+ CW D RPSF LT L
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 8e-66
Identities = 73/280 (26%), Positives = 128/280 (45%), Gaps = 20/280 (7%)
Query: 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 731
P + + +G G+ +G+VY A A K + ++ E+ I+
Sbjct: 10 PEDFWEIIGELGDGA-FGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASC 66
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
HPN+V + A NL I+ EF G++ ++ + E + + +N L
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-- 849
H + I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 127 HDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 850 ---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPL 905
++ P + K DV+S G+ L E+A ++ P +NPM+V+ + L P
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 906 VARIIWECWQTDPSLRPSFAQL-------TVALKPLQRLV 938
+ +C + + R + +QL + KP++ L+
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-65
Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 20/287 (6%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREV 725
EI + + IG G +GEVY + VA+K L ++ ++F E
Sbjct: 3 EIHPSCVTRQKVIGAGE-FGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEA 60
Query: 726 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 785
IM + H N++ G +++ + IITE++ G+L + L + + + M +A
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 786 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPE 842
GM L VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+
Sbjct: 121 AGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 843 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKE 901
W APE + DV+SFG+++WE+ T ++ +V+ A+ RL P +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 237
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 948
+ +++ +CWQ + + RP FA + L L R PD +
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-----APDSLKT 279
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 4e-65
Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 11/255 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLR 732
ED +G +G G +G VY A + +A+K A + +REV+I LR
Sbjct: 6 EDFEIGRPLGKGK-FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HPN++ G + +I E+ P G+++R L + DE+R ++A ++ H
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 123
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+ ++HRD+K NLL+ +K++DFG S ++ + GT +++ PE++
Sbjct: 124 SKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGR 179
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISR 237
Query: 913 CWQTDPSLRPSFAQL 927
+ +PS RP ++
Sbjct: 238 LLKHNPSQRPMLREV 252
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 7e-65
Identities = 84/289 (29%), Positives = 131/289 (45%), Gaps = 18/289 (6%)
Query: 667 DVCECEIPWEDLVL--GERIGLGSSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALL 719
V I L++ E IG G +G VYH D AVK L++ +
Sbjct: 16 AVQHVVIGPSSLIVHFNEVIGRGH-FGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVS 73
Query: 720 EFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQVDEKRRI 778
+F E IM+ HPNV+ +G R ++ ++ G L + K I
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133
Query: 779 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH----NTFLSS 834
L VA+GM L + VHRDL + N ++D+ + VKV+DFGL+R + ++ +
Sbjct: 134 GFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 835 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 893
+WMA E L+ + K DV+SFGV+LWEL T P+ +N + + Q
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQG 250
Query: 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 942
RRL P+ + ++ +CW +RPSF++L + + I H
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 218 bits (556), Expect = 7e-65
Identities = 78/296 (26%), Positives = 128/296 (43%), Gaps = 38/296 (12%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKRE 724
E P ++ IG G+ +G V+ A T VAVK L ++ S +F+RE
Sbjct: 9 EYPRNNIEYVRDIGEGA-FGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQRE 66
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------------- 771
+M +PN+V +G + ++ E++ G L L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 772 ----------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 821
+ ++ +A VA GM L VHRDL + N LV +N VK++DF
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 822 GLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWI 878
GLSR + + + + + A WM PE + + DV+++GV+LWE+ + L P+
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244
Query: 879 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
GM +V+ V L P+ + ++ CW P+ RPSF + L+ +
Sbjct: 245 GMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 5e-64
Identities = 83/280 (29%), Positives = 140/280 (50%), Gaps = 24/280 (8%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKRE 724
E+ E + + +G GS +G VY D T VA+K +++ S +EF E
Sbjct: 16 EVAREKITMSRELGQGS-FGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNE 73
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---------DEK 775
+M+ +VV +G V++ +I E + RG L L +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 776 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 835
+ I+MA ++A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 134 KMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 836 STA--GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 892
WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-ME 250
Query: 893 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932
L+ P ++ ++ CWQ +P +RPSF ++ ++K
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 4e-63
Identities = 86/301 (28%), Positives = 132/301 (43%), Gaps = 46/301 (15%)
Query: 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 735
+VL E IG G +GEV+ W G EVAVK F ++ + E+ LRH N
Sbjct: 3 RTIVLQESIGKGR-FGEVWRGKWRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHEN 58
Query: 736 VVLFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
++ F+ A + L +++++ GSLF L+R V + IK+AL A G+ L
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHL 116
Query: 792 HT------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTP 841
H P I HRDLKS N+LV KN ++D GL+ ++ GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 842 EWMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----------- 884
+MAPEVL + S ++ D+Y+ G++ WE+A Q
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 885 ----VVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935
+ V Q R IP E ++A+I+ ECW + + R + ++ L L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 936 R 936
+
Sbjct: 297 Q 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 4e-63
Identities = 67/264 (25%), Positives = 124/264 (46%), Gaps = 10/264 (3%)
Query: 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKRE 724
+ P + E+IG G+ G VY A G EVA+++ Q E
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGA-SGTVYTAMDVATGQEVAIRQMNLQQQPKKE--LIINE 67
Query: 725 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
+ +MR ++PN+V ++ + L ++ E+L GSL ++ DE + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCREC 125
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844
+ + LH++ ++HRD+KS N+L+ + +VK++DFG + GTP WM
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELD 903
APEV+ + K D++S G++ E+ + P++ NP++ + + L+ P++L
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 904 PLVARIIWECWQTDPSLRPSFAQL 927
+ + C D R S +L
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (541), Expect = 1e-62
Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 20/273 (7%)
Query: 661 DQIFDDDVCECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKF-LDQDFSGAA 717
+ F DD P + IG GS +G VY A N VA+KK S
Sbjct: 6 ELFFKDD------PEKLFSDLREIGHGS-FGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 718 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR 777
+ +EV+ +++LRHPN + + G R ++ E+ + + + E
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEI 117
Query: 778 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 837
+ +G+ LH+ ++HRD+K+ N+L+ + VK+ DFG + + S
Sbjct: 118 AAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSF 171
Query: 838 AGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 894
GTP WMAPEV+ + K DV+S G+ ELA K P MN M + +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231
Query: 895 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ C Q P RP+ L
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-62
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 35/298 (11%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKRE 724
E P L G+ +G G+ +G+V A VAVK L E
Sbjct: 19 EFPRNRLSFGKTLGAGA-FGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSE 76
Query: 725 VKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR---------------- 767
+K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 768 -PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
+D + + + VA+GM L + +HRDL + N+L+ K+ DFGL+R
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 827 --KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPM 883
+ ++ + +WMAPE + N + DV+S+G+ LWEL +L GM
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 941
+ + R+ P+ + I+ CW DP RP+F Q+ ++ +++ + S
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI---VQLIEKQISES 309
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 6e-62
Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 13/292 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRR 730
+ + +G G+ +G VY W G +V + K L + S A E E +M
Sbjct: 9 TEFKKIKVLGSGA-FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 731 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 790
+ +P+V +G + +IT+ +P G L + + + + + +A+GMN
Sbjct: 68 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEV 848
L +VHRDL + N+LV +VK++DFGL++L ++ +WMA E
Sbjct: 127 LED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 849 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907
+ + + DV+S+GV +WEL T P+ G+ ++ + + RL P V
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVY 243
Query: 908 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 959
I+ +CW D RP F +L + + R Q + +S
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 6e-62
Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 14/284 (4%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
E+ +D +G G+ G V+ +G +A K + + A + RE++++
Sbjct: 2 ELKDDDFEKISELGAGN-GGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLH 59
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
P +V F GA +SI E + GSL ++L + ++ E+ K+++ V +G+
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLT 118
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT +M+PE L
Sbjct: 119 YLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL 175
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909
+ + + D++S G+ L E+A + P + ++ + F + E P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTP 233
Query: 910 IWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 953
RP A + L +V P PS E
Sbjct: 234 GRPLSSYGMDSRPPMA----IFELLDYIVNEPPPKLPSGVFSLE 273
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 9e-61
Identities = 89/295 (30%), Positives = 152/295 (51%), Gaps = 36/295 (12%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFK 722
E+P + LVLG+ +G G+ +G+V A+ T+VAVK L D + L +
Sbjct: 9 ELPRDRLVLGKPLGEGA-FGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLI 66
Query: 723 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--------------- 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 767 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826
P Q+ K + A VARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 827 KH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 883
H + + + + +WMAPE L + + DV+SFGV+LWE+ TL P+ G+
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244
Query: 884 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938
++ + + R++ P + ++ +CW PS RP+F QL ++ L R+V
Sbjct: 245 ELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL---VEDLDRIV 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-60
Identities = 72/258 (27%), Positives = 114/258 (44%), Gaps = 11/258 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
ED L + +G G+ YGEV A VAVK +D + K+E+ I + L H
Sbjct: 5 EDWDLVQTLGEGA-YGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNH 62
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
NVV F G + E+ G LF + + E + + G+ LH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRN 851
I HRD+K NLL+D+ N+K+SDFGL+ + +N GT ++APE+L+
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 852 EP-SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARI 909
E DV+S G++L + +LPW + Q + L K++D +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 910 IWECWQTDPSLRPSFAQL 927
+ + +PS R + +
Sbjct: 240 LHKILVENPSARITIPDI 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-60
Identities = 55/273 (20%), Positives = 112/273 (41%), Gaps = 17/273 (6%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR 732
ED G+ +G GS + V A E A+K + RE +M RL
Sbjct: 8 EDFKFGKILGEGS-FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 66
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HP V L + G L + + + DE ++ + LH
Sbjct: 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH 125
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLR 850
I+HRDLK N+L++++ +++++DFG +++ + + S GT ++++PE+L
Sbjct: 126 G--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 851 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910
+ + + D+++ G I+++L P+ N + + + P++ P ++
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLV 241
Query: 911 WECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 943
+ D + R ++ + +HP
Sbjct: 242 EKLLVLDATKRLGCEEM------EGYGPLKAHP 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-58
Identities = 85/295 (28%), Positives = 137/295 (46%), Gaps = 31/295 (10%)
Query: 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALL 719
D + E P + L LG+ +G G+ +G+V AD VAVK L + + +
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGA-FGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHR 61
Query: 720 EFKREVKIMRR-LRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQ------ 771
E+KI+ H NVV +GA T+P L +I EF G+L L +
Sbjct: 62 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 121
Query: 772 ---------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 822
+ + I + VA+GM L + +HRDL + N+L+ + VK+ DFG
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 823 LSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 879
L+R K ++ +WMAPE + + + DV+SFGV+LWE+ +L P+ G
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239
Query: 880 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ + + R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 199 bits (508), Expect = 1e-57
Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 18/284 (6%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
+ + E +G G+ +G V+ G A K + S ++E++ M LRH
Sbjct: 26 DHYDIHEELGTGA-FGVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQTMSVLRH 82
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
P +V A + +I EF+ G LF + H ++ E ++ V +G+ +H
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 141
Query: 794 STPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
VH DLK N++ ++ +K+ DFGL+ + S K T GT E+ APEV
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 852 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARI 909
+P D++S GV+ + L + P+ G N + + V N +
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259
Query: 910 IWECWQTDPSLRPSFAQL------TVALKPLQRLVIPSHPDQPS 947
I + DP+ R + Q T P + IPS
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-56
Identities = 47/259 (18%), Positives = 107/259 (41%), Gaps = 13/259 (5%)
Query: 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 732
+E ++ E +G G +G V+ + K G + K+E+ I+ R
Sbjct: 4 YEKYMIAEDLGRGE-FGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIAR 59
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
H N++ + L +I EF+ +F ++ +++E+ + V + LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 793 TSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 850
+ I H D++ N++ ++ +K+ +FG +R + + PE+ APEV +
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQ 176
Query: 851 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVAR 908
++ + D++S G +++ L + P++ Q++ + E KE+
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 909 IIWECWQTDPSLRPSFAQL 927
+ + R + ++
Sbjct: 237 FVDRLLVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 194 bits (493), Expect = 2e-55
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 12/258 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
+ + E +G G+ +G V+ G K K E+ IM +L H
Sbjct: 29 DYYDILEELGSGA-FGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHH 85
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
P ++ A + +I EFL G LF + ++ E I G+ +H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 794 STPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
+IVH D+K N++ + K +VK+ DFGL+ + + +T T E+ APE++
Sbjct: 146 H--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDR 202
Query: 852 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 909
EP D+++ GV+ + L + P+ G + ++ + V + + + P
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262
Query: 910 IWECWQTDPSLRPSFAQL 927
I Q +P R +
Sbjct: 263 IKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 2e-55
Identities = 63/255 (24%), Positives = 113/255 (44%), Gaps = 13/255 (5%)
Query: 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ +G G+ + EV A+ VA+K + + + E+ ++ +++HPN+V
Sbjct: 13 FRDVLGTGA-FSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797
+L +I + + G LF + E+ ++ V + LH
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD--LG 127
Query: 798 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
IVHRDLK NLL D++ + +SDFGLS+++ + S + GTP ++APEVL +P
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQKPY 186
Query: 855 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWE 912
++ D +S GVI + L P+ N ++ + + P ++ I
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 913 CWQTDPSLRPSFAQL 927
+ DP R + Q
Sbjct: 247 LMEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-55
Identities = 63/255 (24%), Positives = 121/255 (47%), Gaps = 10/255 (3%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRR-L 731
ED +L + +G GS +G+V+ A++ A+K +E E +++
Sbjct: 2 EDFILHKMLGKGS-FGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 732 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
HP + NL + E+L G L + H + D R A ++ G+ L
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL 119
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
H+ IV+RDLK N+L+DK+ ++K++DFG+ + + + GTP+++APE+L
Sbjct: 120 HS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 852 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
+ N D +SFGV+L+E+ + P+ G + ++ ++ + P+ L+ ++
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLV 235
Query: 912 ECWQTDPSLRPSFAQ 926
+ + +P R
Sbjct: 236 KLFVREPEKRLGVRG 250
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 190 bits (483), Expect = 1e-54
Identities = 62/258 (24%), Positives = 114/258 (44%), Gaps = 12/258 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLR 732
+D + +G GS +G V+ NG A+K + +E E ++ +
Sbjct: 4 QDFQILRTLGTGS-FGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HP ++ G + +I +++ G L R + A +V + LH
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+ I++RDLK N+L+DKN ++K++DFG ++ + + GTP+++APEV+ +
Sbjct: 122 S--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTK 176
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
P N+ D +SFG++++E+ P+ N M+ + N L P + V ++
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSR 234
Query: 913 CWQTDPSLRPSFAQLTVA 930
D S R Q
Sbjct: 235 LITRDLSQRLGNLQNGTE 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 185 bits (471), Expect = 2e-53
Identities = 61/271 (22%), Positives = 108/271 (39%), Gaps = 23/271 (8%)
Query: 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-------FKREV 725
+E+ E +G G V E AVK + E +EV
Sbjct: 2 YENYEPKEILGRGV-SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 726 KIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
I+R++ HPN++ ++ + + +G LF L + EK K+ +
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRAL 119
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844
+ LH IVHRDLK N+L+D + N+K++DFG S + GTP ++
Sbjct: 120 LEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYL 176
Query: 845 APEVLRNEPS------NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898
APE++ + ++ D++S GVI++ L P+ M ++ + N +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 899 P--KELDPLVARIIWECWQTDPSLRPSFAQL 927
P + V ++ P R + +
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 9e-53
Identities = 59/258 (22%), Positives = 113/258 (43%), Gaps = 9/258 (3%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR 732
D + +G G+ +G+V G A+K + + + E ++++ R
Sbjct: 5 NDFDYLKLLGKGT-FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
HP + A L + E+ G LF L R E+R ++ + LH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH 122
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+ +V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE++APEVL +
Sbjct: 123 S--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
D + GV+++E+ +LP+ + ++ + + P+ L P ++
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAG 238
Query: 913 CWQTDPSLRPSFAQLTVA 930
+ DP R
Sbjct: 239 LLKKDPKQRLGGGPSDAK 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-52
Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 17/260 (6%)
Query: 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKF----LDQDFSGAALLEFKREVKIMRRLRH 733
GE +G G + V G + A K G + + +REV I++ ++H
Sbjct: 14 TGEELGSGQ-FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
PNV+ ++ +I E + G LF L + E+ + + G+ LH+
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 131
Query: 794 STPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
I H DLK N+++ +K+ DFGL+ K+ GTPE++APE++
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIV 188
Query: 850 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVA 907
EP + D++S GVI + L + P++G + + V N E L
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 908 RIIWECWQTDPSLRPSFAQL 927
I DP R +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDS 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 181 bits (459), Expect = 9e-52
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 18/274 (6%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR 732
+ LGE +G G EV+ A +VAVK D + L F+RE + L
Sbjct: 7 DRYELGEILGFGG-MSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 733 HPNVVLFMGAVTRPPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 788
HP +V I+ E++ +L I+H + KR I++ D + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 124
Query: 789 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMA 845
N H I+HRD+K N+++ VKV DFG++R N+ + + GT ++++
Sbjct: 125 NFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELD 903
PE R + + + DVYS G +L+E+ T + P+ G +P+ V ++ + L
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937
+ ++ + +P R A L R+
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAE--MRADLVRV 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-49
Identities = 52/258 (20%), Positives = 97/258 (37%), Gaps = 23/258 (8%)
Query: 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE----FKREVKIMRRLR- 732
+G +G G +G VY + VA+K S L EV +++++
Sbjct: 8 VGPLLGSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 733 -HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
V+ + RP + +I E + E+ V +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 792 HTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 850
H ++HRD+K N+L+D N +K+ DFG L +T + GT + PE +R
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DFDGTRVYSPPEWIR 182
Query: 851 NEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909
V+S G++L+++ +P+ + ++ + + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHL 234
Query: 910 IWECWQTDPSLRPSFAQL 927
I C PS RP+F ++
Sbjct: 235 IRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-48
Identities = 62/266 (23%), Positives = 114/266 (42%), Gaps = 28/266 (10%)
Query: 679 VLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN 735
V + +GLG G+V + A+K D + +REV++ R + P+
Sbjct: 15 VTSQVLGLGI-NGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPH 66
Query: 736 VV----LFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNC 790
+V ++ L I+ E L G LF + R E+ ++ + +
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 791 LHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 847
LH+ I HRD+K NLL +K++DFG ++ + S + TP ++APE
Sbjct: 127 LHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPE 183
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI------PKE 901
VL E ++ CD++S GVI++ L P+ + + + + + R + E
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQL 927
+ V +I +T+P+ R + +
Sbjct: 244 VSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (441), Expect = 2e-48
Identities = 60/263 (22%), Positives = 103/263 (39%), Gaps = 14/263 (5%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMR 729
D + IG G +GEVY G A+K + L + + ++
Sbjct: 4 NDFSVHRIIGRGG-FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 730 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 789
P +V A P LS I + + G L L + H E A ++ G+
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLE 121
Query: 790 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 849
+H +V+RDLK N+L+D++ +V++SD GL+ ++ GT +MAPEVL
Sbjct: 122 HMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVL 177
Query: 850 -RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVA 907
+ + D +S G +L++L P+ + +E+P P +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237
Query: 908 RIIWECWQTDPSLRPSFAQLTVA 930
++ Q D + R
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 2e-47
Identities = 52/277 (18%), Positives = 100/277 (36%), Gaps = 26/277 (9%)
Query: 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
LG +IG GS +G++Y G EVA+K + + E KI + ++ +
Sbjct: 11 LGRKIGSGS-FGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGI 65
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797
+ + +++ L SL + + + K + +A + + +H+
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--N 123
Query: 798 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMAPE 847
+HRD+K N L+ K V + DFGL++ +H + +K+ GT + +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 848 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------GFQNRRLEIPKE 901
+ + D+ S G +L LPW G+ + K
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALK-PLQRL 937
A + C +P ++ L + R
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 63/282 (22%), Positives = 110/282 (39%), Gaps = 33/282 (11%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
E+ E+IG G+ YG VY A G VA+KK + RE+ +++ L H
Sbjct: 2 ENFQKVEKIGEGT-YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
PN+V + + L ++ EFL + + + + +G+ H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 853
+ ++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 854 -SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV----------------GAVGFQNRRL 896
+ D++S G I E+ T + + G + + + G + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 897 EIPK-----------ELDPLVARIIWECWQTDPSLRPSFAQL 927
PK LD ++ + DP+ R S
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 165 bits (418), Expect = 4e-46
Identities = 45/275 (16%), Positives = 95/275 (34%), Gaps = 27/275 (9%)
Query: 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+G RIG GS +G ++ N +VA+K + + + + E + + L +
Sbjct: 9 VGRRIGEGS-FGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGI 63
Query: 738 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 797
+ + +++ L SL +L + K A + + +H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 798 IVHRDLKSPNLLVDK-----NWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMA 845
+V+RD+K N L+ + + V DFG+ + +H + K+ +GT +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 846 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV------VGAVGFQNRRLEIP 899
+ + D+ + G + LPW G+ +G E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 900 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 934
+ + P + L +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 5e-46
Identities = 58/258 (22%), Positives = 114/258 (44%), Gaps = 12/258 (4%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLR 732
+ + +G GS +G V +G A+K Q +E E +I++ +
Sbjct: 41 DQFDRIKTLGTGS-FGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 733 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 792
P +V + NL ++ E++ G +F L R + E A + LH
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 793 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
+ +++RDLK NLL+D+ ++V+DFG ++ + GTPE +APE++ ++
Sbjct: 159 SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSK 213
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 912
N+ D ++ GV+++E+A P+ P+Q+ + + ++ P + ++
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRN 271
Query: 913 CWQTDPSLRPSFAQLTVA 930
Q D + R + V
Sbjct: 272 LLQVDLTKRFGNLKNGVN 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 164 bits (415), Expect = 7e-46
Identities = 61/281 (21%), Positives = 106/281 (37%), Gaps = 33/281 (11%)
Query: 676 EDLVLGERIGLGSSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 734
E E+IG G+ YG VY A + G A+KK + RE+ I++ L+H
Sbjct: 2 EKYHGLEKIGEGT-YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 735 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 794
N+V + L ++ E L L ++L ++ L + G+ H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 795 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 854
++HRDLK NLL+++ +K++DFGL+R T + AP+VL
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 855 -NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------------------------ 889
+ D++S G I E+ + G++ + +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 890 ---GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
K LD ++ + + DP+ R + Q
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 40/288 (13%)
Query: 676 EDLVLGERIGLGSSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL- 731
+ IG G+ YG+V+ G VA+K+ Q L REV ++R L
Sbjct: 7 QQYECVAEIGEGA-YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 732 --RHPNVVLFMGAVTRPPN-----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
HPNVV T L+++ E + + + P V + M +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ ++ ++ S T +
Sbjct: 126 LRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYR 182
Query: 845 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--------------- 889
APEVL D++S G I E+ K + G + + +G +
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 890 ----------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ ++D L ++ +C +P+ R S
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-44
Identities = 68/304 (22%), Positives = 115/304 (37%), Gaps = 43/304 (14%)
Query: 682 ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA---ALLEFKREVKIMRRLRHPNV 736
+ +G G + VY A VA+KK S A RE+K+++ L HPN+
Sbjct: 4 DFLGEGQ-FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 737 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 796
+ + A N+S++ +F+ L I+ + L +G+ LH
Sbjct: 63 IGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--H 119
Query: 797 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-N 855
I+HRDLK NLL+D+N +K++DFGL++ + + T + APE+L
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 856 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-------------------------G 890
D+++ G IL EL G + + + +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 891 FQNRRL-EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD-QPSS 948
F L I + +I + +P R + Q L+ + P P
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFSNRPGPTPGC 293
Query: 949 ALPQ 952
LP+
Sbjct: 294 QLPR 297
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-43
Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 17/268 (6%)
Query: 676 EDLVLGERIGLGSSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAA--LLEFKREVKIM 728
E+ L + +G G+ YG+V+ G A+K A + E +++
Sbjct: 24 ENFELLKVLGTGA-YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 729 RRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 787
+R P +V A L +I +++ G LF L + + E ++
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLA 141
Query: 788 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAP 846
+ LH I++RD+K N+L+D N +V ++DFGLS + + GT E+MAP
Sbjct: 142 LEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 847 EVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKEL 902
+++R S ++ D +S GV+++EL T P+ + P+E+
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 903 DPLVARIIWECWQTDPSLRPSFAQLTVA 930
L +I DP R
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-43
Identities = 70/319 (21%), Positives = 126/319 (39%), Gaps = 52/319 (16%)
Query: 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
IG G+ YG V A N VA+KK + RE+KI+ R RH N++
Sbjct: 12 NLSYIGEGA-YGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 738 LFMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
+ P + L L+++L H + + RG+ +H+
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHS 127
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEVLR 850
+ ++HRDLK NLL++ ++K+ DFGL+R+ H+ T + APE++
Sbjct: 128 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 851 NE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRL--------- 896
N + D++S G IL E+ + + + G + + ++G +G ++
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 897 ----------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK-P-LQRLV 938
+ D ++ + +P R Q AL P L++
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ---ALAHPYLEQYY 302
Query: 939 IPSHPDQPSSALPQEISVN 957
PS D+P + P + +
Sbjct: 303 DPS--DEPIAEAPFKFDME 319
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-41
Identities = 60/305 (19%), Positives = 116/305 (38%), Gaps = 53/305 (17%)
Query: 672 EIPWEDLV----LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREV 725
E P+ D V +IG G+ +GEV+ A G +VA+KK L ++ + RE+
Sbjct: 2 ECPFCDEVSKYEKLAKIGQGT-FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 726 KIMRRLRHPNVVLFMGAVTRPP--------NLSIITEFLPRGSLFRILHRPHCQVDEKRR 777
KI++ L+H NVV + ++ ++ +F + + + +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 778 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLS 833
++ + G+ +H I+HRD+K+ N+L+ ++ +K++DFGL+R K++
Sbjct: 121 -RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 834 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--- 889
+ T + PE+L E D++ G I+ E+ T G + +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 890 ---------------------------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRP 922
+ + DP +I + DP+ R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 923 SFAQL 927
Sbjct: 298 DSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 7e-41
Identities = 55/283 (19%), Positives = 105/283 (37%), Gaps = 35/283 (12%)
Query: 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 733
+ E+IG G+ YG V+ A VA+K+ D RE+ +++ L+H
Sbjct: 2 QKYEKLEKIGEGT-YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 734 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
N+V + L+++ EF + D + + +G+ H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCH- 118
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 853
+ ++HRDLK NLL+++N +K+++FGL+R + T + P+VL
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 854 S-NEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAV---------------------- 889
+ D++S G I ELA P G + + +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 890 -----GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
+ + +L+ ++ + +P R S +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-37
Identities = 63/284 (22%), Positives = 111/284 (39%), Gaps = 43/284 (15%)
Query: 680 LGERIGLGSSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ +G G+ YG V A G +VA+KK S RE+++++ +RH NV+
Sbjct: 22 DLQPVGSGA-YGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 738 LFMGAVTRPPNLSIITEFL----PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 793
+ T L T+F G+ L + H ++ E R + + +G+ +H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIH- 138
Query: 794 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-E 852
I+HRDLK NL V+++ +K+ DFGL+R + T + APEV+ N
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWM 194
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---------------- 896
+ D++S G I+ E+ T K + G + + + +
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 897 -------------EIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
I PL ++ + D R + +
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-36
Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 22/257 (8%)
Query: 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 737
+ IG G+ G V A VA+KK + RE+ +M+ + H N++
Sbjct: 21 NLKPIGSGA-QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 738 LFMGAVTRPP------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 791
+ T ++ ++ E + I D +R + + G+ L
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHL 135
Query: 792 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 851
H+ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 136 HS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILG 192
Query: 852 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911
E D++S G I+ E+ K+ + G + + N+ +E P + +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW------NKVIEQLGTPCPEFMKKLQ 246
Query: 912 ECWQTDPSLRPSFAQLT 928
+ RP +A LT
Sbjct: 247 PTVRNYVENRPKYAGLT 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-35
Identities = 51/282 (18%), Positives = 89/282 (31%), Gaps = 47/282 (16%)
Query: 684 IGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 741
IG GS +G VY A +G VA+KK L RE++IMR+L H N+V
Sbjct: 28 IGNGS-FGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRY 80
Query: 742 AVTRP------PNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHT 793
L+++ +++P H R + + R + +H+
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 794 STPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 852
I HRD+K LL +K+ DFG ++ + +
Sbjct: 141 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 853 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV----------------------- 889
DV+S G +L EL + + G + + + +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 890 ----GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 927
P + + P+ R + +
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 5e-35
Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 46/293 (15%)
Query: 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMR 729
E+P E +G G+ YG V A G VAVKK S RE+++++
Sbjct: 15 EVP-ERYQNLSPVGSGA-YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 730 RLRHPNVVLFMGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 784
++H NV+ + T +L + L L I+ D + + +
Sbjct: 73 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI--YQI 130
Query: 785 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 844
RG+ +H + I+HRDLK NL V+++ +K+ DFGL+R + T +
Sbjct: 131 LRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYR 185
Query: 845 APEV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV----------------- 886
APE+ L N+ D++S G I+ EL T + + G + + +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 887 ----GAVGFQNRRLEIPK--------ELDPLVARIIWECWQTDPSLRPSFAQL 927
A + ++PK +PL ++ + D R + AQ
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (324), Expect = 2e-33
Identities = 58/320 (18%), Positives = 121/320 (37%), Gaps = 61/320 (19%)
Query: 654 DSSTSKVDQIFDDDVCECEIPW---EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKF 708
D +T + + +D + + W +D L ++G G Y EV+ A N +V VK
Sbjct: 12 DVNTHRPREYWDYE--SHVVEWGNQDDYQLVRKLGRGK-YSEVFEAINITNNEKVVVKIL 68
Query: 709 LDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRIL 765
+ KRE+KI+ LR PN++ V P + +++ E + ++
Sbjct: 69 KPVKKK-----KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123
Query: 766 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLS 824
+ + ++ + ++ H+ I+HRD+K N+++D ++ +++ D+GL+
Sbjct: 124 QT----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
Query: 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP- 882
H + + PE+L + + D++S G +L + K P+ +
Sbjct: 178 EFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 883 -------MQVVGAVGFQNRRLEIPKELDPLVARI-------------------------- 909
+V+G + + ELDP I
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296
Query: 910 --IWECWQTDPSLRPSFAQL 927
+ + + D R + +
Sbjct: 297 DFLDKLLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 2e-26
Identities = 49/288 (17%), Positives = 103/288 (35%), Gaps = 31/288 (10%)
Query: 679 VLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 736
+L ++G G + V+ A N T VA+K + E+K+++R+ +
Sbjct: 16 ILVRKLGWGH-FSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADN 71
Query: 737 VL---------------FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
F ++ ++ E L L I H + +++
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRLKHNTFLSSK 835
+ G++ +H I+H D+K N+L++ +K++D G + +
Sbjct: 132 KQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---T 187
Query: 836 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 895
++ T E+ +PEVL P D++S +++EL T + +
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 896 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 943
+E+ EL + R S + PL+ ++ +
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 5e-20
Identities = 31/194 (15%), Positives = 60/194 (30%), Gaps = 46/194 (23%)
Query: 679 VLGERIGLGSSYGEVYHA-DWNGTEVAVKKF----------------LDQDFSGAALLEF 721
+G+ +G G V++ E VK D FS A+
Sbjct: 3 AIGKLMGEGK-ESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 722 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 781
+ E + +++L+ V +++ E + + +V + ++
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGN----AVLMELID--------AKELYRVRVENPDEVL 109
Query: 782 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 841
+ + + IVH DL N+LV + + DF S
Sbjct: 110 DMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-------------EVG 153
Query: 842 EWMAPEVLRNEPSN 855
E E+L + N
Sbjct: 154 EEGWREILERDVRN 167
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 960 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.69 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.5 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.47 | |
| d2q3za4 | 316 | Transglutaminase catalytic domain {Human (Homo sap | 94.67 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=447.05 Aligned_cols=263 Identities=35% Similarity=0.604 Sum_probs=223.5
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+|+|+.++|+++++||+| +||+||+|++++ .||||+++...........|.+|+.+|++++|||||++++++.+ ..+
T Consensus 2 dwei~~~~~~~~~~lG~G-~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSG-SFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEEC-SSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcccccccEEEEEEEeeC-CCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 468889999999999999 799999998765 69999998776666677889999999999999999999998754 578
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
+||||||++|+|.+++...+..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+++....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999999999999877678999999999999999999999998 99999999999999999999999999987643
Q ss_pred Cc--ccCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cc---cCCCC
Q 002146 830 TF--LSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RR---LEIPK 900 (960)
Q Consensus 830 ~~--~~~~t~~GT~~Y~APEvl~g~---~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~---~~iP~ 900 (960)
.. .......||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+.......+.... .. ..++.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence 21 223456799999999999653 48999999999999999999999999877654443332222 12 23567
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.+++++++||.+||..||.+|||+.+|+++|+.+.+.
T Consensus 237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 7899999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=444.92 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=212.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc--CCceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~--~~~l~L 751 (960)
++|++++.||+| +||+||++++ +|+.||||++......+.....+.+|+++|++++|||||++++++.+ ...+||
T Consensus 4 edy~~~~~iG~G-~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTG-SYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecC-CCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 679999999999 7999999987 68899999998877777777889999999999999999999998854 466899
Q ss_pred EEeecCCCCHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHhhCC---CCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 752 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k---~~~~lse~~~~~Ia~QIa~AL~YLHs~g---~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
|||||++|+|.+++.+ ....+++..++.++.||+.||+|||+++ .+||||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 2346999999999999999999999864 249999999999999999999999999999
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
............+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.. .....+|..++++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHH
Confidence 876544445567899999999999999999999999999999999999999999998888877753 3345678889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++||.+||..||.+||++.||+++
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 9999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=444.37 Aligned_cols=249 Identities=25% Similarity=0.471 Sum_probs=222.9
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
..++|++++.||+| +||+||++++ +++.||||++.+..... .....+.+|+.+|++++|||||++++++.+++.+|
T Consensus 4 ~l~dy~i~~~iG~G-~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 4 ALEDFEIGRPLGKG-KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CGGGEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred chhHeEEEEEEecC-CCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 35789999999999 7999999987 58899999987543222 23457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+|||||++|+|.+++.+.. .+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+++.....
T Consensus 83 ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999999997643 6999999999999999999999999 999999999999999999999999999876443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+. ...+.+|..+++++++||
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 235 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLI 235 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence 2345689999999999999999999999999999999999999999999888888774 345678889999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||.+||.+|||++|++++
T Consensus 236 ~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTC
T ss_pred HHHccCCHhHCcCHHHHHcC
Confidence 99999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=435.67 Aligned_cols=258 Identities=31% Similarity=0.540 Sum_probs=219.8
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
|..++|++++.||+| +||+||+|++ +++.||||++....... .++.+|+++|++++|||||++++++.+++.+++
T Consensus 2 idp~~~~~~~~iG~G-~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSG-QFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp BCCSCEEEEEEEECC-SSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CChHHcEEEEEEeeC-CCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 456789999999999 7999999988 57789999987654443 478899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+++|+|.+++......+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999999999999887778999999999999999999999999 9999999999999999999999999998765432
Q ss_pred c-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 832 L-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 832 ~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
. ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..++...+. ...+...|..+++++.+|
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~l 234 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQI 234 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHH
Confidence 2 2334578999999999999999999999999999999999 577777777777777765 345667788899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 910 IWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
|.+||+.||.+||++++|+++|+++.+.
T Consensus 235 i~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 235 MNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=443.82 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=221.4
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++++.||+| +||+||+|++ +|+.||||++....... .+.+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 19 ~~~Y~~~~~iG~G-~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQG-ASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCS-SSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecC-cCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 3579999999999 7999999985 69999999987654332 35688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
||||+||+|.+++.+. .+++.+++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.......
T Consensus 96 mEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999999998764 5999999999999999999999999 99999999999999999999999999998765544
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-cccCCCCCCcHHHHHHHH
Q 002146 833 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIW 911 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~-~~~~iP~~lS~eLkdLI~ 911 (960)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.... .....|..+++++++||.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence 5566789999999999999999999999999999999999999999988777665554322 234556789999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 002146 912 ECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||.+||++.|++++
T Consensus 252 ~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTC
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=445.94 Aligned_cols=251 Identities=21% Similarity=0.357 Sum_probs=220.3
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
..++|++++.||+| +||+||+|++ +|+.||||++.+.... ......+.+|+++|++++|||||+++++|++++.+|
T Consensus 6 ~p~dy~i~~~lG~G-~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 6 RPEDFKFGKILGEG-SFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CGGGEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCEEEEEEeeC-CCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34689999999999 7999999987 5889999998754321 223457899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
||||||+||+|.+++...+ .+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999999987654 6999999999999999999999999 999999999999999999999999999876432
Q ss_pred --cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHH
Q 002146 831 --FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 831 --~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++...+. ...+.+|..+++++++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARD 239 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHHH
Confidence 223345689999999999999999999999999999999999999999999888888774 3456788899999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||.+||.+|||++|++.+
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHccCCHhHCcCHHHHcCC
Confidence 9999999999999999997554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-50 Score=438.54 Aligned_cols=261 Identities=33% Similarity=0.546 Sum_probs=220.5
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEEC--Cc---EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWN--GT---EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~--g~---~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
++..++|++.++||+| +||+||+|++. ++ .||||++... ......+.|.+|+.+|++++|||||++++++.+.
T Consensus 22 ~i~~~~~~~~~~lG~G-~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAG-EFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEEC-SSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeC-CCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4566789999999999 79999999862 32 5888987643 3455567899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+.+++|||||++|+|.+++......+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+++.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999999999999887778999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc-----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCC
Q 002146 827 KHNTFL-----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 900 (960)
Q Consensus 827 ~~~~~~-----~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~ 900 (960)
...... ......||+.|||||++.+..|+.++|||||||++|||++ |..||.+....++...+. ...++..|.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~ 256 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPM 256 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCT
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCc
Confidence 643221 1122457899999999999999999999999999999998 899999999888887775 345667788
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 901 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 901 ~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
.++.++++||.+||..||.+||++.+|++.|+++.+.
T Consensus 257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 8999999999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=442.25 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=220.2
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
+.|++++.||+| +||+||+|++ +|+.||||++.... ......+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G-~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDG-AFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeC-CCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999 7999999987 68899999987653 233457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|||++|+|.+++.+.+..+++..+..|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+++........
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 999999999998766667999999999999999999999999 999999999999999999999999999876543333
Q ss_pred CCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-ccCCCCCCcHHHH
Q 002146 834 SKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVA 907 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~-----g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~-~~~iP~~lS~eLk 907 (960)
....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..++...+..... ....|..++++++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 45678999999999984 55689999999999999999999999999998888777654322 2344678999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+||.+||++||.+|||+.|++++
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-51 Score=438.22 Aligned_cols=260 Identities=35% Similarity=0.609 Sum_probs=226.6
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
.+|+|..++|++++.||+| +||+||+|.+ +++.||||++...... .+++.+|+.+|++++|||||+++++|.+.
T Consensus 10 ~~wei~~~~~~~~~~iG~G-~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGG-QYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTT-TTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccEecHHHeEEeeEEeeC-CCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 4578888999999999999 7999999987 5889999998765433 35789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhC-CCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 747 PNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k-~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
+.+++|||||++|+|.+++.+ ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999999864 3457899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChhHHHHHhhccccccCCCCCCc
Q 002146 826 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP-WIGMNPMQVVGAVGFQNRRLEIPKELD 903 (960)
Q Consensus 826 ~~~~~~~-~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~P-F~~~~~~ei~~~I~~~~~~~~iP~~lS 903 (960)
....... ......|++.|+|||++.+..|+.++|||||||++|||++|..| |.+.+..++...+. ...++.+|..++
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~ 242 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 242 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-cCCCCCCCccch
Confidence 7654322 22334589999999999999999999999999999999996655 55556655555443 455778888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
+++++||.+||..||.+||++.+|++.|+.+.
T Consensus 243 ~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999999999998874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=449.55 Aligned_cols=252 Identities=23% Similarity=0.400 Sum_probs=227.3
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
|..++|++++.||+| +||+||+++. +|+.||||++.+.... ......+.+|+.+|++++|||||+++++|++.+.+
T Consensus 2 i~l~dy~~~~~lG~G-~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKG-TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CchHhcEEEEEEecC-cCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 567899999999999 7999999986 6899999999764321 22356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
|+|||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+....
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999999998754 6899999999999999999999999 99999999999999999999999999997655
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++...+. ...+.+|..+++++++|
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dl 235 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSL 235 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHH
Confidence 4445567889999999999999999999999999999999999999999999988888774 34678899999999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHHH
Q 002146 910 IWECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPS-----a~eILe~ 930 (960)
|.+||++||.+|++ +.+|+++
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHhhccCCchhhcccccccHHHHHcC
Confidence 99999999999994 8888874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=436.02 Aligned_cols=250 Identities=28% Similarity=0.346 Sum_probs=210.5
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++++.||+| +||+||+|++ +|+.||||++...... .....+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 5 ~dy~~~~~lG~G-~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEG-AYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecC-cCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 579999999999 7999999987 5889999998765432 23456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC--c
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--F 831 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~--~ 831 (960)
|||++|+|.+++.+.+ .+++.+++.|+.||+.||+|||++| ||||||||+||||+.++.+||+|||+|+..... .
T Consensus 83 Ey~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999997644 7999999999999999999999999 999999999999999999999999999876432 2
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHH-HHHhhccccccCCCCCCcHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQV-VGAVGFQNRRLEIPKELDPLVARI 909 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei-~~~I~~~~~~~~iP~~lS~eLkdL 909 (960)
......+||+.|||||++.+..+ +.++|||||||++|||++|++||........ ...+.........+..+++++++|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 23456789999999999998886 5789999999999999999999987654332 222222222223345789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
|.+||+.||.+||+++|++++
T Consensus 240 i~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999763
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=428.67 Aligned_cols=259 Identities=32% Similarity=0.566 Sum_probs=225.7
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
.+|+|+.++|+++++||+| +||+||+|+++ ++.||||++...... .+.|.+|+.+|++++|||||++++++.+ +
T Consensus 6 ~~wei~~~~~~~~~~iG~G-~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAG-QFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEE-TTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CCeecCHHHeEEeEEEecC-CCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 4578888999999999999 79999999985 578999998765433 3478999999999999999999998765 5
Q ss_pred ceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.++|||||+++|+|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEE
Confidence 6899999999999999876533 25899999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 827 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 827 ~~~~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG-~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
..... .......||+.|+|||++.+..++.++|||||||++|||+|| .+||...+..++...+. ...++..|..+++
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPE 237 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChH
Confidence 65432 233456799999999999999999999999999999999995 56666777777776664 4456778889999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
++++||.+||+.||.+|||+.+|++.|+.+-
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 9999999999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=441.78 Aligned_cols=260 Identities=30% Similarity=0.449 Sum_probs=224.0
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEECC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEe
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 740 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g-------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~ 740 (960)
.+|+++.++|+++++||+| +||+||+|++.+ ..||||.+.... .......+.+|+.+|+++ +|||||+++
T Consensus 30 ~kwei~~~~~~l~~~lG~G-~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSG-AFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEEC-SSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeeC-CCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 3567888999999999999 799999998632 269999876543 233345788999999998 899999999
Q ss_pred cccccCCceEEEEeecCCCCHHHHhhCCC----------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCE
Q 002146 741 GAVTRPPNLSIITEFLPRGSLFRILHRPH----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTI 798 (960)
Q Consensus 741 g~f~~~~~l~LVmEY~~gGsL~dlL~k~~----------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~I 798 (960)
+++.+.+.+|||||||++|+|.++|.... ..+++..++.|+.||+.||+|||+++ |
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--I 185 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--C 185 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 99999999999999999999999997643 24788999999999999999999999 9
Q ss_pred EEeccCCCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 002146 799 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKL 875 (960)
Q Consensus 799 IHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~ 875 (960)
|||||||+|||++.++++||+|||+|+....... ...+..||+.|||||++.+..|+.++|||||||++|||++ |..
T Consensus 186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred eeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence 9999999999999999999999999987543322 2234568999999999999999999999999999999997 899
Q ss_pred CCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 002146 876 PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 932 (960)
Q Consensus 876 PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le 932 (960)
||.+.+..+.+..+.....++.+|..+++++++||.+||+.||.+|||++||+++|.
T Consensus 266 Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 266 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 999987766666665566678889999999999999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=429.32 Aligned_cols=249 Identities=31% Similarity=0.464 Sum_probs=215.2
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc----CCceE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLS 750 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~----~~~l~ 750 (960)
.|++.++||+| +||+||++.+ +++.||||++............+.+|+++|++++|||||+++++|.+ ...+|
T Consensus 10 y~~~~~~iG~G-~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 10 FLKFDIEIGRG-SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEEeeeEEecC-cCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 46788899999 7999999987 57889999998877777777789999999999999999999999864 45689
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc-CCCcEEEEecCccccccC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd-~~g~VKL~DFGLAr~~~~ 829 (960)
||||||++|+|.+++.+.. .+++..++.|+.||+.||+|||+++++||||||||+||||+ .++.+||+|||+++....
T Consensus 89 ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999997643 68999999999999999999999887799999999999996 588999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhccccccCCCCCCcHHHHH
Q 002146 830 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVAR 908 (960)
Q Consensus 830 ~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~-~ei~~~I~~~~~~~~iP~~lS~eLkd 908 (960)
. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+... .++...+.....+..++..+++++++
T Consensus 168 ~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 168 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 3 2345789999999999876 599999999999999999999999987644 44555554444445566778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||.+||++|||++||+++
T Consensus 245 li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCCHhHCcCHHHHhCC
Confidence 9999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=429.63 Aligned_cols=260 Identities=25% Similarity=0.444 Sum_probs=227.8
Q ss_pred CcCCCCeEEEEE-eeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 672 EIPWEDLVLGER-IGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 672 ei~~~dy~i~k~-LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
.+..++|.+.+. ||+| +||+||+|.+ ++..||||++... .......+|.+|+++|++++|||||++++++.+
T Consensus 4 ~l~~~~~~~~~~~iG~G-~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCG-NFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp BCCGGGEEEEEEEEECC-TTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eecccCeEECCcEEecc-cCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 355578899885 9999 7999999975 3457999998654 345566789999999999999999999999875
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+.+|||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhc
Confidence 5689999999999999998776668999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCC
Q 002146 827 KHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 827 ~~~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~l 902 (960)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...++.+|..+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 237 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 237 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcC
Confidence 64322 22334568999999999999999999999999999999998 999999998888877775 45577889999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
++++.+||.+||..||.+||++.+|++.|+.+...
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999887543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=425.75 Aligned_cols=254 Identities=31% Similarity=0.518 Sum_probs=228.5
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
..++|+++++||+| +||+||+|++ +++.||||+++...... .++.+|+.++++++|||||++++++.+++.+++|
T Consensus 2 ~~~~~~~~~~iG~G-~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 2 DPKDLTFLKELGTG-QFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCEE-TTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred ChHHCEEeEEEecC-CCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 45789999999999 7999999998 46689999998765543 4788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+++|+|..++......+++..+++|+.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999999999998877778999999999999999999999999 99999999999999999999999999987644322
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 833 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 833 -~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...++..|..+++++++||
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHH
Confidence 2334678999999999999999999999999999999998 899999999988888776 4557778899999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHh
Q 002146 911 WECWQTDPSLRPSFAQLTVALKPL 934 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~Le~i 934 (960)
.+||+.||.+||++.+|+++|..+
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHccCCHhHCcCHHHHHHHhhCC
Confidence 999999999999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=442.03 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=214.3
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
++.-++|+++++||+| +||+||++++ +|+.||||+++... .......+.+|+.+|++++|||||+++++|.++..+
T Consensus 2 el~~d~y~~~~~iG~G-~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAG-NGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECC-SSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecC-CCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4556789999999999 7999999987 68899999987643 334456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
|||||||+||+|.+++.+.+ .+++..++.++.||+.||.|||+ +| ||||||||+||||+.+|++||+|||+|+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999999997654 69999999999999999999997 58 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhh------------------
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------------------ 890 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~------------------ 890 (960)
.. ...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+......
T Consensus 157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 33 2345789999999999999999999999999999999999999998765432211100
Q ss_pred -----------------------ccccccCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHh
Q 002146 891 -----------------------FQNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 934 (960)
Q Consensus 891 -----------------------~~~~~~~iP-~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--Le~i 934 (960)
.....+.++ ..++.++++||.+||..||.+|||++|++++ +++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 011111222 2368899999999999999999999999985 5443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=425.68 Aligned_cols=261 Identities=30% Similarity=0.518 Sum_probs=219.9
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 744 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~ 744 (960)
+|+|+.++|++++.||+| +||.||+|++. +..||||.+... ........+.+|+.+|++++|||||++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G-~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEG-QFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEEC-SSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCcCHHHeEEEEEEeeC-CCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 367888999999999999 79999999863 345888887543 34555678999999999999999999999996
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+ +.+|+||||+++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 79 ~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 79 E-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp S-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC----
T ss_pred c-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhh
Confidence 4 6799999999999999998776668999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCC
Q 002146 825 RLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 825 r~~~~~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~l 902 (960)
+...... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++...+. ...++.+|..+
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~ 234 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 234 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTC
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 8764322 22344568999999999999999999999999999999998 899999999988888775 44567788999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
++++++||.+||..||.+||++.+|+++|+++.+
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=425.26 Aligned_cols=261 Identities=30% Similarity=0.519 Sum_probs=221.8
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEECC------cEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 745 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g------~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~ 745 (960)
+|..++|++.++||+| +||+||+|.+.+ ..||||++... ........|.+|+.+|++++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G-~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAG-EFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEEC-SSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeC-CCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 5677889999999999 799999998632 36999998654 345556679999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 746 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 746 ~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
...+++||||+.+++|.+++......+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999999999988877678999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHhhccccccCCCCC
Q 002146 826 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 901 (960)
Q Consensus 826 ~~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG-~~PF~~~~~~ei~~~I~~~~~~~~iP~~ 901 (960)
....... ......||+.|+|||++.+..++.++|||||||++|||++| .+||.+....++...+. ...++..|..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~ 237 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 237 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchh
Confidence 7643321 22335689999999999999999999999999999999995 55566667777766664 4556778889
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 902 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 902 lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
++.++++||.+||+.||.+||++.+|++.|+++.+.
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999999999999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-50 Score=436.51 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=203.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
+.|++++.||+| +||+||++++ +|+.||||++....... ....+.+|+.+|++++|||||+++++|++++.+||||
T Consensus 9 d~Y~~~~~lG~G-~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTG-AFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSG-GGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeec-cCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 569999999999 7999999987 58899999997654432 2356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc---CCCcEEEEecCccccccCC
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd---~~g~VKL~DFGLAr~~~~~ 830 (960)
|||+||+|.+++.+.+ .+++..+..|+.||+.||+|||++| ||||||||+|||+. +++.+||+|||+++.....
T Consensus 87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999997754 7999999999999999999999999 99999999999995 5789999999999876443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--CCCCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--~iP~~lS~eLkd 908 (960)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|..||.+....++...+....... ..+..+++++++
T Consensus 164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred -CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 23345789999999999999999999999999999999999999999998888887776544333 234678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||.+||.+|||+.|++++
T Consensus 243 li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCHhHCcCHHHHhcC
Confidence 9999999999999999999885
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=426.26 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=216.5
Q ss_pred CeEEE-EEeeccCCeeEEEEEEE----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 677 DLVLG-ERIGLGSSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 677 dy~i~-k~LG~GGsFG~Vy~ak~----~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
.+.+. ++||+| +||+||+|.+ .++.||||++..........+++.+|+.+|++++|||||+++++++. +.++|
T Consensus 7 ~~~le~k~iG~G-~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 7 LLTLEDKELGSG-NFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp GEEEEEEEEEEC-SSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred hCeecCCCcccC-CCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 34444 579999 7999999975 24679999987655555566789999999999999999999999865 46789
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
|||||++|+|.+++.+.. .+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 85 vmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 999999999999997644 6999999999999999999999999 9999999999999999999999999998754322
Q ss_pred ---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 832 ---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 832 ---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...++.+|..++++++
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~ 240 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMY 240 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHH
Confidence 12234568999999999999999999999999999999998 899999999888877765 4557788999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
+||.+||..||.+||++.+|++.|+.+-
T Consensus 241 ~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 241 DLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 9999999999999999999999988763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-49 Score=439.83 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=221.5
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
.++|++++.||+| +||+||+|++ +|+.||||++.... ......+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 25 l~~Y~i~~~lG~G-~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTG-AFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEE-TTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecC-cCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3689999999999 7999999987 58999999987543 34456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc--CCCcEEEEecCccccccCC
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd--~~g~VKL~DFGLAr~~~~~ 830 (960)
||||+||+|.+++.+....+++..++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||+++.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999999776668999999999999999999999999 99999999999996 4689999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC--CCCCCcHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVAR 908 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~--iP~~lS~eLkd 908 (960)
......+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..++...+........ .+..+++++++
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 233457899999999999999999999999999999999999999999998888887754433222 23468999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 002146 909 IIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 909 LI~kcL~kDP~kRPSa~eILe~ 930 (960)
||.+||..||.+|||++|++++
T Consensus 259 li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=426.18 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=219.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHHcCCCceeeEecccccCCce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~----~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l 749 (960)
+.|++++.||+| +||+||+|++ +|+.||||++.+..... .....+.+|+.+|++++|||||+++++|++.+.+
T Consensus 10 d~Y~~~~~lG~G-~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSG-QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCEEEeEEEecC-CCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 569999999999 7999999987 58899999997654332 2356789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC----cEEEEecCccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSR 825 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g----~VKL~DFGLAr 825 (960)
|||||||+||+|.+++.+.+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999997644 6999999999999999999999999 99999999999998776 59999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--CCCCCCc
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 903 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--~iP~~lS 903 (960)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....... .++..++
T Consensus 166 ~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 166 KIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp ECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 76543 23445689999999999999999999999999999999999999999999888887775433222 2346789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 904 PLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+++++||.+||.+||.+||+++|++++
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-49 Score=433.15 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=217.4
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
.|++++.||+| +||+||+|++ +|+.||||++...... ......+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 16 ~y~~l~~lG~G-~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHG-SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEEC-SSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecC-CCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 49999999999 7999999986 6889999999876554 345567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
|||.+|+|..++... ..+++..++.|+.||+.||.|||++| ||||||||+||||+.++++||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 999999998766543 47999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 834 SKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g---~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
....+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+.........+..+++++++||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 335689999999999964 45899999999999999999999999999888877777644444445667899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 002146 911 WECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~eILe~ 930 (960)
.+||..||.+|||+.+++++
T Consensus 248 ~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHTCSSGGGSCCHHHHTTC
T ss_pred HHHCcCChhHCcCHHHHHhC
Confidence 99999999999999999873
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-49 Score=431.61 Aligned_cols=248 Identities=24% Similarity=0.414 Sum_probs=222.0
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceE
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~ 750 (960)
..++|++++.||+| +||+||++++ +|+.||||++.+.... ......+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 2 sl~dy~i~~~lG~G-~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 80 (316)
T d1fota_ 2 SLQDFQILRTLGTG-SFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 80 (316)
T ss_dssp CGGGEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred chhHeEEEEEEecC-cCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence 35789999999999 7999999986 5899999998754322 223567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
+|||||.||+|..++.... .+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999999987654 6788888899999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.. ....+|..++++++++|
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 232 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLL 232 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 3457899999999999999999999999999999999999999999999888887743 35677889999999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHHH
Q 002146 911 WECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 911 ~kcL~kDP~kRP-----Sa~eILe~ 930 (960)
.+||.+||.+|+ ++++|+++
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhhhCHHhccccchhhHHHHHcC
Confidence 999999999996 89999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-49 Score=437.68 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=221.6
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
++|++++.||+| +||+||+|++ +|+.||||++.... ......+.+|+.+|++|+|||||+++++|.+++.+||||
T Consensus 29 d~Y~i~~~lG~G-~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSG-AFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecC-CCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999 7999999986 68999999987653 333457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc--CCCcEEEEecCccccccCCc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd--~~g~VKL~DFGLAr~~~~~~ 831 (960)
|||+||+|.+++.+.+..+++.+++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|+.....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 999999999998877768999999999999999999999999 99999999999998 6789999999999877543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc--cCCCCCCcHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARI 909 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~--~~iP~~lS~eLkdL 909 (960)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+...... ...+..+++++++|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2334567999999999999999999999999999999999999999999988888777543322 22346789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 002146 910 IWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 910 I~kcL~kDP~kRPSa~eILe~ 930 (960)
|.+||.+||.+||++.|++++
T Consensus 263 i~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=422.62 Aligned_cols=256 Identities=33% Similarity=0.588 Sum_probs=221.4
Q ss_pred cCcCCCCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc-CCce
Q 002146 671 CEIPWEDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNL 749 (960)
Q Consensus 671 ~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-~~~l 749 (960)
|+|..++|+++++||+| +||.||+|+++|+.||||+++... ..+.+.+|+++|++++|||||++++++.+ .+.+
T Consensus 2 w~i~~~~~~~~~~lG~G-~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 2 WALNMKELKLLQTIGKG-EFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CBCCGGGEEEEEEEEEC-SSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CccCHHHeEEeEEEecC-CCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 67889999999999999 799999999999999999986543 23578899999999999999999998854 5678
Q ss_pred EEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
|+||||+++|+|.+++.+.. ..+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecC
Confidence 99999999999999997533 35899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
.. .....+|..|+|||++.+..++.++|||||||++|||++ |.+||...+..++...+. ...++.+|..++++++
T Consensus 155 ~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 155 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 230 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred CC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHH
Confidence 33 334578999999999999999999999999999999998 799999998888888775 4567788999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+||.+||..||.+||++.+|+++|++++..
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=422.16 Aligned_cols=267 Identities=31% Similarity=0.497 Sum_probs=218.8
Q ss_pred CccccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceee
Q 002146 667 DVCECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 738 (960)
Q Consensus 667 ~~~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVk 738 (960)
+..+|+|+.++|+++++||+| +||+||+|++ +++.||||++.... .......+.+|..++.++ +|+|||.
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G-~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRG-AFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEEC-SSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccccHHHEEEeeEEeec-CCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 345678889999999999999 7999999986 23679999986543 344556788888888887 6899999
Q ss_pred Eeccccc-CCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEec
Q 002146 739 FMGAVTR-PPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 802 (960)
Q Consensus 739 L~g~f~~-~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRD 802 (960)
+++++.. ...+++|||||++|+|.+++.... ..+++.+++.|+.||+.||+|||+++ |||||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrD 159 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD 159 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCc
Confidence 9998765 456899999999999999986432 24889999999999999999999999 99999
Q ss_pred cCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q 002146 803 LKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 879 (960)
Q Consensus 803 LKPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG-~~PF~~ 879 (960)
|||+||||+.++++||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+||.+
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654332 223456799999999999999999999999999999999986 568888
Q ss_pred CChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 880 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 880 ~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
....+.+..+.....++.+|..+++++++||.+||+.||.+||++.+|+++|+++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 7665555554445667788899999999999999999999999999999999998654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=422.18 Aligned_cols=261 Identities=29% Similarity=0.475 Sum_probs=228.3
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 742 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~ 742 (960)
.++++.++|++++.||+| +||+||+|++. ++.||||++... .......++.+|+.+|++++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G-~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEG-AFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEEC-SSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeC-CCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 467788899999999999 79999999874 368999998654 345556789999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHHHHhhCCC-----------------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEE
Q 002146 743 VTRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIV 799 (960)
Q Consensus 743 f~~~~~l~LVmEY~~gGsL~dlL~k~~-----------------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~II 799 (960)
+.+...+++||||+++|+|.+++.... ..+++..++.|+.||+.||+|||+++ ||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv 162 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 162 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eE
Confidence 999999999999999999999986322 24788899999999999999999999 99
Q ss_pred EeccCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CC
Q 002146 800 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LP 876 (960)
Q Consensus 800 HRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~-~P 876 (960)
||||||+||||+.++++||+|||+++...... ....+.+||+.|+|||++.+..|+.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998654322 2233567899999999999999999999999999999999985 78
Q ss_pred CCCCChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 877 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 877 F~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
|.+.+..++...+. ...++.+|..+++++.+||.+||+.+|.+|||+.||++.|+++.
T Consensus 243 ~~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 99999888888775 34467788899999999999999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=420.13 Aligned_cols=259 Identities=33% Similarity=0.534 Sum_probs=218.9
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
|..++|++.+.||+| +||+||+|++. ...||||++...... ....+.|.+|+.+|++++|||||++++++.+
T Consensus 5 i~~~d~~~~~~iG~G-~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDG-SFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp CCGGGEEEEEECC-----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EchHHeEEEEEEecC-CCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 456789999999999 69999999863 236899988765443 3446789999999999999999999999976
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
..+++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhh
Confidence 4788999999999999988776667999999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCC
Q 002146 827 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 902 (960)
Q Consensus 827 ~~~~~~---~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~l 902 (960)
...... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+.....+++.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccc
Confidence 643321 2234467889999999999999999999999999999998 899999999999988887777778888999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 903 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 903 S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
++++++||.+||+.||.+|||+.+|++.|++.+
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 999999999999999999999999999998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-49 Score=434.65 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=221.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~L 751 (960)
.++|++++.||+| +||+||++++ +|+.||||++.+.... ......+.+|+.+|+.++|||||+++++|.+...+++
T Consensus 40 ld~y~i~~~lG~G-~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTG-SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEEEEeecC-cCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 4789999999999 7999999987 6899999998754322 2234578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 831 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~ 831 (960)
||||+.+|+|..++.+.+ .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.....
T Consensus 119 v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999999987654 6999999999999999999999999 999999999999999999999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHHH
Q 002146 832 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 911 (960)
Q Consensus 832 ~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~ 911 (960)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+...+...+. ...+.+|..+++++++||.
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTCCHHHHHHHH
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHH
Confidence 345789999999999999999999999999999999999999999999888888774 3456778899999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHH
Q 002146 912 ECWQTDPSLRP-----SFAQLTVA 930 (960)
Q Consensus 912 kcL~kDP~kRP-----Sa~eILe~ 930 (960)
+||.+||.+|+ ++++|+++
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccccccHHHHHcC
Confidence 99999999994 89999873
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.3e-48 Score=412.45 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=216.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHHcCCCceeeEecccccCCc----
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN---- 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~-~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~---- 748 (960)
++|++.+.||+| +||+||++++ +|+.||||++...... ......+.+|+.+|+.++|||||++++++...+.
T Consensus 7 drY~i~~~lG~G-~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFG-GMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEeEEEeeC-CCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 579999999999 7999999986 6999999999876543 4456679999999999999999999999876543
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
+||||||++|++|.+++...+ .+++.+++.|+.||+.||+|||++| ||||||||+||||+.++.++|+|||+++...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhc
Confidence 899999999999999887654 6899999999999999999999999 9999999999999999999999999987653
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccccc--CCCCCCc
Q 002146 829 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 903 (960)
Q Consensus 829 ~~~---~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~--~iP~~lS 903 (960)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+......+ ..+..++
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 221 23445679999999999999999999999999999999999999999998887776654333222 2346789
Q ss_pred HHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhHH
Q 002146 904 PLVARIIWECWQTDPSLRP-SFAQLTVALKPLQR 936 (960)
Q Consensus 904 ~eLkdLI~kcL~kDP~kRP-Sa~eILe~Le~i~~ 936 (960)
+++++||.+||.+||.+|| +++++++.|.++++
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 9999999999999999999 89999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=430.15 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=220.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHH-HcCCCceeeEecccccCCceE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~-~~~~~~~~~~Ei~ILk-~L~HPNIVkL~g~f~~~~~l~ 750 (960)
.++|++++.||+| +||+||+|++ +|+.||||++.+... .......+..|+.++. .++|||||++++++.+++.+|
T Consensus 1 iddy~i~~~iG~G-~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 1 IEDFILHKMLGKG-SFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp CTTEEEEEEEEEC-SSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCCeEEeeEEecC-CCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 3689999999999 7999999987 789999999975322 1223445667777765 689999999999999999999
Q ss_pred EEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCC
Q 002146 751 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 751 LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~ 830 (960)
||||||++|+|.+++.... .+++.+++.++.||+.||+|||+++ ||||||||+|||++.+|++||+|||+++.....
T Consensus 80 ivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999997644 6899999999999999999999999 999999999999999999999999999876555
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcHHHHHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 910 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI 910 (960)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+. ...+.+|..+++++++||
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli 234 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKDLL 234 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence 455566789999999999999999999999999999999999999999999988888874 346778899999999999
Q ss_pred HHhhhhCCCCCCCHH-HHHH
Q 002146 911 WECWQTDPSLRPSFA-QLTV 929 (960)
Q Consensus 911 ~kcL~kDP~kRPSa~-eILe 929 (960)
.+||.+||.+||++. +|++
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGG
T ss_pred HHhcccCCCCCcCHHHHHHh
Confidence 999999999999995 7765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=420.30 Aligned_cols=256 Identities=28% Similarity=0.503 Sum_probs=218.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCc----EEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCc
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 748 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~----~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~ 748 (960)
..+|+++++||+| +||+||+|.+ +|+ +||||++.... .....+.+.+|+.+|++++|||||++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G-~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSG-AFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEEC-SSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecC-CCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3579999999999 7999999987 343 58888876432 233456789999999999999999999999864 6
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
.+++|||+.+++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+++...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 77889999999999998877778999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHhhccccccCCCCCCcHH
Q 002146 829 NTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 905 (960)
Q Consensus 829 ~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~e 905 (960)
.... ......||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..++...+. ...++..|..++++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 241 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTID 241 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHH
Confidence 4322 2234468999999999999999999999999999999998 899999988887776664 45567788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 906 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 906 LkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
+++||.+||..||.+||++.+|+++|+++.+
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998854
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=418.96 Aligned_cols=261 Identities=32% Similarity=0.554 Sum_probs=219.5
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 747 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~ 747 (960)
..|+|+.++|++++.||+| .||+||+|++ +++.||||++....... ..|.+|+.+|++++|||||++++++.+ +
T Consensus 10 ~~~~i~~~~~~i~~~iG~G-~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQG-CFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp TCSBCCGGGEEEEEEEEEC-SSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cceEcCHHHEEEeeEEeeC-CCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 3567888999999999999 7999999988 45679999987654433 478999999999999999999999865 5
Q ss_pred ceEEEEeecCCCCHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~-~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+++||||+++|+|..++... ...+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhh
Confidence 689999999999999987642 236899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 827 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 827 ~~~~~-~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG-~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
..... .......||+.|+|||++.+..++.++|||||||++|||++| .+||.+....++...+. ...+..++..+++
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 241 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCH
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCH
Confidence 64332 223345789999999999999999999999999999999995 56666677777776665 3456678899999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
++++||.+||+.||++||++++|++.|+++...
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 999999999999999999999999999887544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=414.90 Aligned_cols=264 Identities=32% Similarity=0.543 Sum_probs=228.8
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceee
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 738 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVk 738 (960)
.+|+|+.++|++++.||+| +||.||+|+.. +..||||+++.. .......++.+|..++.++ +|||||+
T Consensus 6 ~~~~i~~~~~~l~~~iG~G-~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEG-AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC------CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCcccHHHeEEeeEEeec-CCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 3578899999999999999 79999999752 246999998654 3455567889999999998 8999999
Q ss_pred EecccccCCceEEEEeecCCCCHHHHhhCCC---------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 739 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 739 L~g~f~~~~~l~LVmEY~~gGsL~dlL~k~~---------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
++++|.+++.+++|||||++|+|.++|.... ..+++.+++.++.||+.||+|||+++ ||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDi 161 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDL 161 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeee
Confidence 9999999999999999999999999997543 35899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~~--~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 99999999999999999999987654322 2344578999999999999999999999999999999998 79999999
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
+..++...+. ...++.+|..+++++++||.+||+.||.+|||+.+|++.|+++...
T Consensus 242 ~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 242 PVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp CHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 8888877765 4567788999999999999999999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=422.73 Aligned_cols=247 Identities=18% Similarity=0.300 Sum_probs=218.9
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+++|++++.||+| +||+||+|.+ +++.||||++.... .....+.+|+++|++++|||||+++++|++.+.+|||
T Consensus 4 ~~rY~i~~~lG~G-~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRG-EFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecC-CCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999 7999999986 68899999987643 2334678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC--CCcEEEEecCccccccCC
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNT 830 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~--~g~VKL~DFGLAr~~~~~ 830 (960)
||||+||+|.+++.+.+..+++.+++.|+.||+.||+|||++| |+||||||+||||+. .+.+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999876667999999999999999999999999 999999999999984 458999999999876443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCC----CCCcHHH
Q 002146 831 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP----KELDPLV 906 (960)
Q Consensus 831 ~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP----~~lS~eL 906 (960)
......+||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..++...+... ...++ ..+++++
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA--EYTFDEEAFKEISIEA 234 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCHHHHTTSCHHH
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCChhhccCCCHHH
Confidence 2234467999999999999999999999999999999999999999999998888887533 23333 4689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 907 ARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 907 kdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++||.+||.+||.+||++.|++++
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999984
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=419.40 Aligned_cols=260 Identities=32% Similarity=0.605 Sum_probs=223.9
Q ss_pred CcCCCCeEEEEEeeccCCeeEEEEEEE--CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEecccccC
Q 002146 672 EIPWEDLVLGERIGLGSSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 746 (960)
Q Consensus 672 ei~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~--~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~~ 746 (960)
.|.+++|+++++||+| +||+||+|++ +|. .||||++.... .......+.+|+++|+++ +|||||++++++.+.
T Consensus 6 ~i~~~~~~~~~~iG~G-~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEG-NFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECG-GGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccCHHHcEEEEEEeeC-CCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 4678999999999999 7999999987 444 47788775433 233456789999999999 799999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCC---------------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEc
Q 002146 747 PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 811 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~---------------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd 811 (960)
+.+++||||+++|+|.++|++. ...+++..++.++.||+.||.|||+++ ||||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc
Confidence 9999999999999999999754 246899999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHhh
Q 002146 812 KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVG 890 (960)
Q Consensus 812 ~~g~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG-~~PF~~~~~~ei~~~I~ 890 (960)
.++.+||+|||+++..... .......||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..++...+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CCCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999999865433 233456799999999999999999999999999999999996 46898999888887775
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 891 ~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
...++.+|..+++++++||.+||..||++||++.+|+++|+++.+.
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 241 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 4557788899999999999999999999999999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-47 Score=410.72 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=218.7
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh-------HHHHHHHHHHHHHHHcC-CCceeeEecccc
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG-------AALLEFKREVKIMRRLR-HPNVVLFMGAVT 744 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~-------~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~ 744 (960)
.++|++++.||+| +||+||++++ +|+.||||++.+..... .....+.+|+.+|++++ |||||+++++|+
T Consensus 2 ~~~y~~~~~iG~G-~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 2 YENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cccCEEceEEecC-cCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 3689999999999 7999999987 78999999997654321 22346889999999996 999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+++.+|||||||++|+|.+++...+ .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||++
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999997644 7899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCC
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 898 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g------~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~i 898 (960)
+..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.........
T Consensus 158 ~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 158 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred eEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 877543 23455789999999999853 34688999999999999999999999999988877776544333222
Q ss_pred --CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 899 --PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 899 --P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
+..+++++++||.+||+.||.+||+++|++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 34789999999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-47 Score=427.30 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=211.8
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHHcCCCceeeEecccccC
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 746 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~----~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~ 746 (960)
+..++|+++++||+| +||+||+|++ +|+.||||++.+.... ........+|+.+++.++|||||+++++|.+.
T Consensus 1 lslddy~i~~~lG~G-~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 1 LTMNDFSVHRIIGRG-GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CCSTTEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCHHhCeeeeEEecC-CCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 356899999999999 7999999987 6899999998654322 11122333456777777899999999999999
Q ss_pred CceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 747 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
+.+|||||||+||+|.+++.+.. .+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred CEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999999997644 6889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHh-hccccccCCCCCCcH
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRLEIPKELDP 904 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I-~~~~~~~~iP~~lS~ 904 (960)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+........ ........+|..+++
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence 6543 2345689999999999974 56899999999999999999999999876543332211 113445667889999
Q ss_pred HHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPS-----FAQLTVA 930 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPS-----a~eILe~ 930 (960)
++++||.+||.+||.+||+ +++|+++
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 9999999999999999999 6888875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=414.18 Aligned_cols=264 Identities=29% Similarity=0.448 Sum_probs=230.3
Q ss_pred cccCcCCCCeEEEEEeeccCCeeEEEEEEE-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEe
Q 002146 669 CECEIPWEDLVLGERIGLGSSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 740 (960)
Q Consensus 669 ~~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~-------~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~ 740 (960)
.+|+++.++|+++++||.| +||.||+|++ +++.||||+++... .......+.+|+.+++++ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G-~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAG-AFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEEC-SSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeec-CCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 3678888999999999999 7999999986 34579999987653 344566789999999999 799999999
Q ss_pred cccccCCceEEEEeecCCCCHHHHhhCCC-----------------CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEecc
Q 002146 741 GAVTRPPNLSIITEFLPRGSLFRILHRPH-----------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 803 (960)
Q Consensus 741 g~f~~~~~l~LVmEY~~gGsL~dlL~k~~-----------------~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDL 803 (960)
+++.+...++||||||++|+|.+++.+.. ..+++..+..|+.||+.||+|||+++ ||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDL 171 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDL 171 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccc
Confidence 99999999999999999999999986432 25889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002146 804 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 880 (960)
Q Consensus 804 KPeNILLd~~g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLT-G~~PF~~~ 880 (960)
||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765332 22344678999999999999999999999999999999998 67777777
Q ss_pred ChhHHHHHhhccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 881 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 881 ~~~ei~~~I~~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
+....+..+.....++..|..++.++++||.+||+.||.+||++.+|++.|+++..
T Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 76666666555667778888999999999999999999999999999999988654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=412.56 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=210.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+++|++++.||+| +||+||+|++ +|+.||||++......+.....+.+|+++|++++|||||+++++|.+...+|+|
T Consensus 1 ~d~Y~~~~~lG~G-~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEG-TYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEEC-SSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecC-cCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3689999999999 7999999987 589999999976554444456889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
|||+.++.+..+.......+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9999765454444555567999999999999999999999999 99999999999999999999999999988765555
Q ss_pred cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc----------------cc
Q 002146 833 SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------RR 895 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~----------------~~ 895 (960)
......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+.... ..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 556678999999999987766 4789999999999999999999999887666554432100 00
Q ss_pred cCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 LEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ~~i-----------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+ ...+++++++||.+||..||.+|||+.||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 001 12467899999999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=411.70 Aligned_cols=247 Identities=24% Similarity=0.248 Sum_probs=204.6
Q ss_pred EEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEEe
Q 002146 680 LGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 680 i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~---~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVmE 754 (960)
.+++||+| +||+||+|++ +|+.||||++....... .....+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 2 ~l~~lG~G-~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEG-QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEE-TTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccC-cCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 46889999 7999999986 68899999987543322 123468899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 834 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~~ 834 (960)
|+.++.+..++. ....+++..+..|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 998877766654 3457999999999999999999999999 9999999999999999999999999998776655555
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc------------------
Q 002146 835 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------ 895 (960)
Q Consensus 835 ~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~------------------ 895 (960)
...+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+....+......
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 667899999999998754 5799999999999999999999999998877666554311000
Q ss_pred ---cC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ---LE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ---~~-----iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. +...+++++++||.+||..||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 113567899999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=411.70 Aligned_cols=261 Identities=31% Similarity=0.535 Sum_probs=229.7
Q ss_pred ccCcCCCCeEEEEEeeccCCeeEEEEEEEC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecc
Q 002146 670 ECEIPWEDLVLGERIGLGSSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 742 (960)
Q Consensus 670 ~~ei~~~dy~i~k~LG~GGsFG~Vy~ak~~-------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~ 742 (960)
+|+|+.++|+++++||+| +||+||+|.+. ++.||||+++... .......+.+|+.+|++++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G-~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQG-SFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEEC-SSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeC-CCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 578899999999999999 79999999763 4689999987543 44556678999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHHHHhhCC---------CCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC
Q 002146 743 VTRPPNLSIITEFLPRGSLFRILHRP---------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 813 (960)
Q Consensus 743 f~~~~~l~LVmEY~~gGsL~dlL~k~---------~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~ 813 (960)
+.....+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||||+.+
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 169 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC
Confidence 99999999999999999999988632 124688899999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHhh
Q 002146 814 WNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVG 890 (960)
Q Consensus 814 g~VKL~DFGLAr~~~~~~--~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG-~~PF~~~~~~ei~~~I~ 890 (960)
+++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...+.
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998764332 223345689999999999999999999999999999999998 58999999988888775
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 002146 891 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 935 (960)
Q Consensus 891 ~~~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~ 935 (960)
...++..|..+++.+++||.+||+.+|.+||++.+|++.|++..
T Consensus 250 -~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 44567788899999999999999999999999999999998763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=406.57 Aligned_cols=251 Identities=28% Similarity=0.380 Sum_probs=210.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc---CCCceeeEecccc-----
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT----- 744 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~---~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L---~HPNIVkL~g~f~----- 744 (960)
++|+++++||+| +||+||+|++ .++.||||++......+.....+.+|+.+|+.| +|||||+++++|.
T Consensus 7 ~~Y~i~~~LG~G-~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEG-AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEE-TTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecc-cCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 689999999999 7999999986 256799999876544333333456777777766 7999999999885
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
....++++|||+.++.+..........+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhh
Confidence 345689999999988777776666668999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-----------
Q 002146 825 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 893 (960)
Q Consensus 825 r~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~----------- 893 (960)
+..... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+....
T Consensus 164 ~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 164 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 875443 33456789999999999999999999999999999999999999999988776655542110
Q ss_pred --------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 894 --------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 894 --------------~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
....++..+++.+++||.+||.+||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0112345678999999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-47 Score=403.97 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=210.0
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 753 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LVm 753 (960)
.++|+++++||+| +||+||+|++ +|+.||||++......+.....+.+|+.+|++++|||||+++++|...+..+++|
T Consensus 1 ~~~Y~~~~~iG~G-~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEG-TYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEE-TTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecC-CCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 3689999999999 7999999987 6889999999766544444568899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002146 754 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 833 (960)
Q Consensus 754 EY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~~ 833 (960)
||+.++.+..+... ...+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||++.........
T Consensus 80 e~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 99987766666554 457999999999999999999999999 999999999999999999999999999887655455
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc------------------
Q 002146 834 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------ 894 (960)
Q Consensus 834 ~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~------------------ 894 (960)
.....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 5566799999999999765 469999999999999999999999998877665544321000
Q ss_pred ---------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 ---------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 ---------~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
...++..+++++++||++||..||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 012245678999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=415.49 Aligned_cols=245 Identities=26% Similarity=0.402 Sum_probs=203.9
Q ss_pred CCCeEEE-EEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEeccccc----C
Q 002146 675 WEDLVLG-ERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----P 746 (960)
Q Consensus 675 ~~dy~i~-k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f~~----~ 746 (960)
.++|.+. +.||+| +||+||+|++ +++.||||++... ..+.+|+.++.++ +|||||+++++|++ .
T Consensus 10 ~~~y~i~~~~lG~G-~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLG-INGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEEC-SSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeec-cCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 4678886 569999 7999999986 6889999998643 2567899987665 89999999999865 4
Q ss_pred CceEEEEeecCCCCHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecC
Q 002146 747 PNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFG 822 (960)
Q Consensus 747 ~~l~LVmEY~~gGsL~dlL~k~~-~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFG 822 (960)
..+|||||||+||+|+++|.+.+ ..+++.+++.|+.||+.||+|||++| |+||||||+|||++. .+.+||+|||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence 66999999999999999998653 46999999999999999999999999 999999999999985 5679999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--cccccCCC-
Q 002146 823 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIP- 899 (960)
Q Consensus 823 LAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~--~~~~~~iP- 899 (960)
+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.......+.. ......+|
T Consensus 160 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 160 FAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 99876543 334567899999999999999999999999999999999999999988765444333221 12233333
Q ss_pred ---CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 900 ---KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 900 ---~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
..+++++++||.+||.+||.+||++.|++++
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2578999999999999999999999999885
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=403.85 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=217.1
Q ss_pred EEEEEeeccCCeeEEEEEEEC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc-CCceEEE
Q 002146 679 VLGERIGLGSSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSII 752 (960)
Q Consensus 679 ~i~k~LG~GGsFG~Vy~ak~~-----g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~-~~~l~LV 752 (960)
...++||+| +||+||+|.+. ...||||++... .......+|.+|+++|++++|||||++++++.+ +..+++|
T Consensus 30 ~~~~~iG~G-~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRG-HFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEE-TTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeec-CCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 347899999 79999999862 235899998643 345567789999999999999999999998764 5689999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
||||++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999999987778889999999999999999999999 99999999999999999999999999987643321
Q ss_pred ----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHhhccccccCCCCCCcHHHH
Q 002146 833 ----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVA 907 (960)
Q Consensus 833 ----~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~-~~~ei~~~I~~~~~~~~iP~~lS~eLk 907 (960)
......||+.|+|||.+.+..++.++||||||+++|||++|..||... +..++...+. .+.++..|..+++++.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLY 264 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHH
Confidence 222356899999999999999999999999999999999977776553 4444444443 4457778889999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHhHHhhCC
Q 002146 908 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 940 (960)
Q Consensus 908 dLI~kcL~kDP~kRPSa~eILe~Le~i~~~~~p 940 (960)
+||.+||..||++||++.||+++|+.+.+.+..
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 999999999999999999999999999876544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=404.60 Aligned_cols=241 Identities=22% Similarity=0.377 Sum_probs=205.8
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChH----HHHHHHHHHHHHHHcC--CCceeeEecccccCC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGA----ALLEFKREVKIMRRLR--HPNVVLFMGAVTRPP 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~----~~~~~~~Ei~ILk~L~--HPNIVkL~g~f~~~~ 747 (960)
++|+++++||+| +||+||+|++ +|+.||||++........ ...++.+|+.+|++++ |||||+++++|.+++
T Consensus 4 ~~Y~i~~~lG~G-~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSG-GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CeEEEeEEEeeC-CCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 469999999999 7999999987 689999999876543221 1234678999999996 899999999999999
Q ss_pred ceEEEEeecCC-CCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-CCcEEEEecCccc
Q 002146 748 NLSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSR 825 (960)
Q Consensus 748 ~l~LVmEY~~g-GsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-~g~VKL~DFGLAr 825 (960)
.+|+||||+.+ +++.+++.+.. .+++.+++.++.||+.||+|||++| ||||||||+||||+. ++.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 67888876543 6999999999999999999999999 999999999999985 5799999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccCCCCCCcH
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 904 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g~~y-s~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~iP~~lS~ 904 (960)
..... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+ ++ ......++..+++
T Consensus 160 ~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i------~~~~~~~~~~~s~ 229 (273)
T d1xwsa_ 160 LLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EI------IRGQVFFRQRVSS 229 (273)
T ss_dssp ECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH------HHCCCCCSSCCCH
T ss_pred ecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HH------hhcccCCCCCCCH
Confidence 75443 2345789999999999988775 678999999999999999999997632 22 1224567788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 905 LVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 905 eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
++++||.+||.+||.+|||++|++++
T Consensus 230 ~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 230 ECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=396.22 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=207.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC-----
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----- 747 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~----- 747 (960)
.++|+++++||+| +||+||+|.+ +|+.||||++......+.....+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G-~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSG-AYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC-------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecC-CCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3679999999999 7999999986 5899999999876666667778999999999999999999999987655
Q ss_pred -ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccc
Q 002146 748 -NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 826 (960)
Q Consensus 748 -~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~ 826 (960)
.+|+||||+ +.+|..+++.. .+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceec
Confidence 579999999 67888887653 5999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-------------
Q 002146 827 KHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------- 892 (960)
Q Consensus 827 ~~~~~~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~------------- 892 (960)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 171 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 171 ADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 6543 3456899999999999875 4689999999999999999999999987765543332110
Q ss_pred ----------------ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHh
Q 002146 893 ----------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 934 (960)
Q Consensus 893 ----------------~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--Le~i 934 (960)
.....+...+++++++||.+||..||.+|||+.|++++ |+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00112335678999999999999999999999999986 4443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=383.48 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=214.4
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCCceEEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 752 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~~l~LV 752 (960)
+++|+++++||+| +||+||+|++ +++.||||+++..........++.+|+.+|+.++|||||+++++|.+...+++|
T Consensus 1 ~~ry~~i~~LG~G-~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEG-TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEEC-SSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecC-cCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 3689999999999 7999999987 688999999987766666678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 832 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~~~~ 832 (960)
+||+.+++|..++... ..+++..++.++.|++.||+|||++| ||||||||+||||+.++.+||+|||+++.......
T Consensus 80 ~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999999998887654 47889999999999999999999999 99999999999999999999999999998765544
Q ss_pred cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHhhcc------------------
Q 002146 833 SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQ------------------ 892 (960)
Q Consensus 833 ~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~-~~~~ei~~~I~~~------------------ 892 (960)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||.. .+..+....+...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 455566889999999988765 69999999999999999999998654 3444333332110
Q ss_pred ---------ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 893 ---------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 893 ---------~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
......+..+++.+++||.+||+.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112334678899999999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=390.60 Aligned_cols=252 Identities=22% Similarity=0.275 Sum_probs=203.3
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc-------
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------- 745 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~------- 745 (960)
.++|+++++||+| +||+||+|++ +|+.||||++......+.....+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G-~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQG-TFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEEC-SSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecC-cCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4789999999999 7999999987 68999999987665555556678899999999999999999998754
Q ss_pred -CCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 746 -PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 746 -~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
...+|+||||+.++.+..+ ......+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeeccee
Confidence 4568999999977665544 444557899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc----ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccccC--
Q 002146 825 RLKHNTF----LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE-- 897 (960)
Q Consensus 825 r~~~~~~----~~~~t~~GT~~Y~APEvl~g~-~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~~~-- 897 (960)
+...... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 7654221 223446799999999999865 689999999999999999999999998877666554422111000
Q ss_pred C-------------------C---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 898 I-------------------P---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 898 i-------------------P---------~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. + ...++++++||.+||..||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0 0135678999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=392.27 Aligned_cols=256 Identities=33% Similarity=0.521 Sum_probs=202.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC----ceEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSI 751 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~----~l~L 751 (960)
++|.+.++||+| .||.||+|+++|+.||||++.... ......+.|+..+.+++|||||++++++.+.. .+|+
T Consensus 3 ~~~~l~~~iG~G-~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKG-RFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECC-SSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeC-CCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 468999999999 699999999999999999986432 11122334555566789999999999987654 5899
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhC------CCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~------g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
|||||++|+|.+++++. .+++..++.++.|++.||+|||.. ..+||||||||+||||+.++.+||+|||+++
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999999864 588999999999999999999974 1249999999999999999999999999998
Q ss_pred cccCCc----ccCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCC--------------
Q 002146 826 LKHNTF----LSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMN-------------- 881 (960)
Q Consensus 826 ~~~~~~----~~~~t~~GT~~Y~APEvl~g~~------ys~ksDIWSLGvLLyELLTG~~PF~~~~-------------- 881 (960)
...... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 764332 1234567999999999987653 5678999999999999999988774321
Q ss_pred -hhHHHHHhhccccccCCCCCC-----cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHh
Q 002146 882 -PMQVVGAVGFQNRRLEIPKEL-----DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 937 (960)
Q Consensus 882 -~~ei~~~I~~~~~~~~iP~~l-----S~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~ 937 (960)
...+...+.....++.+|..+ ...+.+|+.+||..||.+||++.||++.|+++...
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 122223333333445555432 34689999999999999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-44 Score=391.66 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=201.8
Q ss_pred CeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc------CCc
Q 002146 677 DLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPN 748 (960)
Q Consensus 677 dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~------~~~ 748 (960)
+|+.+++||+| +||+||+|++ +|+.||||++...... +.+|+.+|++++|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G-~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNG-SFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEE-TTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeC-cCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999 7999999987 6899999998765322 2479999999999999999998843 345
Q ss_pred eEEEEeecCCCCHHHHhh--CCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCC-cEEEEecCccc
Q 002146 749 LSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSR 825 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~--k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g-~VKL~DFGLAr 825 (960)
+|||||||+++.+..+.. .....+++.+++.|+.||+.||+|||++| ||||||||+||||+.++ .+||+|||+++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchh
Confidence 889999997664443332 23447999999999999999999999999 99999999999999765 89999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc-----------
Q 002146 826 LKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 893 (960)
Q Consensus 826 ~~~~~~~~~~t~~GT~~Y~APEvl~g-~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~----------- 893 (960)
..... ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||...+..+....+....
T Consensus 172 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 172 QLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp ECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 76543 23445789999999999876 468999999999999999999999999887665544432100
Q ss_pred ----ccc------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 002146 894 ----RRL------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 935 (960)
Q Consensus 894 ----~~~------------~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~--Le~i~ 935 (960)
... .....+++++++||.+||..||.+|||+.|++++ |+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 1123578999999999999999999999999975 55553
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=390.50 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=201.8
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccCC----ce
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NL 749 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~~----~l 749 (960)
++|+++++||+| +||+||+|.. +|+.||||++.... .......+.+|+.+|++++|||||++++++.... ..
T Consensus 8 ~rY~~~~~LG~G-~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEG-AYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC----CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeec-cCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 469999999999 7999999976 69999999987544 3445667899999999999999999999986543 23
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccccC
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~~ 829 (960)
+++++|+.+|+|++++... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 4555667799999999764 5899999999999999999999999 99999999999999999999999999987543
Q ss_pred Cc---ccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-----------
Q 002146 830 TF---LSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------- 894 (960)
Q Consensus 830 ~~---~~~~t~~GT~~Y~APEvl~-g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~----------- 894 (960)
.. ......+||+.|+|||++. +..++.++||||+||++|+|++|..||.+.+..+..........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 22 1234567999999999984 45678999999999999999999999988765444333211000
Q ss_pred -------------cc-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 -------------RL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 -------------~~-----~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
.. .....+++++++||.+||..||.+||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 1123578899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-43 Score=379.30 Aligned_cols=253 Identities=20% Similarity=0.252 Sum_probs=205.0
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCc-eeeEecccccCCceEEE
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSII 752 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPN-IVkL~g~f~~~~~l~LV 752 (960)
++|++++.||+| +||+||+|++ +|+.||||++...... .++.+|+++++.++|+| |+.+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G-~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSG-SFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEEC-SSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeC-CCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 469999999999 7999999986 5889999988764322 24678999999997665 55666677888889999
Q ss_pred EeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC---CCcEEEEecCccccccC
Q 002146 753 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHN 829 (960)
Q Consensus 753 mEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~---~g~VKL~DFGLAr~~~~ 829 (960)
|||+ +++|.+++......+++..+..++.|++.||+|||++| ||||||||+|||++. +..+||+|||+|+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999 56777777665668999999999999999999999999 999999999999864 55799999999987643
Q ss_pred Cc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc------ccccc
Q 002146 830 TF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------QNRRL 896 (960)
Q Consensus 830 ~~-------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~------~~~~~ 896 (960)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.. .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 21 123456799999999999999999999999999999999999999988655433322211 01112
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHH
Q 002146 897 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 936 (960)
Q Consensus 897 ~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~ 936 (960)
.++..+++++.+||.+||..+|.+||++.+|.+.|+.+..
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 2346789999999999999999999999999999988744
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=395.83 Aligned_cols=258 Identities=23% Similarity=0.367 Sum_probs=214.7
Q ss_pred cCCCCeEEEEEeeccCCeeEEEEEEE-----CCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHHcCC-CceeeEecccc
Q 002146 673 IPWEDLVLGERIGLGSSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRH-PNVVLFMGAVT 744 (960)
Q Consensus 673 i~~~dy~i~k~LG~GGsFG~Vy~ak~-----~g~~VAVK~i~~~~~~--~~~~~~~~~Ei~ILk~L~H-PNIVkL~g~f~ 744 (960)
+..++|++++.||+| +||+||+|+. +|+.||||++...... ......+.+|+++|++++| |||+++++++.
T Consensus 21 ~~l~~y~~~~~IG~G-~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 21 VGIENFELLKVLGTG-AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCGGGEEEEEEEEET-TTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cchhceEEEEEEecC-CCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 345889999999999 7999999975 4789999998654321 1223467899999999966 89999999999
Q ss_pred cCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcc
Q 002146 745 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 824 (960)
Q Consensus 745 ~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLA 824 (960)
+...++++|||+.+|+|.+++...+ .+.+..++.++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||++
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred cCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999999997654 5778889999999999999999999 999999999999999999999999999
Q ss_pred ccccCC-cccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--cccccCCC
Q 002146 825 RLKHNT-FLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIP 899 (960)
Q Consensus 825 r~~~~~-~~~~~t~~GT~~Y~APEvl~g~~--ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~--~~~~~~iP 899 (960)
+..... ........|++.|++||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+.. ....+.+|
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence 875432 22344567999999999997654 68899999999999999999999988765544333322 23356678
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH--HHHh
Q 002146 900 KELDPLVARIIWECWQTDPSLRP-----SFAQLTVA--LKPL 934 (960)
Q Consensus 900 ~~lS~eLkdLI~kcL~kDP~kRP-----Sa~eILe~--Le~i 934 (960)
..+++++++||.+||.+||.+|| +++|++++ ++.+
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 88999999999999999999999 58898874 4443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.7e-43 Score=376.72 Aligned_cols=256 Identities=18% Similarity=0.242 Sum_probs=214.6
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC-CceeeEecccccCCceEE
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSI 751 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H-PNIVkL~g~f~~~~~l~L 751 (960)
.++|+++++||+| +||+||+|++ +|+.||||++...... ..+.+|+++++.|.| +||+.+++++.+....++
T Consensus 4 g~~Y~i~~~iG~G-~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEG-SFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEEC-SSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecC-CCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999 6999999986 6889999988654322 246788999999965 899999999999999999
Q ss_pred EEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcC-----CCcEEEEecCcccc
Q 002146 752 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRL 826 (960)
Q Consensus 752 VmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~-----~g~VKL~DFGLAr~ 826 (960)
||||+ +++|.+++...+..+++.....++.|++.||+|||++| ||||||||+||||+. .+.+||+|||+|+.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99999 78999999877778999999999999999999999999 999999999999974 57899999999987
Q ss_pred ccCCc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHhhccc---
Q 002146 827 KHNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQN--- 893 (960)
Q Consensus 827 ~~~~~-------~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~---ei~~~I~~~~--- 893 (960)
..... ......+||+.|||||++.+..++.++|||||||++|||++|..||.+.... .....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 54321 2234567999999999999999999999999999999999999999875433 2222222111
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHHhh
Q 002146 894 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 938 (960)
Q Consensus 894 ~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~Le~i~~~~ 938 (960)
....++..+++++.+|+..||..+|.+||+++.|.+.|+++.+..
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 112234678899999999999999999999999999999886543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=387.01 Aligned_cols=247 Identities=25% Similarity=0.324 Sum_probs=205.7
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEecccccC-----Cc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 748 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~~-----~~ 748 (960)
++|+++++||+| +||+||+|++ +|+.||||++............+.+|+.+|++++|||||+++++|... ..
T Consensus 18 ~rY~i~~~LG~G-~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSG-AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGG-TTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecC-CCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 679999999999 7999999986 699999999987766666677889999999999999999999998643 34
Q ss_pred eEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCcccccc
Q 002146 749 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 828 (960)
Q Consensus 749 l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~~ 828 (960)
.+++|+|+.+|+|.+++... .+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccC
Confidence 46677788899999999653 5999999999999999999999999 9999999999999999999999999997654
Q ss_pred CCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhccccc------------
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 895 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~~------------ 895 (960)
.. .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 173 ~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp GG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred cc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 33 34567999999999977765 689999999999999999999999988766555443211100
Q ss_pred ---------cCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 896 ---------LEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 896 ---------~~i--------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
... ...+++++++||.+||..||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 001 13578999999999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6e-43 Score=380.29 Aligned_cols=243 Identities=20% Similarity=0.299 Sum_probs=199.1
Q ss_pred CCCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEeccccc--CCce
Q 002146 675 WEDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNL 749 (960)
Q Consensus 675 ~~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~--~~~l 749 (960)
.++|+++++||+| +||+||+|++ +|+.||||++.... ..++.+|+.+|+.++ ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G-~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRG-KYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecC-cCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 3679999999999 7999999986 68999999986432 346789999999995 9999999999874 4569
Q ss_pred EEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCC-CcEEEEecCcccccc
Q 002146 750 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKH 828 (960)
Q Consensus 750 ~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~-g~VKL~DFGLAr~~~ 828 (960)
++|||||.+++|..+.. .+++..++.++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+++...
T Consensus 108 ~~v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eEEEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceecc
Confidence 99999999999987653 5899999999999999999999999 9999999999999865 469999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHhhc---------------
Q 002146 829 NTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGF--------------- 891 (960)
Q Consensus 829 ~~~~~~~t~~GT~~Y~APEvl~g~~-ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e-i~~~I~~--------------- 891 (960)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....+..
T Consensus 182 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 182 PG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 43 2345567999999999988765 7999999999999999999999997654321 1111000
Q ss_pred -c-------------------ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 892 -Q-------------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 892 -~-------------------~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
. .........+++++++||++||..||.+|||++|+|++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00001123468899999999999999999999999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=387.38 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=197.1
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCceeeEeccccc------CC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PP 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNIVkL~g~f~~------~~ 747 (960)
++|+++++||+| +||+||+|.+ +|+.||||++...........++.+|+.+|++++|||||+++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G-~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSG-AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC---CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecC-cCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 679999999999 7999999987 58999999998777677777789999999999999999999999854 46
Q ss_pred ceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEecCccccc
Q 002146 748 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 827 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr~~ 827 (960)
.+|+|||||.++ +.+.+.. .+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+|++|||+++..
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhcc
Confidence 789999999765 4455533 5899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccc-------------
Q 002146 828 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 894 (960)
Q Consensus 828 ~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~ei~~~I~~~~~------------- 894 (960)
... ......+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 170 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 170 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred ccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 543 334456799999999999999999999999999999999999999988776544433211000
Q ss_pred -------ccC--------------C------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 002146 895 -------RLE--------------I------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 930 (960)
Q Consensus 895 -------~~~--------------i------P~~lS~eLkdLI~kcL~kDP~kRPSa~eILe~ 930 (960)
... . +...++++++||.+||..||++|||++|+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0 01246789999999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-38 Score=343.20 Aligned_cols=246 Identities=19% Similarity=0.299 Sum_probs=188.3
Q ss_pred CCeEEEEEeeccCCeeEEEEEEE--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-----------CCceeeEecc
Q 002146 676 EDLVLGERIGLGSSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLFMGA 742 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-----------HPNIVkL~g~ 742 (960)
.+|+++++||.| +||+||+|+. +|+.||||+++.. ......+.+|+.+|+.++ |+|||+++++
T Consensus 13 ~rY~i~~~LG~G-~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWG-HFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeC-CCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 359999999999 7999999986 6899999998754 233456788999998875 5789999988
Q ss_pred ccc--CCceEEEEeecCCCCHHH--HhhCCCCCCcHHHHHHHHHHHHHHHHHHhh-CCCCEEEeccCCCcEEEcCCC---
Q 002146 743 VTR--PPNLSIITEFLPRGSLFR--ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW--- 814 (960)
Q Consensus 743 f~~--~~~l~LVmEY~~gGsL~d--lL~k~~~~lse~~~~~Ia~QIa~AL~YLHs-~g~~IIHRDLKPeNILLd~~g--- 814 (960)
+.. ....+++|+++..+.... ........+++..++.++.||+.||+|||+ .| |+||||||+||||+.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCccc
Confidence 754 345667777765544332 233444578999999999999999999997 77 99999999999998655
Q ss_pred ---cEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH------H
Q 002146 815 ---NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ------V 885 (960)
Q Consensus 815 ---~VKL~DFGLAr~~~~~~~~~~t~~GT~~Y~APEvl~g~~ys~ksDIWSLGvLLyELLTG~~PF~~~~~~e------i 885 (960)
.+||+|||.+...... ....+||+.|+|||++.+..|+.++|||||||++++|++|..||....... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 3999999999865432 345789999999999999999999999999999999999999997543210 0
Q ss_pred HHH-hhcc---------------------------------------ccccCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 002146 886 VGA-VGFQ---------------------------------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFA 925 (960)
Q Consensus 886 ~~~-I~~~---------------------------------------~~~~~iP~~lS~eLkdLI~kcL~kDP~kRPSa~ 925 (960)
... +... .....++...++++++||.+||..||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 000 0000 001112234567899999999999999999999
Q ss_pred HHHHH
Q 002146 926 QLTVA 930 (960)
Q Consensus 926 eILe~ 930 (960)
|+|++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.9e-22 Score=202.20 Aligned_cols=166 Identities=18% Similarity=0.140 Sum_probs=120.8
Q ss_pred eEEEEEeeccCCeeEEEEEEE-CCcEEEEEEeecCCCC----------------hHHHHHHHHHHHHHHHcCCCceeeEe
Q 002146 678 LVLGERIGLGSSYGEVYHADW-NGTEVAVKKFLDQDFS----------------GAALLEFKREVKIMRRLRHPNVVLFM 740 (960)
Q Consensus 678 y~i~k~LG~GGsFG~Vy~ak~-~g~~VAVK~i~~~~~~----------------~~~~~~~~~Ei~ILk~L~HPNIVkL~ 740 (960)
+.++++||+| .||+||+|.. +|+.||||+++..... ......+.+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G-~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEG-KESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEEC-SSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeC-cceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 3589999999 6999999975 7899999987532110 01123456789999999999999888
Q ss_pred cccccCCceEEEEeecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCCCEEEeccCCCcEEEcCCCcEEEEe
Q 002146 741 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 820 (960)
Q Consensus 741 g~f~~~~~l~LVmEY~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~~IIHRDLKPeNILLd~~g~VKL~D 820 (960)
++.. .+++|||+++..+.+ +.+.....++.||+.+|.|||++| |+||||||+||||+++ .++|+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECC
T ss_pred EecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEE
Confidence 6532 379999998865543 334445678899999999999999 9999999999999965 489999
Q ss_pred cCccccccCCcccCCCCCCCCCccCcc-----cccCCCCCchhhHHHHHHHH
Q 002146 821 FGLSRLKHNTFLSSKSTAGTPEWMAPE-----VLRNEPSNEKCDVYSFGVIL 867 (960)
Q Consensus 821 FGLAr~~~~~~~~~~t~~GT~~Y~APE-----vl~g~~ys~ksDIWSLGvLL 867 (960)
||+|+....... ..|.... .+..+.|..++|+||+.--+
T Consensus 146 FG~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999976543211 1122110 01235678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=2.5e-07 Score=93.97 Aligned_cols=141 Identities=16% Similarity=0.061 Sum_probs=97.4
Q ss_pred CCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcC-CCceeeEecccccCCceEEEEe
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITE 754 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~-HPNIVkL~g~f~~~~~l~LVmE 754 (960)
+.|++.+..+ |++...||+...++..++||+....... ....+.+|..+|+.|. +=-+.+++.++..++..++||+
T Consensus 14 ~~~~~~~~~~-G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTE-GMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECSC-CCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hceEEEEcCC-CCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 4566666554 4367899999888888999987543221 1224678888888873 3235677777788888999999
Q ss_pred ecCCCCHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHhhCCC--------------------------------------
Q 002146 755 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP-------------------------------------- 796 (960)
Q Consensus 755 Y~~gGsL~dlL~k~~~~lse~~~~~Ia~QIa~AL~YLHs~g~-------------------------------------- 796 (960)
+++|..+....... .....++.++...|..||+...
T Consensus 91 ~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 91 EADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred eccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 99998886654221 1122344555566666664210
Q ss_pred -------------------CEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 797 -------------------TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 797 -------------------~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 28999999999999987666799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=9.6e-06 Score=81.59 Aligned_cols=75 Identities=17% Similarity=0.167 Sum_probs=51.7
Q ss_pred EeeccCCeeEEEEEEEC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC--CceeeEecccccCCceEEEEeecCCC
Q 002146 683 RIGLGSSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNLSIITEFLPRG 759 (960)
Q Consensus 683 ~LG~GGsFG~Vy~ak~~-g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H--PNIVkL~g~f~~~~~l~LVmEY~~gG 759 (960)
.+..|.+-..||+...+ +..+++|....... ..+..|...|+.|.. -.+.+++.+..+++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 45556345789998874 55678887544322 235678888887732 23567788888888999999999886
Q ss_pred CHH
Q 002146 760 SLF 762 (960)
Q Consensus 760 sL~ 762 (960)
.+.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.36 E-value=0.00021 Score=77.75 Aligned_cols=77 Identities=16% Similarity=0.086 Sum_probs=47.9
Q ss_pred EEEeeccCCeeEEEEEEE--CCcEEEEEEeecC-CC----ChHHHHHHHHHHHHHHHc-CC--CceeeEecccccCCceE
Q 002146 681 GERIGLGSSYGEVYHADW--NGTEVAVKKFLDQ-DF----SGAALLEFKREVKIMRRL-RH--PNVVLFMGAVTRPPNLS 750 (960)
Q Consensus 681 ~k~LG~GGsFG~Vy~ak~--~g~~VAVK~i~~~-~~----~~~~~~~~~~Ei~ILk~L-~H--PNIVkL~g~f~~~~~l~ 750 (960)
.+.||.| ....||++.. .++.|+||.-... .. ......+...|.+.|+.+ .+ ..+++++.+ ++...+
T Consensus 31 ~~eig~G-~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 31 CQEIGDG-NLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEECCSS-SSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEeCCC-ceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 4558988 7899999964 4678999964321 00 011223456788888777 33 346666654 345667
Q ss_pred EEEeecCCCC
Q 002146 751 IITEFLPRGS 760 (960)
Q Consensus 751 LVmEY~~gGs 760 (960)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.69 E-value=0.0016 Score=70.25 Aligned_cols=78 Identities=18% Similarity=0.296 Sum_probs=51.0
Q ss_pred CCCCeEEEEEeeccCCeeEEEEEEEC---------CcEEEEEEeecCCCChHHHHHHHHHHHHHHHc-CCCceeeEeccc
Q 002146 674 PWEDLVLGERIGLGSSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 743 (960)
Q Consensus 674 ~~~dy~i~k~LG~GGsFG~Vy~ak~~---------g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L-~HPNIVkL~g~f 743 (960)
+.+++++ +.|+.| .--.+|++... ...|.+++.-... . .....+|..+++.+ .+.-..++++++
T Consensus 41 ~~~~l~v-~~l~GG-ltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGG-MSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp CGGGEEE-EEECCC-TTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred CccceEE-EEcCCc-cccceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 3345555 457667 67899999753 3457777654221 1 22456899999988 454456788877
Q ss_pred ccCCceEEEEeecCCCCH
Q 002146 744 TRPPNLSIITEFLPRGSL 761 (960)
Q Consensus 744 ~~~~~l~LVmEY~~gGsL 761 (960)
.. .+|+||++|..|
T Consensus 115 ~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 115 SG----GRLEEYIPSRPL 128 (395)
T ss_dssp TT----EEEECCCCEEEC
T ss_pred CC----ceEEEEeccccC
Confidence 53 689999987544
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.58 E-value=0.00086 Score=70.43 Aligned_cols=51 Identities=20% Similarity=0.206 Sum_probs=45.9
Q ss_pred ecccccchhhHHHHHHHhhhcCCceEEeecccccCCCCCeeEEEEecC-cceeeeec
Q 002146 261 SINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVDL 316 (960)
Q Consensus 261 ~l~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~y~~~~~~a~~~v~~~~-~~~y~vDl 316 (960)
.-+.|.|.|+|.+|-.+|-.+|||||+|.| |. +|+|+.|...+ ++|.-||-
T Consensus 137 ~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~--~~---~H~W~Ev~~~~~~rWv~vDp 188 (287)
T d2f4ma1 137 ETRCGRCGEWANCFTLCCRALGFEARYVWD--YT---DHVWTEVYSPSQQRWLHCDA 188 (287)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEE--TT---TEEEEEEEETTTTEEEEEET
T ss_pred HhcCccHHHHHHHHHHHHHHcCCCeEEEec--CC---cceeEEEEecCCCcEEEecC
Confidence 457999999999999999999999999999 43 89999999986 46999996
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.50 E-value=0.0066 Score=62.60 Aligned_cols=145 Identities=12% Similarity=0.039 Sum_probs=77.9
Q ss_pred CCeEEEEEeeccCCeeEEEEEEECCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCC-----CceeeEec---ccccCC
Q 002146 676 EDLVLGERIGLGSSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-----PNVVLFMG---AVTRPP 747 (960)
Q Consensus 676 ~dy~i~k~LG~GGsFG~Vy~ak~~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~H-----PNIVkL~g---~f~~~~ 747 (960)
..+.-.+.|..| .--+.|+.+.++..|++|++.... . ...+..|+.+|..|.. |..+...+ +.....
T Consensus 18 g~~~~~~~i~~G-~~N~ny~v~t~~g~yVLri~~~~~-~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~ 92 (316)
T d2ppqa1 18 GSLTSYKGIAEG-VENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 92 (316)
T ss_dssp CCEEEEEEECC----EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred CCceEeecCCCC-cccCeEEEEECCCcEEEEEcCCCC-C---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeec
Confidence 345555667777 668899999888889999876432 1 1245566777777632 22222110 112234
Q ss_pred ceEEEEeecCCCCHHH-----------H---hh---CC-----------------------CCCCcHHHHHHHHHHHHHH
Q 002146 748 NLSIITEFLPRGSLFR-----------I---LH---RP-----------------------HCQVDEKRRIKMALDVARG 787 (960)
Q Consensus 748 ~l~LVmEY~~gGsL~d-----------l---L~---k~-----------------------~~~lse~~~~~Ia~QIa~A 787 (960)
....++.++.+..... . ++ .. ............+..+...
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (316)
T d2ppqa1 93 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 172 (316)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred ccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHh
Confidence 4556666665543210 0 00 00 0001111122223333333
Q ss_pred HHHHhhC--CCCEEEeccCCCcEEEcCCCcEEEEecCccc
Q 002146 788 MNCLHTS--TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 825 (960)
Q Consensus 788 L~YLHs~--g~~IIHRDLKPeNILLd~~g~VKL~DFGLAr 825 (960)
+.-.+.. ..++||+|+.+.||+++.+...-|+||+.+.
T Consensus 173 ~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 173 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 3333321 1259999999999999988777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.47 E-value=0.0034 Score=65.84 Aligned_cols=69 Identities=10% Similarity=0.046 Sum_probs=44.5
Q ss_pred CeeEEEEEEE-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHHcCCCce--eeEec-----ccccCCceEEEEeecCCCC
Q 002146 689 SYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV--VLFMG-----AVTRPPNLSIITEFLPRGS 760 (960)
Q Consensus 689 sFG~Vy~ak~-~g~~VAVK~i~~~~~~~~~~~~~~~Ei~ILk~L~HPNI--VkL~g-----~f~~~~~l~LVmEY~~gGs 760 (960)
.--.||+++. +|+.|++|+.+...... .++..|+..+..|....| +..+. .+......+.+++++.|..
T Consensus 34 ~EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 34 YENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ccceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 4568999986 78889999876543333 356778888888732221 11111 2344566888999987643
|
| >d2q3za4 d.3.1.4 (A:146-461) Transglutaminase catalytic domain {Human (Homo sapiens), tissue isozyme [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Transglutaminase catalytic domain species: Human (Homo sapiens), tissue isozyme [TaxId: 9606]
Probab=94.67 E-value=0.0055 Score=64.15 Aligned_cols=51 Identities=18% Similarity=0.234 Sum_probs=43.3
Q ss_pred HHHhHHHHHHHHHHHhCCceeEeeecccccchhhHHHHHHHhhhcCCceEEeec
Q 002146 237 MLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKG 290 (960)
Q Consensus 237 ~~~~~~~~~~~l~~~~~s~v~pig~l~~g~~~~~a~lfk~l~d~~~~~~~lv~G 290 (960)
.-..|.-....|++-+.+...| ++.|-|.|+|-.+-+++-.+|||||+|.|
T Consensus 105 ~P~~W~GSv~IL~q~~~~~~~p---VkyGqCwvFA~v~~tvlR~lGIPaRvVT~ 155 (316)
T d2q3za4 105 SPMSWIGSVDILRRWKNHGCQR---VKYGQCWVFAAVACTVLRCLGIPTRVVTN 155 (316)
T ss_dssp CTTTCCBSHHHHHHHHHTTTCC---EEEECHHHHHHHHHHHHHHHTCCEEEEEE
T ss_pred CCCCCCCcHHHHHHHHHcCCcc---cccchhHHHHHHHHHHHHhcCCCceEecc
Confidence 3345666777777777777666 79999999999999999999999999999
|